Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABHD5 "CGI-58, NCIE2" ENSG00000011198 "Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase" Q8WTS1 3 43690108-43734371 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Cataract, Deafness, Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 67.8;neutrophil: 42.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 67.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020685, HPA035851, HPA035852" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Cytosol" Nucleoplasm "CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073" "unprognostic (2.58e-1)" "unprognostic (2.73e-1)" "prognostic favorable (8.89e-4)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (6.13e-2)" "unprognostic (2.40e-2)" "unprognostic (5.33e-2)" "unprognostic (3.50e-3)" "unprognostic (2.56e-2)" "unprognostic (4.13e-3)" "prognostic favorable (9.17e-5)" "unprognostic (2.48e-1)" "unprognostic (8.87e-2)" "unprognostic (4.18e-2)" "unprognostic (4.18e-2)" 38.8 12.5 6.7 8.5 8.6 39.6 27.9 10.5 8.9 9.8 6.0 12.3 9.9 5.7 4.1 31.1 5.1 11.6 13.4 6.8 7.4 12.0 21.7 16.4 3.4 9.2 8.2 4.6 16.0 12.2 5.6 10.2 9.1 7.1 7.5 6.3 27.4 8.4 15.0 38.0 10.5 9.3 9.3 9.4 12.1 10.8 8.4 6.8 15.5 18.5 7.9 16.7 16.9 11.9 18.9 6.8 8.2 9.7 32.0 12.8 17.1 77.4 27.1 18.8 14.9 9.4 6.4 16.2 10.9 23.2 15.8 5.8 16.5 18.5 22.6 58.4 13.2 36.6 24.4 7.5 15.7 9.2 13.2 13.0 64.6 31.3 28.5 18.8 33.3 10.8 23.9 14.2 46.9 11.0 7.6 6.9 22.8 16.7 20.4 3.1 24.1 8.6 27.9 40.4 10.6 13.6 36.9 20.5 9.8 9.8 18.9 8.9 19.3 18.1 13.6 35.0 34.5 11.1 34.0 7.7 20.3 17.3 16.0 67.8 14.7 9.5 2.3 7.9 1.7 3.5 1.7 2.7 6.8 4.0 1.6 2.5 42.5 2.0 5.7 1.9 4.8 5.3 6.7 8.6 10.5 8.9 6.8 7.4 9.2 8.2 9.1 9.3 8.4 11.9 117.5 25.6 51.8 12.7 44.8 39.9 27.5 25.9 88.8 11.9 149.9 116.2 10.3 14.3 49.6 27.6 27.1 16.7 80.3 65.0 33.2 57.5 19.5 47.5 49.0 34.6 36.2 69.0 24.1 61.5 24.9 53.7 67.8 114.0 16.5 8.8 18.2 12.7 18.0 3.3 24.1 23.7 34.6 44.1 17.4 17.1 5.3 79.8 7.2 11.2 35.9 11.0 12.3 18.1 28.8 75.2 49.8 5.7 41.8 25.5 98.5 39.8 19.1 17.4 0.0 32.0 46.4 47.3 41.9 111.7 40.9 205.4 42.6 15.2 21.9 71.6 ABRAXAS1 "ABRA1, ABRAXAS, CCDC98, FAM175A, FLJ13614" ENSG00000163322 "Abraxas 1, BRCA1 A complex subunit" Q6UWZ7 4 83459517-83523348 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 43.0;Endometrial stromal cells: 20.7;Proximal tubular cells: 30.1;Respiratory ciliated cells: 21.9;Theca cells: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037654 Uncertain Supported "Nuclear bodies" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" "Nuclear bodies" "HPA037654: AB_2675588" "unprognostic (1.44e-1)" "unprognostic (2.46e-2)" "unprognostic (2.42e-2)" "unprognostic (1.81e-1)" "unprognostic (8.57e-3)" "unprognostic (6.99e-2)" "unprognostic (4.98e-4)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (2.73e-1)" "unprognostic (2.35e-1)" "unprognostic (6.98e-2)" "prognostic favorable (1.53e-4)" "unprognostic (2.24e-3)" "unprognostic (9.34e-3)" "unprognostic (5.58e-2)" "unprognostic (6.57e-2)" 4.4 3.9 2.9 3.9 2.0 7.9 3.8 7.7 3.0 5.1 12.0 3.3 3.7 6.4 2.1 5.2 4.8 5.7 3.7 2.4 1.4 4.1 2.2 3.8 8.0 2.2 2.2 14.8 3.4 2.2 1.1 2.9 2.4 2.7 2.8 3.6 3.5 2.2 6.4 5.7 3.1 2.9 0.5 4.1 3.6 10.8 2.6 4.8 7.4 2.0 3.8 3.8 3.5 5.1 5.6 3.4 6.8 8.2 6.1 25.2 3.6 4.1 5.1 1.9 2.9 7.6 9.0 22.1 3.3 4.3 4.2 2.9 3.7 2.9 3.5 8.8 2.4 12.9 4.6 9.1 4.9 15.3 11.1 10.9 2.5 2.7 2.4 10.2 8.7 12.9 36.7 13.2 4.7 3.7 17.2 5.6 11.5 6.3 5.0 9.3 7.6 5.5 4.2 4.6 6.3 5.1 5.3 2.2 9.6 5.5 6.3 6.3 11.5 7.4 7.6 7.4 6.0 11.5 8.4 16.1 6.7 12.8 5.3 4.0 2.5 2.1 2.0 2.3 2.6 2.1 3.5 2.4 1.9 3.3 5.4 4.2 3.2 5.0 2.3 1.5 3.2 1.9 2.9 2.0 7.7 3.0 2.4 1.4 2.2 2.2 2.4 0.5 2.6 5.1 14.3 16.0 12.4 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.4 13.0 0.0 0.0 8.6 12.9 0.0 5.2 8.8 0.0 43.0 9.2 0.0 11.9 20.7 5.7 0.0 0.0 0.0 6.5 6.9 9.1 0.0 5.9 6.3 12.3 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 7.4 0.0 0.0 1.7 0.0 0.0 30.1 21.9 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 2.9 6.2 26.8 0.0 0.0 ABRAXAS2 "ABRO1, Em:AC068896.4, FAM175B, KIAA0157" ENSG00000165660 "Abraxas 2, BRISC complex subunit" Q15018 10 124801819-124836667 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Collecting duct cells: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037591, HPA037592, HPA074089" Approved Supported Cytosol Yes No "Cluster 41: Basophils - Cellular respiration" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA037591: AB_10671877, HPA037592: AB_2675566, HPA074089: AB_2686659" "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (6.81e-2)" "unprognostic (3.72e-2)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.09e-2)" "unprognostic (1.58e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" 9.1 10.5 8.0 10.3 8.3 12.3 12.2 8.0 9.9 8.8 6.6 9.9 10.2 9.4 9.3 9.8 9.0 8.2 10.0 8.4 8.6 12.3 13.7 9.3 12.5 7.8 8.4 10.4 8.3 12.7 3.9 10.3 8.5 9.5 10.3 5.3 8.5 8.8 19.0 11.6 10.8 10.5 7.7 10.0 9.5 6.7 8.2 12.9 12.7 16.2 13.3 9.7 6.8 7.9 22.2 14.9 15.7 21.6 19.9 19.6 13.5 22.4 35.1 26.2 24.1 12.1 20.9 24.7 18.6 24.4 14.2 24.4 25.0 21.0 27.5 21.6 17.2 18.8 11.8 15.0 25.4 32.6 18.9 21.6 25.1 25.8 46.4 28.3 20.1 21.7 20.0 16.6 21.6 14.5 25.1 29.1 13.5 20.0 13.8 20.0 16.6 15.1 19.5 11.1 10.8 19.8 17.9 17.0 24.4 15.8 14.0 22.2 17.4 14.0 11.2 16.5 27.1 17.2 17.1 23.6 18.3 15.9 10.1 22.8 10.5 9.8 7.6 14.5 10.5 10.5 8.8 10.6 12.9 11.6 9.3 10.3 4.1 7.7 11.8 8.7 11.4 7.0 8.0 8.3 8.0 9.9 8.4 8.6 7.8 8.4 8.5 7.7 8.2 7.9 15.1 25.6 14.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 9.4 10.3 0.0 0.0 6.2 23.9 0.0 16.9 7.0 0.0 17.6 13.7 0.0 11.1 15.6 6.3 0.0 0.0 0.0 12.5 13.0 5.5 0.0 12.3 12.6 12.4 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 20.7 0.0 0.0 0.0 0.0 10.2 0.0 0.0 1.6 0.0 0.0 18.6 12.4 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 16.0 4.3 13.5 0.0 0.0 AC013394.1 ENSG00000279765 "Novel protein" 15 92883413-92949230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "bone marrow: 383.8" "Cell type enhanced" "Detected in many" "Breast glandular cells: 18.5;Breast myoepithelial cells: 17.1;dendritic cells: 13.0;Endometrial ciliated cells: 25.9;Endometrial stromal cells: 20.7;Glandular and luminal cells: 35.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" "unprognostic (7.26e-3)" "unprognostic (1.34e-1)" "unprognostic (1.53e-3)" "unprognostic (1.42e-1)" "unprognostic (2.84e-2)" "unprognostic (8.97e-2)" "unprognostic (4.62e-2)" "unprognostic (9.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.69e-2)" "unprognostic (4.12e-2)" "unprognostic (2.33e-2)" "unprognostic (1.46e-6)" "unprognostic (2.74e-1)" "unprognostic (3.13e-1)" "unprognostic (2.94e-2)" "unprognostic (3.12e-2)" 34.6 43.5 56.0 36.4 63.4 383.8 82.9 62.5 79.9 49.6 56.2 47.9 35.7 50.9 47.6 40.9 45.2 47.5 37.1 53.0 57.0 56.5 44.8 68.4 65.3 62.7 58.6 60.3 40.4 41.1 0.5 55.4 61.1 56.4 53.0 68.1 50.9 44.9 27.7 47.9 38.9 39.2 60.2 58.4 40.5 36.2 57.0 68.3 93.9 36.4 58.0 42.3 0.2 75.2 31.1 23.9 88.6 57.1 27.0 35.0 64.8 30.1 53.6 47.0 35.1 24.5 70.6 32.8 29.3 39.0 35.6 47.2 37.7 30.8 46.9 0.2 37.0 57.7 48.6 23.6 56.0 30.9 36.8 37.5 44.6 17.4 88.5 68.2 45.0 43.0 60.4 92.5 52.5 33.2 36.3 47.6 77.4 68.2 20.1 50.8 44.5 71.0 66.5 59.3 46.9 53.4 64.4 46.0 115.0 82.6 106.4 69.5 31.5 35.0 27.0 27.4 66.7 67.1 86.0 70.9 27.2 58.5 41.2 10.0 0.9 2.9 2.2 0.7 2.4 4.7 2.5 2.6 0.9 2.8 3.2 2.6 5.7 2.7 1.4 3.0 3.1 0.6 56.0 63.4 62.5 79.9 53.0 57.0 62.7 58.6 61.1 60.2 57.0 75.2 6.9 6.4 11.2 0.0 3.9 0.0 0.0 0.0 0.0 0.0 18.5 17.1 0.0 0.0 3.7 1.8 0.0 2.1 13.0 0.0 3.9 1.2 0.0 25.9 20.7 3.5 0.0 0.0 0.0 1.4 2.3 3.8 0.0 35.4 3.8 12.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 2.0 3.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 3.0 8.0 8.4 0.0 0.0 AC068533.4 ENSG00000249319 "Novel protein" 7 66087761-66152277 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 10.6" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (7.24e-2)" "unprognostic (6.28e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.57e-1)" "unprognostic (2.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.74e-1)" "unprognostic (2.32e-1)" "unprognostic (2.50e-3)" "unprognostic (9.62e-2)" "unprognostic (2.23e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-1)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" 0.5 0.4 1.0 0.9 1.2 1.8 1.7 1.1 3.4 2.0 0.8 2.8 2.0 1.0 0.9 0.9 1.1 0.8 0.4 1.1 1.5 1.6 4.7 1.2 0.5 1.3 1.3 0.9 0.5 1.8 0.5 0.5 1.3 1.4 1.8 2.7 0.6 1.4 0.4 0.5 1.0 1.2 1.0 0.7 1.6 0.4 1.2 0.9 1.1 1.3 1.0 0.6 0.4 1.1 1.6 0.0 1.6 1.2 3.9 6.0 0.5 2.1 2.7 0.6 1.0 1.0 2.4 2.1 2.4 6.7 4.1 2.2 0.3 1.4 3.0 0.4 1.8 0.7 0.9 0.0 2.2 1.0 2.3 3.4 3.1 3.7 6.0 5.6 1.1 0.5 1.7 0.9 0.3 0.9 1.5 1.2 0.0 7.9 1.9 0.8 1.1 2.2 2.7 1.1 2.2 2.9 1.6 10.6 0.5 4.0 3.4 0.6 3.8 0.8 0.6 1.9 1.7 1.4 2.0 0.6 7.4 3.0 0.3 2.0 0.8 0.4 1.0 0.5 1.2 1.9 0.4 1.0 0.3 1.0 1.1 1.4 1.6 1.7 1.3 0.4 0.9 0.3 1.0 1.2 1.1 3.4 1.1 1.5 1.3 1.3 1.3 1.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC069544.1 ENSG00000284024 "Zinc finger and SCAN domain containing 29" 10 14838302-14846999 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.8;Breast myoepithelial cells: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.2;Granulosa cells: 2.3;Proximal tubular cells: 1.3;Theca cells: 4.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" 4.3 4.1 2.8 6.2 2.7 8.9 6.8 6.8 4.5 5.5 1.7 5.9 5.4 5.9 3.4 6.7 3.7 6.1 3.6 3.8 3.3 3.0 3.8 3.1 8.4 2.5 2.2 7.3 5.9 5.3 3.6 7.9 2.5 5.3 6.3 10.1 3.8 4.3 2.4 7.6 5.2 4.4 2.2 5.8 6.5 6.8 2.8 9.7 5.3 4.3 7.2 6.3 2.9 3.8 13.9 9.7 15.3 14.9 9.1 7.8 15.1 12.6 5.6 15.7 20.3 16.5 10.0 21.5 6.1 7.9 8.4 14.5 24.1 12.5 20.2 11.9 14.3 22.0 20.1 10.8 11.1 8.9 13.3 5.8 10.2 25.0 11.1 7.4 9.9 13.2 25.1 16.8 18.7 12.8 18.2 8.0 13.5 8.0 6.1 15.8 13.2 14.3 8.8 6.4 12.1 14.6 11.8 13.9 12.6 9.7 9.9 10.2 8.1 16.0 16.9 18.2 12.8 9.9 12.9 19.9 8.3 13.5 7.5 2.9 1.6 1.9 1.8 2.0 2.0 2.1 1.7 1.7 1.6 2.2 2.0 2.5 1.6 3.5 2.9 2.2 1.8 1.7 2.8 2.7 6.8 4.5 3.8 3.3 2.5 2.2 2.5 2.2 2.8 3.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 1.2 1.8 0.3 0.0 0.0 0.0 0.5 0.0 0.3 0.0 1.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 AC090517.4 ENSG00000285253 "Zinc finger protein 280D" 15 56652488-56918571 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 1.5;Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.5;Distal tubular cells: 3.9;Endometrial stromal cells: 2.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 6.9" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" 1.6 1.2 1.5 1.2 2.9 1.0 1.5 1.6 2.0 1.9 0.0 1.2 1.1 2.1 1.0 1.1 1.6 1.4 1.7 1.3 2.5 1.6 1.2 1.3 1.1 2.1 2.2 2.4 3.7 1.5 1.5 2.2 1.4 1.3 1.8 4.3 1.4 2.0 0.9 1.3 1.9 1.4 1.4 1.4 2.5 2.2 2.6 2.3 2.3 0.8 1.1 4.6 1.5 4.0 1.3 1.1 2.6 1.7 1.1 1.1 1.4 1.3 0.9 0.9 1.8 0.3 2.1 1.5 1.2 1.3 0.5 1.3 1.0 2.4 0.0 2.2 1.6 0.1 1.0 0.4 2.3 1.7 0.7 1.2 1.3 1.0 2.5 0.4 3.3 6.1 1.7 0.4 1.2 0.3 1.1 1.2 0.5 3.3 0.3 0.5 1.8 0.3 1.9 3.3 2.0 1.2 2.0 2.5 2.7 3.5 1.8 0.4 3.1 1.7 0.4 2.7 6.9 0.2 1.8 2.9 2.5 0.0 1.5 0.7 1.2 1.6 1.8 0.8 1.2 1.1 1.2 0.9 0.5 1.1 0.1 1.2 0.7 0.3 0.7 0.8 1.5 2.9 1.6 2.0 1.3 2.5 2.1 2.2 2.2 1.4 2.2 4.6 1.5 3.2 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.9 0.6 0.0 0.8 2.2 0.4 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 AC092587.1 ENSG00000273155 "Novel LIPT1-MRPL30 readthrough" 2 99154998-99195298 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Cytotrophoblasts: 1.6;Distal tubular cells: 3.9;Exocrine glandular cells: 2.2;Extravillous trophoblasts: 2.0;Hofbauer cells: 1.5;Proximal tubular cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "unprognostic (5.56e-3)" "unprognostic (2.80e-1)" "unprognostic (5.47e-2)" "unprognostic (2.46e-1)" "unprognostic (1.32e-1)" "unprognostic (5.70e-2)" "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (2.41e-2)" "unprognostic (3.36e-1)" "unprognostic (2.82e-1)" "unprognostic (2.19e-1)" "unprognostic (5.36e-2)" "unprognostic (3.81e-2)" "unprognostic (9.17e-2)" "unprognostic (2.80e-1)" "unprognostic (3.25e-1)" 0.6 0.6 0.0 1.1 0.1 0.6 0.5 0.4 0.6 0.6 0.0 0.5 0.1 0.6 0.1 0.5 0.3 0.5 1.3 0.1 0.1 0.5 0.5 0.4 0.3 0.0 0.1 0.5 0.3 0.3 0.3 0.3 0.0 0.4 0.4 0.2 0.4 0.3 1.2 0.3 0.7 0.3 0.0 0.3 0.4 0.3 0.0 0.0 0.4 0.4 0.5 0.5 0.5 0.2 0.7 1.0 0.7 1.3 0.2 2.1 0.3 0.0 0.4 0.4 0.6 1.0 0.6 0.4 1.1 0.2 0.3 0.9 0.5 0.6 1.1 0.6 0.0 0.0 0.5 1.7 0.0 1.7 0.0 0.3 0.8 0.9 0.2 0.1 0.4 0.4 1.4 0.1 0.2 0.3 1.0 1.4 0.9 0.2 1.3 0.8 0.3 0.8 0.6 0.6 0.2 0.8 0.3 0.7 0.4 1.2 0.9 1.3 0.9 0.6 0.9 0.0 0.3 0.1 0.3 0.5 0.5 1.0 0.2 0.4 1.3 0.8 1.0 0.9 0.7 0.8 1.0 0.9 1.3 0.8 1.0 1.2 0.5 1.0 1.2 0.9 1.3 0.5 0.0 0.1 0.4 0.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 1.8 0.0 1.6 0.1 0.0 3.9 0.9 0.0 0.1 0.3 0.4 0.0 0.0 0.0 2.2 2.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 AC092835.1 ENSG00000233757 "Novel C2H2 type zinc finger protein" 2 95207535-95259774 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Adipocytes: 1.1;Endometrial stromal cells: 1.9;Granulosa cells: 2.2;Theca cells: 1.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (7.89e-2)" "unprognostic (3.55e-1)" "unprognostic (9.21e-2)" "unprognostic (9.21e-3)" "unprognostic (1.74e-2)" "unprognostic (2.44e-1)" "unprognostic (9.49e-2)" "unprognostic (1.04e-1)" "unprognostic (4.50e-2)" "unprognostic (1.73e-1)" "unprognostic (7.72e-2)" "unprognostic (6.65e-3)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (2.96e-1)" "unprognostic (7.92e-2)" "unprognostic (4.47e-2)" 0.7 0.4 0.8 0.6 1.0 0.2 0.7 1.1 1.7 0.9 0.0 0.6 0.4 1.2 0.2 0.5 0.7 0.6 0.7 0.7 0.2 0.7 0.1 0.6 0.5 0.4 0.4 0.9 1.0 1.4 0.3 0.8 0.7 0.5 0.4 1.6 0.8 0.9 0.5 0.2 0.3 0.8 0.0 1.0 0.5 2.1 0.8 1.7 1.5 0.3 0.7 0.5 0.4 3.2 2.0 0.6 3.7 4.1 1.0 2.0 2.3 0.8 0.8 1.9 2.0 0.5 0.5 1.6 0.4 0.8 1.5 1.6 3.1 1.1 2.6 0.0 0.4 0.3 1.6 0.0 0.5 0.0 2.8 0.6 1.1 1.5 3.5 1.5 1.0 4.3 0.0 0.0 1.4 0.0 5.2 0.4 4.5 0.5 0.0 4.6 0.4 0.0 0.6 0.8 5.3 2.4 0.5 1.1 0.0 3.8 1.0 0.8 1.1 0.7 2.5 0.6 0.0 0.0 0.6 0.1 0.0 0.0 2.1 0.0 0.1 0.2 0.7 0.0 0.0 0.5 0.1 0.2 0.2 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.8 1.0 1.1 1.7 0.7 0.2 0.4 0.4 0.7 0.0 0.8 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.6 0.0 0.0 0.1 0.7 0.0 0.0 0.6 0.0 0.5 1.9 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 AC093323.1 ENSG00000170846 "Novel protein, similar to Morf4 family associated protein 1" B2RBV5 4 6663396-6676755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 12.7;Cytotrophoblasts: 18.9;Distal tubular cells: 13.7;Glandular and luminal cells: 13.7;Granulosa cells: 12.2;Theca cells: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (9.08e-2)" "unprognostic (1.73e-3)" "unprognostic (2.10e-2)" "unprognostic (1.48e-1)" "unprognostic (1.81e-1)" "unprognostic (3.00e-2)" "unprognostic (2.33e-3)" "unprognostic (2.07e-1)" "unprognostic (4.59e-2)" "unprognostic (1.59e-2)" "unprognostic (8.95e-3)" "unprognostic (2.77e-2)" "unprognostic (1.17e-2)" "unprognostic (3.20e-1)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-3)" 1.7 3.0 3.4 2.5 3.6 3.6 3.8 2.4 3.7 1.8 2.5 3.2 1.5 3.5 3.6 2.2 2.3 2.2 2.3 3.5 4.5 2.8 2.9 2.7 4.1 2.3 2.8 3.9 2.1 3.2 2.5 2.7 3.6 4.1 2.0 3.2 2.5 4.3 6.9 2.3 2.5 2.6 4.2 4.2 2.6 4.9 3.2 2.0 4.3 4.4 2.1 2.8 4.0 5.0 7.4 7.6 3.5 4.5 7.0 6.0 2.6 4.7 3.8 5.8 5.7 3.8 3.1 2.9 4.8 5.1 5.8 4.2 8.0 1.6 8.2 16.5 7.6 4.4 1.2 17.6 10.0 2.0 3.8 4.6 4.2 6.6 3.1 7.3 12.3 1.3 4.0 7.9 12.0 16.1 7.7 6.0 7.6 5.6 4.9 1.9 1.6 2.8 16.6 5.8 5.1 3.2 2.6 2.6 16.1 5.4 4.2 3.5 0.0 2.6 8.3 2.5 5.8 1.3 1.0 19.3 5.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.4 3.6 2.4 3.7 3.5 4.5 2.3 2.8 2.7 2.6 4.9 2.8 4.3 6.4 12.7 0.0 2.0 0.0 0.0 0.0 0.0 0.0 10.6 9.8 0.0 0.0 4.3 5.5 0.0 18.9 7.2 0.0 13.7 2.1 0.0 9.8 11.0 2.2 0.0 0.0 0.0 3.2 7.0 3.4 0.0 13.7 1.3 12.2 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 5.3 3.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 5.6 5.2 19.5 0.0 0.0 AC116366.1 ENSG00000283782 "Novel protein" 5 132410832-132646079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 9.0;Breast glandular cells: 6.0;Endometrial ciliated cells: 11.7;Endometrial stromal cells: 10.9;Glandular and luminal cells: 22.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052291 Approved Approved Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA052291: AB_2681786" 4.0 3.4 2.5 3.6 2.4 2.0 4.1 3.3 2.9 4.3 2.7 3.7 4.9 3.1 3.3 2.0 3.8 3.5 3.6 2.5 3.3 4.2 4.7 4.4 4.7 3.1 3.0 6.2 1.1 4.3 2.6 3.1 3.8 4.0 2.2 2.8 4.3 3.8 1.8 4.0 3.0 3.2 4.7 3.9 1.9 2.9 6.2 3.2 5.8 5.0 2.8 3.0 3.7 0.2 0.9 2.2 8.0 7.0 5.3 4.0 3.1 6.0 5.7 0.2 7.9 3.7 2.3 3.9 10.2 2.4 2.5 0.9 3.1 7.3 1.2 4.4 0.9 0.5 12.6 2.3 3.1 4.9 1.3 4.1 4.5 6.7 4.7 4.0 0.5 8.6 6.7 0.1 8.6 3.0 1.6 2.2 1.3 7.9 3.2 11.4 1.4 0.3 1.9 1.4 2.0 1.6 3.2 2.6 0.2 3.7 4.4 2.9 1.9 2.0 2.0 12.5 6.7 3.0 3.6 9.0 1.5 2.7 1.1 4.4 4.7 1.9 2.7 3.0 2.6 3.5 0.6 2.9 2.9 3.4 2.7 3.4 1.9 2.0 3.3 2.2 2.5 2.4 3.3 2.9 2.5 3.3 3.1 3.0 3.1 3.2 2.9 3.0 9.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 6.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.7 0.0 11.7 10.9 3.1 0.0 0.0 0.0 0.5 0.0 2.5 0.0 22.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 3.0 1.1 0.0 0.0 AC136475.9 ENSG00000288681 "Novel protein" 11 308408-315272 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 4.1" "Cell type enhanced" "Detected in single" "dendritic cells: 1.1" "Group enriched" "Detected in some" 6 "cerebral cortex: 4.1;hippocampal formation: 1.7" "Immune cell enhanced" "Detected in all" "neutrophil: 473.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 473.0" "Cell line enhanced" "Detected in some" "Hep G2: 3.1;MCF7: 1.2;NB-4: 1.0;U-698: 2.7" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 4.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 2.7 0.0 0.0 0.0 151.8 6.4 206.0 16.5 41.9 20.0 12.0 24.2 8.8 6.0 13.3 10.6 29.8 473.0 87.7 53.0 2.8 6.4 170.9 0.1 0.0 0.3 4.1 1.7 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 AC141272.1 ENSG00000277836 Unmapped 1270984-1271271 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "intestine: 95.2;lymphoid tissue: 128.6;salivary gland: 55.2;stomach 1: 68.3;urinary bladder: 40.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 132 "memory B-cell: 17.6;naive B-cell: 8.6" "Lineage enriched" "Detected in single" 176 "B-cells: 17.6" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.0" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" 2.9 1.1 0.0 41.1 0.0 15.6 10.5 0.0 0.1 16.9 0.0 95.2 90.8 0.5 0.0 11.6 0.2 4.5 0.0 0.0 0.2 0.6 2.8 3.9 26.0 0.2 0.0 0.6 0.4 0.0 0.0 0.0 1.2 31.2 0.0 55.2 1.0 0.0 3.2 52.2 2.3 0.0 29.6 68.3 0.3 0.0 31.4 0.0 0.0 128.6 40.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233723.1 ENSG00000262165 "Novel protein" 17 4801159-4807013 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 15.8;choroid plexus: 7.8" "Cell type enhanced" "Detected in some" "Breast glandular cells: 5.5;Breast myoepithelial cells: 7.4;Cytotrophoblasts: 3.5;Endometrial ciliated cells: 3.4;Hofbauer cells: 3.7;monocytes: 7.8;Proximal tubular cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;SCLC-21H: 10.2" "Region enhanced" "Detected in single" "basal ganglia: 2.9" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 7: Non-specific - Mitochondria" "unprognostic (3.93e-2)" "unprognostic (3.90e-2)" "unprognostic (1.87e-2)" "unprognostic (1.84e-3)" "unprognostic (3.70e-1)" "unprognostic (1.64e-2)" "unprognostic (1.73e-1)" "unprognostic (1.23e-2)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (5.14e-3)" "unprognostic (9.42e-2)" "unprognostic (3.09e-2)" "unprognostic (1.16e-1)" "unprognostic (4.18e-2)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" 0.7 0.7 9.2 0.0 10.5 0.0 0.7 9.4 15.8 1.3 7.8 0.5 0.0 0.5 0.4 0.8 1.0 0.0 0.8 8.8 9.3 0.7 0.8 0.5 0.1 10.9 9.4 2.5 2.0 0.9 1.1 0.1 9.4 0.8 0.0 1.4 0.5 0.5 1.0 1.5 0.2 0.5 9.5 0.4 0.4 0.5 9.4 0.0 0.4 0.2 0.4 0.5 0.9 9.8 0.3 0.6 0.0 3.3 0.5 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.8 0.0 0.0 0.5 1.0 0.9 0.4 0.3 0.7 0.5 0.0 0.9 0.3 0.5 0.0 0.6 0.5 1.0 0.9 0.0 0.1 0.0 1.1 0.0 10.2 0.6 0.0 0.0 0.2 0.9 0.0 0.0 1.4 0.1 0.3 0.2 0.0 0.1 0.0 0.3 0.3 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.3 0.3 0.2 0.0 0.1 0.3 0.3 0.5 0.2 0.0 0.3 0.0 0.0 0.1 9.2 10.5 9.4 15.8 8.8 9.3 10.9 9.4 9.4 9.5 9.4 9.8 1.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 7.4 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 1.9 0.7 0.0 3.4 2.0 0.4 0.0 0.0 0.0 0.2 1.4 0.6 0.0 1.9 0.0 2.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 7.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.1 1.2 0.0 0.0 AFG1L "AFG1, LACE1" ENSG00000135537 "AFG1 like ATPase" Q8WV93 6 108294991-108526796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 6.4;Distal tubular cells: 9.8;Hofbauer cells: 5.7;Proximal tubular cells: 6.3;Respiratory ciliated cells: 5.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030154, HPA030155, HPA030659" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 43: THP-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415" "unprognostic (9.76e-5)" "unprognostic (1.72e-1)" "unprognostic (1.68e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-1)" "unprognostic (7.04e-2)" "unprognostic (2.57e-1)" "unprognostic (5.53e-2)" "unprognostic (2.35e-3)" "unprognostic (1.48e-1)" "unprognostic (2.73e-2)" "unprognostic (9.61e-2)" "unprognostic (8.40e-8)" "unprognostic (2.03e-2)" "unprognostic (2.03e-1)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 1.8 2.1 2.2 1.3 2.7 2.1 2.2 2.0 3.3 1.7 2.7 2.6 4.2 1.5 1.9 1.6 2.2 1.5 4.6 1.7 1.9 5.0 3.7 1.7 1.8 1.8 2.0 1.7 2.1 5.4 1.5 2.2 2.0 1.6 3.1 3.1 1.8 1.7 3.7 1.2 3.0 1.7 1.7 2.0 2.8 10.7 2.7 2.3 3.0 4.0 2.1 1.7 1.1 3.2 2.7 1.4 3.4 6.1 3.5 5.1 3.3 3.0 4.4 4.8 4.7 5.7 3.3 4.8 3.8 4.7 5.8 1.5 4.4 4.5 5.4 2.8 2.6 5.7 1.8 6.6 3.5 5.3 2.7 4.7 3.6 3.6 5.8 3.1 2.6 3.5 5.9 2.2 4.5 2.6 0.9 4.8 2.2 4.6 2.8 3.3 4.6 2.8 6.1 2.9 3.7 3.2 2.4 3.5 6.4 4.5 2.8 9.8 3.2 2.9 0.7 2.6 3.4 1.5 2.6 3.7 3.6 6.0 4.5 0.0 1.6 2.8 1.0 1.2 1.3 2.5 1.5 1.9 1.4 3.4 2.1 1.4 0.4 2.4 4.3 1.6 2.3 0.7 2.2 2.7 2.0 3.3 1.7 1.9 1.8 2.0 2.0 1.7 2.7 3.2 2.4 0.0 4.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 2.2 0.0 0.0 5.0 3.7 0.0 6.4 1.1 0.0 9.8 3.1 0.0 2.6 2.6 2.2 0.0 0.0 0.0 3.8 4.6 1.2 0.0 1.8 2.5 5.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 6.3 5.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.2 0.9 4.5 0.0 0.0 AIF1L "C9orf58, FLJ12783, IBA2" ENSG00000126878 "Allograft inflammatory factor 1 like" Q9BQI0 9 131096476-131123152 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 284.4;kidney: 313.2;lymphoid tissue: 206.8" "Group enriched" "Detected in many" 4 "Adipocytes: 122.9;Collecting duct cells: 356.8;Distal tubular cells: 289.5;Extravillous trophoblasts: 383.2;Proximal tubular cells: 201.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 140.3;MCF7: 96.7;NTERA-2: 106.7;RPTEC TERT1: 299.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020522, HPA056852" Enhanced NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 7: Non-specific - Mitochondria" "HPA020522: AB_2670463, HPA056852: AB_2683256" "unprognostic (2.59e-2)" "unprognostic (1.83e-3)" "unprognostic (2.55e-2)" "unprognostic (2.81e-2)" "unprognostic (1.78e-2)" "unprognostic (2.01e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.77e-1)" "unprognostic (4.39e-1)" "unprognostic (2.81e-2)" "unprognostic (2.68e-1)" "prognostic favorable (5.54e-6)" "unprognostic (2.48e-2)" "unprognostic (2.37e-1)" "unprognostic (1.38e-2)" "unprognostic (6.20e-2)" 44.7 4.8 165.6 4.7 199.6 2.3 39.9 179.6 284.4 20.2 101.5 7.2 1.3 13.5 9.3 105.8 10.8 8.3 41.8 145.4 160.9 313.2 1.6 12.2 1.9 209.2 204.2 5.1 6.5 80.6 18.2 23.8 196.2 6.6 5.7 6.9 32.1 36.6 14.6 15.9 7.9 10.0 172.9 206.8 9.0 6.5 188.0 3.9 91.9 21.9 5.8 9.2 35.3 225.1 0.5 2.2 140.3 24.1 0.0 0.0 59.5 0.0 0.3 0.1 0.3 26.8 11.3 0.0 63.5 0.0 3.0 13.5 21.2 1.5 0.8 0.3 30.0 15.7 7.4 51.4 0.3 0.1 7.6 1.2 6.6 0.5 0.7 0.4 6.7 39.3 10.6 0.1 0.0 96.7 9.3 1.9 106.7 9.0 10.1 0.2 1.9 39.6 299.9 8.5 54.3 8.7 7.4 60.0 20.4 82.7 57.6 0.9 0.9 3.8 10.2 0.5 30.8 0.4 0.5 0.4 6.1 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 165.6 199.6 179.6 284.4 145.4 160.9 209.2 204.2 196.2 172.9 188.0 225.1 122.9 0.0 0.0 5.9 2.8 4.1 2.1 1.5 1.2 0.1 45.0 29.5 6.6 0.0 3.5 356.8 0.0 4.5 1.3 0.8 289.5 1.5 1.0 4.1 3.5 35.0 3.6 0.0 0.3 0.8 383.2 15.5 0.5 15.0 0.0 10.1 33.5 0.0 7.0 0.0 0.3 2.1 2.0 0.3 2.0 3.5 37.6 2.3 67.6 21.5 0.0 15.1 0.0 8.0 36.3 2.9 0.3 59.0 0.0 7.7 0.0 201.5 0.6 0.2 0.0 3.3 10.3 0.2 5.3 4.4 2.4 21.1 1.7 29.9 1.3 2.0 AL139353.1 ENSG00000203546 "Novel protein" 14 31334312-31457441 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.1;skeletal muscle: 1.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Breast glandular cells: 3.2;Breast myoepithelial cells: 5.8;Cytotrophoblasts: 4.6;Distal tubular cells: 3.9;Proximal tubular cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "NK-cell: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (2.86e-4)" "unprognostic (3.48e-1)" "unprognostic (3.52e-1)" "unprognostic (2.21e-1)" "unprognostic (2.52e-1)" "unprognostic (4.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.18e-2)" "unprognostic (3.91e-2)" "unprognostic (3.13e-2)" "unprognostic (5.79e-3)" "unprognostic (1.47e-2)" "unprognostic (2.63e-3)" "unprognostic (8.26e-3)" "unprognostic (3.56e-2)" "unprognostic (4.57e-2)" "unprognostic (5.10e-2)" 1.1 0.1 0.2 0.0 0.3 0.0 0.2 0.3 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.3 0.3 0.3 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.1 0.7 0.2 0.1 0.0 1.3 0.0 0.6 0.5 0.0 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.2 3.2 2.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 3.2 5.8 0.0 0.0 0.6 1.8 0.0 4.6 0.4 0.0 3.9 1.5 0.0 2.5 1.6 0.6 0.0 0.0 0.0 1.3 1.6 1.1 0.0 0.7 0.0 1.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 6.5 2.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.5 0.3 1.1 0.0 0.0 AL157392.5 ENSG00000282246 "Novel protein" 10 13610047-13655929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 2.8;Collecting duct cells: 3.7;granulocytes: 2.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA047950 Uncertain NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "HPA047950: AB_2680221" 3.4 1.6 3.9 3.6 3.7 5.1 4.3 4.4 5.8 1.5 3.2 2.4 4.7 2.6 6.7 1.4 1.6 2.2 1.7 3.7 3.4 1.6 1.7 2.3 5.6 3.4 3.4 2.1 3.3 1.6 0.0 2.4 3.5 2.8 3.5 9.8 5.6 2.1 3.5 12.0 3.4 1.3 2.8 5.3 4.2 5.7 3.7 4.2 2.5 0.5 3.3 2.1 0.0 3.7 1.6 2.1 7.7 1.7 1.6 0.5 4.7 2.5 0.1 1.0 1.1 3.5 2.8 0.6 1.8 1.2 0.7 4.5 1.4 1.8 1.0 1.3 2.7 0.8 4.9 4.4 1.4 1.4 2.6 1.1 4.2 0.4 0.4 6.6 0.4 5.7 2.7 2.4 0.5 1.8 2.3 3.9 0.5 3.2 1.5 0.9 1.3 0.7 1.1 0.9 1.2 1.2 1.0 2.4 2.1 4.8 2.2 1.9 7.0 4.3 1.5 3.6 2.1 2.7 1.8 0.8 1.7 2.4 4.1 1.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.5 0.0 1.6 0.0 0.0 0.2 3.9 3.7 4.4 5.8 3.7 3.4 3.4 3.4 3.5 2.8 3.7 3.7 0.7 9.6 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.0 2.2 0.0 0.0 1.8 3.7 0.0 0.5 0.6 0.0 0.0 0.6 0.0 1.1 1.0 0.6 0.0 0.0 0.0 0.5 0.5 0.3 0.0 1.7 2.5 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.9 0.9 0.0 0.0 AL158151.3 ENSG00000235007 "Novel protein" 9 129139413-129260575 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enhanced" "Detected in single" "Endometrial stromal cells: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "SuSa: 1.8" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "unprognostic (8.74e-2)" "unprognostic (7.80e-2)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (1.33e-1)" 0.2 0.3 0.6 0.4 0.7 0.3 0.2 0.3 0.8 0.2 0.0 0.2 0.3 0.4 0.2 0.1 0.3 0.5 0.1 0.7 0.4 0.1 0.1 0.2 0.4 0.7 0.6 0.4 0.0 0.0 0.2 0.9 0.2 0.2 0.3 0.2 0.2 0.3 0.5 0.2 0.3 0.3 0.8 0.1 0.4 0.7 0.9 0.1 0.2 0.2 0.2 1.1 0.0 0.1 0.2 0.3 0.2 0.1 0.4 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.1 0.6 0.3 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.4 0.3 0.1 0.3 0.0 0.0 0.5 0.4 0.2 0.6 0.2 0.4 0.3 0.2 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.0 0.3 0.2 1.8 0.4 0.1 0.2 0.1 0.4 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.7 0.6 0.2 0.4 0.4 0.2 0.2 0.2 0.5 0.2 0.4 0.9 2.2 0.9 0.4 0.1 0.3 0.2 0.5 0.6 0.7 0.3 0.8 0.7 0.4 0.7 0.6 0.9 0.3 0.7 1.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.6 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AL162231.1 ENSG00000187186 "Uncharacterized LOC730098" 9 34664163-34666112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 292.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 24.5;Breast myoepithelial cells: 36.4;Collecting duct cells: 36.8;Distal tubular cells: 25.4;Proximal tubular cells: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 18.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 51.4" HPA069617 Enhanced Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Endoplasmic reticulum" "HPA069617: AB_2686161" "unprognostic (8.20e-3)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (6.63e-5)" "unprognostic (2.30e-1)" "unprognostic (2.46e-2)" "unprognostic (9.22e-2)" "unprognostic (2.11e-1)" "unprognostic (2.55e-2)" "unprognostic (5.99e-4)" "unprognostic (8.02e-2)" "unprognostic (1.39e-5)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.08e-3)" "unprognostic (2.00e-2)" 6.0 9.8 49.0 2.9 53.7 2.6 7.8 48.5 76.1 9.3 42.3 9.9 3.9 10.4 19.4 2.4 8.3 2.8 27.8 49.4 50.0 14.6 6.7 5.1 1.9 48.4 46.8 14.0 8.8 6.4 60.6 3.1 48.6 11.7 1.4 6.5 7.3 2.5 36.7 4.6 4.3 2.4 47.8 2.6 6.3 292.4 52.6 2.1 13.6 22.2 0.7 8.0 5.9 49.8 0.6 10.1 9.1 11.9 7.4 3.6 8.2 8.0 2.4 4.9 5.7 1.7 4.0 0.0 1.0 5.4 9.8 2.5 5.9 2.8 0.9 22.1 1.1 0.0 51.4 3.0 1.8 4.5 7.4 3.9 3.1 3.0 3.0 6.8 1.4 12.3 5.5 12.3 3.7 0.0 1.0 4.5 7.7 9.1 2.6 0.0 8.7 1.6 9.3 0.0 9.4 15.2 5.5 1.8 14.0 5.1 4.6 12.5 1.8 17.3 24.0 5.5 1.9 13.1 4.7 1.9 21.4 2.5 24.3 18.2 2.4 2.6 1.8 1.4 1.6 4.4 2.1 0.9 0.8 1.3 2.6 1.3 3.4 4.1 0.8 11.7 2.1 1.3 49.0 53.7 48.5 76.1 49.4 50.0 48.4 46.8 48.6 47.8 52.6 49.8 1.6 9.6 7.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 24.5 36.4 0.0 0.0 2.5 36.8 0.0 13.7 0.4 0.0 25.4 16.2 0.0 7.3 10.4 0.7 0.0 0.0 0.0 10.7 12.1 6.6 0.0 6.0 2.5 5.4 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.2 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 37.1 3.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 7.1 1.0 4.0 0.0 0.0 ALYREF "ALY, ALY/REF, BEF, REF, THOC4" ENSG00000183684 "Aly/REF export factor" 17 81887835-81891586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 148.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016281, HPA019799, HPA061282" Supported Enhanced "Nuclear speckles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: AB_2684464" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (4.89e-3)" "unprognostic (5.35e-2)" "unprognostic (3.43e-1)" "unprognostic (2.13e-2)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.77e-2)" "unprognostic (2.26e-1)" "unprognostic (2.55e-3)" "unprognostic (6.58e-2)" "unprognostic (8.07e-2)" "unprognostic (1.74e-3)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" 39.0 30.0 19.2 50.2 19.6 148.9 34.9 20.2 22.9 33.1 17.7 37.4 32.9 35.1 17.1 57.6 31.3 19.6 37.8 19.8 20.0 37.7 29.6 36.0 62.4 19.6 20.7 32.4 26.9 21.3 28.9 32.1 20.9 30.0 24.3 9.4 30.3 15.9 61.5 45.7 34.5 21.1 20.9 44.7 31.6 72.7 19.8 65.7 30.6 21.2 48.8 35.7 36.4 22.1 263.7 237.8 165.5 164.6 34.4 44.8 213.8 130.0 68.0 257.0 161.0 269.4 173.7 291.4 100.8 104.9 155.6 150.5 241.9 137.5 111.7 111.8 425.9 210.8 151.2 295.1 68.6 341.4 183.0 46.1 61.8 155.3 62.0 37.8 155.5 204.6 275.9 175.2 97.2 279.8 721.2 587.2 231.3 152.0 254.2 472.3 206.1 155.1 54.1 152.1 229.8 299.0 123.9 304.8 110.4 89.9 222.1 343.3 103.9 275.1 270.9 130.0 443.2 201.8 107.3 377.6 143.7 217.0 238.2 0.3 1.1 0.1 1.5 1.2 1.0 1.0 1.1 1.0 1.2 1.2 0.3 0.8 0.2 0.9 1.1 2.2 0.6 0.6 19.2 19.6 20.2 22.9 19.8 20.0 19.6 20.7 20.9 20.9 19.8 22.1 68.4 0.0 16.0 1.3 22.9 34.9 22.9 7.5 9.1 11.0 24.7 32.5 13.0 11.5 8.4 20.2 0.0 9.8 59.0 16.1 1.9 5.2 2.3 52.9 49.0 23.4 12.6 43.3 1.7 8.4 23.1 24.9 17.3 53.7 15.2 39.1 8.9 14.8 17.9 5.0 1.7 24.3 6.1 13.9 33.8 3.2 3.4 31.3 14.2 3.7 12.7 21.5 8.2 2.5 5.0 10.5 10.1 4.1 46.4 33.1 7.4 4.3 8.4 7.6 0.0 27.9 30.6 16.5 8.8 22.6 43.0 16.6 27.6 38.2 21.9 31.6 AMD1 SAMDC ENSG00000123505 "Adenosylmethionine decarboxylase 1" P17707 6 110874770-110898879 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 202.9" "Low cell type specificity" "Detected in all" "Cancer enhanced" "Detected in all" "prostate cancer: 70.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029281, HPA029282" Approved Approved Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA029281: AB_10600101, HPA029282: AB_10599965" "prognostic unfavorable (3.87e-4)" "unprognostic (4.68e-2)" "unprognostic (1.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.91e-6)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (6.50e-2)" "unprognostic (2.25e-1)" "unprognostic (4.20e-1)" "prognostic favorable (4.28e-4)" "unprognostic (8.62e-3)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (7.71e-2)" 31.8 28.3 35.0 34.7 44.9 89.9 33.9 39.6 56.1 32.8 32.0 36.9 29.2 35.5 25.7 56.0 25.6 33.3 40.2 37.5 38.2 48.6 33.6 33.4 39.9 45.6 38.5 30.0 39.7 40.3 26.0 59.9 42.2 202.9 36.5 35.9 37.4 34.5 26.7 26.9 26.5 35.4 45.5 27.3 31.2 31.9 37.6 40.5 46.2 50.2 50.3 37.4 25.8 67.1 85.8 57.4 68.6 130.6 101.1 63.9 89.8 119.9 131.8 91.4 106.7 92.2 52.3 149.7 56.7 76.7 97.0 57.4 163.9 108.6 125.1 88.5 94.6 155.4 47.5 96.5 60.2 135.7 88.9 43.4 98.0 63.4 126.4 31.8 81.0 75.4 118.2 126.8 156.3 51.8 181.9 103.3 84.7 84.1 51.9 98.5 68.9 89.3 103.9 112.9 87.4 62.2 73.2 91.7 110.7 55.5 59.5 114.9 53.8 60.5 45.7 325.0 131.5 34.4 59.7 152.8 69.6 106.7 79.4 42.9 23.9 37.7 17.4 28.9 20.2 14.5 17.4 20.3 31.5 14.8 20.4 20.8 102.6 15.5 37.3 13.9 22.5 17.0 35.0 44.9 39.6 56.1 37.5 38.2 45.6 38.5 42.2 45.5 37.6 67.1 169.5 38.5 92.5 23.2 164.8 315.3 241.5 49.5 262.4 101.4 178.5 151.1 95.7 125.8 82.7 55.2 60.5 44.5 208.7 144.1 146.8 67.2 31.8 145.0 106.2 104.4 124.4 184.1 39.2 70.0 152.0 132.1 96.4 214.8 93.9 36.9 53.6 59.3 77.0 77.4 37.9 108.2 28.5 109.1 244.2 53.6 43.8 176.7 131.6 23.4 92.0 303.7 60.8 36.7 111.6 87.6 95.9 50.0 118.9 379.4 66.2 89.9 29.3 105.6 19.7 170.5 124.9 93.0 76.7 246.4 288.1 54.6 184.6 45.7 128.8 147.7 ANKRD13D ENSG00000172932 "Ankyrin repeat domain 13D" Q6ZTN6 11 67289300-67302485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 63.9;SK-MEL-30: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039950 Approved Approved Nucleoplasm,Mitochondria No No "Cluster 10: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Mitochondria "HPA039950: AB_10796337" "unprognostic (1.10e-1)" "unprognostic (1.18e-3)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (9.83e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-3)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (5.06e-3)" "unprognostic (3.71e-2)" "prognostic unfavorable (5.73e-10)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" "unprognostic (4.01e-2)" "unprognostic (6.74e-2)" 12.0 14.7 13.3 6.8 14.3 0.3 11.4 10.9 20.7 19.5 10.8 13.8 3.1 12.5 2.9 24.4 15.3 7.9 12.0 16.5 12.9 16.2 8.9 13.8 15.0 13.8 11.7 14.1 9.5 6.0 28.9 5.2 15.1 23.8 2.3 2.0 14.4 7.3 3.7 15.0 13.8 6.5 10.2 39.2 12.8 12.1 15.8 10.0 11.2 3.8 5.7 17.5 20.5 19.6 9.7 7.2 5.8 12.3 10.9 10.1 3.8 7.0 8.4 7.2 5.6 6.4 10.1 11.6 12.4 5.6 10.7 12.4 4.5 8.6 1.0 19.9 5.3 11.6 11.3 4.3 16.8 14.0 27.8 10.4 11.8 6.2 6.8 14.1 9.5 9.2 6.3 12.4 8.0 14.1 18.0 63.9 2.5 19.8 10.1 28.5 4.9 9.9 13.6 6.0 6.0 9.8 7.0 16.7 57.0 4.5 14.3 33.1 7.7 7.1 6.1 7.9 8.2 9.8 9.4 5.6 17.4 21.4 8.2 6.6 0.6 5.7 2.0 2.1 1.3 0.8 1.5 2.8 1.2 0.5 0.5 3.2 1.9 3.1 1.4 1.8 1.6 1.2 13.3 14.3 10.9 20.7 16.5 12.9 13.8 11.7 15.1 10.2 15.8 19.6 23.2 0.0 18.8 18.9 22.2 14.1 11.7 15.4 17.6 61.1 21.5 20.8 7.0 8.6 14.5 16.5 75.0 8.3 73.6 7.5 1.9 8.3 18.0 27.7 19.7 17.9 10.8 8.2 29.8 6.9 9.0 15.7 20.4 18.0 25.3 25.7 22.1 3.0 20.0 42.1 29.7 7.9 18.3 52.0 21.4 6.0 22.1 45.8 12.4 18.7 49.7 20.8 49.4 17.6 18.4 9.9 4.6 17.0 30.7 19.9 2.3 2.6 30.4 51.7 13.1 13.6 18.5 3.1 8.1 19.3 25.1 7.5 49.9 28.9 8.4 19.8 ARHGAP45 "HA-1, HMHA1, KIAA0223" ENSG00000180448 "Rho GTPase activating protein 45" Q92619 19 1065923-1086628 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 68.3;intestine: 53.2;lung: 39.5;lymphoid tissue: 106.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 48.1;Cytotrophoblasts: 40.1;dendritic cells: 62.7;Extravillous trophoblasts: 56.6;Hofbauer cells: 40.0;monocytes: 72.4;Syncytiotrophoblasts: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 73.7;Karpas-707: 100.4;RPMI-8226: 74.7;THP-1: 92.3;U-266/70: 130.8;U-937: 72.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019816, HPA079252" Enhanced Supported "Plasma membrane,Cytosol" NA NA 1200000 "Cluster 32: T-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA019816: AB_1853923, HPA079252: " "unprognostic (1.34e-1)" "unprognostic (5.13e-3)" "unprognostic (5.17e-3)" "prognostic favorable (6.02e-4)" "unprognostic (2.26e-1)" "prognostic favorable (7.82e-4)" "unprognostic (1.59e-2)" "unprognostic (2.17e-2)" "unprognostic (3.55e-1)" "unprognostic (4.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-2)" "unprognostic (1.00e-1)" "unprognostic (4.59e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (5.33e-2)" 11.2 5.5 3.6 43.1 3.4 68.3 5.5 4.4 7.5 4.2 5.1 12.4 7.2 3.5 0.5 5.5 6.7 5.0 4.4 3.3 4.4 7.8 7.4 39.5 58.4 9.1 5.4 2.0 2.7 0.8 4.5 6.0 6.9 5.9 2.6 8.7 6.4 1.5 2.1 3.9 53.2 2.2 7.6 106.1 10.9 3.5 8.1 32.9 9.0 0.8 18.6 6.6 5.5 11.4 11.2 2.1 0.1 12.1 0.0 0.0 27.8 0.1 0.0 0.0 0.0 29.2 13.9 73.7 3.0 0.0 0.4 9.6 2.1 0.6 0.0 54.7 1.0 10.1 22.6 3.5 0.4 48.6 56.2 0.0 2.9 0.1 0.0 0.0 0.1 46.8 6.8 100.4 0.0 0.6 54.5 43.4 7.6 1.9 5.4 52.0 0.3 74.7 0.0 0.2 0.6 0.2 16.8 0.0 4.5 0.7 3.5 92.3 4.8 0.2 1.9 0.2 0.3 130.8 60.2 58.8 0.3 72.1 5.4 6.7 24.4 25.3 45.7 21.2 38.8 15.9 52.2 54.1 22.5 18.3 68.9 53.6 37.0 28.0 20.9 13.3 43.5 59.8 3.6 3.4 4.4 7.5 3.3 4.4 9.1 5.4 6.9 7.6 8.1 11.4 2.0 48.1 8.4 0.0 17.8 0.0 0.0 0.0 0.0 0.0 15.2 11.0 0.0 0.0 1.8 11.0 0.0 40.1 62.7 0.0 0.0 2.6 0.0 4.5 0.7 1.6 0.0 0.0 0.0 3.8 56.6 1.3 0.0 3.5 3.8 0.2 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 72.4 0.0 0.0 0.0 0.0 7.8 0.0 0.0 15.2 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 75.5 30.2 0.1 0.0 0.0 ARID4A "RBBP1, RBP-1, RBP1" ENSG00000032219 "AT-rich interaction domain 4A" P29374 14 58298504-58373887 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048899 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Plasma membrane, Cytosol" "HPA048899: " "unprognostic (1.57e-1)" "unprognostic (9.39e-2)" "unprognostic (5.17e-2)" "unprognostic (2.69e-1)" "unprognostic (3.70e-2)" "prognostic favorable (1.91e-4)" "unprognostic (2.71e-1)" "prognostic favorable (7.82e-4)" "unprognostic (2.08e-2)" "unprognostic (6.92e-2)" "unprognostic (3.27e-1)" "unprognostic (3.72e-2)" "unprognostic (9.32e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (4.11e-2)" "unprognostic (3.52e-2)" 9.8 6.9 8.6 11.1 9.2 34.7 9.1 14.8 10.0 8.6 8.9 7.7 8.8 9.5 6.8 7.4 6.8 9.0 8.7 8.0 11.7 9.4 18.7 10.3 14.9 7.9 7.7 12.5 7.4 9.8 5.4 9.8 7.6 8.6 8.8 14.0 6.7 7.6 5.4 8.7 9.1 8.2 6.8 14.0 8.9 6.9 12.3 14.5 10.6 6.3 11.2 8.4 7.5 10.7 8.5 7.0 19.2 9.5 9.3 11.2 9.7 9.9 8.4 6.6 10.4 8.3 13.1 20.4 10.3 8.4 6.3 9.6 8.6 4.8 9.6 14.3 5.5 9.2 8.2 8.0 5.6 19.7 12.8 8.4 5.2 6.4 6.6 10.5 10.6 11.6 10.7 16.3 7.1 11.5 14.3 17.7 3.8 8.2 8.7 14.5 16.6 6.1 7.1 14.9 16.5 14.3 16.9 8.4 12.0 9.4 14.3 17.8 15.3 11.2 8.7 9.1 4.6 5.3 4.2 18.3 6.7 12.3 5.8 65.8 19.5 59.1 20.6 20.1 23.3 31.5 25.3 22.1 14.9 42.3 27.0 26.5 109.4 29.1 40.8 19.8 19.8 10.1 8.6 9.2 14.8 10.0 8.0 11.7 7.9 7.7 7.6 6.8 12.3 10.7 57.7 83.3 100.9 68.9 73.5 38.4 21.2 22.1 64.3 111.0 29.5 35.8 55.0 24.3 32.3 27.6 52.1 19.9 74.0 33.0 19.6 23.3 18.2 40.5 37.6 47.1 22.8 45.8 94.2 21.7 21.3 40.1 26.0 52.6 65.2 39.9 37.5 41.9 34.7 112.7 78.6 35.5 20.3 47.7 49.5 8.8 36.4 59.3 26.6 63.7 75.8 63.9 49.4 86.5 91.4 24.9 38.6 36.1 55.1 20.9 43.4 14.9 11.2 64.2 19.7 40.0 43.0 38.6 33.8 55.4 33.4 20.4 77.0 34.1 32.9 17.7 ARIH1 "ARI, HARI, HHARI, UBCH7BP" ENSG00000166233 "Ariadne RBR E3 ubiquitin protein ligase 1" Q9Y4X5 15 72474330-72602987 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.8;testis: 42.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003295 Approved Supported Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA003295: AB_1845017" "unprognostic (3.31e-2)" "unprognostic (1.92e-1)" "unprognostic (2.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.21e-2)" "unprognostic (5.45e-2)" "unprognostic (1.73e-1)" "unprognostic (9.43e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-1)" "unprognostic (4.96e-2)" "unprognostic (9.19e-2)" "unprognostic (1.78e-1)" "unprognostic (2.93e-1)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-2)" 8.5 7.9 2.5 10.1 3.9 16.5 6.0 7.0 5.8 6.4 7.1 8.2 9.5 7.5 3.2 6.8 5.4 4.4 11.4 4.4 4.0 5.2 6.2 7.3 4.9 3.4 2.7 9.0 6.6 3.9 5.9 6.5 3.6 5.8 3.3 10.4 4.3 4.8 47.8 7.6 7.4 6.3 3.0 6.0 6.3 42.5 3.8 3.9 5.0 8.5 4.1 7.6 6.5 4.3 17.6 18.0 17.5 10.2 8.9 6.2 20.6 19.3 7.0 8.6 5.9 18.3 14.6 17.2 28.4 8.3 30.3 24.8 18.1 10.1 4.8 30.6 12.4 13.0 22.5 12.4 6.3 19.6 14.4 7.4 3.4 9.5 12.2 8.2 6.4 12.4 13.8 19.7 8.5 11.5 18.9 7.5 18.9 6.3 6.5 21.4 21.3 9.8 4.8 29.0 16.3 18.4 25.1 11.2 31.4 23.0 9.0 22.0 16.7 14.1 19.6 54.8 27.4 20.7 45.2 20.6 9.2 17.5 15.2 1.6 0.2 0.7 0.5 0.4 0.4 0.2 0.3 0.3 0.2 0.6 0.4 0.4 1.0 0.6 0.2 0.3 0.8 0.1 2.5 3.9 7.0 5.8 4.4 4.0 3.4 2.7 3.6 3.0 3.8 4.3 79.5 19.2 37.7 88.5 64.0 66.3 52.7 13.3 76.2 63.3 74.9 53.3 46.9 30.0 25.7 18.4 91.8 18.4 83.3 32.9 3.9 18.4 110.3 108.7 84.8 50.7 46.5 24.8 141.6 18.9 21.8 43.3 63.7 148.4 43.2 43.7 40.0 28.5 19.0 62.2 152.0 31.2 8.2 30.5 42.1 55.4 28.6 67.5 16.0 104.0 24.2 25.7 27.8 129.7 135.1 24.7 19.1 27.4 60.9 55.8 20.8 13.9 33.0 58.8 19.7 96.8 59.9 45.3 32.1 68.8 59.8 40.8 68.3 36.8 27.0 63.7 ARL8A "ARL10B, FLJ45195, Gie2" ENSG00000143862 "ADP ribosylation factor like GTPase 8A" Q96BM9 1 202133404-202144743 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038759, HPA040515, HPA045924" Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "HPA038759: AB_2676193, HPA040515: AB_2677017, HPA045924: AB_2679500" "unprognostic (1.20e-1)" "unprognostic (7.48e-2)" "prognostic unfavorable (3.08e-5)" "unprognostic (5.15e-3)" "unprognostic (5.10e-2)" "unprognostic (2.50e-3)" "unprognostic (1.17e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (4.30e-1)" "unprognostic (2.26e-2)" "unprognostic (1.57e-1)" "unprognostic (3.29e-2)" "unprognostic (3.63e-2)" "unprognostic (2.75e-1)" "unprognostic (5.39e-2)" "unprognostic (1.66e-2)" 41.7 40.1 61.4 25.0 83.4 70.0 37.5 82.0 78.9 37.9 36.1 36.0 21.6 35.0 16.8 32.4 34.3 21.5 43.9 67.4 70.7 34.6 45.1 46.1 21.3 89.7 81.1 35.3 28.3 26.2 31.7 31.1 82.3 29.7 10.9 18.7 30.8 19.6 46.4 37.2 26.4 21.7 72.1 38.4 32.0 19.5 78.2 18.1 32.3 26.0 13.3 31.4 33.8 103.2 24.2 25.6 26.2 31.9 23.1 19.9 11.3 28.1 36.6 31.3 24.1 9.2 18.7 23.3 18.1 29.2 29.2 34.0 17.6 19.4 10.0 45.7 24.7 14.1 13.2 9.6 45.8 28.6 63.8 21.8 50.4 27.4 23.6 32.9 32.2 23.3 13.6 34.7 22.3 26.4 20.0 39.3 37.4 8.3 8.9 19.2 22.9 20.5 29.5 20.4 24.2 62.8 22.9 73.8 46.2 32.7 34.2 31.6 38.7 25.1 22.8 43.4 24.1 54.0 54.6 19.3 20.4 15.1 21.4 3.5 2.1 7.3 1.5 2.1 1.1 1.1 1.3 1.2 1.5 1.5 0.7 0.9 5.2 0.7 2.0 2.7 1.5 0.9 61.4 83.4 82.0 78.9 67.4 70.7 89.7 81.1 82.3 72.1 78.2 103.2 45.4 19.2 10.2 17.0 16.6 41.3 24.0 12.1 7.4 36.0 39.0 33.5 2.5 22.8 13.2 11.0 14.6 33.3 37.1 11.3 5.9 38.9 0.4 20.7 28.2 26.0 20.5 7.0 17.8 29.3 14.7 25.7 14.3 26.8 19.0 26.0 20.7 39.8 57.2 53.8 18.6 14.7 14.2 57.8 51.0 2.1 33.5 45.7 32.0 6.5 35.4 47.1 18.6 13.0 82.8 50.3 21.1 27.4 14.5 31.8 16.6 27.1 10.7 23.1 26.3 22.8 28.6 1.3 5.2 13.4 51.7 76.1 21.4 16.5 10.1 37.2 ARMC5 FLJ13063 ENSG00000140691 "Armadillo repeat containing 5" Q96C12 16 31458080-31467166 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cushing syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatocytes: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041524, HPA063706" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Intracellular and membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA041524: AB_10796676, HPA063706: AB_2685098" "unprognostic (1.37e-1)" "unprognostic (1.68e-3)" "unprognostic (8.22e-3)" "unprognostic (9.96e-2)" "unprognostic (2.59e-1)" "unprognostic (2.94e-3)" "unprognostic (4.09e-2)" "unprognostic (6.14e-3)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favorable (1.97e-6)" "unprognostic (4.70e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 6.3 7.9 9.0 3.4 9.2 21.4 4.3 8.9 11.7 6.0 7.0 5.8 4.6 6.9 0.9 9.9 5.6 2.0 6.5 9.2 8.1 8.7 24.6 4.6 3.2 12.3 9.4 6.8 6.4 3.0 9.0 2.1 12.4 7.7 0.9 2.4 5.3 2.2 16.0 8.5 7.0 1.7 9.1 8.8 6.8 6.8 9.2 2.9 9.7 3.9 1.3 5.6 6.6 10.5 5.0 7.6 3.3 4.8 2.0 1.5 8.4 6.5 2.8 3.6 3.0 7.2 5.0 4.9 13.3 3.5 3.6 7.5 3.9 5.7 0.7 6.8 9.9 2.2 12.4 16.7 4.0 14.9 14.3 3.7 6.3 3.6 1.0 4.2 5.5 8.0 11.2 11.5 2.5 12.2 5.6 59.5 5.3 2.2 5.0 10.0 4.7 18.2 2.9 5.6 10.7 9.4 5.9 7.8 4.6 2.0 5.1 17.6 10.9 7.8 5.7 3.2 5.4 10.4 9.8 3.0 5.1 12.2 5.7 2.9 2.3 0.7 3.2 1.1 2.7 2.7 2.5 2.6 3.0 2.2 2.2 2.6 1.3 7.1 1.3 7.2 3.2 2.6 9.0 9.2 8.9 11.7 9.2 8.1 12.3 9.4 12.4 9.1 9.2 10.5 8.7 6.4 14.3 4.2 6.2 6.5 9.2 8.7 9.1 6.0 6.3 5.0 5.8 11.5 8.2 0.0 6.2 7.5 7.6 11.1 3.9 5.0 1.2 5.2 8.6 10.8 7.8 8.2 4.3 4.4 5.4 6.1 6.6 7.6 9.5 6.7 8.9 28.7 6.1 13.5 4.0 8.7 6.1 3.7 4.0 0.6 4.4 6.7 1.8 2.8 3.9 7.2 6.2 2.0 4.6 4.4 3.8 5.7 8.0 6.9 9.2 4.6 3.4 5.9 0.0 8.7 6.6 5.5 8.0 9.6 6.3 11.5 7.6 6.1 7.7 6.1 ARMH3 "C10orf76, FLJ13114" ENSG00000120029 "Armadillo like helical domain containing 3" Q5T2E6 10 101845599-102056193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.2;dendritic cells: 10.5;Extravillous trophoblasts: 14.8;Granulosa cells: 11.5;Hofbauer cells: 12.6;Syncytiotrophoblasts: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050913, HPA053580" Approved Approved Vesicles NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 23: Testis - Cell cycle regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA050913: AB_2681270, HPA053580: AB_2682198" "unprognostic (5.88e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "unprognostic (3.41e-2)" "unprognostic (9.41e-2)" "unprognostic (9.55e-2)" "unprognostic (5.28e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (6.03e-3)" "unprognostic (1.40e-3)" "unprognostic (2.76e-1)" "unprognostic (1.86e-2)" "unprognostic (1.16e-1)" "unprognostic (2.48e-1)" "unprognostic (3.85e-1)" "unprognostic (4.87e-2)" 10.4 9.1 5.9 12.0 7.6 21.8 9.9 10.2 7.3 11.2 8.0 12.5 12.8 10.5 9.4 14.3 10.5 9.2 16.6 5.7 7.3 10.0 12.0 11.8 12.7 7.1 8.2 11.2 10.1 16.4 7.9 11.0 6.1 10.8 13.2 16.3 9.5 10.5 19.7 12.2 12.2 12.9 6.0 13.6 10.3 8.9 6.7 13.1 10.0 19.8 13.3 10.8 10.1 7.9 23.2 17.7 15.5 19.1 12.9 17.3 13.9 20.3 24.0 20.0 16.9 12.2 18.6 17.0 13.5 22.9 14.5 17.7 20.4 22.4 18.3 17.9 18.9 30.3 15.9 14.6 15.2 21.3 26.4 16.0 17.7 22.6 19.9 23.4 15.3 15.3 0.9 15.9 16.6 14.4 16.5 13.8 8.5 18.8 11.6 16.0 28.1 11.0 16.4 18.6 7.3 12.1 15.8 10.9 21.0 15.8 28.8 12.4 15.1 10.5 17.1 9.8 14.7 15.4 17.0 17.1 16.9 23.7 7.9 19.4 7.3 7.4 5.9 8.7 5.5 6.1 6.2 4.5 7.7 7.0 4.8 4.9 1.9 5.2 10.7 7.4 6.0 4.7 5.9 7.6 10.2 7.3 5.7 7.3 7.1 8.2 6.1 6.0 6.7 7.9 8.8 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 7.4 6.0 0.0 0.0 0.0 0.0 0.0 11.2 10.5 0.0 1.9 7.8 0.0 6.9 6.8 1.9 0.0 0.0 0.0 9.7 14.8 2.7 0.0 7.7 0.0 11.5 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 9.9 0.0 0.0 2.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 16.3 3.9 5.7 0.0 0.0 ARMT1 "C6orf211, FLJ12910" ENSG00000146476 "Acidic residue methyltransferase 1" Q9H993 6 151452258-151470101 "Predicted intracellular proteins" "DNA damage" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003004, HPA005819" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 410000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA003004: AB_1078358, HPA005819: AB_1845741" "unprognostic (5.16e-3)" "prognostic unfavorable (7.09e-4)" "prognostic favorable (4.14e-4)" "unprognostic (6.39e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (1.37e-2)" "unprognostic (9.47e-2)" "unprognostic (2.33e-2)" "unprognostic (2.16e-1)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.16e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-2)" "unprognostic (4.12e-1)" "unprognostic (1.22e-1)" 17.1 16.0 8.5 15.3 9.5 5.5 25.0 9.6 12.2 16.1 8.3 16.6 18.9 16.0 16.1 12.0 12.6 11.3 16.8 8.6 10.0 41.5 37.6 19.5 21.0 9.0 9.1 11.9 6.8 11.6 5.3 22.2 9.1 12.2 17.6 16.4 7.6 11.1 19.0 8.8 14.5 14.9 9.6 12.8 14.1 14.1 9.8 15.6 27.7 22.6 18.5 17.3 8.1 9.0 24.6 18.4 37.9 34.2 30.3 47.4 60.9 44.8 39.1 36.9 48.4 47.8 19.7 36.2 29.5 31.8 33.7 24.2 112.7 33.5 61.7 40.6 34.9 26.0 21.7 55.9 37.8 50.1 31.7 38.2 23.3 49.3 29.2 30.6 52.8 27.0 38.5 44.3 46.4 101.8 31.7 47.4 64.4 23.7 15.3 41.0 32.7 28.6 112.6 31.2 15.6 10.2 37.5 34.9 23.8 67.4 98.9 38.6 44.6 17.9 25.0 66.8 36.3 21.1 28.5 43.7 31.7 60.7 21.6 53.8 26.9 52.0 13.5 34.5 18.1 17.5 17.4 14.5 22.9 14.7 15.9 14.8 22.1 21.0 33.4 8.5 25.1 21.1 8.5 9.5 9.6 12.2 8.6 10.0 9.0 9.1 9.1 9.6 9.8 9.0 16.3 25.6 40.4 6.5 13.2 0.0 8.4 0.0 11.4 10.0 33.5 16.3 18.6 14.3 6.2 23.9 8.4 31.7 12.6 10.6 45.0 19.5 1.4 19.4 29.3 10.6 4.9 6.5 11.4 17.8 39.0 14.2 12.2 23.3 3.8 7.7 15.4 48.7 35.4 8.4 9.8 8.9 0.0 34.0 0.0 3.1 19.3 23.6 0.0 5.6 36.0 17.3 18.6 6.6 8.9 19.5 7.2 14.7 15.2 5.4 18.6 79.3 10.9 20.9 0.0 6.7 14.3 25.2 14.8 11.1 0.0 36.0 14.0 15.5 10.7 9.6 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1462.0;Endometrial ciliated cells: 1049.4;Glandular and luminal cells: 1429.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.4;intermediate monocyte: 4.0;myeloid DC: 1.6;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 15 "dendritic cells: 1.6;granulocytes: 6.4;monocytes: 6.3" "Cell line enhanced" "Detected in many" "BEWO: 131.5;HDLM-2: 100.4;SuSa: 155.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 9.3" HPA001562 Approved Supported Nucleoplasm,Nucleoli Yes Yes "Cluster 7: Monocytes - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 176.1 82.8 14.2 63.3 17.7 45.3 97.6 16.5 18.7 106.2 17.1 66.6 21.0 108.6 9.3 128.4 122.6 135.0 113.7 14.4 20.2 98.1 139.9 116.0 20.8 21.1 16.7 40.2 67.2 48.8 45.0 66.3 17.2 116.3 60.0 16.2 33.1 24.1 30.7 154.9 45.6 313.0 15.4 24.4 104.8 3.9 18.8 84.5 181.1 30.0 3.1 281.2 55.2 25.0 21.1 1.2 40.7 8.7 3.9 10.4 131.5 14.7 11.9 12.5 29.8 27.7 15.5 0.4 6.5 0.9 68.0 11.6 24.6 4.0 20.5 100.4 24.6 1.6 11.6 10.0 72.9 9.0 22.7 18.3 65.3 34.9 80.4 2.4 2.6 23.9 10.0 77.0 1.9 2.8 27.5 5.9 29.2 11.5 9.2 8.1 27.1 18.4 1.8 3.0 18.3 18.4 19.1 34.2 59.0 155.0 19.9 6.5 2.4 3.6 19.5 12.3 6.7 60.4 27.9 7.4 11.9 4.8 10.8 6.4 0.7 0.0 0.3 4.0 0.3 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.2 0.0 6.3 0.8 0.0 0.7 14.2 17.7 16.5 18.7 14.4 20.2 21.1 16.7 17.2 15.4 18.8 25.0 568.2 423.1 146.5 1.6 55.3 202.8 866.2 236.1 1462.0 4.4 753.9 510.9 689.3 92.9 136.0 55.2 0.0 178.9 100.3 611.7 1.9 186.2 3.7 1049.4 318.2 176.2 889.6 2.7 2.6 122.7 330.8 452.6 966.9 1429.3 78.6 5.6 30.7 25.8 103.7 1.7 2.4 758.4 114.0 29.8 282.8 2.8 17.4 351.8 174.3 3.7 32.3 39.9 0.0 1.5 10.8 185.7 484.8 1.2 161.0 457.5 421.3 3.3 133.2 5.3 98.6 279.4 573.7 2.2 3.1 474.6 202.7 420.6 97.1 5.8 349.6 263.6 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917211 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 16.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 16.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Vesicles Nucleoplasm "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favorable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 16.4 20.1 11.4 6.5 10.9 60.2 16.9 8.6 40.1 19.9 11.4 18.9 7.5 18.2 1.8 15.7 19.2 4.2 18.4 11.5 9.8 22.0 59.2 24.2 6.1 13.9 12.3 24.9 22.7 4.9 21.6 4.9 12.7 21.6 2.6 1.9 15.2 5.7 26.7 34.9 21.4 3.3 9.0 25.7 23.2 15.3 11.4 5.4 19.3 4.4 3.3 17.7 15.6 10.4 13.2 12.6 4.4 12.0 5.7 4.0 12.3 7.1 10.3 9.4 6.8 11.0 9.9 9.3 14.7 6.0 12.0 10.8 4.5 8.3 2.5 9.1 15.7 8.7 19.1 10.0 8.4 6.5 18.2 10.9 7.1 11.8 6.3 5.4 7.9 9.5 16.1 7.3 4.1 21.3 7.8 21.9 5.1 3.5 14.3 8.6 7.1 13.5 5.0 10.9 16.5 6.7 10.6 14.6 13.3 3.3 14.3 8.1 10.1 9.0 8.6 18.3 5.3 14.7 5.5 6.5 13.0 5.2 5.6 3.0 2.0 2.2 2.5 2.1 2.1 0.8 1.7 2.2 1.4 0.9 1.3 2.4 16.9 1.8 1.7 2.4 0.9 1.2 11.4 10.9 8.6 40.1 11.5 9.8 13.9 12.3 12.7 9.0 11.4 10.4 9.8 9.6 16.2 20.2 17.0 28.9 8.7 35.7 16.5 16.6 15.8 10.3 8.1 7.2 17.6 9.2 33.3 12.7 40.1 38.8 1.9 10.2 2.5 12.4 9.2 10.2 35.9 16.2 7.6 10.3 5.3 12.6 16.8 24.4 9.5 15.4 7.9 23.2 10.9 13.5 8.4 17.6 24.4 20.1 19.9 3.6 12.8 24.2 30.2 5.6 11.9 12.3 19.6 6.6 7.1 14.9 21.7 10.1 27.3 12.2 26.8 6.6 13.3 26.0 13.1 11.6 10.6 9.0 6.2 16.3 38.4 66.9 40.2 27.2 19.0 15.9 ATN1 "B37, D12S755E, DRPLA" ENSG00000111676 "Atrophin 1" P54259 12 6924463-6942321 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031619 Enhanced Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA031619: AB_10601667" "unprognostic (3.86e-3)" "unprognostic (2.07e-1)" "unprognostic (1.80e-3)" "unprognostic (5.82e-2)" "unprognostic (1.37e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (1.44e-1)" "unprognostic (6.90e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-2)" "unprognostic (3.19e-1)" "unprognostic (7.43e-2)" "unprognostic (5.46e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-1)" "unprognostic (7.35e-2)" 125.2 148.3 71.7 33.7 60.1 6.9 120.6 94.2 120.0 143.8 14.5 155.4 36.3 146.4 25.5 71.9 148.9 43.2 94.2 66.8 75.7 95.5 42.7 109.0 20.4 81.3 70.6 234.6 79.6 56.7 188.9 43.8 60.0 117.6 21.1 58.8 89.8 59.5 81.9 79.2 82.0 49.4 41.2 74.2 100.4 33.3 71.5 16.3 189.0 34.4 14.0 122.2 108.8 67.4 56.4 72.1 75.9 154.7 69.6 61.7 126.3 65.5 55.4 65.1 45.8 73.6 65.6 15.2 20.4 80.8 54.1 36.8 46.2 63.8 33.3 178.0 46.3 70.6 71.7 35.6 108.3 14.6 103.8 101.8 46.1 82.4 63.6 112.5 64.4 22.4 61.1 29.9 58.2 81.2 31.9 13.5 156.0 26.2 30.1 65.9 40.6 11.2 48.3 78.3 23.4 75.3 66.5 77.2 47.1 73.6 29.5 40.3 85.2 76.7 97.9 61.1 102.2 22.7 8.1 10.7 60.1 18.7 82.3 0.5 0.1 0.7 0.6 0.0 0.5 0.7 0.2 0.3 0.1 0.5 0.3 0.4 0.0 0.1 0.0 0.5 0.3 0.2 71.7 60.1 94.2 120.0 66.8 75.7 81.3 70.6 60.0 41.2 71.5 67.4 66.3 16.0 17.2 76.4 9.1 30.2 13.5 22.9 30.1 26.6 51.5 57.4 16.4 24.3 20.4 29.5 18.8 27.4 11.4 37.4 15.6 20.5 2.3 39.9 61.2 40.7 21.7 4.8 23.8 30.3 15.3 30.9 34.7 51.7 10.1 37.1 39.7 8.0 11.9 25.2 29.7 23.0 8.2 10.9 21.0 3.5 63.6 13.7 21.4 23.4 4.8 17.3 3.1 17.6 18.2 29.9 25.3 52.6 9.5 17.4 24.2 12.1 15.4 23.9 19.7 29.4 39.5 9.7 7.7 22.1 24.9 37.1 10.9 26.2 20.4 17.9 ATP23 "KUB3, XRCC6BP1" ENSG00000166896 "ATP23 metallopeptidase and ATP synthase assembly factor homolog" Q9Y6H3 12 57906039-57959148 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.8" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 12.7;Cytotrophoblasts: 14.4;Distal tubular cells: 17.6;Extravillous trophoblasts: 15.2;Proximal tubular cells: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "A549: 1.0;Karpas-707: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035804, HPA043204" Uncertain Enhanced "Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Plasma membrane" "Cell Junctions, Cytosol" "HPA035804: AB_10601026, HPA043204: AB_2678361" "unprognostic (2.56e-1)" "unprognostic (1.31e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (5.28e-2)" "unprognostic (5.41e-3)" "unprognostic (1.03e-2)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (4.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-1)" 7.5 4.9 0.6 0.4 0.5 0.1 5.6 0.6 0.9 4.1 0.5 8.1 0.2 3.1 0.0 5.6 3.2 0.0 4.6 1.0 0.3 4.0 5.2 2.6 0.1 0.4 0.2 3.1 5.9 0.0 2.8 0.1 0.4 3.3 0.0 0.5 3.6 0.0 12.4 4.4 4.3 0.0 0.3 3.2 4.2 27.8 0.5 0.0 3.5 0.0 0.1 4.7 4.0 0.3 0.6 1.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.9 0.2 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.6 2.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.8 0.1 0.0 0.4 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.0 0.4 0.0 0.0 0.4 0.0 0.6 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.3 0.0 0.3 0.2 0.2 1.6 0.1 0.1 0.1 0.1 0.0 0.6 0.5 0.6 0.9 1.0 0.3 0.4 0.2 0.4 0.3 0.5 0.3 8.0 0.0 9.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 7.4 12.7 0.0 0.0 1.8 3.7 0.0 14.4 4.2 0.0 17.6 6.1 0.0 5.6 4.9 2.8 0.0 0.0 0.0 10.7 15.2 2.3 0.0 6.0 11.4 6.8 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.9 0.0 0.0 26.1 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.4 3.0 9.5 0.0 0.0 ATP5F1A "ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM" ENSG00000152234 "ATP synthase F1 subunit alpha" P25705 18 46080248-46104334 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 1760.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 784.3;Distal tubular cells: 1173.9;Extravillous trophoblasts: 463.0;Proximal tubular cells: 939.6;Syncytiotrophoblasts: 578.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013067, HPA040622, HPA044202" Enhanced Supported Mitochondria NA NA 8800000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855" "unprognostic (3.08e-2)" "unprognostic (9.13e-2)" "unprognostic (1.84e-2)" "unprognostic (3.54e-1)" "unprognostic (6.36e-2)" "unprognostic (2.61e-1)" "unprognostic (1.89e-2)" "unprognostic (6.79e-2)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "unprognostic (7.30e-3)" "unprognostic (1.50e-2)" "prognostic favorable (1.22e-15)" "unprognostic (4.60e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-1)" "unprognostic (4.87e-3)" 251.3 453.6 198.6 177.7 209.2 210.5 260.4 233.0 251.4 195.5 401.9 414.0 438.9 192.6 225.6 362.6 227.2 146.3 1498.3 207.7 246.0 730.4 441.6 175.1 223.7 234.6 237.8 211.1 299.9 868.5 277.4 201.7 226.0 211.4 419.8 465.4 307.4 265.9 1602.0 290.3 335.0 233.0 205.4 226.8 419.1 167.6 226.7 277.3 261.4 1760.3 337.6 244.9 224.7 209.6 355.2 353.0 459.6 434.3 546.0 601.8 508.6 399.5 562.4 601.0 522.8 532.7 271.9 833.2 238.9 487.4 322.3 641.7 801.1 614.1 556.4 373.0 450.3 551.7 413.3 667.2 357.1 1182.7 501.6 559.2 422.3 434.6 448.2 481.3 630.4 442.5 454.0 477.2 521.8 367.6 612.8 579.7 432.3 344.5 367.6 596.5 533.8 1131.4 816.2 849.7 465.7 434.7 293.3 361.5 506.9 428.6 466.3 679.3 370.4 328.7 282.7 174.9 354.9 542.5 501.5 533.0 328.1 698.0 358.7 119.1 573.9 162.7 353.6 511.8 455.9 492.3 422.7 388.4 959.5 392.9 503.3 421.7 55.9 414.5 485.1 468.3 527.4 1339.1 198.6 209.2 233.0 251.4 207.7 246.0 234.6 237.8 226.0 205.4 226.7 209.6 79.2 169.9 167.8 0.0 49.9 0.0 0.0 0.0 0.0 0.0 205.7 169.8 0.0 0.0 100.3 171.0 0.0 784.3 86.3 0.0 1173.9 358.3 0.0 125.3 163.3 73.0 0.0 0.0 0.0 269.7 463.0 97.8 0.0 119.3 89.6 198.7 0.0 0.0 409.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.5 0.0 0.0 179.9 0.0 0.0 0.0 0.0 199.1 0.0 0.0 24.0 0.0 0.0 939.6 95.5 0.0 0.0 0.0 87.1 0.0 0.0 0.0 0.0 578.2 54.6 319.2 0.0 0.0 ATP5F1B "ATP5B, ATPSB" ENSG00000110955 "ATP synthase F1 subunit beta" P06576 12 56638175-56645984 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2590.4;tongue: 3205.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 821.1;Distal tubular cells: 1238.5;Extravillous trophoblasts: 592.7;Hofbauer cells: 608.9;Proximal tubular cells: 951.7;Syncytiotrophoblasts: 1138.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001520, HPA001528, CAB017527" Enhanced Enhanced Mitochondria NA NA 19000000 "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" Mitochondria "CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242" "prognostic unfavorable (7.17e-6)" "unprognostic (5.69e-2)" "unprognostic (1.08e-2)" "unprognostic (7.24e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.92e-2)" "unprognostic (8.19e-3)" "unprognostic (2.38e-2)" "unprognostic (1.44e-2)" "unprognostic (2.11e-2)" "prognostic favorable (1.43e-9)" "unprognostic (2.79e-1)" "unprognostic (3.22e-1)" "unprognostic (1.33e-1)" "unprognostic (3.30e-2)" 432.7 555.5 217.6 300.5 231.4 465.8 301.5 281.6 303.8 241.8 443.3 741.6 689.5 235.4 223.4 527.6 277.9 225.7 2011.6 233.0 307.1 945.9 609.3 253.4 294.6 264.2 242.9 200.2 301.7 1311.6 252.6 301.4 280.4 280.9 767.6 484.2 407.7 356.4 2590.4 398.6 575.5 332.5 230.9 272.5 494.9 236.0 277.5 390.9 342.8 3205.3 458.3 404.1 311.2 244.7 693.6 834.9 632.3 1003.6 578.3 596.7 1159.8 683.2 645.6 1179.1 663.9 1375.7 755.6 1236.3 723.0 863.5 482.9 906.1 1378.1 851.5 1039.4 579.9 987.5 1333.1 726.4 872.5 716.6 1509.7 912.9 755.1 843.3 918.0 1171.2 870.2 985.8 901.7 1246.3 1363.1 992.2 671.5 1134.4 941.3 1085.9 905.6 1637.6 1079.3 711.0 1603.5 1315.6 1196.7 737.5 658.2 1042.3 1481.3 1214.0 663.4 1404.1 1151.8 657.6 454.8 507.9 671.9 751.0 659.5 865.7 1254.8 684.7 1007.8 718.4 403.5 549.4 281.8 293.5 643.6 326.3 303.2 275.4 313.6 713.4 248.4 221.0 266.8 137.1 296.9 750.6 360.9 372.9 1077.1 217.6 231.4 281.6 303.8 233.0 307.1 264.2 242.9 280.4 230.9 277.5 244.7 172.3 134.6 173.2 0.0 48.6 0.0 0.0 0.0 0.0 0.0 176.8 149.1 0.0 0.0 81.1 277.7 0.0 821.1 141.5 0.0 1238.5 517.7 0.0 194.1 169.2 115.7 0.0 0.0 0.0 367.9 592.7 115.0 0.0 163.3 145.1 267.6 0.0 0.0 608.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.3 0.0 0.0 281.2 0.0 0.0 0.0 0.0 333.3 0.0 0.0 26.8 0.0 0.0 951.7 102.7 0.0 0.0 0.0 151.1 0.0 0.0 0.0 0.0 1138.6 77.4 518.4 0.0 0.0 ATP5F1C "ATP5C, ATP5C1, ATP5CL1" ENSG00000165629 "ATP synthase F1 subunit gamma" P36542 10 7788147-7807815 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 895.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 517.1;Distal tubular cells: 890.2;Ductal cells: 453.9;Extravillous trophoblasts: 428.5;Hofbauer cells: 423.4;Proximal tubular cells: 938.6;Theca cells: 413.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060949 Approved NA NA 70000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 7: Non-specific - Mitochondria" "HPA060949: AB_2684395" "unprognostic (1.81e-2)" "unprognostic (8.34e-2)" "unprognostic (3.87e-2)" "unprognostic (1.69e-2)" "unprognostic (2.17e-2)" "unprognostic (1.64e-1)" "unprognostic (2.65e-2)" "unprognostic (8.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.31e-3)" "unprognostic (1.62e-1)" "unprognostic (4.12e-1)" "prognostic favorable (9.26e-4)" "unprognostic (2.47e-1)" "unprognostic (1.92e-1)" "unprognostic (8.30e-2)" "unprognostic (4.08e-2)" 123.7 265.0 82.8 103.2 82.4 149.0 164.8 111.3 111.0 122.5 102.6 240.9 254.7 100.9 150.1 145.9 114.7 112.6 710.9 81.5 94.3 399.9 368.6 93.5 133.0 85.4 83.2 86.8 182.2 411.4 76.7 147.5 86.4 117.5 274.7 161.6 168.3 136.2 537.8 110.7 205.7 146.1 88.8 96.4 174.3 71.1 89.1 192.5 161.7 895.1 175.3 163.8 91.0 90.9 301.2 266.8 255.2 219.3 212.5 276.7 241.2 211.1 176.1 365.7 351.6 511.4 293.8 323.8 163.3 248.0 95.3 337.9 318.3 342.8 325.5 222.3 381.6 351.7 169.3 479.8 172.2 193.6 249.6 222.9 234.1 224.7 134.5 315.7 426.7 321.8 283.4 230.1 352.6 419.0 451.9 217.7 173.3 623.4 201.8 301.9 179.1 460.6 637.5 301.0 141.3 168.2 186.0 417.5 417.1 287.3 437.9 315.9 202.7 151.7 205.3 349.2 229.8 159.2 194.7 265.5 224.7 286.2 127.3 373.0 273.8 241.9 158.5 363.1 185.3 199.2 180.7 174.5 370.4 158.6 146.4 159.6 88.5 226.9 428.2 237.8 261.4 349.3 82.8 82.4 111.3 111.0 81.5 94.3 85.4 83.2 86.4 88.8 89.1 90.9 196.2 118.6 95.4 0.0 30.4 0.0 0.0 0.0 0.0 0.0 156.2 239.3 0.0 0.0 60.7 215.2 0.0 517.1 85.3 0.0 890.2 453.9 0.0 160.9 125.4 76.7 0.0 0.0 0.0 381.8 428.5 89.5 0.0 170.4 97.1 163.2 0.0 0.0 423.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.6 0.0 0.0 140.6 0.0 0.0 0.0 0.0 304.4 0.0 0.0 12.0 0.0 0.0 938.6 64.8 0.0 0.0 0.0 102.0 0.0 0.0 0.0 0.0 371.9 49.1 413.9 0.0 0.0 ATP5F1D ATP5D ENSG00000099624 "ATP synthase F1 subunit delta" P30049 19 1241746-1244825 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 806.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1702.2;Exocrine glandular cells: 566.6;Proximal tubular cells: 1831.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002865 Approved NA NA 160000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "HPA002865: AB_1078244" "unprognostic (4.80e-2)" "unprognostic (9.34e-2)" "unprognostic (7.77e-2)" "prognostic favorable (1.23e-4)" "unprognostic (1.64e-2)" "unprognostic (1.95e-1)" "unprognostic (4.63e-2)" "unprognostic (6.75e-2)" "unprognostic (1.38e-1)" "unprognostic (2.91e-1)" "prognostic favorable (4.60e-4)" "unprognostic (6.95e-2)" "prognostic favorable (3.46e-5)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" 129.0 213.4 74.1 16.2 71.1 31.7 114.0 93.7 110.0 108.1 74.1 196.9 65.6 104.3 8.4 198.2 102.7 11.6 575.2 75.3 80.2 256.0 365.3 87.2 21.6 99.2 74.8 106.8 251.9 34.7 138.4 14.4 95.2 128.1 17.5 6.9 133.9 29.4 806.2 164.9 143.4 11.3 73.1 113.1 200.5 58.6 94.7 15.8 134.4 123.1 15.9 132.5 120.6 74.3 109.6 58.3 17.9 67.2 20.4 29.9 67.0 73.1 30.4 42.4 30.8 60.6 28.4 109.7 46.2 25.6 10.7 92.8 19.9 76.0 5.5 76.5 196.6 66.5 69.6 81.2 50.4 117.4 95.5 59.5 20.6 17.1 23.6 23.9 45.3 72.2 98.4 85.3 19.9 164.8 127.7 84.9 77.6 69.5 284.8 121.1 47.2 233.1 72.3 70.6 71.3 82.1 48.6 76.5 132.4 7.1 57.2 54.8 66.6 38.4 52.9 93.0 61.4 216.0 118.4 41.7 70.8 54.6 59.3 203.0 283.7 128.0 211.9 287.7 255.9 284.2 267.4 233.8 321.3 287.1 242.4 227.7 99.2 246.5 237.6 349.2 287.1 251.6 74.1 71.1 93.7 110.0 75.3 80.2 99.2 74.8 95.2 73.1 94.7 74.3 265.3 16.0 25.4 0.0 101.9 0.0 0.0 0.0 0.0 0.0 402.1 533.8 0.0 0.0 9.3 380.7 0.0 393.5 155.1 0.0 1702.2 351.2 0.0 145.6 261.2 80.3 0.0 0.0 0.0 566.6 471.3 109.6 0.0 256.9 5.1 263.9 0.0 0.0 416.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.7 0.0 0.0 133.4 0.0 0.0 0.0 0.0 437.8 0.0 0.0 40.7 0.0 0.0 1831.8 5.1 0.0 0.0 0.0 145.9 0.0 0.0 0.0 0.0 341.2 82.8 469.2 0.0 0.0 ATP5F1E ATP5E ENSG00000124172 "ATP synthase F1 subunit epsilon" P56381 20 59025475-59032345 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" Hydrolase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 3414.2;Hofbauer cells: 2765.4;Proximal tubular cells: 4125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.73e-1)" "unprognostic (6.30e-2)" "unprognostic (8.16e-2)" "unprognostic (9.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.92e-3)" "unprognostic (7.88e-3)" "unprognostic (2.51e-1)" "unprognostic (5.01e-2)" "unprognostic (6.41e-2)" "unprognostic (4.35e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (3.98e-1)" "unprognostic (3.21e-1)" "unprognostic (1.67e-1)" "unprognostic (2.44e-2)" 81.4 88.3 92.2 98.5 94.5 125.6 62.3 95.3 135.8 49.3 95.7 77.2 80.1 51.2 25.3 77.0 45.2 13.9 162.8 92.7 95.7 128.5 80.2 69.3 69.8 94.2 94.0 42.1 44.9 52.9 104.8 34.0 94.4 50.6 33.1 42.8 62.7 23.7 240.1 42.8 78.9 25.6 95.4 93.5 69.5 47.7 93.7 64.7 64.1 107.0 40.0 63.4 55.5 97.1 150.0 49.6 98.1 90.0 94.0 87.2 65.2 155.9 60.6 102.2 66.0 156.3 143.5 81.1 184.7 82.7 159.6 141.5 70.3 123.7 67.0 66.7 76.4 271.4 107.2 136.5 86.4 193.2 234.6 95.0 105.3 62.5 77.8 99.8 76.9 107.6 103.6 113.8 59.4 144.4 247.8 299.1 32.9 220.4 203.4 120.2 138.3 156.8 107.5 83.0 98.0 146.6 261.6 273.9 328.4 83.5 182.5 312.8 264.3 208.3 222.0 138.9 213.7 180.2 245.9 238.1 201.5 117.9 117.1 613.1 420.6 757.3 237.5 463.8 224.9 351.4 285.8 268.7 356.0 291.7 227.8 259.4 713.9 243.1 470.7 601.7 393.3 781.7 92.2 94.5 95.3 135.8 92.7 95.7 94.2 94.0 94.4 95.4 93.7 97.1 1036.3 516.0 530.8 0.0 331.5 0.0 0.0 0.0 0.0 0.0 1042.4 1138.3 0.0 0.0 289.7 1121.9 0.0 705.8 812.6 0.0 3414.2 998.0 0.0 1145.2 1007.1 436.6 0.0 0.0 0.0 1202.6 956.9 341.7 0.0 1410.3 352.0 594.0 0.0 0.0 2765.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 998.4 0.0 0.0 1473.1 0.0 0.0 0.0 0.0 1427.7 0.0 0.0 132.5 0.0 0.0 4125.3 392.8 0.0 0.0 0.0 334.0 0.0 0.0 0.0 0.0 590.5 431.2 731.9 0.0 0.0 ATP5MC1 "ATP5G, ATP5G1" ENSG00000159199 "ATP synthase membrane subunit c locus 1" P05496 17 48892765-48895871 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 1296.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 387.6;Distal tubular cells: 1449.8;Proximal tubular cells: 913.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 2026.7" "Low region specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "unprognostic (3.43e-2)" "prognostic favorable (3.88e-4)" "unprognostic (6.60e-2)" "unprognostic (2.09e-1)" "unprognostic (8.73e-2)" "unprognostic (4.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.53e-1)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (9.42e-3)" "unprognostic (9.78e-2)" "prognostic favorable (8.24e-6)" "unprognostic (2.07e-2)" "unprognostic (5.60e-2)" "unprognostic (1.95e-1)" "unprognostic (2.33e-1)" 99.1 160.4 210.3 97.5 218.8 116.5 134.1 230.6 265.5 101.7 218.0 359.5 215.2 113.2 179.8 197.7 121.4 58.8 764.0 221.0 230.8 284.4 258.2 81.4 103.5 219.4 211.3 88.4 117.3 268.3 125.6 82.4 217.5 101.2 344.4 117.1 127.1 118.4 874.7 130.9 187.1 149.9 213.2 99.0 195.4 47.2 220.7 129.5 133.2 1296.3 173.1 113.9 118.7 213.2 477.3 631.0 196.6 287.1 212.4 257.7 284.6 257.0 214.9 334.5 329.8 415.1 333.9 514.1 597.5 224.2 357.5 422.5 353.9 449.8 496.5 434.6 475.0 507.8 379.7 848.2 148.9 611.0 244.4 209.4 302.3 353.7 393.3 180.4 384.8 420.5 305.4 344.4 393.5 484.9 586.6 285.5 122.5 2026.7 617.4 364.0 511.3 832.9 645.8 266.7 290.8 210.7 192.0 409.1 227.3 296.6 602.2 411.3 214.2 210.3 288.3 322.3 333.1 309.0 382.7 706.8 302.5 476.7 255.7 75.4 328.5 91.8 193.7 299.5 236.9 463.9 220.0 209.5 448.5 375.2 293.6 253.9 18.2 270.6 179.2 555.2 211.7 341.6 210.3 218.8 230.6 265.5 221.0 230.8 219.4 211.3 217.5 213.2 220.7 213.2 139.6 48.1 87.9 0.0 43.2 0.0 0.0 0.0 0.0 0.0 214.6 312.5 0.0 0.0 49.5 274.0 0.0 387.6 48.6 0.0 1449.8 185.5 0.0 101.4 144.9 61.6 0.0 0.0 0.0 298.1 283.3 82.6 0.0 126.3 73.2 129.8 0.0 0.0 270.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.9 0.0 0.0 72.4 0.0 0.0 0.0 0.0 196.4 0.0 0.0 11.4 0.0 0.0 913.9 53.2 0.0 0.0 0.0 74.6 0.0 0.0 0.0 0.0 222.3 36.5 327.9 0.0 0.0 ATP5MC2 ATP5G2 ENSG00000135390 "ATP synthase membrane subunit c locus 2" Q06055 12 53632726-53677408 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 1335.2;Breast myoepithelial cells: 1873.6;Distal tubular cells: 1762.9;Hofbauer cells: 1076.1;Proximal tubular cells: 2061.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051469 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA051469: AB_2681496" "unprognostic (1.48e-1)" "unprognostic (1.06e-1)" "unprognostic (3.01e-1)" "unprognostic (3.37e-3)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (2.97e-3)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (3.78e-2)" "unprognostic (5.71e-2)" "unprognostic (3.32e-3)" "unprognostic (3.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.42e-1)" "unprognostic (7.09e-2)" 250.6 297.8 487.0 240.0 510.5 445.5 485.5 498.2 574.6 338.4 492.0 444.0 383.6 279.1 463.7 340.5 533.7 296.1 759.6 475.9 499.0 437.4 469.4 243.6 406.4 509.5 488.1 487.2 499.1 503.0 18.9 265.3 507.8 322.2 551.7 275.9 483.0 284.9 1405.5 345.5 322.5 361.1 504.7 295.8 312.1 126.9 500.7 453.9 314.0 1447.2 540.2 365.6 15.2 519.7 325.4 684.8 701.3 640.3 478.0 1162.4 330.7 278.3 630.3 824.5 561.2 236.2 745.1 392.9 668.3 554.8 263.9 304.7 914.6 652.8 729.3 660.9 1096.7 1068.7 515.2 495.7 1034.1 819.7 508.5 1297.4 956.8 797.0 1315.9 1313.7 1078.7 468.0 776.8 1116.6 852.6 857.0 842.8 1996.5 603.6 681.5 756.7 838.3 665.2 981.9 1019.4 407.0 365.8 669.0 376.5 431.6 974.2 610.1 1403.7 1473.7 512.5 396.4 542.2 307.5 441.4 577.6 537.6 288.1 589.9 863.0 620.2 367.7 977.3 281.8 645.6 924.4 710.5 1119.6 826.1 693.6 1324.3 974.6 896.6 755.0 214.2 769.1 849.6 1023.6 955.8 1565.2 487.0 510.5 498.2 574.6 475.9 499.0 509.5 488.1 507.8 504.7 500.7 519.7 412.1 182.7 266.7 0.0 167.8 0.0 0.0 0.0 0.0 0.0 1335.2 1873.6 0.0 0.0 177.0 527.8 0.0 732.4 297.0 0.0 1762.9 470.7 0.0 529.1 446.9 190.2 0.0 0.0 0.0 676.5 777.5 222.2 0.0 454.1 224.5 715.4 0.0 0.0 1076.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 358.0 0.0 0.0 380.9 0.0 0.0 0.0 0.0 392.7 0.0 0.0 52.8 0.0 0.0 2061.3 215.7 0.0 0.0 0.0 248.9 0.0 0.0 0.0 0.0 507.7 182.6 802.8 0.0 0.0 ATP5MC3 ATP5G3 ENSG00000154518 "ATP synthase membrane subunit c locus 3" P48201 2 175176258-175181710 "Metabolic proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1214.0;tongue: 1088.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 880.5;Distal tubular cells: 2666.7;Extravillous trophoblasts: 1022.6;Hofbauer cells: 1008.2;Proximal tubular cells: 2131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (4.45e-3)" "unprognostic (1.67e-1)" "prognostic favorable (9.90e-4)" "unprognostic (1.67e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.46e-2)" "unprognostic (6.03e-3)" "unprognostic (1.42e-2)" "unprognostic (7.90e-2)" "unprognostic (4.71e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.31e-6)" "unprognostic (2.86e-1)" "unprognostic (3.93e-1)" "unprognostic (4.55e-2)" "unprognostic (2.31e-2)" 195.7 199.2 134.9 131.1 142.0 141.2 164.5 160.3 155.0 126.4 168.1 343.9 378.7 127.8 126.5 305.3 107.3 75.8 1214.0 143.0 164.7 432.4 385.3 118.1 127.3 153.7 143.6 99.7 120.2 550.6 139.5 102.4 157.3 110.0 315.0 126.5 184.8 114.5 777.9 169.7 297.3 122.2 147.4 131.4 272.4 62.3 154.2 188.9 135.1 1088.5 176.3 171.8 165.4 150.0 268.4 232.3 346.7 381.8 290.0 255.9 387.1 242.7 255.1 334.8 290.9 700.0 216.4 661.1 276.5 272.0 365.7 343.3 440.2 419.9 348.5 278.3 411.7 538.7 312.1 896.6 225.9 702.4 308.8 279.9 317.7 377.5 239.3 257.4 341.9 313.2 587.0 305.1 370.3 361.9 541.1 587.3 460.6 638.4 726.1 417.1 321.5 648.4 664.5 590.9 310.5 196.3 195.1 521.4 557.0 487.5 313.4 567.0 231.6 55.9 263.2 1.7 338.0 239.5 327.1 582.4 319.8 420.8 251.8 115.2 293.9 126.9 168.4 332.1 170.7 202.4 176.5 184.2 425.2 163.2 164.2 181.1 32.6 197.9 309.4 314.5 204.0 438.5 134.9 142.0 160.3 155.0 143.0 164.7 153.7 143.6 157.3 147.4 154.2 150.0 250.4 176.3 157.2 0.0 69.0 0.0 0.0 0.0 0.0 0.0 324.8 399.4 0.0 0.0 125.7 310.8 0.0 880.5 134.2 0.0 2666.7 479.0 0.0 271.2 264.1 79.3 0.0 0.0 0.0 375.2 1022.6 154.1 0.0 301.5 88.3 236.8 0.0 0.0 1008.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 205.5 0.0 0.0 205.7 0.0 0.0 0.0 0.0 391.9 0.0 0.0 26.5 0.0 0.0 2131.8 129.7 0.0 0.0 0.0 181.9 0.0 0.0 0.0 0.0 690.9 81.0 469.5 0.0 0.0 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396492 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1340.2;Ductal cells: 705.9;Exocrine glandular cells: 723.1;Pancreatic endocrine cells: 884.5;Proximal tubular cells: 1879.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria NA NA 55000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA044798: AB_2679091" "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 332.3 343.0 502.9 155.1 517.7 193.0 324.6 514.9 721.8 215.1 515.2 484.6 273.5 176.9 410.2 426.1 194.3 140.8 1229.7 526.1 539.0 546.7 587.1 215.3 180.3 501.2 501.9 157.5 321.4 519.2 309.2 157.4 506.1 254.2 449.6 245.3 234.8 236.4 1019.3 204.6 261.7 229.8 511.8 185.4 369.8 142.5 509.3 319.0 191.2 1325.5 251.0 284.7 258.9 518.0 557.8 559.4 528.4 648.2 570.2 696.0 348.3 523.2 612.7 501.0 556.6 925.2 605.3 312.4 288.9 575.3 398.6 559.4 502.2 522.7 697.9 414.7 887.3 331.8 682.1 1057.7 545.7 688.3 491.3 569.2 801.1 456.4 715.7 849.2 661.5 470.0 441.5 517.5 849.4 842.0 552.0 1167.5 397.8 830.1 959.1 355.8 326.0 495.3 1218.4 878.4 203.7 464.8 269.4 419.7 824.9 723.5 373.4 619.9 388.6 255.2 394.2 394.0 692.8 537.2 958.4 543.5 545.2 678.2 200.3 575.3 271.2 395.8 214.7 384.0 248.0 301.6 296.3 259.8 314.1 219.1 251.4 256.7 231.1 230.5 375.3 456.3 307.9 304.4 502.9 517.7 514.9 721.8 526.1 539.0 501.2 501.9 506.1 511.8 509.3 518.0 169.1 211.5 173.2 0.0 40.9 0.0 0.0 0.0 0.0 0.0 323.4 417.6 0.0 0.0 91.0 388.1 0.0 298.0 76.3 0.0 1340.2 705.9 0.0 406.0 245.4 114.5 0.0 0.0 0.0 723.1 439.4 81.8 0.0 424.5 118.6 176.9 0.0 0.0 543.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.4 0.0 0.0 432.6 0.0 0.0 0.0 0.0 884.5 0.0 0.0 0.0 0.0 0.0 1879.7 121.0 0.0 0.0 0.0 127.9 0.0 0.0 0.0 0.0 305.8 69.4 209.9 0.0 0.0 ATP5ME ATP5I ENSG00000169020 "ATP synthase membrane subunit e" P56385 4 672436-674330 "Metabolic proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2048.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 886.5;Distal tubular cells: 1729.5;Proximal tubular cells: 2485.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035010 Enhanced Supported Mitochondria NA NA 280000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA035010: AB_10669853" "unprognostic (1.42e-1)" "unprognostic (4.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.32e-1)" "unprognostic (1.35e-3)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (2.46e-3)" "unprognostic (6.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.48e-1)" "unprognostic (6.45e-3)" 360.1 412.7 940.1 212.2 960.8 312.4 277.4 981.5 1172.2 263.3 926.5 555.7 460.3 237.4 242.7 511.9 218.8 94.5 1507.7 932.5 968.9 572.0 591.7 235.6 174.6 980.1 955.6 257.5 330.9 774.8 312.8 144.8 972.5 262.0 331.4 336.4 304.8 220.4 2048.3 297.8 436.7 172.8 952.6 281.3 414.9 130.6 960.4 315.7 270.1 1688.5 223.8 293.5 323.8 998.1 542.0 560.8 781.7 599.5 622.4 544.4 390.7 561.8 445.4 407.4 359.4 525.4 548.4 299.0 472.8 612.4 683.8 361.8 668.9 924.1 241.4 249.9 1082.7 854.6 1107.9 1435.2 659.0 1118.6 368.0 721.6 533.5 472.2 491.0 665.5 503.3 608.1 756.0 314.4 464.7 904.5 972.6 1337.3 861.9 1071.7 1438.9 584.4 555.0 620.7 863.9 1053.2 667.7 530.1 401.6 525.0 620.2 502.7 590.4 695.7 580.2 348.0 340.7 308.2 730.9 739.7 1273.2 947.0 528.0 712.7 391.3 1049.3 1044.5 1188.8 742.1 920.0 776.3 1470.4 909.2 839.0 1067.0 1131.6 837.1 811.9 962.2 943.5 822.7 1179.7 1086.3 1456.6 940.1 960.8 981.5 1172.2 932.5 968.9 980.1 955.6 972.5 952.6 960.4 998.1 311.8 153.8 199.7 0.0 88.6 0.0 0.0 0.0 0.0 0.0 461.7 421.8 0.0 0.0 121.9 886.5 0.0 404.9 188.8 0.0 1729.5 467.4 0.0 468.6 315.6 125.1 0.0 0.0 0.0 692.9 335.8 139.4 0.0 484.2 122.4 311.8 0.0 0.0 676.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 201.6 0.0 0.0 278.1 0.0 0.0 0.0 0.0 509.6 0.0 0.0 50.1 0.0 0.0 2485.3 183.6 0.0 0.0 0.0 156.7 0.0 0.0 0.0 0.0 274.9 97.8 146.6 0.0 0.0 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466186 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 777.4;Distal tubular cells: 1430.2;Exocrine glandular cells: 578.8;Extravillous trophoblasts: 636.3;Hofbauer cells: 787.4;Pancreatic endocrine cells: 589.5;Proximal tubular cells: 1616.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 60000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 328.8 423.5 636.9 268.7 655.2 404.4 310.8 658.3 868.4 247.8 671.0 470.9 442.7 188.3 299.1 526.6 191.7 143.8 1184.8 658.1 663.7 559.3 561.2 241.8 293.1 657.5 648.0 179.1 271.6 509.6 332.1 235.7 647.0 315.5 367.9 320.7 317.8 205.9 1337.1 287.0 384.6 192.0 637.6 281.8 354.7 310.5 652.7 439.3 241.4 1439.0 301.2 303.1 303.5 641.3 1251.5 1130.6 905.3 1400.5 752.1 739.2 561.1 799.3 705.9 947.2 994.6 1226.2 1091.7 1161.7 822.7 548.5 1513.9 735.7 1064.0 981.3 1021.4 831.0 1333.6 800.1 1584.6 1555.4 530.7 1324.4 824.4 835.6 944.9 766.6 858.9 760.5 919.8 1009.4 1681.6 1213.0 1057.4 3128.1 1984.5 2396.1 1228.2 2594.9 1410.9 874.9 741.6 1985.9 1936.7 1376.1 845.3 925.9 1073.7 2519.4 773.1 1365.1 644.9 1687.5 703.0 706.0 1142.1 1197.3 1181.5 685.7 1795.6 2432.4 829.7 1325.8 1131.8 1020.3 904.1 1069.1 440.2 912.7 425.6 597.7 508.3 494.8 1122.9 512.2 445.1 468.3 428.0 555.2 731.2 890.5 754.9 1505.3 636.9 655.2 658.3 868.4 658.1 663.7 657.5 648.0 647.0 637.6 652.7 641.3 147.7 22.4 44.9 0.0 57.9 0.0 0.0 0.0 0.0 0.0 252.4 289.6 0.0 0.0 36.5 386.2 0.0 777.4 125.6 0.0 1430.2 460.9 0.0 302.6 225.3 82.0 0.0 0.0 0.0 578.8 636.3 110.5 0.0 278.3 64.3 188.1 0.0 0.0 787.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 190.2 0.0 0.0 339.1 0.0 0.0 0.0 0.0 589.5 0.0 0.0 18.6 0.0 0.0 1616.3 51.0 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 436.3 64.0 206.4 0.0 0.0 ATP5MG "ATP5JG, ATP5L" ENSG00000167283 "ATP synthase membrane subunit g" O75964 11 118401606-118431496 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1407.2;Distal tubular cells: 2907.4;Hofbauer cells: 1367.3;Proximal tubular cells: 2520.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044629 Approved Supported Mitochondria NA NA 44000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA044629: AB_2679028" "unprognostic (1.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (1.61e-1)" "unprognostic (3.27e-2)" "unprognostic (3.90e-2)" "unprognostic (8.19e-2)" "unprognostic (5.13e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (7.41e-2)" "prognostic favorable (4.09e-5)" "unprognostic (6.26e-2)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (3.05e-2)" 119.8 137.2 154.2 103.3 158.5 165.6 132.5 158.5 184.3 81.1 168.3 153.6 146.4 79.3 143.3 116.9 96.5 68.1 329.8 157.2 160.8 205.1 154.5 77.9 150.0 155.5 153.1 112.0 110.9 140.7 49.5 83.7 154.0 83.5 164.3 100.8 133.9 92.2 340.7 55.3 118.2 95.2 153.6 86.0 112.3 46.9 155.5 204.1 87.5 373.6 183.1 105.3 41.5 154.7 163.1 87.9 209.3 183.1 167.6 198.0 200.1 149.0 175.9 138.4 146.6 259.9 259.9 314.3 352.7 167.5 206.2 190.4 204.4 214.8 155.3 247.6 138.0 472.8 112.5 197.4 175.3 279.3 210.2 207.1 203.4 169.0 162.9 164.1 189.8 216.6 227.4 253.1 199.5 305.8 365.2 497.3 130.1 427.9 224.0 247.0 174.9 422.9 371.1 260.3 184.3 161.9 232.3 361.1 161.9 221.6 303.0 307.7 172.8 123.0 144.7 109.2 190.9 112.8 184.8 402.1 93.8 353.0 154.7 325.4 437.2 299.0 241.8 360.8 339.7 462.7 398.8 321.5 481.2 378.5 472.9 379.7 214.8 357.2 333.3 534.3 464.5 1112.1 154.2 158.5 158.5 184.3 157.2 160.8 155.5 153.1 154.0 153.6 155.5 154.7 324.3 362.2 364.1 0.0 211.2 0.0 0.0 0.0 0.0 0.0 893.9 1061.2 0.0 0.0 166.5 610.6 0.0 1407.2 378.3 0.0 2907.4 748.6 0.0 449.8 327.9 188.9 0.0 0.0 0.0 986.0 935.6 204.7 0.0 404.6 258.6 368.2 0.0 0.0 1367.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 427.7 0.0 0.0 678.1 0.0 0.0 0.0 0.0 922.2 0.0 0.0 94.9 0.0 0.0 2520.3 188.0 0.0 0.0 0.0 217.5 0.0 0.0 0.0 0.0 1001.4 224.2 370.0 0.0 0.0 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1602.3;Extravillous trophoblasts: 671.4;Hofbauer cells: 920.9;Proximal tubular cells: 1883.7;Syncytiotrophoblasts: 710.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA058978: AB_2683867, HPA060520: AB_2684302" "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favorable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 107.8 166.9 304.6 75.7 318.3 177.4 127.5 305.8 446.6 94.9 306.0 165.2 165.1 80.5 139.6 159.4 87.0 48.8 548.2 321.9 313.4 205.2 181.9 79.9 94.4 301.2 297.7 98.3 113.8 257.3 159.9 77.1 302.4 108.5 167.5 169.9 100.9 87.8 489.6 106.1 128.9 78.9 303.1 108.7 135.6 83.4 305.5 135.0 111.5 471.6 122.5 103.0 101.1 304.1 244.6 278.5 233.6 222.8 275.0 284.2 228.5 185.2 211.7 228.6 199.5 240.6 167.4 254.4 187.9 191.2 183.4 201.1 306.4 225.3 310.0 207.9 306.8 280.4 227.5 380.4 180.4 346.2 188.4 298.6 301.5 155.7 164.2 260.8 264.4 330.6 176.7 264.7 253.7 730.8 333.1 493.9 182.1 560.5 523.7 211.5 202.7 231.2 358.4 345.0 201.2 238.4 155.9 289.0 371.4 256.2 355.3 401.7 142.7 87.9 137.9 242.0 153.2 199.3 372.5 360.2 207.8 195.7 152.3 405.1 512.8 336.0 204.9 409.1 232.9 309.5 261.1 234.1 367.0 261.9 295.5 260.0 517.5 206.2 401.4 355.4 282.2 656.9 304.6 318.3 305.8 446.6 321.9 313.4 301.2 297.7 302.4 303.1 305.5 304.1 88.0 221.2 225.1 0.0 47.9 0.0 0.0 0.0 0.0 0.0 369.7 334.4 0.0 0.0 92.2 413.8 0.0 609.1 63.1 0.0 1602.3 504.6 0.0 341.3 245.9 104.1 0.0 0.0 0.0 572.6 671.4 113.8 0.0 297.7 93.4 207.9 0.0 0.0 920.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 210.3 0.0 0.0 335.5 0.0 0.0 0.0 0.0 570.5 0.0 0.0 0.0 0.0 0.0 1883.7 146.5 0.0 0.0 0.0 104.8 0.0 0.0 0.0 0.0 710.1 70.2 228.6 0.0 0.0 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 135.8;tongue: 131.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 346.5;Distal tubular cells: 461.8;Extravillous trophoblasts: 405.2;Hofbauer cells: 373.0;Proximal tubular cells: 434.6;Syncytiotrophoblasts: 347.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 170000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.26e-9)" "prognostic favorable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 19.3 15.7 10.3 11.5 12.5 15.3 18.8 14.5 27.4 17.4 3.9 51.6 28.8 16.6 16.0 26.8 23.9 16.3 109.0 12.1 10.2 40.3 40.2 13.7 24.0 13.4 12.0 19.2 18.5 33.8 7.1 21.6 14.9 22.3 33.6 28.5 29.8 18.7 135.8 15.7 19.0 17.9 9.6 15.2 22.6 15.5 12.8 15.7 31.1 131.0 22.4 21.9 7.4 14.1 55.6 17.6 44.1 36.9 35.6 34.2 34.1 57.0 68.9 67.3 54.7 31.8 29.1 84.9 52.3 45.5 14.3 56.1 69.4 79.5 65.1 61.9 33.2 76.1 21.3 21.5 26.0 98.3 70.8 30.3 40.9 69.3 66.9 17.7 60.0 11.9 78.7 33.6 46.3 35.4 153.3 30.0 34.9 19.2 90.5 41.2 143.6 34.0 54.7 26.0 37.2 13.4 49.4 72.7 55.6 12.6 54.8 46.0 50.6 32.0 49.1 59.4 61.2 41.8 44.5 172.1 70.8 77.6 60.8 3.5 15.4 7.1 14.8 10.0 12.2 12.9 15.1 13.3 16.1 15.2 16.9 10.4 4.8 9.8 9.0 9.2 15.1 44.2 10.3 12.5 14.5 27.4 12.1 10.2 13.4 12.0 14.9 9.6 12.8 14.1 73.2 67.3 83.8 0.0 31.5 0.0 0.0 0.0 0.0 0.0 112.9 155.3 0.0 0.0 57.6 125.0 0.0 346.5 56.4 0.0 461.8 237.3 0.0 132.5 111.0 58.8 0.0 0.0 0.0 196.7 405.2 57.0 0.0 125.4 89.6 82.1 0.0 0.0 373.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.8 0.0 0.0 98.8 0.0 0.0 0.0 0.0 162.6 0.0 0.0 9.8 0.0 0.0 434.6 74.3 0.0 0.0 0.0 58.0 0.0 0.0 0.0 0.0 347.7 41.8 208.0 0.0 0.0 ATP5PD "ATP5H, ATP5JD, ATPQ" ENSG00000167863 "ATP synthase peripheral stalk subunit d" O75947 17 75038863-75046985 "Metabolic proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1142.6;Hofbauer cells: 465.0;Proximal tubular cells: 1059.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042777, HPA048459" Enhanced Supported Mitochondria NA NA 60000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA042777: AB_2678160, HPA048459: AB_2680402" "unprognostic (1.37e-1)" "unprognostic (4.41e-2)" "unprognostic (1.70e-3)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "unprognostic (4.81e-2)" "unprognostic (7.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (2.72e-1)" "unprognostic (8.72e-2)" "unprognostic (2.56e-2)" "unprognostic (1.42e-1)" "unprognostic (3.26e-1)" "unprognostic (1.73e-1)" "unprognostic (4.29e-2)" 253.8 271.0 253.5 156.0 260.5 187.2 228.8 270.5 385.7 190.7 282.9 337.1 295.1 170.7 279.9 355.9 173.5 140.1 985.5 261.9 271.1 465.2 454.2 174.0 166.0 264.8 256.9 147.5 222.2 427.1 203.9 174.1 260.8 177.9 323.6 256.0 240.8 200.5 1102.8 264.7 257.4 211.3 260.2 155.0 307.4 93.8 262.3 175.2 263.7 1025.5 221.2 230.3 221.5 261.7 522.8 445.4 335.6 439.8 532.6 647.4 449.1 437.2 571.3 478.5 452.2 351.8 397.1 349.8 282.5 550.2 450.2 462.2 409.0 571.6 637.5 171.6 346.0 359.1 340.2 703.1 524.2 463.5 225.8 555.3 444.8 390.7 552.7 380.9 646.8 268.5 380.1 462.6 595.1 503.3 461.8 515.6 257.1 1185.3 626.9 322.3 970.4 652.3 1007.3 499.7 335.8 368.5 515.5 811.0 730.7 496.9 805.1 463.2 337.4 591.1 413.2 520.0 520.4 369.0 315.5 360.8 530.2 455.4 390.3 410.8 440.7 481.0 274.8 540.9 320.8 364.5 467.5 341.7 509.7 292.8 416.1 388.9 253.0 301.6 458.0 453.6 492.8 495.9 253.5 260.5 270.5 385.7 261.9 271.1 264.8 256.9 260.8 260.2 262.3 261.7 173.8 173.1 156.4 0.0 35.0 0.0 0.0 0.0 0.0 0.0 159.6 234.2 0.0 0.0 102.8 259.3 0.0 384.3 74.0 0.0 1142.6 313.6 0.0 188.2 153.6 70.4 0.0 0.0 0.0 379.5 328.4 82.7 0.0 207.6 88.3 84.6 0.0 0.0 465.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.1 0.0 0.0 208.8 0.0 0.0 0.0 0.0 284.3 0.0 0.0 13.8 0.0 0.0 1059.2 101.3 0.0 0.0 0.0 88.3 0.0 0.0 0.0 0.0 336.3 54.4 155.9 0.0 0.0 ATP5PF "ATP5, ATP5A, ATP5J, ATPM, CF6" ENSG00000154723 "ATP synthase peripheral stalk subunit F6" P18859 21 25716503-25735673 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 1595.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 2375.2;Proximal tubular cells: 1906.2;Syncytiotrophoblasts: 708.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031069 Supported Supported Mitochondria NA NA 820000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA031069: AB_10603676" "unprognostic (3.52e-2)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (4.87e-2)" "unprognostic (1.77e-1)" "unprognostic (8.83e-2)" "prognostic favorable (2.37e-5)" "unprognostic (1.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.56e-1)" "unprognostic (2.15e-2)" 274.6 276.3 291.2 136.4 295.4 175.1 205.5 302.5 424.4 156.3 316.1 333.5 276.4 128.8 368.1 258.1 129.9 129.7 1052.1 295.2 306.2 489.5 756.3 110.8 166.4 299.3 297.8 127.2 188.2 458.8 140.4 171.5 295.7 160.1 314.4 249.5 214.6 228.5 1161.7 113.6 250.6 189.8 298.7 111.2 226.9 131.5 299.4 217.5 166.0 1595.8 210.9 194.9 138.4 299.6 355.9 260.0 314.5 351.4 344.8 313.5 389.4 305.8 373.0 305.8 300.8 607.6 274.4 439.3 194.2 312.9 467.8 191.5 441.3 379.2 339.2 373.1 441.1 910.6 520.6 618.4 386.8 673.2 284.5 303.1 471.2 284.0 258.6 399.9 363.0 412.2 582.2 522.9 458.2 416.3 468.6 683.2 562.3 824.0 460.7 358.0 606.5 840.0 669.8 504.6 360.2 394.1 516.5 521.7 493.0 449.4 376.5 590.5 260.6 219.6 266.6 209.3 265.9 501.7 954.7 568.2 341.5 707.8 283.1 444.8 447.0 443.7 293.3 487.1 316.1 475.1 385.5 368.6 531.9 399.7 377.4 370.7 292.3 389.9 505.7 504.0 520.3 661.3 291.2 295.4 302.5 424.4 295.2 306.2 299.3 297.8 295.7 298.7 299.4 299.6 532.1 169.9 179.3 0.0 56.0 0.0 0.0 0.0 0.0 0.0 346.3 468.4 0.0 0.0 105.9 419.3 0.0 652.7 116.4 0.0 2375.2 447.0 0.0 299.2 257.6 150.6 0.0 0.0 0.0 472.5 522.8 135.6 0.0 308.5 109.7 341.2 0.0 0.0 522.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.2 0.0 0.0 226.4 0.0 0.0 0.0 0.0 427.1 0.0 0.0 21.4 0.0 0.0 1906.2 142.1 0.0 0.0 0.0 161.4 0.0 0.0 0.0 0.0 708.2 79.2 387.8 0.0 0.0 ATP5PO "ATP5O, ATPO, OSCP" ENSG00000241837 "ATP synthase peripheral stalk subunit OSCP" P48047 21 33903453-33915814 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 1601.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 610.3;Distal tubular cells: 1794.2;Extravillous trophoblasts: 623.2;Hofbauer cells: 627.0;Proximal tubular cells: 1236.8;Syncytiotrophoblasts: 542.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016209, HPA041394" Enhanced Approved Mitochondria NA NA 150000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" Mitochondria "CAB016209: AB_631361, HPA041394: AB_2677450" "unprognostic (2.08e-1)" "unprognostic (4.77e-3)" "unprognostic (3.30e-1)" "unprognostic (6.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.34e-1)" "unprognostic (8.47e-2)" "unprognostic (1.42e-1)" "unprognostic (3.27e-1)" "unprognostic (1.81e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (3.26e-2)" "unprognostic (7.89e-3)" 213.0 181.0 282.7 147.9 289.4 310.6 280.4 306.0 417.7 204.8 325.2 351.9 357.2 169.2 251.1 288.3 216.7 157.9 1114.5 291.2 317.4 458.0 401.8 148.9 243.3 298.2 290.8 273.1 196.7 432.9 108.0 192.2 296.5 158.0 391.9 219.4 236.3 202.0 1063.7 188.4 293.8 217.4 290.9 143.4 304.2 150.3 291.4 281.7 224.4 1601.7 292.9 242.3 161.6 292.4 398.4 187.3 491.1 486.6 340.0 435.1 554.6 218.5 394.4 371.4 361.9 553.5 372.7 531.5 187.2 345.1 355.2 217.5 549.0 764.7 440.6 400.0 544.0 790.3 260.4 513.5 389.7 603.7 260.9 445.8 467.9 358.4 581.9 407.0 522.8 421.2 656.3 665.9 488.5 402.5 461.6 593.0 561.3 992.2 540.1 471.6 490.1 1007.5 1032.8 337.0 404.4 232.1 380.2 559.7 525.7 425.6 562.9 660.5 291.0 236.8 280.6 423.0 252.6 429.1 524.2 559.7 438.2 1046.2 349.3 329.7 561.5 407.8 335.9 596.2 400.9 575.4 439.5 404.8 753.0 487.3 540.9 459.4 136.2 412.6 539.8 445.4 585.3 1077.9 282.7 289.4 306.0 417.7 291.2 317.4 298.2 290.8 296.5 290.9 291.4 292.4 195.8 243.6 191.1 0.0 82.1 0.0 0.0 0.0 0.0 0.0 282.6 476.1 0.0 0.0 121.3 222.5 0.0 610.3 81.3 0.0 1794.2 394.5 0.0 133.0 140.9 87.3 0.0 0.0 0.0 420.2 623.2 109.7 0.0 114.8 114.8 198.9 0.0 0.0 627.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 131.2 0.0 0.0 218.1 0.0 0.0 0.0 0.0 331.9 0.0 0.0 17.8 0.0 0.0 1236.8 102.0 0.0 0.0 0.0 119.0 0.0 0.0 0.0 0.0 542.1 67.4 208.9 0.0 0.0 ATP6V1E1 "ATP6E, ATP6E2, ATP6V1E, P31, Vma4" ENSG00000131100 "ATPase H+ transporting V1 subunit E1" P36543 22 17592136-17628749 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 461.8;Proximal tubular cells: 411.3;Syncytiotrophoblasts: 479.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009528, CAB018699, HPA029196" Enhanced Approved Nucleoplasm NA NA 34000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944" "unprognostic (1.53e-3)" "unprognostic (5.78e-3)" "unprognostic (1.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.24e-3)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.17e-1)" "unprognostic (2.09e-1)" "unprognostic (3.37e-2)" "unprognostic (7.72e-3)" "prognostic favorable (4.18e-4)" "prognostic favorable (7.66e-8)" "unprognostic (3.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (2.75e-1)" 119.5 165.0 209.8 68.3 220.9 90.4 109.5 214.3 287.3 101.7 200.4 128.9 56.6 112.2 135.8 117.2 96.0 84.7 224.9 231.8 226.9 230.5 85.6 110.3 88.6 220.3 202.3 81.9 59.5 239.9 117.1 113.8 230.8 95.0 99.7 128.4 83.7 126.4 232.8 120.3 83.1 121.0 215.9 99.0 101.8 67.3 218.1 108.2 100.8 178.6 109.5 114.5 97.6 245.6 121.8 108.6 96.4 94.3 314.4 169.6 106.0 159.3 212.0 198.7 228.0 137.3 97.5 76.1 132.8 215.0 251.8 187.9 152.8 140.2 174.9 145.9 173.3 137.1 97.5 182.7 459.9 159.8 226.5 212.9 267.7 192.4 138.7 220.9 170.2 95.0 174.8 150.3 341.9 127.4 136.5 114.5 71.0 269.6 152.6 80.3 140.7 45.7 331.6 189.0 70.3 122.7 146.0 101.0 358.9 187.0 98.6 180.4 146.3 137.5 72.6 174.0 119.2 145.7 275.5 96.3 221.2 76.7 189.3 178.1 106.3 184.7 64.0 100.9 63.0 78.7 64.7 61.5 83.6 59.8 60.8 63.7 137.6 76.0 120.5 81.2 97.7 112.8 209.8 220.9 214.3 287.3 231.8 226.9 220.3 202.3 230.8 215.9 218.1 245.6 66.5 76.9 83.4 13.4 47.1 41.9 77.6 121.8 19.9 54.6 33.9 34.8 126.8 74.4 83.9 138.0 27.1 235.1 63.8 105.2 461.8 143.8 7.6 74.3 56.9 69.3 41.9 49.4 24.9 119.7 143.9 60.8 40.8 79.2 90.5 41.6 72.5 46.8 186.8 53.8 24.4 54.0 116.0 75.1 52.1 17.9 94.1 91.9 80.0 15.0 144.1 94.1 85.5 13.0 31.9 154.7 104.7 97.8 38.3 60.1 65.4 411.3 78.8 50.4 59.2 39.0 74.5 71.7 74.7 34.3 51.6 479.1 54.6 57.6 40.1 93.1 ATRIP "FLJ12343, MGC20625, MGC21482, MGC26740" ENSG00000164053 "ATR interacting protein" Q8WXE1 3 48446710-48467645 "Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 14.9" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033109, HPA047590" Approved Supported Nucleoplasm NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB033109: AB_634993, HPA047590: AB_2680094" "unprognostic (5.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.85e-1)" "unprognostic (8.87e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "unprognostic (4.72e-2)" "unprognostic (8.88e-3)" "unprognostic (2.66e-1)" "unprognostic (7.94e-2)" "unprognostic (2.53e-2)" "unprognostic (7.05e-2)" "unprognostic (2.01e-1)" "unprognostic (8.89e-2)" "unprognostic (2.59e-1)" "unprognostic (1.40e-2)" "unprognostic (8.52e-2)" 3.8 2.6 2.0 3.7 2.1 5.0 3.8 3.9 2.3 3.9 2.2 3.1 2.4 3.4 1.4 3.7 3.0 2.0 2.4 2.0 1.7 3.1 2.5 3.6 3.6 2.0 1.9 3.6 2.7 4.0 1.8 3.2 1.9 3.0 3.5 2.7 2.5 3.6 4.7 4.4 2.6 3.0 1.6 3.0 2.8 14.9 2.0 4.9 5.4 3.0 4.9 3.3 3.5 2.3 8.7 3.7 9.7 7.4 5.6 9.5 10.2 13.1 6.0 15.7 12.8 5.1 6.3 19.3 5.9 5.4 7.3 9.2 10.9 10.2 15.1 11.5 5.6 14.9 19.1 3.7 3.2 15.0 9.7 3.8 3.1 8.5 4.0 3.5 7.0 7.1 12.0 9.6 14.7 4.9 12.6 5.4 7.5 4.4 10.5 8.5 8.7 13.7 5.3 4.3 4.7 6.9 10.4 10.5 3.9 8.5 8.8 5.7 8.1 10.7 7.0 13.0 15.3 11.6 20.0 13.6 5.7 11.2 6.0 0.2 0.7 0.0 1.1 0.3 0.1 0.3 0.9 0.5 0.5 0.2 0.7 1.0 0.5 0.5 0.6 1.1 1.2 0.7 2.0 2.1 3.9 2.3 2.0 1.7 2.0 1.9 1.9 1.6 2.0 2.3 4.3 0.0 1.5 2.0 0.9 2.9 0.0 0.9 0.0 1.0 4.1 4.7 1.6 0.0 2.0 0.0 2.1 0.2 4.4 2.4 0.0 3.6 0.0 3.8 6.4 2.3 0.0 0.4 3.2 3.9 0.1 2.2 1.5 5.8 0.0 5.5 0.0 0.0 0.1 1.7 3.2 1.7 2.0 0.0 0.5 0.0 0.0 2.5 0.0 1.9 1.6 0.5 3.1 2.0 3.3 4.1 1.1 0.0 0.7 0.0 0.0 2.1 3.6 2.1 0.0 0.0 4.5 0.0 0.0 0.0 3.8 0.1 2.2 4.2 1.3 0.0 B3GNT10 ENSG00000214654 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 10 (putative)" A8MXE2 9 120792403-120799918 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;Distal tubular cells: 1.9;Endometrial ciliated cells: 1.5;Endometrial stromal cells: 1.3;Proximal tubular cells: 1.3;Respiratory ciliated cells: 1.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" "unprognostic (4.59e-3)" "unprognostic (2.71e-2)" "unprognostic (3.04e-2)" "unprognostic (5.71e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (7.99e-4)" "unprognostic (1.21e-1)" "unprognostic (2.42e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (2.57e-2)" "unprognostic (1.08e-7)" "unprognostic (1.91e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (1.73e-1)" 1.2 1.2 0.7 1.8 1.3 4.8 2.1 0.9 0.7 1.3 1.4 1.8 1.5 0.8 2.0 1.2 1.9 1.2 1.1 0.7 0.8 2.7 1.2 1.1 2.7 1.2 0.8 1.7 1.4 2.2 0.8 1.2 1.1 1.9 2.2 2.4 1.3 1.5 1.0 1.2 1.5 0.9 1.0 1.9 2.3 2.4 1.2 2.1 2.8 0.4 2.9 1.2 0.5 2.7 3.0 3.7 4.0 2.6 3.4 2.6 4.9 2.8 2.9 4.7 2.8 1.2 4.5 5.7 2.4 1.4 5.5 7.8 7.1 5.7 5.4 7.0 2.2 3.3 2.7 1.9 5.7 3.9 1.4 2.8 2.9 3.5 8.2 1.0 0.9 6.5 10.2 7.7 2.9 4.3 2.9 0.9 5.8 6.4 3.6 3.0 7.6 8.8 2.6 2.9 5.7 4.4 5.2 2.5 5.5 2.5 10.1 0.8 1.4 2.3 2.0 5.0 2.8 9.1 14.8 5.4 4.9 2.2 4.8 0.3 0.5 1.2 0.9 0.5 1.0 0.8 0.9 1.1 0.6 0.8 1.3 0.7 0.4 1.1 1.0 0.4 1.2 0.7 0.7 1.3 0.9 0.7 0.7 0.8 1.2 0.8 1.1 1.0 1.2 2.7 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 3.7 0.0 0.0 0.6 0.0 1.9 0.5 0.0 1.5 1.3 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 B4GALT2 beta4Gal-T2 ENSG00000117411 "Beta-1,4-galactosyltransferase 2" O60909 1 43978943-43991170 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007620, HPA047739" Supported Supported "Golgi apparatus,Vesicles" NA NA 3100000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Vesicles" "HPA007620: AB_2667879, HPA047739: AB_2680141" "unprognostic (1.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (1.19e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (1.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" "unprognostic (4.23e-3)" "unprognostic (7.58e-2)" "prognostic unfavorable (3.62e-5)" "unprognostic (6.54e-2)" "unprognostic (1.52e-1)" "unprognostic (7.66e-2)" "unprognostic (3.12e-3)" 29.0 19.0 61.4 13.0 55.0 6.6 24.6 48.0 70.1 28.4 44.0 43.7 12.5 31.0 9.6 32.4 20.0 14.9 40.8 58.4 51.6 24.6 38.8 19.6 5.9 53.6 53.6 19.6 51.5 14.2 24.7 10.1 53.0 31.2 10.2 8.9 27.3 23.8 61.0 32.8 15.2 26.3 52.6 12.0 22.4 22.6 55.2 3.1 14.3 33.2 6.8 37.0 26.8 52.6 61.6 38.4 45.3 76.0 51.3 54.5 37.8 54.2 55.9 54.8 50.9 30.4 51.4 38.4 31.6 112.3 52.5 39.9 36.8 72.8 14.0 39.6 80.2 23.2 37.8 66.9 43.2 20.6 0.8 47.0 79.1 39.3 71.4 55.3 65.5 15.9 51.7 25.3 46.7 45.3 15.3 18.6 65.6 35.7 56.7 44.3 48.2 62.7 33.9 29.3 72.7 58.5 31.1 89.4 38.5 16.9 38.6 17.5 39.3 90.8 102.4 63.8 78.5 7.6 17.8 15.9 40.4 16.9 64.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 61.4 55.0 48.0 70.1 58.4 51.6 53.6 53.6 53.0 52.6 55.2 52.6 9.7 0.0 8.8 7.5 2.2 7.8 10.3 10.8 1.8 13.3 15.0 18.9 14.0 7.2 7.4 14.7 4.2 2.0 1.2 10.2 1.9 13.3 16.4 6.2 16.2 10.4 16.3 1.3 8.0 20.6 8.0 15.2 13.7 8.7 0.0 23.8 6.1 18.7 2.3 18.5 5.6 22.6 2.0 1.0 3.3 6.7 16.4 1.5 3.6 1.0 1.6 15.0 0.0 5.0 9.8 27.3 6.1 12.4 5.0 25.9 6.4 8.8 4.4 12.2 6.6 9.8 14.3 6.2 15.6 7.6 12.6 0.5 1.7 21.1 15.3 16.1 BABAM2 "BRCC4, BRCC45, BRE" ENSG00000158019 "BRISC and BRCA1 A complex member 2" Q9NXR7 2 27889941-28338901 "Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "adrenal gland: 380.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.1;Distal tubular cells: 84.1;Ductal cells: 53.4;Proximal tubular cells: 84.1;Syncytiotrophoblasts: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017926, HPA048867" Enhanced Supported Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA017926: AB_1845443, HPA048867: " "unprognostic (1.28e-1)" "unprognostic (2.30e-1)" "unprognostic (1.53e-3)" "unprognostic (1.61e-3)" "unprognostic (1.89e-1)" "unprognostic (2.68e-3)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.03e-1)" "unprognostic (2.38e-2)" "unprognostic (8.98e-2)" "unprognostic (2.13e-1)" "unprognostic (6.52e-2)" "unprognostic (4.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.74e-2)" "unprognostic (2.91e-2)" "unprognostic (1.22e-2)" 30.9 380.0 22.1 21.2 25.2 41.6 27.5 22.9 28.4 31.8 24.6 27.2 18.3 32.1 33.5 24.5 31.0 32.0 54.2 27.4 28.4 54.2 28.6 24.9 20.5 22.4 23.4 36.3 21.7 35.1 32.8 23.3 30.9 24.9 26.2 26.2 20.5 29.0 73.8 25.9 23.0 36.9 18.6 28.6 25.2 27.2 21.1 21.4 24.0 54.8 26.3 31.2 25.3 21.6 39.5 42.8 33.6 35.7 42.4 56.5 33.2 19.4 49.0 36.0 37.2 36.5 39.4 44.4 64.1 47.3 28.9 25.7 27.7 50.9 52.5 37.8 37.1 53.2 17.5 40.9 61.3 28.1 41.5 139.0 43.6 50.3 51.9 45.1 38.7 41.0 27.7 47.3 50.7 33.3 32.8 34.2 25.7 51.4 27.8 29.9 53.6 42.9 104.2 20.4 22.0 35.0 23.0 39.9 40.3 33.9 28.6 36.5 31.7 34.1 45.2 31.7 27.1 53.5 55.8 57.7 63.5 75.6 36.4 106.3 65.6 27.8 57.9 53.1 64.6 50.6 48.7 55.3 86.3 37.6 45.7 43.6 34.3 59.0 55.3 34.4 62.2 56.9 22.1 25.2 22.9 28.4 27.4 28.4 22.4 23.4 30.9 18.6 21.1 21.6 26.7 3.2 19.6 0.0 7.0 0.0 0.0 0.0 0.0 0.0 16.0 18.0 0.0 0.0 5.6 40.5 0.0 46.1 19.0 0.0 84.1 53.4 0.0 22.6 17.4 10.0 0.0 0.0 0.0 44.3 36.8 11.0 0.0 32.5 31.5 23.1 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 25.8 0.0 0.0 0.0 0.0 20.2 0.0 0.0 4.0 0.0 0.0 84.1 8.7 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 48.2 9.7 44.5 0.0 0.0 BCAS2 "DAM1, Snt309, SPF27" ENSG00000116752 "BCAS2 pre-mRNA processing factor" O75934 1 114567557-114581629 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 613.4" "Low region specificity" "Detected in all" HPA067881 Supported Supported "Nuclear speckles,Centrosome" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles, Centrosome" "HPA067881: AB_2685915" "unprognostic (6.93e-2)" "unprognostic (1.88e-2)" "unprognostic (8.58e-3)" "unprognostic (4.74e-2)" "unprognostic (2.49e-1)" "unprognostic (2.99e-3)" "prognostic unfavorable (8.23e-7)" "unprognostic (1.16e-1)" "unprognostic (8.51e-3)" "prognostic favorable (7.96e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (4.27e-4)" "prognostic favorable (6.49e-4)" "unprognostic (2.25e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.24e-4)" "unprognostic (1.87e-1)" 31.9 40.6 32.8 28.0 35.4 76.2 38.2 36.7 45.3 27.1 34.6 31.6 25.5 35.1 49.7 34.1 24.9 31.8 39.3 35.7 38.8 44.6 51.3 26.9 38.5 34.9 37.6 32.5 28.8 41.3 33.1 27.8 37.8 35.6 32.1 40.4 29.6 27.2 56.4 29.8 26.1 27.8 34.7 26.1 28.7 31.8 34.6 32.2 42.4 25.9 36.2 41.5 23.4 37.7 100.0 35.6 70.8 69.9 37.8 43.8 108.8 71.3 57.0 95.6 97.4 50.8 40.6 88.8 93.9 46.9 64.3 47.8 85.5 72.7 133.3 76.7 75.7 45.0 67.2 74.6 68.8 117.8 48.1 39.2 79.4 97.5 121.3 44.2 63.7 95.0 89.6 64.5 80.5 613.4 103.1 87.5 125.6 60.8 80.8 73.9 127.6 62.2 68.1 85.9 93.5 62.2 90.3 70.3 114.3 59.6 62.3 91.0 52.8 58.2 74.7 116.9 138.2 68.5 76.9 143.4 113.4 94.7 223.9 54.4 36.8 65.3 56.0 45.2 78.9 63.3 71.6 70.6 39.7 58.0 73.8 71.9 34.7 75.0 51.0 51.2 77.6 72.8 32.8 35.4 36.7 45.3 35.7 38.8 34.9 37.6 37.8 34.7 34.6 37.7 51.6 28.9 45.4 11.1 110.1 77.9 114.2 155.9 91.0 62.6 36.7 49.1 76.0 27.1 85.4 49.7 37.5 76.6 99.0 26.4 95.9 66.6 30.3 79.0 51.5 46.9 50.0 30.5 16.4 66.8 89.8 60.0 25.0 139.1 99.1 46.0 28.2 31.3 66.9 38.7 15.1 43.1 103.7 34.9 93.3 17.7 39.7 80.8 67.6 12.2 50.6 98.3 55.6 15.1 18.1 51.2 37.9 43.6 176.7 49.8 29.4 103.9 55.6 67.1 39.5 55.5 71.4 80.8 40.6 95.7 63.4 101.2 117.4 64.2 36.0 114.2 BCLAF3 CXorf23 ENSG00000173681 "BCLAF1 and THRAP3 family member 3" A2AJT9 X 19912860-19970298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 17.0;Granulosa cells: 12.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027215 Approved Approved Nucleoplasm NA NA "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA027215: AB_1847358" "unprognostic (2.46e-1)" "unprognostic (1.96e-1)" "unprognostic (3.15e-1)" "unprognostic (2.24e-1)" "unprognostic (2.27e-2)" "unprognostic (2.48e-2)" "unprognostic (3.72e-2)" "prognostic favorable (5.42e-4)" "unprognostic (1.82e-2)" "unprognostic (1.10e-1)" "unprognostic (1.43e-1)" "unprognostic (4.83e-2)" "unprognostic (2.03e-2)" "unprognostic (2.21e-1)" "unprognostic (9.38e-2)" "unprognostic (2.30e-2)" "prognostic favorable (5.56e-4)" 4.6 3.0 3.5 3.8 4.0 3.6 5.2 10.2 3.8 4.7 2.0 5.2 3.4 5.5 8.3 3.5 4.0 4.2 3.4 4.0 3.1 4.3 2.7 4.5 4.3 3.4 3.4 5.0 3.4 5.7 3.4 3.3 3.6 5.0 5.9 6.4 3.4 5.1 4.5 6.0 4.4 4.0 2.6 4.1 3.9 2.6 5.0 5.3 4.7 5.2 4.2 4.2 4.1 5.0 4.8 3.8 5.1 8.7 4.5 6.3 2.8 4.4 3.7 2.8 3.9 3.4 5.0 4.9 2.6 5.2 4.9 3.5 4.6 3.3 5.3 3.2 3.7 3.1 4.3 3.4 6.3 4.4 5.3 5.7 5.0 3.1 4.2 6.5 3.2 3.9 2.3 11.5 3.2 3.6 3.1 2.9 4.5 4.5 4.8 1.3 5.1 6.7 7.3 4.7 3.1 4.8 5.6 4.6 4.5 9.5 5.5 3.9 6.0 4.7 2.3 11.4 3.3 3.6 3.0 4.0 4.0 2.4 4.1 1.8 0.3 0.6 0.4 0.4 0.5 0.4 0.3 0.4 0.2 0.8 0.3 0.4 1.5 0.4 0.4 0.7 0.2 0.1 3.5 4.0 10.2 3.8 4.0 3.1 3.4 3.4 3.6 2.6 5.0 5.0 10.8 16.0 17.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 8.8 8.1 0.0 0.0 7.4 9.2 0.0 4.5 8.9 0.0 1.9 6.1 0.0 8.2 9.4 3.4 0.0 0.0 0.0 3.6 3.5 5.0 0.0 10.9 6.3 12.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 6.1 0.0 0.0 3.6 0.0 0.0 6.2 4.4 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 4.5 3.9 7.4 0.0 0.0 BICRA GLTSCR1 ENSG00000063169 "BRD4 interacting chromatin remodeling complex associated protein" Q9NZM4 19 47608196-47703277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.5;Breast myoepithelial cells: 6.1;Collecting duct cells: 7.3;Endometrial stromal cells: 6.4;Glandular and luminal cells: 6.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056211 Approved Supported Nucleoplasm NA NA "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA056211: AB_2683068" "unprognostic (2.36e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-2)" "unprognostic (9.58e-2)" "unprognostic (7.75e-2)" "prognostic favorable (1.34e-4)" "unprognostic (8.38e-2)" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-2)" "unprognostic (1.56e-3)" "unprognostic (2.21e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (9.72e-2)" "unprognostic (7.98e-2)" "unprognostic (1.61e-1)" "prognostic favorable (9.34e-4)" 6.7 5.0 1.6 5.0 2.1 5.3 6.9 4.3 3.6 9.6 0.9 9.1 6.5 10.6 1.6 6.9 9.1 2.4 6.2 3.6 1.1 3.9 4.9 7.0 3.9 1.9 0.5 8.6 4.4 4.0 5.6 4.8 1.0 8.2 3.6 4.2 7.0 4.1 13.7 9.9 7.3 5.3 0.0 6.1 6.3 3.0 2.2 5.6 7.5 5.5 3.5 8.6 8.3 5.5 6.8 6.6 12.3 9.5 6.0 6.1 7.0 5.8 4.9 6.4 4.3 7.3 3.5 7.3 3.0 6.7 5.4 6.9 7.7 4.1 6.4 7.5 6.5 4.3 5.3 3.1 7.7 5.1 7.5 5.2 5.6 7.0 6.3 5.3 6.5 6.2 6.7 8.4 3.9 4.8 9.1 16.3 8.6 8.7 5.4 9.7 4.2 2.1 2.5 4.6 7.4 9.6 14.4 8.3 3.7 10.0 3.4 4.0 8.1 5.3 10.8 4.4 7.9 6.8 11.8 7.1 1.2 3.6 8.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.6 2.1 4.3 3.6 3.6 1.1 1.9 0.5 1.0 0.0 2.2 5.5 5.1 9.6 6.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.2 6.1 0.0 0.0 0.6 7.3 0.0 4.3 3.8 0.0 0.0 3.2 0.0 4.9 6.4 2.0 0.0 0.0 0.0 3.8 3.9 1.6 0.0 6.0 1.3 4.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 5.5 2.0 3.3 0.0 0.0 BICRAL "GLTSCR1L, KIAA0240" ENSG00000112624 "BRD4 interacting chromatin remodeling complex associated protein like" Q6AI39 6 42746958-42868560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 10.3;Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.4;Breast glandular cells: 10.2;Breast myoepithelial cells: 9.1;dendritic cells: 11.6;Endometrial stromal cells: 9.6;Glandular and luminal cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029390, HPA029391" Approved Supported Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA029390: AB_10599730, HPA029391: AB_10599949" "unprognostic (2.30e-1)" "unprognostic (1.76e-1)" "unprognostic (2.15e-2)" "unprognostic (3.46e-2)" "unprognostic (9.25e-2)" "prognostic favorable (5.47e-4)" "unprognostic (2.74e-1)" "unprognostic (6.17e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-2)" "unprognostic (1.55e-1)" "unprognostic (7.24e-2)" "unprognostic (1.54e-3)" "unprognostic (4.71e-2)" "unprognostic (2.60e-1)" "unprognostic (1.29e-1)" "unprognostic (6.54e-2)" 8.5 5.7 4.5 8.3 4.4 7.7 9.5 15.9 6.9 9.4 1.1 7.6 6.1 11.3 7.7 6.5 10.2 7.2 7.0 4.2 5.0 6.1 5.7 7.8 12.2 4.8 4.0 16.2 7.0 10.4 5.8 5.2 5.1 9.2 9.5 14.3 8.3 8.1 8.0 8.7 6.7 9.6 2.9 9.8 7.5 5.0 4.0 11.6 11.3 9.4 12.2 7.7 7.3 7.4 6.2 4.9 4.3 6.9 8.7 10.0 3.7 5.4 5.6 4.7 3.6 2.2 4.4 14.4 4.8 9.1 7.2 4.8 4.2 5.6 7.7 10.8 2.7 10.1 4.9 6.3 4.6 8.6 8.8 6.2 10.6 4.6 8.4 8.9 4.9 8.4 9.8 12.5 5.6 7.4 1.4 4.9 4.8 24.3 3.0 8.9 2.5 14.3 4.8 4.0 14.6 7.8 6.1 8.7 6.1 4.1 7.6 10.0 5.7 6.5 6.4 4.3 5.4 11.3 7.0 21.6 3.9 10.8 4.7 2.3 0.5 2.8 2.2 0.4 1.9 1.2 1.3 2.1 0.4 1.3 1.2 1.6 3.7 1.6 0.8 0.7 1.6 0.6 4.5 4.4 15.9 6.9 4.2 5.0 4.8 4.0 5.1 2.9 4.0 7.4 10.3 9.6 9.4 0.0 4.2 0.0 0.0 0.0 0.0 0.0 10.2 9.1 0.0 0.0 4.3 3.7 0.0 2.3 11.6 0.0 0.0 3.8 0.0 6.2 9.6 3.1 0.0 0.0 0.0 3.8 2.1 3.9 0.0 9.8 1.3 8.4 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 3.5 0.0 0.0 4.3 2.9 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.4 5.0 5.2 0.0 0.0 BMT2 "C7orf60, DKFZp762M126, FLJ31818, SAMTOR" ENSG00000164603 "Base methyltransferase of 25S rRNA 2 homolog" Q1RMZ1 7 112819147-112939875 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;Extravillous trophoblasts: 25.9;Hofbauer cells: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044405, HPA050733" Uncertain Approved Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA044405: AB_10959783, HPA050733: AB_2681223" "unprognostic (5.26e-2)" "unprognostic (3.95e-2)" "unprognostic (2.86e-1)" "unprognostic (2.39e-1)" "unprognostic (2.48e-1)" "unprognostic (1.11e-1)" "unprognostic (7.61e-5)" "unprognostic (1.50e-3)" "unprognostic (1.61e-2)" "unprognostic (9.82e-3)" "unprognostic (1.68e-1)" "unprognostic (2.30e-1)" "unprognostic (1.04e-1)" "unprognostic (6.94e-2)" "unprognostic (1.13e-1)" "unprognostic (8.22e-2)" "unprognostic (9.10e-2)" 3.9 4.0 7.2 4.8 7.4 4.9 5.8 8.9 10.7 5.9 5.7 4.9 2.6 7.3 4.2 7.3 4.4 5.0 12.7 7.3 8.4 5.4 2.3 4.3 5.8 5.3 6.6 5.8 3.1 4.8 2.9 5.1 5.6 5.6 4.3 9.3 5.0 6.4 3.2 3.8 3.3 7.2 6.1 6.0 3.1 8.0 8.7 8.2 5.2 4.2 5.7 6.3 4.3 5.8 5.9 4.9 12.3 11.1 16.3 18.6 3.7 6.1 27.5 10.8 15.6 3.0 4.6 2.0 7.7 11.2 11.9 2.8 6.6 9.1 17.6 6.2 6.7 10.3 3.1 3.7 7.3 4.0 9.6 14.2 7.1 8.5 7.4 13.5 8.8 3.7 3.3 3.8 13.2 4.5 9.5 11.5 2.7 4.2 5.1 4.7 16.1 6.2 8.3 7.8 4.9 12.5 11.5 4.7 6.8 11.8 2.3 3.6 6.2 13.8 3.3 8.9 4.8 4.9 4.9 3.7 14.9 5.9 8.2 6.7 3.8 6.5 3.2 3.9 3.9 2.5 3.1 3.7 3.9 2.4 4.2 3.7 8.7 3.7 4.4 2.3 5.2 1.6 7.2 7.4 8.9 10.7 7.3 8.4 5.3 6.6 5.6 6.1 8.7 5.8 6.8 6.4 5.6 0.0 2.0 0.0 0.0 0.0 0.0 0.0 7.9 7.6 0.0 0.0 1.8 12.9 0.0 6.9 4.8 0.0 0.0 3.4 0.0 4.6 8.5 2.6 0.0 0.0 0.0 2.5 25.9 2.7 0.0 5.4 0.0 8.9 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.6 0.0 0.0 6.6 3.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 8.2 2.6 5.8 0.0 0.0 BORCS5 "LOH12CR1, LOH1CR12" ENSG00000165714 "BLOC-1 related complex subunit 5" Q969J3 12 12357078-12471233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 42.6;T-cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039509, HPA043627" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Plasma membrane" "HPA039509: AB_2676550, HPA043627: AB_2678588" "unprognostic (1.82e-1)" "unprognostic (2.87e-1)" "unprognostic (2.81e-1)" "unprognostic (2.41e-1)" "unprognostic (8.00e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (6.78e-2)" "unprognostic (6.16e-2)" "unprognostic (2.79e-2)" "unprognostic (6.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-1)" "unprognostic (9.51e-2)" 6.3 8.1 5.1 2.5 7.1 6.2 6.1 5.2 6.4 6.6 2.3 5.8 1.7 5.8 5.8 8.0 5.7 2.4 7.1 4.1 5.8 5.9 8.5 6.5 2.9 5.6 5.4 4.9 7.2 3.8 7.1 2.7 6.2 5.9 2.2 2.8 5.4 1.9 8.4 8.7 4.7 3.0 4.7 6.2 5.9 9.1 5.4 3.1 4.6 3.3 3.9 5.6 6.8 8.2 3.9 4.1 2.9 3.0 6.4 8.7 3.3 3.4 3.9 4.1 5.1 10.0 3.9 4.9 2.0 5.5 2.9 2.7 5.0 4.9 4.4 14.0 4.5 2.7 3.9 5.7 6.1 2.9 3.8 4.9 3.5 5.6 6.5 6.5 4.9 6.1 3.8 6.6 5.4 8.4 4.2 3.0 9.0 4.1 2.6 3.4 4.1 5.3 5.1 2.6 3.6 4.1 3.3 3.0 7.5 9.6 2.3 3.1 4.1 2.7 6.1 3.5 3.1 3.4 3.2 11.1 5.8 4.4 4.6 2.8 6.1 9.5 10.1 10.3 11.9 7.7 11.5 11.2 7.3 5.9 7.6 7.7 6.7 12.4 6.7 5.1 14.2 7.0 5.1 7.1 5.2 6.4 4.1 5.8 5.6 5.4 6.2 4.7 5.4 8.2 11.1 9.6 2.3 0.0 37.9 0.0 11.9 0.0 10.8 16.9 10.5 8.4 0.0 10.0 2.5 7.3 12.5 9.2 42.6 2.2 9.8 9.5 5.6 8.8 9.0 6.7 4.9 5.9 0.0 12.4 11.7 8.3 19.9 8.9 2.5 7.4 6.1 5.1 14.5 13.5 0.0 3.8 0.0 11.0 0.0 3.9 5.3 26.3 0.0 0.0 19.0 12.5 14.4 0.0 0.0 9.5 3.5 7.2 33.0 9.1 10.3 14.1 2.9 16.6 26.3 8.3 8.1 23.4 8.6 14.6 0.0 14.5 39.5 7.5 4.6 8.3 BORCS8 MEF2BNB ENSG00000254901 "BLOC-1 related complex subunit 8" Q96FH0 19 19176903-19192591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045700 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Vesicles Nucleoplasm "HPA045700: AB_10968570" "unprognostic (4.23e-3)" "unprognostic (1.61e-2)" "unprognostic (2.75e-1)" "unprognostic (3.58e-2)" "unprognostic (2.28e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (6.82e-2)" "prognostic favorable (4.05e-5)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" "unprognostic (3.16e-1)" "unprognostic (1.38e-2)" "unprognostic (3.00e-2)" 12.7 12.4 27.2 11.9 27.1 15.9 8.4 27.1 34.7 6.1 25.3 9.7 11.0 6.5 6.4 11.7 10.8 7.6 17.4 27.2 29.7 13.4 10.7 10.5 12.5 28.0 27.7 5.3 11.0 15.9 20.3 7.6 28.8 10.0 8.7 5.5 9.9 7.9 14.3 8.7 8.1 8.8 25.4 10.1 9.8 8.6 27.2 12.2 12.5 18.0 8.7 10.8 6.3 28.4 21.9 15.4 13.5 14.4 17.8 8.7 22.5 22.4 16.3 25.9 25.7 17.9 26.1 12.9 36.6 22.1 19.1 12.9 12.9 28.5 9.9 12.6 18.9 11.1 23.0 18.0 14.8 17.4 17.8 13.6 15.0 23.2 9.2 11.0 29.7 19.0 26.1 21.1 28.5 38.6 25.7 14.5 9.8 23.3 18.7 10.3 9.9 18.7 27.3 17.1 26.2 14.5 22.4 17.0 15.9 10.0 20.8 17.3 17.0 14.1 14.9 32.5 34.3 15.7 15.3 15.3 16.8 14.0 27.8 45.3 32.4 57.2 14.5 44.9 12.5 27.0 15.4 14.6 22.2 19.6 12.9 13.2 79.9 14.9 45.9 30.1 19.7 20.0 27.2 27.1 27.1 34.7 27.2 29.7 28.0 27.7 28.8 25.4 27.2 28.4 16.6 12.8 21.6 0.0 13.6 0.0 15.4 0.0 5.2 17.0 19.6 18.5 0.0 25.8 7.4 14.7 10.4 31.8 22.5 11.6 43.0 38.0 5.0 25.4 12.1 12.3 10.9 10.8 0.0 32.7 34.9 11.1 13.3 15.7 10.1 11.6 12.1 16.6 41.0 18.5 0.0 9.3 0.0 23.4 0.0 5.2 7.8 24.0 0.0 0.0 37.1 13.2 15.5 0.0 0.0 42.4 9.5 6.8 15.3 14.7 25.6 40.8 13.1 18.3 0.0 11.6 15.0 33.8 23.9 7.4 0.0 39.5 14.0 18.6 9.5 17.2 BRD2 "BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3" ENSG00000204256 "Bromodomain containing 2" P25440 6 32968594-32981505 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042816 Approved Enhanced "Nuclear speckles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "HPA042816: AB_10794766" "unprognostic (2.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.10e-1)" "unprognostic (4.60e-2)" "unprognostic (1.45e-1)" "unprognostic (9.89e-2)" "unprognostic (5.03e-2)" "unprognostic (2.54e-1)" "unprognostic (6.85e-3)" "unprognostic (1.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.42e-2)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.49e-1)" "unprognostic (1.20e-2)" "unprognostic (1.44e-2)" 64.2 61.8 0.8 22.1 2.1 66.5 62.4 4.7 3.8 67.7 0.2 62.1 19.8 71.3 1.8 67.9 66.6 17.4 51.7 3.0 2.8 68.3 61.9 65.3 22.1 1.5 2.4 81.7 80.4 26.3 71.4 19.4 2.1 60.8 11.6 10.1 66.1 18.2 71.4 69.5 60.8 11.7 1.4 71.2 66.0 82.9 2.3 26.9 77.0 10.4 21.2 61.6 65.0 4.0 45.7 19.5 41.6 41.8 31.8 28.5 38.3 44.6 44.4 48.5 35.8 22.7 22.5 37.3 44.6 37.2 32.4 28.1 39.3 33.2 27.7 49.5 147.7 41.2 18.3 14.6 23.5 60.6 39.2 29.2 28.7 38.2 44.9 27.6 21.3 35.2 44.4 76.0 21.7 12.1 77.0 8.5 24.0 28.9 20.4 76.2 18.7 53.8 13.8 26.6 85.6 28.9 54.5 63.7 52.7 27.8 37.4 39.0 27.5 58.6 32.0 21.5 50.0 61.1 69.5 77.9 23.1 19.7 47.8 9.6 7.6 11.6 14.5 8.8 13.0 9.2 9.4 9.9 10.6 8.7 6.6 10.4 9.7 10.3 9.5 8.5 13.3 11.7 0.8 2.1 4.7 3.8 3.0 2.8 1.5 2.4 2.1 1.4 2.3 4.0 325.8 76.9 121.5 38.2 327.1 212.1 232.7 70.0 478.1 78.6 295.5 383.9 171.7 94.4 80.1 60.7 104.3 91.7 395.7 210.7 21.5 69.2 302.4 201.9 149.3 191.2 259.1 97.6 16.1 91.4 145.0 224.2 249.8 256.6 115.2 103.1 113.2 85.3 79.9 55.5 19.9 247.5 77.3 92.6 209.2 177.9 86.9 194.5 124.5 26.2 94.7 62.8 107.1 15.1 22.1 81.2 137.3 77.1 313.0 211.5 133.7 39.5 84.4 65.1 39.5 240.0 251.3 88.4 137.9 365.0 226.9 205.1 356.7 71.2 179.5 248.4 BRD3OS "bA374P20.3, FLJ35348, LINC00094, NCRNA00094" ENSG00000235106 "BRD3 opposite strand" A0A1B0GUI7 9 134025481-134034666 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Collecting duct cells: 16.5;Distal tubular cells: 19.6;Endometrial ciliated cells: 18.3;Endometrial stromal cells: 11.9;Proximal tubular cells: 15.5;Respiratory ciliated cells: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (7.26e-2)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-1)" "unprognostic (3.02e-1)" "unprognostic (3.87e-2)" "unprognostic (1.62e-1)" "unprognostic (1.83e-1)" "unprognostic (2.66e-1)" "unprognostic (1.83e-1)" "unprognostic (7.12e-3)" "unprognostic (1.97e-1)" "prognostic favorable (4.24e-5)" "unprognostic (1.95e-1)" "unprognostic (5.25e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.31e-4)" 8.0 13.9 29.4 5.3 30.6 2.0 7.8 23.6 32.1 12.5 26.0 11.8 3.0 12.0 11.5 6.1 22.5 9.6 7.7 31.1 28.4 10.7 5.5 6.9 7.8 26.8 29.2 16.3 8.7 18.0 28.0 4.9 25.4 11.0 3.7 30.3 7.3 12.7 2.8 4.7 6.5 8.7 26.4 7.0 7.6 11.6 30.2 7.7 14.5 4.5 7.9 9.7 7.2 25.6 11.4 17.6 14.6 26.0 21.1 28.5 6.4 12.9 18.0 21.8 11.2 13.1 9.6 6.7 9.4 26.5 25.8 16.3 15.4 16.8 11.9 10.2 7.9 4.8 26.2 5.3 13.3 10.4 9.3 18.2 24.5 22.5 9.5 37.5 14.6 20.0 5.7 10.0 16.6 16.2 20.5 5.0 19.8 14.9 15.6 8.9 13.5 13.3 21.5 5.1 35.3 17.6 18.3 9.1 6.6 8.5 28.7 9.8 15.5 22.0 16.7 26.7 15.4 3.9 7.9 3.3 26.1 10.0 10.5 1.4 3.6 0.1 12.3 3.7 11.0 12.7 13.0 11.9 3.5 14.4 13.1 10.6 2.6 10.6 9.3 4.7 5.5 6.6 29.4 30.6 23.6 32.1 31.1 28.4 26.8 29.2 25.4 26.4 30.2 25.6 3.3 12.8 3.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 6.1 7.1 0.0 0.0 5.0 16.5 0.0 2.2 2.7 0.0 19.6 10.5 0.0 18.3 11.9 1.5 0.0 0.0 0.0 7.8 7.1 4.5 0.0 4.6 0.0 4.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.7 0.0 0.0 15.5 21.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 1.4 1.5 10.0 0.0 0.0 BTBD19 ENSG00000222009 "BTB domain containing 19" C9JJ37 1 44808482-44815585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.0" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.4;HUVEC TERT2: 5.1;TIME: 11.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042633, HPA076404" Uncertain Uncertain Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA042633: AB_2678091, HPA076404: AB_2686796" "unprognostic (4.69e-2)" "unprognostic (8.74e-3)" "unprognostic (1.82e-3)" "unprognostic (1.20e-4)" "unprognostic (5.32e-2)" "unprognostic (3.80e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.70e-1)" "unprognostic (1.53e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.18e-8)" "unprognostic (2.20e-3)" "unprognostic (2.78e-2)" "unprognostic (8.29e-2)" "unprognostic (1.70e-1)" 2.7 4.3 0.4 1.1 0.4 0.9 1.4 0.5 1.0 3.8 9.0 1.1 0.4 5.4 0.7 0.7 4.0 1.2 2.0 0.5 1.2 1.5 0.8 2.3 0.4 3.2 2.1 4.2 0.6 1.5 5.3 0.8 2.0 1.3 0.4 0.0 0.8 1.2 0.4 0.6 1.1 1.6 1.4 0.9 1.0 0.7 1.7 0.1 3.2 0.4 0.3 1.1 2.1 1.5 0.1 0.9 0.8 0.8 1.7 2.0 0.6 1.7 1.0 0.7 1.6 0.0 0.7 0.0 0.7 2.9 0.4 0.2 0.0 0.8 0.3 0.8 0.1 1.6 0.3 0.9 1.8 0.0 1.2 3.0 0.1 2.9 0.5 5.4 5.1 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.1 0.9 1.0 0.0 0.0 11.9 3.0 2.3 1.4 1.3 0.4 0.1 0.0 1.8 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 1.0 0.5 1.2 3.2 2.1 2.0 1.4 1.7 1.5 5.8 3.2 4.2 0.0 1.4 2.0 1.9 0.8 3.4 0.1 4.2 1.8 1.3 1.5 2.9 1.8 0.0 0.4 1.2 2.6 0.0 0.9 0.6 3.8 6.8 5.2 0.0 0.4 0.6 0.6 0.4 6.2 2.0 7.3 2.5 1.1 6.1 3.3 2.9 0.0 0.3 1.7 0.0 5.9 6.2 0.1 3.1 8.1 3.6 1.9 0.5 1.1 0.0 0.5 0.1 1.0 1.4 1.2 2.3 1.1 2.6 3.3 1.5 0.1 0.0 9.3 4.5 1.0 0.2 2.1 2.3 1.2 2.7 4.1 1.0 1.4 BTBD6 BDPL ENSG00000184887 "BTB domain containing 6" Q96KE9 14 105248490-105251093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031355 Approved Approved Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA031355: AB_10611812" "prognostic favorable (1.11e-4)" "unprognostic (2.01e-2)" "unprognostic (2.65e-1)" "unprognostic (1.97e-2)" "unprognostic (2.69e-1)" "unprognostic (2.58e-1)" "unprognostic (2.23e-2)" "unprognostic (4.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-1)" "prognostic favorable (2.25e-4)" "unprognostic (8.48e-3)" "prognostic favorable (6.51e-5)" "unprognostic (6.55e-2)" "unprognostic (3.22e-1)" "unprognostic (6.86e-2)" "unprognostic (9.85e-2)" 69.4 26.3 52.1 20.4 52.6 28.2 56.6 48.3 60.3 32.6 48.1 43.8 28.8 31.4 28.1 50.9 30.8 20.5 52.1 54.2 51.7 34.5 44.2 34.7 22.0 49.7 51.0 36.7 13.2 12.6 39.9 15.6 49.9 43.6 23.1 14.6 42.8 23.5 169.4 48.5 39.5 18.8 48.4 31.4 46.9 79.3 52.1 18.4 30.4 144.6 19.0 38.9 37.7 51.3 50.8 39.8 21.4 56.8 66.8 46.2 0.1 45.6 41.1 69.2 46.9 31.3 45.2 15.9 27.4 67.0 14.5 66.2 41.3 43.9 34.0 41.2 33.5 11.7 58.6 0.0 45.6 35.8 21.7 48.3 59.6 31.9 25.7 26.9 55.9 52.2 0.0 0.3 37.3 71.8 37.8 14.5 9.1 47.6 67.6 40.3 0.1 14.9 26.5 55.0 34.8 14.8 42.9 34.3 35.0 14.7 69.9 45.3 37.9 55.5 1.5 82.1 57.8 10.2 14.7 7.8 57.2 16.4 44.1 0.5 0.6 2.9 2.3 1.0 2.2 1.3 2.4 2.3 0.7 0.7 1.8 1.2 0.3 0.4 0.8 1.5 5.3 0.6 52.1 52.6 48.3 60.3 54.2 51.7 49.7 51.0 49.9 48.4 52.1 51.3 31.5 25.6 24.3 3.9 5.4 11.7 25.7 6.5 6.2 23.1 24.0 23.4 22.0 14.3 15.3 11.0 6.2 2.8 25.3 31.0 21.5 5.7 15.0 25.6 19.5 17.8 20.4 5.2 12.4 0.0 3.8 17.3 10.2 34.9 24.7 22.2 17.9 15.4 7.8 20.2 12.5 31.2 10.2 9.8 10.0 35.2 9.3 10.3 12.4 8.4 3.6 19.1 5.2 5.0 3.7 1.0 11.6 7.5 7.6 16.3 20.5 11.6 15.5 18.8 13.1 15.7 13.0 7.8 8.3 9.6 12.6 2.2 16.4 15.2 21.9 19.5 BTG2 "APRO1, MGC126063, MGC126064, PC3, TIS21" ENSG00000159388 "BTG anti-proliferation factor 2" P78543 1 203305491-203309602 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Enteroendocrine cells: 965.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 161.8;HMC-1: 160.8;RT4: 131.3;U-266/70: 259.8;U-266/84: 141.2" "Low region specificity" "Detected in all" HPA002355 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles Nucleoplasm "HPA002355: AB_1078304" "prognostic favorable (8.53e-4)" "unprognostic (1.54e-1)" "unprognostic (4.63e-2)" "unprognostic (4.81e-3)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (2.47e-1)" "unprognostic (7.87e-3)" "unprognostic (4.72e-1)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.18e-2)" "unprognostic (4.46e-2)" "unprognostic (6.22e-2)" "unprognostic (4.34e-1)" "unprognostic (1.17e-1)" "unprognostic (2.86e-3)" 274.5 244.6 38.3 124.3 40.7 309.3 118.8 58.4 45.0 101.7 36.7 231.5 88.5 91.9 41.5 313.4 355.0 157.8 256.3 35.1 49.0 132.2 20.8 105.0 122.0 61.8 42.1 554.9 488.9 37.4 209.2 106.7 43.6 265.9 205.7 152.6 75.1 182.9 210.7 134.4 111.1 213.7 49.3 107.1 244.5 10.2 42.4 334.6 201.2 287.1 132.3 279.9 79.1 42.1 4.3 6.1 10.9 4.5 13.4 9.8 92.9 11.2 21.4 2.8 10.5 8.8 1.6 161.8 7.8 3.5 1.8 69.5 39.6 42.6 5.2 10.8 20.3 84.5 12.3 18.4 29.5 0.4 160.8 10.1 76.7 10.3 18.7 9.5 57.6 8.2 40.6 106.9 28.1 3.6 18.1 5.4 4.9 1.7 1.2 11.4 36.5 84.3 5.3 131.3 1.9 11.3 8.6 3.6 1.4 80.0 9.0 10.1 14.3 0.3 18.2 2.9 0.6 259.8 141.2 103.4 2.2 4.1 6.3 8.4 19.7 23.1 10.0 27.1 14.8 29.9 10.9 10.2 11.5 29.0 17.5 12.6 77.1 12.7 35.6 38.6 11.2 19.7 38.3 40.7 58.4 45.0 35.1 49.0 61.8 42.1 43.6 49.3 42.4 42.1 555.8 157.0 241.8 6.5 330.1 230.2 464.4 311.4 548.7 25.4 355.1 276.7 274.8 48.6 128.5 187.6 29.2 50.0 343.9 345.8 15.6 113.2 1.4 336.7 211.7 196.4 965.1 127.6 2.9 163.7 16.6 352.8 562.2 643.2 369.3 40.6 148.2 6.5 120.1 3.3 2.0 617.1 264.5 98.8 183.6 3.1 72.7 227.0 120.9 25.3 47.5 478.8 58.7 4.5 10.4 55.9 399.9 55.3 725.2 230.1 397.5 13.9 88.5 38.9 124.9 537.5 305.0 1.8 1.7 343.8 447.9 138.0 300.8 278.6 360.7 211.8 BUD23 "MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22" ENSG00000071462 "BUD23 rRNA methyltransferase and ribosome maturation factor" O43709 7 73683025-73705161 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 119.9;Endometrial ciliated cells: 133.6;Exocrine glandular cells: 140.8;Pancreatic endocrine cells: 126.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 712.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052185 Approved Supported Nucleoplasm,Nucleoli Yes No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA052185: AB_2681753" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.67e-2)" "unprognostic (4.79e-2)" "unprognostic (3.62e-3)" "unprognostic (8.54e-2)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (9.20e-2)" "unprognostic (6.71e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" 39.8 49.2 34.5 40.0 36.7 58.7 43.4 36.4 39.8 36.3 41.0 48.6 47.0 38.6 72.3 41.7 58.9 34.5 87.9 36.1 39.0 53.3 47.2 38.5 52.6 37.0 36.1 37.8 70.8 49.2 45.1 30.7 36.3 37.8 47.7 20.3 55.9 42.2 128.0 43.8 40.3 41.4 36.4 42.1 44.9 130.0 36.6 44.7 56.5 78.4 51.7 51.9 32.8 38.5 142.1 151.8 53.6 429.2 72.0 64.2 91.1 95.1 83.3 118.5 96.1 211.4 182.6 163.6 48.9 99.5 204.0 97.0 124.8 91.0 108.4 116.6 147.1 72.0 174.8 86.7 91.2 200.3 98.8 57.3 102.2 103.2 93.9 59.7 77.4 130.3 285.4 288.9 103.7 219.6 128.0 277.8 130.2 317.8 172.2 110.5 106.8 712.0 132.5 100.2 163.4 124.4 126.3 329.2 146.5 53.0 207.9 159.0 85.2 101.8 130.3 130.0 208.3 99.5 192.6 275.5 232.3 155.6 218.0 54.8 64.9 60.6 112.0 74.2 124.9 175.3 127.1 122.5 122.9 153.5 132.8 121.5 11.9 125.4 68.0 190.9 150.6 132.6 34.5 36.7 36.4 39.8 36.1 39.0 37.0 36.1 36.3 36.4 36.6 38.5 67.0 44.8 64.5 0.0 26.5 0.0 0.0 0.0 0.0 0.0 75.4 85.7 0.0 0.0 42.7 46.0 0.0 75.7 64.1 0.0 97.8 119.9 0.0 133.6 51.2 28.6 0.0 0.0 0.0 140.8 82.7 24.5 0.0 79.6 46.7 49.2 0.0 0.0 70.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 21.2 0.0 0.0 0.0 0.0 126.0 0.0 0.0 16.5 0.0 0.0 103.5 78.7 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 106.7 28.1 73.0 0.0 0.0 C10orf143 LINC00959 ENSG00000237489 "Chromosome 10 open reading frame 143" A0A1B0GUT2 10 130020025-130110830 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 6.7;Breast glandular cells: 8.2;Breast myoepithelial cells: 9.7;Collecting duct cells: 11.0;Distal tubular cells: 13.7;Proximal tubular cells: 12.8;Theca cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 9.6;MCF7: 8.8;NB-4: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 7: Non-specific - Mitochondria" "unprognostic (3.58e-2)" "unprognostic (3.36e-2)" "unprognostic (5.61e-2)" "unprognostic (1.24e-2)" "unprognostic (8.12e-2)" "unprognostic (6.64e-3)" "unprognostic (8.68e-3)" "unprognostic (2.48e-3)" "unprognostic (1.59e-1)" "unprognostic (8.61e-2)" "unprognostic (7.26e-4)" "unprognostic (1.34e-1)" "unprognostic (2.36e-7)" "unprognostic (2.06e-1)" "unprognostic (3.29e-1)" "unprognostic (1.90e-1)" "unprognostic (1.49e-2)" 3.5 4.1 3.5 3.3 3.6 2.3 4.9 3.6 4.7 4.7 3.7 6.9 5.2 5.5 5.8 3.5 4.7 3.8 2.4 3.1 3.4 5.7 4.7 2.9 5.2 3.8 3.6 3.9 4.3 3.9 4.5 1.0 3.7 5.7 3.3 1.6 3.8 6.6 9.6 4.3 4.5 3.9 3.7 5.4 4.2 3.9 3.6 5.5 5.8 5.0 4.7 6.0 4.3 3.5 1.1 1.5 1.7 3.5 9.6 3.6 0.2 2.1 3.0 0.9 1.3 0.0 0.9 7.3 0.4 2.0 1.1 1.5 0.6 0.1 0.3 2.0 1.1 1.3 0.1 0.9 3.8 3.5 1.4 3.5 1.9 0.4 2.2 1.1 0.5 5.9 0.2 1.6 3.3 8.8 1.5 13.5 3.5 1.6 1.4 1.3 0.2 0.3 3.2 0.6 0.8 1.0 1.3 0.4 0.9 1.3 0.2 1.1 0.4 1.3 0.2 3.7 0.3 2.1 4.3 1.1 2.5 0.6 0.0 0.0 6.5 4.0 16.7 10.6 17.8 20.7 18.1 19.3 11.4 17.6 17.9 23.6 1.2 22.0 9.7 7.3 23.6 9.1 3.5 3.6 3.6 4.7 3.1 3.4 3.8 3.6 3.7 3.7 3.6 3.5 3.1 0.0 6.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 8.2 9.7 0.0 0.0 2.5 11.0 0.0 0.7 5.0 0.0 13.7 4.2 0.0 3.9 3.2 1.1 0.0 0.0 0.0 3.1 0.1 1.4 0.0 2.2 1.3 3.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 12.8 5.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 3.1 7.8 0.0 0.0 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123233385-123258079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 60.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol No Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 63: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favorable (7.82e-5)" 7.3 12.6 16.2 10.2 16.1 9.0 8.0 23.0 19.6 13.0 13.5 10.9 11.4 12.1 13.8 9.5 11.4 8.2 15.0 16.0 13.2 12.6 14.5 8.9 18.2 12.6 12.3 17.2 8.5 10.2 19.7 7.3 14.9 13.7 8.2 15.7 16.2 9.0 13.0 13.8 11.3 7.0 8.8 12.8 10.6 16.7 14.8 60.0 12.3 12.5 13.4 10.3 11.0 18.3 28.4 20.5 20.8 39.1 12.0 11.1 13.7 22.3 16.5 25.1 18.0 21.8 15.8 36.1 20.3 8.4 23.5 20.4 25.7 12.5 25.0 29.2 22.5 44.0 20.7 18.6 26.1 20.4 19.7 14.2 33.2 18.9 35.1 37.0 17.0 53.6 45.6 13.4 16.7 12.3 46.2 39.3 13.7 25.6 31.7 35.7 25.9 33.5 22.8 13.0 40.7 18.2 24.0 8.8 23.4 16.5 18.3 24.7 14.8 23.1 27.3 23.3 24.4 22.7 28.3 32.6 17.1 26.2 28.1 85.3 12.9 50.6 53.9 14.9 67.6 83.9 72.3 71.9 21.7 73.5 96.6 78.2 11.8 63.3 16.3 36.6 73.1 33.5 16.2 16.1 23.0 19.6 16.0 13.2 12.6 12.3 14.9 8.8 14.8 18.3 46.0 41.7 47.7 9.8 54.3 45.4 36.7 29.4 59.2 34.5 23.3 50.0 52.7 14.3 18.0 25.8 14.6 41.1 56.2 16.4 60.7 20.7 22.9 12.2 24.2 27.9 9.6 37.0 13.7 10.8 22.8 41.3 23.0 11.2 15.2 24.1 18.5 33.5 14.3 45.4 15.9 20.7 28.5 9.2 24.2 6.2 37.9 19.7 24.9 7.5 26.3 35.7 44.3 14.6 10.4 13.6 17.4 42.2 42.2 22.8 19.9 39.3 14.8 36.6 13.1 42.7 33.1 115.2 59.7 40.6 36.1 10.8 63.0 43.3 20.8 8.0 C2orf92 LINC01125 ENSG00000228486 "Chromosome 2 open reading frame 92" A0A1B0GVN3 2 97664217-97703064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 11.7" "Cell type enhanced" "Detected in some" "Adipocytes: 2.5;Alveolar cells type 2: 7.5;Breast glandular cells: 3.3;Breast myoepithelial cells: 2.7;Club cells: 2.5;Endometrial ciliated cells: 3.7;Endometrial stromal cells: 2.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;HDLM-2: 2.0" "Not detected" "Not detected" NA NA "Cluster 43: Testis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (5.53e-2)" "unprognostic (8.76e-2)" "unprognostic (1.65e-2)" "unprognostic (2.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.09e-3)" "unprognostic (9.29e-2)" "unprognostic (1.22e-2)" "unprognostic (1.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.98e-3)" "unprognostic (2.76e-2)" "unprognostic (7.45e-7)" "unprognostic (5.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.11e-1)" "unprognostic (5.23e-5)" 1.4 1.3 2.5 0.3 2.6 0.3 1.8 2.7 4.4 1.8 2.6 1.1 0.4 0.9 1.7 0.8 1.2 0.2 1.6 2.5 2.5 1.5 2.6 1.6 0.2 2.6 2.6 0.9 2.0 0.3 1.5 0.3 2.7 2.0 0.4 0.7 1.9 0.6 1.5 2.0 1.3 0.2 2.6 3.0 1.1 11.7 2.6 0.4 3.5 0.0 0.5 0.8 1.3 2.8 0.1 0.0 1.6 0.3 0.7 0.6 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.8 0.2 0.0 0.0 0.5 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.4 0.1 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.8 0.4 0.6 0.1 0.5 0.7 0.2 1.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.6 2.7 4.4 2.5 2.5 2.6 2.6 2.7 2.6 2.6 2.8 2.5 0.0 7.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.3 2.7 0.0 0.0 2.5 0.0 0.0 0.7 1.6 0.0 0.0 0.6 0.0 3.7 2.7 0.5 0.0 0.0 0.0 1.6 0.6 0.6 0.0 2.3 1.3 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.9 1.6 0.0 0.0 C6orf62 "DKFZP564G182, FLJ12619, XTP12" ENSG00000112308 "Chromosome 6 open reading frame 62" Q9GZU0 6 24704861-24719998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 354.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030564, HPA030566" Supported Approved Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA030564: AB_10600000, HPA030566: AB_10599425" "unprognostic (2.07e-2)" "unprognostic (2.92e-1)" "unprognostic (7.10e-2)" "unprognostic (6.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (1.18e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.04e-4)" "unprognostic (4.16e-3)" "unprognostic (3.94e-2)" "unprognostic (3.08e-2)" "unprognostic (9.01e-2)" "unprognostic (4.03e-1)" "unprognostic (1.93e-2)" "prognostic favorable (3.62e-6)" 110.0 82.6 105.0 115.1 108.3 118.0 87.3 101.8 112.5 60.7 92.1 76.5 90.3 70.6 100.7 56.6 76.6 62.7 59.7 94.2 103.9 92.9 107.5 96.5 144.3 121.4 120.6 93.8 121.8 71.2 45.4 87.4 106.2 84.2 76.8 151.0 94.0 75.4 84.1 93.5 93.1 69.2 107.8 156.2 110.3 125.0 126.8 133.1 85.5 58.3 143.0 73.7 36.9 109.6 154.6 73.9 108.2 169.8 106.6 142.2 118.5 178.0 172.6 204.4 211.2 91.8 116.7 177.9 258.3 172.0 230.8 114.5 103.7 137.1 221.0 301.2 61.9 194.0 104.8 112.7 191.0 235.0 201.4 106.0 267.6 138.6 182.8 152.2 162.0 97.8 160.6 121.6 199.3 96.3 160.4 325.9 118.0 79.9 86.0 127.8 126.0 164.7 131.2 165.5 170.9 99.5 219.8 239.4 349.4 105.4 197.1 174.2 192.7 214.7 108.8 83.7 239.4 289.6 494.0 213.6 75.9 294.8 209.8 214.5 246.5 271.9 211.0 253.7 227.1 204.4 215.0 229.7 192.9 170.8 216.6 241.0 177.8 223.4 277.4 198.1 226.3 522.4 105.0 108.3 101.8 112.5 94.2 103.9 121.4 120.6 106.2 107.8 126.8 109.6 136.4 83.3 76.7 67.3 91.1 57.5 53.0 56.7 58.6 56.6 107.7 86.7 36.6 94.4 56.3 93.8 50.1 50.8 147.9 105.8 37.2 63.4 147.2 83.1 92.0 85.9 95.9 128.6 50.9 74.0 62.2 78.0 86.6 112.8 55.2 122.8 86.7 132.8 90.1 42.1 39.4 89.3 48.8 354.8 105.3 53.9 54.0 138.8 49.8 94.6 120.8 43.6 96.8 35.2 53.1 83.2 84.9 47.4 54.3 98.3 90.2 71.5 80.5 63.3 52.6 120.5 64.9 98.9 101.6 103.2 56.0 75.2 95.7 61.6 98.8 63.3 CACTIN "C19orf29, fSAPc, NY-REN-24" ENSG00000105298 "Cactin, spliceosome C complex subunit" Q8WUQ7 19 3610645-3626815 "Predicted intracellular proteins" "Immunity, Innate immunity, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042504, HPA042548" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear speckles" Cytosol "HPA042504: AB_10797501, HPA042548: AB_10794760" "unprognostic (1.18e-1)" "unprognostic (7.90e-3)" "unprognostic (1.09e-1)" "prognostic favorable (3.69e-5)" "unprognostic (5.93e-2)" "unprognostic (2.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (7.22e-3)" "unprognostic (3.88e-2)" "unprognostic (4.98e-3)" "unprognostic (5.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.55e-3)" 14.6 14.2 20.6 7.8 19.6 10.0 14.8 19.4 24.0 15.7 16.6 15.4 6.2 16.7 2.6 15.4 16.8 3.0 16.3 20.3 18.8 17.0 19.9 12.3 7.6 21.1 19.6 24.7 17.3 4.2 13.3 4.6 19.1 17.2 3.2 4.6 13.2 4.2 19.4 17.8 15.2 2.9 18.5 18.4 15.8 18.2 19.8 8.7 15.3 6.1 4.4 16.5 14.6 20.1 22.2 12.5 10.3 17.9 7.4 7.2 15.6 15.4 6.3 9.1 10.2 12.5 9.7 18.4 12.9 9.7 10.6 20.4 10.8 12.9 5.5 18.7 14.8 11.4 19.2 15.1 10.3 15.7 15.9 7.1 12.2 8.4 5.8 5.4 13.2 15.6 25.9 19.8 4.9 13.3 28.0 13.5 22.0 13.4 14.8 29.4 13.5 17.5 8.5 11.0 14.2 19.9 17.4 12.1 13.3 5.5 9.8 17.7 17.2 12.3 15.5 27.0 27.4 30.3 21.6 20.7 15.2 24.8 16.8 0.0 0.4 0.0 1.2 1.0 0.4 0.6 0.5 0.5 0.3 0.6 0.6 0.8 0.2 0.3 0.1 1.4 0.5 0.4 20.6 19.6 19.4 24.0 20.3 18.8 21.1 19.6 19.1 18.5 19.8 20.1 7.4 0.0 2.7 5.9 6.3 6.0 4.1 2.8 5.7 5.1 6.9 7.1 3.1 5.7 2.2 1.8 2.1 3.6 7.2 6.9 0.0 5.1 3.3 6.7 5.8 5.3 1.2 7.4 3.9 4.9 5.2 5.1 9.2 7.4 4.5 8.5 3.3 4.8 5.1 0.0 4.1 5.8 2.0 3.9 6.5 4.5 5.9 5.3 1.8 3.7 6.1 6.0 8.2 2.5 5.8 5.2 4.4 5.7 6.0 6.0 3.6 3.1 2.4 6.2 0.0 7.2 6.4 10.8 8.8 7.9 8.0 3.3 5.6 7.6 6.1 3.6 CALM1 "CALML2, CAMI, DD132, PHKD" ENSG00000198668 "Calmodulin 1" P0DP23 14 90396502-90408268 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Disease variant, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018558, HPA044999" Supported Supported Cytosol NA NA 75000000 "Cluster 44: Non-specific - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 7: Non-specific - Mitochondria" Cytosol "CAB018558: AB_2069454, HPA044999: AB_2679177" "unprognostic (5.35e-3)" "unprognostic (3.96e-1)" "unprognostic (4.99e-3)" "unprognostic (2.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.52e-1)" "unprognostic (6.44e-2)" "unprognostic (1.16e-3)" "prognostic favorable (5.62e-4)" "unprognostic (2.77e-1)" "prognostic favorable (6.49e-4)" "unprognostic (2.66e-1)" "unprognostic (2.68e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (2.38e-5)" 264.2 143.5 429.9 152.3 537.5 349.1 123.1 442.8 839.7 134.2 259.8 332.9 289.6 105.1 209.7 304.6 251.4 153.8 287.0 635.9 371.6 326.3 210.9 209.1 165.7 466.2 374.6 104.4 121.7 225.5 143.9 207.4 447.5 169.5 312.2 241.6 188.0 215.3 588.9 104.0 279.2 227.2 328.7 166.6 202.2 123.6 443.5 146.5 118.0 185.6 210.5 191.6 125.2 527.2 189.3 256.3 308.0 115.7 332.2 286.5 256.9 347.4 295.3 260.0 283.2 278.1 320.9 200.8 171.1 413.0 123.4 309.4 194.6 490.1 431.0 398.3 119.7 212.4 211.0 264.1 185.9 327.6 167.2 188.0 232.7 261.6 93.1 173.6 592.9 140.3 101.3 270.0 353.9 653.7 112.4 316.2 178.4 521.1 351.6 216.9 264.9 134.4 215.3 574.5 621.2 259.1 292.3 507.7 195.5 254.0 335.6 112.0 363.1 212.9 137.7 224.8 289.0 149.5 371.0 222.2 335.9 267.6 301.5 1289.6 356.8 826.7 1005.3 420.4 1230.3 496.8 1039.1 1079.6 483.1 400.2 745.7 882.7 513.3 1036.9 647.3 453.3 1168.3 1477.9 429.9 537.5 442.8 839.7 635.9 371.6 466.2 374.6 447.5 328.7 443.5 527.2 1812.3 387.8 374.4 119.8 573.2 567.1 572.2 604.2 543.5 1729.1 343.7 514.8 867.5 346.0 523.1 399.1 123.0 427.7 1471.8 828.8 459.7 550.8 154.9 1026.1 249.0 996.0 599.8 143.5 367.6 444.7 984.2 521.4 317.0 377.6 490.3 148.5 652.5 333.7 795.1 604.0 258.9 513.9 730.4 286.5 837.4 101.5 210.6 639.9 627.9 131.2 856.3 1061.8 1100.9 108.0 188.9 534.2 615.8 500.2 591.8 287.7 1637.2 1430.5 1618.4 321.1 315.5 387.5 901.6 128.8 199.8 553.8 580.4 1147.6 1139.3 247.8 666.6 458.5 CARM1 PRMT4 ENSG00000142453 "Coactivator associated arginine methyltransferase 1" Q86X55 19 10871553-10923075 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 110.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032961, HPA043561, HPA048073, HPA069313" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 19000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: " "unprognostic (9.46e-2)" "unprognostic (3.61e-1)" "unprognostic (2.94e-2)" "unprognostic (2.23e-1)" "unprognostic (2.69e-2)" "unprognostic (3.13e-2)" "unprognostic (1.66e-3)" "unprognostic (3.76e-2)" "unprognostic (7.81e-2)" "unprognostic (6.18e-2)" "unprognostic (9.31e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (7.88e-6)" "unprognostic (1.71e-2)" "unprognostic (6.26e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (8.37e-4)" 20.3 17.1 24.7 19.6 26.6 22.7 17.6 18.9 34.1 30.6 17.2 28.4 17.3 31.7 7.8 36.7 23.4 14.7 25.4 27.6 23.7 18.8 20.1 16.4 19.8 22.8 21.8 21.9 22.3 11.5 14.8 20.4 22.6 20.2 14.3 6.4 20.2 17.5 110.5 22.6 20.9 21.3 19.9 18.6 20.3 45.4 22.6 10.9 13.4 72.4 15.4 26.3 28.0 26.0 62.5 46.8 64.9 88.3 52.5 71.1 63.2 42.8 75.6 63.9 61.0 73.4 21.8 85.2 52.4 77.4 32.1 58.0 65.4 66.2 40.1 98.4 52.7 26.5 29.1 89.9 44.8 39.3 33.9 49.0 42.4 43.8 52.4 35.9 82.1 67.9 65.8 79.2 38.2 116.7 70.0 34.3 81.4 40.7 74.8 97.5 32.8 100.7 38.9 29.7 47.0 45.1 30.7 36.2 43.6 31.7 38.4 35.3 48.7 75.4 43.2 72.3 54.0 75.0 64.1 77.2 51.1 63.8 35.3 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.5 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.1 24.7 26.6 18.9 34.1 27.6 23.7 22.8 21.8 22.6 19.9 22.6 26.0 12.9 9.6 12.2 7.2 11.6 7.8 5.9 4.1 12.0 36.4 14.0 13.7 1.1 14.3 6.5 9.2 52.1 18.5 6.4 42.3 7.9 13.4 32.7 20.1 30.8 12.7 27.6 30.7 12.9 19.7 33.1 13.8 13.7 25.4 1.3 17.8 12.8 27.8 26.7 45.4 10.6 24.9 4.1 20.0 10.9 23.5 28.3 14.8 5.4 5.6 23.9 8.7 4.1 10.6 5.8 24.8 27.2 19.2 11.7 14.1 22.6 9.2 7.4 21.1 6.6 19.6 13.0 23.8 17.5 25.7 7.0 12.0 6.5 6.6 25.7 11.8 CARMIL2 "LRRC16C, RLTPR" ENSG00000159753 "Capping protein regulator and myosin 1 linker 2" Q6F5E8 16 67644988-67657569 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.4;intestine: 13.4;lymphoid tissue: 21.6" "Group enriched" "Detected in some" 4 "B-cells: 3.6;dendritic cells: 3.7;T-cells: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 64.2;JURKAT: 47.3;MOLT-4: 64.6;REH: 105.6;RPMI-8226: 58.4;U-698: 107.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041402 Approved NA NA "Cluster 15: NK-cells - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "HPA041402: AB_10795591" "unprognostic (1.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.35e-2)" "unprognostic (6.37e-2)" "unprognostic (5.47e-3)" "unprognostic (4.27e-4)" "unprognostic (1.38e-2)" "unprognostic (1.44e-1)" "unprognostic (3.85e-2)" "unprognostic (1.52e-1)" "unprognostic (7.90e-5)" "unprognostic (4.07e-2)" "unprognostic (5.14e-10)" "unprognostic (2.25e-1)" "unprognostic (1.89e-1)" "unprognostic (1.85e-1)" "unprognostic (6.57e-2)" 0.9 0.5 5.9 12.5 6.3 5.9 0.5 4.5 11.4 0.4 2.4 2.0 1.8 0.3 0.1 0.9 0.5 1.2 0.3 9.8 5.1 0.9 0.8 1.7 21.6 5.6 4.0 0.2 0.4 0.1 4.5 0.2 5.4 0.8 0.7 0.3 1.4 0.1 0.0 0.4 13.4 0.2 3.4 19.9 1.9 0.9 4.9 20.9 1.2 0.0 10.9 1.5 0.7 6.8 0.2 0.1 0.1 0.3 0.0 0.1 18.1 0.6 0.0 0.5 0.0 9.6 0.6 64.2 1.1 0.0 0.1 0.1 6.0 0.0 0.0 14.3 7.5 3.8 0.3 1.2 0.5 7.1 0.6 0.1 0.0 0.0 0.1 0.1 0.0 47.3 0.9 1.0 0.0 1.1 64.6 32.2 10.7 0.3 0.3 105.6 0.1 58.4 0.0 0.0 15.9 1.7 0.1 0.2 0.5 1.5 0.4 1.9 0.2 0.9 2.0 0.1 0.4 17.6 33.4 107.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.7 0.1 0.0 0.4 0.2 0.1 0.0 0.4 0.0 0.3 0.7 0.1 5.9 6.3 4.5 11.4 9.8 5.1 5.6 4.0 5.4 3.4 4.9 6.8 0.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 CARMIL3 "BC008134, C14orf121, crml-1, LRRC16B" ENSG00000186648 "Capping protein regulator and myosin 1 linker 3" Q8ND23 14 24052009-24069729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.6;pituitary gland: 8.1;skin 1: 3.9;testis: 2.2" "Cell type enhanced" "Detected in single" "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 5.5;HMC-1: 3.7;Karpas-707: 3.3;SCLC-21H: 5.4;SH-SY5Y: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030596 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "HPA030596: AB_10603012" "unprognostic (2.67e-2)" "unprognostic (2.07e-3)" "unprognostic (1.50e-1)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (1.29e-4)" "unprognostic (6.13e-2)" "unprognostic (8.92e-4)" "unprognostic (4.02e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-4)" "unprognostic (4.49e-2)" "unprognostic (1.17e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-2)" "unprognostic (4.19e-1)" "unprognostic (2.16e-1)" 0.1 0.3 2.0 0.3 1.5 0.2 0.3 3.6 2.1 0.3 0.0 0.5 0.5 0.2 0.0 0.6 0.1 0.3 0.1 1.9 1.3 0.7 0.2 0.3 0.3 2.0 1.4 0.1 0.7 0.0 8.1 0.0 2.0 0.3 0.1 1.0 0.6 0.0 0.0 3.9 0.7 0.0 0.5 0.5 0.3 2.2 1.9 0.1 0.5 0.0 0.4 0.1 0.5 1.8 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.2 0.8 0.0 0.3 0.1 0.1 0.4 0.0 0.0 0.0 0.0 5.4 2.6 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.5 3.6 2.1 1.9 1.3 2.0 1.4 2.0 0.5 1.9 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 CAVIN1 "cavin-1, CGL4, PTRF" ENSG00000177469 "Caveolae associated protein 1" Q6NZI2 17 42402449-42423256 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "RNA-binding, rRNA-binding" "Congenital generalized lipodystrophy, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 575.1;Alveolar cells type 1: 429.5;Breast myoepithelial cells: 154.9;Cytotrophoblasts: 159.8;Endothelial cells: 217.4;Smooth muscle cells: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 1105.9;fHDF/TERT166: 796.6;TIME: 920.9;U-138 MG: 912.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049838, HPA074213" Supported Supported "Vesicles,Plasma membrane" NA NA 440000 "Cluster 11: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane" Vesicles "HPA049838: AB_2680907, HPA074213: AB_2686674" "unprognostic (1.59e-1)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.36e-4)" "unprognostic (1.56e-1)" "unprognostic (1.76e-3)" "unprognostic (6.33e-3)" "unprognostic (1.72e-1)" "unprognostic (1.04e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.92e-4)" "unprognostic (7.18e-3)" "unprognostic (2.36e-1)" "unprognostic (3.44e-3)" "unprognostic (4.24e-3)" "unprognostic (3.21e-2)" "unprognostic (2.07e-3)" "prognostic unfavorable (5.87e-4)" 397.8 65.3 42.6 69.1 47.2 3.7 295.3 55.8 40.9 239.9 50.6 314.0 30.8 344.3 56.8 101.0 207.5 78.1 220.9 35.4 49.7 66.4 21.0 202.8 30.0 68.8 55.0 162.5 28.4 26.5 34.8 151.3 60.1 181.5 50.7 3.6 84.2 215.4 144.8 161.9 104.1 242.3 53.5 109.0 132.8 22.6 47.2 16.6 112.4 92.7 24.0 255.4 192.3 58.0 315.9 264.8 5.5 69.8 342.3 409.6 6.9 1105.9 477.8 432.2 340.5 134.6 20.1 0.5 216.3 796.6 177.4 509.7 46.8 331.6 351.0 1.1 9.5 137.5 154.8 66.1 215.8 0.3 1.2 283.0 120.5 340.8 115.8 230.2 592.3 0.4 95.5 1.3 187.9 5.0 7.4 1.6 25.8 48.1 1.8 0.6 173.3 0.6 186.1 1.6 0.4 2.0 371.9 6.4 91.7 145.2 29.8 2.0 920.9 912.0 429.5 330.9 407.9 0.8 0.9 1.6 270.7 0.5 104.8 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 42.6 47.2 55.8 40.9 35.4 49.7 68.8 55.0 60.1 53.5 47.2 58.0 575.1 429.5 117.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 55.4 154.9 0.0 0.0 50.8 23.9 0.0 159.8 3.4 0.0 3.9 45.6 0.0 11.7 130.4 217.4 0.0 0.0 0.0 4.4 11.3 114.2 0.0 16.9 63.1 116.3 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.5 0.0 0.0 0.5 0.0 0.0 1.1 3.6 0.0 0.0 0.0 211.7 0.0 0.0 0.0 0.0 77.2 4.5 6.6 0.0 0.0 CBX4 "hPC2, NBP16, PC2" ENSG00000141582 "Chromobox 4" O00257 17 79833156-79839440 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 130.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 110.8;SK-MEL-30: 130.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008228, HPA012021" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies" "HPA008228: AB_1078413, HPA012021: AB_2668603" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (3.97e-2)" "unprognostic (8.80e-2)" "unprognostic (5.39e-3)" "unprognostic (1.49e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-2)" "unprognostic (7.62e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (8.72e-8)" "unprognostic (7.49e-2)" "unprognostic (2.87e-1)" "unprognostic (3.99e-2)" "unprognostic (1.07e-1)" 9.3 14.2 9.6 11.1 10.8 130.3 9.0 8.8 12.5 9.1 0.0 7.9 7.1 6.3 4.6 20.7 8.1 6.3 16.0 12.4 9.7 10.6 21.6 12.3 14.6 11.5 9.5 9.6 19.0 17.0 19.1 15.2 10.7 9.3 3.2 12.3 13.2 4.6 3.4 31.6 11.9 3.8 8.2 20.9 12.9 6.9 12.2 23.1 8.6 1.4 7.2 6.7 10.3 16.6 32.1 28.3 8.4 36.3 5.2 4.7 23.5 14.3 8.5 5.1 5.4 20.5 17.5 12.3 19.7 5.6 11.4 16.3 9.3 9.5 3.8 13.3 17.7 7.0 28.0 38.4 25.4 37.0 52.5 6.5 54.4 4.7 8.4 8.5 4.3 35.5 21.7 67.5 5.5 23.0 50.9 37.7 4.6 33.2 28.2 51.9 8.6 56.3 7.2 15.3 8.7 16.6 21.4 110.8 130.9 3.5 26.3 58.3 11.2 29.8 26.3 18.4 18.6 58.0 32.4 35.0 18.7 31.6 40.4 1.6 0.5 1.8 0.9 0.6 0.6 1.5 1.2 1.3 0.3 1.5 1.4 1.3 2.1 0.4 0.7 1.7 0.2 0.6 9.6 10.8 8.8 12.5 12.4 9.7 11.5 9.5 10.7 8.2 12.2 16.6 40.4 3.2 15.7 4.6 31.8 23.3 5.4 13.4 36.5 31.7 65.2 79.8 51.6 30.0 12.1 1.8 22.9 34.2 77.6 26.6 0.0 7.5 0.2 63.9 19.3 21.6 52.7 7.8 5.5 7.3 5.0 15.8 20.9 62.8 7.0 22.3 15.7 16.3 13.8 20.2 5.5 49.5 2.0 19.8 17.0 1.0 4.4 35.4 17.8 12.2 15.4 39.2 15.5 6.0 11.6 10.0 18.4 5.7 26.1 6.3 9.6 2.8 14.6 44.3 6.6 15.3 24.4 0.5 2.4 65.7 30.7 8.6 42.5 13.7 29.7 5.2 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: AB_2681128" "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 91.6 61.0 35.1 19.1 34.6 7.8 75.3 37.4 40.6 48.5 36.0 117.8 19.2 74.2 31.1 25.1 60.6 15.3 90.3 34.5 35.3 37.7 50.3 43.6 15.4 35.5 35.7 32.3 62.7 12.8 33.0 13.9 36.0 55.9 16.8 13.9 26.6 29.2 64.4 32.5 47.1 28.2 34.7 41.2 74.4 17.1 37.3 26.0 31.4 22.4 14.4 76.6 39.1 35.0 17.9 15.7 12.8 16.3 63.3 40.3 7.4 29.5 26.4 18.5 17.2 7.2 5.2 11.5 12.8 38.9 47.6 5.9 9.6 14.2 13.6 34.4 15.3 5.5 25.1 18.3 15.0 8.5 20.1 24.1 16.6 19.8 15.3 34.4 13.1 19.2 7.2 21.7 23.4 11.6 9.5 12.6 9.5 12.6 48.2 13.7 2.9 9.3 62.8 9.6 8.4 14.0 15.2 21.1 15.4 9.5 11.1 10.4 16.7 29.5 16.3 21.6 27.3 9.6 15.4 23.1 54.6 13.5 26.2 33.3 39.3 20.1 128.7 43.2 168.8 79.5 111.6 113.8 45.0 79.5 53.2 74.2 7.8 69.3 25.9 123.8 140.8 75.1 35.1 34.6 37.4 40.6 34.5 35.3 35.5 35.7 36.0 34.7 37.3 35.0 68.7 67.3 25.0 11.1 104.8 70.2 38.0 76.9 8.6 31.9 39.2 65.3 0.7 60.1 48.4 82.8 8.4 15.0 175.2 143.9 17.6 74.1 7.6 33.5 34.1 36.1 88.1 15.8 8.6 140.2 66.2 60.0 121.8 30.5 34.3 24.4 53.9 77.3 90.9 32.0 10.2 100.5 69.2 46.9 185.9 28.3 59.4 82.0 113.8 13.1 43.5 57.2 133.9 7.5 10.8 86.7 108.6 102.3 53.3 45.3 146.7 66.9 48.2 34.1 118.3 33.7 135.3 37.9 63.1 17.8 66.9 13.8 132.7 44.9 51.7 29.5 CCDC163 "C1orf231, CCDC163P, LOC126661" ENSG00000280670 "Coiled-coil domain containing 163" A0A0D9SF12 1 45493866-45500079 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Adipocytes: 1.9;Breast glandular cells: 2.3;Breast myoepithelial cells: 3.4;Cytotrophoblasts: 3.2;Distal tubular cells: 1.9;Exocrine glandular cells: 2.0;Extravillous trophoblasts: 2.0;Glandular and luminal cells: 2.0;Theca cells: 1.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 5.2;U-266/70: 5.7" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (5.25e-1)" "unprognostic (1.94e-1)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" "unprognostic (3.00e-1)" "unprognostic (2.11e-3)" "unprognostic (9.50e-8)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "unprognostic (6.23e-2)" "unprognostic (2.63e-1)" "unprognostic (1.02e-1)" "unprognostic (8.38e-6)" "unprognostic (4.73e-3)" "unprognostic (7.69e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (1.61e-1)" 0.3 0.2 0.2 0.4 0.2 0.8 0.4 0.1 0.6 0.5 0.1 0.2 0.3 0.3 0.3 0.1 0.2 0.1 0.1 0.2 0.2 0.4 0.3 0.4 0.3 0.4 0.2 0.2 0.8 0.8 0.2 0.1 0.2 0.1 0.2 0.1 0.7 0.1 0.2 0.3 0.4 0.2 0.1 0.4 0.3 0.1 0.2 0.5 0.8 0.0 0.3 0.1 0.1 0.2 1.7 0.0 0.0 0.2 0.2 0.5 0.6 0.2 0.2 1.6 0.6 1.4 0.7 0.4 0.8 0.2 0.0 1.3 0.2 1.7 1.0 1.3 1.6 0.8 0.7 1.9 1.5 1.4 0.3 0.1 0.1 0.4 0.8 0.4 0.4 1.6 0.6 5.2 0.7 1.3 2.2 0.6 1.1 1.1 1.0 2.0 0.0 0.8 0.5 0.3 0.2 0.8 0.3 2.9 0.9 0.6 0.6 0.0 0.0 0.5 0.7 0.0 0.7 5.7 2.7 1.2 0.4 0.8 0.2 1.0 0.3 0.7 0.7 0.1 0.7 0.4 0.5 0.5 0.0 0.4 0.3 0.6 0.2 0.2 0.0 0.7 0.0 0.4 0.2 0.2 0.1 0.6 0.2 0.2 0.4 0.2 0.2 0.1 0.2 0.2 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 3.4 0.0 0.0 0.0 0.0 0.0 3.2 1.3 0.0 1.9 1.6 0.0 0.9 1.3 0.6 0.0 0.0 0.0 2.0 2.0 0.4 0.0 2.0 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.6 1.9 0.0 0.0 CCDC32 "C15orf57, MGC20481" ENSG00000128891 "Coiled-coil domain containing 32" Q9BV29 15 40528683-40565057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 80.5;Hofbauer cells: 72.0;Syncytiotrophoblasts: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041688 Uncertain Approved "Nuclear speckles,Vesicles" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" Vesicles "HPA041688: AB_10796779" "unprognostic (7.10e-2)" "unprognostic (1.04e-1)" "unprognostic (9.86e-3)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (4.25e-5)" "unprognostic (4.03e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.70e-2)" "unprognostic (2.34e-1)" "unprognostic (1.23e-2)" "unprognostic (5.77e-2)" "unprognostic (3.72e-1)" "unprognostic (1.18e-1)" "unprognostic (2.20e-1)" "unprognostic (6.47e-2)" 16.0 20.5 16.2 17.0 14.8 20.2 15.5 13.9 18.1 16.0 16.9 17.3 17.0 14.6 17.3 9.3 18.2 17.8 18.1 18.3 17.1 22.8 13.0 14.2 28.7 16.1 17.6 25.0 17.9 20.0 13.6 21.3 18.6 13.9 19.8 15.1 13.0 14.9 15.5 10.3 14.9 15.4 15.6 21.5 18.0 8.3 18.2 19.4 20.9 11.1 25.8 19.2 12.1 16.2 15.4 10.8 14.1 22.8 28.8 29.9 8.4 12.0 17.8 20.9 21.8 16.4 20.9 5.6 32.9 18.0 30.2 28.3 13.8 13.8 14.8 35.0 16.2 62.6 18.1 20.6 19.6 24.0 31.5 25.4 14.1 16.3 11.0 19.8 26.7 22.0 35.0 36.9 16.1 13.3 11.2 20.4 5.6 35.3 13.6 19.1 18.5 19.1 39.6 36.3 15.8 15.5 17.9 18.5 9.3 16.6 19.6 43.4 29.8 19.5 17.0 34.1 17.5 21.1 21.1 18.4 20.7 37.2 27.8 58.2 32.4 33.9 32.6 34.2 25.9 147.1 35.6 35.3 43.0 167.2 35.8 30.7 34.0 29.1 35.7 57.6 50.6 42.1 16.2 14.8 13.9 18.1 18.3 17.1 16.1 17.6 18.6 15.6 18.2 16.2 32.1 12.8 13.4 0.0 24.6 0.0 0.0 0.0 0.0 0.0 18.6 20.8 0.0 0.0 9.9 20.2 0.0 80.5 19.6 0.0 29.4 27.0 0.0 22.7 13.7 10.2 0.0 0.0 0.0 29.2 32.5 11.3 0.0 14.4 6.3 15.5 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 10.3 0.0 0.0 0.0 0.0 38.3 0.0 0.0 7.8 0.0 0.0 30.0 12.4 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 81.4 10.1 35.0 0.0 0.0 CCNL1 ania-6a ENSG00000163660 "Cyclin L1" Q9UK58 3 157146508-157160760 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057911 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" "HPA057911: AB_2683553" "unprognostic (1.03e-2)" "unprognostic (3.66e-2)" "unprognostic (1.38e-1)" "unprognostic (6.90e-3)" "unprognostic (1.79e-1)" "unprognostic (6.58e-2)" "unprognostic (3.16e-3)" "unprognostic (7.50e-2)" "unprognostic (5.54e-3)" "unprognostic (3.37e-1)" "unprognostic (3.06e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.01e-6)" "unprognostic (3.71e-1)" "unprognostic (2.24e-1)" "unprognostic (5.62e-2)" "prognostic favorable (6.96e-7)" 52.1 25.2 12.4 11.6 12.9 56.6 27.3 14.2 21.2 21.9 12.6 22.5 13.5 19.4 5.7 22.1 30.5 13.5 23.1 13.0 13.2 31.8 45.3 30.2 14.1 15.1 12.8 31.2 33.5 8.3 21.8 10.3 13.1 23.8 6.6 5.3 18.7 6.2 21.3 25.3 29.7 9.1 11.9 35.6 29.1 9.1 13.0 20.0 23.7 10.3 9.8 19.4 22.9 14.7 19.2 11.4 16.8 11.6 16.1 10.9 16.0 12.0 14.4 13.9 13.0 19.7 14.8 20.3 10.0 8.9 9.7 14.7 12.4 14.6 12.8 18.2 14.1 12.6 12.2 17.2 13.2 8.8 7.7 13.3 25.1 13.2 17.7 13.9 11.1 11.4 8.7 12.7 10.2 13.8 17.8 16.7 13.9 14.7 12.5 16.2 13.6 31.7 8.9 11.4 8.9 16.5 9.1 8.4 26.1 12.5 8.7 26.1 9.1 12.8 7.1 13.8 15.9 25.3 21.5 26.7 12.8 13.1 12.6 5.9 10.3 16.0 13.5 8.4 14.1 13.4 12.5 14.0 13.1 15.2 17.1 14.2 28.6 17.4 11.3 14.0 15.4 8.2 12.4 12.9 14.2 21.2 13.0 13.2 15.1 12.8 13.1 11.9 13.0 14.7 367.4 218.0 392.4 33.0 222.5 268.0 499.2 203.8 310.7 73.7 279.3 247.0 54.3 177.3 259.0 68.0 133.5 139.2 253.6 389.6 23.5 189.4 41.0 379.7 426.5 287.1 247.7 86.5 30.6 127.8 152.9 302.7 268.1 761.2 222.2 281.6 167.8 90.4 164.6 40.4 32.3 294.6 154.6 241.5 251.4 20.9 128.0 292.5 140.5 42.2 160.1 69.5 122.6 35.7 66.3 143.2 378.2 75.2 258.5 408.2 415.6 21.2 188.9 183.3 131.5 460.0 276.4 46.5 25.0 252.6 276.9 209.1 282.8 182.6 244.1 503.2 CCNQ "CycM, FAM58A" ENSG00000262919 "Cyclin Q" Q8N1B3 X 153587925-153600045 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 72.4;Extravillous trophoblasts: 98.6;Syncytiotrophoblasts: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050137, HPA059843" Uncertain Approved Nucleoplasm,Cytosol Yes No "Cluster 37: B-cells - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "HPA050137: AB_2681029, HPA059843: AB_2684140" "unprognostic (3.94e-1)" "unprognostic (1.94e-2)" "unprognostic (7.36e-2)" "unprognostic (2.92e-1)" "unprognostic (5.08e-2)" "unprognostic (1.02e-2)" "unprognostic (1.47e-3)" "unprognostic (2.12e-1)" "unprognostic (8.50e-3)" "unprognostic (2.08e-2)" "unprognostic (1.57e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (8.75e-2)" "unprognostic (2.31e-1)" "unprognostic (2.71e-2)" "unprognostic (5.25e-2)" 11.8 12.8 19.9 8.2 21.3 7.3 11.7 19.6 24.9 11.9 15.6 16.2 8.9 12.9 12.7 13.1 11.1 4.0 33.9 20.8 20.5 13.5 13.2 10.6 12.5 23.2 21.6 10.5 15.0 10.3 23.6 9.2 23.4 13.6 8.0 6.4 12.9 8.8 34.3 12.1 13.6 6.1 20.0 17.2 13.3 6.2 21.2 9.0 11.1 13.6 12.2 14.0 11.7 24.9 43.7 31.2 12.1 43.5 20.9 11.2 18.7 25.0 21.8 23.5 23.6 33.3 14.3 34.9 44.6 25.1 35.3 26.7 38.4 22.6 22.2 20.3 39.2 7.8 19.4 23.5 19.0 28.2 18.9 14.1 20.1 15.7 16.1 10.0 19.0 16.1 10.6 15.6 19.1 50.5 19.7 38.0 15.1 44.4 52.4 22.6 20.0 17.8 17.0 17.6 16.0 21.1 12.0 19.3 34.4 11.9 7.3 25.0 14.6 20.5 29.3 46.7 38.5 21.8 23.1 43.4 18.5 45.4 15.7 0.0 1.6 4.9 2.7 1.4 1.0 6.1 2.3 1.9 1.3 4.1 2.5 1.7 0.9 0.7 0.8 1.2 3.4 1.1 19.9 21.3 19.6 24.9 20.8 20.5 23.2 21.6 23.4 20.0 21.2 24.9 21.0 3.2 13.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 24.1 31.0 0.0 0.0 3.1 7.3 0.0 40.7 20.4 0.0 72.4 23.3 0.0 11.9 17.3 7.8 0.0 0.0 0.0 37.1 98.6 8.4 0.0 8.7 2.5 16.3 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 22.7 0.0 0.0 0.0 0.0 34.0 0.0 0.0 5.9 0.0 0.0 41.6 2.2 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 120.9 10.0 18.4 0.0 0.0 CDK3 ENSG00000250506 "Cyclin dependent kinase 3" Q00526 17 76000906-76005999 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 5.3;Breast myoepithelial cells: 5.0;Glandular and luminal cells: 5.2;Granulosa cells: 6.3;Ionocytes: 10.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA007420 Uncertain Approved Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA007420: AB_1078490" "unprognostic (6.77e-2)" "unprognostic (1.26e-1)" "unprognostic (3.69e-2)" "unprognostic (1.87e-3)" "unprognostic (6.41e-2)" "unprognostic (1.10e-3)" "unprognostic (1.61e-2)" "unprognostic (1.56e-1)" "unprognostic (8.12e-3)" "unprognostic (1.34e-1)" "unprognostic (9.80e-5)" "unprognostic (1.19e-2)" "unprognostic (6.75e-7)" "unprognostic (4.25e-2)" "unprognostic (1.63e-2)" "unprognostic (4.68e-1)" "unprognostic (4.47e-4)" 12.7 11.0 11.4 7.7 11.8 10.6 12.2 11.5 13.8 15.7 12.0 14.9 10.4 11.5 10.7 11.1 13.7 10.3 8.4 11.3 12.2 18.4 34.8 14.2 10.5 12.0 11.7 15.9 15.1 4.8 19.7 8.9 12.2 25.7 10.1 6.9 13.6 8.4 3.6 24.7 14.7 7.6 11.5 21.9 12.2 15.6 11.8 5.8 19.5 3.3 10.5 10.8 13.3 13.6 5.5 7.5 13.5 6.5 7.3 9.0 26.1 4.6 4.6 8.0 7.4 7.0 11.0 6.5 4.5 5.7 4.6 11.6 10.2 4.1 5.6 3.3 14.1 12.7 17.8 7.3 6.7 5.9 14.9 8.7 10.8 7.3 5.1 13.0 6.9 4.1 5.6 4.5 4.3 12.1 6.3 21.8 6.3 3.8 8.4 10.4 5.2 7.2 6.9 15.8 8.4 22.0 3.8 12.0 3.2 14.2 17.4 10.9 5.5 16.4 9.6 5.4 6.7 9.9 7.2 6.2 5.4 5.5 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 11.4 11.8 11.5 13.8 11.3 12.2 12.0 11.7 12.2 11.5 11.8 13.6 4.3 0.0 0.0 0.0 0.5 2.7 0.0 4.0 0.0 0.0 5.3 5.0 0.3 0.0 2.2 0.0 0.0 0.0 3.1 0.0 1.9 2.0 0.0 2.9 3.9 1.4 0.0 0.0 0.0 2.3 0.0 1.3 0.0 5.2 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 4.4 0.0 0.0 1.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.5 0.0 0.0 1.2 2.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.7 0.0 1.0 2.8 0.0 0.0 CDKN1A "CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1" ENSG00000124762 "Cyclin dependent kinase inhibitor 1A" P38936 6 36676460-36687337 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 74.5" "Group enriched" "Detected in many" 9 "B-cells: 20.7;dendritic cells: 21.5;monocytes: 74.5" "Cell line enhanced" "Detected in many" "HHSteC: 798.5;HSkMC: 586.5;hTCEpi: 775.8;LHCN-M2: 604.2" "Region enhanced" "Detected in all" "olfactory bulb: 76.0" "Low region specificity" "Detected in all" "CAB000064, HPA005946, CAB069401" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" "CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477" "unprognostic (7.99e-3)" "unprognostic (4.01e-2)" "unprognostic (1.58e-1)" "prognostic favorable (3.14e-5)" "unprognostic (1.57e-2)" "unprognostic (2.19e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.30e-1)" "unprognostic (7.27e-2)" "unprognostic (2.79e-2)" "unprognostic (7.55e-3)" "prognostic favorable (4.95e-5)" "unprognostic (8.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (3.21e-2)" 322.1 98.1 47.0 62.1 48.1 72.7 144.2 47.3 60.9 123.3 85.9 119.0 115.2 74.4 41.0 203.2 213.9 132.6 170.6 47.2 49.5 149.9 173.4 182.2 17.3 63.7 54.6 184.9 130.5 70.1 104.4 44.7 53.4 91.4 108.2 29.2 79.1 29.4 241.6 224.4 130.0 114.3 55.0 34.4 121.3 47.0 50.3 59.7 77.5 26.9 21.8 212.7 142.3 53.6 27.0 108.1 80.1 2.0 273.3 490.3 149.5 435.6 344.8 52.3 203.7 9.6 25.3 18.3 15.5 267.9 48.0 60.2 3.7 477.7 82.4 36.2 22.0 3.0 85.8 137.0 798.5 0.5 127.7 586.5 775.8 476.2 147.1 309.3 275.3 1.4 5.1 120.8 604.2 57.4 3.9 11.3 10.2 112.8 15.5 54.4 67.1 31.9 91.2 201.5 36.7 35.6 101.3 8.4 21.3 185.2 32.7 111.2 155.8 91.5 86.9 6.2 36.4 202.0 42.9 54.5 118.7 9.9 261.0 0.0 22.8 0.5 0.5 52.2 0.8 20.7 1.1 0.6 20.0 16.2 0.3 0.4 4.2 0.7 74.5 21.5 2.9 34.2 47.0 48.1 47.3 60.9 47.2 49.5 63.7 54.6 53.4 55.0 50.3 53.6 571.2 83.3 45.1 1.0 126.9 440.5 340.1 293.1 512.8 0.8 203.9 187.6 151.6 41.5 214.4 68.0 0.0 42.1 56.4 505.3 46.9 217.6 0.9 227.9 57.3 327.1 175.5 5.7 0.5 264.7 52.8 302.4 150.9 199.2 104.4 20.4 71.7 68.9 72.9 0.0 0.4 197.1 156.6 62.0 556.0 3.9 34.5 277.6 218.7 5.6 280.6 58.4 2.1 0.0 0.5 429.9 466.1 16.6 376.4 201.7 383.2 17.2 215.1 3.1 26.3 303.6 471.6 1.2 1.7 620.9 672.0 155.3 106.0 10.7 75.8 478.0 CEBPZOS CEBPZ-AS1 ENSG00000218739 "CEBPZ opposite strand" A8MTT3 2 37196488-37216193 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053866 Uncertain Approved Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA053866: AB_2682283" "unprognostic (2.13e-1)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" "unprognostic (8.05e-3)" "prognostic unfavorable (1.72e-6)" "unprognostic (2.34e-2)" "unprognostic (2.40e-2)" "unprognostic (5.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (3.46e-7)" "unprognostic (3.69e-2)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" 22.3 46.5 23.6 15.0 24.7 25.4 22.4 26.4 32.7 23.9 25.6 28.8 23.8 23.4 38.5 24.3 23.9 17.7 42.5 26.4 24.9 35.9 27.9 17.8 22.7 24.7 24.0 28.3 22.9 24.9 31.1 22.0 24.8 29.9 22.6 28.1 26.1 18.2 53.4 23.9 22.5 20.2 23.1 20.6 24.5 22.7 24.5 18.3 26.0 37.3 19.6 24.0 22.0 27.9 59.9 19.4 41.1 32.9 42.5 47.0 39.4 43.2 39.3 27.2 19.8 18.5 26.4 20.7 22.9 42.8 36.2 33.7 22.4 32.9 33.4 55.3 47.1 56.2 21.6 29.0 38.2 70.5 29.4 49.6 44.0 37.1 42.1 36.7 44.3 21.4 42.6 28.9 45.3 11.9 17.2 67.6 60.2 47.6 29.5 51.4 55.8 47.2 48.6 15.9 43.4 42.6 33.4 54.0 43.5 22.1 23.9 41.2 39.0 29.1 35.9 43.2 38.1 53.0 0.5 44.1 54.0 41.2 42.5 32.4 23.0 21.2 27.3 26.4 32.2 34.1 31.1 29.2 22.8 26.9 38.5 34.9 8.8 23.2 20.6 49.2 23.5 22.3 23.6 24.7 26.4 32.7 26.4 24.9 24.7 24.0 24.8 23.1 24.5 27.9 46.6 54.5 40.9 13.7 37.7 0.0 51.6 0.0 51.2 46.5 37.6 38.9 43.0 27.1 21.1 38.6 18.8 83.0 43.6 25.7 92.0 46.8 76.0 59.1 35.7 27.9 17.5 30.1 14.7 33.7 50.7 35.6 41.3 41.4 17.1 30.3 27.5 27.4 44.5 32.0 19.5 32.6 0.0 27.7 0.0 18.2 47.2 34.7 0.0 18.7 39.9 59.8 46.4 13.6 27.1 41.8 31.0 44.4 30.4 38.9 54.2 92.1 27.0 56.2 46.0 31.0 33.0 115.8 58.8 48.5 0.0 69.1 37.8 33.4 33.1 41.6 CENPX "CENP-X, FAAP10, MGC14480, MHF2, STRA13" ENSG00000169689 "Centromere protein X" A8MT69 17 82018702-82024107 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 172.6;Breast myoepithelial cells: 190.2;Cytotrophoblasts: 197.7;Extravillous trophoblasts: 455.2;Hofbauer cells: 146.1;Pancreatic endocrine cells: 151.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 45: Intestine - Brush border" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "unprognostic (3.11e-1)" "unprognostic (3.57e-3)" "unprognostic (1.84e-2)" "unprognostic (1.58e-2)" "unprognostic (4.76e-2)" "unprognostic (2.60e-1)" "unprognostic (2.95e-3)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (3.59e-3)" "unprognostic (2.74e-1)" "unprognostic (1.60e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.57e-2)" "unprognostic (3.48e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-1)" 39.0 29.1 57.8 27.8 58.7 44.3 41.6 62.4 70.6 34.4 54.4 56.3 38.4 26.2 11.6 63.1 29.0 14.9 33.1 56.8 58.2 45.9 89.5 33.4 25.3 58.7 58.9 29.2 33.0 26.2 18.2 30.2 59.6 65.0 30.6 16.2 50.1 18.3 37.7 44.3 40.8 17.1 57.6 29.6 50.3 22.3 60.2 25.4 34.1 21.1 20.7 42.2 38.4 61.0 131.3 352.7 78.4 116.6 30.0 27.6 62.2 91.9 78.1 116.7 79.3 144.1 101.1 47.8 83.9 50.0 113.0 76.1 71.3 88.6 52.7 51.1 259.0 86.0 157.1 247.8 32.2 103.6 61.5 26.8 43.4 90.4 31.6 34.7 111.8 88.4 153.9 75.0 72.7 376.1 174.3 94.3 51.9 329.6 230.9 78.0 84.4 70.9 69.5 157.5 177.5 113.1 51.3 302.0 49.4 38.0 238.1 80.1 40.7 125.0 154.5 215.1 161.3 50.4 27.5 65.6 86.3 84.7 103.2 47.9 112.3 61.5 82.4 99.4 80.6 106.1 79.4 78.7 85.4 83.8 85.3 72.5 24.5 74.4 90.3 105.4 110.7 99.6 57.8 58.7 62.4 70.6 56.8 58.2 58.7 58.9 59.6 57.6 60.2 61.0 61.2 41.7 59.6 0.0 11.3 0.0 0.0 0.0 0.0 0.0 172.6 190.2 0.0 0.0 29.1 44.1 0.0 197.7 33.7 0.0 129.1 102.4 0.0 41.1 34.6 27.6 0.0 0.0 0.0 128.8 455.2 33.4 0.0 49.3 11.4 60.5 0.0 0.0 146.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.0 0.0 51.1 0.0 0.0 0.0 0.0 151.5 0.0 0.0 5.5 0.0 0.0 139.3 17.5 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 105.2 21.8 40.1 0.0 0.0 CFAP97D1 C17orf105 ENSG00000231256 "CFAP97 domain containing 1" B2RV13 17 43780435-43787620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053028 Approved NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 7: Non-specific - Mitochondria" "HPA053028: AB_2682020" "unprognostic (7.80e-2)" "unprognostic (5.46e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.64e-2)" "unprognostic (1.87e-1)" "unprognostic (1.36e-1)" "unprognostic (1.98e-1)" "unprognostic (2.77e-1)" "unprognostic (4.80e-2)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.73e-1)" "unprognostic (6.24e-2)" "unprognostic (2.28e-3)" "unprognostic (1.41e-1)" 0.0 0.0 0.1 0.1 0.1 0.5 0.1 1.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.1 13.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.1 1.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CGAS "C6orf150, MB21D1" ENSG00000164430 "Cyclic GMP-AMP synthase" Q8N884 6 73413515-73452297 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity" "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.0" "Cell type enhanced" "Detected in some" "Adipocytes: 10.2;dendritic cells: 12.0;Glandular and luminal cells: 12.5;Hofbauer cells: 12.4;Macrophages: 10.0;monocytes: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 37.1;RH-30: 43.8;RPMI-8226: 45.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031700, HPA031702" Enhanced Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA031700: AB_10601693, HPA031702: AB_2673999" "unprognostic (2.49e-1)" "unprognostic (2.36e-1)" "unprognostic (4.61e-2)" "unprognostic (4.95e-2)" "unprognostic (2.49e-2)" "unprognostic (1.81e-1)" "unprognostic (4.84e-3)" "unprognostic (1.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.25e-2)" "unprognostic (2.20e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.27e-7)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-1)" 2.9 1.1 1.7 6.4 2.1 14.0 1.7 2.2 3.0 2.4 1.7 1.9 2.7 1.9 0.6 2.3 1.8 2.6 1.5 1.9 2.0 1.1 0.8 3.5 7.4 2.6 2.2 1.2 1.2 0.6 0.6 3.1 2.6 1.9 1.8 0.2 1.8 1.8 0.5 1.1 2.5 2.0 2.4 5.2 2.3 1.0 3.0 2.3 1.6 0.9 4.7 4.3 2.1 3.4 19.9 5.8 0.1 0.2 1.2 2.7 0.1 10.1 3.7 11.3 12.6 20.7 14.2 0.2 20.9 4.3 6.3 10.1 9.8 0.2 12.0 31.9 0.0 16.9 8.2 0.1 4.0 12.3 11.5 1.6 3.2 11.8 0.1 0.0 3.5 0.1 0.0 37.1 8.7 8.0 0.0 27.1 6.2 2.4 11.2 23.4 43.8 45.2 0.0 7.3 0.3 0.1 17.3 0.4 10.2 0.2 0.0 33.9 5.0 0.0 9.1 8.5 0.2 8.1 19.8 0.2 0.1 17.5 11.4 26.3 12.7 19.0 6.0 17.5 4.7 8.4 7.9 5.9 7.5 6.7 1.8 3.4 8.5 4.2 11.6 17.6 8.0 6.0 1.7 2.1 2.2 3.0 1.9 2.0 2.6 2.2 2.6 2.4 3.0 3.4 10.2 3.2 4.8 0.0 4.7 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 0.6 0.0 0.0 0.2 12.0 0.0 0.0 2.0 0.0 8.4 8.5 6.0 0.0 0.0 0.0 3.9 0.7 2.3 0.0 12.5 5.1 1.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 3.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.3 8.0 0.7 0.0 0.0 CHTF8 "CTF8, FLJ20400" ENSG00000168802 "Chromosome transmission fidelity factor 8" P0CG13 16 69118010-69132588 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (7.86e-3)" "unprognostic (1.99e-2)" "unprognostic (2.59e-2)" "unprognostic (2.46e-2)" "unprognostic (6.44e-2)" "unprognostic (1.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.86e-3)" "unprognostic (9.88e-2)" "unprognostic (7.45e-2)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "prognostic favorable (3.59e-9)" "unprognostic (3.74e-2)" "unprognostic (1.85e-1)" "unprognostic (3.75e-2)" "unprognostic (1.45e-1)" 30.5 38.8 27.0 20.0 29.8 12.3 30.7 26.2 45.0 30.9 33.4 32.5 23.6 33.5 39.6 39.5 41.6 17.3 33.5 29.0 27.7 57.0 62.5 31.4 31.2 26.9 27.1 26.6 42.2 43.6 29.9 24.9 26.9 36.6 32.8 17.8 36.1 30.6 27.7 35.0 32.0 35.4 27.2 41.9 42.1 37.0 27.4 36.5 36.6 23.2 42.5 34.8 26.3 29.4 69.1 58.3 48.8 20.1 66.2 57.5 53.0 55.2 49.7 64.3 62.7 45.3 70.4 64.1 64.3 48.5 38.7 83.7 41.3 92.9 64.0 46.2 46.7 58.2 40.6 34.7 49.1 76.1 60.1 55.5 54.4 63.1 48.1 54.0 85.9 46.5 59.9 26.2 65.8 65.4 55.7 58.7 25.3 82.6 49.8 68.6 36.7 78.5 75.2 50.6 51.4 33.7 83.0 29.7 55.2 46.6 50.7 41.5 67.7 36.0 44.5 25.4 40.6 57.9 63.8 64.8 34.3 36.2 28.6 77.2 41.9 39.1 32.7 42.1 35.4 37.4 33.5 39.7 39.1 41.5 33.5 33.3 23.5 33.5 45.6 33.8 40.6 46.5 27.0 29.8 26.2 45.0 29.0 27.7 26.9 27.1 26.9 27.2 27.4 29.4 22.9 16.0 14.2 7.2 31.2 14.4 21.1 26.5 32.5 12.3 32.4 30.6 12.8 24.3 15.5 23.9 4.2 66.6 21.4 32.7 60.7 40.6 7.4 21.1 16.9 27.1 28.2 25.2 5.3 48.2 63.6 21.8 15.8 17.5 7.0 28.4 26.7 36.8 43.4 6.7 5.8 27.7 12.2 30.4 19.7 18.5 21.5 24.8 12.4 9.4 40.2 21.7 25.7 9.0 11.1 44.8 22.2 27.1 27.2 29.2 27.7 75.6 18.0 10.4 6.6 17.6 21.7 26.4 49.1 19.5 17.2 66.6 22.7 29.1 32.4 21.4 CKS2 ENSG00000123975 "CDC28 protein kinase regulatory subunit 2" P33552 9 89311195-89316703 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 177.3;testis: 186.3" "Cell type enhanced" "Detected in many" "Langerhans cells: 474.6;Spermatocytes: 692.7;Spermatogonia: 503.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 187.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol NA Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: AB_2666948, HPA030762: AB_10670044" "unprognostic (8.30e-2)" "unprognostic (3.00e-1)" "unprognostic (1.50e-2)" "unprognostic (2.80e-2)" "unprognostic (2.96e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (3.57e-3)" "unprognostic (7.04e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (2.13e-3)" "unprognostic (1.44e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" 13.6 82.9 9.6 38.5 10.0 177.3 20.1 11.9 26.9 10.1 11.8 44.1 43.3 13.0 8.8 53.2 12.1 18.7 10.3 12.7 10.3 35.6 31.2 24.0 102.8 10.5 10.1 9.4 4.2 19.8 4.8 44.3 11.0 15.0 41.0 27.9 10.8 17.8 9.4 19.9 33.1 17.6 10.6 32.6 20.4 186.3 10.8 121.1 12.8 4.8 84.7 26.5 19.9 11.3 685.9 570.1 342.6 230.6 98.7 89.1 249.5 396.1 211.4 428.1 340.0 236.1 328.6 504.9 228.4 149.1 761.4 466.5 415.5 305.1 488.2 398.1 335.5 257.5 378.9 637.5 42.4 531.7 281.2 33.0 69.2 307.2 269.1 162.9 403.2 409.1 313.2 430.6 556.0 509.1 420.7 928.3 501.6 795.5 521.5 358.4 376.4 303.7 342.8 153.5 288.4 171.7 328.7 314.9 324.5 318.4 379.7 304.2 231.4 184.1 350.3 449.6 588.2 345.9 759.2 415.3 271.3 303.1 268.5 40.8 19.5 44.1 22.6 26.5 25.3 61.3 30.4 21.9 22.5 44.7 16.3 21.8 14.5 40.9 14.8 187.9 62.7 23.6 9.6 10.0 11.9 26.9 12.7 10.3 10.5 10.1 11.0 10.6 10.8 11.3 138.6 38.5 103.9 0.3 175.7 280.2 92.1 126.1 259.0 4.1 107.2 169.0 61.3 5.7 49.9 14.7 0.0 231.1 201.1 79.4 23.5 20.1 37.3 149.7 66.4 66.1 122.3 266.9 1.2 11.2 379.4 63.1 74.9 250.2 145.0 144.7 29.3 25.0 184.6 0.0 1.9 164.9 111.9 40.5 474.6 77.0 25.7 164.3 140.5 1.9 31.0 26.1 28.8 1.0 1.1 31.1 67.1 16.6 89.3 72.1 37.6 209.7 32.8 7.3 46.0 75.2 206.5 692.7 503.6 197.5 299.1 199.5 156.0 70.3 162.7 102.1 CNBD2 "C20orf152, CNMPD1, dJ954P9.1" ENSG00000149646 "Cyclic nucleotide binding domain containing 2" Q96M20 20 35954564-36030700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.9" "Cell type enhanced" "Detected in many" "Early spermatids: 173.9;Late spermatids: 99.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA043182 Uncertain NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" "HPA043182: AB_10794389" "unprognostic (1.88e-1)" "unprognostic (1.47e-1)" "unprognostic (1.58e-1)" "unprognostic (3.27e-2)" "unprognostic (2.81e-2)" "unprognostic (6.59e-3)" "unprognostic (2.77e-2)" "unprognostic (6.71e-2)" "unprognostic (2.22e-1)" "unprognostic (1.44e-1)" "unprognostic (4.82e-4)" "unprognostic (1.63e-1)" "unprognostic (1.29e-1)" "unprognostic (2.05e-1)" "unprognostic (2.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" 2.5 4.4 6.3 1.8 6.6 8.8 3.9 6.9 7.7 2.8 6.9 4.2 3.8 3.1 12.5 3.1 2.8 1.6 4.0 6.2 6.6 7.7 5.5 2.4 4.1 6.7 6.6 2.7 7.0 5.7 5.0 1.7 6.5 3.7 2.8 15.8 4.2 2.5 23.7 5.8 4.6 1.9 6.6 5.7 3.8 25.9 6.6 4.3 4.6 16.8 3.3 2.8 2.5 6.9 2.2 3.3 4.4 4.4 3.7 1.8 2.9 0.5 1.9 3.5 3.2 8.2 4.7 3.9 1.5 2.7 2.6 3.5 3.4 5.9 3.5 1.5 5.4 5.8 10.7 17.1 3.0 3.2 1.4 3.5 5.4 2.7 2.9 1.7 5.4 6.2 1.7 19.0 2.2 5.7 3.4 8.7 1.1 3.1 4.9 3.2 3.2 13.8 4.8 1.9 9.6 4.1 2.0 5.6 4.4 1.2 2.6 5.3 2.3 2.4 4.1 1.6 0.4 15.9 10.0 9.9 2.4 5.5 0.7 2.1 0.4 0.1 1.5 2.0 0.3 1.0 0.6 0.7 0.2 2.1 0.7 0.4 0.6 3.7 0.8 0.4 3.4 0.5 6.3 6.6 6.9 7.7 6.2 6.6 6.7 6.6 6.5 6.6 6.6 6.9 8.3 0.0 6.5 7.8 11.7 0.3 9.3 0.1 8.6 10.8 18.3 23.5 0.6 14.3 3.1 11.0 22.9 7.0 32.1 13.6 29.4 4.4 173.9 7.8 6.5 5.5 12.7 8.6 4.1 5.5 7.1 4.5 11.2 6.1 1.3 4.7 8.2 9.7 8.0 23.5 6.7 16.2 0.0 13.8 0.4 99.0 6.5 7.9 0.0 3.7 4.6 21.1 9.2 7.5 5.9 3.3 13.9 3.0 20.8 6.9 19.1 19.5 2.2 39.7 19.7 7.1 5.9 20.2 16.4 18.4 0.1 4.9 20.5 5.8 10.3 7.0 CNMD "BRICD3, CHM-I, CHM1, LECT1, MYETS1" ENSG00000136110 Chondromodulin O75829 13 52703264-52739820 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9;retina: 8.4;salivary gland: 6.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 35 "NTERA-2: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010510 Uncertain "Secreted to extracellular matrix" NA NA 9500 "Cluster 77: Retina - Visual perception" "Cluster 5: NTERA-2 - Transcription" "Cluster 7: Non-specific - Mitochondria" "HPA010510: AB_10602021" "unprognostic (7.52e-3)" "unprognostic (1.34e-1)" "unprognostic (7.36e-2)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (3.22e-1)" "unprognostic (2.84e-2)" "unprognostic (2.63e-2)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-1)" 0.0 0.0 1.8 0.0 4.9 0.0 0.0 2.3 2.6 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 2.0 0.0 0.0 1.6 0.0 2.4 2.3 0.0 0.3 0.0 1.0 0.1 2.2 0.5 0.0 8.4 6.7 0.0 0.1 0.0 0.1 0.0 2.7 0.3 0.0 1.8 2.4 0.1 3.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 4.9 2.3 2.6 1.8 2.0 2.4 2.3 2.2 2.7 2.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CNOT9 "CAF40, CT129, RCD1, RCD1+, RQCD1" ENSG00000144580 "CCR4-NOT transcription complex subunit 9" Q92600 2 218568580-218597080 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046622 Approved Approved "Cytoplasmic bodies" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Cytoplasmic bodies" "HPA046622: AB_10962694" "unprognostic (7.70e-2)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (8.58e-2)" "unprognostic (1.34e-1)" "unprognostic (1.30e-2)" "prognostic unfavorable (8.41e-9)" "unprognostic (8.08e-3)" "unprognostic (1.91e-3)" "unprognostic (1.53e-2)" "unprognostic (7.02e-2)" "unprognostic (6.89e-2)" "prognostic unfavorable (4.69e-9)" "unprognostic (1.87e-2)" "unprognostic (2.38e-2)" "unprognostic (2.05e-1)" "unprognostic (4.67e-2)" 17.2 21.9 18.3 26.0 19.7 40.2 16.6 20.8 19.4 17.8 18.9 17.7 18.1 17.6 19.4 21.4 18.8 16.1 20.1 18.7 19.4 16.3 21.0 18.2 31.3 18.6 19.2 18.7 15.8 21.0 25.2 18.0 18.6 18.4 22.6 26.1 15.1 15.0 22.4 20.5 17.3 20.2 19.4 22.6 17.1 27.0 18.9 33.6 15.4 17.1 36.2 21.8 17.6 22.1 49.9 38.2 62.2 82.2 35.2 33.8 79.8 55.5 57.4 69.6 67.4 68.2 40.4 55.4 33.7 64.3 60.9 57.2 88.1 61.6 81.4 79.8 55.6 110.6 72.1 81.1 48.9 120.2 61.7 31.0 48.5 73.1 74.2 32.7 53.1 74.0 67.1 121.1 56.3 40.0 117.2 72.8 94.5 38.4 60.4 97.8 88.7 57.1 37.1 71.5 79.2 64.8 54.5 47.5 52.2 59.1 38.1 66.5 43.2 75.5 55.8 55.3 69.0 57.6 62.6 128.3 53.7 73.1 55.0 36.9 25.6 29.1 41.5 31.7 36.4 29.9 34.0 35.4 30.4 26.6 31.8 35.0 10.5 35.5 34.0 35.1 30.8 37.9 18.3 19.7 20.8 19.4 18.7 19.4 18.6 19.2 18.6 19.4 18.9 22.1 22.1 22.4 20.7 0.0 10.0 0.0 0.0 0.0 0.0 0.0 20.4 15.1 0.0 0.0 9.9 12.9 0.0 28.4 27.1 0.0 27.4 21.2 0.0 32.2 21.2 10.3 0.0 0.0 0.0 20.7 40.7 10.9 0.0 22.4 16.4 18.9 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 20.7 0.0 0.0 0.0 0.0 25.6 0.0 0.0 7.0 0.0 0.0 16.1 10.2 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 28.3 11.0 16.9 0.0 0.0 COP1 "CFAP78, FAP78, FLJ10416, RFWD2, RNF200" ENSG00000143207 "COP1 E3 ubiquitin ligase" Q8NHY2 1 175944831-176207286 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 28.1;Extravillous trophoblasts: 33.5;Syncytiotrophoblasts: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 15: RT4 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.99e-1)" "unprognostic (3.76e-2)" "unprognostic (4.17e-2)" "prognostic unfavorable (3.96e-4)" "unprognostic (2.95e-2)" "unprognostic (4.33e-1)" "unprognostic (2.01e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" "unprognostic (3.52e-2)" "unprognostic (9.24e-2)" "unprognostic (1.67e-1)" "unprognostic (1.33e-2)" "unprognostic (6.68e-2)" "unprognostic (7.01e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-1)" 14.2 9.5 5.9 12.0 7.1 16.8 12.7 11.4 9.1 12.1 8.4 18.1 13.8 11.8 9.8 14.2 9.4 9.5 9.8 8.5 5.9 12.4 16.6 12.5 15.7 4.6 5.0 8.7 13.2 10.5 8.0 11.2 5.0 10.1 16.7 8.6 13.1 8.5 13.6 17.5 13.9 11.0 5.7 16.7 13.7 15.6 6.1 14.9 10.6 7.4 16.8 14.7 11.9 8.8 35.3 17.5 22.1 13.8 23.0 22.6 56.1 21.7 22.0 17.7 18.6 30.0 28.1 59.4 25.8 20.9 18.9 32.3 16.9 27.0 17.7 23.7 17.0 22.6 19.4 28.0 18.9 49.2 33.0 16.8 28.9 17.6 19.8 17.9 26.6 21.7 43.9 24.9 24.8 42.5 27.0 28.2 47.4 55.8 2.0 26.1 20.4 40.2 26.8 93.7 22.6 41.6 27.8 44.9 35.9 37.4 32.1 69.1 40.4 19.4 16.1 28.3 23.4 35.3 62.7 49.8 19.1 26.7 26.9 8.5 3.0 12.0 1.9 3.7 1.4 1.7 2.0 1.4 2.1 1.5 2.7 2.0 14.1 0.6 3.4 1.1 1.7 1.0 5.9 7.1 11.4 9.1 8.5 5.9 4.6 5.0 5.0 5.7 6.1 8.8 15.8 22.4 14.5 0.0 4.4 0.0 0.0 0.0 0.0 0.0 15.4 10.9 0.0 0.0 3.1 9.2 0.0 28.1 12.2 0.0 21.5 14.8 0.0 17.9 14.6 7.2 0.0 0.0 0.0 22.7 33.5 7.4 0.0 20.1 7.6 18.1 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 21.8 0.0 0.0 3.1 0.0 0.0 22.1 4.4 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 31.3 6.7 13.8 0.0 0.0 COPS9 "CSNAP, MYEOV2" ENSG00000172428 "COP9 signalosome subunit 9" Q8WXC6 2 240126563-240136807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 340.8;Breast myoepithelial cells: 395.6;Distal tubular cells: 498.9;Exocrine glandular cells: 383.2;Pancreatic endocrine cells: 347.0;Proximal tubular cells: 720.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044845 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "HPA044845: AB_10962975" "unprognostic (6.05e-3)" "unprognostic (1.44e-1)" "unprognostic (7.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (3.72e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (1.79e-2)" "unprognostic (1.26e-1)" "unprognostic (1.25e-3)" "unprognostic (9.02e-2)" "unprognostic (3.02e-1)" "unprognostic (3.71e-1)" "unprognostic (2.26e-2)" "unprognostic (3.03e-1)" "unprognostic (4.37e-2)" 141.9 129.3 373.7 62.2 373.1 80.5 139.6 386.7 485.1 118.8 367.8 164.4 73.5 97.0 142.5 167.4 93.3 59.3 245.9 386.8 372.6 176.8 93.3 92.1 88.4 373.9 376.2 105.7 183.9 72.3 168.3 50.2 375.8 129.9 52.1 50.3 124.6 69.2 282.2 142.7 99.4 59.3 376.9 113.7 149.6 105.2 384.0 74.9 119.2 131.2 58.0 115.3 125.4 396.2 151.7 200.3 154.5 162.4 209.0 169.6 142.0 213.7 147.0 136.5 173.9 146.2 131.7 41.4 62.5 196.0 218.1 118.9 138.4 197.5 94.0 177.6 510.6 125.0 182.8 458.8 166.1 126.7 112.4 201.1 159.9 102.0 126.3 126.1 203.2 207.8 147.3 87.0 201.8 324.3 204.2 391.0 235.5 188.5 433.3 158.3 207.2 129.3 172.4 256.1 178.7 178.8 112.1 150.7 243.1 118.5 139.0 242.2 165.7 179.5 203.1 231.3 206.9 177.4 166.2 220.1 223.8 148.6 180.9 514.1 298.1 415.1 292.3 315.9 293.1 322.9 298.6 301.0 287.2 237.6 260.5 294.1 106.3 259.4 330.2 364.2 386.0 415.1 373.7 373.1 386.7 485.1 386.8 372.6 373.9 376.2 375.8 376.9 384.0 396.2 187.9 128.2 121.1 0.0 41.2 0.0 0.0 0.0 0.0 0.0 340.8 395.6 0.0 0.0 55.7 275.8 0.0 175.1 117.0 0.0 498.9 220.7 0.0 182.6 190.7 75.6 0.0 0.0 0.0 383.2 193.7 82.8 0.0 193.1 61.8 174.9 0.0 0.0 322.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.4 0.0 0.0 145.3 0.0 0.0 0.0 0.0 347.0 0.0 0.0 18.6 0.0 0.0 720.0 67.1 0.0 0.0 0.0 93.1 0.0 0.0 0.0 0.0 132.4 69.8 129.2 0.0 0.0 COQ8A "ADCK3, CABC1, COQ8, SCAR9" ENSG00000163050 "Coenzyme Q8A" Q8NI60 1 226940286-226987544 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Kinase, Transferase" "Disease variant, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skeletal muscle: 1165.1;tongue: 484.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 21.9;Collecting duct cells: 33.1;Ductal cells: 21.2;Exocrine glandular cells: 32.7;Proximal tubular cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 82.0;RPMI-8226: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061662 Supported Mitochondria NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA061662: AB_2684578" "unprognostic (6.37e-3)" "unprognostic (2.09e-2)" "unprognostic (2.29e-1)" "unprognostic (9.06e-2)" "unprognostic (8.94e-2)" "unprognostic (2.49e-1)" "unprognostic (4.42e-2)" "unprognostic (3.50e-3)" "unprognostic (1.81e-1)" "unprognostic (4.02e-1)" "unprognostic (4.15e-3)" "unprognostic (8.67e-2)" "unprognostic (2.40e-2)" "unprognostic (9.24e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (2.62e-1)" 63.9 123.8 7.1 10.3 8.0 26.1 35.8 17.3 8.1 16.5 16.1 30.8 29.9 15.9 0.5 32.2 24.6 19.7 123.5 7.1 5.6 14.4 35.7 9.6 12.7 8.9 5.4 34.1 93.8 6.4 5.3 6.5 9.8 18.5 6.4 1.3 32.7 11.7 1165.1 25.1 18.5 7.2 5.9 14.4 52.8 6.7 5.9 8.6 9.4 484.7 4.3 40.8 13.4 11.5 8.0 14.4 3.3 10.3 11.4 7.3 57.7 3.6 2.9 5.2 6.9 23.0 12.8 24.5 17.9 2.4 2.6 9.2 6.9 8.2 0.8 25.5 82.0 16.7 11.2 38.8 2.5 25.8 9.3 14.2 12.2 4.0 5.4 4.9 2.5 24.7 29.4 19.4 0.7 11.0 15.2 37.3 15.5 62.8 29.5 14.9 17.1 78.6 1.6 5.9 59.9 24.2 7.3 28.7 20.6 3.4 15.1 34.8 2.5 5.9 5.3 8.2 13.3 43.0 40.5 13.1 5.3 29.3 6.0 47.7 23.5 68.4 15.8 17.1 15.3 22.2 15.8 14.6 18.6 26.8 21.5 17.0 43.1 21.2 13.6 8.1 21.5 26.0 7.1 8.0 17.3 8.1 7.1 5.6 8.9 5.4 9.8 5.9 5.9 11.5 11.4 3.2 21.9 0.0 5.8 0.0 0.0 0.0 0.0 0.0 18.1 17.1 0.0 0.0 4.3 33.1 0.0 12.2 10.2 0.0 15.6 21.2 0.0 12.3 8.9 5.4 0.0 0.0 0.0 32.7 10.0 6.3 0.0 9.6 13.9 9.8 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 11.4 0.0 0.0 0.0 0.0 10.8 0.0 0.0 3.2 0.0 0.0 24.8 2.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 7.7 5.2 16.0 0.0 0.0 COQ8B "ADCK4, COQ8, FLJ12229" ENSG00000123815 "Coenzyme Q8B" Q96D53 19 40691514-40725784 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 16.5;Endometrial ciliated cells: 16.4;Theca cells: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027229, HPA027277, HPA027279, HPA028303" Supported Enhanced Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551" "unprognostic (7.57e-2)" "unprognostic (9.48e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (2.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (2.27e-1)" "unprognostic (2.82e-2)" "unprognostic (1.48e-1)" "unprognostic (2.93e-2)" "unprognostic (6.18e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (2.65e-2)" 15.1 25.2 10.1 5.7 10.7 5.9 15.3 10.4 12.8 23.4 10.9 19.4 9.7 22.0 2.3 16.0 29.8 7.6 21.9 9.8 10.6 21.0 25.7 16.4 6.0 10.6 10.8 22.5 20.7 8.4 49.3 3.5 10.3 23.2 2.3 1.3 16.9 7.3 14.4 20.2 17.8 3.8 11.2 18.3 23.9 17.3 10.6 8.8 23.3 8.6 3.3 20.3 18.4 10.5 9.9 39.5 7.9 18.5 7.8 6.1 8.5 6.6 7.8 5.6 5.1 15.4 14.3 13.8 20.0 4.3 7.8 9.8 7.0 10.5 2.0 20.0 10.4 11.6 12.7 6.4 12.1 4.1 19.2 8.4 10.6 5.4 5.4 5.2 7.4 13.7 7.7 8.1 6.0 6.4 4.9 5.7 6.4 11.5 3.6 11.5 13.1 12.4 15.7 17.6 15.1 11.0 12.5 20.4 21.0 4.4 22.8 17.1 9.4 5.1 20.6 3.9 5.5 9.4 9.0 7.3 27.8 5.2 9.1 10.2 9.4 8.7 6.7 9.3 8.3 7.1 5.5 7.8 9.9 5.9 4.6 5.1 9.0 6.9 9.2 4.6 4.9 7.3 10.1 10.7 10.4 12.8 9.8 10.6 10.6 10.8 10.3 11.2 10.6 10.5 8.5 12.8 3.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 11.6 8.0 0.0 0.0 2.5 12.9 0.0 11.1 6.8 0.0 11.7 16.5 0.0 16.4 7.8 1.7 0.0 0.0 0.0 10.9 9.8 5.0 0.0 10.3 1.3 11.7 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 9.5 0.0 0.0 1.2 0.0 0.0 13.0 8.7 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.4 3.2 19.8 0.0 0.0 COX20 "FAM36A, FLJ43269" ENSG00000203667 "Cytochrome c oxidase assembly factor COX20" Q5RI15 1 244835616-244845057 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 414.8;Proximal tubular cells: 464.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043617, HPA045490" Approved Enhanced Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA043617: AB_10965694, HPA045490: AB_10962869" "unprognostic (5.84e-3)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (2.86e-1)" "unprognostic (3.62e-1)" "unprognostic (3.70e-2)" "unprognostic (1.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "prognostic favorable (3.13e-4)" "unprognostic (1.99e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (2.54e-2)" "unprognostic (3.70e-2)" "unprognostic (3.10e-1)" "unprognostic (7.02e-3)" 17.5 44.2 28.1 23.3 30.9 20.1 22.1 37.4 49.2 13.9 23.6 23.9 24.3 24.8 29.9 21.5 17.2 15.3 42.9 27.9 30.1 50.2 29.6 15.8 21.4 30.3 30.3 35.4 23.2 22.8 11.1 17.7 28.8 28.7 18.7 58.3 17.1 18.6 43.3 15.2 25.0 20.5 29.2 15.0 23.1 25.0 29.3 16.3 37.0 37.4 16.5 20.4 9.6 30.1 132.6 34.1 33.5 100.4 22.5 17.3 75.2 54.0 35.7 31.0 27.2 93.9 88.9 21.3 65.7 36.6 58.3 36.1 17.8 43.0 40.8 56.0 15.6 38.6 47.6 85.7 28.7 95.7 57.5 16.0 20.2 44.5 30.8 44.9 35.2 22.7 81.2 80.2 63.0 33.0 53.5 43.5 84.2 94.9 68.6 38.5 42.0 121.5 59.5 33.1 19.6 54.2 68.1 36.1 79.6 32.1 67.0 28.7 69.3 67.3 88.7 59.9 120.1 128.0 188.7 43.7 90.9 108.2 65.3 14.5 15.3 21.4 27.1 36.4 26.3 34.2 31.3 30.2 26.5 32.6 21.2 28.7 3.9 24.2 34.5 26.1 43.4 20.4 28.1 30.9 37.4 49.2 27.9 30.1 30.3 30.3 28.8 29.2 29.3 30.1 66.7 19.2 52.1 44.1 77.7 85.1 115.1 144.3 38.1 111.5 104.4 110.1 68.6 183.0 90.5 191.3 45.9 231.5 74.4 97.7 414.8 154.1 38.6 78.4 74.1 61.4 61.8 82.0 16.6 188.9 164.6 56.1 57.6 119.5 73.4 53.1 42.5 294.8 122.1 89.2 24.4 91.7 77.3 64.8 79.6 75.9 69.6 73.4 72.9 9.4 97.6 195.2 110.2 27.6 34.1 178.6 87.0 80.1 51.9 75.9 134.8 464.0 67.7 133.4 65.7 83.2 85.0 67.1 122.4 61.6 75.6 264.5 81.4 63.6 115.3 87.8 CPLANE1 "C5orf42, FLJ13231, Hug, JBTS17" ENSG00000197603 "Ciliogenesis and planar polarity effector 1" Q9H799 5 37106228-37249376 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 19.4;Collecting duct cells: 22.0;Endometrial ciliated cells: 50.3;Endometrial stromal cells: 42.9;Glandular and luminal cells: 20.6;Granulosa cells: 40.8;Theca cells: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 21.9;SiHa: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036775, HPA036776" Approved Approved Cytosol NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA036775: AB_10669914, HPA036776: AB_2675308" "unprognostic (3.06e-1)" "unprognostic (2.00e-1)" "unprognostic (4.96e-2)" "unprognostic (4.13e-3)" "unprognostic (1.65e-1)" "unprognostic (1.44e-2)" "unprognostic (1.38e-3)" "unprognostic (5.88e-2)" "unprognostic (3.13e-2)" "unprognostic (6.20e-3)" "unprognostic (3.02e-1)" "unprognostic (5.31e-2)" "unprognostic (2.72e-2)" "unprognostic (2.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.44e-2)" "unprognostic (2.09e-1)" 2.4 3.1 1.4 1.4 1.9 1.0 3.8 2.6 2.7 3.4 2.5 1.9 1.0 4.2 3.7 2.3 4.2 3.2 1.8 1.4 1.8 3.6 1.5 3.3 1.7 1.3 1.3 5.3 2.4 5.4 2.2 3.3 0.6 4.3 2.0 5.7 2.9 3.6 1.4 2.3 1.1 3.2 0.3 2.3 2.2 4.8 2.5 6.3 6.9 3.3 1.7 2.7 1.4 2.8 5.7 3.5 8.4 6.4 11.4 10.3 3.7 5.8 4.2 6.6 5.2 4.0 7.6 1.4 3.7 5.2 10.4 2.7 2.4 3.5 6.5 3.8 2.6 3.3 21.9 2.4 5.8 0.0 1.8 7.8 4.7 6.7 3.5 7.8 6.5 3.6 0.0 1.2 11.8 0.0 4.2 4.8 2.2 0.0 2.7 4.0 14.9 0.0 6.0 1.7 4.7 3.3 48.7 0.3 3.1 6.8 2.6 3.5 8.0 10.0 6.2 2.7 4.5 1.7 0.0 1.6 2.4 0.1 3.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 1.4 1.9 2.6 2.7 1.4 1.8 1.3 1.3 0.6 0.3 2.5 2.8 19.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 11.3 8.9 0.0 0.0 0.0 22.0 0.0 7.4 8.8 0.0 0.0 8.8 0.0 50.3 42.9 4.8 0.0 0.0 0.0 5.3 5.8 7.6 0.0 20.6 0.0 40.8 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 2.6 0.0 0.0 3.9 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 3.6 3.2 18.9 0.0 0.0 CPLANE2 "C1orf89, MGC10731, RSG1" ENSG00000132881 "Ciliogenesis and planar polarity effector 2" Q9BU20 1 16231692-16237183 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Collecting duct cells: 7.3;Distal tubular cells: 3.9;Ductal cells: 2.4;Endometrial ciliated cells: 4.1;Extravillous trophoblasts: 2.3;Hofbauer cells: 2.4;Proximal tubular cells: 3.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028453 Approved Approved Nucleoplasm NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA028453: AB_10601692" "unprognostic (7.52e-2)" "unprognostic (3.22e-1)" "unprognostic (3.61e-2)" "unprognostic (1.34e-2)" "unprognostic (1.05e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-3)" "unprognostic (1.11e-1)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "prognostic favorable (1.36e-10)" "unprognostic (1.45e-2)" "unprognostic (2.36e-1)" "unprognostic (1.56e-1)" "unprognostic (2.16e-2)" 2.0 5.9 9.7 2.3 9.2 3.8 2.1 4.7 8.8 3.2 3.3 3.2 2.5 4.5 1.4 5.2 6.7 2.3 4.8 9.1 12.7 4.2 3.2 2.3 2.9 9.2 10.9 5.6 4.9 6.2 6.5 1.8 10.2 3.0 1.9 2.3 4.9 4.0 1.9 4.4 2.4 1.7 5.9 3.7 3.9 6.3 12.8 2.9 6.1 1.7 2.4 4.0 2.4 3.5 4.5 12.1 3.6 12.0 2.4 4.3 3.3 5.0 3.2 4.0 1.7 4.4 6.7 9.7 9.7 2.8 7.8 3.6 6.6 6.4 0.4 14.7 5.6 4.8 11.1 0.9 5.9 3.2 8.4 2.3 5.4 4.6 4.1 4.0 3.8 7.3 17.8 3.7 3.3 5.5 3.5 2.4 0.9 4.8 4.7 8.8 0.4 7.8 3.4 2.8 8.7 5.8 1.9 3.0 4.7 2.7 9.0 3.0 3.8 1.1 1.9 2.3 1.6 10.1 4.1 5.7 3.1 7.0 6.7 0.0 0.5 1.9 2.2 1.6 2.8 1.2 1.3 0.6 1.0 1.3 1.3 0.9 0.4 1.4 1.1 0.3 1.5 0.6 9.7 9.2 4.7 8.8 9.1 12.7 9.2 10.9 10.2 5.9 12.8 3.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 7.3 0.0 2.0 0.7 0.0 3.9 2.4 0.0 4.1 0.9 0.3 0.0 0.0 0.0 0.9 2.3 0.4 0.0 1.5 0.0 1.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.4 1.4 0.0 0.0 CPNE7 ENSG00000178773 "Copine 7" Q9UBL6 16 89575758-89597246 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;epididymis: 19.3;pituitary gland: 14.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.2;Collecting duct cells: 20.2;Excitatory neurons: 9.3;Inhibitory neurons: 9.1;Spermatogonia: 10.2;T-cells: 9.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 5 "T-cells: 4.9" "Cell line enhanced" "Detected in many" "HHSteC: 103.2;TIME: 58.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043359 Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "HPA043359: AB_10794884" "unprognostic (6.77e-2)" "unprognostic (1.30e-2)" "unprognostic (1.43e-1)" "unprognostic (1.97e-1)" "unprognostic (3.08e-2)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.28e-3)" "unprognostic (2.55e-1)" "unprognostic (6.47e-2)" "unprognostic (5.88e-2)" "unprognostic (6.93e-2)" "prognostic unfavorable (9.52e-6)" "unprognostic (1.87e-2)" "unprognostic (1.17e-1)" "unprognostic (3.08e-1)" "prognostic favorable (7.22e-4)" 0.5 0.4 13.5 0.9 13.2 0.9 1.5 0.0 17.6 1.4 0.0 0.7 3.6 0.6 19.3 2.1 2.1 3.3 0.4 15.1 11.4 4.3 1.2 1.7 0.5 2.6 16.2 0.5 0.9 2.4 14.1 0.3 7.4 1.8 0.1 1.6 1.4 6.1 0.0 1.6 3.4 0.2 1.0 0.8 3.2 4.1 28.0 1.6 0.8 0.1 0.4 1.6 1.3 6.0 0.1 24.7 0.2 0.4 40.8 41.8 0.3 10.7 4.5 14.6 11.2 24.8 20.7 0.0 9.5 4.2 0.5 16.8 15.4 0.7 5.0 6.0 12.2 0.2 21.5 0.5 103.2 0.1 4.1 16.3 1.1 7.7 29.0 49.3 0.2 17.4 27.3 0.3 35.1 3.8 8.0 4.8 16.1 15.6 19.1 0.4 0.0 17.6 2.2 0.1 13.7 0.2 3.6 5.2 1.1 0.3 4.6 3.2 58.8 28.4 0.0 17.7 0.0 0.1 0.0 5.0 27.8 17.3 12.0 0.0 0.0 0.1 0.7 0.0 4.9 0.0 1.1 1.8 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.2 0.2 13.5 13.2 0.0 17.6 15.1 11.4 2.6 16.2 7.4 1.0 28.0 6.0 0.5 0.0 0.6 1.3 0.1 2.3 1.1 0.1 0.6 11.2 3.9 5.2 0.8 1.5 0.8 20.2 0.0 0.0 1.4 0.1 0.0 0.9 0.0 1.0 0.5 0.7 0.0 0.4 9.3 0.2 0.2 0.3 3.1 2.2 0.0 0.1 0.4 0.0 0.1 0.0 9.1 0.3 0.0 0.0 0.4 0.6 0.3 0.9 1.8 0.0 0.0 0.3 0.0 3.5 0.6 0.6 0.0 0.7 0.1 1.2 0.7 1.7 0.2 0.9 0.0 0.3 0.5 0.3 10.2 1.2 1.1 0.0 9.5 0.0 1.9 2.1 CSKMT "CS-KMT, METTL12, U99HG" ENSG00000214756 "Citrate synthase lysine methyltransferase" A8MUP2 11 62665309-62668496 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "Adipocytes: 40.4;Alveolar cells type 2: 41.4;Breast glandular cells: 65.9;Breast myoepithelial cells: 68.5;dendritic cells: 46.3;Endometrial stromal cells: 37.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" HPA038533 Approved NA Yes "Cluster 30: Non-specific - Translation" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" "HPA038533: AB_10697392" "prognostic favorable (8.73e-4)" "unprognostic (2.59e-1)" "unprognostic (3.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.48e-2)" "unprognostic (3.17e-1)" "unprognostic (9.43e-5)" "unprognostic (1.55e-2)" "unprognostic (7.62e-2)" "unprognostic (2.88e-1)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (4.98e-3)" "unprognostic (2.72e-3)" "unprognostic (1.85e-1)" "unprognostic (1.57e-2)" "unprognostic (3.28e-1)" 0.3 0.3 0.4 0.1 0.3 0.1 0.4 0.3 0.7 0.5 0.3 0.4 0.5 0.4 0.1 0.5 0.5 0.1 0.3 0.3 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.6 0.7 0.1 0.2 0.5 0.4 0.4 0.4 0.1 0.3 0.4 0.9 0.3 0.2 0.1 0.3 0.2 0.4 0.0 0.4 0.2 0.2 0.2 0.3 0.4 0.5 0.4 0.9 0.9 0.3 0.4 2.6 1.0 0.4 0.3 0.6 0.7 0.9 0.7 0.9 1.6 0.4 1.2 0.2 1.7 1.6 0.8 1.4 0.5 0.0 0.6 0.0 1.0 0.0 0.0 0.6 0.9 2.7 0.2 1.0 0.7 0.2 0.2 0.7 0.0 1.0 0.8 0.5 0.7 1.6 0.0 0.8 0.8 0.4 0.2 0.3 0.1 0.0 0.0 0.8 1.0 0.9 0.4 2.0 0.2 0.0 0.2 0.9 2.4 0.0 0.3 0.0 0.0 0.2 0.4 0.4 0.7 1.1 0.1 0.8 1.8 1.7 2.9 2.4 1.1 1.1 1.5 2.9 2.5 0.0 0.5 1.3 1.3 1.3 1.4 0.4 0.3 0.3 0.7 0.3 0.4 0.4 0.3 0.4 0.3 0.4 0.4 40.4 12.8 41.4 0.0 25.0 0.0 0.0 0.0 0.0 0.0 65.9 68.5 0.0 0.0 21.1 18.4 0.0 27.7 46.3 0.0 5.9 7.4 0.0 17.5 37.7 10.1 0.0 0.0 0.0 5.6 20.0 13.2 0.0 23.0 27.8 15.3 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 8.8 0.0 0.0 9.8 6.6 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 26.5 24.4 13.5 0.0 0.0 CSRNP1 "AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1" ENSG00000144655 "Cysteine and serine rich nuclear protein 1" Q96S65 3 39141855-39154562 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 193.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 17.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 64.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045207, HPA058463" Supported Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "HPA045207: AB_10967202, HPA058463: AB_2683726" "unprognostic (2.90e-2)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (1.46e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.07e-4)" "prognostic unfavorable (6.47e-4)" "unprognostic (2.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" 88.9 55.8 13.6 34.0 13.7 193.1 51.7 17.2 22.5 34.7 15.4 35.6 12.0 30.2 6.4 61.7 79.8 67.5 49.9 12.8 18.0 29.2 67.3 80.8 14.9 21.3 16.2 41.5 39.4 23.5 43.3 25.0 15.7 32.7 15.4 5.8 21.3 18.5 36.9 57.1 26.4 64.1 18.3 20.3 48.0 14.7 17.1 34.9 33.8 19.0 8.7 51.6 27.7 15.4 4.4 9.7 2.5 4.8 4.7 4.9 7.8 15.9 22.1 13.0 10.6 13.7 4.0 14.4 3.3 12.1 9.3 4.9 3.0 21.0 6.4 21.6 4.0 16.4 8.0 10.5 5.8 4.1 15.7 2.3 11.3 20.4 3.2 11.6 17.8 3.9 12.7 24.9 10.7 13.9 0.8 6.7 11.4 7.4 8.1 6.8 10.4 23.7 10.3 15.9 7.0 1.1 8.7 64.2 5.5 14.5 7.2 7.5 9.0 6.6 28.2 5.6 11.9 6.3 5.8 6.6 14.4 5.2 8.4 0.1 3.0 3.8 1.7 5.9 2.1 3.6 1.6 2.0 3.3 3.7 2.0 1.3 17.1 2.6 11.0 4.2 2.7 2.3 13.6 13.7 17.2 22.5 12.8 18.0 21.3 16.2 15.7 18.3 17.1 15.4 200.8 48.1 66.3 6.8 75.0 103.2 88.1 40.2 153.1 1.4 121.1 95.8 15.8 37.1 31.2 11.0 0.0 19.7 86.3 77.3 9.8 37.6 54.4 119.6 65.2 92.8 59.3 13.2 3.5 38.5 43.0 98.1 75.4 199.4 96.5 4.2 73.9 40.7 38.7 0.0 1.5 54.7 22.4 36.7 165.2 46.8 1.5 94.5 69.4 4.7 14.8 7.6 7.2 1.5 1.3 49.2 60.9 4.1 74.3 49.4 54.1 6.0 21.0 1.7 13.1 154.4 103.9 0.6 4.7 85.7 79.6 90.7 132.4 8.9 38.0 38.9 CSRNP2 "C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12" ENSG00000110925 "Cysteine and serine rich nuclear protein 2" Q9H175 12 51061205-51083664 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018503, HPA019914" Approved Approved "Nuclear speckles" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 58: Brain - Synaptic function" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "HPA018503: AB_1845535, HPA019914: AB_2670315" "unprognostic (8.67e-3)" "unprognostic (1.00e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (1.83e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.38e-1)" "unprognostic (1.20e-1)" "unprognostic (2.41e-2)" "unprognostic (1.14e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (6.51e-4)" "unprognostic (1.10e-1)" "unprognostic (8.98e-2)" "unprognostic (1.74e-2)" "prognostic favorable (2.78e-4)" 12.2 10.4 19.1 7.4 19.3 3.3 11.1 15.5 21.9 13.4 13.3 11.9 6.7 13.7 11.9 7.7 11.2 11.6 12.7 19.3 19.7 12.2 6.8 10.8 8.3 14.1 15.4 12.4 9.3 11.8 17.6 11.4 14.2 11.6 7.0 20.5 9.9 10.5 16.8 9.5 8.8 14.6 12.0 10.0 10.0 26.2 19.2 13.9 11.4 14.7 7.0 12.3 9.7 16.5 9.0 10.2 30.2 27.1 22.8 16.0 31.5 17.3 19.9 23.8 16.3 19.6 6.4 7.5 16.2 18.7 16.2 10.8 14.9 9.5 18.8 15.4 10.4 8.9 12.1 6.1 24.7 6.2 12.8 19.6 26.4 27.6 15.6 25.9 23.6 34.0 12.5 13.1 27.8 15.6 21.3 8.6 24.8 4.2 14.3 12.5 19.1 6.0 13.6 11.6 21.2 25.1 25.1 20.0 25.9 21.2 12.7 17.2 21.4 23.6 12.4 15.8 11.9 13.5 16.0 6.9 14.5 8.1 7.7 0.0 0.3 1.0 0.7 0.0 0.2 0.4 0.7 0.4 0.4 0.2 0.7 1.0 1.0 2.2 0.2 0.1 0.5 0.2 19.1 19.3 15.5 21.9 19.3 19.7 14.1 15.4 14.2 12.0 19.2 16.5 17.8 3.2 6.8 13.1 9.4 17.8 11.4 7.1 8.0 6.8 14.1 20.2 19.5 5.7 5.4 5.5 25.0 6.6 13.8 15.4 3.9 6.9 23.5 10.3 14.4 12.7 8.3 4.0 39.9 5.0 9.2 15.6 63.2 10.0 11.4 13.1 13.6 2.6 6.5 6.7 32.3 10.8 8.2 4.4 14.8 14.8 6.2 9.7 16.0 11.2 4.2 5.4 5.2 23.6 20.7 8.0 7.5 7.9 10.8 10.0 8.6 4.2 7.4 7.6 0.0 20.2 17.3 28.6 13.8 6.8 16.1 15.1 12.5 5.9 5.7 6.6 CTDNEP1 "DULLARD, HSA011916, NET56" ENSG00000175826 "CTD nuclear envelope phosphatase 1" O95476 17 7243591-7252491 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 410.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037439, HPA066466" Uncertain Approved "Lipid droplets" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Lipid droplets" "HPA037439: AB_10601264, HPA066466: AB_2732745" "unprognostic (7.11e-2)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "prognostic favorable (6.45e-4)" "unprognostic (3.12e-1)" "unprognostic (2.13e-1)" "unprognostic (4.61e-2)" "unprognostic (1.50e-2)" "unprognostic (2.98e-1)" "unprognostic (9.90e-2)" "prognostic favorable (1.81e-4)" "unprognostic (3.37e-1)" "unprognostic (2.77e-3)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (9.97e-2)" "unprognostic (2.02e-2)" 99.7 94.2 53.0 41.4 52.5 48.8 91.4 49.2 55.1 102.4 51.2 89.8 36.4 97.6 37.1 105.2 88.2 32.1 119.0 49.9 49.0 85.5 69.1 91.6 45.9 55.9 52.7 103.4 98.5 44.4 83.8 41.1 51.2 81.8 46.7 29.7 82.6 33.6 410.0 114.7 93.8 45.0 50.5 115.9 95.4 66.5 55.8 56.2 81.2 179.2 61.8 88.2 87.0 52.8 86.2 123.9 68.4 73.7 105.0 128.0 52.5 62.4 102.8 97.4 83.1 59.6 57.7 80.6 65.6 111.5 68.6 70.5 90.8 95.4 108.6 118.5 74.6 55.2 79.7 104.1 96.5 63.3 100.3 103.4 113.8 111.9 118.3 99.9 105.2 76.2 50.9 56.3 93.3 53.4 77.3 67.0 48.3 75.7 50.9 85.3 61.3 62.6 77.9 44.1 26.3 75.5 49.8 48.9 69.8 67.6 46.3 51.5 61.6 70.9 61.3 57.5 119.4 49.2 46.0 40.6 91.5 85.8 75.1 4.2 6.3 11.0 5.5 6.7 4.4 7.8 5.2 5.9 4.6 7.4 4.0 5.9 8.4 4.1 4.5 9.7 5.7 2.3 53.0 52.5 49.2 55.1 49.9 49.0 55.9 52.7 51.2 50.5 55.8 52.8 48.0 25.6 23.2 12.7 47.1 47.2 42.4 36.1 19.9 44.8 73.9 70.1 13.1 37.1 33.5 40.5 22.9 66.1 68.3 84.5 11.7 63.7 4.8 50.0 59.9 47.2 73.7 18.5 14.7 85.2 129.9 43.5 22.4 68.5 20.3 71.3 44.6 35.6 90.6 30.3 17.0 79.6 22.4 104.4 62.2 7.9 57.8 69.8 28.4 14.0 69.2 47.9 59.8 11.6 21.9 84.5 52.1 47.0 41.3 58.3 62.8 34.8 25.8 35.4 26.3 42.5 51.4 23.7 35.5 32.5 67.1 83.2 41.3 68.3 69.6 61.8 CYB5D1 FLJ32499 ENSG00000182224 "Cytochrome b5 domain containing 1" Q6P9G0 17 7857746-7862282 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 71.9;Endometrial ciliated cells: 45.5;Late spermatids: 42.6;Respiratory ciliated cells: 47.3;Skeletal myocytes: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021632 Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 30: Non-specific - Translation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoli, Golgi apparatus" "HPA021632: AB_1847368" "unprognostic (1.99e-1)" "unprognostic (2.91e-1)" "unprognostic (1.23e-1)" "unprognostic (5.10e-3)" "unprognostic (2.34e-1)" "unprognostic (4.44e-3)" "unprognostic (1.12e-1)" "unprognostic (2.16e-2)" "unprognostic (1.34e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-4)" "unprognostic (2.38e-2)" "unprognostic (1.25e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-2)" 17.2 13.0 8.6 5.5 9.4 7.8 12.1 9.6 9.7 10.2 16.0 9.4 6.2 10.1 15.2 8.2 26.4 8.7 15.0 9.0 10.1 17.9 12.6 8.3 4.8 10.0 10.8 13.0 11.4 10.8 16.6 6.6 9.0 11.3 7.1 30.0 10.3 11.6 10.6 9.6 6.3 8.7 9.3 6.0 8.8 8.8 11.5 7.5 21.3 13.6 5.4 7.4 7.8 8.0 24.6 17.9 8.5 22.4 14.8 13.0 5.0 12.5 12.2 13.0 12.4 11.3 4.6 10.5 8.6 10.0 7.6 21.3 18.9 16.1 19.4 7.1 21.9 6.9 24.6 16.3 6.7 12.4 4.7 11.2 19.9 22.8 20.2 8.0 14.0 25.3 5.2 7.0 7.3 10.7 19.5 5.0 10.7 16.0 18.2 13.2 3.9 10.7 20.4 4.7 11.4 7.6 19.9 10.8 11.6 8.5 12.6 5.0 9.9 9.9 8.7 17.8 15.9 3.7 9.7 5.8 20.8 6.7 6.5 0.3 0.9 0.0 1.0 0.7 1.1 1.2 0.8 0.5 1.2 0.5 2.1 1.1 0.9 0.6 0.4 0.5 0.8 0.7 8.6 9.4 9.6 9.7 9.0 10.1 10.0 10.8 9.0 9.3 11.5 8.0 21.8 12.8 19.5 5.9 4.5 5.1 6.7 4.9 1.8 4.8 22.2 18.4 0.3 7.2 11.0 5.5 20.9 4.2 7.7 5.0 13.7 4.2 71.9 45.5 16.3 14.7 6.0 0.8 6.8 3.1 2.7 13.2 13.3 27.2 10.8 4.6 6.8 8.3 3.9 1.7 5.9 8.5 4.1 1.6 4.3 42.6 4.7 29.1 5.4 2.8 0.3 6.7 0.0 0.5 2.2 7.7 4.5 3.8 5.1 7.8 4.5 11.9 47.3 20.3 6.6 41.9 7.5 4.4 2.7 8.5 6.1 2.6 4.4 2.9 8.3 2.5 CYBC1 "C17orf62, Eros, FLJ90469, MGC4368" ENSG00000178927 "Cytochrome b-245 chaperone 1" Q9BQA9 17 82442586-82450829 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Chaperone "Chronic granulomatous disease, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 47.4;Ductal cells: 39.7;Granulosa cells: 56.1;Hofbauer cells: 80.2;monocytes: 54.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045696 Uncertain Approved "Plasma membrane,Cell Junctions" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane" "Cell Junctions" "HPA045696: AB_2679421" "unprognostic (1.87e-2)" "unprognostic (6.92e-3)" "unprognostic (2.25e-1)" "unprognostic (2.15e-3)" "unprognostic (5.75e-2)" "unprognostic (2.05e-3)" "unprognostic (3.81e-3)" "unprognostic (4.86e-2)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-3)" "unprognostic (7.99e-2)" "prognostic unfavorable (6.83e-11)" "unprognostic (1.47e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-2)" "unprognostic (9.14e-3)" 39.2 35.7 34.4 70.1 36.1 37.2 37.4 36.7 42.6 40.9 36.3 33.8 24.6 33.7 23.7 34.1 34.9 46.0 30.7 33.2 35.6 51.2 64.9 41.4 110.5 41.8 37.8 33.8 45.0 24.5 25.9 30.7 37.7 43.4 27.7 9.9 30.8 23.2 14.9 29.4 49.3 40.7 37.1 117.4 36.9 17.8 36.7 63.3 28.9 13.6 72.1 49.7 28.2 40.6 48.5 67.4 37.1 61.4 57.9 60.6 35.0 42.2 51.6 61.8 73.1 26.2 47.8 122.4 37.8 60.6 75.4 48.3 25.7 32.4 42.6 87.4 21.1 33.4 19.2 30.6 59.3 38.1 94.4 68.5 45.7 53.1 29.3 59.0 81.5 90.3 28.4 88.2 52.9 50.8 160.2 33.0 27.5 65.0 35.3 120.1 22.7 93.1 44.8 60.7 31.7 60.7 77.0 88.1 55.7 66.3 91.4 148.3 27.9 46.7 46.0 79.3 45.9 157.8 58.3 93.1 61.2 61.0 42.5 223.8 136.7 182.9 96.3 181.3 74.7 114.8 88.2 93.6 125.2 115.9 73.0 71.1 300.6 104.5 169.4 130.9 101.1 161.4 34.4 36.1 36.7 42.6 33.2 35.6 41.8 37.8 37.7 37.1 36.7 40.6 35.6 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 19.0 17.1 0.0 0.0 0.0 22.0 0.0 27.6 47.4 0.0 9.8 39.7 0.0 11.9 21.9 12.9 0.0 0.0 0.0 33.6 36.1 10.9 0.0 12.4 0.0 56.1 0.0 0.0 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 54.8 0.0 0.0 0.0 0.0 34.9 0.0 0.0 11.1 0.0 0.0 19.6 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 27.6 19.5 23.8 0.0 0.0 CYREN "C7orf49, FLJ22450, FLJ27285, MGC5242, MRI, MRI-2" ENSG00000122783 "Cell cycle regulator of NHEJ" Q9BWK5 7 135092363-135170795 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 69.1;Distal tubular cells: 72.4;Ductal cells: 51.0;Extravillous trophoblasts: 65.6;Hofbauer cells: 41.3;Proximal tubular cells: 47.3;Syncytiotrophoblasts: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020060 Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA020060: AB_2290651" "unprognostic (3.32e-1)" "unprognostic (1.78e-2)" "unprognostic (1.20e-1)" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (1.92e-3)" "prognostic unfavorable (2.52e-5)" "unprognostic (8.89e-3)" "unprognostic (2.92e-2)" "unprognostic (3.21e-3)" "unprognostic (8.39e-2)" "unprognostic (3.09e-1)" "unprognostic (1.59e-1)" "unprognostic (1.60e-1)" "unprognostic (8.65e-2)" "unprognostic (3.96e-1)" "unprognostic (2.69e-1)" 16.2 20.1 11.8 15.4 15.7 16.5 16.2 15.0 13.1 16.4 18.9 14.5 13.7 18.5 16.6 18.6 21.1 11.6 15.9 11.5 13.1 30.1 14.1 13.9 19.3 18.7 14.6 18.3 21.0 26.2 16.3 20.6 17.4 15.4 13.9 6.6 22.5 22.8 33.4 13.6 13.6 18.1 13.8 17.2 18.5 13.9 14.6 19.5 15.0 18.9 23.7 16.6 14.8 18.9 59.9 62.7 29.4 46.0 24.9 23.7 49.1 38.3 38.8 49.0 38.1 40.1 42.0 48.3 42.2 39.2 52.1 32.8 42.2 69.6 31.6 62.1 27.1 32.0 34.2 37.2 35.4 64.0 37.4 27.6 68.4 38.3 44.0 22.5 21.2 37.4 117.5 31.9 40.3 60.4 60.6 44.0 67.8 50.5 46.1 44.1 36.4 64.1 57.1 35.4 34.7 53.4 43.4 37.7 42.5 32.1 30.0 57.4 18.4 43.8 24.6 39.0 66.3 56.8 69.8 65.8 60.7 62.5 90.9 32.2 27.5 27.9 12.3 24.5 13.4 18.3 10.8 16.7 30.3 19.4 15.8 15.9 6.1 27.2 24.1 25.8 5.4 20.9 11.8 15.7 15.0 13.1 11.5 13.1 18.7 14.6 17.4 13.8 14.6 18.9 12.2 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 15.2 13.8 0.0 0.0 0.0 31.3 0.0 69.1 9.9 0.0 72.4 51.0 0.0 11.8 13.4 6.3 0.0 0.0 0.0 35.4 65.6 8.0 0.0 25.6 0.0 17.0 0.0 0.0 41.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 32.0 0.0 0.0 0.0 0.0 34.7 0.0 0.0 2.2 0.0 0.0 47.3 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 46.7 4.3 17.8 0.0 0.0 DBR1 ENSG00000138231 "Debranching RNA lariats 1" Q9UK59 3 138160988-138174921 "Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035365 Supported Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA035365: AB_10611956" "unprognostic (1.20e-1)" "unprognostic (3.72e-2)" "unprognostic (8.48e-3)" "unprognostic (2.04e-2)" "unprognostic (2.83e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.33e-1)" "unprognostic (5.24e-2)" "unprognostic (9.99e-2)" "unprognostic (2.60e-1)" "unprognostic (3.33e-2)" "prognostic favorable (1.36e-4)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (5.35e-2)" "unprognostic (4.79e-2)" 6.6 6.7 4.4 6.7 5.1 15.3 7.6 5.4 4.8 6.2 5.8 6.4 5.3 7.4 8.2 6.6 6.5 5.6 6.0 4.2 5.1 7.2 6.1 7.7 9.0 5.1 4.8 8.2 7.3 7.4 5.6 5.6 5.4 6.7 6.2 5.1 7.0 6.1 6.7 7.6 7.2 6.9 5.4 9.6 11.3 3.0 4.8 9.7 8.2 6.5 9.0 6.2 5.5 5.9 24.5 9.9 17.7 19.7 9.6 9.0 18.4 14.2 10.4 15.1 18.2 16.9 10.6 22.3 26.4 12.9 22.8 17.8 20.6 7.0 19.7 19.2 17.1 24.2 12.3 13.9 11.8 31.5 20.5 12.4 11.6 14.0 13.1 8.9 12.6 19.1 16.0 4.7 15.4 18.9 31.2 18.5 20.4 18.9 11.4 19.3 20.1 20.4 13.2 23.6 17.1 22.0 38.0 13.1 21.1 14.4 24.6 25.5 11.9 12.6 8.8 23.6 16.7 7.1 10.5 46.6 8.2 22.4 16.8 4.2 7.1 13.3 8.4 9.7 11.1 7.0 9.6 8.1 8.6 7.4 9.6 10.7 2.9 8.4 8.4 5.2 8.4 6.2 4.4 5.1 5.4 4.8 4.2 5.1 5.1 4.8 5.4 5.4 4.8 5.9 7.5 6.4 12.9 6.5 8.2 5.2 3.4 6.2 6.2 5.9 6.9 11.9 6.1 7.2 5.9 9.2 0.0 11.3 14.7 4.7 9.8 10.8 0.1 6.1 9.8 6.7 6.0 16.2 4.2 9.0 8.6 8.6 9.2 9.5 5.7 8.7 6.1 6.9 10.4 6.7 4.8 6.6 6.1 16.7 4.8 0.5 8.7 10.2 3.6 8.4 9.0 8.0 6.2 8.5 7.8 8.2 5.6 8.2 7.0 3.7 3.9 5.3 5.5 5.1 0.0 10.0 8.7 4.3 2.1 5.6 4.1 4.5 12.9 6.5 7.3 2.9 DCAF1 "KIAA0800, MGC102804, VPRBP" ENSG00000145041 "DDB1 and CUL4 associated factor 1" Q9Y4B6 3 51395867-51500002 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.4" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 17.9;Granulosa cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036142, HPA052445, HPA053203" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" No No "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli fibrillar center" "HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080" "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (3.71e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (9.75e-2)" "unprognostic (2.58e-2)" "unprognostic (1.24e-1)" "unprognostic (8.75e-2)" "unprognostic (2.15e-1)" "unprognostic (2.89e-2)" "unprognostic (2.21e-2)" "prognostic favorable (7.45e-5)" "unprognostic (5.49e-2)" "unprognostic (5.00e-1)" "unprognostic (6.81e-2)" "unprognostic (1.64e-1)" 11.4 11.3 7.6 11.7 8.8 15.9 11.2 11.2 9.4 9.4 9.8 11.0 7.9 10.3 9.4 10.6 8.9 7.4 9.5 7.8 9.3 11.0 11.5 10.0 14.8 8.4 8.8 10.3 10.4 18.9 8.6 10.3 8.6 9.7 10.9 19.7 11.3 9.6 27.9 13.5 11.4 9.2 8.0 11.3 10.3 53.4 8.5 18.6 14.6 16.1 15.9 11.2 10.0 9.0 19.9 23.9 22.8 20.7 20.1 15.9 21.6 21.8 16.2 23.1 22.5 26.4 18.8 48.1 11.7 17.2 35.3 17.1 43.3 19.5 29.6 33.7 21.5 41.2 32.4 22.8 14.7 54.4 28.7 10.6 22.2 29.8 21.6 15.0 18.2 26.1 24.5 30.3 18.3 20.3 41.8 22.0 24.0 23.5 26.0 17.5 24.4 32.0 18.0 30.5 11.8 21.0 24.1 22.0 13.2 16.7 15.0 22.8 22.9 18.8 25.1 31.4 33.9 20.5 29.7 48.2 21.9 36.6 15.7 2.5 3.0 2.4 6.5 3.3 7.4 5.1 5.6 5.6 4.8 4.9 6.0 5.1 0.7 5.8 5.0 3.8 6.7 4.9 7.6 8.8 11.2 9.4 7.8 9.3 8.4 8.8 8.6 8.0 8.5 9.0 11.1 3.2 10.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 11.3 9.4 0.0 0.0 6.8 3.7 0.0 7.6 9.7 0.0 1.9 7.0 0.0 11.2 10.3 5.6 0.0 0.0 0.0 6.7 5.7 3.0 0.0 17.9 6.3 13.1 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.6 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.8 0.0 0.0 6.1 5.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 10.5 5.0 7.4 0.0 0.0 DCAF15 "C19orf72, MGC99481" ENSG00000132017 "DDB1 and CUL4 associated factor 15" Q66K64 19 13952492-13961449 "Predicted intracellular proteins" "Immunity, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068351 Approved Vesicles,Mitochondria NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Mitochondria Vesicles "HPA068351: AB_2685977" "unprognostic (6.91e-2)" "unprognostic (6.55e-3)" "unprognostic (3.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.95e-1)" "unprognostic (1.89e-2)" "unprognostic (1.83e-3)" "unprognostic (9.72e-2)" "unprognostic (8.03e-2)" "unprognostic (1.21e-1)" "prognostic favorable (7.97e-4)" "unprognostic (1.98e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (7.97e-3)" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" 17.6 10.7 5.9 10.3 6.0 20.5 18.1 7.1 7.9 18.7 4.7 18.1 6.9 17.0 4.3 24.0 16.7 4.5 18.6 6.0 5.6 16.2 13.9 18.6 13.5 5.6 5.2 15.5 13.7 7.1 16.5 7.3 5.2 17.0 5.2 3.6 16.1 5.3 22.9 30.2 23.4 5.1 4.9 33.4 14.0 44.7 5.6 14.6 17.0 8.6 10.8 15.6 21.6 5.4 18.9 11.5 29.5 16.2 3.1 4.5 13.5 12.7 8.8 26.1 25.9 20.4 7.9 17.3 14.4 12.3 15.4 16.7 18.9 12.0 9.2 21.0 33.8 21.3 21.0 21.4 6.5 17.8 30.2 5.9 10.9 19.3 8.6 9.4 13.1 27.4 22.9 24.8 11.6 28.7 32.0 33.0 35.2 12.7 17.8 29.2 10.4 11.8 14.1 14.3 18.8 19.3 11.4 8.1 10.7 12.1 10.5 22.7 9.2 17.8 13.1 28.3 24.1 17.4 20.7 18.3 11.4 25.8 15.6 0.2 0.3 0.9 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.4 0.1 0.3 0.6 0.1 0.2 0.4 0.6 0.2 5.9 6.0 7.1 7.9 6.0 5.6 5.6 5.2 5.2 4.9 5.6 5.4 19.5 0.0 0.0 6.8 19.7 4.8 10.5 6.9 8.6 17.3 8.9 10.7 2.9 10.0 3.8 9.2 8.4 13.7 24.4 9.6 1.9 11.0 5.0 7.0 7.8 10.9 7.7 9.4 5.2 10.3 15.1 7.5 13.7 7.0 1.3 15.0 7.1 3.4 15.7 15.2 3.4 5.7 4.1 8.1 7.0 9.5 18.3 14.3 1.8 8.4 13.8 9.2 16.5 7.1 5.5 9.9 9.6 12.0 18.3 6.4 4.5 4.7 3.9 13.9 6.6 6.0 7.9 35.6 19.9 10.0 9.8 13.8 21.2 10.4 7.9 8.9 DDIT3 "CHOP, CHOP10, GADD153" ENSG00000175197 "DNA damage inducible transcript 3" P35638 12 57516588-57521737 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Growth arrest, Stress response, Transcription, Transcription regulation, Unfolded protein response, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 170.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 784.2;hTERT-HME1: 399.9;SK-MEL-30: 409.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058416, HPA068416" Uncertain Supported Nucleoplasm No No "Cluster 33: Neutrophils - Chromatin organization" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA058416: AB_2683712, HPA068416: AB_2685985" "unprognostic (1.12e-1)" "unprognostic (5.33e-2)" "unprognostic (2.20e-3)" "unprognostic (4.92e-2)" "unprognostic (7.86e-3)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.55e-4)" "unprognostic (8.55e-2)" "unprognostic (1.26e-3)" "unprognostic (9.40e-3)" "unprognostic (4.92e-2)" "unprognostic (4.16e-2)" "unprognostic (3.52e-2)" "unprognostic (3.70e-1)" "unprognostic (1.62e-1)" "unprognostic (2.56e-1)" "unprognostic (6.76e-2)" 65.3 66.2 90.6 16.1 97.8 196.5 64.3 97.4 145.5 51.0 92.9 52.0 20.7 39.1 109.3 31.6 41.2 32.1 85.1 89.0 99.2 106.4 81.7 55.4 18.8 95.9 98.4 57.4 37.3 80.5 81.4 37.6 97.1 45.5 26.6 123.1 43.3 25.8 44.8 48.7 28.0 29.2 95.5 34.2 44.4 40.9 106.4 17.8 182.1 55.4 17.5 56.2 49.5 129.5 17.8 16.1 10.1 34.5 90.7 61.0 53.8 48.2 106.0 70.1 65.4 57.2 45.7 25.3 46.9 14.3 186.7 21.4 38.5 7.3 72.2 21.0 15.5 19.9 19.9 42.3 784.2 31.8 29.3 175.7 152.7 118.6 399.9 81.7 16.9 26.5 86.4 94.0 31.2 10.8 21.1 41.5 19.7 37.3 37.5 11.8 220.7 22.3 25.0 22.3 20.9 15.3 14.2 16.2 409.0 37.2 34.4 82.8 9.9 47.5 20.2 45.4 42.0 164.4 60.3 26.8 57.4 29.1 85.8 121.1 17.9 48.8 25.1 16.6 22.7 48.3 17.9 23.6 12.8 44.8 34.1 31.1 170.7 35.6 19.4 15.9 23.8 18.0 90.6 97.8 97.4 145.5 89.0 99.2 95.9 98.4 97.1 95.5 106.4 129.5 237.9 19.2 55.1 17.0 96.6 56.3 176.5 93.1 177.0 114.9 86.3 265.7 177.9 37.1 56.7 22.0 91.8 42.3 101.8 265.7 115.4 43.3 9.5 111.3 39.4 62.3 230.7 12.8 9.6 16.0 17.5 115.7 74.5 82.4 204.0 26.3 27.5 20.1 45.7 55.5 14.5 218.4 101.7 30.4 81.6 6.3 28.0 81.5 88.9 6.5 8.2 156.1 17.5 14.1 23.0 33.0 300.0 38.0 43.2 115.1 61.7 61.6 38.1 160.0 13.1 56.9 122.2 77.7 15.6 91.5 45.7 107.8 89.7 37.2 127.2 65.1 DDX3X "DBX, DDX14, DDX3, HLP2" ENSG00000215301 "DEAD-box helicase 3 X-linked" O00571 X 41333348-41364472 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 887.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059585" Supported Supported Approved Nucleoplasm,Cytosol NA NA 260000 "Cluster 18: Basophils - Vesicular transport" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073" "unprognostic (2.42e-2)" "unprognostic (1.11e-1)" "unprognostic (8.01e-3)" "unprognostic (1.66e-1)" "unprognostic (8.12e-2)" "unprognostic (6.43e-2)" "unprognostic (1.17e-3)" "unprognostic (1.88e-1)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.25e-2)" "unprognostic (2.05e-1)" "unprognostic (1.51e-1)" "unprognostic (2.95e-1)" "unprognostic (4.77e-1)" "unprognostic (9.44e-2)" "unprognostic (2.93e-2)" 164.7 123.2 28.7 113.3 29.9 146.1 99.8 31.9 37.3 102.4 38.8 85.6 80.7 123.4 39.1 107.6 108.8 111.0 96.4 27.0 36.0 110.5 130.6 103.5 118.7 33.6 29.8 108.1 76.9 133.0 52.5 107.3 34.2 68.7 75.8 81.9 72.9 64.8 126.9 91.2 81.6 145.1 32.4 103.2 84.4 43.0 30.9 169.6 104.3 112.5 111.5 153.3 97.7 34.7 230.5 225.6 236.3 122.3 273.6 211.1 136.4 150.6 239.3 167.1 132.3 238.8 141.4 2.5 103.9 185.8 212.4 149.4 292.2 235.0 248.3 130.2 232.9 132.6 237.6 152.1 140.5 253.8 236.4 159.1 150.9 278.4 270.3 204.1 258.3 131.5 258.4 134.5 158.9 157.8 163.0 83.2 212.2 121.3 114.2 187.8 223.3 182.6 143.7 279.1 147.1 220.0 352.3 184.3 194.3 248.9 158.9 172.4 224.5 159.6 166.3 178.7 188.2 153.6 194.0 215.7 161.5 156.1 151.5 50.8 39.0 30.7 23.3 35.3 33.5 21.0 23.3 26.3 34.7 13.0 25.4 25.3 54.0 30.7 39.4 11.7 24.8 37.8 28.7 29.9 31.9 37.3 27.0 36.0 33.6 29.8 34.2 32.4 30.9 34.7 466.5 86.6 150.0 66.9 280.1 264.3 160.5 63.7 191.8 77.1 295.1 237.6 158.0 81.5 96.5 58.8 131.3 94.6 415.2 231.1 43.0 64.3 370.6 261.1 237.7 238.5 183.7 113.0 43.8 85.6 95.1 191.8 178.9 290.1 165.5 180.6 144.2 174.5 123.1 60.6 47.1 161.4 71.2 208.7 269.1 887.5 66.5 319.0 128.1 47.8 112.2 90.0 79.3 44.7 63.1 114.1 156.7 62.8 241.8 145.0 234.9 87.3 102.5 127.1 72.3 351.4 210.1 30.6 57.7 212.6 333.4 172.9 342.4 144.8 129.1 225.8 DELE1 "DELE, KIAA0141" ENSG00000081791 "DAP3 binding cell death enhancer 1" Q14154 5 141923855-141942047 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 31.3;Cytotrophoblasts: 26.2;Exocrine glandular cells: 24.3;Granulosa cells: 24.4;Hofbauer cells: 29.1;Syncytiotrophoblasts: 25.7;Theca cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036548, HPA061490" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Golgi apparatus" "HPA036548: AB_10673356, HPA061490: " "unprognostic (1.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.78e-3)" "unprognostic (1.00e-1)" "unprognostic (1.80e-1)" "unprognostic (7.77e-2)" "unprognostic (2.72e-2)" "unprognostic (7.99e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (6.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.80e-1)" "unprognostic (2.15e-3)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (2.28e-3)" 42.5 54.2 26.5 22.5 29.1 39.7 42.0 30.4 32.9 43.3 33.6 43.8 30.3 41.2 14.6 35.4 38.8 24.9 78.9 26.8 27.7 44.5 53.5 46.2 30.2 29.9 28.6 37.9 42.9 38.1 34.0 29.4 28.9 41.4 31.2 14.0 33.1 24.5 71.1 32.3 39.6 30.1 27.7 65.7 42.4 15.6 29.5 19.3 40.3 49.7 27.1 43.4 38.7 29.6 23.6 31.5 44.7 65.9 34.7 45.5 29.7 29.8 48.8 51.6 56.8 46.0 54.0 55.1 33.2 32.9 29.9 35.1 27.2 62.8 28.4 31.7 24.0 33.4 37.9 34.5 43.8 48.3 63.3 55.8 31.3 45.4 37.0 46.0 54.5 11.5 21.4 72.9 26.9 30.8 13.0 26.8 17.2 28.6 49.9 43.5 29.7 61.8 37.2 33.7 25.0 31.8 35.2 54.0 72.6 28.8 70.3 42.6 44.1 38.9 23.8 20.7 27.0 20.1 23.3 34.0 32.0 38.1 43.4 21.2 43.0 14.8 21.2 56.7 19.7 20.6 16.5 20.7 56.1 19.1 13.8 18.2 18.2 24.7 66.9 22.2 27.2 25.3 26.5 29.1 30.4 32.9 26.8 27.7 29.9 28.6 28.9 27.7 29.5 29.6 31.3 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 16.0 17.0 0.0 0.0 0.0 11.0 0.0 26.2 13.7 0.0 13.7 12.4 0.0 12.0 13.7 10.9 0.0 0.0 0.0 24.3 13.8 6.3 0.0 12.1 0.0 24.4 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 17.2 0.0 0.0 5.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 25.7 4.8 34.5 0.0 0.0 DHFR2 "DHFRL1, DHFRP4, FLJ16119" ENSG00000178700 "Dihydrofolate reductase 2" Q86XF0 3 94047836-94063389 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Ductal cells: 6.3;Respiratory ciliated cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 13 "hTERT-RPE1: 154.6" HPA051465 Uncertain Approved Mitochondria NA NA "Cluster 32: T-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA051465: AB_2681494" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.10e-2)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (1.38e-1)" "unprognostic (5.92e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (4.62e-2)" "unprognostic (2.95e-1)" "unprognostic (1.52e-1)" "prognostic favorable (2.30e-6)" "unprognostic (1.63e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-2)" 3.3 4.9 3.9 3.8 5.2 1.8 5.3 6.0 5.2 5.2 4.8 4.2 4.1 7.9 6.4 3.5 6.3 5.1 3.7 4.1 4.1 5.9 6.7 4.5 5.7 4.8 4.2 10.1 5.3 6.5 2.5 3.2 5.0 6.4 4.6 3.2 4.4 4.9 1.4 4.2 4.9 5.4 4.2 4.9 4.7 4.7 4.4 5.7 6.7 2.1 4.6 3.3 2.4 6.5 3.8 6.5 4.2 4.4 5.7 7.2 1.7 5.7 6.0 2.8 3.2 1.4 5.7 2.5 3.8 3.0 3.7 5.0 3.3 3.9 4.4 8.5 1.8 3.1 2.9 3.4 6.0 2.2 3.6 7.6 5.1 3.3 4.2 154.6 2.9 11.9 1.6 5.6 3.7 4.5 10.8 1.2 3.7 10.8 6.7 2.7 5.7 4.1 4.1 1.9 5.4 5.3 8.3 2.2 9.6 3.3 5.6 3.1 4.8 4.4 7.4 1.8 2.2 4.1 4.4 3.5 4.4 5.5 6.2 2.2 1.1 2.0 1.8 1.7 3.3 1.8 2.4 2.9 0.7 2.2 3.2 3.0 1.7 1.4 1.8 2.1 3.2 1.3 3.9 5.2 6.0 5.2 4.1 4.1 4.8 4.2 5.0 4.2 4.4 6.5 2.8 12.8 5.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.6 3.4 0.0 0.0 1.8 3.7 0.0 2.4 2.3 0.0 3.9 6.3 0.0 3.5 4.4 2.5 0.0 0.0 0.0 5.5 1.7 2.5 0.0 2.9 2.5 4.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 5.6 8.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 1.3 3.5 0.0 0.0 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479155-11537551 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 9.8;pituitary gland: 3.5;retina: 4.6;testis: 6.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;NTERA-2: 2.1;SCLC-21H: 2.0;SH-SY5Y: 6.8;SiHa: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA054579: AB_2682529" "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.0 0.3 7.1 0.1 9.4 0.0 0.0 4.1 9.8 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 8.6 6.9 0.1 0.0 0.1 0.1 3.3 5.7 0.1 0.5 0.0 3.5 0.0 4.6 0.5 0.0 4.6 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.3 0.1 6.3 7.8 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 4.9 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.5 0.0 1.3 0.0 0.1 2.0 6.8 1.6 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 9.4 4.1 9.8 8.6 6.9 3.3 5.7 4.6 3.7 7.8 3.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DMAC1 "C9orf123, MGC4730, TMEM261" ENSG00000137038 "Distal membrane arm assembly complex 1" Q96GE9 9 7796500-7888380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 500.8;Hofbauer cells: 221.7;Proximal tubular cells: 254.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA014585 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 36: HEL - Hemostasis" "Cluster 7: Non-specific - Mitochondria" "HPA014585: AB_1845803" "unprognostic (1.48e-2)" "unprognostic (3.74e-2)" "unprognostic (7.23e-3)" "prognostic favorable (4.15e-4)" "unprognostic (2.78e-2)" "unprognostic (2.79e-3)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (3.26e-3)" "unprognostic (3.65e-1)" "prognostic favorable (1.96e-11)" "unprognostic (1.75e-1)" "unprognostic (4.19e-1)" "unprognostic (2.35e-1)" "unprognostic (7.41e-2)" 10.6 11.9 16.8 7.7 17.0 6.2 12.4 17.5 21.0 9.3 9.0 12.6 9.8 10.0 11.8 9.3 11.0 6.3 25.4 16.3 17.8 15.9 10.2 7.2 10.0 15.2 15.0 13.2 9.2 21.8 12.3 8.1 15.6 11.9 9.9 9.0 14.3 11.6 43.1 8.5 9.1 8.1 15.1 10.4 10.7 7.0 16.0 20.6 11.8 29.8 8.9 11.5 8.3 16.9 18.5 21.8 19.7 12.3 15.4 19.1 13.3 11.0 7.7 11.5 10.4 9.9 11.3 27.1 5.6 9.8 15.0 9.8 21.2 18.8 11.6 16.2 24.3 49.3 32.7 31.8 15.6 17.2 6.7 24.1 13.2 9.1 13.9 10.6 11.0 24.3 9.2 5.6 12.2 15.7 25.1 39.7 17.5 15.6 10.5 19.0 11.1 16.4 13.2 17.6 31.5 17.6 12.0 8.0 14.1 13.5 10.5 10.5 14.0 8.8 14.2 11.6 7.7 7.0 12.0 14.5 7.4 14.3 9.0 2.0 10.1 4.5 11.5 12.2 17.4 26.5 15.7 12.3 12.6 22.5 20.5 16.5 1.6 20.8 9.8 13.1 19.9 19.6 16.8 17.0 17.5 21.0 16.3 17.8 15.2 15.0 15.6 15.1 16.0 16.9 42.2 70.5 48.5 0.0 15.7 0.0 0.0 0.0 0.0 0.0 69.5 81.5 0.0 0.0 24.1 101.2 0.0 113.6 13.9 0.0 500.8 94.2 0.0 81.4 64.3 30.0 0.0 0.0 0.0 90.7 96.3 32.8 0.0 58.6 27.8 127.7 0.0 0.0 221.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 25.8 0.0 0.0 0.0 0.0 62.4 0.0 0.0 3.1 0.0 0.0 254.7 70.7 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 55.4 17.3 79.3 0.0 0.0 DMAC2 "ATP5SL, FLJ10241" ENSG00000105341 "Distal membrane arm assembly complex 2" Q9NW81 19 41431318-41440717 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 47.9;Distal tubular cells: 39.2;Ductal cells: 44.0;Exocrine glandular cells: 40.5;Extravillous trophoblasts: 67.9;Hofbauer cells: 40.4;Proximal tubular cells: 46.3;Syncytiotrophoblasts: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041427 Approved Approved Mitochondria NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA041427: AB_2677473" "unprognostic (1.42e-3)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.20e-1)" "unprognostic (6.88e-3)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.77e-4)" "unprognostic (4.37e-1)" "unprognostic (3.83e-2)" "unprognostic (1.18e-2)" "unprognostic (1.52e-2)" "unprognostic (2.10e-1)" "prognostic favorable (4.07e-5)" "unprognostic (5.20e-2)" "unprognostic (2.48e-1)" "unprognostic (6.60e-2)" "unprognostic (7.29e-3)" 27.3 33.2 29.3 16.1 29.5 18.2 26.2 30.6 34.7 27.6 26.1 41.1 44.9 31.5 10.4 34.5 27.0 14.1 110.1 29.5 30.7 40.8 36.2 32.6 20.5 31.4 31.4 24.4 35.9 33.2 16.2 18.8 31.0 27.5 17.9 18.7 26.4 20.2 68.4 30.8 42.6 22.3 29.8 26.7 38.2 13.9 31.7 25.7 26.9 80.1 17.2 37.1 26.2 30.5 39.1 134.9 48.4 32.4 33.2 32.9 28.8 31.9 36.9 55.7 49.5 96.7 43.5 40.4 47.8 47.3 30.1 28.6 36.9 59.0 28.4 37.3 47.4 38.1 35.2 70.8 49.5 64.6 36.8 52.5 53.3 44.6 31.3 37.9 66.2 54.7 52.3 39.2 38.0 48.4 59.2 26.4 60.5 55.7 40.3 48.7 38.1 35.8 53.8 53.4 34.6 57.1 51.4 41.9 35.0 38.4 39.2 72.3 50.0 47.7 52.0 29.3 55.7 41.0 41.7 36.6 42.5 46.5 35.0 15.0 28.4 24.2 22.0 25.7 22.9 16.8 16.7 22.2 40.3 19.7 17.7 17.2 9.3 22.9 22.8 26.6 21.0 23.2 29.3 29.5 30.6 34.7 29.5 30.7 31.4 31.4 31.0 29.8 31.7 30.5 25.4 28.9 16.9 0.0 3.1 0.0 0.0 0.0 0.0 0.0 25.7 19.7 0.0 0.0 5.6 12.9 0.0 47.9 9.6 0.0 39.2 44.0 0.0 10.3 17.3 11.6 0.0 0.0 0.0 40.5 67.9 9.3 0.0 14.7 7.6 22.4 0.0 0.0 40.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 31.6 0.0 0.0 0.0 0.0 29.2 0.0 0.0 1.4 0.0 0.0 46.3 2.9 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 46.4 6.5 21.0 0.0 0.0 DNAJA1 "dj-2, hdj-2, HSJ2, HSPF4, NEDD7" ENSG00000086061 "DnaJ heat shock protein family (Hsp40) member A1" P31689 9 33025273-33039907 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 438.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001306, CAB033665" Approved Supported Microtubules,Cytosol NA Yes 160000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 65: Brain - Ion transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol Microtubules "CAB033665: AB_2094242, HPA001306: AB_1079043" "unprognostic (3.11e-2)" "unprognostic (5.05e-2)" "unprognostic (5.14e-2)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (9.80e-2)" "unprognostic (3.17e-2)" "unprognostic (2.88e-2)" "unprognostic (5.58e-2)" "prognostic favorable (5.39e-4)" "unprognostic (1.69e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.40e-4)" "unprognostic (3.27e-1)" "unprognostic (2.65e-1)" "unprognostic (1.25e-1)" "unprognostic (4.70e-2)" 102.6 134.7 143.9 83.9 154.7 148.8 65.8 147.4 438.9 83.7 142.7 61.9 44.5 81.0 80.4 51.7 102.7 83.6 72.9 154.1 159.8 114.6 216.9 94.4 80.6 147.7 152.8 83.5 59.7 105.2 80.7 108.3 160.9 85.8 63.5 78.2 61.0 64.7 47.3 43.8 50.1 87.2 155.3 72.0 67.7 135.0 164.6 95.7 66.0 61.5 89.1 130.7 57.3 174.0 255.6 447.5 353.7 123.6 240.2 155.1 202.4 256.5 205.9 451.2 348.2 299.2 115.0 259.5 191.6 175.4 254.9 113.1 515.7 154.7 386.1 368.2 150.2 208.3 537.3 382.7 115.1 242.5 234.2 96.1 156.1 170.4 53.9 218.4 273.6 110.9 330.5 109.7 262.0 208.6 407.7 530.3 345.3 254.2 308.2 294.7 126.6 132.9 254.1 148.8 223.8 243.5 345.4 220.6 120.0 262.5 103.5 231.5 236.1 160.0 273.1 184.6 346.2 69.9 233.3 271.7 209.9 208.3 140.9 154.1 140.8 160.9 93.3 202.0 111.1 127.5 116.8 105.7 127.8 119.7 119.6 113.4 176.2 117.8 268.3 213.4 110.4 209.9 143.9 154.7 147.4 438.9 154.1 159.8 147.7 152.8 160.9 155.3 164.6 174.0 1110.8 214.7 154.9 7.8 368.7 264.6 942.8 245.3 327.8 209.3 307.8 513.5 187.7 95.8 257.7 82.8 208.5 274.0 619.1 287.9 172.1 247.7 536.4 549.2 348.2 427.8 391.1 198.9 16.2 181.1 341.6 392.8 188.6 526.1 424.7 127.6 133.2 129.6 231.1 121.1 16.7 327.3 213.6 156.0 497.4 222.2 99.1 402.3 284.6 22.5 243.7 150.5 91.6 8.0 22.5 189.8 334.7 94.8 195.8 393.8 134.7 178.1 417.8 161.7 105.2 391.1 476.0 492.7 209.4 238.5 265.4 464.9 678.9 179.2 273.3 636.8 DTD1 "bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68" ENSG00000125821 "D-aminoacyl-tRNA deacylase 1" Q8TEA8 20 18587942-18766644 "Enzymes, Predicted intracellular proteins" "DNA replication" "DNA-binding, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA 350000 "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Nucleoli, Cytosol" "HPA040981: AB_10673268" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (1.82e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-3)" "unprognostic (9.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.81e-1)" "unprognostic (6.84e-2)" "unprognostic (1.32e-1)" "unprognostic (9.09e-3)" "unprognostic (2.42e-1)" "unprognostic (8.44e-2)" "unprognostic (2.59e-2)" "unprognostic (8.53e-2)" 23.5 21.1 7.0 3.7 7.0 4.5 21.5 7.2 7.6 18.9 7.1 15.6 2.7 19.7 4.8 26.6 18.6 3.2 17.5 7.1 7.6 25.6 10.8 16.0 4.1 7.3 6.9 17.6 20.4 7.7 33.8 3.4 7.4 13.7 4.2 6.6 21.9 3.1 29.1 27.4 13.7 4.0 7.2 15.3 16.2 19.1 7.3 2.1 19.3 6.7 4.5 17.1 19.4 7.3 10.1 15.7 15.8 16.2 8.8 12.2 9.1 4.3 12.3 10.5 11.3 10.0 11.4 0.1 4.1 13.6 13.9 5.3 13.1 25.0 10.4 6.8 3.2 10.2 4.0 18.7 22.8 9.4 8.2 10.2 22.4 11.8 42.1 8.7 16.5 3.0 7.0 22.5 15.3 24.9 1.7 23.8 11.0 13.5 9.9 0.0 16.6 11.1 16.6 8.2 16.6 13.0 4.4 20.4 23.6 7.1 12.3 9.2 10.2 14.3 3.8 17.7 14.5 5.5 10.2 4.6 8.6 13.9 11.1 1.7 0.7 0.4 1.8 1.0 0.8 1.1 0.6 1.0 1.5 0.7 0.5 0.5 0.9 1.4 1.0 0.2 0.4 0.6 7.0 7.0 7.2 7.6 7.1 7.6 7.3 6.9 7.4 7.2 7.3 7.3 35.5 35.3 24.0 32.0 26.8 23.6 40.9 48.3 22.2 42.4 27.9 33.0 18.8 28.6 23.1 42.3 2.1 26.7 24.7 9.9 43.0 71.9 38.4 16.2 33.1 36.4 23.3 22.1 41.9 87.4 37.8 29.9 13.7 17.8 42.5 24.6 35.7 11.2 47.8 43.7 60.6 23.5 28.5 23.5 35.9 21.8 18.0 27.1 42.7 12.2 42.8 58.2 38.1 53.3 52.2 90.6 19.1 19.5 24.6 50.6 9.3 73.8 22.8 34.9 0.0 30.1 27.5 93.5 124.2 33.2 35.7 12.4 35.5 42.7 26.8 31.9 DYNC1I2 "DIC74, DNCI2" ENSG00000077380 "Dynein cytoplasmic 1 intermediate chain 2" Q13409 2 171687409-171750158 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transport" "Motor protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033836, HPA040619, HPA053987" Supported Supported "Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol" NA NA 82000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum, Cytosol" "Nucleoli, Microtubules" "CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-2)" "unprognostic (8.15e-2)" "unprognostic (8.90e-2)" "unprognostic (1.37e-3)" "unprognostic (2.51e-3)" "unprognostic (6.30e-3)" "unprognostic (1.23e-1)" "unprognostic (1.89e-2)" "unprognostic (1.40e-2)" "unprognostic (4.19e-1)" "prognostic favorable (8.04e-4)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (1.35e-3)" "unprognostic (6.42e-2)" 65.1 58.5 89.2 44.4 121.1 23.1 65.3 122.6 185.9 62.3 70.4 62.3 54.3 74.5 51.0 68.3 47.1 58.6 65.9 89.2 101.4 80.0 41.3 51.7 38.7 130.5 116.2 71.7 38.7 68.2 29.4 76.2 124.1 59.9 64.7 63.5 46.7 60.3 51.0 48.8 51.0 80.4 104.0 41.4 49.3 55.9 112.9 60.0 56.3 57.7 47.4 72.3 53.3 155.5 87.5 55.0 167.0 61.9 151.2 144.0 94.2 149.2 115.7 122.9 133.7 96.5 84.4 79.2 127.7 178.8 168.0 86.2 132.5 143.5 159.8 30.1 59.7 69.3 65.7 109.6 75.5 80.0 71.7 113.0 133.4 152.3 97.3 171.7 219.1 76.5 112.1 21.3 246.1 54.4 68.9 65.7 77.0 127.0 55.5 68.7 149.8 58.3 163.3 138.0 105.8 116.6 82.7 65.6 90.6 126.0 64.1 77.3 238.3 185.9 91.9 75.2 90.9 26.3 54.0 64.5 126.8 64.2 139.2 209.6 93.9 49.2 50.7 98.0 54.3 77.2 58.1 59.4 68.7 71.1 51.7 49.5 5.8 64.4 100.1 111.8 66.2 39.6 89.2 121.1 122.6 185.9 89.2 101.4 130.5 116.2 124.1 104.0 112.9 155.5 146.2 198.7 60.6 30.3 49.2 50.6 59.2 138.5 19.9 73.1 101.7 87.1 75.4 158.7 124.8 169.2 64.6 101.9 46.3 169.5 131.0 207.6 129.5 118.2 147.3 117.1 84.3 95.2 102.4 161.5 107.5 91.2 42.8 172.6 102.3 69.3 174.9 150.7 101.1 80.8 104.9 140.0 116.0 148.1 39.8 48.0 128.6 75.9 35.6 45.9 156.2 91.3 70.0 35.7 182.4 189.2 126.9 138.0 22.7 44.7 139.2 270.3 108.0 128.9 111.7 61.4 111.0 248.4 95.2 43.2 60.0 115.6 46.7 60.6 123.9 58.5 ECPAS "ECM29, FLJ22036, KIAA0368" ENSG00000136813 "Ecm29 proteasome adaptor and scaffold" Q5VYK3 9 111360692-111484745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 245.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Alveolar cells type 2: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021646, HPA059795" Uncertain Approved Nucleoplasm Yes No 5400 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA021646: AB_2670788, HPA059795: AB_2684127" "unprognostic (1.64e-1)" "unprognostic (1.57e-1)" "unprognostic (7.42e-2)" "unprognostic (5.72e-2)" "unprognostic (3.81e-1)" "unprognostic (1.79e-1)" "unprognostic (1.80e-2)" "unprognostic (5.12e-2)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (9.99e-2)" "unprognostic (1.67e-1)" "unprognostic (3.72e-3)" "unprognostic (2.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" "unprognostic (1.05e-1)" 41.6 34.1 33.8 23.5 43.7 28.6 31.8 33.9 52.9 31.6 31.6 34.0 32.1 28.4 23.6 28.7 26.5 19.9 44.4 52.7 30.6 31.0 28.2 31.0 21.6 32.0 31.9 33.0 38.4 40.6 32.7 24.0 33.7 34.3 29.6 28.3 32.0 25.6 245.0 32.4 29.6 28.5 26.1 22.4 31.2 35.6 31.4 16.2 32.4 97.1 21.2 31.6 30.9 40.1 58.9 53.1 35.0 37.7 81.6 81.1 57.5 70.8 60.4 57.0 39.1 49.7 35.6 59.3 32.5 62.6 46.5 83.7 45.1 47.4 52.7 65.4 28.3 36.6 64.5 72.0 60.4 68.9 38.2 74.2 48.8 57.3 84.4 64.6 58.8 14.7 85.4 81.1 47.1 49.5 0.3 39.9 68.6 74.7 44.1 33.4 107.2 35.7 48.9 52.2 66.7 31.7 60.5 64.1 46.2 37.6 50.5 36.4 64.7 38.1 43.6 57.5 65.5 71.2 144.9 71.3 55.7 27.8 36.0 2.7 5.8 1.9 4.6 6.0 5.3 3.9 4.7 5.3 8.1 4.2 2.8 4.9 1.7 4.8 4.5 3.6 4.1 2.9 33.8 43.7 33.9 52.9 52.7 30.6 32.0 31.9 33.7 26.1 31.4 40.1 24.6 57.7 63.9 0.0 5.3 0.0 0.0 0.0 0.0 0.0 19.0 14.7 0.0 0.0 32.8 12.9 0.0 17.3 11.6 0.0 9.8 21.0 0.0 19.3 32.0 12.1 0.0 0.0 0.0 21.7 11.4 12.5 0.0 26.2 24.0 30.6 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 10.9 0.0 0.0 0.0 0.0 25.7 0.0 0.0 4.9 0.0 0.0 14.4 24.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 20.2 6.5 29.2 0.0 0.0 EEF1AKMT1 N6AMT2 ENSG00000150456 "EEF1A lysine methyltransferase 1" Q8WVE0 13 20728731-20773961 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Breast myoepithelial cells: 19.9;Cytotrophoblasts: 19.8;Distal tubular cells: 27.4;Endometrial ciliated cells: 20.9;Proximal tubular cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040417, HPA042543" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA040417: AB_2676973, HPA042543: AB_2678045" "unprognostic (4.14e-1)" "unprognostic (5.11e-2)" "unprognostic (8.57e-2)" "prognostic favorable (1.82e-4)" "unprognostic (9.14e-2)" "unprognostic (3.44e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (2.39e-3)" "unprognostic (3.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.81e-2)" "unprognostic (4.31e-2)" 9.6 10.3 11.1 5.3 11.6 3.4 9.8 11.8 16.8 11.2 10.5 9.5 4.5 10.8 14.3 5.8 11.1 6.3 9.9 11.2 12.6 9.5 13.5 6.4 6.8 11.1 11.6 10.4 6.3 9.5 9.9 6.5 11.8 10.2 6.0 10.2 7.9 8.9 11.1 5.9 5.6 9.2 12.0 5.8 7.1 4.3 12.0 9.2 9.5 12.2 6.8 8.8 7.5 12.3 11.1 8.5 6.9 11.4 28.3 29.2 16.9 14.4 11.0 12.4 6.4 11.9 12.1 18.0 10.5 15.8 5.8 9.0 9.4 12.2 12.8 11.7 8.4 23.3 3.8 22.8 15.6 46.3 4.6 20.1 10.7 9.2 20.4 13.8 22.4 15.7 13.6 2.4 35.5 30.7 15.6 41.0 12.0 20.2 6.2 19.2 7.6 3.5 17.8 12.7 15.8 9.4 12.5 6.1 16.5 5.9 6.4 42.4 13.3 8.5 0.0 19.1 6.4 3.3 6.7 19.9 7.3 31.4 6.1 0.0 5.2 0.9 8.6 4.1 9.6 13.1 10.3 9.0 8.9 5.4 13.0 11.3 0.7 16.3 4.4 10.8 12.0 6.7 11.1 11.6 11.8 16.8 11.2 12.6 11.1 11.6 11.8 12.0 12.0 12.3 15.0 22.4 9.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 13.3 19.9 0.0 0.0 8.1 7.3 0.0 19.8 3.1 0.0 27.4 12.6 0.0 20.9 16.2 6.0 0.0 0.0 0.0 10.4 15.2 8.9 0.0 7.0 3.8 13.2 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 36.5 7.3 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 15.7 2.2 9.9 0.0 0.0 EEF1AKMT2 "C10orf138, Efm4, METTL10" ENSG00000203791 "EEF1A lysine methyltransferase 2" Q5JPI9 10 124748149-124791887 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 29.1;Distal tubular cells: 66.5;Extravillous trophoblasts: 29.8;Proximal tubular cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA050138 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Vesicles, Cytosol" "HPA050138: AB_2681030" "unprognostic (1.64e-3)" "unprognostic (3.42e-2)" "unprognostic (1.34e-1)" "unprognostic (9.75e-2)" "unprognostic (7.19e-2)" "unprognostic (1.17e-1)" "unprognostic (2.33e-2)" "unprognostic (2.29e-3)" "unprognostic (9.04e-3)" "unprognostic (9.76e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.82e-4)" "unprognostic (3.90e-2)" "unprognostic (4.44e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (9.09e-2)" 4.8 3.8 3.0 2.1 3.3 3.6 5.3 4.8 4.2 4.6 3.0 3.7 1.8 4.0 4.6 4.0 3.8 2.1 4.1 3.1 3.0 4.9 5.2 3.3 2.5 2.8 3.1 5.5 4.4 4.5 4.3 2.7 2.8 4.3 3.8 2.5 5.1 2.8 4.0 5.0 3.5 2.6 2.7 3.5 3.7 5.6 2.8 3.3 5.1 3.3 3.1 3.4 4.2 3.6 12.6 3.3 4.8 8.0 3.1 8.0 3.1 5.8 7.6 7.4 6.5 4.3 7.1 8.4 3.0 4.7 2.5 3.8 6.8 4.2 11.5 7.0 2.5 6.8 4.2 3.9 6.0 10.9 4.1 3.9 3.9 4.1 9.9 6.2 4.7 7.0 7.6 9.3 9.3 3.7 5.2 8.5 5.9 4.6 4.8 2.3 5.7 2.6 4.6 2.7 1.5 3.8 3.7 6.2 8.7 3.3 5.4 8.5 5.8 2.7 2.9 4.5 8.8 4.3 3.7 6.8 4.9 5.7 3.9 0.8 1.0 1.6 1.6 1.1 2.5 1.9 1.6 2.0 1.2 1.3 2.2 1.6 0.1 4.4 0.8 1.5 1.9 1.1 3.0 3.3 4.8 4.2 3.1 3.0 2.8 3.1 2.8 2.7 2.8 3.6 23.2 3.2 11.3 0.0 8.9 0.0 0.0 0.0 0.0 0.0 20.5 22.4 0.0 0.0 2.5 11.0 0.0 29.1 13.4 0.0 66.5 20.0 0.0 11.4 11.8 7.5 0.0 0.0 0.0 20.4 29.8 10.4 0.0 10.5 2.5 17.8 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 11.4 0.0 0.0 0.0 0.0 19.8 0.0 0.0 2.8 0.0 0.0 30.5 3.6 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 17.1 7.1 14.7 0.0 0.0 EEF1AKMT3 "DKFZP586D0919, FAM119B, METTL21B" ENSG00000123427 "EEF1A lysine methyltransferase 3" Q96AZ1 12 57771492-57782541 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 14.9;Breast myoepithelial cells: 7.6;Exocrine glandular cells: 12.7;monocytes: 8.8;Proximal tubular cells: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 7 "RH-30: 152.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043020, HPA045492" Uncertain Approved "Nucleoplasm,Mitotic chromosome,Centrosome" Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 7: Non-specific - Mitochondria" Centrosome "Nucleoplasm, Mitotic chromosome" "HPA043020: AB_2678274, HPA045492: " "unprognostic (2.00e-1)" "unprognostic (6.52e-2)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (1.06e-1)" "unprognostic (7.34e-3)" "unprognostic (7.52e-3)" "unprognostic (1.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.54e-3)" "unprognostic (5.77e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-2)" "unprognostic (1.23e-1)" 7.5 6.2 2.5 3.6 2.3 2.6 9.2 4.1 2.7 10.5 2.6 5.6 3.9 9.3 9.6 5.6 8.4 5.4 3.7 2.4 1.8 11.6 6.5 5.3 3.6 2.6 2.4 11.4 21.7 6.4 3.7 4.6 2.7 8.2 4.6 3.7 19.4 8.7 2.9 7.3 3.8 7.6 2.1 4.0 7.2 4.2 2.4 1.9 10.1 3.1 3.1 6.3 7.3 3.1 5.4 11.0 4.6 5.9 12.8 12.0 4.0 5.8 10.9 8.9 9.0 5.6 9.5 3.1 7.4 7.6 7.2 5.2 3.7 3.3 9.3 4.0 5.6 14.9 6.6 9.2 11.3 3.7 6.6 12.6 8.7 9.3 9.8 15.2 9.7 13.2 8.9 22.6 5.4 3.8 4.7 11.0 3.4 4.3 8.0 8.5 152.1 10.0 6.0 5.3 4.4 6.0 10.0 7.5 6.2 4.1 11.9 10.0 9.5 13.7 7.7 5.8 6.4 5.7 2.3 3.8 11.3 15.4 10.0 0.4 3.0 0.1 1.8 1.1 7.8 0.5 3.5 2.2 3.1 0.4 1.7 1.4 0.7 1.5 4.6 1.5 2.2 2.3 2.5 2.3 4.1 2.7 2.4 1.8 2.6 2.4 2.7 2.1 2.4 3.1 3.9 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.9 7.6 0.0 0.0 1.8 1.8 0.0 3.4 1.3 0.0 5.9 5.5 0.0 2.0 6.0 1.9 0.0 0.0 0.0 12.7 4.9 3.4 0.0 2.5 2.5 5.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 8.8 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 16.4 1.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.6 0.5 4.7 0.0 0.0 EEF1AKMT4 ENSG00000284753 "EEF1A lysine methyltransferase 4" P0DPD7 3 184249672-184258759 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast glandular cells: 9.9;Breast myoepithelial cells: 11.7;Distal tubular cells: 15.6;Ductal cells: 14.7;Exocrine glandular cells: 15.3;Pancreatic endocrine cells: 9.2;Proximal tubular cells: 21.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 2.4 3.0 1.0 4.1 1.0 5.0 4.3 3.9 1.6 3.1 1.3 5.6 5.3 1.6 1.4 6.1 1.8 2.2 2.0 0.9 1.7 2.9 14.0 2.0 4.3 1.4 1.2 0.7 12.7 4.8 6.0 1.3 1.9 5.3 0.4 6.6 2.0 2.3 5.3 3.4 3.2 1.2 2.0 3.8 11.4 1.4 4.5 7.2 5.4 5.0 6.2 1.0 50.8 29.9 5.1 17.3 9.9 6.8 41.2 6.4 12.5 10.0 9.4 56.9 7.9 63.7 40.2 7.2 41.8 19.5 31.1 32.2 5.6 23.8 36.9 17.1 18.1 36.8 12.1 43.8 12.8 8.5 39.0 10.8 19.1 3.3 8.2 20.8 33.0 54.7 4.8 84.2 18.6 54.9 11.7 71.0 52.1 32.6 7.0 53.4 11.8 11.2 26.8 9.7 10.8 95.1 24.6 9.2 76.0 21.4 5.8 7.5 11.5 22.4 30.2 33.1 74.5 64.6 7.0 74.9 10.0 0.0 22.9 2.5 8.0 19.1 8.8 8.8 8.4 7.8 19.4 6.5 5.8 9.2 0.5 7.3 13.3 17.5 15.5 10.9 1.0 1.0 3.9 1.6 0.9 1.7 1.4 1.2 1.3 1.2 1.4 1.0 3.8 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.9 11.7 0.0 0.0 3.1 7.3 0.0 0.0 1.7 0.0 15.6 14.7 0.0 1.8 3.5 2.1 0.0 0.0 0.0 15.3 0.0 1.5 0.0 2.0 1.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.8 0.0 0.0 21.2 1.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.0 6.7 0.0 0.0 EGR2 KROX20 ENSG00000122877 "Early growth response 2" P11161 10 62811996-62919900 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 59.9;thyroid gland: 136.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 55.5;Breast myoepithelial cells: 68.1;Enteroendocrine cells: 73.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 19.7" "Group enriched" "Detected in many" 5 "cerebral cortex: 10.2;hippocampal formation: 5.2" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.5;non-classical monocyte: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-87 MG: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031165 Supported Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA031165: AB_2673768" "prognostic favorable (7.30e-5)" "unprognostic (1.86e-3)" "unprognostic (1.45e-2)" "unprognostic (8.72e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (2.70e-1)" "unprognostic (1.75e-1)" "unprognostic (9.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (2.47e-3)" "unprognostic (6.54e-2)" "unprognostic (1.74e-2)" "unprognostic (3.46e-1)" "unprognostic (1.11e-3)" 13.7 10.6 0.4 9.8 1.2 8.2 8.6 1.3 10.2 18.5 2.0 3.3 1.9 6.0 59.9 8.8 4.5 31.9 14.9 5.2 0.2 7.9 5.4 15.2 14.4 0.3 0.3 9.4 4.2 7.0 8.7 3.0 0.7 17.5 3.7 1.4 2.9 1.9 0.9 14.2 4.6 16.8 0.1 4.5 2.3 4.1 0.6 26.4 136.4 9.1 7.1 15.7 1.7 1.5 0.0 0.2 2.5 1.0 1.8 2.4 0.4 0.5 0.2 0.6 0.8 0.0 0.3 0.6 0.0 0.6 0.7 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.6 3.8 0.3 0.6 1.3 0.2 0.8 0.1 0.3 0.2 0.8 0.1 1.2 0.0 1.8 0.2 0.1 1.1 0.1 0.3 0.4 0.0 0.2 0.1 0.3 0.2 0.5 4.2 0.5 0.0 0.5 0.1 0.5 0.4 0.2 0.3 1.3 0.7 0.3 22.5 0.5 0.4 0.0 0.5 0.2 0.1 2.5 0.0 0.4 0.0 0.1 0.5 0.4 0.0 0.1 0.7 0.2 2.3 0.0 0.0 0.4 0.4 1.2 1.3 10.2 5.2 0.2 0.3 0.3 0.7 0.1 0.6 1.5 15.9 0.0 12.6 0.0 14.0 21.3 30.1 36.0 33.0 1.4 55.5 68.1 7.8 0.0 9.4 0.0 0.0 1.1 9.9 9.5 0.0 1.4 8.9 13.9 14.0 16.7 73.1 0.0 1.7 0.6 1.6 30.4 13.3 26.1 20.8 2.3 5.3 2.4 25.2 0.0 0.5 29.4 14.2 28.1 39.5 4.3 1.8 40.5 8.8 0.0 0.8 4.1 0.0 0.0 0.1 1.0 4.4 7.2 6.4 5.5 7.7 0.0 7.1 0.7 6.6 20.7 12.0 0.1 2.0 14.8 12.5 1.1 13.6 5.1 25.8 3.1 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2;skin 1: 45.6" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 284.3;Glandular and luminal cells: 116.6;granulocytes: 108.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 47.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.5;HMC-1: 9.5;MCF7: 31.9;SK-MEL-30: 22.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "amygdala: 19.3;basal ganglia: 52.5;cerebral cortex: 47.8;hippocampal formation: 41.3;olfactory bulb: 33.7" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles NA NA "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favorable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 29.0 24.5 7.7 19.0 9.9 10.1 10.3 0.6 47.2 9.5 0.0 4.6 1.5 5.6 0.4 5.9 17.3 30.0 12.1 16.1 0.0 5.8 2.9 5.8 11.4 5.1 0.0 15.3 4.5 13.8 6.8 1.0 2.0 14.4 3.2 4.5 3.1 0.9 1.9 45.6 3.9 12.5 1.3 3.3 6.5 5.4 0.0 19.5 8.4 3.2 5.9 14.8 3.6 5.8 0.2 0.0 0.2 0.3 1.8 5.5 0.1 0.6 0.6 0.0 0.1 0.1 0.0 0.1 0.1 1.3 0.4 0.5 0.2 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 9.5 0.6 0.2 0.2 0.0 0.8 0.1 0.2 0.3 0.1 0.0 31.9 0.0 0.2 0.1 2.2 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.1 0.5 0.0 22.5 0.3 1.4 0.1 0.0 0.3 0.1 0.2 0.4 0.4 0.1 0.0 0.9 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.7 9.9 0.6 47.2 16.1 0.0 5.1 0.0 2.0 1.3 0.0 5.8 80.2 6.4 11.2 0.3 46.7 23.1 31.9 43.8 39.3 2.3 73.0 68.2 47.1 0.0 12.2 0.0 0.0 1.3 9.3 3.5 0.0 3.3 18.4 47.1 52.7 36.5 284.3 0.0 16.0 4.2 1.3 33.9 35.2 116.6 108.7 21.8 37.5 0.5 4.7 0.0 0.9 19.2 8.2 19.0 20.3 11.6 3.1 27.8 21.4 3.7 0.0 5.1 0.0 1.0 0.7 4.5 2.2 0.4 3.7 16.1 0.2 0.1 5.7 1.3 0.0 41.3 35.9 0.3 0.2 16.5 50.0 9.7 11.5 6.5 7.0 9.8 EIF2S3B "eIF-2-gamma2, eIF2gA" ENSG00000180574 "Eukaryotic translation initiation factor 2 subunit gamma B" Q2VIR3 12 10505602-10523135 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Club cells: 1.3;granulocytes: 1.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 5.0;MOLT-4: 4.3;RH-30: 3.0" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 71: Testis - DNA repair" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (2.23e-1)" "unprognostic (6.09e-2)" "unprognostic (1.03e-2)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (1.45e-1)" "unprognostic (1.16e-2)" "unprognostic (9.02e-2)" "unprognostic (7.67e-2)" "unprognostic (2.56e-1)" "unprognostic (2.58e-4)" "unprognostic (4.95e-2)" "unprognostic (2.29e-1)" "unprognostic (3.24e-2)" "unprognostic (9.45e-3)" "unprognostic (2.73e-1)" "unprognostic (4.39e-1)" 0.9 0.8 0.1 0.3 0.1 0.1 0.8 0.1 0.1 1.3 0.1 1.1 1.0 1.4 0.0 0.9 0.7 0.1 0.7 0.0 0.0 0.7 0.5 0.8 0.1 0.1 0.0 1.6 1.4 0.0 0.4 0.0 0.2 0.5 0.0 0.3 0.9 0.0 1.2 0.9 0.9 0.0 0.0 0.6 1.0 2.4 0.1 0.0 0.6 0.1 0.0 1.1 1.0 0.2 0.4 0.3 0.3 2.0 0.3 0.7 1.3 0.2 0.0 0.0 0.1 0.2 0.2 0.1 1.6 0.1 0.6 2.7 1.0 0.3 0.0 0.5 1.2 0.2 0.8 2.2 0.0 5.0 1.3 0.0 0.0 0.7 0.1 0.1 0.6 0.3 0.3 0.2 0.1 0.0 4.3 0.0 1.0 0.0 0.4 0.1 3.0 0.4 0.1 0.1 0.9 0.2 0.8 0.2 0.3 0.4 0.4 0.1 0.0 0.2 0.1 0.3 2.6 0.3 2.2 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 1.3 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.0 EIF4A3 "DDX48, EIF4AIII, Fal1, KIAA0111" ENSG00000141543 "Eukaryotic translation initiation factor 4A3" P38919 17 80134369-80147151 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021878 Supported Supported Nucleoplasm NA NA 280000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA021878: AB_1848090" "unprognostic (7.24e-2)" "unprognostic (7.33e-3)" "prognostic favorable (3.57e-5)" "unprognostic (1.29e-2)" "unprognostic (2.95e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.68e-5)" "prognostic unfavorable (1.87e-4)" "unprognostic (3.71e-1)" "unprognostic (5.06e-2)" "unprognostic (4.64e-2)" "unprognostic (2.64e-2)" "unprognostic (9.78e-3)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (1.38e-2)" "unprognostic (2.91e-3)" 65.8 81.4 19.0 49.1 21.1 185.8 44.2 21.5 27.2 51.2 22.8 44.3 38.6 46.6 38.8 81.9 54.7 40.1 38.0 22.3 21.0 45.1 42.6 44.0 67.0 19.9 19.5 66.5 37.0 58.5 41.1 52.9 20.3 38.7 47.5 32.3 42.4 32.6 37.3 64.8 38.9 42.6 22.7 47.6 41.4 42.8 20.0 78.2 37.0 34.9 74.7 83.4 55.1 24.7 237.2 208.9 140.5 103.8 105.5 63.2 114.4 119.3 91.0 177.7 141.4 223.7 110.3 221.4 67.9 112.9 126.4 152.2 194.9 136.2 195.0 71.5 192.3 142.5 159.3 244.3 103.1 253.8 133.4 98.7 68.7 149.5 119.4 71.8 147.2 128.7 189.8 140.2 105.3 178.9 224.8 132.8 145.0 223.8 190.0 168.5 282.7 172.2 85.8 196.5 186.1 100.1 170.9 334.2 151.9 130.1 219.3 166.7 100.5 108.7 138.6 159.9 200.3 104.4 86.2 403.2 88.0 158.7 113.3 126.1 167.0 137.4 101.1 174.6 131.2 142.4 128.2 119.4 200.0 119.8 116.9 115.2 98.7 132.9 143.4 326.0 158.2 232.6 19.0 21.1 21.5 27.2 22.3 21.0 19.9 19.5 20.3 22.7 20.0 24.7 117.9 41.7 48.0 6.8 135.1 283.1 273.4 212.9 107.0 23.3 77.0 109.2 61.5 38.6 107.8 29.5 16.7 140.1 165.7 75.4 64.6 85.6 33.2 132.9 109.2 70.5 60.3 24.4 4.1 115.2 225.1 144.3 149.4 248.2 92.6 42.6 32.2 27.0 108.5 6.7 4.3 83.2 89.5 63.4 255.0 12.1 67.1 199.6 103.2 10.3 67.9 48.6 23.7 5.5 7.6 86.6 83.1 49.7 118.6 96.0 47.9 65.0 61.4 32.5 85.5 109.7 207.8 99.4 123.2 77.6 299.1 261.9 138.4 98.0 77.7 252.5 EIF5 ENSG00000100664 "Eukaryotic translation initiation factor 5" P55010 14 103333544-103345025 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 787.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA000867, CAB004226" Supported Enhanced Cytosol NA NA 77000 "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Cytosol "CAB004226: AB_627507, HPA000867: AB_1078731" "unprognostic (1.39e-1)" "unprognostic (3.13e-1)" "unprognostic (4.02e-2)" "unprognostic (6.47e-3)" "unprognostic (6.33e-2)" "unprognostic (3.02e-1)" "unprognostic (2.01e-1)" "unprognostic (5.59e-2)" "unprognostic (7.82e-2)" "unprognostic (3.92e-3)" "unprognostic (1.08e-1)" "unprognostic (2.70e-2)" "prognostic favorable (5.67e-7)" "unprognostic (2.76e-1)" "unprognostic (8.41e-2)" "unprognostic (5.43e-3)" "unprognostic (3.14e-2)" 90.5 60.4 82.6 54.5 86.9 194.4 72.1 89.7 90.9 48.7 73.7 81.6 79.5 56.3 54.9 74.4 66.2 63.3 85.2 87.8 92.7 92.4 151.4 64.6 62.3 88.1 93.0 45.6 78.1 81.7 40.8 66.3 93.4 54.9 77.9 50.4 63.5 75.1 163.6 56.8 67.4 71.0 96.3 55.3 65.3 94.9 87.4 61.6 93.4 144.5 80.1 62.9 46.0 103.2 132.9 149.4 174.0 79.1 147.0 129.1 182.3 190.7 205.1 192.5 145.3 223.7 137.3 136.4 117.2 172.4 165.0 173.3 220.9 193.3 325.6 111.9 87.4 121.9 76.3 119.6 152.8 222.1 100.6 139.7 127.0 170.8 230.6 160.2 196.9 98.9 255.8 126.7 161.3 188.7 152.7 73.4 90.5 251.7 285.8 127.4 226.1 85.1 112.8 423.7 153.7 107.7 191.6 141.3 155.9 161.0 135.5 100.8 149.7 152.8 103.3 196.3 201.5 376.2 787.9 287.4 150.5 154.3 182.4 356.8 245.1 323.9 235.1 249.1 265.2 335.0 239.4 224.3 241.5 334.1 283.0 236.8 266.1 315.1 273.0 329.2 221.1 401.0 82.6 86.9 89.7 90.9 87.8 92.7 88.1 93.0 93.4 96.3 87.4 103.2 282.4 144.2 158.6 56.5 269.5 340.1 346.0 216.0 362.0 196.8 260.5 252.3 307.3 101.5 172.4 73.5 185.6 233.0 298.1 221.9 215.2 243.8 280.6 182.0 162.9 227.9 199.6 408.1 47.3 282.3 212.1 267.6 137.1 252.4 278.7 218.7 134.6 255.5 173.1 176.7 40.9 220.3 187.2 158.4 313.2 683.5 128.0 282.5 152.9 30.9 238.7 167.7 129.8 24.6 60.6 247.8 161.7 173.8 414.4 260.4 233.7 272.3 179.8 212.9 118.3 460.0 372.7 507.8 367.8 323.2 265.2 493.8 281.7 213.1 232.0 254.0 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 48.6;Distal tubular cells: 50.9;Ductal cells: 28.7;Extravillous trophoblasts: 36.9;Hofbauer cells: 34.0;Proximal tubular cells: 41.6;Syncytiotrophoblasts: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803" "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 8.5 15.2 24.8 13.8 25.6 18.2 9.8 24.3 27.3 9.3 20.5 13.6 12.2 9.9 19.4 19.7 13.2 7.7 11.9 26.0 26.2 17.9 16.5 9.3 19.2 22.2 23.2 6.9 10.5 15.8 27.8 9.1 23.9 9.5 11.8 15.9 11.2 7.8 14.0 13.9 10.6 10.6 22.9 14.6 10.8 11.6 25.1 22.2 22.4 15.2 18.0 10.8 11.1 23.6 25.4 48.2 25.9 28.2 15.7 21.1 56.2 26.8 27.8 32.0 24.2 32.5 32.6 45.3 46.8 28.3 30.1 25.9 20.9 39.3 17.3 35.5 37.5 40.7 28.4 76.2 29.9 40.2 49.9 19.5 35.1 32.2 43.6 17.6 41.9 79.0 45.2 30.9 29.7 48.5 37.6 57.9 29.4 61.5 38.1 43.6 26.6 61.6 39.6 35.7 54.5 62.6 18.5 31.7 30.1 13.8 29.0 36.9 29.9 25.3 13.1 21.2 36.9 34.9 88.0 37.8 30.0 40.8 24.1 22.2 15.2 12.8 19.7 17.9 19.6 16.8 16.1 20.6 27.4 20.6 17.6 18.8 6.5 22.2 16.7 30.3 22.2 18.6 24.8 25.6 24.3 27.3 26.0 26.2 22.2 23.2 23.9 22.9 25.1 23.6 5.6 3.2 9.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 8.5 7.0 0.0 0.0 6.2 20.2 0.0 48.6 7.0 0.0 50.9 28.7 0.0 14.9 7.5 7.0 0.0 0.0 0.0 16.0 36.9 5.0 0.0 11.5 3.8 13.7 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 16.5 0.0 0.0 0.0 0.0 20.7 0.0 0.0 2.3 0.0 0.0 41.6 4.4 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 26.7 5.7 24.5 0.0 0.0 ELOA "SIII, TCEB3, TCEB3A" ENSG00000011007 "Elongin A" Q14241 1 23743155-23762059 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 83.9;Ductal cells: 41.3;Syncytiotrophoblasts: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005910 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" Cytosol "HPA005910: AB_1080227" "unprognostic (6.90e-2)" "unprognostic (5.99e-3)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.99e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.72e-1)" "unprognostic (8.84e-3)" "unprognostic (6.00e-2)" "unprognostic (4.94e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-3)" "unprognostic (2.90e-1)" "unprognostic (4.27e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 25.7 12.7 9.8 18.8 10.8 33.4 16.5 13.0 11.5 15.7 10.4 14.8 12.6 13.3 10.1 23.8 12.9 15.4 15.5 10.1 10.9 14.4 29.6 25.8 17.7 10.9 10.6 16.1 42.4 27.0 11.5 19.2 11.0 14.9 16.5 12.7 17.4 13.3 33.2 20.1 13.9 16.8 9.7 16.2 26.5 18.9 11.1 21.6 21.3 26.4 23.6 24.5 14.6 11.8 52.0 28.3 40.2 34.6 46.2 28.6 25.3 52.4 46.9 76.2 66.1 34.9 44.1 27.0 62.7 53.3 42.8 48.5 83.0 55.2 84.4 77.8 41.1 60.9 42.2 41.1 40.9 64.7 35.3 30.6 43.6 83.3 63.2 28.2 46.4 43.7 91.8 45.3 61.6 39.3 33.5 26.1 46.8 57.7 42.4 49.8 50.9 51.3 35.8 34.8 76.2 42.9 47.7 47.5 58.5 44.3 34.4 23.5 49.5 59.5 52.8 106.9 62.5 46.8 56.4 59.2 52.1 63.2 60.7 28.2 24.6 19.6 16.5 24.9 16.3 23.5 13.8 15.1 22.6 18.5 11.2 14.9 6.5 13.7 24.1 18.4 17.1 17.7 9.8 10.8 13.0 11.5 10.1 10.9 10.9 10.6 11.0 9.7 11.1 11.8 24.1 28.9 83.9 0.0 7.9 0.0 0.0 0.0 0.0 0.0 19.6 16.0 0.0 0.0 18.0 18.4 0.0 28.1 17.5 0.0 5.9 41.3 0.0 15.4 27.4 12.5 0.0 0.0 0.0 32.7 35.7 10.1 0.0 23.3 13.9 21.5 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 35.2 0.0 0.0 0.0 0.0 37.9 0.0 0.0 4.9 0.0 0.0 19.0 16.8 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 41.3 9.6 32.5 0.0 0.0 ELOB "SIII, TCEB2" ENSG00000103363 "Elongin B" Q15370 16 2771414-2777280 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1279.6;Exocrine glandular cells: 911.2;Pancreatic endocrine cells: 1027.1;Proximal tubular cells: 1789.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064006 Approved NA NA 82000 "Cluster 2: Granulocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "HPA064006: " "unprognostic (1.77e-1)" "unprognostic (5.27e-3)" "unprognostic (3.93e-1)" "unprognostic (1.50e-3)" "unprognostic (2.02e-1)" "unprognostic (2.28e-2)" "unprognostic (3.19e-1)" "unprognostic (1.27e-1)" "unprognostic (1.81e-2)" "unprognostic (4.05e-2)" "unprognostic (3.14e-1)" "unprognostic (7.15e-2)" "unprognostic (7.83e-2)" "unprognostic (3.42e-1)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (6.32e-2)" 234.7 293.3 355.3 130.9 359.6 289.7 235.0 363.3 479.4 217.1 339.1 275.5 141.6 214.1 80.8 297.1 217.7 180.2 485.0 365.8 363.9 301.6 340.1 206.6 185.6 356.8 360.3 187.8 207.5 203.4 279.9 109.8 358.2 233.8 83.2 51.4 332.2 112.9 573.1 254.5 203.5 89.5 362.8 208.8 255.6 428.5 366.5 154.6 199.4 266.2 93.4 220.1 228.6 367.5 185.8 559.0 254.5 407.0 263.5 354.6 265.7 233.1 242.6 254.3 210.0 408.8 372.6 288.6 309.4 256.7 275.1 206.6 146.4 403.4 61.9 349.4 593.0 188.5 773.6 578.7 410.1 276.9 286.6 362.8 517.3 242.4 180.6 254.7 225.8 420.1 258.4 465.0 265.5 1212.8 459.7 708.6 331.4 363.2 570.0 487.9 248.3 636.9 311.8 404.2 461.4 335.2 310.0 472.3 320.1 79.0 434.1 506.3 303.5 323.4 308.9 232.4 277.7 382.8 503.1 619.8 152.5 279.6 347.2 3022.8 1566.1 2928.2 711.2 1154.9 687.1 877.6 741.7 760.1 951.3 757.8 638.9 671.0 1519.2 892.1 1236.0 848.6 1046.2 2212.0 355.3 359.6 363.3 479.4 365.8 363.9 356.8 360.3 358.2 362.8 366.5 367.5 401.9 182.7 218.4 0.0 89.7 0.0 0.0 0.0 0.0 0.0 633.1 738.0 0.0 0.0 131.8 505.8 0.0 562.9 243.1 0.0 1279.6 752.8 0.0 641.0 734.0 188.1 0.0 0.0 0.0 911.2 689.1 219.6 0.0 551.8 107.2 339.5 0.0 0.0 719.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 304.4 0.0 0.0 419.2 0.0 0.0 0.0 0.0 1027.1 0.0 0.0 46.1 0.0 0.0 1789.2 241.9 0.0 0.0 0.0 233.3 0.0 0.0 0.0 0.0 496.8 132.1 310.6 0.0 0.0 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 266.1;Extravillous trophoblasts: 326.2;Hofbauer cells: 313.7;Pancreatic endocrine cells: 317.3;Proximal tubular cells: 341.3;Syncytiotrophoblasts: 332.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" NA NA 140000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Cell Junctions" "HPA078113: AB_2686877" "prognostic unfavorable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 78.3 83.9 86.5 45.0 89.6 93.1 59.9 88.6 116.1 47.9 79.8 61.3 30.2 48.1 67.0 75.3 46.2 39.3 141.0 92.5 85.3 97.2 76.0 62.0 52.5 83.6 83.9 46.1 41.1 58.5 57.2 56.0 83.9 45.2 44.8 69.4 46.7 43.7 190.3 48.4 40.7 54.8 84.2 48.2 57.3 111.2 85.1 64.4 43.3 125.6 65.7 69.3 52.0 89.5 211.2 169.2 151.1 110.2 113.0 146.7 108.1 203.6 165.3 194.8 199.0 151.1 178.2 106.3 160.7 181.9 263.4 147.2 168.7 203.6 256.8 123.2 141.5 185.7 174.2 243.0 147.3 120.4 133.6 149.4 159.9 177.0 226.8 144.2 184.8 180.2 166.2 137.8 260.2 155.9 311.7 214.9 137.5 341.9 271.8 111.9 95.1 100.8 216.2 181.9 142.1 134.3 85.2 458.9 202.4 155.1 169.2 127.9 142.2 140.1 160.6 156.1 208.1 155.6 204.5 198.9 169.6 130.2 175.0 138.6 66.4 85.6 62.0 78.6 68.3 83.1 74.2 70.8 73.6 73.9 66.5 67.5 79.8 73.4 77.3 118.4 99.1 60.0 86.5 89.6 88.6 116.1 92.5 85.3 83.6 83.9 83.9 84.2 85.1 89.5 236.0 67.3 98.9 0.0 24.8 0.0 0.0 0.0 0.0 0.0 147.6 185.4 0.0 0.0 49.5 119.5 0.0 220.1 74.5 0.0 266.1 216.7 0.0 147.9 98.9 77.1 0.0 0.0 0.0 227.2 326.2 66.0 0.0 168.8 69.4 65.9 0.0 0.0 313.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.9 0.0 0.0 112.7 0.0 0.0 0.0 0.0 317.3 0.0 0.0 12.1 0.0 0.0 341.3 63.4 0.0 0.0 0.0 78.2 0.0 0.0 0.0 0.0 332.5 40.7 98.8 0.0 0.0 ELOVL3 CIG-30 ENSG00000119915 "ELOVL fatty acid elongase 3" Q9HB03 10 102226299-102229589 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 30.5" "Cell type enhanced" "Detected in some" "Adipocytes: 2.5;Breast myoepithelial cells: 3.2;Skeletal myocytes: 5.0;Spermatogonia: 3.4;Theca cells: 2.2" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 10 "classical monocyte: 7.1;intermediate monocyte: 2.4;myeloid DC: 2.0;non-classical monocyte: 5.9" "Group enriched" "Detected in many" 10 "dendritic cells: 2.0;monocytes: 7.1" "Cell line enhanced" "Detected in many" "ASC diff: 9.5;ASC TERT1: 9.4;HSkMC: 13.9;NB-4: 11.6;SiHa: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA036236 Enhanced Approved Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Cytosol" "HPA036236: AB_10601550" "unprognostic (1.52e-2)" "unprognostic (6.76e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (6.25e-5)" "unprognostic (8.23e-3)" "unprognostic (9.82e-2)" "unprognostic (2.17e-4)" "unprognostic (4.27e-2)" "unprognostic (2.28e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (5.36e-3)" "unprognostic (2.66e-9)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" 3.2 0.7 1.0 0.3 0.8 1.8 3.5 0.5 1.3 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.2 1.0 0.4 0.8 0.0 1.0 0.1 0.4 0.9 0.1 0.0 0.1 0.0 0.9 0.4 0.2 0.1 0.1 0.3 0.1 0.2 30.5 0.2 0.0 0.4 0.8 0.1 1.2 0.4 0.0 0.0 0.3 0.0 0.2 0.3 0.5 3.2 0.2 0.2 7.8 9.5 9.4 2.8 0.1 0.3 0.4 0.5 0.5 3.0 0.0 0.3 0.0 0.0 0.1 5.9 0.1 0.5 0.0 0.0 0.2 0.4 0.8 0.3 0.0 0.1 13.9 1.6 3.6 0.0 0.0 0.0 0.9 0.1 3.5 0.8 0.0 0.0 11.6 0.1 1.1 1.0 0.0 5.1 0.0 2.0 0.1 0.0 0.4 22.6 0.9 0.7 0.6 8.1 2.7 0.0 1.5 0.0 0.3 0.3 0.5 7.2 0.0 3.4 6.5 0.0 0.0 7.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 5.9 0.0 0.0 1.7 1.0 0.8 0.5 1.3 1.0 0.4 0.4 0.9 0.4 0.4 0.4 0.5 2.5 0.0 1.1 0.0 0.2 0.4 0.5 0.6 0.6 0.0 1.1 3.2 0.3 0.0 0.5 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 0.0 1.3 1.9 0.0 0.0 0.3 0.0 0.7 1.3 0.0 0.2 0.0 0.0 1.4 0.4 0.2 0.0 0.0 0.2 0.0 1.5 0.8 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 5.0 1.2 0.1 3.4 0.6 0.1 0.3 0.3 2.2 0.2 0.1 ELP1 "DYS, IKAP, IKBKAP, IKI3, TOT1" ENSG00000070061 "Elongator complex protein 1" O95163 9 108866898-108934328 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.8;Collecting duct cells: 14.7;Exocrine glandular cells: 21.1;Theca cells: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "basophil: 36.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 36.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021340, HPA049677, HPA050686" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol Nucleoplasm "CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216" "prognostic unfavorable (1.57e-4)" "unprognostic (8.71e-2)" "unprognostic (5.13e-2)" "unprognostic (4.21e-2)" "unprognostic (6.44e-2)" "unprognostic (4.49e-2)" "unprognostic (2.76e-2)" "unprognostic (1.55e-1)" "unprognostic (1.67e-1)" "unprognostic (4.02e-2)" "unprognostic (1.10e-2)" "unprognostic (2.80e-2)" "unprognostic (1.77e-3)" "unprognostic (1.69e-1)" "unprognostic (1.57e-1)" "unprognostic (2.27e-2)" "unprognostic (4.98e-2)" 13.6 39.7 5.8 6.5 6.2 6.5 13.6 6.9 8.1 21.5 8.4 17.5 5.8 17.1 9.5 13.0 19.9 6.7 18.2 5.9 7.8 14.4 18.4 15.2 9.6 6.6 6.5 29.9 17.6 29.3 38.1 6.8 7.9 18.0 8.1 24.8 14.8 8.3 15.7 15.9 15.9 8.9 5.9 18.2 15.5 12.0 6.9 9.5 20.1 11.4 8.8 15.5 18.3 6.3 15.6 26.7 19.7 12.8 21.7 21.1 21.1 23.4 15.1 20.8 16.9 31.5 9.2 31.0 12.0 20.2 27.5 35.7 40.7 29.8 25.8 28.6 26.6 15.2 38.2 63.3 18.6 28.7 13.7 18.7 19.1 34.5 26.7 18.0 20.9 33.6 43.1 17.9 22.9 25.3 21.2 13.6 32.1 41.0 34.4 20.7 31.9 18.3 17.3 16.1 26.6 23.9 27.8 23.3 15.7 22.4 33.3 14.1 15.4 10.4 16.2 26.0 25.1 15.5 47.2 13.8 20.0 20.2 19.1 36.6 1.4 2.8 2.9 2.2 4.4 2.2 3.4 4.6 2.4 1.2 3.1 4.0 0.2 4.5 3.3 1.6 2.6 2.1 5.8 6.2 6.9 8.1 5.9 7.8 6.6 6.5 7.9 5.9 6.9 6.3 7.3 12.8 18.8 0.0 2.9 0.0 0.0 0.0 0.0 0.0 7.7 7.0 0.0 0.0 3.1 14.7 0.0 6.9 5.8 0.0 0.0 5.8 0.0 9.9 10.6 4.7 0.0 0.0 0.0 21.1 6.2 3.8 0.0 9.6 2.5 11.4 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.6 0.0 0.0 2.7 0.0 0.0 6.3 6.6 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 5.6 2.8 24.4 0.0 0.0 ENTR1 "NY-CO-3, SDCCAG3" ENSG00000165689 "Endosome associated trafficking regulator 1" Q96C92 9 136401922-136410614 "Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 20.4;Breast glandular cells: 15.7;Breast myoepithelial cells: 21.5;Endometrial stromal cells: 22.5;Granulosa cells: 18.7;Hofbauer cells: 18.2;Pancreatic endocrine cells: 18.3;Theca cells: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029303 Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA029303: AB_10602222" "unprognostic (8.94e-2)" "unprognostic (1.70e-1)" "unprognostic (3.20e-1)" "unprognostic (8.84e-3)" "unprognostic (6.35e-2)" "unprognostic (8.97e-2)" "unprognostic (2.56e-3)" "unprognostic (1.12e-1)" "unprognostic (2.39e-2)" "unprognostic (2.29e-2)" "unprognostic (1.51e-1)" "unprognostic (6.44e-3)" "prognostic unfavorable (8.50e-5)" "unprognostic (1.88e-2)" "unprognostic (1.04e-1)" "unprognostic (1.24e-2)" "unprognostic (6.23e-2)" 19.5 18.0 11.5 14.2 12.4 10.5 18.0 12.5 13.7 18.9 13.9 21.4 14.3 17.3 4.2 20.7 17.9 10.9 17.0 11.5 11.6 17.8 46.9 16.6 21.0 13.0 11.9 18.5 25.4 7.9 13.5 8.6 12.8 17.9 9.0 5.1 15.1 8.6 26.8 22.0 20.7 11.0 11.5 27.7 19.8 33.2 14.2 10.9 17.4 10.6 13.2 21.3 18.3 14.6 39.0 47.7 30.4 63.6 29.8 27.7 61.6 36.2 21.1 36.6 23.2 61.2 29.3 32.8 29.4 28.6 45.3 94.0 57.5 42.0 21.4 63.7 39.0 28.5 87.3 42.4 41.1 46.0 31.1 25.9 59.5 35.1 74.1 19.1 28.8 49.3 66.9 23.6 33.8 72.2 19.6 48.1 107.4 101.5 49.3 36.7 33.2 130.8 30.2 31.7 60.3 49.4 38.6 61.2 60.5 23.1 88.2 50.7 31.0 55.5 33.1 72.9 71.6 18.1 36.1 48.9 47.6 56.5 56.5 0.0 0.6 1.0 0.6 0.2 1.9 2.3 1.0 0.8 0.3 1.2 1.1 1.3 0.4 1.0 0.6 0.9 1.1 0.5 11.5 12.4 12.5 13.7 11.5 11.6 13.0 11.9 12.8 11.5 14.2 14.6 20.4 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 15.7 21.5 0.0 0.0 0.0 9.2 0.0 4.3 12.8 0.0 0.0 9.3 0.0 10.9 22.5 4.9 0.0 0.0 0.0 13.6 6.0 6.2 0.0 11.7 0.0 18.7 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 3.1 0.0 0.0 9.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 2.9 5.0 24.0 0.0 0.0 ERBIN "ERBB2IP, LAP2" ENSG00000112851 "Erbb2 interacting protein" Q96RT1 5 65926556-66082546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 119.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 70.5;dendritic cells: 61.3;Endometrial ciliated cells: 62.3;Glandular and luminal cells: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048606, HPA059863" Approved Supported "Nuclear speckles,Plasma membrane" NA NA 39000 "Cluster 38: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles, Plasma membrane" "HPA048606: AB_2680461, HPA059863: AB_2684146" "unprognostic (4.34e-1)" "unprognostic (5.56e-2)" "unprognostic (9.88e-2)" "unprognostic (2.15e-2)" "unprognostic (2.04e-1)" "unprognostic (4.23e-3)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (1.46e-2)" "unprognostic (6.52e-2)" "unprognostic (5.45e-3)" "unprognostic (7.98e-2)" "unprognostic (5.62e-3)" "unprognostic (7.21e-3)" "unprognostic (3.08e-1)" "unprognostic (6.86e-2)" "unprognostic (7.81e-2)" 15.7 14.5 65.2 29.5 109.6 30.0 24.7 64.2 67.6 23.2 19.0 27.8 24.5 22.6 27.0 20.1 20.0 28.4 16.9 56.2 91.6 29.5 33.3 21.5 40.6 91.3 88.0 20.0 18.8 22.6 8.3 16.4 106.0 26.4 26.3 28.1 21.8 20.2 19.8 32.8 44.1 19.7 64.4 31.4 40.3 27.5 86.6 48.7 29.9 20.7 39.0 28.5 13.0 119.1 97.8 32.2 41.5 49.6 30.0 36.0 31.5 61.5 62.6 85.3 94.3 31.5 113.8 82.2 58.8 95.3 67.2 31.7 26.5 45.1 149.4 36.3 12.0 28.3 41.3 24.7 39.5 22.0 26.3 39.4 29.2 47.2 67.5 50.0 32.1 37.1 29.4 54.6 58.1 33.5 59.0 25.1 10.1 9.7 9.5 53.7 33.0 45.8 49.9 65.6 20.0 18.7 65.0 21.7 46.4 30.9 38.4 53.8 29.8 48.3 85.9 29.8 80.8 47.2 31.7 69.8 31.6 35.9 28.1 13.1 4.1 5.5 5.2 5.8 4.8 4.7 3.9 4.6 3.5 3.7 4.5 4.8 9.2 3.9 5.1 2.2 3.8 2.8 65.2 109.6 64.2 67.6 56.2 91.6 91.3 88.0 106.0 64.4 86.6 119.1 53.0 70.5 57.5 0.0 13.2 0.0 0.0 0.0 0.0 0.0 39.4 24.8 0.0 0.0 31.6 53.3 0.0 6.5 61.3 0.0 11.7 26.7 0.0 62.3 50.0 26.1 0.0 0.0 0.0 24.9 11.2 16.2 0.0 101.9 27.8 47.8 0.0 0.0 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 50.3 0.0 0.0 13.3 0.0 0.0 41.7 24.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 8.9 20.0 51.4 0.0 0.0 ERCC6 "ARMD5, CKN2, CSB, RAD26" ENSG00000225830 "ERCC excision repair 6, chromatin remodeling factor" "P0DP91, Q03468" 10 49454168-49539538 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 53.8;hTERT-RPE1: 123.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071297 Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 6: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies" "HPA071297: AB_2732177" "unprognostic (1.92e-2)" "unprognostic (1.85e-1)" "unprognostic (9.79e-3)" "unprognostic (7.26e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-2)" "unprognostic (3.03e-2)" "unprognostic (2.99e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-1)" "unprognostic (1.80e-1)" "unprognostic (4.57e-2)" "unprognostic (1.04e-1)" "unprognostic (8.61e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" 2.7 2.1 1.6 1.9 1.5 4.6 3.8 3.0 2.3 3.1 7.7 2.4 2.0 3.0 1.5 3.8 2.9 2.7 3.4 1.2 1.1 3.2 3.3 2.7 2.9 2.4 1.9 4.5 3.1 5.9 2.8 3.4 2.1 3.3 2.7 3.1 3.2 2.2 3.5 4.6 2.5 2.3 2.2 2.9 2.4 3.1 2.1 3.3 5.1 3.6 3.4 2.6 3.3 1.9 11.2 5.5 4.1 2.1 6.6 10.5 3.4 21.2 27.1 14.1 9.9 6.2 5.6 4.9 3.7 18.7 6.7 9.5 6.3 16.6 13.5 8.4 4.1 3.9 21.7 3.4 3.9 5.0 3.7 4.3 17.2 12.9 53.8 123.4 19.8 2.9 6.8 0.8 16.8 8.3 3.4 2.0 4.0 3.5 10.2 2.3 5.8 2.6 4.1 7.1 5.9 4.7 15.4 3.6 8.2 9.4 7.1 2.7 38.9 7.0 5.5 8.6 5.2 3.3 4.5 4.1 7.3 5.0 5.1 13.1 3.0 7.5 4.1 2.6 3.0 6.8 2.3 2.2 3.9 5.2 2.8 1.4 7.2 1.2 5.3 2.2 3.1 1.8 1.6 1.5 3.0 2.3 1.2 1.1 2.4 1.9 2.1 2.2 2.1 1.9 6.9 16.0 13.2 14.7 6.0 3.6 1.4 1.5 5.2 0.0 7.1 7.1 7.1 5.7 8.2 9.2 0.0 2.5 10.9 4.8 5.9 5.2 11.3 8.1 8.7 5.1 1.2 1.3 24.3 6.0 2.1 4.9 2.0 10.1 7.6 8.9 5.3 4.3 2.6 0.0 21.7 5.3 0.0 4.4 2.6 15.3 2.8 8.0 1.8 23.4 11.2 0.0 4.1 17.6 16.6 5.2 2.6 2.2 3.6 2.5 5.0 3.6 9.0 0.0 6.6 4.4 4.2 5.3 5.0 3.5 4.1 1.8 7.4 11.4 2.8 1.9 ERG28 "C14orf1, NET51" ENSG00000133935 "Ergosterol biosynthesis 28 homolog" Q9UKR5 14 75649791-75660876 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 152.0;Ductal cells: 95.4;Exocrine glandular cells: 110.3;Extravillous trophoblasts: 154.2;Syncytiotrophoblasts: 116.3;Theca cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043172 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 7: Non-specific - Mitochondria" "HPA043172: AB_10793942" "unprognostic (2.68e-3)" "unprognostic (2.11e-2)" "unprognostic (4.55e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-1)" "unprognostic (1.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.66e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" "unprognostic (2.47e-1)" "unprognostic (3.01e-2)" "prognostic favorable (4.30e-5)" "unprognostic (1.28e-1)" "unprognostic (2.77e-1)" "unprognostic (9.58e-3)" "unprognostic (2.20e-1)" 9.8 27.7 24.0 9.1 23.3 13.2 17.3 24.6 26.2 16.9 25.1 16.5 21.6 14.9 40.6 34.6 16.9 11.9 13.6 24.6 25.0 18.5 70.2 22.6 11.5 26.2 25.2 20.0 16.1 29.7 17.4 14.9 25.4 21.2 15.5 19.4 19.9 13.8 10.3 24.8 14.5 14.6 25.4 8.3 13.6 47.1 25.8 10.2 21.5 11.3 14.6 12.5 20.1 27.5 39.2 21.6 42.7 33.5 28.6 53.1 26.6 15.6 48.2 29.9 51.0 33.8 91.4 16.6 22.3 19.6 59.7 42.4 38.5 67.0 34.0 31.2 25.4 17.8 20.5 48.4 41.4 19.7 25.5 66.5 56.7 42.9 23.8 24.0 35.3 44.7 16.0 39.3 20.9 77.7 30.2 21.8 41.8 62.5 34.7 23.9 28.7 33.0 99.8 50.5 36.6 20.1 39.2 33.5 24.1 37.8 56.1 28.3 25.1 16.1 32.0 15.8 15.8 25.3 32.5 36.1 25.7 28.5 27.7 33.5 12.3 20.0 40.0 12.7 39.5 39.4 43.1 41.8 29.8 34.5 39.1 38.5 6.6 31.8 13.2 38.4 42.7 31.9 24.0 23.3 24.6 26.2 24.6 25.0 26.2 25.2 25.4 25.4 25.8 27.5 18.8 22.4 57.5 0.0 9.3 0.0 0.0 0.0 0.0 0.0 74.7 57.7 0.0 0.0 11.2 60.7 0.0 152.0 23.6 0.0 49.0 95.4 0.0 43.4 11.5 18.0 0.0 0.0 0.0 110.3 154.2 21.4 0.0 30.3 5.1 63.2 0.0 0.0 64.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 37.7 0.0 0.0 0.0 0.0 76.9 0.0 0.0 3.5 0.0 0.0 47.1 18.2 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 116.3 12.4 121.2 0.0 0.0 ERO1B "ERO1-L(beta), Ero1beta, ERO1LB" ENSG00000086619 "Endoplasmic reticulum oxidoreductase 1 beta" Q86YB8 1 236215101-236281958 "Predicted intracellular proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 153.9" "Cell type enhanced" "Detected in many" "dendritic cells: 72.8;Early spermatids: 133.4;Spermatocytes: 94.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 15.4" "Group enriched" "Detected in all" 5 "dendritic cells: 6.0;granulocytes: 15.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028085 Enhanced "Intracellular and membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 25: Pancreas - Digestion" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA028085: AB_10601214" "unprognostic (1.16e-1)" "unprognostic (1.33e-3)" "unprognostic (1.00e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-1)" "unprognostic (9.80e-2)" "unprognostic (2.49e-2)" "prognostic favorable (7.53e-5)" "unprognostic (1.73e-2)" "unprognostic (2.85e-2)" "unprognostic (4.65e-2)" "unprognostic (5.90e-2)" "unprognostic (8.26e-3)" "unprognostic (7.87e-2)" "unprognostic (3.37e-1)" "unprognostic (2.22e-3)" "unprognostic (8.09e-3)" 5.8 5.5 4.2 5.6 4.1 7.3 7.7 8.5 5.1 5.1 4.3 5.1 10.2 5.1 21.3 2.8 4.9 9.1 4.9 4.5 4.8 8.3 18.8 5.2 7.0 3.7 3.6 6.4 153.9 14.8 9.7 5.2 3.4 5.8 3.2 17.3 8.0 5.4 3.3 3.3 5.4 5.0 2.9 8.3 46.8 28.3 3.1 5.7 27.2 3.9 6.3 4.7 4.0 5.1 2.0 2.3 3.9 3.4 3.0 1.8 4.5 3.1 2.9 2.2 1.7 0.7 2.2 5.5 8.2 4.8 8.3 1.0 1.8 2.8 3.0 5.8 11.1 1.6 0.3 2.1 7.9 2.1 0.9 3.5 5.6 3.8 7.3 4.5 2.6 5.0 0.8 14.2 2.7 1.1 0.9 0.9 1.5 0.3 0.7 11.3 2.6 1.5 4.0 4.7 7.8 4.6 10.2 3.3 8.7 2.0 7.9 9.5 2.5 3.2 2.8 3.2 4.2 9.3 0.6 3.4 4.3 3.1 5.0 15.4 1.5 3.0 2.2 1.6 1.9 1.5 1.2 1.5 1.6 2.1 1.7 1.7 3.1 1.1 0.7 6.0 1.2 0.8 4.2 4.1 8.5 5.1 4.5 4.8 3.7 3.6 3.4 2.9 3.1 5.1 33.4 9.6 9.4 0.0 47.8 0.0 17.9 0.0 45.5 20.7 27.9 23.7 0.0 27.1 3.1 16.5 14.6 12.7 72.8 0.2 1.9 5.3 133.4 1.7 13.2 12.8 14.6 5.5 0.0 16.9 5.1 16.9 32.1 3.9 5.1 9.6 17.5 26.4 6.9 25.2 0.0 5.3 0.0 21.5 0.0 25.6 19.3 34.5 0.0 0.0 11.9 12.2 29.9 0.0 0.0 9.9 0.2 11.3 69.5 18.4 2.7 7.7 1.5 55.4 0.0 36.0 15.1 94.3 14.9 13.6 0.0 22.6 43.8 2.8 1.8 11.0 ESS2 "bis1, DGCR13, DGCR14, DGS-H, DGSI, ES2, Es2el, ESS-2" ENSG00000100056 "Ess-2 splicing factor homolog" Q96DF8 22 19130279-19144684 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 4.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 15.7;Distal tubular cells: 13.7;Syncytiotrophoblasts: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 9.4;RH-30: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001221, HPA001222" Enhanced Approved Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA001221: AB_1078645, HPA001222: AB_1078647" "unprognostic (8.31e-2)" "unprognostic (1.81e-3)" "unprognostic (2.26e-1)" "unprognostic (2.83e-1)" "unprognostic (5.75e-3)" "unprognostic (4.70e-2)" "unprognostic (2.43e-2)" "unprognostic (6.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (5.89e-2)" "unprognostic (9.36e-2)" "unprognostic (3.04e-2)" "unprognostic (1.71e-3)" 0.6 0.4 3.2 0.6 3.2 0.2 0.5 4.9 3.3 1.2 1.9 2.2 0.4 1.4 0.5 1.0 0.9 0.5 1.3 2.9 2.9 0.9 0.4 0.5 0.8 3.2 3.2 1.3 0.7 0.7 1.1 0.5 3.3 1.0 0.4 1.3 0.6 1.2 1.6 1.4 0.9 0.9 2.8 0.9 1.1 2.0 3.0 0.8 0.8 1.6 0.8 1.7 0.9 3.4 1.6 3.0 1.7 1.9 2.7 0.5 0.7 1.5 0.9 2.6 2.1 2.4 0.6 2.3 0.5 0.7 0.6 2.8 5.1 0.8 1.3 3.4 5.8 0.6 2.7 0.4 0.7 2.8 2.0 0.4 3.0 1.8 0.5 0.7 0.5 1.6 9.4 0.3 1.2 1.7 1.7 1.6 1.5 1.8 2.3 2.6 8.3 0.0 0.7 1.2 4.3 0.9 0.7 1.3 1.9 1.1 0.9 1.3 0.4 2.2 3.2 2.2 1.2 1.1 2.5 0.8 0.7 1.7 1.4 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.0 0.2 0.0 0.1 3.2 3.2 4.9 3.3 2.9 2.9 3.2 3.2 3.3 2.8 3.0 3.4 6.3 6.4 4.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 6.1 6.7 0.0 0.0 1.8 9.2 0.0 15.7 8.3 0.0 13.7 13.2 0.0 7.5 6.9 4.0 0.0 0.0 0.0 10.4 12.4 3.7 0.0 7.5 5.1 10.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 10.3 0.0 0.0 0.0 0.0 13.4 0.0 0.0 2.3 0.0 0.0 12.7 4.4 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 16.3 4.0 10.2 0.0 0.0 ETAA1 ETAA16 ENSG00000143971 "ETAA1 activator of ATR kinase" Q9NY74 2 67397322-67412089 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035048, HPA035049" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 51: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA035048: AB_10670300, HPA035049: AB_2674430" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (5.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (3.39e-2)" "unprognostic (6.47e-2)" "unprognostic (5.53e-2)" "unprognostic (1.12e-2)" "unprognostic (8.33e-2)" "unprognostic (9.89e-2)" "unprognostic (1.87e-1)" "unprognostic (8.52e-3)" "unprognostic (9.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.01e-2)" "unprognostic (1.14e-2)" 4.7 11.1 2.7 4.3 3.1 3.9 7.1 4.0 3.3 6.7 3.9 5.0 3.6 6.9 6.2 5.9 6.6 4.3 3.9 2.4 2.7 6.1 5.3 5.4 6.5 2.9 2.8 7.3 8.2 6.1 3.3 4.2 2.9 5.0 4.4 5.7 6.2 3.9 3.5 6.2 5.5 5.1 2.7 5.5 5.2 4.6 2.8 6.3 6.3 3.1 5.0 5.1 6.6 3.5 7.9 5.9 10.2 9.0 7.6 10.4 8.0 8.2 10.8 8.7 8.3 4.8 9.3 14.8 4.4 6.8 12.1 9.5 8.9 10.0 12.3 8.6 6.8 8.1 14.7 7.1 7.2 8.3 7.4 8.3 13.8 6.4 9.7 13.7 13.8 11.8 6.8 6.1 12.0 3.5 12.3 9.0 10.3 12.7 6.3 8.6 16.0 6.8 10.5 5.1 8.5 16.7 8.4 7.6 8.0 9.9 6.6 4.0 9.6 11.6 8.9 5.6 9.8 6.8 6.5 11.6 10.9 8.6 9.0 1.3 1.1 0.9 2.2 1.8 2.4 3.5 2.0 1.3 1.4 3.6 2.7 2.4 0.1 2.0 2.6 2.0 3.2 1.3 2.7 3.1 4.0 3.3 2.4 2.7 2.9 2.8 2.9 2.7 2.8 3.5 7.7 22.4 21.0 10.4 7.6 2.4 7.9 8.3 6.8 5.1 8.8 8.4 10.1 15.7 9.1 12.9 0.0 6.6 9.1 3.5 11.7 17.8 0.6 15.0 15.0 7.8 10.7 13.7 6.3 18.4 6.3 10.9 6.6 11.1 6.3 15.4 10.4 8.9 4.8 5.0 6.6 7.1 2.0 5.1 1.5 1.9 12.2 4.8 1.8 2.8 9.4 6.5 15.5 15.1 13.6 20.4 4.7 13.2 7.0 8.0 5.9 15.0 16.6 4.6 0.0 8.9 7.3 12.7 8.2 7.9 2.6 2.1 7.2 14.1 7.0 6.1 ETFBKMT "C12orf72, DKFZp451L235, METTL20, MGC50559" ENSG00000139160 "Electron transfer flavoprotein subunit beta lysine methyltransferase" Q8IXQ9 12 31647160-31673114 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 7.3;Distal tubular cells: 7.9;Endometrial ciliated cells: 10.3;Proximal tubular cells: 18.1;Theca cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039024 Uncertain NA NA "Cluster 38: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 7: Non-specific - Mitochondria" "HPA039024: AB_10670917" "unprognostic (1.05e-1)" "unprognostic (6.46e-2)" "unprognostic (1.16e-1)" "unprognostic (7.91e-3)" "unprognostic (1.93e-1)" "unprognostic (6.13e-2)" "unprognostic (3.49e-4)" "unprognostic (5.23e-3)" "unprognostic (1.06e-1)" "unprognostic (1.72e-2)" "unprognostic (7.82e-3)" "unprognostic (2.77e-1)" "unprognostic (6.12e-5)" "unprognostic (3.68e-1)" "unprognostic (1.18e-1)" "unprognostic (8.69e-2)" "unprognostic (1.32e-2)" 2.4 3.8 2.0 1.6 2.3 2.3 2.9 3.1 2.7 3.7 0.7 2.4 2.9 2.8 5.4 2.5 4.4 2.7 3.7 1.8 1.8 6.1 9.7 2.1 1.6 1.6 1.7 4.8 3.8 4.7 2.6 2.1 1.7 2.6 2.5 6.1 2.2 2.7 7.6 2.5 2.0 3.0 1.8 2.4 2.7 3.7 1.7 1.0 3.7 7.8 1.4 2.1 1.6 2.9 1.8 1.1 1.6 2.3 6.8 4.7 1.4 1.7 1.7 1.9 2.1 2.1 3.2 0.8 1.6 1.2 1.7 0.4 1.0 1.2 2.0 1.3 1.2 1.3 1.6 0.6 2.4 0.8 1.8 4.4 2.1 2.3 2.1 1.8 3.0 2.5 1.5 2.9 2.4 1.7 0.8 0.8 1.8 1.5 1.9 1.2 2.0 2.2 2.7 0.6 1.0 1.0 1.6 1.2 2.6 4.1 5.1 1.6 2.3 1.9 1.7 5.0 1.4 5.3 3.2 1.4 1.6 1.5 1.5 7.8 1.7 2.1 0.9 1.0 0.8 2.0 1.1 1.5 1.2 2.3 1.8 1.6 4.5 1.6 1.2 2.5 1.3 0.9 2.0 2.3 3.1 2.7 1.8 1.8 1.6 1.7 1.7 1.8 1.7 2.9 5.9 6.4 3.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 7.3 6.3 0.0 0.0 0.6 3.7 0.0 3.0 2.5 0.0 7.9 2.9 0.0 10.3 5.2 2.1 0.0 0.0 0.0 2.6 2.6 2.1 0.0 5.3 2.5 5.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.0 0.0 18.1 3.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.7 1.6 7.6 0.0 0.0 ETFRF1 LYRM5 ENSG00000205707 "Electron transfer flavoprotein regulatory factor 1" Q6IPR1 12 25195216-25209645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 305.2;Proximal tubular cells: 183.8;Theca cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044255 Approved NA NA "Cluster 30: Non-specific - Translation" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" "HPA044255: AB_10967895" "prognostic favorable (9.63e-4)" "unprognostic (1.30e-1)" "unprognostic (2.01e-1)" "unprognostic (9.17e-2)" "unprognostic (5.96e-2)" "unprognostic (1.70e-1)" "unprognostic (3.57e-3)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "unprognostic (4.32e-2)" "unprognostic (2.49e-2)" "unprognostic (3.41e-2)" "prognostic favorable (9.23e-5)" "unprognostic (1.55e-1)" "unprognostic (4.04e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-3)" 28.2 46.3 43.9 13.5 48.3 12.9 35.0 49.5 69.8 25.7 41.2 17.9 33.4 19.6 35.6 22.5 18.3 22.5 53.1 43.4 47.4 55.9 121.3 21.7 17.9 50.0 46.4 20.6 24.1 37.2 15.1 17.5 49.5 26.4 19.4 30.4 30.4 20.6 89.1 24.2 23.9 18.3 49.7 18.3 30.3 56.3 45.8 18.9 43.2 101.5 16.5 18.1 12.0 57.0 13.4 12.6 16.8 11.1 25.4 40.4 12.1 14.7 21.4 15.1 17.4 6.0 15.0 4.3 10.2 23.4 9.6 9.4 14.2 14.9 17.0 15.9 12.1 21.5 13.8 7.9 27.3 19.4 12.1 26.1 48.9 13.8 23.5 46.5 23.9 23.9 25.5 13.5 24.1 14.1 16.9 50.1 26.8 29.6 16.1 11.2 19.8 26.2 40.8 10.4 17.3 12.2 13.4 14.1 40.2 42.5 21.7 27.1 14.0 6.0 8.1 33.1 9.2 16.6 10.9 16.6 26.2 15.2 18.7 24.9 8.5 7.8 8.5 9.5 12.1 21.3 15.2 11.6 8.9 16.8 27.7 22.6 15.6 17.1 6.2 13.3 7.7 12.3 43.9 48.3 49.5 69.8 43.4 47.4 50.0 46.4 49.5 49.7 45.8 57.0 38.0 19.2 24.4 0.0 10.6 0.0 0.0 0.0 0.0 0.0 39.1 48.8 0.0 0.0 9.3 27.6 0.0 56.2 11.9 0.0 305.2 31.0 0.0 36.8 17.0 13.8 0.0 0.0 0.0 45.8 19.2 12.1 0.0 36.1 11.4 14.2 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 25.6 0.0 0.0 3.0 0.0 0.0 183.8 4.4 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 65.5 9.0 69.1 0.0 0.0 FAAP20 "C1orf86, FLJ31031" ENSG00000162585 "FA core complex associated protein 20" Q6NZ36 1 2184461-2212720 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 337.5;Proximal tubular cells: 290.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038829 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Cell Junctions" "HPA038829: AB_10673476" "unprognostic (1.36e-2)" "unprognostic (2.86e-2)" "unprognostic (2.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.64e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (2.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.88e-4)" "unprognostic (1.59e-1)" "unprognostic (1.96e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (8.55e-2)" 39.3 57.5 18.1 3.2 18.9 5.6 41.2 20.8 28.0 52.5 20.5 48.5 4.6 50.0 1.3 38.8 37.8 1.5 50.0 14.5 19.6 64.8 52.1 37.9 3.6 24.6 18.9 45.3 38.7 5.1 75.5 3.2 19.6 61.1 1.8 3.7 30.7 7.1 26.4 42.7 31.8 1.8 20.2 45.0 47.3 54.8 26.9 2.9 52.9 4.0 3.1 43.7 40.7 18.9 27.7 4.4 5.8 7.3 3.6 4.7 34.8 30.4 11.0 9.6 12.9 6.7 18.0 31.7 43.7 4.8 9.0 13.5 4.2 4.6 4.9 68.3 61.0 26.5 6.8 14.4 13.5 18.7 24.8 8.1 9.8 5.8 6.3 5.9 11.9 24.6 37.1 7.6 6.7 11.6 27.0 57.6 20.8 5.4 55.6 36.0 18.1 30.7 4.6 4.5 47.4 63.5 19.8 8.6 58.5 5.3 8.5 7.5 25.6 15.1 35.8 18.7 17.4 68.9 39.9 48.2 28.0 11.4 6.4 9.8 16.4 63.4 18.4 16.9 18.1 28.3 16.5 19.8 17.0 25.7 22.2 18.6 20.6 10.8 15.6 42.4 16.2 10.6 18.1 18.9 20.8 28.0 14.5 19.6 24.6 18.9 19.6 20.2 26.9 18.9 71.7 6.4 11.9 0.0 82.3 0.0 97.7 0.0 79.6 29.1 120.9 138.2 22.1 62.9 6.8 97.5 4.2 119.7 83.6 14.5 170.2 128.5 102.7 44.3 77.2 62.1 43.7 36.8 0.0 110.8 144.1 65.3 64.7 49.9 7.6 74.8 84.6 94.5 134.0 15.2 0.0 56.0 0.0 110.8 0.0 337.5 86.0 82.3 0.0 0.0 178.9 84.7 91.6 0.0 0.0 141.1 40.8 82.8 60.9 152.8 56.2 290.1 8.0 29.5 65.7 63.3 68.8 101.5 38.3 88.4 0.0 89.8 62.4 102.5 42.2 113.2 FAM241A "C4orf32, FLJ39370" ENSG00000174749 "Family with sequence similarity 241 member A" Q8N8J7 4 112145454-112195256 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 272.0;Alveolar cells type 1: 60.9;Alveolar cells type 2: 69.9;Breast glandular cells: 87.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 41.3;HUVEC TERT2: 28.0" "Low region specificity" "Detected in all" "HPA062443, HPA069294" Approved Enhanced "Golgi apparatus" No No "Cluster 17: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA062443: AB_2684765, HPA069294: AB_2686111" "unprognostic (3.07e-1)" "unprognostic (1.11e-2)" "unprognostic (2.42e-2)" "unprognostic (5.58e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (1.61e-2)" "unprognostic (3.16e-1)" "unprognostic (1.21e-1)" "unprognostic (5.05e-2)" "unprognostic (4.81e-2)" "unprognostic (5.25e-2)" "unprognostic (9.20e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (4.08e-1)" "unprognostic (7.16e-2)" "unprognostic (1.39e-2)" 16.7 4.1 7.7 5.3 8.6 7.2 11.2 16.6 15.5 2.8 0.5 2.8 2.9 3.8 3.8 4.3 2.3 5.1 7.2 6.7 1.7 4.5 4.6 5.1 5.2 1.6 2.3 2.8 2.2 3.9 1.5 10.8 2.9 3.8 2.8 10.5 8.8 2.9 6.0 6.3 3.4 5.1 0.4 5.0 7.3 6.0 3.9 3.2 4.2 5.0 4.1 5.1 2.5 13.7 6.3 2.4 2.5 2.1 12.5 7.1 3.7 5.3 1.2 1.0 1.6 1.9 7.9 41.3 4.9 2.9 3.5 3.1 3.9 5.5 1.8 19.7 6.6 4.4 6.4 3.4 7.4 10.3 2.7 7.8 8.7 1.5 9.1 2.0 28.0 5.8 8.4 19.6 3.1 6.5 3.8 7.4 3.2 10.3 5.9 8.6 4.2 8.5 4.2 6.1 4.6 3.8 5.0 9.0 2.7 3.6 6.5 4.4 17.9 3.2 9.7 2.1 1.9 8.2 11.3 19.1 7.3 5.1 4.1 2.8 0.6 0.6 0.5 0.5 0.4 0.6 0.5 0.4 0.3 0.9 0.5 0.6 1.5 0.6 0.6 1.0 0.6 0.3 7.7 8.6 16.6 15.5 6.7 1.7 1.6 2.3 2.9 0.4 3.9 13.7 272.0 60.9 69.9 0.0 4.9 0.0 0.0 0.0 0.0 0.0 87.0 42.2 0.0 0.0 36.5 33.1 0.0 1.6 9.2 0.0 7.9 12.0 0.0 4.6 3.9 44.0 0.0 0.0 0.0 17.3 2.8 13.8 0.0 12.0 32.8 0.4 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 4.6 0.0 0.0 0.0 0.0 28.2 0.0 0.0 4.0 0.0 0.0 3.5 42.3 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 2.5 9.8 1.3 0.0 0.0 FAM89B "LRAP25, MTVR1" ENSG00000176973 "Family with sequence similarity 89 member B" Q8N5H3 11 65572349-65574198 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046895 Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "HPA046895: AB_2679858" "unprognostic (1.16e-1)" "unprognostic (9.46e-3)" "unprognostic (1.02e-1)" "unprognostic (5.11e-2)" "unprognostic (4.09e-1)" "unprognostic (3.92e-3)" "prognostic unfavorable (2.98e-4)" "unprognostic (8.32e-2)" "unprognostic (1.51e-1)" "prognostic favorable (6.00e-4)" "unprognostic (1.69e-1)" "unprognostic (4.07e-3)" "prognostic unfavorable (9.48e-5)" "unprognostic (3.59e-2)" "unprognostic (2.63e-1)" "unprognostic (3.27e-2)" "unprognostic (1.12e-2)" 39.9 33.8 59.0 19.8 54.9 22.5 34.2 53.9 84.7 46.1 40.2 70.7 13.7 47.7 13.0 46.2 42.7 24.8 56.7 60.7 46.6 39.6 36.0 39.7 25.8 52.2 50.6 43.8 76.2 23.2 22.9 14.6 52.9 50.3 10.9 3.2 47.0 24.2 129.7 44.1 34.4 23.0 50.8 48.3 45.0 18.4 53.8 31.3 26.1 95.1 19.4 54.0 43.1 55.9 16.6 26.3 38.4 47.8 45.7 52.5 12.5 29.3 26.2 21.4 12.7 15.8 18.2 11.2 38.7 45.9 23.7 28.1 16.3 17.5 5.0 38.0 43.6 21.3 18.8 9.0 27.8 10.5 38.7 41.1 34.8 17.7 12.2 68.3 57.5 26.2 24.2 73.3 30.7 24.6 48.1 37.1 17.2 16.1 61.2 59.2 5.9 49.6 24.1 15.2 43.5 57.6 21.5 30.8 50.0 11.7 31.1 15.7 37.9 45.6 23.9 44.6 15.5 36.3 61.3 7.4 39.9 15.7 33.2 7.8 5.7 11.6 5.0 10.5 6.8 2.6 6.3 6.4 5.0 2.3 5.3 5.4 8.5 5.8 14.0 5.5 10.1 3.5 59.0 54.9 53.9 84.7 60.7 46.6 52.2 50.6 52.9 50.8 53.8 55.9 45.3 9.6 3.9 9.8 33.4 47.4 32.8 4.3 18.8 10.1 67.0 57.8 10.7 21.5 5.3 23.9 2.1 27.7 63.9 27.2 13.7 23.6 10.4 19.7 33.3 39.7 29.2 36.7 13.6 27.5 19.9 32.8 10.7 20.3 4.5 26.5 43.5 27.6 32.5 16.8 10.9 15.2 2.0 40.6 48.8 27.8 26.4 47.1 44.4 13.1 27.1 29.1 73.2 9.0 10.6 33.3 21.7 30.1 43.6 31.8 16.1 14.9 4.2 8.7 46.0 22.3 48.8 2.9 13.1 19.1 57.4 22.3 46.5 26.2 16.6 48.5 FBH1 "Fbx18, FBXO18, FLJ14590" ENSG00000134452 "F-box DNA helicase 1" Q8NFZ0 10 5890203-5937594 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 22.4;Distal tubular cells: 21.5;Granulosa cells: 23.6;Syncytiotrophoblasts: 32.0;Theca cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002844 Supported NA NA "Cluster 15: NK-cells - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA002844: AB_1078829" "unprognostic (3.14e-2)" "unprognostic (1.55e-1)" "unprognostic (6.35e-3)" "unprognostic (4.42e-2)" "unprognostic (3.37e-2)" "unprognostic (8.98e-3)" "prognostic unfavorable (7.73e-7)" "unprognostic (1.89e-1)" "unprognostic (2.42e-1)" "unprognostic (3.37e-2)" "unprognostic (1.56e-2)" "unprognostic (2.23e-1)" "unprognostic (6.91e-3)" "unprognostic (3.69e-1)" "unprognostic (4.35e-2)" "unprognostic (1.24e-1)" "unprognostic (9.54e-2)" 28.7 38.8 17.5 22.8 20.3 24.6 26.8 17.7 19.1 32.4 25.7 30.4 24.6 34.3 21.3 24.0 36.4 23.0 44.5 17.2 18.0 25.2 28.8 27.6 27.6 17.7 18.2 30.7 21.9 28.5 26.1 26.6 18.0 28.6 24.2 14.8 24.3 25.8 30.3 30.4 29.7 30.1 17.8 35.3 27.6 24.7 19.2 40.2 25.2 27.4 27.2 28.8 27.1 19.0 31.8 34.0 31.3 34.4 70.4 46.3 28.1 35.9 24.6 34.8 38.8 40.4 28.3 29.6 23.0 52.5 16.7 46.3 42.6 38.2 31.3 32.2 31.5 28.6 27.3 34.8 48.2 14.2 26.4 58.2 36.4 44.2 19.4 44.0 59.7 39.7 50.9 30.4 37.3 48.1 34.5 20.9 14.3 54.7 18.9 37.6 14.8 49.9 34.0 25.5 17.7 26.6 36.8 33.1 50.8 35.7 33.7 28.5 37.9 22.1 24.7 59.1 28.1 30.9 26.1 16.3 29.8 20.7 15.8 0.0 2.1 3.3 1.9 1.7 1.3 3.0 2.0 2.5 2.0 4.1 2.5 1.8 1.3 4.6 1.3 4.0 6.2 1.7 17.5 20.3 17.7 19.1 17.2 18.0 17.7 18.2 18.0 17.8 19.2 19.0 22.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 15.6 16.1 0.0 0.0 0.0 7.3 0.0 20.3 9.3 0.0 21.5 16.8 0.0 11.4 19.0 7.1 0.0 0.0 0.0 15.1 19.4 9.8 0.0 14.9 0.0 23.6 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 10.3 0.0 0.0 0.0 0.0 18.3 0.0 0.0 3.2 0.0 0.0 20.9 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 32.0 4.4 27.9 0.0 0.0 FBRS "FBS, FBS1, FLJ11618" ENSG00000156860 Fibrosin Q9HAH7 16 30658431-30670810 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 109.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044117 Approved Approved Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA044117: AB_10794394" "unprognostic (1.87e-1)" "unprognostic (8.48e-3)" "unprognostic (2.41e-2)" "unprognostic (9.52e-3)" "unprognostic (1.03e-1)" "unprognostic (4.80e-2)" "unprognostic (2.07e-3)" "unprognostic (7.01e-3)" "unprognostic (6.32e-2)" "unprognostic (7.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.01e-1)" "unprognostic (1.25e-2)" "unprognostic (2.13e-1)" "unprognostic (4.16e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" 25.6 34.3 23.0 24.4 22.2 55.9 25.8 21.5 24.6 34.2 14.9 39.1 21.2 35.6 5.5 57.2 36.0 9.4 28.7 22.9 19.7 33.3 29.9 29.2 21.8 24.7 20.9 33.8 29.8 16.6 57.6 12.6 19.4 37.3 6.5 6.5 30.2 15.6 38.4 53.5 40.0 9.7 16.8 53.4 33.8 117.3 22.9 21.3 36.6 11.4 15.9 34.7 33.2 23.0 28.8 30.2 15.6 12.9 15.3 15.5 39.5 20.9 16.9 17.7 13.3 17.8 25.9 26.8 34.0 17.0 16.0 23.6 16.6 19.9 8.3 72.7 41.5 36.0 29.3 33.0 37.4 26.5 52.3 23.1 26.4 34.3 16.6 19.8 22.0 24.4 32.0 50.2 13.1 59.1 33.7 51.7 4.4 12.9 19.0 48.5 11.8 29.4 18.8 21.2 21.8 24.5 16.4 31.2 22.9 6.7 70.5 34.6 34.3 40.0 24.2 25.0 27.8 58.6 30.5 25.4 38.4 25.6 24.1 0.0 1.0 0.8 0.8 0.4 0.8 0.6 0.7 0.8 0.5 0.7 0.2 0.9 2.1 0.5 0.6 1.0 0.0 0.9 23.0 22.2 21.5 24.6 22.9 19.7 24.7 20.9 19.4 16.8 22.9 23.0 21.2 16.0 21.8 9.8 30.0 18.7 15.9 13.2 38.7 22.3 26.8 19.3 9.3 11.5 11.0 7.3 33.3 10.2 38.1 36.3 5.9 11.0 82.2 33.4 25.1 18.2 16.8 4.6 9.5 14.7 9.3 15.8 29.0 32.2 19.0 21.5 19.2 9.4 14.0 43.7 8.7 21.5 10.2 15.8 22.0 109.9 17.1 25.8 10.6 7.5 20.1 14.7 15.5 7.5 14.5 21.1 26.3 16.1 13.3 22.2 33.5 8.9 24.4 25.7 0.0 19.0 17.7 69.1 23.9 37.8 24.3 33.0 28.8 22.2 19.3 27.9 FBXL18 "Fbl18, FLJ11467" ENSG00000155034 "F-box and leucine rich repeat protein 18" Q96ME1 7 5431335-5513809 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036049 Approved Nucleoplasm,Cytosol No No "Cluster 42: Non-specific - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "HPA036049: AB_2674918" "unprognostic (2.86e-3)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.26e-2)" "unprognostic (8.73e-3)" "unprognostic (1.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.98e-4)" "unprognostic (1.50e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-3)" "unprognostic (1.04e-2)" "unprognostic (3.69e-1)" "unprognostic (8.28e-4)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" "unprognostic (7.30e-4)" "unprognostic (1.73e-3)" 2.3 1.9 6.8 2.0 7.0 2.7 1.1 3.2 14.2 1.0 1.8 1.3 1.7 1.5 1.1 2.0 1.1 0.9 1.9 10.2 4.3 1.3 1.2 1.3 1.9 5.3 2.5 1.2 2.6 2.1 1.4 1.3 2.6 1.4 0.9 1.4 2.0 1.2 3.6 3.8 1.5 1.3 0.7 1.5 1.6 1.6 5.8 1.4 1.4 2.0 1.6 1.3 1.0 5.1 11.0 15.2 3.7 9.7 5.7 4.2 6.9 6.5 2.9 4.0 3.9 12.0 7.4 5.2 7.5 4.0 7.4 17.3 4.9 14.7 2.8 3.5 6.3 2.8 10.7 4.7 4.2 4.9 4.3 4.3 7.9 6.4 3.6 3.8 5.0 3.0 8.0 3.5 3.7 16.4 3.0 5.3 13.7 5.1 12.1 6.8 7.8 3.6 4.0 6.1 7.9 12.2 10.2 18.1 3.5 4.5 17.9 4.4 11.4 12.9 16.6 10.1 9.9 5.2 7.5 3.8 7.1 7.1 16.1 6.3 2.1 0.9 1.4 2.1 1.3 1.3 0.9 1.4 1.6 1.8 1.0 1.2 5.0 2.3 2.9 1.4 1.2 1.5 6.8 7.0 3.2 14.2 10.2 4.3 5.3 2.5 2.6 0.7 5.8 5.1 4.8 6.4 4.8 6.2 2.6 2.5 3.0 0.9 1.2 9.7 3.9 9.1 5.3 2.8 5.8 0.0 4.2 3.9 5.5 4.8 0.0 2.4 1.5 7.6 3.5 2.8 4.8 0.4 10.8 2.6 2.7 2.7 4.6 7.3 2.5 3.0 2.5 1.8 1.5 1.7 8.5 1.9 4.1 3.5 2.9 0.5 1.5 2.4 0.0 7.5 3.2 4.7 5.2 4.0 7.8 2.2 2.1 0.7 1.4 2.4 2.4 1.2 3.2 6.6 0.0 4.7 3.0 2.7 4.9 2.4 3.3 2.2 2.9 1.5 4.8 1.8 FDX2 "FDX1L, MGC19604" ENSG00000267673 "Ferredoxin 2" Q6P4F2 19 10310045-10316015 "Disease related genes, Predicted intracellular proteins" "Electron transport, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Ductal cells: 38.5;Exocrine glandular cells: 30.3;Hofbauer cells: 37.0;monocytes: 31.6;Pancreatic endocrine cells: 30.2;Proximal tubular cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 266.8" HPA043986 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA043986: AB_10960282" "unprognostic (1.48e-2)" "unprognostic (3.76e-2)" "unprognostic (7.61e-3)" "unprognostic (3.83e-2)" "unprognostic (1.48e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-3)" "unprognostic (9.70e-3)" "unprognostic (2.29e-1)" "unprognostic (1.42e-3)" "unprognostic (4.92e-2)" "unprognostic (3.73e-2)" "unprognostic (3.93e-2)" "unprognostic (3.14e-1)" "unprognostic (4.74e-2)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" 16.1 27.2 58.1 9.1 59.5 4.9 15.1 53.8 79.8 15.4 55.1 20.5 7.7 16.3 13.2 14.4 13.6 9.8 23.3 60.7 60.6 32.1 28.2 14.1 11.2 54.9 57.9 15.3 20.0 29.9 28.8 9.3 58.7 20.2 6.8 4.4 14.0 16.0 24.6 12.6 11.5 13.3 52.3 15.2 17.4 12.1 57.8 8.7 24.4 22.1 7.9 19.5 13.9 61.9 34.9 28.4 19.4 33.4 40.2 31.7 20.2 32.2 51.0 53.6 44.5 41.4 24.5 26.2 59.2 45.9 37.7 26.5 32.3 61.1 20.7 28.6 46.0 38.3 30.0 30.5 58.4 18.7 12.3 28.9 42.6 45.2 44.4 25.9 32.9 30.0 47.2 20.4 61.2 56.2 35.1 266.8 33.8 32.7 52.2 26.3 16.0 39.0 62.1 36.4 42.5 25.7 40.0 46.7 36.6 13.1 39.3 13.7 23.2 73.9 18.6 76.7 48.2 44.9 73.2 42.1 68.6 41.2 39.3 0.0 9.1 0.0 10.8 19.6 14.7 19.7 10.9 14.0 20.9 14.1 13.6 15.6 1.7 24.4 19.0 15.4 15.5 7.7 58.1 59.5 53.8 79.8 60.7 60.6 54.9 57.9 58.7 52.3 57.8 61.9 11.3 9.6 10.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 18.9 18.7 0.0 0.0 4.3 11.0 0.0 14.1 3.5 0.0 29.4 38.5 0.0 5.7 5.1 4.9 0.0 0.0 0.0 30.3 19.5 5.7 0.0 4.3 2.5 5.5 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 31.6 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.9 0.0 0.0 69.9 5.8 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 7.9 2.1 5.7 0.0 0.0 FMC1 "C7orf55, HSPC268" ENSG00000164898 "Formation of mitochondrial complex V assembly factor 1 homolog" Q96HJ9 7 139339457-139346328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 84.6;Distal tubular cells: 199.6;Proximal tubular cells: 196.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 67.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045663, HPA050553" Approved Approved Mitochondria NA NA "Cluster 37: B-cells - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA045663: AB_2679410, HPA050553: AB_2681173" "unprognostic (3.71e-2)" "unprognostic (1.15e-2)" "unprognostic (3.69e-1)" "unprognostic (3.80e-2)" "unprognostic (8.90e-2)" "unprognostic (9.00e-2)" "unprognostic (4.39e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.19e-1)" "prognostic favorable (5.63e-6)" "unprognostic (1.04e-3)" "unprognostic (2.39e-2)" "prognostic favorable (2.05e-5)" "unprognostic (1.50e-1)" "unprognostic (3.40e-2)" "unprognostic (4.67e-1)" "unprognostic (3.02e-2)" 8.5 11.5 19.1 2.8 20.1 6.2 8.2 20.1 23.1 6.6 20.0 9.7 7.0 8.1 11.6 5.5 9.3 5.2 28.5 19.3 19.8 16.2 17.7 5.2 5.5 20.0 19.8 11.2 10.3 11.1 12.0 3.3 19.9 11.2 5.1 3.1 12.8 7.7 30.5 5.0 7.0 3.7 19.5 6.4 11.3 5.7 19.6 7.5 10.7 39.0 3.0 8.6 5.8 21.5 5.6 19.5 11.2 11.7 6.0 5.2 4.9 1.8 4.6 13.2 9.8 6.6 7.1 12.6 11.3 5.9 10.5 4.3 11.0 4.8 3.2 6.3 67.5 6.1 19.9 29.3 12.8 5.3 8.8 13.5 9.3 4.4 3.7 4.8 10.8 8.6 12.4 18.9 7.6 39.2 12.8 35.7 11.1 9.9 28.2 7.7 5.5 17.6 11.1 5.0 22.1 14.5 6.3 5.2 8.1 1.8 2.5 4.3 5.1 4.7 4.4 5.6 5.0 6.7 7.2 14.4 12.1 11.7 7.7 13.3 10.3 10.9 11.2 6.7 9.9 25.3 13.7 11.4 12.0 20.5 15.7 11.2 3.3 16.1 7.6 21.4 16.9 6.6 19.1 20.1 20.1 23.1 19.3 19.8 20.0 19.8 19.9 19.5 19.6 21.5 31.3 44.8 47.6 0.0 10.1 0.0 0.0 0.0 0.0 0.0 57.1 57.4 0.0 0.0 19.8 84.6 0.0 63.0 11.9 0.0 199.6 35.4 0.0 67.8 40.1 14.5 0.0 0.0 0.0 35.3 24.2 20.3 0.0 43.9 12.6 27.6 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 12.9 0.0 0.0 0.0 0.0 23.6 0.0 0.0 4.1 0.0 0.0 196.2 37.2 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 47.6 9.4 40.9 0.0 0.0 FOSB "AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291" ENSG00000125740 "FosB proto-oncogene, AP-1 transcription factor subunit" P53539 19 45467995-45475179 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 1627.1;Skeletal myocytes: 2234.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 45.6" "Immune cell enhanced" "Detected in some" "neutrophil: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 11.4;HMC-1: 13.3;hTCEpi: 8.1;Karpas-707: 6.8;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010267, HPA054663" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB010267: AB_640583, HPA054663: AB_2682562" "unprognostic (7.22e-2)" "unprognostic (9.74e-2)" "unprognostic (2.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (1.30e-3)" "unprognostic (9.43e-2)" "unprognostic (2.04e-2)" "unprognostic (2.99e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (4.99e-3)" "unprognostic (8.72e-2)" "unprognostic (4.45e-2)" "unprognostic (4.04e-2)" 394.7 121.6 2.1 118.4 5.5 433.8 91.7 35.7 45.6 150.3 4.8 37.6 24.8 46.6 3.9 187.7 404.1 347.1 48.9 11.1 7.8 34.7 85.5 113.5 67.7 1.5 1.6 274.4 126.3 46.2 27.3 57.8 1.5 118.5 78.4 10.7 76.8 29.6 3.3 267.8 63.1 353.7 0.8 21.8 104.4 8.8 1.2 152.2 316.0 81.3 1.6 213.9 11.0 3.8 0.4 0.6 0.1 0.3 1.2 0.3 1.8 2.3 1.0 0.7 0.7 0.5 1.0 2.0 0.4 1.5 11.4 0.8 0.5 1.6 0.5 0.3 0.7 0.6 0.8 0.4 0.8 1.1 13.3 0.5 8.1 1.7 1.9 0.4 0.9 2.3 0.8 6.8 0.2 0.2 0.2 1.2 0.4 1.0 0.4 0.5 0.1 1.4 0.6 1.3 3.1 0.4 1.4 9.6 1.2 1.9 0.5 0.8 0.1 0.5 0.6 1.1 0.7 5.1 0.8 0.5 1.1 0.8 1.3 0.9 1.2 1.0 0.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.1 2.1 5.5 35.7 45.6 11.1 7.8 1.5 1.6 1.5 0.8 1.2 3.8 1048.7 685.9 761.3 2.6 445.7 380.5 533.4 162.4 865.6 50.6 1627.1 1523.2 177.8 370.3 174.4 11.0 135.5 237.5 359.6 551.1 1.9 145.5 10.1 667.9 1204.4 442.6 877.0 68.6 1.3 74.2 301.9 788.2 911.3 1541.3 830.4 239.3 393.7 77.9 210.3 8.4 0.3 898.4 42.7 345.2 353.4 11.3 240.2 797.3 172.5 1.0 16.3 186.1 1.0 0.0 0.3 111.6 457.3 59.5 503.4 307.3 417.8 2.7 111.5 217.6 302.4 2234.0 608.8 3.3 4.5 476.3 380.9 396.9 481.8 174.2 616.5 208.5 FP565260.6 ENSG00000280433 "Novel protein, similar to trafficking protein particle complex 10 TRAPPC10" 21 5155499-5165472 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.3;Collecting duct cells: 3.7;Glandular and luminal cells: 2.4;Pancreatic endocrine cells: 3.9;Proximal tubular cells: 3.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.36e-1)" "unprognostic (2.11e-3)" "unprognostic (1.01e-1)" "unprognostic (2.05e-1)" "unprognostic (5.60e-2)" "unprognostic (7.47e-2)" "unprognostic (9.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-2)" "unprognostic (2.13e-3)" "unprognostic (7.46e-2)" "unprognostic (2.15e-2)" "unprognostic (1.17e-1)" "unprognostic (2.62e-2)" "unprognostic (7.41e-2)" "unprognostic (7.71e-6)" 6.5 6.2 12.7 5.1 13.3 4.9 5.6 12.9 20.1 5.3 12.1 10.5 6.7 5.5 7.2 6.7 5.1 4.3 6.6 12.9 12.9 10.6 10.6 6.3 12.3 13.1 13.1 4.9 6.0 5.8 8.2 3.3 13.2 5.6 7.5 7.2 5.6 3.0 6.2 6.4 11.9 3.0 12.6 15.2 6.9 6.3 12.9 10.0 8.2 3.8 5.4 5.0 5.1 14.3 7.0 2.1 5.8 4.0 6.7 3.9 3.5 2.3 2.4 1.0 2.0 1.2 3.3 3.3 2.2 5.7 7.4 4.3 5.6 3.8 2.1 2.3 2.9 12.0 3.9 5.2 6.3 9.2 8.6 6.2 8.7 4.6 4.8 4.3 5.8 4.8 5.8 3.8 4.8 6.2 4.8 16.6 7.4 8.3 3.3 4.8 2.8 3.7 10.4 6.1 4.2 7.6 4.2 7.7 8.7 2.6 5.3 16.6 3.7 4.5 3.1 0.9 7.0 3.3 3.8 6.1 4.3 12.6 3.1 0.2 0.1 1.2 1.9 0.4 3.9 1.5 1.0 1.8 0.2 1.2 0.9 1.2 0.6 2.0 0.9 0.4 0.3 0.7 12.7 13.3 12.9 20.1 12.9 12.9 13.1 13.1 13.2 12.6 12.9 14.3 0.8 0.0 3.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.0 1.8 3.7 0.0 1.1 2.1 0.0 0.0 1.3 0.0 1.3 1.2 0.9 0.0 0.0 0.0 1.3 0.6 0.8 0.0 2.4 0.0 0.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 3.1 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 1.0 0.5 0.0 0.0 FRAT2 ENSG00000181274 "FRAT regulator of WNT signaling pathway 2" O75474 10 97332497-97334729 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 4 "testis cancer: 70.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 15.0;neutrophil: 58.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 58.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049763 Uncertain Approved Nucleoplasm,Mitochondria No No "Cluster 9: Neutrophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Mitochondria "HPA049763: AB_2680868" "unprognostic (4.93e-2)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (4.04e-3)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.17e-3)" "unprognostic (2.60e-1)" "unprognostic (8.02e-2)" "unprognostic (4.60e-2)" "unprognostic (3.25e-2)" "prognostic favorable (2.55e-4)" "unprognostic (7.87e-3)" "unprognostic (4.83e-2)" "unprognostic (2.34e-1)" "unprognostic (9.08e-2)" 5.3 3.6 7.2 10.4 7.1 31.0 8.0 7.7 7.4 6.0 9.8 17.1 25.1 4.1 6.2 14.4 7.1 4.0 6.0 6.3 6.8 7.8 18.3 9.7 8.7 7.7 7.6 2.8 14.0 5.2 3.0 7.4 6.8 7.9 15.5 3.3 15.1 4.3 10.1 20.4 15.9 4.1 7.0 28.9 13.2 14.6 7.5 8.9 5.3 9.1 10.8 6.7 8.1 6.0 10.9 4.3 6.9 31.2 4.9 4.0 25.7 2.4 8.9 3.7 3.7 6.8 12.5 13.3 8.4 2.5 2.2 20.3 18.3 9.5 2.9 20.0 28.0 17.9 9.2 15.0 2.8 28.9 20.6 3.2 20.0 3.6 11.4 7.9 9.3 11.7 15.8 4.2 1.8 17.9 12.6 36.5 42.9 36.2 17.5 12.8 2.9 19.1 8.9 9.8 12.5 10.2 3.1 19.1 12.6 28.0 28.8 44.8 4.2 2.2 2.7 1.7 6.4 11.4 12.5 6.6 2.6 49.3 0.8 8.3 7.2 15.0 1.1 4.8 0.6 1.1 1.3 1.8 3.8 3.2 2.2 1.3 58.2 1.6 7.9 1.0 0.7 2.3 7.2 7.1 7.7 7.4 6.3 6.8 7.7 7.6 6.8 7.0 7.5 6.0 18.2 0.0 3.9 2.9 15.7 31.7 25.3 6.6 46.1 19.7 24.7 19.6 6.4 20.0 5.0 14.7 4.2 6.1 26.1 31.0 11.7 2.2 40.7 39.6 9.7 10.3 13.8 14.5 2.0 5.3 18.5 6.4 37.2 46.3 1.3 16.7 8.6 11.3 8.6 11.8 2.8 30.6 4.1 28.3 9.0 42.3 2.1 25.2 10.6 7.5 24.7 5.0 14.4 2.0 1.1 3.4 21.6 2.6 8.4 30.0 13.5 3.7 4.5 18.1 0.0 14.9 8.7 2.3 4.4 37.7 52.7 7.8 18.8 20.1 31.6 32.3 FUS "ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS" ENSG00000089280 "FUS RNA binding protein" P35637 16 31180138-31191605 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008784, CAB033036, CAB058691" Supported Supported Nucleoplasm NA NA 480000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181" "unprognostic (3.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.86e-2)" "unprognostic (8.68e-2)" "unprognostic (1.44e-1)" "unprognostic (8.03e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.22e-3)" "unprognostic (1.01e-1)" "unprognostic (1.01e-3)" "unprognostic (1.12e-3)" "unprognostic (1.87e-1)" "unprognostic (5.27e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 88.6 47.6 43.6 102.9 48.6 98.9 65.1 50.6 59.2 85.3 27.2 72.5 59.5 102.0 40.9 58.5 99.2 38.8 70.4 46.9 48.6 83.6 54.3 64.8 97.9 44.3 43.0 134.2 57.3 85.0 47.2 58.3 46.9 59.1 62.8 59.4 60.0 70.4 98.6 53.8 62.6 98.1 45.7 69.3 59.4 69.1 44.8 174.1 58.6 86.0 113.2 87.5 63.2 52.1 386.6 337.2 492.6 292.9 128.3 101.7 429.3 504.1 253.1 319.6 238.3 440.7 254.9 579.6 359.3 310.7 349.4 173.0 563.6 421.0 284.3 341.5 304.7 486.6 224.6 445.3 222.7 529.7 348.5 222.4 99.8 437.5 258.9 120.1 295.7 419.6 537.6 204.7 357.0 483.0 446.2 475.5 649.0 307.7 402.0 677.0 535.9 350.1 344.0 265.6 279.1 478.9 344.5 255.7 267.8 314.9 291.8 597.5 276.3 371.5 365.5 242.1 520.5 181.4 350.4 779.0 204.4 364.2 460.9 12.3 38.2 52.8 53.6 67.3 49.9 29.1 36.5 45.9 41.7 35.2 40.3 43.9 35.0 37.3 59.3 50.3 31.0 27.4 43.6 48.6 50.6 59.2 46.9 48.6 44.3 43.0 46.9 45.7 44.8 52.1 414.6 102.5 121.2 58.1 470.7 144.8 345.7 201.0 507.6 272.6 209.8 223.8 102.1 112.9 156.3 104.8 131.3 299.3 488.8 266.8 68.4 183.6 130.8 201.0 366.1 278.4 212.1 188.2 75.4 154.8 398.5 309.0 222.8 309.7 229.7 445.0 174.2 59.1 208.5 201.9 85.9 229.5 132.2 148.4 270.7 51.2 307.3 282.7 165.4 94.6 185.4 230.8 341.9 117.6 122.2 175.7 219.4 215.5 266.6 245.4 205.4 69.7 115.4 266.3 164.3 584.4 344.2 221.0 237.1 443.6 154.3 295.1 518.2 327.9 232.6 281.2 FYB1 "ADAP, FYB, FYB-120/130, SLAP-130" ENSG00000082074 "FYN binding protein 1" O15117 5 39105252-39274528 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 53.0;lymphoid tissue: 112.8" "Cell type enhanced" "Detected in many" "dendritic cells: 142.9;Extravillous trophoblasts: 88.7;Hofbauer cells: 157.0;Macrophages: 104.2;T-cells: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1670.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HEL: 61.5;JURKAT: 211.9;MOLT-4: 212.9;REH: 61.3;U-937: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025336, HPA026796, HPA067427" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 6200000 "Cluster 1: Neutrophils - Mixed function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane" Nucleoplasm "CAB025336: , HPA026796: AB_10964126, HPA067427: " "unprognostic (5.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (6.26e-2)" "unprognostic (4.08e-1)" "unprognostic (3.29e-2)" "unprognostic (2.60e-1)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (5.63e-2)" "unprognostic (5.35e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.40e-1)" "unprognostic (4.14e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-1)" 10.2 5.8 5.7 82.5 5.5 53.0 5.1 6.3 9.3 6.6 7.4 10.0 9.1 3.8 10.5 5.7 3.6 16.8 2.4 5.4 7.9 5.0 13.6 17.6 85.8 16.7 19.1 2.7 1.8 2.1 1.5 17.9 15.8 4.2 11.0 0.5 7.4 3.0 1.2 2.0 15.0 11.6 9.3 73.0 12.2 3.3 13.3 112.8 2.6 2.7 63.0 17.1 1.8 13.9 0.2 4.2 0.0 0.0 0.5 0.0 21.1 0.1 1.2 0.3 0.4 0.4 0.3 0.3 0.0 0.0 8.0 16.4 0.0 0.3 0.1 0.3 0.0 61.5 0.0 0.1 0.0 23.3 18.6 0.3 0.4 0.0 0.4 0.1 0.0 211.9 0.0 0.0 0.0 0.0 212.9 13.5 0.2 0.1 0.1 61.3 0.0 0.3 1.0 3.5 0.1 0.0 0.1 0.5 6.5 1.4 0.0 5.2 0.0 0.0 0.2 0.2 0.2 0.4 0.0 4.5 0.0 81.4 0.2 151.3 359.0 354.6 76.3 406.5 52.9 1.8 216.7 134.5 127.6 1.3 271.7 169.8 1670.8 89.9 483.9 30.8 231.5 400.1 5.7 5.5 6.3 9.3 5.4 7.9 16.7 19.1 15.8 9.3 13.3 13.9 4.4 16.0 24.7 0.0 6.2 0.0 0.0 0.0 0.0 0.0 3.2 7.6 0.0 0.0 5.6 14.7 0.0 28.8 142.9 0.0 9.8 0.4 0.0 0.7 1.1 4.3 0.0 0.0 0.0 0.0 88.7 3.8 0.0 1.0 15.2 0.1 0.0 0.0 157.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 35.9 3.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 40.2 119.3 0.1 0.0 0.0 GADD45B "DKFZP566B133, GADD45BETA, MYD118" ENSG00000099860 "Growth arrest and DNA damage inducible beta" O75293 19 2476122-2478259 "Predicted intracellular proteins" "Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1997.9;Breast myoepithelial cells: 1851.8;Smooth muscle cells: 1753.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 16.3" HPA029816 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA029816: AB_10601325" "unprognostic (1.32e-1)" "unprognostic (4.51e-2)" "unprognostic (3.94e-3)" "unprognostic (5.06e-2)" "unprognostic (1.53e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (2.95e-1)" "unprognostic (2.79e-1)" "unprognostic (4.37e-2)" "unprognostic (1.09e-3)" "unprognostic (3.90e-2)" "unprognostic (8.27e-3)" "unprognostic (6.00e-2)" 343.5 75.9 45.3 41.4 52.8 321.4 217.4 51.4 63.8 104.8 55.0 205.1 17.2 83.4 3.3 53.9 190.0 91.4 372.7 45.1 57.8 245.6 408.9 343.2 33.1 56.3 55.5 159.2 92.6 49.2 174.1 45.1 54.9 90.8 9.9 57.1 72.6 28.5 84.1 144.8 67.9 27.3 55.0 75.9 187.3 17.1 59.7 65.9 209.2 30.8 12.7 103.9 100.0 49.5 62.1 12.2 1.4 8.1 44.1 33.6 3.8 61.7 17.7 47.6 24.4 17.1 23.3 29.1 40.7 30.7 17.1 33.8 3.2 20.5 11.5 22.5 11.0 3.2 13.9 6.6 74.3 6.7 19.7 54.8 13.1 14.3 70.2 51.3 19.0 3.1 1.6 76.9 49.5 19.9 7.7 33.0 7.3 6.2 25.7 28.5 22.0 46.6 21.7 11.0 0.6 0.6 68.7 50.6 20.9 26.2 26.9 49.5 78.8 47.2 43.2 34.0 77.9 34.3 27.9 12.5 11.5 20.0 15.7 32.1 33.5 131.2 58.1 40.8 52.3 21.0 40.7 45.2 32.9 30.2 35.5 47.9 92.5 43.3 33.5 36.9 54.6 35.3 45.3 52.8 51.4 63.8 45.1 57.8 56.3 55.5 54.9 55.0 59.7 49.5 1997.9 423.1 571.3 24.5 450.9 341.7 805.4 147.3 376.2 11.9 666.3 1851.8 952.6 173.0 226.3 51.5 6.2 93.0 988.3 213.7 191.7 374.3 1.6 614.2 539.7 800.0 85.3 8.6 3.0 209.8 54.0 1143.0 400.1 1122.9 786.6 53.9 138.8 126.1 430.9 13.5 1.5 164.4 282.8 174.8 1169.6 4.7 74.0 863.0 517.6 1.9 157.1 269.8 33.0 0.5 0.9 292.5 309.0 29.3 416.8 823.3 294.3 142.1 211.4 34.2 177.5 818.8 1753.4 1.4 7.8 399.0 308.9 144.2 514.7 128.4 98.8 301.3 GATD1 "FLJ34283, PDDC1" ENSG00000177225 "Glutamine amidotransferase like class 1 domain containing 1" Q8NB37 11 767220-777488 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Alveolar cells type 2: 22.1;Collecting duct cells: 22.0;Theca cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 120.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008812 Uncertain Supported Nucleoplasm "Secreted to blood" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA008812: AB_10962724" "unprognostic (3.39e-1)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.03e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (3.50e-2)" "unprognostic (2.19e-1)" "unprognostic (5.67e-2)" "unprognostic (5.23e-3)" "unprognostic (4.89e-3)" "prognostic favorable (3.79e-5)" "unprognostic (2.84e-2)" "unprognostic (8.40e-2)" "unprognostic (6.11e-2)" "unprognostic (6.61e-3)" 15.9 37.5 37.7 11.3 35.8 7.9 16.7 35.1 37.8 22.7 36.6 23.3 15.4 24.9 12.6 23.7 22.7 7.3 16.3 37.4 36.5 24.0 19.3 15.4 11.2 46.4 41.8 25.9 15.9 10.5 30.1 9.2 35.8 23.0 6.5 9.7 17.5 12.2 14.4 21.0 18.2 7.9 38.4 19.6 17.8 18.6 45.3 8.8 22.0 6.5 6.8 19.7 20.4 37.5 41.3 22.3 22.2 23.9 10.2 15.6 20.9 24.2 10.5 22.0 19.3 15.8 62.5 22.1 8.6 16.0 23.2 42.7 16.7 21.6 11.0 28.1 120.5 13.0 38.8 36.0 17.5 25.4 27.8 22.4 23.2 9.3 14.2 19.9 17.1 25.8 34.2 20.0 12.4 11.0 29.3 27.5 21.3 13.4 42.8 31.4 15.1 28.0 19.2 9.1 56.9 22.3 22.9 32.0 16.6 5.7 28.5 16.8 31.3 23.2 17.5 12.7 18.8 23.4 12.9 28.4 35.4 33.9 19.6 1.0 5.2 0.9 2.9 6.6 2.1 2.7 3.0 2.9 6.9 2.3 2.4 1.7 0.5 1.2 2.6 4.0 1.4 2.0 37.7 35.8 35.1 37.8 37.4 36.5 46.4 41.8 35.8 38.4 45.3 37.5 8.7 44.8 22.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 11.9 10.4 0.0 0.0 7.4 22.0 0.0 13.8 5.2 0.0 5.9 10.3 0.0 11.8 15.2 3.8 0.0 0.0 0.0 7.6 7.9 8.5 0.0 9.6 6.3 19.2 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 16.6 0.0 0.0 1.3 0.0 0.0 14.7 7.3 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 9.6 3.9 25.8 0.0 0.0 GATD3A "C21orf33, D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI" ENSG00000160221 "Glutamine amidotransferase like class 1 domain containing 3A" P0DPI2 21 44133610-44210114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 178.6" "Cell type enhanced" "Detected in some" "Breast glandular cells: 7.0;Granulosa cells: 4.6;Hofbauer cells: 8.6;Proximal tubular cells: 4.8;Theca cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 156.3;U-266/70: 128.2;U-266/84: 117.9" HPA018517 Supported Approved Centrosome,Mitochondria "Intracellular and membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Mitochondria Centrosome "HPA018517: AB_2669899" "unprognostic (9.61e-3)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (1.71e-1)" "unprognostic (2.85e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-3)" "unprognostic (6.57e-2)" "unprognostic (8.19e-2)" "unprognostic (1.36e-2)" "unprognostic (8.61e-3)" "unprognostic (9.43e-2)" "unprognostic (4.60e-3)" "unprognostic (1.97e-3)" "unprognostic (1.40e-1)" "unprognostic (6.96e-2)" "unprognostic (1.30e-2)" 21.3 25.3 10.4 7.7 11.8 1.3 18.6 12.2 50.3 18.9 8.2 19.0 2.0 12.1 25.7 19.8 27.4 1.3 68.4 10.3 11.9 51.0 78.2 12.3 8.0 15.0 13.5 18.8 18.2 18.3 16.0 5.8 12.8 16.6 1.0 6.1 18.2 7.8 60.2 17.1 15.7 1.0 12.3 16.3 19.2 11.3 13.4 8.2 15.2 178.6 20.7 18.3 15.1 12.7 1.8 3.7 2.6 0.7 34.4 34.0 52.0 64.2 39.7 49.2 38.9 82.4 0.6 156.3 0.9 0.2 1.6 0.8 0.4 35.3 25.1 35.0 77.7 8.0 11.3 49.0 38.3 3.1 1.1 0.4 2.8 15.7 1.9 29.5 2.2 40.0 31.7 56.5 19.7 6.5 1.6 3.9 1.4 4.9 9.0 1.6 0.8 28.4 2.6 1.2 55.8 0.6 1.3 1.6 52.7 1.0 2.8 4.4 33.8 22.7 1.4 38.1 0.8 128.2 117.9 2.5 1.7 10.2 29.5 10.8 16.4 9.6 16.9 24.9 15.6 27.4 21.5 21.3 3.7 28.1 17.6 15.1 7.6 21.0 40.4 17.6 18.5 23.1 10.4 11.8 12.2 50.3 10.3 11.9 15.0 13.5 12.8 12.3 13.4 12.7 4.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 7.0 2.5 0.0 0.0 0.0 0.0 0.0 2.6 3.4 0.0 3.9 1.6 0.0 2.6 1.1 2.1 0.0 0.0 0.0 2.5 3.6 1.9 0.0 1.9 0.0 4.6 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 4.8 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.8 11.9 0.0 0.0 GCNA "ACRC, NAAR1" ENSG00000147174 "Germ cell nuclear acidic peptidase" Q96QF7 X 71578411-71613583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.0" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;dendritic cells: 6.9;Endometrial ciliated cells: 2.9;Glandular and luminal cells: 7.0;Plasma cells: 3.3;T-cells: 4.7;Theca cells: 4.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA023476, HPA030870" Enhanced Supported Nucleoplasm NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 78: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA023476: AB_1844530, HPA030870: " "unprognostic (6.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.43e-2)" "unprognostic (4.37e-3)" "unprognostic (1.39e-1)" "unprognostic (2.35e-4)" "unprognostic (5.84e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-1)" "unprognostic (1.68e-1)" "unprognostic (1.03e-2)" "unprognostic (2.06e-1)" "unprognostic (5.07e-10)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (4.74e-1)" "unprognostic (1.15e-5)" 1.9 4.6 4.1 1.3 4.5 1.3 1.4 5.1 8.1 2.0 3.7 1.5 0.8 1.3 0.9 1.3 1.5 0.7 1.9 4.5 4.7 2.2 2.6 2.4 1.9 4.8 3.8 1.8 2.5 0.2 2.0 0.4 4.4 1.8 0.7 2.2 1.3 0.4 4.2 1.4 2.4 0.7 3.4 4.9 1.8 11.0 4.1 1.1 2.2 1.2 1.0 1.5 1.7 4.8 0.3 0.5 1.1 1.0 2.2 2.0 0.6 1.8 1.0 0.6 1.0 1.0 0.7 2.9 1.4 1.0 0.6 1.4 2.2 0.1 0.9 0.5 1.5 0.6 2.8 0.3 0.6 0.5 2.6 0.8 3.5 0.5 0.5 2.3 0.4 2.2 0.8 1.8 1.3 0.3 0.2 2.1 1.1 1.3 1.3 0.5 0.0 2.1 1.4 0.8 0.6 0.1 0.6 0.3 1.6 1.1 0.2 1.8 0.7 0.7 1.3 0.9 0.5 0.5 1.4 1.1 1.2 1.1 1.1 0.2 0.1 0.0 0.1 0.1 0.3 0.3 0.4 0.8 0.1 0.1 0.2 0.2 0.2 0.3 0.0 0.1 0.8 0.1 4.1 4.5 5.1 8.1 4.5 4.7 4.8 3.8 4.4 3.4 4.1 4.8 1.8 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.0 2.8 0.0 0.0 0.0 3.7 0.0 0.0 6.9 0.0 0.0 0.8 0.0 2.9 1.5 0.5 0.0 0.0 0.0 1.0 0.1 0.9 0.0 7.0 2.5 2.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 4.7 4.0 0.0 0.0 GLA GALA ENSG00000102393 "Galactosidase alpha" P06280 X 101393273-101408012 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 229.9;Plasma cells: 171.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 328.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000237, HPA000966" Enhanced "Intracellular and membrane" NA NA 1300000 "Cluster 7: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "HPA000237: AB_1078968, HPA000966: AB_1078969" "unprognostic (7.27e-3)" "unprognostic (1.47e-2)" "unprognostic (1.57e-2)" "unprognostic (2.94e-1)" "unprognostic (1.60e-1)" "unprognostic (3.15e-2)" "prognostic unfavorable (5.62e-5)" "unprognostic (2.53e-1)" "unprognostic (3.42e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (3.27e-2)" "unprognostic (2.73e-2)" "prognostic favorable (6.16e-4)" "unprognostic (1.13e-1)" "unprognostic (5.44e-2)" "unprognostic (2.21e-1)" 15.6 21.5 5.2 12.7 5.4 25.1 26.7 6.6 6.9 13.8 6.2 13.0 22.4 10.9 17.5 9.3 15.2 11.8 9.9 5.6 6.2 15.6 12.7 17.2 13.2 7.0 7.3 9.2 6.7 31.7 9.9 22.1 7.3 7.9 15.3 6.9 10.0 39.3 6.2 9.2 13.5 15.4 6.5 13.2 9.3 3.8 6.9 12.0 7.9 6.5 15.6 14.7 9.1 8.1 30.5 117.9 30.8 31.9 68.9 26.8 13.8 34.1 51.9 63.5 176.3 64.7 45.9 33.6 70.0 35.3 151.8 70.3 65.9 38.3 53.8 19.3 47.1 18.3 87.9 78.4 19.2 26.7 328.1 24.3 11.3 72.9 21.6 17.4 50.9 18.2 28.6 71.2 60.8 52.3 24.4 53.7 48.2 72.5 46.4 18.2 39.5 81.5 95.1 61.9 11.5 19.4 78.6 34.6 30.9 54.4 15.2 51.2 29.9 20.7 23.8 52.6 27.0 23.0 26.3 25.4 36.9 39.9 23.1 22.5 37.3 11.9 6.9 38.5 9.0 8.8 5.6 8.8 29.8 9.0 5.6 6.9 21.6 5.6 40.6 10.9 7.3 20.4 5.2 5.4 6.6 6.9 5.6 6.2 7.0 7.3 7.3 6.5 6.9 8.1 31.5 16.0 10.2 3.3 65.8 30.2 32.6 23.7 45.5 4.0 34.0 23.2 7.7 4.3 19.3 11.0 6.2 38.4 25.5 26.5 17.6 22.5 3.9 57.6 19.5 30.8 33.9 12.6 3.2 18.7 26.3 66.1 39.8 97.6 31.0 9.6 8.9 7.1 93.0 8.4 3.9 15.9 20.3 28.5 229.9 0.9 11.1 115.7 88.9 4.7 30.3 17.5 14.4 3.0 3.9 14.4 25.3 18.0 171.4 20.5 30.9 9.5 29.9 5.3 6.6 22.6 70.8 6.4 5.8 31.0 23.7 75.5 33.2 19.8 19.2 27.9 GNAI2 "GIP, GNAI2B" ENSG00000114353 "G protein subunit alpha i2" P04899 3 50226292-50259362 "Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 656.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007704 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 4000000 "Cluster 52: Eosinophils - Transcription" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Cytosol "Nucleoplasm, Plasma membrane" "HPA007704: AB_1849230" "prognostic favorable (1.03e-4)" "unprognostic (3.89e-1)" "unprognostic (3.35e-2)" "unprognostic (8.40e-3)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (2.59e-2)" "unprognostic (3.23e-1)" "unprognostic (1.08e-3)" "unprognostic (6.01e-2)" "unprognostic (7.00e-3)" "unprognostic (1.12e-1)" "unprognostic (6.24e-3)" "unprognostic (1.44e-1)" "unprognostic (4.30e-2)" "unprognostic (4.33e-2)" "unprognostic (1.38e-1)" 210.2 100.3 155.2 217.9 167.3 367.1 152.8 166.3 181.6 146.0 120.2 142.1 69.9 141.7 66.9 124.4 136.9 152.5 157.1 144.3 184.6 79.4 126.5 214.5 251.3 199.8 170.2 147.7 64.1 66.9 99.2 241.8 194.8 103.6 64.3 35.6 71.9 156.9 69.3 87.0 103.0 154.0 173.6 262.1 73.6 69.6 173.3 160.3 101.3 89.4 170.4 169.7 108.4 193.2 128.2 63.0 186.3 197.6 220.7 277.5 35.5 271.1 399.6 354.9 361.1 70.4 173.2 149.1 119.2 567.0 193.4 100.1 132.8 350.3 222.8 331.2 50.9 364.8 158.0 110.2 219.8 329.2 479.8 270.3 152.9 319.1 129.8 289.6 837.8 124.1 26.1 307.1 357.5 155.7 313.6 433.0 109.7 59.0 302.4 185.0 89.8 219.7 232.6 130.9 48.4 86.1 189.5 57.1 124.4 150.4 94.3 346.1 792.3 330.9 187.5 309.2 274.7 199.4 278.3 127.0 373.6 466.9 398.1 16.6 59.3 113.7 33.7 80.9 20.2 28.8 26.8 34.3 57.3 26.1 20.2 25.8 145.2 23.5 74.5 47.2 34.0 27.3 155.2 167.3 166.3 181.6 144.3 184.6 199.8 170.2 194.8 173.6 173.3 193.2 656.8 41.7 32.1 25.1 119.5 56.7 59.7 32.3 45.5 29.0 61.6 83.8 22.9 55.8 26.6 44.1 14.6 79.5 311.4 11.7 5.9 124.3 203.3 57.8 115.7 340.3 92.2 52.1 12.4 60.5 84.4 101.9 21.9 71.8 89.9 150.0 221.3 79.7 336.0 6.7 14.8 24.6 18.3 342.7 291.7 302.0 90.7 386.1 83.6 58.1 356.6 292.6 151.4 26.7 45.4 160.3 40.9 95.5 104.8 46.1 30.3 24.5 24.4 21.9 52.6 85.3 163.1 16.6 22.6 37.6 62.9 116.4 164.9 156.3 20.5 70.1 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease variant, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 1886.1;Late spermatids: 1756.9;Skeletal myocytes: 1998.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 39: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favorable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 784.8 1215.3 1564.4 512.6 1524.7 887.4 578.9 1413.1 1768.3 828.5 1373.3 657.1 492.4 611.4 1253.8 883.1 742.9 672.7 1990.6 1557.3 2716.9 625.0 651.1 640.3 769.2 1710.5 1949.4 766.5 1917.7 1799.4 1153.6 884.6 1963.4 577.3 607.3 731.2 2943.9 594.4 2400.4 526.8 527.3 782.4 1598.4 606.6 587.1 357.9 1882.0 854.4 3432.2 2813.1 800.0 687.1 239.3 1483.9 215.6 897.3 1501.9 663.3 2691.8 1822.3 1200.1 1219.1 1635.0 1937.3 1201.8 2480.5 1446.7 911.9 1670.3 2314.3 1305.6 976.1 1499.0 2195.3 1540.9 401.4 784.6 984.9 1651.7 2232.7 1420.7 641.6 483.0 1566.4 1113.6 875.1 1399.1 1561.0 1669.7 1100.6 692.0 1294.6 1319.1 4131.0 1759.5 1452.8 487.9 214.0 894.4 1436.7 1287.3 1589.4 2165.5 1315.8 1818.3 3853.2 2157.6 2117.1 1354.2 1921.8 1570.0 1581.7 1343.3 2210.2 1477.0 688.5 1452.3 1314.0 993.3 1583.2 900.0 473.7 1107.1 217.9 96.7 114.2 68.9 127.3 80.0 103.2 73.4 74.8 129.2 93.6 65.8 82.6 103.4 95.6 150.3 174.9 92.7 100.9 1564.4 1524.7 1413.1 1768.3 1557.3 2716.9 1710.5 1949.4 1963.4 1598.4 1882.0 1483.9 982.6 221.2 258.8 192.0 310.8 130.4 182.0 130.0 205.5 397.8 465.6 684.4 1025.3 237.4 212.2 261.1 56.3 832.6 390.8 357.3 444.1 233.9 734.9 487.7 515.7 518.3 463.1 252.1 232.5 228.9 342.0 380.9 196.3 685.0 138.6 542.3 380.1 256.4 379.1 1886.1 439.7 327.2 181.0 380.4 405.7 1756.9 265.3 437.1 222.3 236.1 204.0 1367.2 137.0 194.5 166.6 339.9 300.0 197.1 309.7 268.1 273.7 153.6 218.0 222.0 210.4 1998.0 560.4 226.0 73.6 240.5 117.8 1211.7 301.8 860.9 304.4 316.5 GPR174 FKSG79 ENSG00000147138 "G protein-coupled receptor 174" Q9BXC1 X 79144688-79175318 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 16.9" "Cell type enhanced" "Detected in some" "B-cells: 6.6;dendritic cells: 30.6;Plasma cells: 4.2;T-cells: 18.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "JURKAT: 42.3;MOLT-4: 75.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041025, HPA058306" Enhanced Supported "Vesicles,Plasma membrane,Centriolar satellite" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane" "Vesicles, Centriolar satellite" "HPA041025: AB_10794260, HPA058306: " "unprognostic (6.38e-3)" "unprognostic (9.87e-3)" "unprognostic (4.36e-2)" "unprognostic (1.18e-2)" "unprognostic (1.84e-1)" "unprognostic (8.48e-4)" "unprognostic (7.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.75e-1)" "unprognostic (2.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.05e-1)" "unprognostic (6.53e-5)" "unprognostic (2.27e-1)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "unprognostic (1.78e-2)" 0.8 0.4 0.5 6.9 0.3 2.5 0.9 0.6 0.6 0.4 0.3 1.0 2.0 0.5 0.6 0.3 0.3 1.1 0.3 0.4 0.4 0.5 1.0 1.9 15.2 0.7 0.5 0.2 0.1 0.1 0.1 0.2 0.7 0.7 1.6 0.2 1.5 0.1 0.2 0.2 3.6 0.3 0.3 8.1 2.1 0.1 0.4 16.9 0.9 0.1 10.4 1.4 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.3 0.0 1.2 0.0 0.0 75.1 0.1 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.2 0.0 0.0 0.0 6.5 0.0 3.6 3.6 2.0 1.2 2.5 4.8 6.1 0.1 2.6 4.2 4.9 0.3 4.6 5.5 1.0 4.8 1.6 0.5 0.3 0.6 0.6 0.4 0.4 0.7 0.5 0.7 0.3 0.4 0.5 0.7 0.0 2.4 0.0 6.6 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.6 1.8 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 18.5 0.1 0.0 0.0 GRK2 "ADRBK1, BARK1" ENSG00000173020 "G protein-coupled receptor kinase 2" P25098 11 67266473-67286556 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 197.1" "Cell type enhanced" "Detected in many" "Adipocytes: 33.4;dendritic cells: 80.2;Hofbauer cells: 35.8;Macrophages: 37.6;Pancreatic endocrine cells: 32.4;T-cells: 31.0;Theca cells: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 318.0;REH: 417.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005021, CAB037248, HPA060707" Enhanced Approved Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 14: REH - Unknown function" "Cluster 7: Non-specific - Mitochondria" Cytosol "CAB005021: AB_562360, CAB037248: AB_1078280, HPA060707: " "unprognostic (5.58e-2)" "unprognostic (1.75e-1)" "unprognostic (2.01e-2)" "unprognostic (5.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.29e-3)" "unprognostic (3.31e-2)" "unprognostic (6.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-2)" "unprognostic (2.22e-1)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (3.66e-1)" "unprognostic (2.40e-1)" "unprognostic (4.04e-2)" "unprognostic (5.19e-3)" 41.2 35.6 42.4 73.0 42.7 197.1 38.0 31.6 63.8 41.3 16.9 54.3 38.2 34.7 10.4 68.1 41.6 28.8 49.1 44.4 32.5 38.6 47.4 64.1 102.4 36.4 31.6 30.1 33.1 16.2 37.5 25.5 36.5 59.1 33.3 7.9 47.1 22.8 55.6 68.3 88.7 25.1 29.1 186.8 45.4 24.1 36.9 74.7 32.2 40.9 77.8 41.3 47.4 41.8 43.1 29.8 28.1 48.0 22.2 19.9 28.7 24.7 23.4 33.0 27.4 67.1 69.0 215.3 39.5 23.0 44.0 56.7 41.3 33.5 17.2 264.4 26.3 122.5 35.4 30.8 27.9 259.5 238.3 18.0 38.2 26.5 34.8 24.4 42.8 87.7 45.3 107.7 29.0 80.7 147.5 318.0 35.3 125.8 44.4 417.0 55.3 65.2 34.0 54.6 57.0 30.8 36.9 52.9 90.5 16.9 49.7 283.0 24.5 26.7 34.8 33.6 28.4 69.2 67.5 195.3 34.0 153.6 24.6 12.6 17.8 19.2 8.4 27.6 6.3 6.1 6.3 7.0 10.2 6.4 5.0 4.9 35.7 6.9 33.7 9.0 4.4 15.9 42.4 42.7 31.6 63.8 44.4 32.5 36.4 31.6 36.5 29.1 36.9 41.8 33.4 3.2 17.9 0.0 16.7 0.0 0.0 0.0 0.0 0.0 24.5 19.7 0.0 0.0 4.3 5.5 0.0 8.9 80.2 0.0 1.9 10.3 0.0 16.6 14.7 9.0 0.0 0.0 0.0 12.6 5.9 6.1 0.0 18.9 21.5 22.3 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.6 0.0 0.0 8.8 0.0 0.0 0.0 0.0 32.4 0.0 0.0 17.7 0.0 0.0 5.6 0.7 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 9.6 31.0 36.3 0.0 0.0 GSK3A ENSG00000105723 "Glycogen synthase kinase 3 alpha" P49840 19 42226225-42242625 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase" "Alzheimer disease, Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004422, HPA028423" Approved Approved Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "CAB004422: AB_627680, HPA028423: AB_10612116" "unprognostic (5.46e-2)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.02e-4)" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (3.80e-3)" "unprognostic (2.27e-1)" "unprognostic (2.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.36e-1)" "unprognostic (2.69e-1)" "unprognostic (2.77e-2)" "unprognostic (4.49e-2)" "unprognostic (7.22e-2)" "unprognostic (8.22e-3)" 30.6 43.3 37.5 22.1 44.0 30.7 29.4 33.6 90.2 34.5 13.7 39.4 40.9 38.1 21.7 40.2 31.8 18.7 45.8 47.0 30.9 39.2 30.4 30.4 23.7 39.1 30.9 34.5 29.6 34.4 32.1 19.9 37.6 33.3 21.1 32.6 31.7 25.9 79.2 42.9 37.1 23.0 20.5 31.2 35.4 30.6 38.2 32.9 29.6 42.0 22.7 37.7 33.0 49.5 57.0 102.1 54.3 53.2 30.3 29.5 25.9 42.7 36.1 49.6 46.0 39.0 39.6 41.0 39.6 33.9 44.8 25.6 49.5 51.3 38.5 33.8 74.5 41.5 41.3 42.7 42.7 51.7 54.0 27.2 45.8 41.9 47.7 44.8 46.5 34.7 73.9 63.0 41.1 80.0 87.7 39.0 42.8 84.5 40.0 58.4 33.8 30.4 43.4 76.1 63.7 67.5 52.8 71.6 36.6 42.8 39.5 69.5 40.6 52.0 40.9 31.0 71.9 65.8 82.8 38.7 66.4 49.8 58.2 0.9 0.5 1.4 0.5 0.8 0.9 0.3 0.3 0.7 0.2 0.2 0.2 0.8 1.7 0.3 0.4 0.6 0.5 0.7 37.5 44.0 33.6 90.2 47.0 30.9 39.1 30.9 37.6 20.5 38.2 49.5 45.6 6.4 16.2 5.2 16.4 24.6 17.7 7.3 14.8 40.8 35.0 39.2 12.9 17.2 7.9 16.5 62.6 23.4 31.4 42.3 3.9 15.2 8.6 19.6 21.5 26.6 23.4 28.6 15.1 17.2 25.3 21.3 16.8 25.0 2.5 27.2 18.2 13.9 20.3 60.6 14.9 29.7 6.1 21.3 15.4 14.6 17.7 25.2 16.0 8.4 14.4 41.8 21.6 11.1 12.2 24.2 24.3 16.6 12.6 29.0 45.0 16.0 5.9 47.0 6.6 50.4 27.4 16.4 19.4 20.2 28.1 44.1 20.6 42.6 28.8 30.1 GTF2B TFIIB ENSG00000137947 "General transcription factor IIB" Q00403 1 88852633-88891944 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061626 Supported Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" "HPA061626: AB_2684570" "prognostic favorable (4.81e-4)" "unprognostic (5.21e-2)" "unprognostic (3.94e-3)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" "unprognostic (2.43e-1)" "unprognostic (1.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.37e-3)" "unprognostic (3.37e-1)" "unprognostic (1.37e-2)" "unprognostic (3.13e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.06e-3)" "unprognostic (3.74e-2)" 25.3 26.4 14.8 18.8 15.7 62.2 28.3 16.4 24.0 22.9 17.7 22.6 17.9 21.8 30.3 26.3 22.7 23.8 15.7 15.5 16.5 22.9 32.6 22.0 28.9 15.5 15.9 26.3 23.3 22.7 20.3 25.2 15.7 18.1 23.1 17.9 22.9 16.3 23.1 28.3 23.9 20.7 16.2 28.7 23.0 16.3 15.1 40.2 21.2 18.5 31.3 31.5 23.7 17.0 40.0 13.6 34.6 18.8 49.8 34.4 42.9 32.1 39.4 44.1 46.4 17.9 24.3 45.5 37.8 28.0 53.3 22.0 36.8 32.1 38.3 42.8 34.3 48.6 21.2 32.1 31.9 56.8 28.7 30.0 32.1 38.2 21.7 33.4 25.1 41.1 43.1 33.6 47.0 12.6 54.9 46.7 28.8 35.4 29.3 34.4 46.8 34.2 47.0 47.2 26.7 22.4 28.5 35.4 57.8 30.7 15.9 51.1 22.3 19.2 24.0 35.0 38.8 35.1 29.9 62.6 12.8 48.8 16.7 91.2 49.3 82.1 45.9 57.1 53.2 57.8 52.1 50.5 62.5 48.2 62.9 53.9 99.7 54.9 60.4 40.5 70.1 50.9 14.8 15.7 16.4 24.0 15.5 16.5 15.5 15.9 15.7 16.2 15.1 17.0 106.6 6.4 29.7 13.7 114.9 46.3 75.4 63.3 58.6 14.6 39.7 104.9 12.3 21.5 45.6 11.0 2.1 74.0 122.3 39.1 39.2 49.2 22.9 53.9 28.4 30.3 20.3 51.1 22.7 38.6 60.0 53.0 41.8 29.8 48.9 30.2 16.8 17.6 40.5 18.5 21.4 30.5 52.9 32.3 42.5 7.9 36.4 93.4 28.4 22.5 40.3 30.7 33.0 18.1 25.2 49.9 70.5 29.3 74.3 27.8 26.9 47.4 55.2 18.5 13.1 86.6 65.0 24.2 29.0 40.1 50.0 150.1 122.8 34.5 22.7 79.4 GZF1 "dJ322G13.2, ZBTB23, ZNF336" ENSG00000125812 "GDNF inducible zinc finger protein 1" Q9H116 20 23362182-23373062 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024520 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 32: T-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA024520: AB_10963938" "unprognostic (3.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.81e-7)" "unprognostic (8.98e-2)" "unprognostic (2.66e-1)" "unprognostic (8.70e-2)" "unprognostic (3.88e-2)" "unprognostic (1.92e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-1)" 5.9 18.7 9.6 5.5 10.4 31.5 5.0 11.1 10.9 6.0 9.2 6.5 3.9 6.5 5.3 4.4 6.5 5.5 12.4 9.4 9.8 7.7 6.4 6.0 5.2 10.0 12.8 9.2 5.2 6.7 7.9 6.4 9.9 5.9 4.1 10.5 5.0 6.8 9.4 4.7 4.8 5.7 10.6 5.3 5.4 13.3 11.7 5.5 7.0 8.1 4.4 5.8 4.6 10.4 8.2 14.2 8.9 9.0 10.3 10.0 7.1 9.8 9.0 9.9 9.2 10.9 6.4 16.6 8.5 8.5 19.3 14.3 10.3 13.2 11.2 2.8 6.7 15.4 6.0 14.7 13.4 9.3 9.0 10.1 9.6 10.7 16.3 13.8 6.7 11.4 10.6 25.2 14.3 10.9 14.5 11.6 6.6 11.5 19.3 9.5 21.3 11.6 7.4 8.2 13.7 7.8 8.7 15.4 20.9 7.3 10.2 13.4 8.7 16.0 9.2 12.1 10.6 20.5 9.0 14.4 4.7 41.8 8.8 0.0 1.6 0.8 0.7 0.9 0.5 1.0 1.0 1.0 1.6 0.6 0.9 1.0 1.2 0.5 1.2 1.3 0.3 0.9 9.6 10.4 11.1 10.9 9.4 9.8 10.0 12.8 9.9 10.6 11.7 10.4 9.8 6.4 9.6 5.5 12.6 10.8 3.1 3.8 8.6 12.6 6.0 6.9 19.7 1.5 4.7 3.7 18.8 4.9 8.7 3.9 7.9 3.6 18.9 10.4 9.7 8.4 5.4 4.0 6.6 3.3 3.2 8.3 7.1 17.8 13.9 8.2 2.2 5.2 8.7 6.7 7.6 4.2 4.1 13.2 28.8 27.5 9.3 23.9 1.8 1.0 2.5 10.3 5.2 4.5 5.6 4.0 4.6 8.2 11.6 3.2 2.8 3.8 7.7 13.4 0.0 8.8 11.5 20.7 8.9 7.6 8.4 5.6 7.9 14.0 3.7 1.8 HDGFL2 "Hdgfrp2, HRP2" ENSG00000167674 "HDGF like 2" Q7Z4V5 19 4472297-4502208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 37.0;Endometrial stromal cells: 31.0;Extravillous trophoblasts: 30.1;Granulosa cells: 44.7;Theca cells: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 5.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042559, HPA044208" Enhanced Supported Nucleoplasm,Mitochondria No No "Cluster 24: B-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Mitochondria "HPA042559: AB_2678049, HPA044208: AB_2678858" "unprognostic (1.33e-1)" "unprognostic (2.38e-2)" "unprognostic (5.47e-3)" "unprognostic (6.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.96e-2)" "unprognostic (1.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "prognostic favorable (6.57e-4)" "unprognostic (2.12e-2)" "unprognostic (1.36e-1)" "unprognostic (9.73e-3)" "unprognostic (4.75e-1)" "unprognostic (1.58e-1)" "unprognostic (2.05e-1)" 27.2 29.0 24.8 16.5 25.5 14.4 28.1 24.2 32.3 42.9 17.8 40.4 15.7 39.3 9.6 29.4 35.6 10.0 32.0 27.4 20.5 31.2 31.3 25.4 17.7 22.9 22.2 49.5 26.9 12.5 38.3 15.0 22.0 36.4 7.6 10.8 26.0 18.6 67.8 29.3 27.0 12.6 19.7 33.4 28.1 74.6 22.2 18.6 29.3 19.1 11.8 34.2 34.8 24.6 71.6 41.2 70.1 65.5 29.9 30.3 49.0 56.2 30.1 60.4 53.3 47.5 30.4 62.6 32.1 41.6 31.8 40.2 46.9 51.1 35.2 70.4 74.7 38.6 32.4 63.5 38.5 38.3 52.8 43.5 27.4 41.6 20.2 42.8 55.9 57.8 45.1 76.3 29.6 50.6 86.9 76.4 80.2 28.5 73.3 85.4 57.6 40.6 38.0 35.8 77.0 76.1 54.7 31.0 47.2 38.1 30.6 60.2 74.8 38.0 51.7 72.3 54.1 94.1 52.9 43.6 53.2 60.8 41.1 0.0 0.9 1.7 0.6 0.6 0.1 0.5 0.7 0.5 0.7 5.6 1.1 0.4 0.2 1.3 0.3 1.0 1.0 0.5 24.8 25.5 24.2 32.3 27.4 20.5 22.9 22.2 22.0 19.7 22.2 24.6 25.5 6.4 5.4 0.0 2.3 0.0 0.0 0.0 0.0 0.0 13.3 15.2 0.0 0.0 5.0 12.9 0.0 37.0 14.3 0.0 19.6 26.4 0.0 26.9 31.0 9.8 0.0 0.0 0.0 19.8 30.1 13.9 0.0 19.8 1.3 44.7 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 15.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 2.3 0.0 0.0 23.6 9.5 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 15.2 7.1 42.7 0.0 0.0 HDGFL3 "Hdgfrp3, HRP-3" ENSG00000166503 "HDGF like 3" Q9Y3E1 15 83112738-83207823 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 96.9;Breast glandular cells: 34.3;Endometrial ciliated cells: 34.2;Endometrial stromal cells: 48.4;Granulosa cells: 41.4;Theca cells: 48.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 1.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040719 Approved Supported Nucleoplasm NA NA "Cluster 11: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA040719: AB_2677097" "unprognostic (1.28e-3)" "unprognostic (1.13e-1)" "unprognostic (3.52e-2)" "unprognostic (3.38e-2)" "unprognostic (1.53e-1)" "unprognostic (2.55e-2)" "unprognostic (1.91e-2)" "unprognostic (2.95e-2)" "unprognostic (2.99e-2)" "unprognostic (4.68e-2)" "unprognostic (1.93e-3)" "unprognostic (3.39e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-2)" "unprognostic (3.55e-1)" "unprognostic (1.25e-1)" "unprognostic (1.85e-1)" 6.3 5.9 11.1 2.9 12.0 2.4 5.6 11.6 14.9 5.0 7.2 7.0 1.2 6.0 8.3 3.6 4.7 4.0 5.7 11.8 11.5 4.8 0.8 5.1 2.9 10.5 10.5 5.0 1.7 17.7 6.8 3.0 10.5 4.9 2.6 8.5 2.4 4.6 2.5 2.0 2.9 5.3 11.1 3.4 2.9 9.7 11.8 4.3 6.5 2.5 2.2 5.6 3.8 10.7 7.2 6.2 17.9 9.3 7.4 10.1 5.9 6.7 11.9 7.0 7.3 0.5 13.2 0.1 8.0 1.8 7.5 2.9 19.9 10.3 10.1 33.5 10.2 11.6 3.0 0.1 10.3 0.4 1.8 6.0 8.4 8.0 13.9 10.8 17.0 12.4 9.0 0.3 13.2 7.4 7.1 0.7 13.3 0.0 3.5 0.1 17.4 0.1 10.5 14.6 22.5 17.1 10.1 2.4 8.9 12.9 2.8 1.3 14.7 14.5 10.8 3.0 20.9 2.1 0.8 8.6 6.7 5.5 10.0 0.7 0.3 1.0 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.8 1.8 0.1 0.2 0.0 0.1 11.1 12.0 11.6 14.9 11.8 11.5 10.5 10.5 10.5 11.1 11.8 10.7 96.9 12.8 17.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 34.3 27.3 0.0 0.0 10.5 20.2 0.0 0.3 14.1 0.0 15.6 21.1 0.0 34.2 48.4 25.8 0.0 0.0 0.0 22.9 0.6 15.4 0.0 25.6 5.1 41.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 23.6 0.0 0.0 3.1 0.0 0.0 0.3 9.5 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.3 3.5 48.1 0.0 0.0 HDHD5 CECR5 ENSG00000069998 "Haloacid dehalogenase like hydrolase domain containing 5" Q9BXW7 22 17137511-17165287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 43.0;Ductal cells: 35.2;Extravillous trophoblasts: 42.2;Granulosa cells: 37.0;Hofbauer cells: 42.3;Proximal tubular cells: 41.1;Theca cells: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005548 Approved Approved Mitochondria "Intracellular and membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA005548: AB_1078497" "unprognostic (4.04e-2)" "unprognostic (5.04e-2)" "unprognostic (4.54e-3)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.71e-2)" "unprognostic (1.04e-3)" "unprognostic (7.35e-2)" "unprognostic (1.70e-1)" "unprognostic (4.98e-2)" "unprognostic (5.76e-2)" "unprognostic (2.35e-1)" "unprognostic (1.10e-1)" "unprognostic (7.07e-3)" "unprognostic (1.71e-1)" "unprognostic (1.20e-2)" "unprognostic (7.21e-3)" 17.4 29.7 15.0 13.2 15.3 16.5 17.3 15.4 15.7 12.9 16.7 21.5 26.5 14.6 6.8 21.7 13.6 9.8 45.0 15.4 14.8 19.8 40.5 12.6 14.5 15.4 14.9 12.2 20.9 17.5 11.6 8.1 14.6 15.5 14.1 5.7 18.6 10.0 46.9 23.0 17.2 11.4 14.8 19.3 19.9 15.9 15.9 13.6 10.1 55.7 12.0 16.5 14.1 15.0 64.0 41.5 30.5 41.5 17.7 10.8 38.8 17.9 19.6 47.1 50.2 61.1 23.3 103.9 29.3 21.6 23.0 44.0 38.7 42.0 21.8 31.6 56.7 0.0 30.7 0.0 29.4 47.6 23.5 26.1 51.1 21.0 23.1 26.4 33.3 67.4 31.0 26.2 24.9 62.1 84.2 97.2 46.6 97.9 36.7 47.4 45.8 26.3 32.2 34.7 61.4 46.5 34.9 49.9 54.3 23.9 50.1 58.5 29.1 39.7 29.4 28.2 31.3 41.3 48.5 77.8 32.0 0.1 34.2 12.3 86.2 4.7 28.4 56.7 35.6 24.6 26.4 25.8 74.5 23.6 34.3 29.3 4.5 30.7 31.4 30.9 29.7 48.0 15.0 15.3 15.4 15.7 15.4 14.8 15.4 14.9 14.6 14.8 15.9 15.0 21.5 6.4 2.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 23.9 22.4 0.0 0.0 5.0 5.5 0.0 26.5 9.3 0.0 43.0 35.2 0.0 8.4 14.9 9.2 0.0 0.0 0.0 28.2 42.2 7.7 0.0 11.5 5.1 37.0 0.0 0.0 42.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 5.2 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.5 0.0 0.0 41.1 1.5 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 15.7 3.4 55.8 0.0 0.0 HEXIM1 "CLP-1, EDG1, HIS1, MAQ1" ENSG00000186834 "HEXIM P-TEFb complex subunit 1" O94992 17 45148475-45152099 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 467.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008926, CAB011625" Supported Enhanced Nucleoplasm,Vesicles NA NA "Cluster 10: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB011625: AB_2233058, HPA008926: AB_1079048" "unprognostic (2.82e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (2.39e-1)" "unprognostic (2.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (2.89e-3)" "unprognostic (1.26e-2)" 16.8 32.6 16.3 13.2 15.4 36.3 17.0 16.2 16.5 17.2 16.5 22.5 17.7 19.6 15.9 24.2 21.3 14.3 15.0 14.8 16.8 21.1 26.8 17.3 12.8 17.0 19.1 14.4 19.7 14.1 19.2 25.2 16.0 24.2 10.2 9.0 19.2 19.8 33.2 22.6 24.9 13.0 17.7 25.6 23.1 21.6 19.7 15.4 20.1 21.6 12.4 19.7 17.6 14.2 35.7 111.1 22.8 33.0 36.7 19.6 55.3 30.9 27.8 25.0 27.8 52.6 49.3 15.5 93.1 32.7 12.1 28.2 13.8 30.4 20.0 32.2 32.9 48.2 65.8 65.0 32.0 30.3 61.4 23.0 25.5 18.6 8.1 62.6 12.7 26.8 21.5 36.6 19.0 47.8 31.9 34.9 20.9 32.9 33.4 13.1 19.9 19.2 66.5 62.1 12.2 9.2 46.6 52.0 52.2 23.0 54.2 23.5 24.3 25.1 34.6 14.6 58.5 33.1 11.4 10.0 23.0 28.1 29.1 16.2 4.0 6.8 4.2 6.1 2.4 3.0 4.2 3.7 3.3 3.2 3.7 3.9 10.0 3.7 7.3 3.4 3.8 2.2 16.3 15.4 16.2 16.5 14.8 16.8 17.0 19.1 16.0 17.7 19.7 14.2 210.3 73.7 111.8 7.2 76.1 84.5 75.0 57.7 157.1 25.1 127.0 215.9 59.7 87.2 60.5 25.8 22.9 134.8 114.3 250.4 7.9 35.0 2.2 88.8 66.1 91.3 52.8 82.1 10.7 23.6 70.1 99.2 94.3 137.9 125.9 16.5 42.5 40.5 42.1 15.2 12.9 122.0 54.9 33.9 83.2 3.0 35.1 83.0 53.4 9.4 38.4 27.7 28.8 7.1 8.2 25.3 127.1 43.6 44.1 52.1 184.9 53.8 45.7 24.8 26.3 249.2 128.2 2.6 7.9 126.7 71.5 467.5 111.1 16.9 92.2 34.4 HIKESHI "C11orf73, HSPC138, HSPC179, OPI10" ENSG00000149196 "Heat shock protein nuclear import factor hikeshi" Q53FT3 11 86302211-86345943 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 129.6;Extravillous trophoblasts: 146.2;Hofbauer cells: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012708, HPA035063, HPA035064" Approved Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441" "unprognostic (1.10e-3)" "unprognostic (5.09e-2)" "unprognostic (1.92e-1)" "unprognostic (2.40e-2)" "unprognostic (1.50e-1)" "unprognostic (2.18e-1)" "prognostic unfavorable (8.81e-4)" "unprognostic (9.92e-2)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (8.24e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.01e-12)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.33e-3)" "unprognostic (1.71e-1)" 34.7 27.0 46.1 17.8 46.7 19.0 31.4 47.8 71.5 33.9 44.5 40.8 10.4 32.3 24.7 33.4 31.0 15.0 57.1 46.1 47.2 17.0 24.7 23.9 26.0 46.6 46.0 37.5 22.8 22.9 31.5 28.3 47.1 24.5 19.1 32.5 19.8 28.6 59.9 29.5 20.8 31.1 49.1 28.5 23.5 19.0 47.1 32.9 17.7 57.8 30.8 32.8 31.8 50.9 28.6 30.5 72.7 40.5 59.9 74.2 38.2 43.2 52.0 44.2 52.6 90.8 77.8 29.0 96.9 57.4 83.9 59.9 54.2 95.1 47.0 62.0 47.6 47.0 47.5 68.2 80.8 58.0 36.8 52.7 94.9 52.8 62.5 56.9 85.9 54.7 51.1 64.6 91.5 78.0 69.6 136.7 59.5 186.3 20.1 53.0 35.7 65.4 77.2 53.2 44.8 38.7 53.8 39.8 31.1 72.7 64.1 38.5 44.2 52.1 36.4 105.8 32.7 27.7 68.3 57.6 26.6 54.4 52.6 47.8 53.4 44.4 48.6 52.5 54.3 61.8 59.1 53.6 68.9 52.9 51.1 52.3 11.2 57.9 53.9 53.7 84.5 43.2 46.1 46.7 47.8 71.5 46.1 47.2 46.6 46.0 47.1 49.1 47.1 50.9 59.9 38.5 32.1 0.0 16.1 0.0 0.0 0.0 0.0 0.0 53.4 81.3 0.0 0.0 14.9 27.6 0.0 129.6 28.7 0.0 41.1 76.1 0.0 41.4 60.4 28.7 0.0 0.0 0.0 66.3 146.2 30.2 0.0 36.8 22.7 52.1 0.0 0.0 94.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 50.1 0.0 0.0 0.0 0.0 49.8 0.0 0.0 4.1 0.0 0.0 43.2 27.7 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 77.6 18.1 59.3 0.0 0.0 HNRNPH1 "hnRNPH, HNRPH1" ENSG00000169045 "Heterogeneous nuclear ribonucleoprotein H1" P31943 5 179614178-179634784 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000914, HPA001359, HPA016884, CAB032820" Supported Enhanced Nucleoplasm NA NA 2800000 "Cluster 49: Eosinophils - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444" "unprognostic (9.01e-2)" "unprognostic (3.83e-1)" "unprognostic (3.45e-3)" "unprognostic (8.82e-2)" "unprognostic (1.01e-1)" "prognostic favorable (7.85e-4)" "prognostic unfavorable (3.29e-7)" "unprognostic (7.99e-2)" "unprognostic (6.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.65e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (1.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.40e-3)" "unprognostic (1.72e-3)" 115.8 108.5 83.6 103.2 88.9 242.9 90.4 100.4 99.6 134.4 95.6 109.5 73.3 120.3 67.9 112.7 109.5 71.4 93.0 84.6 88.2 159.3 137.1 102.5 175.0 86.2 86.0 148.4 123.5 99.2 95.5 91.3 86.1 117.5 79.2 162.9 92.5 84.1 142.1 110.5 137.4 102.9 82.8 209.3 105.0 121.2 88.1 210.8 130.8 84.3 166.6 115.6 112.0 88.6 425.0 432.1 496.0 291.0 155.8 135.0 391.5 227.3 188.7 472.0 271.1 519.4 222.0 618.0 205.4 235.2 297.1 227.0 517.8 345.3 552.9 582.8 322.2 335.5 497.3 528.4 196.1 426.0 295.5 104.7 249.1 379.8 230.0 182.6 247.1 293.8 494.4 281.7 279.8 338.5 724.8 371.1 534.9 249.0 226.8 660.7 507.2 368.3 180.4 485.0 431.5 364.3 410.7 232.7 421.8 344.6 275.7 567.1 250.5 415.3 304.2 184.8 556.0 252.0 674.2 723.6 213.0 405.1 501.6 55.7 44.8 46.5 61.4 73.2 82.6 63.4 65.8 66.4 67.9 52.1 81.5 86.8 9.1 62.9 57.6 87.3 83.1 38.9 83.6 88.9 100.4 99.6 84.6 88.2 86.2 86.0 86.1 82.8 88.1 88.6 374.3 115.4 238.0 80.6 263.0 775.3 182.3 89.2 202.1 118.0 332.7 242.1 136.4 165.8 125.5 156.3 131.3 158.3 419.8 183.0 78.2 97.1 151.3 178.7 246.3 237.8 255.2 189.8 81.8 124.1 181.8 241.7 128.0 258.9 247.3 178.6 189.5 225.3 108.2 70.7 85.8 213.7 81.4 186.2 621.4 86.6 111.6 224.0 334.4 104.9 148.3 93.4 110.2 148.8 121.8 105.2 153.0 117.4 269.3 200.4 142.7 75.4 95.9 166.0 184.1 306.3 253.2 189.1 120.6 181.0 718.0 192.5 311.9 87.4 266.4 191.5 HPF1 "C4orf27, FLJ20534" ENSG00000056050 "Histone PARylation factor 1" Q9NWY4 4 169729470-169757944 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 71.0;Distal tubular cells: 92.0;Extravillous trophoblasts: 61.2;Granulosa cells: 56.4;Hofbauer cells: 56.3;Proximal tubular cells: 63.9;Theca cells: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043467 Uncertain Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "Microtubules, Cytokinetic bridge" "HPA043467: AB_10793949" "unprognostic (1.09e-1)" "unprognostic (1.15e-2)" "unprognostic (1.72e-2)" "unprognostic (1.47e-1)" "unprognostic (2.70e-1)" "unprognostic (1.09e-1)" "unprognostic (8.68e-3)" "unprognostic (2.74e-2)" "prognostic unfavorable (5.63e-4)" "prognostic favorable (7.47e-4)" "unprognostic (6.34e-2)" "unprognostic (4.55e-1)" "unprognostic (3.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.32e-1)" "unprognostic (5.51e-2)" "unprognostic (1.09e-1)" 19.3 18.6 18.6 16.4 19.9 16.8 21.2 19.6 26.0 19.6 22.0 22.0 12.2 23.3 24.8 15.7 17.1 13.1 22.5 19.2 19.7 18.1 22.1 14.3 21.1 20.2 19.3 22.7 14.4 16.0 19.5 16.8 20.9 17.3 17.7 21.3 13.2 15.7 21.3 19.6 12.8 24.8 19.6 17.5 15.8 14.1 19.6 26.9 18.8 20.9 21.1 16.8 16.8 22.2 33.7 21.0 71.2 37.7 42.6 52.4 30.3 59.9 58.8 72.8 76.7 14.3 35.5 17.5 15.7 39.2 53.3 14.7 49.5 43.6 76.7 55.1 33.7 57.0 30.0 20.5 29.9 48.7 20.1 34.1 43.2 47.1 14.5 44.1 64.1 59.1 43.7 66.2 64.4 27.3 102.7 42.4 29.2 32.2 27.0 44.7 33.8 21.2 41.9 21.9 17.2 63.1 39.7 17.2 56.3 49.1 34.0 43.1 31.3 24.8 39.2 58.4 54.3 31.3 49.8 52.4 68.3 47.0 40.3 19.3 20.0 22.4 28.7 24.0 34.6 22.0 33.0 35.1 26.1 18.1 32.1 33.3 5.3 25.4 23.7 17.9 38.1 21.9 18.6 19.9 19.6 26.0 19.2 19.7 20.2 19.3 20.9 19.6 19.6 22.2 41.6 44.8 26.4 0.0 5.7 0.0 0.0 0.0 0.0 0.0 19.9 29.6 0.0 0.0 17.3 27.6 0.0 71.0 14.3 0.0 92.0 45.7 0.0 31.9 36.9 20.1 0.0 0.0 0.0 46.3 61.2 26.1 0.0 21.9 17.7 56.4 0.0 0.0 56.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 31.1 0.0 0.0 1.6 0.0 0.0 63.9 15.3 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 16.3 10.5 56.0 0.0 0.0 IER2 ETR101 ENSG00000160888 "Immediate early response 2" Q9BTL4 19 13150411-13154911 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 255.5;U-266/84: 338.3" "Low region specificity" "Detected in all" "HPA055387, HPA060574" Enhanced Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 31: Skin - Epidermis development" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA055387: AB_2682802, HPA060574: AB_2684324" "unprognostic (3.09e-2)" "unprognostic (1.78e-1)" "unprognostic (1.99e-1)" "unprognostic (4.86e-2)" "unprognostic (3.86e-2)" "unprognostic (2.47e-2)" "unprognostic (2.10e-1)" "unprognostic (3.31e-1)" "unprognostic (2.35e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" "unprognostic (2.86e-1)" "unprognostic (1.01e-1)" 193.3 74.8 26.8 44.2 20.3 239.8 103.8 50.0 28.5 53.8 20.7 115.7 39.6 65.1 7.3 128.6 298.3 36.8 90.7 20.0 23.3 117.8 118.5 136.4 47.3 30.0 27.1 107.5 119.3 31.0 87.8 33.9 30.3 83.8 29.9 16.7 104.8 27.9 26.4 276.3 78.3 45.4 26.4 95.4 139.7 13.7 28.9 45.2 107.7 49.5 20.8 90.7 78.4 25.7 62.4 36.3 28.2 43.0 18.3 24.5 62.2 47.4 25.6 32.0 18.8 31.4 36.9 36.7 46.7 34.5 53.8 41.4 13.1 27.4 15.9 22.2 24.6 48.2 67.9 26.5 22.4 61.2 51.9 12.7 66.3 34.5 21.4 38.9 37.9 37.4 123.6 48.1 12.5 102.4 37.1 255.5 53.5 66.9 155.8 71.8 28.4 45.0 29.5 36.2 34.7 49.7 53.0 160.0 114.5 22.1 19.1 36.6 68.8 67.0 46.2 56.1 138.6 139.9 338.3 37.9 36.3 120.4 53.0 363.9 167.4 273.7 249.7 191.3 214.5 139.9 175.1 202.5 100.5 155.3 114.7 146.8 833.3 215.0 183.7 45.1 178.2 275.5 26.8 20.3 50.0 28.5 20.0 23.3 30.0 27.1 30.3 26.4 28.9 25.7 1678.3 176.3 492.4 31.3 636.9 319.0 1201.7 587.9 659.0 82.2 977.1 1651.1 61.3 571.9 330.0 95.6 35.5 539.9 974.9 807.5 52.8 873.6 14.0 714.9 1302.8 718.1 977.5 75.6 6.7 380.3 541.6 721.1 1071.4 1261.4 489.2 279.8 427.3 83.5 593.9 15.2 7.5 973.4 553.4 316.8 366.4 11.9 137.9 714.3 236.5 48.7 144.7 453.1 185.3 7.5 6.7 494.4 691.5 38.7 484.3 779.5 680.9 44.5 221.7 141.9 644.2 591.4 730.3 6.6 10.1 720.1 441.6 915.6 671.4 313.4 652.7 418.5 IER5 ENSG00000162783 "Immediate early response 5" Q5VY09 1 181088700-181092900 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 282.8;Macrophages: 276.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029894 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA029894: AB_10601433" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "prognostic favorable (2.42e-7)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.81e-3)" "unprognostic (8.37e-2)" "unprognostic (1.46e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.36e-4)" "unprognostic (1.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" 12.8 6.3 9.5 11.2 10.2 49.5 8.4 10.1 19.3 10.2 11.2 10.6 5.6 14.8 2.5 26.5 15.2 6.1 27.8 10.7 9.7 5.8 6.7 23.2 9.4 10.0 9.2 3.3 5.2 1.8 5.2 11.0 9.1 5.6 5.6 1.1 6.8 3.7 33.4 22.1 13.3 8.3 9.8 32.7 9.0 5.4 10.3 8.7 5.0 16.5 10.8 10.9 13.3 12.8 25.3 21.8 11.7 10.3 15.9 21.9 31.3 43.6 45.9 24.1 21.4 6.1 13.8 8.3 18.9 16.9 16.9 45.5 3.8 29.7 15.6 47.6 18.7 7.4 11.5 4.1 24.9 8.6 23.1 15.7 29.5 28.0 18.7 18.3 16.6 6.9 31.0 36.5 43.3 11.5 8.6 13.8 12.2 9.5 10.8 9.8 20.4 31.6 8.8 13.7 16.9 18.2 22.1 21.3 51.7 14.2 17.0 7.5 25.3 17.3 30.5 19.9 26.8 23.9 9.1 6.5 13.5 9.0 4.9 3.6 1.4 2.7 1.0 5.5 1.2 4.0 0.8 1.4 1.1 3.0 0.1 0.5 1.2 1.1 5.3 0.2 1.3 0.7 9.5 10.2 10.1 19.3 10.7 9.7 10.0 9.2 9.1 9.8 10.3 12.8 156.4 22.4 66.7 3.6 124.8 69.8 163.7 24.2 53.5 24.2 198.1 197.7 110.9 21.5 25.9 9.2 37.5 10.9 131.1 94.2 0.0 10.6 5.1 66.7 83.0 87.2 56.4 32.0 8.7 6.9 56.4 74.7 50.0 67.3 36.1 35.0 41.4 5.6 50.9 8.4 2.8 110.6 6.1 149.5 282.8 11.9 12.2 276.4 46.2 11.2 56.1 17.8 17.5 0.5 1.3 21.9 54.8 9.4 61.5 94.9 35.0 1.5 27.4 21.3 0.0 177.9 102.8 3.6 5.4 115.9 59.7 34.2 151.3 15.5 62.0 146.8 IER5L bA247A12.2 ENSG00000188483 "Immediate early response 5 like" Q5T953 9 129175552-129178261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 177.5;Breast myoepithelial cells: 110.2;dendritic cells: 121.9;Endometrial stromal cells: 218.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 24.7;SiHa: 34.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021327 Approved Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA021327: AB_2121674" "unprognostic (2.46e-1)" "unprognostic (3.73e-3)" "unprognostic (3.90e-3)" "unprognostic (8.49e-3)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.48e-6)" "unprognostic (6.91e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.99e-2)" "unprognostic (1.08e-3)" "unprognostic (7.23e-3)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (2.29e-1)" 21.4 10.6 3.7 1.2 4.7 0.4 10.7 3.5 7.3 39.4 2.1 9.4 0.8 13.9 2.1 9.4 16.6 1.9 21.6 3.3 4.1 27.2 14.6 13.1 0.7 6.2 4.1 18.9 4.8 0.6 10.7 1.4 4.8 12.3 0.4 0.5 7.5 3.3 3.5 7.5 5.7 1.0 3.7 6.3 9.1 4.7 4.6 0.3 12.4 0.9 0.3 16.2 19.5 4.8 8.6 24.7 6.9 13.3 5.0 7.9 20.9 12.6 1.1 1.9 1.9 1.3 13.8 0.2 4.9 2.9 5.5 18.6 0.3 1.5 0.3 1.2 1.8 0.0 5.7 2.4 3.8 0.3 0.2 8.6 1.9 1.4 0.2 10.8 0.9 0.2 0.7 4.4 0.3 22.1 0.3 1.1 0.6 2.2 12.9 1.2 0.5 3.8 7.6 1.2 3.1 4.1 34.8 11.1 15.7 2.8 3.4 2.2 5.1 11.7 7.0 7.9 18.3 2.4 1.7 0.3 14.9 2.5 5.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.7 4.7 3.5 7.3 3.3 4.1 6.2 4.1 4.8 3.7 4.6 4.8 177.5 16.0 1.7 12.7 25.5 6.8 9.2 11.1 27.9 6.1 52.7 110.2 1.6 25.8 10.7 47.8 0.0 3.9 121.9 34.7 9.8 14.5 0.7 87.1 218.9 42.6 10.7 0.8 13.1 27.1 11.8 41.4 19.9 102.7 0.0 2.2 30.0 11.7 31.0 3.3 4.3 20.6 26.4 17.0 17.2 1.6 10.8 64.7 14.2 15.0 7.4 13.9 0.0 2.0 1.4 20.0 12.5 7.2 11.2 9.8 8.4 17.3 13.4 2.8 26.3 41.8 99.0 0.1 3.6 37.6 4.5 8.1 55.1 3.9 15.4 7.7 IFIT2 "cig42, G10P2, GARG-39, IFI-54, IFI54, ISG-54K" ENSG00000119922 "Interferon induced protein with tetratricopeptide repeats 2" P09913 10 89283694-89309271 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.4" "Cell type enhanced" "Detected in many" "Adipocytes: 53.5;Glandular and luminal cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 420.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 420.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 141.0;BJ hTERT+ SV40 Large T+ RasG12V: 113.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003408 Approved Approved Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA003408: AB_1079100" "unprognostic (1.77e-1)" "unprognostic (2.10e-1)" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (1.75e-2)" "unprognostic (9.28e-2)" "unprognostic (6.71e-3)" "unprognostic (2.22e-1)" "unprognostic (5.40e-1)" "unprognostic (1.36e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.92e-2)" "unprognostic (1.03e-2)" "unprognostic (5.33e-3)" "unprognostic (6.46e-2)" 7.7 6.7 12.6 13.1 17.3 48.4 5.4 14.7 16.2 6.1 8.2 5.4 6.7 5.0 6.2 2.8 9.3 13.6 7.5 11.7 14.1 10.2 21.8 21.0 7.9 19.5 16.6 9.2 3.1 10.0 2.5 16.4 18.9 4.1 4.5 1.7 8.8 6.5 2.3 3.7 5.7 6.5 30.1 27.5 3.6 2.2 15.9 12.6 3.4 6.8 5.7 6.3 2.9 20.8 29.3 1.1 0.3 14.5 13.0 14.4 5.2 10.7 32.4 141.0 113.0 0.1 20.0 3.2 5.9 7.8 20.6 28.9 0.6 1.5 15.4 11.6 0.1 5.3 14.3 0.0 22.2 0.7 2.3 8.2 0.7 10.7 1.6 8.6 0.7 2.8 0.1 0.5 2.2 0.1 3.4 6.6 3.5 0.0 6.1 2.1 3.7 0.8 4.8 5.6 0.1 0.2 3.8 0.6 24.7 1.8 0.7 1.6 0.9 1.5 0.3 3.9 1.1 1.4 5.1 0.5 2.3 2.4 2.9 97.6 32.6 107.8 9.5 75.9 5.1 19.2 8.0 6.5 10.6 17.7 7.6 6.8 420.2 8.9 92.3 12.7 3.9 17.6 12.6 17.3 14.7 16.2 11.7 14.1 19.5 16.6 18.9 30.1 15.9 20.8 53.5 41.7 6.7 1.6 12.3 1.5 5.3 6.6 1.2 1.3 5.6 9.5 7.4 11.5 9.4 12.9 0.0 2.9 27.6 23.5 9.8 35.0 0.2 34.9 9.1 34.9 3.5 0.8 1.0 4.2 1.6 10.9 2.0 67.0 5.1 3.8 16.4 6.1 26.0 25.2 2.1 5.9 4.1 25.5 3.3 0.2 8.1 29.5 7.2 4.7 20.9 13.3 12.3 2.0 20.3 6.3 11.5 11.7 2.4 19.1 18.9 30.8 4.7 0.9 0.0 8.3 14.3 0.2 0.2 3.2 0.6 1.4 13.1 6.2 2.1 5.8 IFNG ENSG00000111537 "Interferon gamma" P01579 12 68154768-68159740 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Antiviral defense, Growth regulation" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 11.5;lymphoid tissue: 7.4" "Group enriched" "Detected in many" 12 "dendritic cells: 283.2;T-cells: 200.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 7 "T-cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB010344 Approved "Secreted to blood" NA NA 1470 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 7: Non-specific - Mitochondria" "CAB010344: AB_2123447" "unprognostic (2.16e-4)" "unprognostic (1.93e-3)" "unprognostic (9.21e-2)" "unprognostic (1.04e-4)" "unprognostic (5.14e-1)" "unprognostic (3.96e-3)" "unprognostic (1.33e-1)" "unprognostic (3.17e-4)" "unprognostic (7.79e-2)" "unprognostic (7.97e-3)" "unprognostic (1.63e-2)" "unprognostic (5.36e-2)" "unprognostic (7.62e-9)" "unprognostic (3.54e-2)" "unprognostic (5.36e-1)" "unprognostic (6.32e-2)" "unprognostic (7.38e-3)" 0.7 0.7 0.1 3.5 0.2 11.5 0.3 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.5 0.2 0.0 0.0 0.3 1.5 1.8 7.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.3 0.0 0.9 0.2 0.0 0.0 0.3 0.2 0.0 1.3 0.4 0.1 0.1 0.5 0.3 0.0 0.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 2.4 6.6 0.0 0.4 0.5 3.7 0.1 0.9 0.0 0.0 0.1 0.9 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.7 0.0 0.0 0.0 3.1 3.2 1.3 0.0 0.0 0.0 4.8 5.5 0.2 1.5 0.0 0.0 0.0 0.0 283.2 0.1 0.0 0.0 0.2 1.0 1.1 1.3 0.0 0.4 0.0 0.0 0.0 1.5 6.1 1.1 0.0 0.0 1.4 1.2 0.1 0.0 0.0 0.5 0.0 4.4 5.5 0.0 0.0 10.4 7.2 0.0 0.0 0.0 19.6 0.0 0.1 0.0 1.1 0.0 10.9 0.2 0.0 0.3 0.0 0.0 0.0 1.0 2.9 0.0 0.0 0.8 4.0 0.0 200.1 0.0 0.2 0.2 IFRD1 "PC4, TIS7" ENSG00000006652 "Interferon related developmental regulator 1" O00458 7 112422887-112481017 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "eosinophil: 64.2;neutrophil: 112.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 112.3" "Low cell line specificity" "Detected in all" "HPA024122, HPA072413" Enhanced Approved "Plasma membrane,Cytosol" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 17: WM-115 - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA024122: AB_1851452, HPA072413: " "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.10e-1)" "unprognostic (9.82e-3)" "unprognostic (1.36e-2)" "unprognostic (2.39e-1)" "unprognostic (5.73e-3)" "unprognostic (1.37e-1)" "unprognostic (2.48e-2)" "prognostic favorable (5.45e-4)" "unprognostic (6.41e-2)" "unprognostic (2.93e-3)" "unprognostic (1.50e-3)" "unprognostic (4.81e-2)" "unprognostic (1.98e-1)" "unprognostic (2.89e-1)" "unprognostic (4.70e-2)" 35.2 24.6 11.2 6.5 14.4 57.7 32.3 13.2 16.2 23.0 31.7 30.3 8.1 20.8 4.8 24.0 25.4 4.6 30.9 13.9 19.0 21.3 27.3 40.1 3.9 11.0 13.2 31.3 102.9 9.8 31.2 7.9 13.0 28.1 5.5 13.4 25.7 6.4 58.9 21.9 22.2 10.2 11.7 19.9 38.3 24.5 13.1 4.5 25.6 3.1 3.9 24.1 25.8 19.6 22.1 26.8 25.9 21.7 44.4 28.2 25.0 23.8 26.6 36.0 29.6 42.7 21.1 12.2 52.9 18.8 64.6 15.0 21.5 29.2 46.9 17.1 31.7 13.8 46.1 37.9 61.5 19.9 9.5 24.7 43.4 39.7 47.1 18.9 18.3 22.2 46.5 17.4 14.2 35.7 24.1 20.1 51.8 26.9 30.1 24.6 9.2 22.9 6.0 6.1 37.9 18.9 28.0 15.5 61.2 57.7 9.8 15.2 12.6 45.8 10.4 35.0 68.5 27.2 34.8 37.1 12.9 43.6 63.8 19.8 7.6 64.2 7.2 6.5 6.2 8.7 7.7 7.9 6.6 7.2 6.8 7.0 112.3 8.0 6.4 4.6 8.6 5.2 11.2 14.4 13.2 16.2 13.9 19.0 11.0 13.2 13.0 11.7 13.1 19.6 179.3 32.1 31.4 39.2 110.6 197.3 159.3 55.6 259.6 50.3 141.7 142.6 60.6 37.1 55.0 18.4 89.6 66.5 130.9 276.0 17.6 49.6 43.9 123.2 159.7 96.8 138.2 24.6 36.1 56.5 84.2 135.5 162.6 190.1 74.4 51.3 52.8 21.7 126.1 21.9 24.4 183.5 54.9 96.9 153.4 10.1 36.7 141.8 103.2 44.0 55.8 32.4 20.6 24.1 42.6 55.1 287.8 41.0 104.6 143.9 226.9 13.3 34.1 86.8 39.5 138.9 172.7 25.5 14.5 135.1 126.0 151.7 129.8 53.4 180.0 154.4 IGHV2-70D ENSG00000211974 "Immunoglobulin heavy variable 2-70D" A0A0C4DH43 14 106723574-106724093 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 36.8;lymphoid tissue: 90.8;stomach 1: 47.0" "Cell type enriched" "Detected in single" 10 "B-cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 68 "memory B-cell: 9.7;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 97 "B-cells: 9.7" "Cell line enriched" "Detected in single" 7 "MOLT-4: 1.7" "Immunoglobulin genes" NA NA 110000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (5.57e-2)" "unprognostic (9.48e-3)" "prognostic favorable (3.34e-4)" "unprognostic (4.34e-2)" "unprognostic (8.37e-3)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (2.13e-2)" "unprognostic (6.01e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (6.70e-2)" "unprognostic (3.83e-1)" "unprognostic (3.66e-2)" "unprognostic (8.11e-2)" 1.7 0.7 0.0 16.6 0.0 4.1 7.1 0.0 0.0 5.6 0.1 36.8 14.2 1.9 0.0 5.2 4.5 20.9 1.7 0.0 0.0 2.5 2.3 6.2 4.6 0.0 0.0 0.8 0.3 0.1 0.1 0.0 0.0 0.7 33.1 0.0 30.3 0.1 0.0 0.1 21.7 0.6 0.0 41.4 47.0 0.0 0.0 4.5 2.5 0.0 90.8 3.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-64D ENSG00000282639 "Immunoglobulin heavy variable 3-64D" A0A0J9YX35 14 106088122-106088573 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 145.2;lymphoid tissue: 272.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 301 "memory B-cell: 43.3;naive B-cell: 18.7" "Lineage enriched" "Detected in single" 420 "B-cells: 43.3" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 2500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 7: Non-specific - Mitochondria" 8.3 0.5 0.2 140.3 0.1 10.9 84.2 0.0 0.8 12.9 0.3 130.9 20.4 3.3 1.4 35.4 7.8 46.3 4.8 0.5 0.0 1.5 4.2 36.7 48.8 0.1 0.0 5.1 8.1 0.1 0.1 0.1 0.0 4.1 145.2 0.0 28.9 11.5 0.0 3.8 68.8 3.6 0.1 67.4 74.8 0.5 0.0 16.5 2.9 0.0 272.7 40.5 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.2 0.1 0.0 0.8 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV5-10-1 IGHV5-A ENSG00000282651 "Immunoglobulin heavy variable 5-10-1" A0A0J9YXX1 14 106107972-106108464 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 316.6;lymphoid tissue: 568.1" "Cell type enriched" "Detected in single" 36 "B-cells: 3.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "memory B-cell: 74.8;naive B-cell: 66.7" "Lineage enriched" "Detected in many" 16 "B-cells: 74.8" "Group enriched" "Detected in some" 6 "Daudi: 9.4;U-698: 4.8" HPA006014 Approved "Immunoglobulin genes" NA NA 1200000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "HPA006014: " 4.5 28.4 0.0 229.8 0.0 38.7 102.0 0.0 0.9 68.9 0.1 274.0 0.9 10.8 0.0 111.5 20.0 92.5 6.2 0.0 0.0 5.5 7.3 128.3 121.2 0.1 0.0 54.0 5.7 0.4 0.3 0.2 0.2 6.9 316.6 0.0 75.5 19.0 0.1 1.6 51.6 10.9 0.0 203.8 148.3 0.1 0.0 39.3 7.3 0.0 568.1 196.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.0 4.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.8 0.0 0.0 0.0 66.7 0.0 0.0 4.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL2 "IL-2, TCGF" ENSG00000109471 "Interleukin 2" P60568 4 122451470-122456725 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Cytokine, Growth factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Melanocytes: 3.6;T-cells: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB010310 Uncertain "Secreted to blood" NA NA 20300 "Cluster 7: Non-specific - Mitochondria" "CAB010310: AB_649346" "unprognostic (8.87e-5)" "unprognostic (6.13e-3)" "unprognostic (1.38e-3)" "unprognostic (9.79e-3)" "unprognostic (2.56e-2)" "unprognostic (7.32e-2)" "unprognostic (2.06e-5)" "unprognostic (5.21e-3)" "unprognostic (8.01e-2)" 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 13.4 0.0 0.0 0.0 IL3 "IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF" ENSG00000164399 "Interleukin 3" P08700 5 132060655-132063204 "Predicted secreted proteins" "Cytokine, Growth factor" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "HMC-1: 2.8" "Not detected" "Not detected" "Secreted to blood" NA NA 17800 "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (9.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ING1 "p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a" ENSG00000153487 "Inhibitor of growth family member 1" Q9UK53 13 110712736-110723339 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 212.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016136, CAB017773, HPA052591" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "CAB016136: AB_628077, CAB017773: , HPA052591: AB_2681876" "unprognostic (1.14e-2)" "unprognostic (3.25e-2)" "unprognostic (3.51e-2)" "prognostic favorable (5.81e-4)" "unprognostic (4.62e-2)" "unprognostic (3.47e-2)" "unprognostic (3.36e-1)" "unprognostic (1.87e-1)" "unprognostic (9.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.36e-3)" "unprognostic (1.35e-1)" "unprognostic (7.05e-3)" "unprognostic (6.78e-2)" "unprognostic (2.40e-3)" 13.7 7.3 5.9 8.6 6.2 20.2 10.2 6.5 10.2 10.6 5.9 13.4 9.7 12.6 5.3 8.3 14.4 6.7 9.1 6.6 6.7 9.5 18.6 12.8 9.7 7.2 6.2 22.4 8.2 3.1 9.4 7.7 6.4 11.2 4.3 6.7 9.9 4.9 11.7 9.4 12.2 4.8 6.0 14.4 10.0 31.5 6.4 13.0 7.6 9.5 6.3 10.1 9.4 8.0 28.8 11.1 19.8 19.0 9.1 6.1 19.7 14.5 12.1 9.2 11.1 21.5 19.9 18.4 22.9 5.7 14.3 17.8 8.0 7.2 7.7 34.8 15.3 16.3 16.2 16.2 5.2 21.7 15.2 5.6 7.4 8.0 4.8 7.2 6.5 19.6 15.3 15.0 6.0 16.5 37.7 24.9 19.4 17.9 9.3 27.0 10.0 10.4 8.1 14.5 19.4 20.9 14.2 28.3 20.7 6.8 9.5 25.3 9.8 11.3 13.9 11.9 16.5 18.0 19.5 24.0 18.9 17.6 18.8 38.5 4.5 18.0 15.9 5.6 16.7 23.4 13.2 14.2 4.3 27.5 13.5 11.2 6.2 20.4 6.5 4.7 18.8 9.4 5.9 6.2 6.5 10.2 6.6 6.7 7.2 6.2 6.4 6.0 6.4 8.0 87.2 9.6 18.8 5.9 34.5 36.3 15.4 17.0 54.7 16.7 49.8 88.9 27.0 12.8 11.1 7.3 14.6 14.3 32.0 31.5 7.9 11.7 212.5 51.6 58.5 28.6 12.5 12.6 4.4 6.9 78.8 36.1 27.5 55.7 2.5 20.1 11.0 27.4 17.3 3.3 3.8 31.6 12.2 18.2 23.8 45.8 9.3 29.3 17.8 1.9 14.2 17.8 21.6 2.0 4.3 8.0 18.6 14.7 19.7 22.9 34.2 11.5 21.4 21.1 13.1 70.5 57.7 25.5 17.9 48.8 43.8 15.3 29.6 18.0 24.2 22.4 INPP5E "CORS1, JBTS1, pharbin, PPI5PIV" ENSG00000148384 "Inositol polyphosphate-5-phosphatase E" Q9NRR6 9 136428619-136439845 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065758 Approved Approved "Golgi apparatus,Focal adhesion sites" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Focal adhesion sites" "HPA065758: AB_2685554" "unprognostic (1.99e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-2)" "unprognostic (4.00e-1)" "unprognostic (6.92e-2)" "unprognostic (9.60e-3)" "unprognostic (3.21e-1)" "unprognostic (5.81e-2)" "unprognostic (2.65e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.03e-1)" "unprognostic (3.04e-2)" "unprognostic (3.76e-1)" "unprognostic (5.48e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" 12.1 10.8 15.0 6.9 15.0 6.4 11.7 15.3 19.9 15.1 11.3 13.1 5.7 15.2 2.3 10.6 17.6 5.3 13.7 14.0 14.3 13.3 12.2 11.9 8.2 15.1 13.3 16.2 10.8 6.6 14.3 5.7 15.5 12.3 3.3 7.4 9.5 5.3 8.5 11.2 11.7 5.6 11.4 20.8 8.9 20.1 14.8 6.4 15.1 3.8 4.7 12.2 12.0 13.9 8.9 10.3 12.6 13.2 6.5 7.1 14.9 10.7 5.7 7.4 5.1 12.5 6.0 10.8 10.5 11.1 11.9 25.2 6.2 8.6 2.8 36.8 25.4 8.5 27.1 8.4 10.3 9.5 11.9 10.9 8.8 9.8 7.2 10.3 8.9 14.8 14.5 14.0 7.0 22.3 11.4 19.9 8.1 5.3 16.0 21.1 8.7 8.3 7.4 9.8 14.1 12.2 10.4 8.5 7.6 7.6 15.1 15.6 11.8 24.1 9.4 10.1 18.2 11.6 10.6 4.5 12.0 7.8 9.7 0.0 0.1 0.5 0.5 0.0 0.3 0.7 0.6 0.4 0.1 0.4 0.2 0.4 0.1 0.0 0.0 0.2 0.7 0.1 15.0 15.0 15.3 19.9 14.0 14.3 15.1 13.3 15.5 11.4 14.8 13.9 14.7 3.2 6.9 17.0 5.0 5.5 1.8 2.6 5.7 7.4 6.5 6.9 5.0 7.2 3.4 3.7 2.1 2.3 7.6 4.0 1.9 4.8 0.9 11.8 8.1 7.4 6.1 0.8 12.2 5.6 2.8 5.7 3.6 6.8 8.9 8.3 6.1 3.8 3.2 15.2 12.9 2.6 6.1 3.5 3.5 1.3 7.5 3.7 5.4 6.5 3.5 8.9 1.0 8.5 8.5 6.7 1.6 5.7 2.5 3.3 3.4 2.4 10.0 10.8 0.0 5.5 7.5 15.3 9.1 5.4 4.8 0.8 5.3 5.6 3.9 1.6 INTS11 "CPSF3L, CPSF73L, FLJ20542, INT11, RC-68" ENSG00000127054 "Integrator complex subunit 11" Q5TA45 1 1311585-1324687 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 77.3;Ductal cells: 56.4;Extravillous trophoblasts: 63.9;Syncytiotrophoblasts: 77.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028379, HPA029025" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol Nucleoplasm "HPA028379: AB_10599598, HPA029025: AB_10600425" "unprognostic (7.54e-2)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (2.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.97e-1)" "unprognostic (1.71e-1)" "unprognostic (2.75e-2)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.27e-1)" "unprognostic (2.76e-3)" "unprognostic (5.14e-2)" "unprognostic (5.62e-3)" 39.7 40.8 26.0 24.0 28.6 29.0 39.0 37.2 40.1 64.7 27.7 70.6 32.8 66.6 26.4 43.9 61.1 24.1 54.9 27.2 28.4 40.4 45.7 35.6 31.8 30.3 27.2 63.6 53.6 28.9 40.0 28.2 30.6 52.9 20.8 13.0 38.3 27.6 90.3 47.2 44.9 26.7 24.5 45.4 52.4 76.0 28.0 29.6 40.7 44.2 25.1 67.5 50.6 33.6 58.4 56.2 31.5 62.1 52.4 41.7 34.1 31.2 49.9 67.6 50.1 53.2 71.0 63.2 43.6 60.7 40.6 41.4 46.3 67.7 29.9 60.3 60.5 49.8 79.7 70.2 80.2 39.1 52.5 72.1 35.9 61.7 91.7 38.2 71.7 59.7 59.5 56.3 34.2 50.8 77.6 52.1 39.1 53.6 60.1 61.0 30.8 93.1 47.6 31.3 45.0 42.1 31.9 83.8 91.7 23.4 45.5 57.0 54.5 43.6 39.6 50.8 40.0 87.3 101.8 85.1 60.4 68.7 22.0 66.5 69.6 48.0 65.2 82.1 68.9 50.3 56.4 59.8 81.2 44.0 52.2 50.2 33.2 64.8 101.7 52.9 78.7 81.0 26.0 28.6 37.2 40.1 27.2 28.4 30.3 27.2 30.6 24.5 28.0 33.6 36.4 38.5 33.7 0.0 9.5 0.0 0.0 0.0 0.0 0.0 32.6 33.9 0.0 0.0 13.0 18.4 0.0 77.3 24.1 0.0 31.3 56.4 0.0 27.1 27.2 14.0 0.0 0.0 0.0 53.9 63.9 18.7 0.0 23.2 10.1 40.4 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 36.2 0.0 0.0 0.0 0.0 54.8 0.0 0.0 6.8 0.0 0.0 34.4 14.6 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 77.0 12.7 49.8 0.0 0.0 INTS13 "ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30" ENSG00000064102 "Integrator complex subunit 13" Q9NVM9 12 26905181-26938326 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Endometrial stromal cells: 16.7;Extravillous trophoblasts: 16.1;Theca cells: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039543, HPA040109, HPA073020" Uncertain Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Vesicles" "HPA039543: AB_10795150, HPA040109: , HPA073020: " "unprognostic (2.09e-1)" "unprognostic (8.48e-3)" "unprognostic (2.75e-2)" "unprognostic (1.40e-3)" "unprognostic (3.94e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (1.17e-10)" "unprognostic (5.22e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.78e-3)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.16e-6)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (4.37e-2)" "unprognostic (4.78e-2)" 9.9 21.4 9.3 11.3 13.4 17.2 11.7 13.2 14.3 10.4 8.1 9.7 9.9 10.0 10.3 14.6 8.5 8.2 12.2 9.5 11.6 13.2 15.1 7.9 16.7 15.4 12.0 8.0 11.5 8.0 8.1 10.0 14.8 8.5 10.7 21.8 9.0 7.0 19.0 11.8 8.5 11.9 13.9 12.9 15.4 12.1 12.2 18.6 9.9 18.1 16.8 12.8 10.6 20.0 33.4 38.1 21.5 46.4 30.5 48.9 30.9 44.9 27.4 43.3 48.1 58.4 43.1 82.7 45.0 25.1 40.6 46.2 56.1 43.6 72.8 39.5 37.4 66.7 44.5 44.9 53.9 110.6 38.4 26.3 32.2 69.5 147.0 53.5 56.8 35.6 71.5 31.9 46.7 40.9 57.9 197.8 94.6 45.6 68.9 40.8 62.3 114.0 36.4 31.0 17.8 16.7 39.1 30.6 47.4 72.8 42.6 23.4 36.5 50.1 36.2 85.6 55.1 15.6 19.6 119.4 33.1 75.8 36.2 7.8 8.1 7.8 14.6 5.7 22.1 9.7 18.2 18.2 9.9 11.3 12.7 15.7 2.5 25.9 5.2 6.7 28.1 10.5 9.3 13.4 13.2 14.3 9.5 11.6 15.4 12.0 14.8 13.9 12.2 20.0 7.2 22.4 7.8 0.0 2.7 0.0 0.0 0.0 0.0 0.0 7.9 8.3 0.0 0.0 2.5 5.5 0.0 11.8 8.8 0.0 3.9 13.7 0.0 8.7 16.7 3.9 0.0 0.0 0.0 11.9 16.1 8.3 0.0 8.2 7.6 13.9 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 5.7 0.0 0.0 0.0 0.0 13.7 0.0 0.0 1.6 0.0 0.0 11.6 2.9 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 13.1 6.5 18.5 0.0 0.0 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.5;Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" No No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 12.5 15.8 13.2 14.2 15.8 18.0 22.3 14.7 16.6 20.9 18.2 21.8 14.1 18.1 27.4 16.1 24.2 19.6 13.4 13.5 14.8 21.3 21.1 15.6 22.7 14.5 14.9 18.4 17.7 22.9 16.3 19.2 14.6 19.1 23.6 13.1 16.2 19.8 9.9 18.0 17.2 18.8 14.8 18.9 18.1 18.9 15.8 25.4 23.2 13.6 24.3 23.6 13.6 17.7 26.4 46.7 46.1 36.8 25.2 31.4 29.5 28.4 36.5 46.4 42.5 42.2 61.2 42.9 38.9 35.6 38.5 52.0 99.4 47.6 40.5 37.8 60.2 37.5 32.2 46.4 50.0 38.7 46.2 30.6 46.9 35.1 53.7 34.1 50.8 64.8 52.2 24.3 33.4 41.7 44.3 41.2 33.8 66.2 25.6 37.5 38.8 49.0 36.7 48.6 33.1 26.3 34.2 34.5 49.5 39.2 32.3 44.0 25.2 31.8 33.2 28.8 45.6 23.9 48.4 58.1 32.1 70.0 38.1 25.7 11.0 6.2 19.8 12.7 22.3 19.3 20.3 22.6 19.8 14.8 21.1 19.2 1.2 23.8 9.5 17.9 30.8 16.6 13.2 15.8 14.7 16.6 13.5 14.8 14.5 14.9 14.6 14.8 15.8 17.7 12.2 22.4 10.9 0.0 3.8 0.0 0.0 0.0 0.0 0.0 13.0 11.0 0.0 0.0 5.6 12.9 0.0 40.5 7.7 0.0 21.5 18.2 0.0 12.8 11.8 6.8 0.0 0.0 0.0 15.4 30.5 6.7 0.0 12.6 7.6 22.5 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 9.3 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.5 0.0 0.0 15.1 10.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 49.8 4.8 24.0 0.0 0.0 INTS6 "DBI-1, DDX26, DDX26A, DICE1, HDB, INT6, Notchl2" ENSG00000102786 "Integrator complex subunit 6" Q9UL03 13 51354077-51454264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 374.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001552, HPA001846" Supported Supported "Nucleoplasm,Actin filaments" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Actin filaments" "HPA001552: AB_1078659, HPA001846: AB_1847669" "unprognostic (1.99e-1)" "unprognostic (4.81e-2)" "unprognostic (3.58e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.79e-1)" "unprognostic (1.14e-1)" "unprognostic (3.19e-2)" "unprognostic (6.70e-2)" "unprognostic (9.16e-2)" "unprognostic (3.32e-2)" "unprognostic (3.18e-2)" "unprognostic (2.80e-1)" "unprognostic (5.83e-2)" "unprognostic (2.36e-1)" "unprognostic (6.26e-2)" 14.0 14.8 7.7 16.6 9.1 15.0 11.8 17.8 10.0 12.8 11.1 12.1 11.2 14.8 11.6 19.7 10.5 14.0 14.0 9.5 9.0 12.9 28.2 10.0 20.9 9.1 8.2 13.7 37.9 15.9 9.4 14.8 10.1 10.7 10.9 18.9 11.5 9.7 8.4 15.2 13.1 13.4 8.2 15.2 15.4 62.1 8.3 20.7 15.7 16.7 17.3 16.0 11.7 18.2 17.6 13.8 32.8 17.2 17.2 40.6 17.8 36.3 33.5 35.9 25.1 16.2 46.9 20.3 8.5 26.3 22.7 31.0 45.2 20.0 50.6 39.3 12.6 38.7 21.9 19.1 41.6 43.4 33.6 25.3 36.5 33.7 50.7 46.1 31.3 25.5 24.1 30.2 35.9 13.3 26.9 26.8 23.5 51.6 12.4 20.2 23.4 20.3 26.8 11.6 18.2 18.0 36.5 30.2 24.3 24.2 15.4 41.5 17.7 22.1 15.2 23.6 20.8 26.5 21.7 33.0 18.2 22.7 39.2 8.0 2.0 3.2 5.9 1.3 6.7 3.9 4.0 5.0 2.1 4.0 5.6 6.5 5.5 5.0 1.5 4.6 5.0 2.4 7.7 9.1 17.8 10.0 9.5 9.0 9.1 8.2 10.1 8.2 8.3 18.2 241.6 25.6 49.5 75.4 121.4 76.3 68.7 12.0 162.8 58.3 157.5 215.6 78.4 47.1 18.3 22.0 118.9 81.4 164.8 107.2 15.6 23.4 94.3 48.4 67.4 94.5 76.0 29.5 82.2 26.3 47.5 127.4 61.7 64.5 48.2 71.4 57.8 37.3 34.8 45.4 66.7 94.8 12.2 44.2 60.1 81.3 44.1 97.5 23.2 78.7 33.3 55.9 53.5 94.0 118.9 25.9 59.7 31.6 90.9 53.7 77.1 11.9 12.9 74.9 26.3 374.7 119.4 122.4 40.5 161.3 72.5 73.7 137.8 66.5 90.3 68.0 INTS6L "DDX26B, FLJ41215" ENSG00000165359 "Integrator complex subunit 6 like" Q5JSJ4 X 135520659-135582510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Breast myoepithelial cells: 14.0;dendritic cells: 15.9;Endometrial ciliated cells: 16.0;Glandular and luminal cells: 11.1;granulocytes: 25.2;Theca cells: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 20.7;U-937: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001552, HPA013200, HPA013335, HPA030747" Uncertain Approved "Nuclear bodies,Centrosome,Mitochondria" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Centrosome "Nuclear bodies, Mitochondria" "HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589" "unprognostic (2.03e-1)" "prognostic favorable (5.39e-4)" "unprognostic (1.96e-1)" "unprognostic (7.42e-2)" "unprognostic (2.89e-2)" "unprognostic (1.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.33e-3)" "prognostic favorable (5.54e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (2.87e-1)" "unprognostic (1.81e-1)" "unprognostic (5.37e-2)" "prognostic favorable (2.94e-4)" 3.4 7.5 3.3 6.3 2.9 13.1 3.8 8.7 3.7 6.7 2.6 7.7 2.6 4.6 2.8 4.7 6.5 3.8 4.4 3.0 3.0 3.8 1.1 4.4 12.6 3.5 3.6 8.2 2.1 1.8 6.7 3.3 3.4 5.0 7.1 5.1 12.0 3.6 1.1 6.1 7.3 3.7 3.3 10.2 3.4 6.3 3.4 8.4 3.3 0.8 11.3 5.7 5.1 3.7 0.1 0.0 7.5 8.9 2.2 2.5 0.0 1.9 4.0 2.2 6.6 0.7 3.2 7.5 6.3 1.6 5.4 5.6 8.4 2.5 1.5 5.8 3.0 6.5 0.7 0.0 1.9 6.8 0.5 3.3 2.4 2.5 2.5 3.8 2.8 4.9 4.3 11.8 1.6 5.5 6.5 20.7 3.5 8.0 3.1 5.3 2.4 6.4 1.8 3.0 1.2 2.7 2.6 2.6 0.2 3.2 2.8 12.5 1.6 5.6 3.2 0.0 2.2 13.5 11.2 11.3 1.9 19.0 1.1 0.0 1.6 1.4 2.9 1.4 3.8 3.3 3.4 3.5 2.3 3.5 5.2 3.4 0.8 1.9 1.8 2.2 2.0 2.5 3.3 2.9 8.7 3.7 3.0 3.0 3.5 3.6 3.4 3.3 3.4 3.7 6.8 12.8 5.8 0.0 7.3 0.0 0.0 0.0 0.0 0.0 7.2 14.0 0.0 0.0 3.7 3.7 0.0 2.1 15.9 0.0 0.0 1.3 0.0 16.0 5.3 3.3 0.0 0.0 0.0 1.6 0.3 3.3 0.0 11.1 25.2 7.3 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.3 0.0 0.0 1.0 6.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.8 6.9 11.1 0.0 0.0 IQCN KIAA1683 ENSG00000130518 "IQ motif containing N" Q9H0B3 19 18257097-18274509 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 16.8;testis: 33.7" "Cell type enhanced" "Detected in many" "Adipocytes: 23.6;Alveolar cells type 2: 43.7;Breast glandular cells: 13.8;Breast myoepithelial cells: 17.5;dendritic cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA042409 Enhanced NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 78: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "HPA042409: AB_10794421" "unprognostic (1.36e-3)" "unprognostic (5.42e-3)" "unprognostic (2.21e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (2.15e-4)" "unprognostic (9.79e-2)" "unprognostic (9.53e-3)" "unprognostic (5.44e-2)" "unprognostic (1.12e-1)" "unprognostic (1.64e-4)" "unprognostic (4.17e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (7.68e-2)" "unprognostic (1.30e-1)" "unprognostic (4.92e-3)" 1.4 0.7 8.5 0.7 7.4 3.1 1.8 16.8 16.4 3.7 5.9 1.0 0.4 3.2 1.9 0.9 3.2 0.9 0.4 7.7 8.6 1.3 1.0 1.9 1.2 8.7 7.9 3.9 1.4 0.7 2.6 0.3 9.3 1.5 0.8 2.0 1.1 0.8 1.5 2.3 1.4 1.5 5.5 2.0 1.2 33.7 8.8 0.9 3.0 0.1 0.5 0.7 1.5 11.0 0.0 2.2 0.3 1.3 0.5 1.0 0.3 0.3 0.2 0.0 0.1 0.3 0.7 0.5 0.2 0.7 0.3 0.0 0.0 0.2 0.0 0.6 0.1 0.8 1.0 0.4 0.1 0.1 0.2 0.5 0.0 0.2 0.4 1.2 0.2 0.1 0.0 0.6 0.0 0.9 0.2 0.3 0.2 0.6 0.0 0.2 0.0 0.2 0.3 0.3 1.0 0.2 0.1 0.1 0.5 0.7 0.7 0.2 0.0 0.1 0.1 0.7 0.0 0.3 0.2 0.2 0.4 0.0 0.0 0.5 0.3 0.2 0.3 0.1 0.1 0.4 0.3 0.1 0.1 0.6 0.3 0.2 1.7 0.4 0.1 0.6 0.2 0.1 8.5 7.4 16.8 16.4 7.7 8.6 8.7 7.9 9.3 5.5 8.8 11.0 23.6 3.2 43.7 0.0 5.8 0.0 0.0 0.0 0.0 0.0 13.8 17.5 0.0 0.0 1.3 1.8 0.0 1.5 22.3 0.0 0.0 2.7 0.0 6.7 4.5 1.4 0.0 0.0 0.0 0.9 0.5 2.8 0.0 10.2 5.1 4.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.6 0.0 0.0 0.3 2.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.8 8.5 4.2 0.0 0.0 IRF1 MAR ENSG00000125347 "Interferon regulatory factor 1" P10914 5 132440440-132508719 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 142.1" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 516.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 138.1;REH: 114.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011662, HPA063131" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "CAB011662: AB_775784, HPA063131: AB_2684945" "unprognostic (1.30e-3)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (1.21e-1)" "unprognostic (2.27e-1)" "unprognostic (4.48e-2)" "unprognostic (3.67e-1)" "unprognostic (1.64e-1)" "unprognostic (1.52e-2)" "unprognostic (2.24e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.09e-7)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (9.53e-3)" 53.7 19.1 8.2 88.0 7.6 142.1 29.5 8.1 9.4 21.3 7.7 46.3 84.8 21.3 11.7 24.3 24.4 32.6 25.8 7.3 7.5 32.9 54.4 119.0 86.3 17.2 8.1 18.4 15.6 7.4 17.3 22.2 15.8 36.4 38.1 2.8 28.7 16.2 16.7 19.7 68.8 33.1 8.8 117.4 47.4 13.5 10.5 66.4 25.8 13.3 45.3 63.9 24.1 8.0 26.7 22.8 2.3 8.1 22.1 18.9 42.5 14.7 58.8 41.6 52.2 11.3 79.4 26.7 15.8 18.4 64.8 35.7 7.4 33.7 14.3 54.2 7.1 33.2 8.1 6.9 138.1 14.6 34.3 36.9 9.4 31.7 32.2 26.5 22.4 19.1 6.9 97.5 13.1 15.9 87.6 32.7 3.4 9.3 14.6 114.5 23.2 31.7 22.5 27.8 6.4 3.6 14.6 30.8 13.4 10.1 4.7 24.2 13.0 20.5 8.1 12.8 19.8 74.8 27.0 19.3 24.9 27.2 15.5 175.3 167.1 257.0 157.2 244.1 106.9 68.4 104.2 129.9 95.7 62.5 63.5 91.7 621.0 136.9 272.4 52.4 122.1 160.0 8.2 7.6 8.1 9.4 7.3 7.5 17.2 8.1 15.8 8.8 10.5 8.0 369.9 102.5 114.3 1.0 216.5 88.1 129.4 66.3 306.7 14.7 216.5 186.6 17.0 47.1 58.0 22.0 33.3 24.0 396.3 183.6 19.6 112.1 92.5 242.3 170.8 223.1 87.1 36.6 1.1 114.3 42.6 224.4 212.0 288.1 105.2 32.0 58.2 14.6 49.7 1.7 1.2 137.4 57.0 73.9 228.7 9.1 27.4 134.1 72.9 7.5 257.2 16.7 399.6 2.5 1.1 88.6 140.6 7.9 248.6 270.9 155.5 22.4 110.9 46.5 13.1 516.2 225.0 1.3 6.8 118.8 82.7 11.2 301.4 20.5 94.6 95.0 IRGM "IFI1, IRGM1, LRG-47, LRG47" ENSG00000237693 "Immunity related GTPase M" A1A4Y4 5 150846523-150900736 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Immunity, Inflammatory response, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.2" "Cell type enhanced" "Detected in some" "dendritic cells: 1.4;granulocytes: 4.5;T-cells: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 5 "basophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "HL-60: 1.4;JURKAT: 1.8;NB-4: 2.4;THP-1: 1.2;U-937: 3.1" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (8.73e-2)" "unprognostic (2.28e-2)" "unprognostic (2.96e-2)" "unprognostic (2.29e-1)" "unprognostic (4.71e-2)" "unprognostic (9.62e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-3)" "unprognostic (1.43e-1)" "unprognostic (9.36e-2)" "unprognostic (1.38e-1)" "unprognostic (1.28e-3)" "unprognostic (1.12e-10)" "unprognostic (5.93e-2)" "unprognostic (8.28e-2)" "unprognostic (2.53e-1)" "unprognostic (1.11e-1)" 0.0 0.1 0.2 0.3 0.4 0.5 0.1 1.2 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.1 0.0 0.1 0.3 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.6 0.1 0.1 0.4 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.3 0.2 0.7 0.4 0.2 0.2 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.3 0.1 0.0 1.4 0.4 0.1 0.1 0.0 0.0 0.0 0.0 1.8 0.1 0.7 0.0 0.2 0.4 2.4 1.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 1.2 0.0 0.1 0.4 0.2 0.1 0.2 0.2 0.2 0.2 3.1 0.0 2.1 0.1 0.1 0.2 0.1 0.4 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.4 0.2 0.1 0.1 0.1 0.2 0.2 0.4 1.2 0.5 0.3 0.2 0.2 0.1 0.6 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.4 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.6 0.0 0.1 0.1 2.3 0.1 0.0 0.1 JMJD6 "KIAA0585, PTDSR, PTDSR1" ENSG00000070495 "Jumonji domain containing 6, arginine demethylase and lysine hydroxylase" Q6NYC1 17 76712832-76726799 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 121.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004548, HPA059156" Supported Supported Nucleoplasm No No "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB004548: AB_628185, HPA059156: AB_2683934" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (8.06e-2)" "unprognostic (9.46e-2)" "unprognostic (5.95e-2)" "unprognostic (4.14e-3)" "prognostic unfavorable (5.75e-6)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (2.56e-2)" "prognostic favorable (5.71e-4)" "unprognostic (5.66e-2)" "prognostic unfavorable (7.59e-7)" "unprognostic (1.15e-1)" "unprognostic (1.31e-1)" "unprognostic (8.86e-2)" "unprognostic (3.82e-1)" 30.3 27.0 14.2 17.0 16.3 121.7 19.6 19.2 29.5 20.2 15.3 32.3 15.4 19.4 7.4 18.8 22.4 18.7 41.2 14.3 16.5 18.3 18.5 26.8 15.7 16.2 16.2 27.6 18.0 11.0 22.4 16.2 16.2 19.9 10.3 29.5 15.2 10.7 38.2 15.6 18.4 16.0 14.6 21.1 24.4 17.8 16.9 13.4 16.6 28.1 12.8 23.9 20.4 20.8 39.0 53.3 18.0 23.5 22.6 19.4 17.6 34.7 26.8 49.6 47.6 53.6 18.7 25.3 14.9 37.6 72.6 28.8 57.3 17.3 47.2 18.6 45.9 37.3 37.5 54.4 36.8 19.7 55.0 23.9 26.8 54.2 18.2 31.6 41.6 13.8 57.1 45.2 37.0 24.4 34.7 28.4 15.9 37.3 62.4 27.1 33.6 39.2 16.6 12.1 31.1 31.1 30.2 43.7 43.7 30.4 39.5 28.6 27.7 56.7 33.3 29.9 65.8 50.6 28.8 23.4 55.7 17.4 32.5 50.8 28.6 40.2 24.7 37.8 24.0 20.5 28.4 28.2 25.9 13.0 23.3 22.2 23.3 14.6 39.4 22.4 31.0 20.1 14.2 16.3 19.2 29.5 14.3 16.5 16.2 16.2 16.2 14.6 16.9 20.8 44.1 25.6 22.9 9.1 29.3 83.2 79.9 46.1 67.2 16.5 30.8 42.8 30.5 14.3 29.2 9.2 50.1 29.0 96.5 33.1 17.6 28.1 30.3 39.1 29.6 36.0 39.4 13.0 6.6 27.4 52.9 37.9 33.1 58.6 65.2 18.6 28.2 10.2 32.7 6.7 7.4 32.0 24.4 19.5 79.2 12.5 16.1 52.4 58.7 3.7 26.9 11.8 21.6 7.1 7.9 29.6 32.1 17.7 50.0 38.5 40.8 7.9 20.5 35.4 13.1 32.7 69.2 59.6 27.2 48.8 73.6 30.5 80.4 29.9 31.3 60.2 JMJD8 C16orf20 ENSG00000161999 "Jumonji domain containing 8" Q96S16 16 681670-684528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (2.32e-2)" "unprognostic (1.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" "unprognostic (8.38e-2)" "unprognostic (1.03e-2)" "unprognostic (2.87e-1)" "unprognostic (4.79e-2)" "unprognostic (1.46e-1)" "unprognostic (1.50e-2)" "unprognostic (4.33e-2)" "unprognostic (1.63e-2)" "unprognostic (4.96e-3)" "unprognostic (5.53e-2)" "unprognostic (1.86e-1)" "unprognostic (3.29e-1)" "unprognostic (7.04e-2)" 24.5 25.9 19.9 14.5 19.8 17.4 17.3 18.9 23.7 25.9 31.4 21.0 17.5 24.9 30.5 24.7 29.6 21.3 37.2 20.1 20.0 23.0 23.1 19.2 15.6 22.4 19.9 23.7 41.0 31.5 14.0 15.4 19.9 23.8 10.9 7.5 40.5 32.6 13.1 22.4 15.3 21.9 20.2 15.7 19.3 15.7 21.8 15.1 32.2 14.5 10.8 22.3 15.5 19.6 21.5 59.5 14.6 63.0 59.8 22.9 8.5 26.3 49.0 26.9 30.6 33.7 49.8 7.4 28.2 38.1 0.3 36.8 17.4 34.2 10.2 28.6 27.5 15.5 32.5 4.3 26.4 35.7 27.3 27.3 22.8 18.0 20.9 20.1 41.4 14.9 20.0 40.8 16.1 52.8 18.8 28.1 34.9 35.5 25.3 22.6 3.8 76.3 54.0 13.4 26.1 28.3 38.1 43.0 9.3 8.4 44.3 33.3 21.8 1.9 21.5 12.8 15.6 23.7 14.5 9.5 7.1 16.6 22.5 0.2 6.3 0.1 5.0 5.2 6.5 3.9 5.7 5.0 7.3 4.6 4.8 4.8 0.2 3.4 4.8 4.9 6.7 3.0 19.9 19.8 18.9 23.7 20.1 20.0 22.4 19.9 19.9 20.2 21.8 19.6 33.8 9.6 21.3 5.5 14.0 13.8 21.1 7.2 14.2 15.2 34.5 37.6 11.5 21.5 11.3 23.9 14.6 35.8 19.8 26.2 29.4 46.4 21.2 22.5 23.9 19.8 21.6 9.2 4.3 42.0 40.7 29.1 15.8 18.8 2.5 29.9 15.4 26.8 20.5 16.8 5.0 17.0 8.2 16.1 17.3 50.1 23.3 13.9 17.8 1.9 15.5 31.8 17.5 3.5 4.4 31.0 10.7 29.3 19.9 23.3 15.4 30.6 11.0 21.2 0.0 16.3 32.0 22.4 13.0 18.8 19.5 30.4 14.2 39.2 23.5 18.3 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 406.9" "Cell type enhanced" "Detected in many" "Ductal cells: 371.3;Exocrine glandular cells: 437.2;Extravillous trophoblasts: 1344.2;monocytes: 375.7;Pancreatic endocrine cells: 1434.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 767.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA 40000 "Cluster 5: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 26.1 74.9 44.0 87.5 43.7 83.5 21.3 49.4 54.7 44.1 31.0 140.1 119.2 18.0 7.3 225.1 15.5 63.7 23.3 44.3 54.4 72.2 49.1 49.3 87.6 38.6 42.8 13.4 22.6 6.7 24.3 66.3 49.3 28.3 70.4 17.0 62.1 27.8 96.1 40.7 141.6 23.4 34.3 100.5 134.2 406.9 53.1 88.0 16.1 24.3 91.5 93.9 75.7 36.3 775.3 743.0 371.8 384.7 75.5 75.2 309.5 391.8 111.5 364.6 278.0 614.8 449.1 210.1 247.4 303.0 401.7 446.5 344.3 481.9 278.5 215.7 438.3 336.1 275.2 624.8 177.5 256.3 318.3 117.1 218.4 307.3 308.7 107.1 672.2 388.7 197.3 431.3 335.4 561.4 845.0 248.7 216.9 627.8 979.0 520.8 447.5 326.8 392.7 479.1 465.4 373.8 553.8 293.3 213.4 393.8 786.0 154.9 395.1 214.3 615.7 305.0 469.0 165.9 298.1 332.5 186.9 233.4 254.4 241.7 127.0 372.6 79.6 187.8 57.2 102.3 109.3 96.8 100.7 57.2 51.6 76.1 767.6 74.5 206.7 67.4 202.6 118.4 44.0 43.7 49.4 54.7 44.3 54.4 38.6 42.8 49.3 34.3 53.1 36.3 61.6 25.6 18.1 0.0 36.2 0.0 0.0 0.0 0.0 0.0 81.8 133.2 0.0 0.0 18.0 246.5 0.0 137.6 171.2 0.0 99.7 371.3 0.0 113.2 79.7 32.9 0.0 0.0 0.0 437.2 1344.2 40.4 0.0 194.0 7.6 179.6 0.0 0.0 319.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 102.5 0.0 0.0 375.7 0.0 0.0 0.0 0.0 1434.1 0.0 0.0 13.9 0.0 0.0 203.3 16.8 0.0 0.0 0.0 76.2 0.0 0.0 0.0 0.0 96.9 73.9 95.0 0.0 0.0 JUN "AP-1, c-Jun" ENSG00000177606 "Jun proto-oncogene, AP-1 transcription factor subunit" P05412 1 58776845-58784048 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 295.6" "Low region specificity" "Detected in all" "CAB003801, CAB007780, HPA031174, HPA059474" Enhanced Enhanced Nucleoplasm Yes No "Cluster 21: B-cells - Adaptive immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030" "unprognostic (2.06e-2)" "unprognostic (1.76e-2)" "unprognostic (1.34e-1)" "unprognostic (7.85e-2)" "unprognostic (1.60e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" "unprognostic (5.21e-2)" "unprognostic (1.24e-1)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "unprognostic (2.82e-1)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.83e-1)" "unprognostic (2.37e-1)" "unprognostic (2.81e-3)" 331.1 92.7 34.4 36.3 37.0 129.1 308.2 41.6 38.1 172.0 28.0 154.7 34.7 116.4 15.8 100.2 314.1 89.6 158.4 39.1 37.2 94.0 205.2 202.8 52.1 32.7 30.7 197.0 192.2 59.8 75.0 40.1 30.5 153.4 55.0 29.7 154.5 71.7 114.3 286.6 79.1 113.3 34.3 62.0 239.5 20.2 33.8 71.5 189.5 158.8 5.4 156.4 164.5 36.9 49.8 2.8 22.4 2.6 35.3 40.0 0.2 69.4 27.0 57.1 34.3 10.1 3.5 1.7 23.8 57.4 133.6 12.9 2.0 27.7 40.6 29.8 128.9 0.5 1.9 16.9 29.4 5.3 10.2 42.0 74.0 78.1 34.0 27.7 47.2 2.4 15.6 29.6 24.9 8.0 2.5 32.5 13.5 34.6 32.2 1.1 295.6 7.0 60.7 5.8 43.7 12.8 49.9 62.3 26.4 24.5 17.2 3.0 61.6 127.5 37.3 35.3 96.8 37.9 9.8 4.4 133.9 8.4 35.2 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.6 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 34.4 37.0 41.6 38.1 39.1 37.2 32.7 30.7 30.5 34.3 33.8 36.9 2721.4 538.5 543.8 187.7 1018.8 1235.5 2850.5 772.6 2825.1 103.4 1647.1 2067.3 1487.5 1315.4 449.3 104.8 262.7 675.8 651.1 1653.6 50.9 987.0 49.3 1337.1 2845.2 1443.8 1497.4 174.3 12.2 516.4 93.9 2730.7 2663.1 1822.2 541.9 333.4 737.2 158.6 650.5 87.5 4.9 1909.1 836.2 584.9 632.0 48.2 1227.4 1034.9 757.7 65.6 140.1 1234.2 8.2 17.6 10.0 562.8 1529.6 258.8 1540.3 1489.1 1654.1 48.6 216.3 453.5 1538.3 1892.9 2392.5 17.4 20.9 2146.3 964.4 415.6 1065.5 846.5 1199.5 545.7 JUNB ENSG00000171223 "JunB proto-oncogene, AP-1 transcription factor subunit" P17275 19 12791486-12793315 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 679.4" "Group enriched" "Detected in all" 5 "granulocytes: 679.4;monocytes: 182.7" "Cell line enhanced" "Detected in all" "HDLM-2: 629.0;U-266/70: 256.4;U-266/84: 411.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004464, HPA019149" Approved Supported Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB004464: AB_2130023, HPA019149: AB_1852053" "unprognostic (1.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.04e-1)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.79e-1)" "unprognostic (9.78e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (7.20e-2)" "unprognostic (7.06e-2)" "unprognostic (3.77e-1)" "unprognostic (1.02e-1)" 722.8 259.5 22.9 110.3 28.0 455.2 248.5 90.1 65.2 283.3 30.4 287.0 52.8 130.1 2.2 449.1 874.8 92.6 383.5 28.3 68.8 184.2 279.0 399.2 65.0 83.5 29.8 649.5 150.0 20.8 351.9 39.4 33.6 195.0 22.0 32.0 131.6 56.1 144.6 605.9 145.0 58.1 51.5 153.3 309.8 30.0 31.3 78.8 198.7 73.3 12.9 333.0 330.6 34.8 52.9 10.4 2.8 6.4 11.3 27.4 10.2 22.8 19.2 11.0 10.0 6.8 30.4 18.2 77.4 8.4 33.5 98.5 2.5 34.3 1.2 629.0 9.9 18.0 42.2 9.0 15.1 24.3 80.5 34.9 97.6 10.0 7.5 22.0 5.3 12.9 48.1 32.6 3.6 158.8 16.8 147.5 1.7 36.1 40.0 22.4 7.7 38.8 7.5 65.5 23.7 36.0 98.4 59.5 30.5 1.7 10.5 27.0 17.6 32.2 18.7 64.3 28.9 256.4 411.4 17.1 37.7 62.7 8.9 29.1 132.2 132.2 33.4 182.7 33.4 30.6 36.8 42.0 87.1 25.4 25.5 28.5 679.4 18.6 177.2 7.9 38.7 124.1 22.9 28.0 90.1 65.2 28.3 68.8 83.5 29.8 33.6 51.5 31.3 34.8 3158.0 115.4 423.2 130.2 1751.7 1463.9 1778.3 2367.7 1985.1 81.0 1296.9 1693.1 374.0 474.7 707.4 154.5 39.6 129.7 1766.9 819.7 49.0 833.3 9.5 468.5 1091.4 1469.5 1502.1 244.8 8.7 546.7 224.7 2182.3 1060.1 627.8 510.5 310.0 852.4 84.6 1178.4 21.9 4.4 1029.3 740.6 674.1 2747.6 27.9 815.2 1583.3 894.6 20.6 379.3 634.6 115.4 4.5 2.4 1026.7 875.3 263.3 842.5 1036.7 701.0 84.2 337.3 168.8 1163.6 2566.6 2624.1 9.4 10.5 1164.3 1804.1 440.3 2362.6 417.0 687.7 472.6 JUND AP-1 ENSG00000130522 "JunD proto-oncogene, AP-1 transcription factor subunit" P17535 19 18279694-18281622 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 2129.8;dendritic cells: 1844.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005268, HPA063029" Supported Supported Nucleoplasm No No "Cluster 33: Neutrophils - Chromatin organization" "Cluster 35: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB005268: AB_2130177, HPA063029: AB_2684925" "prognostic favorable (6.15e-5)" "unprognostic (4.18e-3)" "unprognostic (8.89e-2)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (6.39e-2)" "unprognostic (1.63e-2)" "unprognostic (6.35e-2)" "unprognostic (3.48e-2)" "unprognostic (2.00e-1)" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-1)" "unprognostic (3.99e-1)" "unprognostic (5.37e-2)" "unprognostic (1.49e-1)" 296.3 189.3 190.3 38.9 201.6 429.1 257.3 172.1 208.5 159.7 153.1 185.2 62.9 186.6 37.5 118.3 291.4 30.0 210.6 187.5 192.5 148.8 211.8 227.3 28.8 261.3 213.2 424.2 178.4 40.4 256.4 45.1 180.9 159.1 33.0 25.7 112.7 33.8 81.0 287.7 161.3 57.5 182.5 100.5 201.4 97.4 180.4 58.2 154.8 37.1 15.9 129.5 147.7 263.8 84.2 35.3 33.3 37.9 25.9 28.8 150.5 35.0 40.8 19.2 25.4 38.3 72.9 42.1 39.4 34.8 31.1 46.1 8.2 8.3 9.5 84.6 75.9 62.7 30.3 84.9 58.6 29.5 81.4 27.8 33.7 20.0 25.9 44.5 15.3 18.8 86.5 119.8 5.2 113.6 89.9 92.5 69.7 22.7 50.6 32.7 20.9 94.0 27.8 13.1 184.2 75.1 41.7 45.4 122.0 37.5 38.6 43.9 54.7 11.8 54.8 74.4 20.9 171.3 73.8 36.3 41.5 44.7 27.9 10.5 6.5 6.8 4.9 8.2 3.8 8.4 6.4 4.5 4.9 8.7 4.5 5.0 19.7 4.8 8.3 11.3 5.7 2.4 190.3 201.6 172.1 208.5 187.5 192.5 261.3 213.2 180.9 182.5 180.4 263.8 2129.8 179.5 386.7 104.5 1176.8 317.1 400.4 76.0 188.4 129.8 1147.5 1419.1 158.8 291.7 84.4 257.5 79.2 78.5 1844.7 810.5 31.3 96.5 80.8 1026.0 1289.3 468.1 568.8 78.3 51.6 140.8 112.9 950.9 336.4 1561.4 257.7 514.1 338.4 436.1 100.1 139.7 41.0 569.6 67.1 332.7 506.0 59.2 123.3 847.7 249.1 65.6 91.7 625.2 27.8 44.7 132.0 154.4 464.2 88.8 734.5 253.6 538.1 65.4 90.4 174.3 131.5 1064.7 798.4 11.8 22.7 172.0 394.1 164.3 1158.2 448.7 297.4 232.7 KANSL2 "C12orf41, FLJ20436, NSL2" ENSG00000139620 "KAT8 regulatory NSL complex subunit 2" Q9H9L4 12 48653211-48682238 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038497, HPA038498" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Plasma membrane, Cytosol" "HPA038497: AB_10674685, HPA038498: AB_2676046" "unprognostic (3.87e-3)" "unprognostic (6.18e-2)" "unprognostic (3.67e-1)" "unprognostic (8.89e-2)" "unprognostic (5.37e-2)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.98e-4)" "unprognostic (5.46e-2)" "unprognostic (1.35e-3)" "unprognostic (6.16e-2)" "unprognostic (6.75e-3)" "unprognostic (4.19e-3)" "unprognostic (8.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "prognostic favorable (4.32e-4)" 11.9 11.4 6.0 8.2 7.0 41.8 12.2 8.6 8.0 13.9 7.3 11.8 8.1 14.1 11.5 13.3 12.6 7.7 13.4 6.5 6.9 12.2 9.8 10.9 13.9 7.0 6.5 16.3 9.7 12.2 9.3 12.2 6.7 11.1 9.3 11.8 13.0 8.3 40.7 13.4 11.9 9.8 6.7 13.2 10.8 14.6 6.8 14.2 11.5 23.1 13.8 12.4 12.8 8.8 19.5 26.5 21.8 12.8 25.6 22.0 48.1 20.8 17.6 35.9 19.5 45.2 25.1 31.9 39.0 25.5 14.0 18.3 37.1 23.5 29.5 30.4 22.5 37.1 20.2 12.9 29.2 40.0 13.9 20.8 31.2 25.5 46.2 18.0 17.2 24.8 43.7 20.9 25.0 18.7 39.2 29.2 28.6 28.1 26.0 33.4 21.3 35.9 17.2 27.1 25.1 17.6 43.2 30.0 25.7 21.8 40.2 43.4 12.8 25.5 18.9 10.9 19.7 29.8 50.7 46.2 12.4 89.5 13.6 35.3 19.7 23.5 25.1 21.2 23.7 27.3 23.9 25.9 25.8 23.8 27.9 26.9 9.0 24.3 23.0 20.2 32.2 24.0 6.0 7.0 8.6 8.0 6.5 6.9 7.0 6.5 6.7 6.7 6.8 8.8 18.0 3.2 14.3 9.8 24.7 11.9 14.7 17.9 32.5 15.6 15.7 15.5 10.9 8.6 15.0 14.7 29.2 22.5 36.5 10.2 9.8 13.3 24.4 8.2 13.9 13.7 9.0 14.1 11.5 9.8 12.5 15.1 12.2 12.4 11.4 19.8 14.6 9.6 11.9 15.2 13.8 9.1 10.2 11.9 13.2 13.8 12.5 13.7 16.0 7.5 14.8 8.2 11.3 15.1 18.8 12.2 4.7 10.1 16.9 12.1 10.8 15.6 10.2 22.8 26.3 15.7 16.6 38.5 34.8 19.9 11.2 25.3 30.6 15.9 12.4 9.8 KANTR "LINC01155, Spasm" ENSG00000232593 "KDM5C adjacent transcript" X 53094145-53170914 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 3.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 15.9;Astrocytes: 13.4;Excitatory neurons: 20.5;Inhibitory neurons: 24.9;Oligodendrocytes: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 1.3" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (2.89e-1)" "unprognostic (1.66e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (5.52e-2)" "unprognostic (2.18e-2)" "unprognostic (7.30e-2)" "unprognostic (4.79e-2)" "unprognostic (2.30e-3)" "unprognostic (2.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.46e-2)" "unprognostic (3.47e-6)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-3)" "unprognostic (1.81e-3)" 0.0 0.1 2.5 0.0 2.0 0.7 0.1 2.8 2.5 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 1.9 2.9 0.1 0.0 0.1 0.0 1.6 2.5 0.3 0.0 0.0 0.4 0.1 1.9 0.1 0.0 0.3 0.1 0.0 0.1 0.3 0.1 0.0 0.9 0.1 0.0 0.2 3.5 0.0 0.1 0.0 0.0 0.1 0.1 1.8 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.2 0.1 0.5 0.2 0.1 0.2 1.3 0.2 0.2 0.0 0.1 0.2 0.3 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.6 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.3 0.5 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 2.0 2.8 2.5 1.9 2.9 1.6 2.5 1.9 0.9 3.5 1.8 6.9 0.0 15.9 13.4 4.3 0.0 0.2 0.0 5.2 1.2 6.6 6.1 0.7 0.0 3.7 5.5 10.4 0.2 7.1 0.0 0.0 2.6 0.0 2.7 8.3 2.6 0.0 1.7 20.5 2.3 0.3 3.3 0.5 3.6 1.3 7.7 0.4 0.2 0.2 1.7 24.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 8.4 0.6 0.2 0.0 12.5 16.8 1.1 0.0 0.0 5.0 0.3 0.2 2.4 2.2 3.3 0.0 0.9 3.2 0.0 0.1 1.5 0.0 0.3 3.8 4.2 0.0 0.3 KHSRP "FBP2, FUBP2, KSRP" ENSG00000088247 "KH-type splicing regulatory protein" Q92945 19 6413102-6424811 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034739, HPA056518" Supported Enhanced Nucleoplasm NA NA 710000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA034739: AB_10601582, HPA056518: AB_2683162" "unprognostic (2.16e-1)" "unprognostic (3.98e-2)" "unprognostic (2.41e-1)" "unprognostic (4.27e-1)" "unprognostic (4.57e-2)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.25e-1)" "unprognostic (7.12e-2)" "unprognostic (1.74e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.38e-2)" "unprognostic (2.84e-2)" 78.3 90.9 39.2 44.8 37.0 63.9 73.6 35.0 44.6 109.8 14.0 90.2 53.8 121.7 17.0 111.3 105.3 27.5 62.5 39.3 32.0 66.8 89.9 73.5 52.1 35.8 34.4 120.7 89.5 24.7 77.5 44.0 32.6 75.7 34.2 41.0 75.1 33.1 100.5 93.7 88.4 36.3 31.1 79.6 81.8 106.5 35.5 53.8 83.4 26.0 45.7 94.5 91.5 44.1 302.1 128.6 148.0 139.2 62.0 67.0 216.8 103.7 84.0 147.2 148.3 259.2 77.2 286.8 187.3 76.7 82.8 162.6 203.5 104.5 162.2 2.6 240.3 209.2 94.9 158.2 86.0 204.9 186.2 74.9 47.6 108.3 117.0 65.8 124.0 138.6 328.7 142.5 95.7 146.9 290.7 182.3 264.3 78.9 187.9 284.3 124.5 206.5 73.0 143.9 152.5 160.7 133.8 119.7 144.3 121.7 118.5 222.4 111.4 108.0 160.9 230.4 230.9 257.1 306.8 279.8 107.3 298.1 130.9 1.6 2.7 2.1 2.2 3.1 2.5 2.4 2.6 2.9 2.9 3.2 1.5 1.6 1.9 1.3 2.8 4.8 1.9 1.7 39.2 37.0 35.0 44.6 39.3 32.0 35.8 34.4 32.6 31.1 35.5 44.1 39.8 9.6 17.5 9.1 27.9 58.8 23.6 18.7 33.6 44.6 50.9 49.7 12.8 41.5 23.5 31.3 50.1 41.8 35.7 46.5 5.9 28.0 84.2 38.5 52.4 32.7 57.6 41.8 12.3 30.9 47.5 33.8 21.9 51.9 18.4 41.8 41.4 44.0 38.9 50.5 12.9 50.5 10.2 42.9 44.2 24.4 50.7 32.0 26.6 12.2 26.7 37.9 15.5 11.1 19.1 32.9 34.9 46.3 33.8 36.9 36.0 23.0 17.4 57.4 26.3 39.7 29.9 92.1 57.3 48.8 72.5 40.0 22.9 34.6 60.4 32.1 KIRREL1 "KIRREL, NEPH1" ENSG00000183853 "Kirre like nephrin family adhesion molecule 1" Q96J84 1 157993273-158100262 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 6.2;Alveolar cells type 1: 19.2;Breast myoepithelial cells: 6.9;Endometrial stromal cells: 19.4;Fibroblasts: 7.2;Smooth muscle cells: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 169.8;WM-115: 262.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030458 Approved NA NA 890000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "HPA030458: AB_10601438" "unprognostic (8.92e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (3.76e-1)" "unprognostic (1.07e-3)" "unprognostic (7.96e-3)" "unprognostic (3.62e-2)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (4.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.12e-8)" "unprognostic (2.11e-3)" "unprognostic (5.24e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.85e-4)" 23.3 13.4 3.2 11.9 2.7 0.1 18.0 3.9 3.0 16.0 8.7 16.8 3.8 22.2 5.0 7.9 17.4 21.3 10.3 1.7 2.9 15.2 2.8 16.8 4.4 3.1 4.4 22.7 4.2 3.2 4.8 27.5 3.0 9.9 8.1 5.9 8.2 16.7 3.7 7.7 8.6 25.0 3.8 8.7 7.7 3.0 4.0 4.6 10.6 5.9 3.6 14.1 10.6 1.4 24.7 31.4 67.2 56.2 100.6 82.4 0.0 65.1 87.7 50.9 42.2 59.3 49.0 0.0 101.0 75.8 36.2 45.5 38.9 56.8 47.9 0.2 7.6 0.1 34.8 0.0 70.6 0.0 0.6 104.2 25.0 84.4 74.9 71.9 33.5 15.4 0.5 0.3 54.1 0.1 9.1 0.1 49.2 0.0 26.4 9.2 30.5 0.4 169.8 0.9 9.6 0.7 55.3 0.2 114.6 75.3 4.4 1.3 59.9 64.5 40.5 64.5 86.5 0.1 0.3 0.3 56.1 0.2 262.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.7 3.9 3.0 1.7 2.9 3.1 4.4 3.0 3.8 4.0 1.4 6.2 19.2 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 6.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.9 4.7 0.0 1.7 19.4 2.4 0.0 0.0 0.0 0.4 0.2 7.2 0.0 3.6 0.0 4.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.4 0.1 5.0 0.0 0.0 KLF10 "EGRA, TIEG, TIEG1" ENSG00000155090 "Kruppel like factor 10" Q13118 8 102648784-102655725 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 409.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (6.67e-2)" "unprognostic (1.29e-2)" "unprognostic (4.75e-2)" "unprognostic (1.74e-1)" "unprognostic (1.42e-3)" "unprognostic (7.76e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.61e-5)" "unprognostic (4.88e-1)" "unprognostic (2.74e-2)" "unprognostic (3.44e-2)" "unprognostic (3.77e-1)" "unprognostic (6.60e-3)" "unprognostic (3.27e-2)" "unprognostic (8.23e-2)" "unprognostic (7.51e-3)" "unprognostic (1.06e-1)" 65.4 28.8 6.1 25.4 7.2 152.8 40.3 4.9 14.3 37.6 8.2 58.4 28.3 40.7 17.0 39.6 42.4 64.9 33.5 7.8 6.8 40.0 95.7 71.3 22.6 6.3 6.8 25.0 126.2 15.2 16.4 71.1 6.0 45.4 46.1 11.4 32.0 33.3 158.9 72.1 26.2 60.3 6.1 34.9 41.1 26.7 6.4 45.6 30.0 122.9 22.3 46.4 27.4 6.2 22.3 32.4 17.3 15.7 30.4 66.3 30.8 43.0 22.9 26.8 12.8 17.3 42.2 35.5 38.2 39.1 49.4 24.0 10.0 106.5 35.4 20.3 17.4 27.6 24.4 15.9 24.7 16.3 41.3 94.5 105.2 36.8 42.1 62.1 60.0 6.8 18.2 68.3 87.2 36.2 17.8 28.3 13.5 58.5 78.8 7.2 59.7 34.0 38.8 67.6 25.4 27.6 64.0 26.3 35.0 25.0 25.4 19.1 67.0 55.9 39.5 65.3 44.0 61.6 51.7 32.6 52.1 20.1 32.2 17.2 52.5 14.3 16.5 48.2 9.0 17.1 12.5 17.2 57.2 5.8 3.1 12.7 5.3 15.6 26.0 10.1 18.4 34.7 6.1 7.2 4.9 14.3 7.8 6.8 6.3 6.8 6.0 6.1 6.4 6.2 195.5 141.1 74.9 1.0 49.2 137.1 167.6 117.3 409.8 3.5 115.9 119.6 117.9 40.0 56.6 44.1 6.2 52.3 41.7 74.6 9.8 58.3 8.5 110.1 121.6 134.7 94.2 11.2 6.7 43.3 87.7 147.7 46.4 183.3 100.1 34.9 94.2 53.5 61.1 8.4 0.6 49.2 93.6 73.1 185.6 10.4 66.5 117.6 76.5 7.5 83.7 7.7 8.2 0.5 0.5 42.7 41.2 29.3 51.4 136.7 35.5 43.8 50.7 2.6 26.3 157.1 124.1 18.7 30.7 222.9 164.8 72.7 47.8 40.6 48.1 58.8 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 436.6" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 2075.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Supported Nucleoplasm,Nucleoli,Vesicles,Cytosol No No "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli, Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: AB_2686157" "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favorable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 211.3 46.9 19.0 122.1 18.0 436.6 129.7 19.2 22.4 95.4 21.9 92.1 55.4 98.1 17.7 165.5 77.2 181.9 49.7 18.0 19.2 64.1 141.8 117.0 65.4 29.4 20.1 47.3 118.3 31.8 12.0 98.2 25.2 32.8 99.6 18.4 73.8 33.7 84.9 197.1 106.0 208.2 22.7 64.3 73.2 14.6 23.0 56.8 193.9 41.3 45.0 136.3 92.7 25.0 55.0 14.7 27.2 9.0 155.1 154.3 17.1 91.7 46.5 95.9 64.8 38.0 71.4 15.6 20.8 100.0 74.5 32.7 17.0 84.9 79.5 76.6 10.2 2.2 17.5 35.8 66.4 10.3 51.5 51.4 158.2 68.6 129.3 34.2 99.3 10.1 17.5 117.9 123.6 4.0 19.4 15.9 10.2 29.2 26.0 12.6 28.2 55.5 94.1 53.4 12.0 11.5 22.5 64.0 142.8 73.5 32.0 8.6 130.9 128.7 17.8 76.9 43.0 22.6 78.1 28.6 34.7 13.7 40.8 318.8 85.2 234.1 129.8 74.2 115.9 81.1 147.4 131.5 67.6 70.9 44.9 69.0 391.6 72.5 104.6 152.8 120.6 148.7 19.0 18.0 19.2 22.4 18.0 19.2 29.4 20.1 25.2 22.7 23.0 25.0 511.0 1246.8 489.4 14.0 716.9 585.5 1298.4 625.8 1227.0 39.6 985.9 630.0 63.6 544.7 451.9 138.0 33.3 163.1 518.3 1507.0 21.5 808.6 58.0 1065.6 618.9 469.9 397.3 77.9 18.5 553.0 473.8 545.5 1120.3 1905.9 626.7 195.9 248.4 309.9 583.6 37.0 10.0 746.7 429.3 968.7 885.1 53.2 130.5 992.1 483.8 58.1 609.8 42.9 150.4 7.5 4.3 857.9 949.9 133.9 1172.5 600.2 1009.9 97.4 342.0 90.1 138.1 194.8 441.8 9.0 19.4 2075.6 628.2 195.9 920.5 67.1 542.0 572.5 KLHL15 KIAA1677 ENSG00000174010 "Kelch like family member 15" Q96M94 X 23983720-24027186 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065730 Uncertain Approved Aggresome,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol Aggresome "HPA065730: AB_2685547" "unprognostic (5.89e-2)" "unprognostic (6.98e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.13e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (7.37e-3)" "unprognostic (7.42e-2)" "unprognostic (9.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-2)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (8.40e-2)" 4.8 9.6 2.9 3.7 3.7 53.1 3.3 4.0 3.6 4.1 3.9 3.1 2.9 5.1 8.0 8.7 4.2 4.5 3.3 3.3 3.8 5.0 12.8 3.4 4.0 2.8 3.2 5.9 6.4 7.3 3.3 3.4 2.5 5.8 3.1 5.5 2.5 3.9 3.6 2.1 2.9 5.1 2.8 4.0 4.0 18.3 3.2 6.2 5.1 3.2 3.4 3.5 1.8 2.9 5.0 4.8 5.2 7.7 7.6 5.4 5.4 7.9 6.9 3.6 4.3 4.4 4.4 13.2 2.7 5.2 5.6 3.7 8.4 4.3 8.7 5.2 17.2 8.4 13.4 2.3 4.8 11.0 5.6 5.7 2.2 6.2 6.0 3.2 2.6 7.7 5.4 18.0 6.7 1.7 9.9 10.7 9.9 2.5 5.8 7.8 9.5 8.2 3.3 4.4 13.7 6.5 11.0 2.6 9.2 6.5 3.6 9.7 3.3 5.4 3.3 10.9 5.2 9.9 10.6 14.8 4.3 7.0 4.4 0.2 0.2 0.5 0.3 0.4 0.4 0.1 0.3 0.3 0.3 0.2 0.4 0.4 0.2 0.2 0.4 0.3 0.3 0.2 2.9 3.7 4.0 3.6 3.3 3.8 2.8 3.2 2.5 2.8 3.2 2.9 20.1 6.4 7.9 4.2 10.4 18.0 4.5 4.0 18.8 8.1 18.7 16.9 11.5 5.7 5.4 3.7 12.5 0.5 12.2 3.9 0.0 1.4 3.1 15.5 20.7 10.5 8.4 6.9 7.0 1.4 1.3 12.7 6.6 31.4 8.2 6.3 8.9 11.9 3.6 20.2 9.1 5.0 2.0 9.1 14.1 2.8 3.4 19.8 12.4 3.7 3.9 7.9 3.1 6.0 5.4 1.6 0.7 4.1 8.8 5.6 3.8 2.4 2.8 7.6 0.0 22.6 16.4 2.8 17.7 15.3 9.9 1.4 11.7 13.3 4.8 3.3 KMT5A "PR-Set7, SET07, SET8, SETD8" ENSG00000183955 "Lysine methyltransferase 5A" Q9NQR1 12 123383773-123409353 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064495 Supported Nucleoplasm,Cytosol NA Yes "Cluster 49: Eosinophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA064495: AB_2685273" "unprognostic (5.62e-2)" "unprognostic (4.45e-2)" "unprognostic (3.90e-1)" "unprognostic (3.04e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.21e-7)" "unprognostic (3.88e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-2)" "unprognostic (6.13e-2)" "unprognostic (3.44e-1)" "unprognostic (4.75e-3)" "unprognostic (4.27e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.06e-1)" 13.7 10.1 22.6 15.3 22.1 39.2 13.1 20.8 23.2 22.2 18.7 17.7 12.8 21.3 12.9 40.7 21.7 13.6 17.0 22.2 20.6 13.7 14.0 15.5 15.4 22.4 22.7 12.0 19.7 11.4 10.7 16.5 22.9 30.2 14.4 11.7 24.0 19.7 24.4 28.1 15.6 16.7 21.4 16.8 16.9 7.9 23.3 17.9 25.7 15.3 16.6 16.6 25.7 23.9 37.3 24.3 27.8 43.5 18.1 30.9 40.1 57.4 26.3 32.0 26.9 28.8 21.9 84.9 33.1 37.5 11.7 35.8 41.6 21.7 33.3 39.3 45.0 68.8 26.4 15.2 26.5 54.8 18.8 15.1 27.1 34.7 32.8 30.2 26.2 36.4 136.8 38.1 27.5 29.9 58.1 84.9 13.8 34.6 29.0 70.4 22.1 24.1 22.8 43.4 37.9 30.9 51.3 28.3 28.6 23.6 39.6 75.3 32.4 35.2 26.0 42.3 42.3 23.0 25.9 75.9 24.6 29.6 29.9 2.3 1.2 4.3 1.3 2.1 2.7 1.7 1.6 2.1 1.0 1.1 0.9 1.1 1.8 2.3 2.1 2.0 1.5 0.3 22.6 22.1 20.8 23.2 22.2 20.6 22.4 22.7 22.9 21.4 23.3 23.9 34.5 12.8 14.5 0.0 12.7 0.0 17.6 0.0 20.5 20.8 32.0 27.3 0.0 7.2 6.8 27.6 6.2 15.1 22.4 10.4 7.9 9.2 10.1 46.8 43.8 20.7 4.9 62.1 0.0 9.4 16.6 14.7 15.8 41.1 2.5 21.3 30.4 19.5 17.7 3.3 0.0 22.2 0.0 16.8 0.0 3.2 16.1 19.6 0.0 0.0 3.4 28.7 7.2 0.0 0.0 13.6 9.6 42.9 15.9 24.1 14.3 13.1 11.7 17.9 6.6 23.2 19.7 9.7 10.2 38.8 0.0 14.2 14.5 18.4 12.7 22.5 KYAT3 "CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3" ENSG00000137944 "Kynurenine aminotransferase 3" Q6YP21 1 88935773-88992953 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 70.7;Exocrine glandular cells: 38.2;Extravillous trophoblasts: 39.9;Proximal tubular cells: 35.6;Syncytiotrophoblasts: 83.5;Theca cells: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026538, HPA027168" Enhanced Approved "Nucleoli,Cytokinetic bridge,Cytosol" Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "Nucleoli, Cytokinetic bridge" "HPA026538: AB_1852076, HPA027168: AB_1852078" "prognostic favorable (3.19e-5)" "unprognostic (3.36e-3)" "unprognostic (1.88e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" "prognostic favorable (1.86e-4)" "unprognostic (2.61e-1)" "unprognostic (3.61e-3)" "unprognostic (2.11e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.04e-1)" "unprognostic (3.17e-1)" "prognostic favorable (5.02e-6)" "unprognostic (1.17e-1)" "unprognostic (1.06e-1)" "unprognostic (2.51e-1)" "unprognostic (2.78e-1)" 19.3 22.5 8.3 16.0 9.3 13.4 29.8 10.0 12.2 18.0 12.3 19.9 22.6 21.3 21.7 26.5 18.3 20.0 11.3 9.4 9.5 30.5 27.4 15.4 22.1 8.5 9.5 25.7 30.0 33.4 15.2 22.7 9.2 21.1 21.7 11.0 20.5 22.1 10.6 18.8 17.4 15.7 8.7 17.6 22.7 9.9 8.7 21.6 26.2 10.0 23.7 24.6 14.9 8.9 55.1 11.1 52.2 18.0 19.1 51.2 46.4 31.7 57.2 39.8 49.4 15.6 18.9 35.6 23.8 23.8 27.3 15.7 15.6 25.6 57.7 22.7 21.3 32.4 9.8 26.8 61.8 45.6 8.5 44.9 25.2 29.0 50.1 26.8 37.0 41.0 41.5 19.0 37.9 17.8 48.0 21.6 31.0 42.5 10.3 49.3 36.2 19.2 87.0 49.2 38.9 45.6 44.4 60.0 29.1 31.8 33.3 13.9 27.7 17.5 11.4 55.5 23.1 23.7 13.6 23.6 8.4 19.5 14.7 8.3 12.1 7.5 8.0 7.7 11.1 8.6 10.6 9.5 16.3 8.9 10.6 9.3 8.8 11.3 10.2 5.9 16.3 8.3 8.3 9.3 10.0 12.2 9.4 9.5 8.5 9.5 9.2 8.7 8.7 8.9 10.6 12.8 11.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 16.0 13.7 0.0 0.0 8.1 12.9 0.0 70.7 13.1 0.0 25.4 34.4 0.0 12.7 14.1 4.6 0.0 0.0 0.0 38.2 39.9 10.1 0.0 14.3 5.1 17.5 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 32.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 1.8 0.0 0.0 35.6 3.6 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 83.5 7.6 43.3 0.0 0.0 LARGE1 "KIAA0609, LARGE" ENSG00000133424 "LARGE xylosyl- and glucuronyltransferase 1" O95461 22 33162226-33922841 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Glycosyltransferase, Multifunctional enzyme, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 8.5;Alveolar cells type 2: 8.2;Ductal cells: 7.1;Endometrial stromal cells: 10.5;Exocrine glandular cells: 7.9;Glandular and luminal cells: 8.6;Hofbauer cells: 6.0;Pancreatic endocrine cells: 6.3" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 18.3;basal ganglia: 23.4;cerebral cortex: 33.2;hippocampal formation: 45.4;white matter: 16.4" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.16e-1)" "unprognostic (7.77e-3)" "unprognostic (3.79e-1)" "unprognostic (1.74e-3)" "unprognostic (1.63e-1)" "unprognostic (1.48e-2)" "unprognostic (4.90e-2)" "unprognostic (1.39e-2)" "unprognostic (5.21e-3)" "unprognostic (6.00e-2)" "unprognostic (2.12e-2)" "unprognostic (1.35e-2)" "unprognostic (7.12e-3)" "unprognostic (1.19e-1)" "unprognostic (3.68e-2)" "unprognostic (2.93e-1)" "unprognostic (3.96e-3)" 11.9 10.1 18.3 5.9 23.4 0.4 9.1 3.4 33.2 15.3 19.7 27.8 9.2 22.4 8.1 6.7 13.5 9.0 58.4 45.4 2.2 8.4 8.1 6.5 5.1 1.0 2.9 20.8 8.3 6.0 7.4 4.1 4.7 15.2 8.7 13.2 5.9 24.8 49.5 8.5 11.4 15.7 0.0 5.8 16.7 7.6 6.3 2.0 5.3 27.5 5.0 21.6 11.5 16.4 4.1 12.3 19.5 8.4 3.2 0.6 7.4 14.1 7.1 2.7 0.0 2.6 0.4 19.5 2.4 14.0 4.6 1.6 11.6 0.0 0.1 0.3 9.8 0.0 0.0 13.1 4.1 0.1 2.0 1.8 0.9 0.2 0.0 0.0 0.1 0.2 0.2 2.7 3.2 16.5 0.1 9.5 7.7 16.3 0.4 10.6 20.2 3.5 2.5 18.1 7.0 2.4 8.4 11.4 13.6 13.7 16.4 0.6 0.1 8.8 13.8 5.2 3.7 21.3 23.4 0.4 16.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 18.3 23.4 3.4 33.2 45.4 2.2 1.0 2.9 4.7 0.0 6.3 16.4 8.5 0.0 8.2 0.0 4.9 0.0 0.0 0.0 0.0 0.0 4.2 4.2 0.0 0.0 2.5 1.8 0.0 0.3 0.9 0.0 0.0 7.1 0.0 5.7 10.5 1.9 0.0 0.0 0.0 7.9 0.7 2.9 0.0 8.6 1.3 3.9 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.4 0.0 0.0 2.0 1.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.8 1.2 0.0 0.0 LINC02210-CRHR1 ENSG00000263715 "LINC02210-CRHR1 readthrough" 17 45620344-45835826 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.9" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.1;Collecting duct cells: 3.7;Distal tubular cells: 1.9;Endometrial ciliated cells: 1.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 7: Non-specific - Mitochondria" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 1.9 0.4 0.1 0.1 0.2 0.1 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 3.7 0.0 0.1 0.3 0.0 1.9 0.2 0.0 1.9 0.7 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.6 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 LNPK "KIAA1715, LNP, LNP1, Ul" ENSG00000144320 "Lunapark, ER junction formation factor" Q9C0E8 2 175923882-176002839 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Developmental protein" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 19.3;Endometrial stromal cells: 24.6;Hofbauer cells: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 159.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014205 Approved Supported "Nucleoplasm,Endoplasmic reticulum" NA NA 15000 "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" Nucleoplasm "HPA014205: AB_2234186" "unprognostic (4.93e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-2)" "unprognostic (8.73e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (3.13e-1)" "unprognostic (4.17e-3)" "unprognostic (1.63e-1)" "unprognostic (9.27e-2)" "unprognostic (2.35e-3)" "unprognostic (3.43e-2)" 13.5 8.9 6.3 7.7 10.1 30.1 9.8 10.2 8.7 12.0 4.2 12.0 7.6 8.6 6.2 13.1 6.3 7.7 12.2 7.6 13.2 8.2 14.4 6.7 7.2 11.3 9.2 10.7 5.5 15.6 6.0 6.1 14.1 10.1 10.2 24.1 6.4 8.2 34.1 12.1 7.5 9.6 11.3 5.9 7.8 24.5 9.3 14.0 8.8 26.8 7.9 7.6 9.2 19.0 24.5 12.3 28.3 40.1 58.5 36.1 14.3 70.8 33.7 32.2 45.1 17.0 28.2 24.4 39.4 31.5 42.3 26.5 26.9 18.9 44.6 37.5 27.4 27.6 14.8 15.2 13.8 47.2 32.9 29.9 17.5 31.4 15.4 26.4 6.0 19.3 28.9 31.5 44.9 16.0 31.4 18.8 9.2 24.9 23.4 31.3 28.6 18.0 13.6 22.2 32.6 32.9 31.3 17.5 24.1 26.6 26.2 15.4 9.2 159.0 23.6 53.9 33.7 18.5 36.6 20.3 49.4 15.2 30.4 3.7 4.2 7.9 4.9 4.8 5.8 4.3 4.2 5.4 3.9 3.3 4.2 6.7 3.4 6.5 4.5 4.4 7.8 3.4 6.3 10.1 10.2 8.7 7.6 13.2 11.3 9.2 14.1 11.3 9.3 19.0 10.8 19.2 13.6 0.0 4.4 0.0 0.0 0.0 0.0 0.0 19.3 15.0 0.0 0.0 6.2 16.5 0.0 5.7 14.5 0.0 5.9 14.0 0.0 10.1 24.6 3.5 0.0 0.0 0.0 9.6 17.3 12.8 0.0 12.7 11.4 10.6 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.3 0.0 0.0 9.1 8.7 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 8.3 7.2 12.0 0.0 0.0 LRMDA "C10orf11, CDA017, OCA7" ENSG00000148655 "Leucine rich melanocyte differentiation associated" Q9H2I8 10 75431624-76560168 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation Albinism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 61.5;epididymis: 59.5" "Cell type enhanced" "Detected in many" "Adipocytes: 42.4;Distal tubular cells: 33.2;Endometrial ciliated cells: 27.8;Hofbauer cells: 56.9;Proximal tubular cells: 113.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 57.6;eosinophil: 22.1;intermediate monocyte: 28.8;myeloid DC: 67.5;non-classical monocyte: 17.1" "Group enriched" "Detected in many" 7 "dendritic cells: 67.5;granulocytes: 22.1;monocytes: 57.6" "Cell line enhanced" "Detected in many" "Hep G2: 46.3;HMC-1: 34.0;NB-4: 65.6;SK-MEL-30: 93.0;THP-1: 48.7;U-937: 43.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047446, HPA050419" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA047446: AB_2680050, HPA050419: AB_2756316" "unprognostic (1.04e-1)" "unprognostic (8.03e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (8.57e-3)" "unprognostic (5.86e-2)" "unprognostic (6.80e-2)" "unprognostic (8.34e-2)" "unprognostic (1.26e-1)" "unprognostic (7.34e-3)" "unprognostic (7.26e-2)" "unprognostic (6.50e-2)" "unprognostic (4.98e-3)" "unprognostic (3.64e-2)" 16.1 61.5 8.0 5.4 8.6 27.5 10.3 7.7 7.7 12.0 4.7 8.1 5.8 6.4 59.5 7.5 9.7 10.2 13.3 7.8 8.4 20.6 35.8 12.8 5.2 11.5 9.6 13.0 24.9 20.6 10.1 12.7 11.8 10.7 7.2 2.4 9.2 10.0 2.7 3.1 4.5 9.0 10.2 10.5 16.8 3.7 10.9 4.1 18.6 4.8 5.1 11.4 4.5 11.5 0.3 5.7 0.2 0.1 2.9 3.5 0.1 0.7 0.0 0.3 0.5 7.6 13.4 0.0 25.8 0.0 0.1 0.3 0.0 0.0 0.1 0.5 1.6 1.6 2.9 46.3 1.1 9.4 34.0 1.4 1.0 0.6 0.1 5.5 0.8 0.1 0.0 1.4 0.1 1.0 0.1 65.6 0.3 3.9 2.2 0.1 0.2 0.1 0.6 8.3 0.3 0.4 8.1 0.0 93.0 0.2 0.5 48.7 0.9 0.3 3.1 2.4 5.3 0.4 0.2 0.2 22.6 43.6 11.3 6.4 57.6 22.1 0.1 28.8 0.3 0.1 0.0 0.0 67.5 0.1 0.1 0.1 3.2 7.1 17.1 0.5 0.2 18.9 8.0 8.6 7.7 7.7 7.8 8.4 11.5 9.6 11.8 10.2 10.9 11.5 42.4 22.4 19.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.1 5.7 0.0 0.0 3.7 12.9 0.0 1.1 0.8 0.0 33.2 16.6 0.0 27.8 2.5 13.2 0.0 0.0 0.0 15.8 0.8 4.5 0.0 10.0 7.6 16.1 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 6.7 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.1 0.0 0.0 113.4 6.6 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 1.2 0.6 25.7 0.0 0.0 LRRC61 "FLJ31392, HSPC295, MGC3036" ENSG00000127399 "Leucine rich repeat containing 61" Q9BV99 7 150323263-150338156 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 80.6;Hep G2: 53.3;NTERA-2: 67.0" "Low region specificity" "Detected in all" HPA019355 Approved Approved Nucleoplasm NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA019355: AB_1853339" "unprognostic (4.05e-2)" "unprognostic (9.50e-2)" "unprognostic (1.61e-3)" "unprognostic (5.91e-3)" "prognostic unfavorable (1.11e-5)" "unprognostic (1.46e-2)" "unprognostic (4.43e-3)" "unprognostic (1.82e-1)" "unprognostic (1.76e-2)" "unprognostic (4.22e-2)" "unprognostic (2.53e-2)" "unprognostic (1.56e-1)" "unprognostic (1.66e-2)" "prognostic favorable (2.85e-4)" "unprognostic (1.21e-1)" "unprognostic (3.27e-1)" "unprognostic (1.69e-3)" 4.0 18.3 9.5 4.5 8.4 1.6 4.5 6.9 8.7 7.5 9.8 5.7 4.3 6.5 2.0 8.8 14.5 4.0 4.1 7.7 13.1 12.1 23.4 4.4 7.3 9.7 10.1 15.2 11.2 11.4 13.5 3.8 10.4 6.6 1.9 2.8 5.3 4.3 2.2 6.8 5.8 2.0 8.2 6.1 6.1 9.1 13.4 11.5 8.7 2.3 3.9 4.7 6.5 6.7 20.0 0.5 0.6 0.1 0.0 0.0 9.0 0.2 0.0 2.4 7.8 37.9 19.4 6.2 8.2 0.3 0.0 17.6 0.0 0.0 1.3 80.6 24.4 7.4 23.5 53.3 13.8 0.0 3.7 1.6 7.9 0.0 0.0 0.6 0.1 40.2 25.9 11.5 0.0 36.5 37.5 3.2 67.0 13.8 0.0 0.0 0.1 16.5 5.7 13.2 34.6 33.4 33.6 7.2 13.7 5.6 5.6 4.5 0.1 0.0 0.1 0.0 0.1 12.5 4.4 0.0 0.0 0.0 0.0 2.8 2.9 8.5 10.8 1.1 8.3 8.7 7.3 8.2 3.0 10.7 7.0 8.4 13.1 8.7 1.3 17.9 12.7 5.7 9.5 8.4 6.9 8.7 7.7 13.1 9.7 10.1 10.4 8.2 13.4 6.7 0.3 6.4 1.5 2.3 7.1 1.1 4.7 16.5 8.6 7.8 8.0 8.9 2.2 11.5 6.8 16.5 0.0 25.2 11.1 9.4 19.6 27.3 5.7 20.9 1.6 1.7 19.3 3.8 1.7 28.4 24.5 4.7 7.1 5.8 1.3 22.9 1.8 22.6 6.0 13.5 3.6 6.7 18.3 1.3 0.0 16.3 10.2 3.3 3.6 0.0 16.5 13.7 11.3 4.5 0.3 27.9 11.2 5.7 3.5 4.0 11.7 48.7 20.1 4.5 0.0 5.3 3.2 20.8 23.7 8.1 2.7 27.0 7.4 9.0 10.6 3.0 LSMEM1 "C7orf53, FLJ39575" ENSG00000181016 "Leucine rich single-pass membrane protein 1" Q8N8F7 7 112480853-112491062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 81.6" "Cell type enhanced" "Detected in many" "Early spermatids: 49.2;Glandular and luminal cells: 27.7;Late spermatids: 67.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HeLa: 8.7" "Group enriched" "Detected in many" 4 "amygdala: 1.4;basal ganglia: 1.0;cerebellum: 4.0;olfactory bulb: 3.3" "Low region specificity" "Detected in many" "HPA013753, HPA047988" Uncertain Supported Vesicles,Cytosol NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Cytosol Vesicles "HPA013753: AB_1848926, HPA047988: AB_2680229" "unprognostic (6.87e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-2)" "unprognostic (2.77e-2)" "unprognostic (1.38e-1)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (6.68e-2)" "unprognostic (3.54e-2)" "unprognostic (2.80e-3)" "unprognostic (1.47e-6)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.25e-2)" "unprognostic (3.42e-2)" 2.2 2.1 1.2 0.2 1.7 0.3 1.5 2.1 2.5 1.7 1.1 2.0 0.5 1.0 1.0 2.0 1.6 0.1 2.9 1.2 1.7 4.0 7.2 4.3 0.1 1.2 1.1 1.7 5.5 0.0 2.3 0.2 1.1 2.5 0.3 0.8 1.7 0.3 81.6 1.4 2.2 0.1 0.8 4.2 2.7 2.9 1.3 0.1 2.2 17.0 0.0 1.8 2.2 1.5 0.0 0.1 0.1 0.6 0.5 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.2 8.7 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.9 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.7 1.3 0.0 0.2 0.4 0.1 0.0 0.2 0.5 0.3 0.1 0.2 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.7 2.1 2.5 1.2 1.7 1.2 1.1 1.1 0.8 1.3 1.5 16.8 0.0 2.8 5.9 5.1 5.5 2.7 1.3 9.6 2.1 12.8 23.4 9.9 2.8 2.2 1.8 2.1 1.3 9.5 17.5 0.0 0.8 49.2 12.7 18.4 5.3 3.0 0.0 8.5 0.9 1.1 7.2 7.7 27.7 0.0 0.5 1.1 1.0 4.0 0.0 7.6 5.7 0.0 1.2 4.8 67.8 0.9 13.6 1.8 3.7 1.8 0.6 0.0 1.5 5.0 0.8 7.1 0.4 4.2 6.1 5.2 0.5 1.4 3.2 0.0 22.3 8.1 0.5 0.5 9.5 4.7 1.9 6.3 2.2 5.4 3.6 MACO1 "FLJ10747, TMEM57" ENSG00000204178 "Macoilin 1" Q8N5G2 1 25430858-25500209 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 38.8;Exocrine glandular cells: 62.3;Pancreatic endocrine cells: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019680 Approved Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA019680: AB_1858125" "unprognostic (2.42e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.83e-2)" "unprognostic (2.16e-1)" "unprognostic (1.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.69e-2)" "unprognostic (6.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (7.02e-2)" "prognostic favorable (7.13e-4)" "unprognostic (2.54e-2)" "unprognostic (4.22e-2)" "unprognostic (5.22e-2)" "unprognostic (5.35e-3)" 8.5 15.0 11.2 5.3 10.8 28.4 8.7 19.9 14.9 8.6 12.8 8.5 6.2 7.9 12.5 16.1 6.9 7.4 8.4 10.9 11.2 11.8 26.3 8.3 7.8 10.6 9.9 16.2 24.9 9.2 8.9 6.8 11.1 12.3 7.8 11.0 16.3 7.9 30.3 9.6 9.0 7.4 10.5 8.7 11.7 14.1 10.0 11.4 12.4 15.2 9.0 7.3 9.6 12.7 8.6 3.6 9.3 18.0 16.4 10.1 4.3 9.0 11.1 9.2 8.6 2.6 11.0 20.1 10.1 11.9 5.2 8.0 8.8 9.2 10.4 9.4 7.9 26.8 5.7 7.7 9.3 10.1 15.3 10.3 13.3 12.5 8.9 9.7 11.6 12.4 15.8 7.5 9.3 5.0 19.0 13.8 13.2 10.1 7.1 12.1 11.0 15.0 15.0 3.7 15.2 15.5 7.5 19.3 10.9 7.3 7.7 14.3 13.8 9.3 6.2 12.9 6.2 12.1 7.2 10.6 10.5 13.1 7.9 0.5 0.3 1.6 0.3 0.2 0.5 0.4 0.5 0.5 0.2 0.5 0.4 0.7 0.1 0.3 0.3 1.1 0.3 0.2 11.2 10.8 19.9 14.9 10.9 11.2 10.6 9.9 11.1 10.5 10.0 12.7 31.3 19.2 23.6 0.0 9.9 0.0 0.0 0.0 0.0 0.0 27.8 17.8 0.0 0.0 11.2 7.3 0.0 13.7 27.0 0.0 5.9 38.8 0.0 19.4 23.8 12.9 0.0 0.0 0.0 62.3 22.7 9.2 0.0 32.5 10.1 26.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 7.2 0.0 0.0 0.0 0.0 48.6 0.0 0.0 9.8 0.0 0.0 19.6 13.8 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 10.4 11.0 22.7 0.0 0.0 MAP1LC3B ATG8F ENSG00000140941 "Microtubule associated protein 1 light chain 3 beta" Q9GZQ8 16 87383953-87404779 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037216, HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Vesicles Nucleoplasm "CAB037216: AB_796155, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253" "unprognostic (4.70e-3)" "unprognostic (2.89e-1)" "unprognostic (3.21e-1)" "unprognostic (9.70e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-2)" "unprognostic (4.98e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "prognostic favorable (2.77e-7)" "prognostic unfavorable (8.97e-4)" "unprognostic (9.66e-2)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" 92.0 82.9 108.4 37.5 112.9 245.6 72.9 123.7 135.3 46.1 110.7 46.2 25.5 52.6 44.7 45.0 48.2 57.0 102.7 105.2 130.1 71.3 50.3 50.9 52.5 131.5 132.0 43.3 37.1 74.2 51.1 75.6 140.8 43.6 47.1 125.9 49.2 49.3 195.2 62.5 36.9 66.6 120.5 44.4 42.3 51.8 126.5 54.9 63.5 176.7 51.4 57.3 42.0 123.8 56.9 33.7 63.8 59.2 188.5 145.3 41.9 111.4 130.1 88.0 59.9 56.0 42.4 37.7 82.0 155.7 97.5 50.8 95.2 72.3 125.3 49.9 81.0 39.4 40.2 94.4 313.4 28.3 40.0 194.9 234.8 137.0 326.0 131.1 101.1 57.2 107.4 79.0 150.4 61.5 48.4 64.0 66.1 27.7 81.2 76.2 42.2 37.6 119.0 28.4 53.0 60.3 174.8 29.4 230.8 85.2 48.0 34.0 134.1 94.7 59.7 86.4 65.3 99.4 131.5 137.7 133.9 68.3 69.6 312.5 86.8 198.1 78.6 81.6 80.5 72.5 75.8 81.1 69.2 58.2 58.4 62.0 214.3 104.7 85.3 75.1 108.2 109.2 108.4 112.9 123.7 135.3 105.2 130.1 131.5 132.0 140.8 120.5 126.5 123.8 523.1 89.8 90.5 15.7 185.3 221.0 203.1 176.2 301.7 70.4 183.9 227.3 180.7 72.9 117.2 77.3 52.1 130.6 242.7 309.1 262.2 310.9 222.1 283.6 235.9 191.7 132.2 364.2 29.2 134.8 140.2 177.7 96.4 530.5 131.1 49.3 80.7 70.1 206.4 87.5 41.4 137.3 238.0 150.9 268.5 269.7 90.7 262.2 188.5 19.7 207.0 194.3 143.2 14.6 26.9 322.8 407.6 89.1 202.0 209.3 217.4 236.9 133.5 124.0 59.2 129.5 168.2 361.2 206.7 221.8 213.5 631.5 221.6 85.7 122.4 294.5 MAP3K20 "MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK" ENSG00000091436 "Mitogen-activated protein kinase kinase kinase 20" Q9NYL2 2 173075435-173268015 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 261.9;tongue: 279.7" "Cell type enhanced" "Detected in many" "Adipocytes: 57.5;Alveolar cells type 2: 57.7;Cytotrophoblasts: 52.6;Endometrial stromal cells: 96.7;Granulosa cells: 100.7;Smooth muscle cells: 83.2;Theca cells: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 15.5" "Group enriched" "Detected in many" 5 "dendritic cells: 15.5;monocytes: 9.4" "Cell line enhanced" "Detected in many" "U-138 MG: 176.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017205 Approved Supported Cytosol NA Yes "Cluster 28: Myeloid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA017205: AB_1858933" "unprognostic (2.90e-2)" "unprognostic (9.99e-3)" "unprognostic (4.63e-3)" "unprognostic (1.98e-1)" "unprognostic (7.63e-2)" "unprognostic (5.02e-2)" "unprognostic (2.34e-2)" "unprognostic (3.89e-3)" "unprognostic (2.83e-2)" "unprognostic (9.27e-2)" "unprognostic (4.54e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.41e-6)" "unprognostic (2.34e-1)" "unprognostic (1.86e-1)" "unprognostic (2.23e-1)" "unprognostic (1.19e-2)" 71.0 11.4 9.5 20.5 9.7 4.7 21.4 10.3 8.5 44.9 15.7 65.8 13.0 76.4 18.6 50.0 48.0 31.4 195.7 9.3 12.1 7.5 25.2 22.5 9.8 13.8 14.7 69.5 11.7 49.3 3.8 27.6 11.2 44.0 20.9 2.5 12.4 57.1 261.9 14.1 19.2 75.0 11.1 12.5 31.5 10.6 12.5 11.5 16.4 279.7 10.2 56.1 21.2 9.4 34.6 28.6 22.0 29.1 62.7 92.5 13.8 121.9 94.7 55.9 59.6 19.5 22.2 26.5 31.2 122.5 48.8 22.9 33.1 64.6 124.2 52.0 22.0 43.3 30.5 4.1 24.8 39.3 43.8 74.7 27.2 105.2 164.2 46.3 37.5 28.5 19.8 4.9 36.8 14.8 24.8 19.0 12.2 28.9 16.0 36.2 45.0 0.1 13.6 19.6 12.9 12.4 47.0 11.3 19.7 35.6 12.9 20.9 37.9 176.3 71.4 53.1 27.9 0.1 0.1 5.5 126.2 10.6 18.9 0.2 9.4 0.0 1.0 8.3 1.0 1.6 0.8 1.7 15.5 2.5 0.0 0.8 2.6 0.5 8.2 0.3 0.8 3.4 9.5 9.7 10.3 8.5 9.3 12.1 13.8 14.7 11.2 11.1 12.5 9.4 57.5 38.5 57.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 20.0 44.4 0.0 0.0 7.4 11.0 0.0 52.6 2.3 0.0 1.9 43.9 0.0 36.7 96.7 14.1 0.0 0.0 0.0 27.6 21.9 36.5 0.0 35.6 5.1 100.7 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 15.5 0.0 0.0 0.0 0.0 38.6 0.0 0.0 1.4 0.0 0.0 1.9 13.1 0.0 0.0 0.0 83.2 0.0 0.0 0.0 0.0 21.6 3.6 70.5 0.0 0.0 MARF1 "KIAA0430, LKAP, LMKB, PPP1R34" ENSG00000166783 "Meiosis regulator and mRNA stability factor 1" Q9Y4F3 16 15594387-15643154 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 28.7;Breast glandular cells: 26.3;Endometrial stromal cells: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017992 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Vesicles" "HPA017992: AB_1852921" "unprognostic (2.33e-1)" "unprognostic (6.44e-3)" "unprognostic (8.84e-2)" "unprognostic (3.78e-2)" "unprognostic (1.28e-1)" "unprognostic (6.13e-3)" "unprognostic (2.35e-1)" "unprognostic (2.10e-2)" "unprognostic (2.47e-2)" "unprognostic (6.93e-2)" "unprognostic (8.44e-3)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (8.74e-2)" "unprognostic (7.94e-2)" 10.5 7.1 2.1 10.8 5.2 9.7 9.4 1.5 6.6 10.0 3.7 16.0 10.4 12.8 1.0 12.3 13.7 12.5 9.2 4.5 3.4 13.5 8.3 9.3 14.6 3.6 4.5 18.2 12.9 12.3 5.9 9.4 2.6 10.4 12.1 8.4 14.4 13.7 18.3 10.5 11.2 12.0 0.0 12.1 10.1 4.9 4.4 12.7 14.8 15.2 22.0 12.1 8.8 4.5 8.3 9.4 15.0 8.2 12.1 22.4 7.2 9.6 12.4 8.2 13.5 2.7 6.2 29.8 17.0 12.3 6.7 5.6 7.7 12.4 13.6 11.6 5.0 13.1 12.3 10.4 13.4 15.7 10.5 13.4 13.4 15.3 15.5 16.9 19.5 12.8 12.6 13.3 15.6 7.7 13.9 2.6 5.6 7.1 7.2 19.5 22.0 5.9 7.1 6.4 9.1 10.8 7.7 8.9 14.3 6.7 9.2 13.2 19.7 11.2 5.5 11.6 6.3 12.3 12.9 15.9 12.4 9.6 16.4 2.5 0.7 4.6 1.1 1.2 0.7 4.1 1.7 1.3 0.8 5.2 1.9 1.4 7.1 0.9 1.8 0.3 1.7 0.9 2.1 5.2 1.5 6.6 4.5 3.4 3.6 4.5 2.6 0.0 4.4 4.5 21.4 22.4 28.7 0.0 10.7 0.0 0.0 0.0 0.0 0.0 26.3 19.8 0.0 0.0 18.6 23.9 0.0 5.7 14.7 0.0 15.6 10.4 0.0 17.8 27.5 8.4 0.0 0.0 0.0 14.2 5.9 7.7 0.0 20.0 11.4 23.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 7.2 0.0 0.0 0.0 0.0 13.7 0.0 0.0 6.8 0.0 0.0 19.0 17.5 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 7.7 7.8 17.9 0.0 0.0 MCRIP1 "FAM195B, GRAN2, MCRIP" ENSG00000225663 "MAPK regulated corepressor interacting protein 1" C9JLW8 17 81822361-81833302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 116.5;Exocrine glandular cells: 243.8;Extravillous trophoblasts: 154.1;Hofbauer cells: 161.7;Pancreatic endocrine cells: 137.0;Proximal tubular cells: 140.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045542 Approved Approved Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA045542: AB_2679363" "unprognostic (3.11e-3)" "unprognostic (3.82e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-3)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" "unprognostic (3.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (9.08e-3)" "prognostic favorable (2.26e-4)" "unprognostic (2.53e-2)" "unprognostic (3.65e-2)" "unprognostic (4.84e-2)" "unprognostic (1.64e-1)" "unprognostic (2.87e-1)" "unprognostic (1.86e-1)" 93.2 76.0 70.1 18.7 68.1 27.4 87.6 65.7 98.5 98.8 46.6 139.6 9.1 100.8 10.4 35.6 87.3 18.3 150.1 68.0 66.0 97.7 82.6 77.6 24.1 72.8 70.8 94.5 97.6 16.8 94.1 18.1 69.7 108.6 3.7 7.3 54.6 15.6 52.2 46.3 57.3 15.9 65.5 85.1 71.5 168.4 71.6 19.9 85.5 16.5 8.0 106.0 65.2 67.0 25.8 38.0 42.8 44.8 26.7 30.1 32.8 29.7 21.1 34.8 37.8 9.9 24.8 15.6 17.3 24.6 12.7 5.8 5.1 17.0 8.6 17.1 52.5 28.0 7.1 38.4 26.2 18.7 25.4 32.7 16.4 19.7 8.5 18.9 61.3 35.5 22.7 13.0 23.1 16.8 60.2 42.4 27.0 10.2 21.5 24.0 27.4 7.1 11.9 22.7 36.0 111.7 14.9 19.5 93.2 16.3 17.9 25.0 39.8 50.1 55.0 56.0 55.3 6.8 2.3 10.8 46.6 16.6 40.5 65.7 31.8 45.4 37.8 43.2 29.2 23.7 29.6 34.0 29.4 33.8 23.7 27.3 24.9 28.3 46.3 39.9 39.5 40.3 70.1 68.1 65.7 98.5 68.0 66.0 72.8 70.8 69.7 65.5 71.6 67.0 84.9 19.2 35.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 69.4 76.6 0.0 0.0 11.2 38.6 0.0 116.5 57.9 0.0 74.3 113.5 0.0 27.5 48.5 38.9 0.0 0.0 0.0 243.8 154.1 38.3 0.0 37.7 20.2 70.7 0.0 0.0 161.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.6 0.0 0.0 49.1 0.0 0.0 0.0 0.0 137.0 0.0 0.0 6.1 0.0 0.0 140.0 13.8 0.0 0.0 0.0 54.3 0.0 0.0 0.0 0.0 98.6 23.3 50.9 0.0 0.0 MCUB "CCDC109B, FLJ20647" ENSG00000005059 "Mitochondrial calcium uniporter dominant negative subunit beta" Q9NWR8 4 109560209-109688719 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 32.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 127.7;Exocrine glandular cells: 111.4;Extravillous trophoblasts: 91.9;Hofbauer cells: 106.8;Pancreatic endocrine cells: 67.9;Syncytiotrophoblasts: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 93.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048776 Enhanced Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Cluster 30: Non-specific - Translation" "Cluster 3: T-cells - Adaptive immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Vesicles, Mitochondria" "HPA048776: AB_2680518" "unprognostic (6.12e-3)" "unprognostic (1.70e-2)" "unprognostic (3.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.42e-1)" "unprognostic (1.70e-1)" "unprognostic (1.70e-2)" "unprognostic (3.06e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-3)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.35e-6)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" 10.2 2.0 2.6 18.4 3.0 10.6 7.6 2.1 3.4 7.0 3.5 5.3 3.8 8.8 1.5 6.8 5.8 7.8 10.5 2.7 4.6 3.5 2.2 7.2 32.2 4.3 3.0 5.6 1.5 1.2 3.7 6.1 3.2 3.0 6.3 3.7 4.9 2.1 1.4 6.2 7.8 8.2 3.7 13.5 4.6 3.0 5.2 31.4 3.3 3.5 25.7 9.2 7.5 4.6 26.9 11.7 6.4 32.6 6.9 18.1 23.9 23.3 14.2 24.9 22.1 0.6 21.6 93.0 4.6 20.2 13.8 7.6 24.1 14.0 21.9 59.2 18.4 11.3 11.6 1.6 12.1 23.6 0.4 11.7 3.8 15.1 13.0 17.7 33.9 35.0 3.3 59.4 19.2 34.0 54.1 0.4 28.2 4.8 15.6 20.4 47.7 10.8 29.6 12.1 25.6 11.1 24.2 73.4 7.7 5.3 9.2 1.2 23.9 9.8 12.6 51.8 40.2 22.3 16.4 22.7 29.9 4.9 6.9 0.4 51.4 0.8 18.9 32.2 26.6 43.6 79.1 56.5 49.8 50.7 114.7 66.2 3.6 65.0 24.4 35.1 74.9 92.2 2.6 3.0 2.1 3.4 2.7 4.6 4.3 3.0 3.2 3.7 5.2 4.6 21.5 9.6 5.2 0.0 19.5 0.0 0.0 0.0 0.0 0.0 12.7 9.9 0.0 0.0 2.5 5.5 0.0 127.7 36.0 0.0 0.0 25.2 0.0 7.0 5.9 11.7 0.0 0.0 0.0 111.4 91.9 15.1 0.0 8.9 1.3 9.1 0.0 0.0 106.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 14.5 0.0 0.0 0.0 0.0 67.9 0.0 0.0 5.8 0.0 0.0 0.9 2.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 73.5 28.2 7.4 0.0 0.0 MED29 "DKFZp434H247, IXL, MED2" ENSG00000063322 "Mediator complex subunit 29" Q9NX70 19 39391303-39400641 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055956 Supported Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA055956: AB_2682986" "unprognostic (3.30e-2)" "unprognostic (3.51e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.68e-1)" "unprognostic (1.92e-1)" "unprognostic (2.85e-2)" "unprognostic (1.71e-1)" "unprognostic (5.36e-3)" "unprognostic (1.46e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-2)" "prognostic favorable (5.15e-5)" "unprognostic (9.51e-2)" "unprognostic (4.84e-2)" "unprognostic (2.17e-1)" "unprognostic (1.87e-2)" 18.8 28.6 38.3 16.0 39.5 18.1 19.0 37.5 39.5 22.6 27.9 23.1 17.2 23.2 21.4 16.3 28.7 17.1 24.1 37.8 37.0 21.8 27.9 17.4 19.1 39.6 39.2 31.9 24.0 42.0 27.9 15.6 37.7 23.1 13.1 18.3 23.1 22.8 38.0 17.7 17.4 18.5 37.2 19.7 20.2 16.5 42.1 18.6 29.9 14.1 16.7 20.7 17.5 38.9 28.3 73.2 21.7 22.3 31.0 23.5 17.3 29.9 31.9 27.1 21.8 36.2 26.6 20.9 38.9 27.7 23.7 14.5 20.3 25.4 16.1 40.8 37.3 26.9 28.8 24.6 25.2 25.8 22.7 25.0 20.3 28.5 31.5 29.3 21.8 39.4 18.1 25.3 27.9 36.7 25.3 7.7 16.6 34.5 25.4 41.3 29.8 29.6 26.3 47.0 33.3 30.1 60.8 39.4 26.6 13.1 30.8 27.9 25.2 22.9 23.8 29.0 30.4 32.5 40.3 35.2 32.3 19.2 37.7 48.2 48.3 41.2 38.3 59.7 38.2 46.5 35.7 35.2 36.9 43.0 42.4 40.6 54.2 40.0 77.5 30.0 46.8 47.0 38.3 39.5 37.5 39.5 37.8 37.0 39.6 39.2 37.7 37.2 42.1 38.9 33.6 28.9 41.1 8.8 36.5 22.2 30.2 31.9 25.6 24.9 45.0 57.9 36.5 25.8 30.1 31.3 12.5 36.6 34.9 53.3 52.8 28.0 49.8 46.6 40.6 30.4 32.8 27.8 8.1 28.4 31.4 36.3 126.9 46.7 43.7 28.0 37.5 43.4 40.7 23.5 10.1 40.2 40.7 40.3 72.5 71.6 38.5 46.9 28.4 8.4 38.1 37.5 26.8 5.5 13.5 25.5 60.2 32.4 47.8 17.6 86.8 62.3 37.1 15.9 52.6 33.3 52.5 34.8 16.4 29.3 20.3 28.9 40.1 27.9 32.7 17.9 MEPCE "BCDIN3, FLJ20257" ENSG00000146834 "Methylphosphate capping enzyme" Q7L2J0 7 100428790-100434118 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026384, HPA051587" Supported Approved "Nucleoplasm,Cell Junctions" NA Yes "Cluster 26: Non-specific - Mitochondria" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Cell Junctions" "CAB026384: , HPA051587: AB_2681544" "unprognostic (8.59e-2)" "unprognostic (1.23e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (6.01e-6)" "unprognostic (1.09e-1)" "unprognostic (1.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.09e-1)" "prognostic favorable (1.01e-10)" "unprognostic (9.66e-2)" "unprognostic (9.31e-2)" "unprognostic (4.57e-1)" "unprognostic (9.50e-3)" 26.4 41.0 27.5 19.4 28.3 28.3 24.2 30.4 31.5 26.1 23.6 25.8 18.5 28.8 27.8 27.5 27.0 19.4 26.8 26.7 27.0 37.0 36.9 21.9 29.0 27.6 27.3 36.0 22.5 35.0 23.6 20.9 27.4 26.5 12.9 9.9 24.9 20.7 38.5 34.5 27.2 18.0 26.8 56.6 24.6 79.8 28.0 28.1 36.5 31.5 24.2 28.3 21.9 28.2 42.6 53.6 38.9 41.9 36.8 36.7 29.1 46.4 66.5 48.7 37.4 43.8 60.1 87.1 75.5 29.1 38.5 38.4 43.0 34.9 32.0 39.4 49.4 45.1 41.5 33.3 30.9 58.0 53.0 38.2 40.9 55.7 70.0 26.5 41.1 27.4 90.6 62.2 47.2 155.6 66.3 129.8 72.1 35.0 58.9 53.0 31.5 79.1 32.7 25.6 58.5 50.6 72.5 139.1 49.1 19.3 35.6 52.1 36.2 81.5 63.5 55.9 62.0 41.0 42.4 96.3 45.8 71.1 72.9 2.6 2.6 3.7 3.8 2.3 4.6 6.2 4.4 4.2 3.3 6.6 6.2 5.5 6.4 5.9 1.9 6.3 4.5 7.5 27.5 28.3 30.4 31.5 26.7 27.0 27.6 27.3 27.4 26.8 28.0 28.2 34.2 9.6 18.9 5.5 33.8 30.2 17.3 7.1 19.9 9.9 30.2 21.6 25.6 20.0 7.8 22.0 8.4 15.8 34.3 32.2 15.6 10.3 29.6 18.3 13.1 21.7 10.7 9.9 2.8 12.0 8.5 17.3 54.6 18.8 18.3 14.5 28.9 22.1 12.7 11.8 2.6 26.1 8.2 26.7 16.9 66.5 17.4 32.9 8.8 7.5 18.1 19.4 15.5 2.5 2.7 10.4 23.6 15.4 14.9 15.6 39.9 14.4 10.4 9.5 6.6 35.0 17.9 44.8 15.1 22.3 25.1 21.2 25.0 19.5 20.3 9.9 MESD "BOCA, KIAA0081, MESDC2" ENSG00000117899 "Mesoderm development LRP chaperone" Q14696 15 80946289-80989828 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" Chaperone "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 341.4;Extravillous trophoblasts: 279.3;Syncytiotrophoblasts: 436.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039414, HPA041721" Approved Supported "Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 1600000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "Nuclear bodies, Cytosol" "HPA039414: AB_10674981, HPA041721: AB_2756310" "unprognostic (9.21e-2)" "unprognostic (4.50e-2)" "unprognostic (8.02e-2)" "prognostic favorable (2.31e-4)" "unprognostic (4.93e-3)" "unprognostic (2.32e-3)" "unprognostic (3.47e-2)" "unprognostic (3.09e-3)" "unprognostic (4.04e-1)" "prognostic favorable (1.12e-4)" "unprognostic (7.93e-2)" "unprognostic (3.05e-2)" "unprognostic (3.42e-2)" "unprognostic (1.68e-1)" "unprognostic (4.32e-2)" "unprognostic (3.83e-1)" "unprognostic (1.88e-1)" 14.4 17.4 11.9 13.7 13.6 5.4 13.9 13.7 13.0 17.8 14.6 14.6 12.8 11.3 42.7 14.6 12.4 11.5 12.8 11.7 14.2 14.4 20.6 14.1 14.0 13.4 13.1 17.4 19.2 14.0 17.8 26.9 13.8 18.2 14.5 10.4 18.4 14.3 7.7 10.9 12.7 11.1 13.4 13.8 15.3 9.8 13.8 14.2 33.7 10.6 13.2 15.4 14.4 15.0 26.8 40.2 34.6 22.3 57.1 32.4 54.0 40.0 47.4 42.7 51.6 36.0 72.9 22.4 45.4 32.3 45.1 43.8 54.1 41.1 40.3 50.2 35.5 28.3 33.0 61.9 43.7 33.8 30.0 33.9 46.6 36.1 42.4 35.7 41.1 27.0 34.7 55.5 36.7 34.0 20.9 28.3 41.9 39.3 16.4 31.7 21.3 59.7 35.6 36.3 29.9 17.6 43.9 29.3 70.0 62.4 34.0 26.8 32.4 40.9 39.1 22.1 52.2 35.0 48.0 30.2 38.5 59.7 43.8 39.4 26.1 19.1 35.6 24.9 41.8 34.5 37.2 35.4 27.2 35.4 34.6 34.7 8.1 44.8 22.5 45.2 42.5 31.1 11.9 13.6 13.7 13.0 11.7 14.2 13.4 13.1 13.8 13.4 13.8 15.0 59.7 80.1 59.6 0.0 20.6 0.0 0.0 0.0 0.0 0.0 51.0 44.2 0.0 0.0 27.9 58.8 0.0 341.4 41.6 0.0 13.7 100.9 0.0 41.4 79.4 36.9 0.0 0.0 0.0 111.9 279.3 48.4 0.0 69.8 36.6 56.4 0.0 0.0 122.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 86.3 0.0 0.0 0.0 0.0 82.5 0.0 0.0 18.8 0.0 0.0 48.8 43.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 436.0 25.8 63.6 0.0 0.0 METTL26 "C16orf13, MGC13114" ENSG00000130731 "Methyltransferase like 26" Q96S19 16 634427-636366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 172.6;Distal tubular cells: 168.3;Extravillous trophoblasts: 187.2;Proximal tubular cells: 289.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044004, HPA067414" Uncertain Approved "Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA044004: AB_10964777, HPA067414: " "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (3.35e-1)" "unprognostic (1.52e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (6.27e-2)" "unprognostic (6.93e-2)" "unprognostic (6.21e-2)" "unprognostic (1.20e-1)" "unprognostic (4.71e-2)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.73e-6)" "unprognostic (2.59e-1)" "unprognostic (1.37e-1)" "unprognostic (2.53e-1)" "unprognostic (2.72e-2)" 55.7 71.7 97.8 14.5 100.4 23.6 49.9 90.3 158.9 55.2 90.2 65.7 18.6 57.0 23.8 47.4 50.3 10.6 82.3 102.3 95.8 68.8 75.5 44.9 12.0 92.5 92.7 65.5 50.3 30.2 54.3 13.7 93.0 59.0 10.5 5.2 49.1 22.3 91.3 54.0 39.7 13.6 91.4 47.3 56.0 55.1 97.2 25.8 46.3 35.1 11.8 55.2 47.9 97.7 59.6 60.7 20.0 48.6 28.7 47.2 72.5 46.5 39.2 40.1 30.3 55.6 50.2 71.8 77.7 38.2 47.9 74.5 28.7 73.8 12.5 54.1 140.1 45.9 86.6 83.0 68.5 68.6 41.5 43.1 41.3 53.5 39.9 47.0 48.8 87.7 55.5 29.2 23.3 94.0 75.8 120.4 61.7 83.5 174.9 105.2 23.1 147.6 64.2 25.4 86.9 60.1 43.0 77.9 57.5 14.3 57.4 67.7 35.1 40.4 52.9 67.1 46.5 69.8 47.2 52.7 41.2 43.6 35.7 102.9 119.8 68.3 110.1 145.3 121.6 145.4 114.9 109.2 150.7 124.1 108.6 105.2 26.2 123.0 167.7 162.7 160.0 120.9 97.8 100.4 90.3 158.9 102.3 95.8 92.5 92.7 93.0 91.4 97.2 97.7 70.2 32.1 61.3 0.0 20.9 0.0 0.0 0.0 0.0 0.0 119.6 172.6 0.0 0.0 19.2 49.7 0.0 113.3 52.9 0.0 168.3 118.6 0.0 72.7 73.3 29.2 0.0 0.0 0.0 94.1 187.2 42.7 0.0 59.0 25.2 119.7 0.0 0.0 106.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 0.0 41.3 0.0 0.0 0.0 0.0 91.8 0.0 0.0 8.4 0.0 0.0 289.7 28.4 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 57.9 30.9 125.9 0.0 0.0 MIA2 "cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI" ENSG00000150527 "MIA SH3 domain ER export factor 2" Q96PC5 14 39230231-39388513 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 138.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 44.1;Ductal cells: 42.9;Endometrial ciliated cells: 78.7;Exocrine glandular cells: 42.7;Glandular and luminal cells: 93.5;Pancreatic endocrine cells: 41.3;Proximal tubular cells: 61.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 125.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000387, HPA000922, HPA054066, HPA055459" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819" "unprognostic (2.62e-1)" "unprognostic (7.17e-3)" "unprognostic (2.33e-1)" "unprognostic (5.27e-4)" "unprognostic (3.21e-4)" "unprognostic (2.63e-1)" "unprognostic (2.48e-1)" "unprognostic (7.18e-2)" "unprognostic (1.12e-1)" "unprognostic (1.21e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "prognostic favorable (2.81e-4)" "unprognostic (6.93e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-1)" "unprognostic (3.97e-2)" 12.1 26.6 5.6 16.8 6.9 23.6 22.1 5.8 7.9 29.7 58.0 30.8 80.4 15.7 40.2 26.9 22.2 30.3 16.6 9.4 6.5 78.4 138.9 15.5 16.2 5.6 4.7 9.6 43.6 40.5 15.5 11.2 6.4 21.1 34.6 12.8 52.5 19.2 54.5 9.9 78.4 12.3 4.1 14.5 45.3 21.0 5.1 14.3 46.7 20.7 19.8 16.2 17.2 7.1 23.0 25.1 10.4 18.5 20.6 23.2 14.5 13.3 13.9 9.3 9.6 19.7 125.4 27.5 40.1 15.0 18.9 34.1 12.7 15.0 11.0 21.4 10.6 17.2 11.5 106.1 48.2 23.2 30.7 14.4 83.7 9.2 69.2 59.0 15.3 31.8 16.6 68.3 14.0 22.1 14.9 18.9 12.0 87.2 20.8 15.2 18.3 34.9 42.7 24.7 8.7 5.1 31.0 32.5 20.4 13.1 31.2 24.8 24.3 14.1 9.2 10.4 8.8 38.7 35.7 27.2 7.9 14.5 12.0 40.9 16.3 25.9 15.4 18.0 14.0 11.7 11.6 14.4 17.8 13.1 14.2 13.2 34.5 14.6 21.0 12.3 11.8 11.8 5.6 6.9 5.8 7.9 9.4 6.5 5.6 4.7 6.4 4.1 5.1 7.1 26.7 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 33.1 19.9 0.0 5.7 0.0 44.1 0.0 5.6 35.9 0.8 7.9 42.9 0.5 78.7 30.7 7.1 0.0 0.0 0.1 42.7 5.0 4.6 0.0 93.5 0.0 10.3 0.0 3.8 7.6 0.0 0.1 1.8 0.0 0.0 0.0 0.6 0.0 12.7 0.0 0.0 23.8 0.0 1.0 0.0 0.0 41.3 0.0 0.0 8.1 0.0 6.6 61.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 7.0 13.6 20.0 0.2 0.0 MIDN ENSG00000167470 Midnolin Q504T8 19 1248553-1259140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 455.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 11.8" "Lineage enriched" "Detected in many" 9 "granulocytes: 11.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042018, HPA049432" Uncertain Approved Nucleoplasm Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA042018: AB_2677800, HPA049432: AB_2680765" "unprognostic (1.82e-2)" "unprognostic (6.21e-2)" "unprognostic (2.27e-2)" "unprognostic (2.18e-2)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (1.06e-2)" "unprognostic (2.04e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "unprognostic (3.56e-1)" "unprognostic (1.19e-2)" 71.4 61.9 25.6 25.2 25.0 82.6 42.7 24.9 32.3 48.0 16.1 53.9 22.3 34.2 6.3 99.2 64.6 31.4 72.9 21.1 32.1 46.9 50.5 67.0 19.1 44.8 30.1 61.4 37.4 8.2 81.9 15.5 29.8 39.2 12.0 12.4 46.6 11.5 141.6 79.1 52.6 12.4 29.8 50.3 56.1 19.6 32.4 19.0 35.0 17.4 15.1 42.2 55.7 23.1 14.7 31.8 53.5 25.0 11.2 19.0 39.2 25.0 14.9 12.6 8.9 41.8 16.1 23.3 26.6 18.9 6.8 29.6 16.3 26.5 4.9 32.9 30.0 32.8 21.8 33.3 22.7 33.3 46.9 29.4 24.4 15.1 14.3 19.5 20.8 27.3 42.7 24.0 13.5 58.9 44.6 13.6 117.6 28.6 21.1 68.8 15.2 10.7 23.8 17.2 42.7 55.9 52.9 50.1 33.7 27.7 20.2 37.7 26.2 22.9 25.4 106.2 27.3 22.4 13.2 32.2 43.9 14.6 79.5 1.6 1.0 1.1 1.0 1.0 0.7 0.2 0.3 0.7 0.4 0.3 0.2 0.5 11.8 1.3 1.1 0.4 0.1 0.7 25.6 25.0 24.9 32.3 21.1 32.1 44.8 30.1 29.8 29.8 32.4 23.1 330.7 38.5 60.5 17.3 101.1 98.9 128.3 114.4 175.8 53.9 290.6 224.2 84.3 117.2 86.2 134.3 31.3 15.8 184.8 455.8 19.6 125.5 34.7 220.6 84.5 186.1 164.5 19.4 8.0 155.5 47.3 84.0 132.0 294.7 61.5 60.6 197.4 80.9 77.9 21.9 5.6 219.5 59.0 100.0 134.9 33.3 49.7 150.9 42.7 24.4 49.7 77.8 96.8 32.2 10.3 259.0 306.8 33.1 69.9 190.9 242.1 35.8 109.6 35.7 39.5 219.8 142.4 3.3 12.0 227.3 148.0 81.3 122.9 33.2 167.8 190.7 MIGA1 "FAM73A, FLJ35093" ENSG00000180488 "Mitoguardin 1" Q8NAN2 1 77779624-77879539 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 33.2;Alveolar cells type 1: 35.3;Breast glandular cells: 28.1;Glandular and luminal cells: 29.1;Proximal tubular cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017589 Approved Supported Mitochondria NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA017589: AB_1848409" "unprognostic (3.27e-1)" "unprognostic (1.19e-2)" "unprognostic (7.31e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (3.48e-2)" "unprognostic (2.70e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (6.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.89e-1)" "unprognostic (1.68e-1)" "unprognostic (4.71e-2)" "unprognostic (4.75e-2)" 8.8 7.9 6.0 5.4 10.3 6.8 14.2 8.2 9.1 7.2 0.0 6.2 7.3 8.8 5.2 6.3 6.5 7.7 6.5 6.7 9.3 14.9 8.5 6.1 5.3 10.8 9.0 9.0 6.1 18.9 3.4 7.7 11.0 9.6 5.7 5.6 9.2 6.6 7.1 4.6 8.1 7.4 9.5 5.9 7.5 5.2 8.5 4.5 16.5 9.4 4.2 6.0 3.6 19.3 11.8 7.5 4.6 5.9 11.1 14.3 12.1 16.7 7.8 9.6 9.8 7.7 8.0 5.1 18.0 11.5 11.6 7.9 6.3 9.9 18.0 7.4 6.4 6.0 8.9 3.9 11.4 5.6 4.5 10.4 10.5 19.7 14.2 13.8 9.8 4.5 3.4 6.7 14.8 1.9 5.5 3.2 3.9 5.8 9.2 2.9 11.3 2.6 11.6 12.5 9.2 7.4 7.7 11.4 21.8 7.6 4.4 3.6 15.8 13.7 6.3 20.9 17.6 4.0 6.0 3.2 12.1 4.8 6.0 3.7 2.2 2.7 2.1 2.7 2.2 1.7 1.6 1.7 1.5 2.1 2.4 2.1 1.2 2.4 1.7 1.1 1.7 1.2 6.0 10.3 8.2 9.1 6.7 9.3 10.8 9.0 11.0 9.5 8.5 19.3 33.2 35.3 26.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 28.1 20.6 0.0 0.0 10.5 23.9 0.0 17.0 16.5 0.0 5.9 16.4 0.0 15.6 27.0 9.9 0.0 0.0 0.0 14.7 14.0 12.9 0.0 29.1 12.6 18.8 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 18.9 0.0 0.0 5.5 0.0 0.0 31.2 8.7 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 13.3 7.5 16.2 0.0 0.0 MINDY1 "FAM63A, FLJ11280, MINDY-1" ENSG00000143409 "MINDY lysine 48 deubiquitinase 1" Q8N5J2 1 150996086-151008375 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Distal tubular cells: 39.2;Ductal cells: 11.6;Proximal tubular cells: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 98.4;eosinophil: 56.2;neutrophil: 85.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 98.4" "Cell line enhanced" "Detected in many" "T-47d: 49.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028351, HPA028358, HPA061086" Approved Enhanced Nucleoplasm NA NA 220000 "Cluster 2: Granulocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425" "unprognostic (5.73e-2)" "unprognostic (2.86e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-1)" "unprognostic (3.39e-2)" "unprognostic (6.90e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.22e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.43e-8)" "unprognostic (2.30e-1)" "unprognostic (7.95e-2)" "unprognostic (2.50e-2)" "unprognostic (6.06e-2)" 13.8 13.0 24.9 8.2 49.9 7.2 15.0 42.7 33.7 19.0 30.9 18.4 16.8 18.1 7.0 37.1 17.4 14.0 33.5 22.2 30.7 30.4 19.0 12.9 6.4 58.7 43.9 21.7 47.6 30.1 15.1 6.8 53.4 14.3 17.2 13.3 29.6 13.7 16.7 20.6 14.8 15.6 33.3 15.1 25.9 23.6 43.1 3.6 47.3 18.0 8.7 15.0 20.1 75.6 11.3 7.3 7.7 10.8 13.4 11.1 6.4 3.6 9.1 5.0 7.9 15.6 26.3 0.7 8.4 4.7 1.5 5.5 6.1 6.8 2.2 8.6 9.2 11.0 13.8 13.5 3.0 3.3 4.3 9.1 5.9 9.0 2.5 16.8 12.9 3.8 7.0 27.5 5.3 17.4 0.6 7.4 3.5 3.5 2.5 8.3 1.4 34.8 23.4 22.1 13.1 9.7 6.9 12.4 7.4 3.6 49.5 11.1 12.0 4.3 5.5 2.2 3.1 10.1 9.9 37.5 10.2 7.2 20.4 98.4 9.3 56.2 0.4 4.1 0.3 0.8 3.5 1.0 11.5 1.5 5.8 2.0 85.4 4.7 2.8 1.7 4.8 9.9 24.9 49.9 42.7 33.7 22.2 30.7 58.7 43.9 53.4 33.3 43.1 75.6 4.5 9.6 5.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.8 5.8 0.0 0.0 3.7 3.7 0.0 3.8 1.4 0.0 39.2 11.6 0.0 3.4 3.7 3.7 0.0 0.0 0.0 7.0 0.8 2.9 0.0 4.5 3.8 6.4 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.1 0.0 0.0 12.0 2.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.6 0.8 5.0 0.0 0.0 MINDY2 "FAM63B, KIAA1164" ENSG00000128923 "MINDY lysine 48 deubiquitinase 2" Q8NBR6 15 58771192-58861900 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 147.4;Collecting duct cells: 82.8;Endometrial ciliated cells: 66.4;Extravillous trophoblasts: 108.7;Glandular and luminal cells: 73.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2197: 72.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051103, HPA063669" Approved Enhanced Nucleoplasm No No "Cluster 18: Basophils - Vesicular transport" "Cluster 57: Non-specific - Angiogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA051103: AB_2681345, HPA063669: AB_2685082" "unprognostic (4.71e-2)" "unprognostic (8.92e-3)" "unprognostic (4.63e-2)" "unprognostic (4.13e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (8.60e-2)" "unprognostic (7.23e-2)" "unprognostic (7.09e-2)" "unprognostic (2.36e-3)" "unprognostic (4.74e-2)" "prognostic favorable (3.00e-8)" "unprognostic (2.53e-1)" "unprognostic (3.59e-1)" "unprognostic (6.76e-2)" "unprognostic (4.77e-2)" 9.4 5.4 9.3 5.7 9.6 3.8 6.6 15.0 10.4 7.0 8.9 5.4 3.5 7.1 4.6 7.1 6.8 6.3 10.8 8.0 11.6 10.1 3.5 7.7 4.1 10.5 11.0 6.8 3.3 7.3 4.9 9.0 10.0 8.9 3.9 16.3 4.9 6.1 3.4 7.1 3.6 8.5 9.2 6.1 4.8 3.9 11.2 5.9 9.6 8.9 3.7 8.0 5.2 10.3 10.9 5.3 7.3 4.4 10.7 19.7 11.5 9.8 20.8 3.0 4.3 8.4 5.4 5.6 10.5 11.8 5.3 10.3 13.4 7.9 4.6 5.6 4.9 7.8 5.7 7.6 6.6 5.9 6.9 8.7 12.9 3.5 8.0 11.3 7.4 5.9 13.7 6.1 7.1 1.4 7.4 4.4 15.7 1.4 2.7 3.3 21.0 6.0 8.9 12.1 6.7 4.9 7.1 10.0 17.9 15.3 3.0 12.5 8.7 4.2 3.7 72.5 4.3 5.4 8.3 5.4 9.4 9.5 10.2 3.0 0.7 1.3 1.1 0.6 2.1 0.9 1.0 1.3 0.2 1.6 0.8 1.2 1.4 0.8 1.4 1.1 0.9 0.5 9.3 9.6 15.0 10.4 8.0 11.6 10.5 11.0 10.0 9.2 11.2 10.3 65.2 147.4 39.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 43.8 44.8 0.0 0.0 18.0 82.8 0.0 65.2 27.5 0.0 46.9 44.4 0.0 66.4 46.8 19.8 0.0 0.0 0.0 21.2 108.7 21.7 0.0 73.2 11.4 11.6 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 32.4 0.0 0.0 7.5 0.0 0.0 14.2 28.4 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 53.2 11.3 17.6 0.0 0.0 MINDY3 "C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042" ENSG00000148481 "MINDY lysine 48 deubiquitinase 3" Q9H8M7 10 15778170-15860507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038400, HPA038406" Uncertain Supported "Nucleoplasm,Nuclear membrane" NA NA 23000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear membrane" "HPA038400: AB_10669724, HPA038406: AB_2676001" "unprognostic (9.20e-2)" "unprognostic (5.84e-2)" "unprognostic (3.09e-1)" "unprognostic (3.26e-1)" "unprognostic (1.99e-2)" "unprognostic (3.67e-1)" "unprognostic (8.29e-2)" "unprognostic (2.81e-2)" "unprognostic (3.85e-2)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (6.50e-2)" "unprognostic (1.32e-1)" "unprognostic (2.97e-1)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.19e-1)" 15.0 22.4 12.8 8.6 16.3 19.1 19.2 21.9 19.0 18.6 2.9 15.0 9.3 19.5 20.6 14.1 15.6 14.2 9.9 14.7 10.5 16.8 17.5 12.1 12.4 10.6 11.4 18.5 13.7 20.5 5.3 21.1 10.9 19.3 18.7 20.0 11.5 16.4 4.3 16.4 11.6 16.4 11.3 10.5 15.7 21.3 15.5 7.5 18.3 2.4 11.6 15.3 10.3 17.7 12.4 11.1 21.5 22.9 30.9 28.9 17.9 38.1 19.4 28.4 33.1 9.6 19.0 9.2 7.2 41.8 19.9 11.2 18.5 22.8 25.5 28.2 25.5 30.0 16.0 10.8 39.3 6.2 24.3 22.5 19.6 25.3 18.1 27.4 23.1 21.7 18.6 7.6 28.5 13.4 13.2 7.5 7.8 19.9 21.6 6.5 12.5 6.4 32.1 9.2 17.6 19.2 18.5 17.5 16.1 19.2 20.4 13.4 23.9 18.5 14.4 31.4 11.2 45.6 18.8 15.7 21.2 13.6 15.1 2.6 1.7 1.5 2.2 3.5 1.8 1.3 1.5 2.4 1.9 1.9 1.0 2.0 1.5 1.7 4.0 2.0 3.1 1.5 12.8 16.3 21.9 19.0 14.7 10.5 10.6 11.4 10.9 11.3 15.5 17.7 17.3 22.4 14.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 9.7 7.4 0.0 0.0 3.7 14.7 0.0 18.7 10.7 0.0 19.6 11.6 0.0 8.2 18.1 5.2 0.0 0.0 0.0 8.3 17.0 7.5 0.0 9.7 1.3 11.5 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 9.0 0.0 0.0 4.0 0.0 0.0 17.7 11.7 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 32.7 3.0 13.7 0.0 0.0 MKNK2 "GPRK7, MNK2" ENSG00000099875 "MAPK interacting serine/threonine kinase 2" Q9HBH9 19 2037465-2051244 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 475.7;tongue: 551.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 367.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021875, CAB037253, HPA070499" Supported Supported "Nuclear bodies" No No "Cluster 33: Neutrophils - Chromatin organization" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Nuclear bodies" "CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157" "unprognostic (8.76e-2)" "unprognostic (1.71e-1)" "unprognostic (1.64e-1)" "prognostic favorable (4.86e-5)" "unprognostic (3.08e-1)" "unprognostic (1.59e-2)" "unprognostic (6.42e-3)" "unprognostic (1.35e-1)" "unprognostic (4.32e-2)" "unprognostic (7.52e-2)" "unprognostic (1.08e-1)" "unprognostic (6.56e-2)" "unprognostic (4.07e-2)" "prognostic favorable (4.01e-4)" "unprognostic (1.63e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-1)" 87.2 50.2 70.5 51.3 78.0 133.6 39.5 109.2 131.2 41.9 80.6 55.2 47.4 24.7 47.8 114.5 38.1 26.7 54.8 67.2 65.4 27.6 71.2 51.8 66.8 80.3 70.7 34.5 191.9 34.5 39.6 35.3 74.6 38.6 30.0 35.7 133.8 39.7 475.7 63.8 57.3 21.8 68.2 80.2 55.1 21.6 75.7 34.5 54.6 551.1 58.6 39.9 60.9 91.0 64.9 71.8 30.1 66.3 219.5 79.0 65.1 37.3 27.1 26.5 26.8 45.5 111.8 88.2 50.7 77.4 27.9 78.4 38.4 110.9 12.0 122.1 34.4 36.8 62.1 49.2 367.4 72.3 61.6 84.1 262.0 50.8 107.2 61.9 63.5 59.2 62.0 155.4 18.6 37.7 42.8 59.3 78.6 49.6 78.1 81.8 8.6 113.1 48.1 41.2 39.9 48.2 89.0 125.1 166.4 33.5 52.7 89.5 96.5 9.5 37.5 38.5 46.0 238.9 97.0 85.7 78.2 53.5 17.9 4.4 9.2 9.8 8.1 10.2 7.5 16.9 8.4 9.4 7.7 15.0 5.4 6.6 41.7 9.5 13.6 9.2 12.5 3.6 70.5 78.0 109.2 131.2 67.2 65.4 80.3 70.7 74.6 68.2 75.7 91.0 102.2 38.5 56.5 9.8 91.4 82.5 105.6 84.5 50.1 55.7 99.0 103.5 54.5 38.6 65.5 36.8 25.0 23.5 106.5 155.3 9.8 27.3 8.7 60.2 28.0 51.9 150.2 80.2 5.6 56.6 47.2 45.0 57.6 76.2 29.2 14.5 82.5 60.3 36.9 42.1 5.9 104.1 46.8 52.5 134.6 13.0 20.2 68.0 56.9 8.4 41.8 63.6 30.9 6.0 5.2 47.2 86.6 20.3 55.4 94.2 98.8 18.6 55.2 47.5 19.7 132.6 48.7 18.1 19.5 97.8 117.2 56.5 69.3 18.1 79.7 114.0 MMP24OS MMP24-AS1 ENSG00000126005 "MMP24 opposite strand" A0A0U1RRL7 20 35201745-35278131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 167.3;Distal tubular cells: 403.0;Ductal cells: 225.8;Exocrine glandular cells: 205.2;Pancreatic endocrine cells: 278.9;Proximal tubular cells: 388.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (6.31e-2)" "unprognostic (4.34e-2)" "unprognostic (1.14e-1)" "unprognostic (4.42e-2)" "unprognostic (5.73e-3)" "unprognostic (2.10e-1)" "unprognostic (1.72e-1)" "unprognostic (4.34e-3)" "unprognostic (5.75e-2)" "unprognostic (4.33e-1)" "unprognostic (1.90e-2)" "unprognostic (1.38e-1)" "unprognostic (1.47e-3)" "unprognostic (4.57e-2)" "unprognostic (2.73e-1)" "unprognostic (6.64e-2)" "unprognostic (7.58e-2)" 49.6 51.2 31.0 15.2 24.7 26.0 38.1 23.4 40.7 35.4 41.6 32.3 27.1 31.3 10.0 48.7 27.4 15.5 31.4 24.7 27.7 69.1 44.8 31.5 12.2 30.8 23.8 32.9 36.4 14.9 50.1 9.2 30.2 37.2 19.1 4.2 34.9 18.4 24.9 39.0 29.0 11.5 17.9 24.3 31.8 20.0 33.8 10.9 27.6 8.9 9.9 31.1 36.4 25.3 3.3 22.6 1.6 10.2 21.8 39.2 12.3 44.3 31.1 37.4 58.4 15.5 27.1 11.4 22.5 30.6 25.8 14.6 5.9 46.7 31.1 19.2 27.1 36.0 8.4 6.5 13.4 13.9 30.1 36.6 41.3 21.0 29.7 13.1 16.2 12.1 11.0 24.2 53.2 17.1 47.8 20.5 7.1 9.2 29.0 20.8 11.1 23.2 35.2 12.5 10.7 13.3 31.5 72.3 35.5 22.2 31.8 8.4 37.4 65.5 5.4 25.1 23.0 10.1 3.2 4.6 35.5 6.2 21.8 2.9 2.1 7.5 2.3 3.2 2.2 1.8 1.5 1.6 1.6 2.4 1.5 2.2 6.7 0.9 5.5 2.3 0.6 0.8 31.0 24.7 23.4 40.7 24.7 27.7 30.8 23.8 30.2 17.9 33.8 25.3 49.1 22.4 28.6 0.0 14.9 0.0 0.0 0.0 0.0 0.0 98.3 99.8 0.0 0.0 14.2 167.3 0.0 46.8 58.1 0.0 403.0 225.8 0.0 85.3 45.2 16.4 0.0 0.0 0.0 205.2 80.2 26.0 0.0 65.5 7.6 44.5 0.0 0.0 110.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.8 0.0 0.0 98.8 0.0 0.0 0.0 0.0 278.9 0.0 0.0 11.7 0.0 0.0 388.2 9.5 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 75.4 22.5 68.2 0.0 0.0 MOSMO "ATTHOG, BC030336, C16orf52" ENSG00000185716 "Modulator of smoothened" Q8NHV5 16 22007638-22087534 "Predicted membrane proteins" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 50.9;Breast glandular cells: 18.2;Breast myoepithelial cells: 20.2;Endometrial stromal cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "WM-115: 87.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 17: WM-115 - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "unprognostic (4.18e-2)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (4.10e-2)" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (2.78e-2)" "unprognostic (8.84e-2)" "unprognostic (5.50e-2)" "unprognostic (1.54e-1)" "unprognostic (1.27e-2)" "unprognostic (2.22e-3)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (2.75e-1)" 10.3 21.6 8.1 9.1 9.7 2.1 9.2 12.4 14.6 12.0 5.6 8.2 7.8 12.8 7.5 9.6 9.7 10.3 9.7 9.4 6.9 8.5 13.4 10.6 10.2 6.0 7.4 11.8 7.4 18.3 9.4 12.7 6.0 10.4 8.0 13.1 8.0 7.8 10.2 9.7 7.0 9.7 5.5 9.4 10.0 10.0 7.6 8.6 9.5 11.4 9.4 10.4 11.5 10.8 17.7 6.2 11.9 9.4 20.9 42.4 8.5 18.2 21.7 9.5 14.3 5.9 11.4 9.0 7.2 19.1 14.6 9.8 7.6 19.1 17.5 21.3 8.4 7.6 13.4 20.7 19.2 6.4 11.5 24.5 12.8 14.1 34.5 16.1 22.9 7.4 5.3 23.0 41.5 11.0 6.1 5.5 8.9 8.4 15.9 13.5 12.2 9.4 8.6 8.7 8.1 14.0 9.4 4.7 33.2 11.9 10.0 6.8 13.1 17.9 13.5 13.0 8.0 11.4 11.2 6.0 13.0 7.8 87.1 0.3 0.2 0.4 0.3 0.3 0.2 0.3 0.1 0.1 0.0 1.0 0.3 0.3 0.1 0.3 0.2 0.2 0.6 0.0 8.1 9.7 12.4 14.6 9.4 6.9 6.0 7.4 6.0 5.5 7.6 10.8 50.9 0.0 8.4 0.0 4.9 0.0 0.0 0.0 0.0 0.0 18.2 20.2 0.0 0.0 5.0 5.5 0.0 5.7 12.6 0.0 1.9 4.2 0.0 13.2 35.3 9.1 0.0 0.0 0.0 5.7 4.3 11.3 0.0 12.9 2.5 16.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 3.3 0.0 0.0 8.1 0.7 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 5.1 5.0 13.1 0.0 0.0 MRE11 "ATLD, MRE11A" ENSG00000020922 "MRE11 homolog, double strand break repair nuclease" P49959 11 94415570-94493885 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Meiosis" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes, Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Cytotrophoblasts: 39.2;Granulosa cells: 34.1;Syncytiotrophoblasts: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002691, CAB004081" Supported Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB004081: AB_2145100, HPA002691: AB_1079409" "unprognostic (5.59e-3)" "unprognostic (4.35e-2)" "unprognostic (8.55e-2)" "unprognostic (2.76e-2)" "unprognostic (9.82e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (7.14e-4)" "unprognostic (2.85e-1)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (8.66e-3)" "unprognostic (6.96e-3)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.22e-1)" "unprognostic (8.06e-3)" 9.1 6.1 3.4 11.7 3.7 22.6 13.9 6.8 3.4 8.8 6.0 7.6 6.8 11.7 8.9 7.1 7.9 7.3 5.0 3.3 3.5 6.0 6.4 7.7 12.6 5.1 4.4 11.1 7.5 5.6 3.1 12.1 3.8 9.3 11.5 6.3 7.8 7.3 5.0 15.6 7.7 9.9 4.0 12.7 7.3 8.3 4.4 14.3 7.4 5.4 16.1 8.5 7.4 6.7 21.5 21.5 39.9 5.0 13.1 18.2 22.8 29.4 19.0 25.9 30.6 39.4 43.3 55.8 47.0 15.3 32.5 40.1 33.7 22.1 34.1 37.5 20.0 48.7 31.5 22.7 6.0 32.7 33.6 12.8 13.4 33.7 21.0 11.7 23.0 26.8 34.9 35.6 20.9 15.5 33.2 30.5 13.0 49.3 23.3 29.0 35.3 28.1 16.8 29.6 14.1 19.8 40.6 26.0 8.6 33.2 43.4 19.3 16.9 38.7 28.6 33.9 21.5 8.8 33.2 54.4 10.4 50.3 31.5 5.7 8.0 6.5 8.2 10.0 8.3 6.4 6.0 8.9 11.6 6.9 5.1 8.4 3.8 8.6 8.4 8.7 8.8 6.7 3.4 3.7 6.8 3.4 3.3 3.5 5.1 4.4 3.8 4.0 4.4 6.7 23.6 28.9 14.3 0.0 6.3 0.0 0.0 0.0 0.0 0.0 12.5 13.7 0.0 0.0 9.3 9.2 0.0 39.2 20.8 0.0 3.9 11.4 0.0 19.5 22.2 8.4 0.0 0.0 0.0 8.1 15.8 8.9 0.0 16.3 17.7 34.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 8.8 0.0 0.0 6.1 0.0 0.0 6.5 11.7 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 28.0 7.2 16.8 0.0 0.0 MRM2 "FJH1, FTSJ2, RRMJ2" ENSG00000122687 "Mitochondrial rRNA methyltransferase 2" Q9UI43 7 2234195-2242205 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 59.7;Distal tubular cells: 31.3;Extravillous trophoblasts: 37.0;Hofbauer cells: 35.8;Syncytiotrophoblasts: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019826, HPA049622" Uncertain NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA019826: AB_2670282, HPA049622: AB_2680834" "unprognostic (8.05e-2)" "unprognostic (1.65e-1)" "unprognostic (2.14e-2)" "unprognostic (2.59e-1)" "unprognostic (1.49e-2)" "unprognostic (2.50e-3)" "prognostic unfavorable (5.21e-6)" "unprognostic (8.49e-2)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (9.99e-2)" "unprognostic (8.33e-2)" "unprognostic (1.69e-1)" "unprognostic (2.37e-1)" "unprognostic (1.70e-1)" "unprognostic (1.46e-2)" "unprognostic (1.48e-1)" 9.3 12.8 12.7 12.1 13.3 6.1 13.0 13.5 15.7 9.2 14.2 10.7 10.8 8.2 11.5 11.5 10.8 6.7 14.1 12.5 13.2 12.6 17.3 11.0 17.8 13.9 13.2 11.7 8.0 13.3 6.9 13.7 13.5 10.0 10.8 8.0 10.1 12.0 21.7 11.2 9.1 9.1 14.0 12.8 9.7 10.7 13.4 12.2 8.5 12.6 18.3 10.4 7.9 14.0 62.2 39.9 34.2 25.2 21.3 22.3 24.8 35.3 35.5 45.3 43.9 56.7 29.8 57.5 15.8 27.4 37.5 48.0 49.3 40.0 49.0 22.2 37.9 36.6 37.0 35.0 25.8 54.3 34.5 19.1 34.2 30.4 35.4 19.6 20.2 35.3 59.3 33.0 35.6 73.4 17.1 68.7 94.9 38.6 38.0 34.1 42.5 45.1 31.9 46.4 31.2 44.3 28.9 81.1 34.1 44.8 70.0 81.6 15.1 27.4 64.2 53.8 56.0 29.1 43.4 59.0 31.7 55.9 85.2 17.2 49.1 32.9 28.0 57.1 33.9 52.1 29.9 32.1 71.8 48.8 36.9 32.1 3.7 47.8 48.9 37.8 36.5 40.4 12.7 13.3 13.5 15.7 12.5 13.2 13.9 13.2 13.5 14.0 13.4 14.0 11.3 22.4 19.8 0.0 5.1 0.0 0.0 0.0 0.0 0.0 15.0 19.6 0.0 0.0 8.1 11.0 0.0 59.7 6.6 0.0 31.3 24.1 0.0 7.7 14.3 6.0 0.0 0.0 0.0 19.9 37.0 7.2 0.0 6.7 11.4 15.9 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 11.9 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.9 0.0 0.0 20.4 9.5 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 37.1 3.6 28.8 0.0 0.0 MRM3 "FLJ10581, HC90, RMTL1, RNMTL1" ENSG00000171861 "Mitochondrial rRNA methyltransferase 3" Q9HC36 17 782353-792509 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 27.1;Distal tubular cells: 19.6;Ductal cells: 18.9;Exocrine glandular cells: 18.4;Extravillous trophoblasts: 24.6;Proximal tubular cells: 20.0;Syncytiotrophoblasts: 19.6;Theca cells: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022534, HPA023031, HPA023292" Enhanced Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388" "unprognostic (1.66e-1)" "unprognostic (5.83e-3)" "unprognostic (6.72e-2)" "prognostic favorable (2.81e-4)" "unprognostic (2.67e-1)" "unprognostic (1.83e-1)" "unprognostic (2.48e-1)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (8.20e-2)" "unprognostic (3.72e-3)" "unprognostic (8.47e-2)" "prognostic favorable (3.00e-4)" "unprognostic (3.82e-2)" "unprognostic (9.98e-2)" "unprognostic (1.05e-2)" "unprognostic (1.42e-2)" 9.3 12.9 7.9 6.8 8.4 17.6 8.7 9.9 9.2 6.7 9.7 9.7 7.8 7.6 5.2 11.6 8.0 4.8 17.3 8.2 7.9 9.7 20.5 6.0 10.4 8.2 8.7 8.7 19.6 9.1 6.2 6.9 8.6 7.5 7.5 4.3 9.5 6.0 29.4 14.7 8.2 6.6 7.7 9.9 13.0 18.6 8.6 8.3 7.0 18.7 9.3 8.6 7.2 8.3 26.4 53.9 11.3 19.8 16.2 13.8 22.5 13.6 12.8 27.3 22.8 31.8 12.0 47.3 14.1 10.6 13.1 21.7 33.0 12.0 24.8 16.2 55.9 18.3 30.6 27.9 16.7 15.8 16.0 16.7 16.2 29.0 23.9 13.6 20.7 28.3 31.3 20.1 14.5 28.5 27.5 20.8 16.9 19.3 28.2 33.1 7.9 25.3 18.2 14.2 15.1 17.6 19.8 16.6 26.5 9.0 20.6 14.2 16.6 14.6 11.2 21.0 38.3 8.0 11.8 18.9 18.3 22.1 20.0 12.5 24.6 14.7 25.0 20.6 27.0 38.2 27.1 30.8 25.8 38.4 32.8 28.4 1.8 32.7 21.1 20.8 31.9 26.8 7.9 8.4 9.9 9.2 8.2 7.9 8.2 8.7 8.6 7.7 8.6 8.3 11.3 6.4 1.1 0.0 4.2 0.0 0.0 0.0 0.0 0.0 9.8 10.4 0.0 0.0 1.3 5.5 0.0 27.1 7.6 0.0 19.6 18.9 0.0 8.3 8.0 5.1 0.0 0.0 0.0 18.4 24.6 4.1 0.0 8.8 3.8 15.6 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.5 0.0 0.0 20.0 0.7 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 19.6 4.4 28.9 0.0 0.0 MRNIP "C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537" ENSG00000161010 "MRN complex interacting protein" Q6NTE8 5 179835133-179862173 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 46.9;Endometrial ciliated cells: 49.7;Glandular and luminal cells: 31.3;Respiratory ciliated cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043975 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA043975: AB_2678754" "unprognostic (4.97e-2)" "unprognostic (2.79e-1)" "unprognostic (7.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (5.15e-3)" "unprognostic (1.68e-3)" "unprognostic (2.51e-2)" "unprognostic (1.10e-1)" "unprognostic (6.11e-2)" "unprognostic (3.63e-3)" "unprognostic (2.05e-2)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (7.00e-2)" "unprognostic (1.43e-3)" 7.8 7.2 10.5 3.5 10.6 1.4 9.5 13.1 12.9 21.8 11.5 12.3 2.5 11.4 5.9 6.4 16.7 2.2 7.1 10.6 10.3 13.1 10.0 8.9 5.5 10.8 10.6 21.0 10.3 5.2 19.2 1.5 10.8 15.4 2.8 3.0 9.9 7.1 5.4 7.9 17.1 3.8 10.0 19.0 8.8 10.1 10.6 2.7 15.5 2.7 5.3 12.7 13.7 11.8 1.0 1.9 3.5 8.4 7.4 6.6 4.0 2.5 2.3 3.2 4.8 2.5 3.2 4.1 2.9 1.3 1.4 2.6 4.4 8.3 2.6 3.7 3.5 1.3 4.3 2.1 4.6 1.7 1.6 4.9 7.0 3.7 3.0 2.4 3.6 4.1 2.0 1.8 3.5 3.9 2.8 1.7 1.7 1.3 1.9 3.3 1.4 3.2 5.7 0.8 6.6 2.1 1.2 3.3 3.1 2.6 4.1 1.4 0.7 1.8 1.4 1.4 1.5 2.2 1.4 2.9 1.7 2.7 1.3 1.5 0.6 2.9 2.7 0.7 3.8 8.0 4.0 3.2 0.8 10.2 6.4 4.5 0.9 3.5 0.9 4.9 2.6 1.9 10.5 10.6 13.1 12.9 10.6 10.3 10.8 10.6 10.8 10.0 10.6 11.8 22.4 16.0 15.6 0.0 6.2 0.0 0.0 0.0 0.0 0.0 13.7 21.1 0.0 0.0 11.8 18.4 0.0 10.5 11.6 0.0 46.9 5.1 0.0 49.7 19.0 5.8 0.0 0.0 0.0 2.2 6.8 9.7 0.0 31.3 11.4 20.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 3.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 3.0 0.0 0.0 14.5 29.9 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 9.3 7.6 18.4 0.0 0.0 MRPL30 "MRP-L28, RPML28" ENSG00000185414 "Mitochondrial ribosomal protein L30" Q8TCC3 2 99181152-99199561 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047255 Approved NA NA "Cluster 24: B-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA047255: AB_2680002" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "unprognostic (9.77e-2)" "unprognostic (7.87e-2)" "unprognostic (1.65e-1)" "unprognostic (4.34e-2)" "unprognostic (2.60e-3)" "unprognostic (2.53e-1)" "unprognostic (9.37e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (9.25e-2)" "unprognostic (1.50e-3)" "unprognostic (2.84e-1)" "unprognostic (3.49e-2)" "unprognostic (3.16e-2)" "unprognostic (2.72e-1)" 9.9 12.5 4.0 5.0 4.1 3.4 9.3 4.8 4.5 10.0 2.8 9.8 7.1 9.8 4.1 14.6 8.0 4.0 16.7 4.3 4.1 12.4 13.6 6.0 5.2 3.2 3.3 9.6 11.3 7.4 7.2 5.1 3.4 8.6 6.8 6.0 9.9 5.6 29.6 10.6 8.1 5.3 3.2 7.1 10.1 4.0 4.1 7.4 7.0 21.1 7.0 9.3 10.1 4.3 30.7 8.5 14.4 10.6 9.6 15.7 14.3 12.7 11.1 15.3 12.3 23.3 7.4 22.8 7.7 11.3 9.2 15.1 25.9 30.8 24.9 14.8 21.3 23.4 10.9 25.3 13.0 19.8 8.2 13.6 10.6 12.3 23.1 11.8 26.3 12.3 36.3 14.2 14.8 10.8 29.0 16.6 15.6 10.2 24.5 28.1 28.4 19.9 17.7 17.5 20.2 20.3 9.8 21.4 29.3 14.5 17.1 16.4 13.0 20.7 11.2 10.8 15.6 17.2 22.7 33.7 14.2 17.3 22.1 3.1 4.7 3.2 3.5 4.9 3.6 4.6 2.7 5.1 4.0 4.2 3.6 3.4 1.5 3.8 3.1 3.8 4.3 3.3 4.0 4.1 4.8 4.5 4.3 4.1 3.2 3.3 3.4 3.2 4.1 4.3 15.9 9.6 7.5 11.8 16.2 0.6 12.7 1.0 20.5 9.4 14.0 15.7 27.3 15.7 6.7 11.0 6.2 22.5 15.1 15.4 35.2 23.3 3.0 16.9 28.1 11.5 13.8 16.6 18.9 24.7 25.3 13.6 13.7 20.2 6.3 15.1 14.3 25.8 19.9 16.8 17.3 19.5 2.0 19.7 0.5 2.4 22.4 14.9 1.8 11.2 24.2 9.8 21.6 9.0 17.2 29.7 11.9 22.6 19.1 9.0 20.6 34.6 5.3 9.3 0.0 10.8 12.3 7.5 13.8 22.9 0.9 13.4 14.4 17.9 19.8 10.3 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 549.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Yes No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 76.5 105.6 106.9 53.7 109.6 51.9 72.4 113.6 130.8 66.5 109.4 88.3 70.0 72.8 30.8 141.6 61.0 20.6 193.7 107.7 110.4 130.8 154.2 73.5 41.7 113.4 109.8 59.9 108.7 70.6 70.1 32.9 113.6 83.5 33.9 15.2 79.6 35.6 155.2 96.6 77.7 25.6 111.5 96.3 113.4 67.7 112.0 62.0 83.2 55.4 41.3 85.0 78.2 112.9 237.5 181.4 97.4 121.4 59.3 69.1 236.8 161.2 115.0 140.8 133.4 224.1 321.9 178.8 172.5 111.3 143.4 210.8 79.8 223.4 105.6 190.8 132.6 133.6 65.6 518.5 180.3 211.9 183.6 104.8 150.4 182.7 154.5 111.2 226.6 222.7 139.4 172.8 104.6 329.2 172.5 320.0 180.1 292.5 397.5 210.2 121.5 210.4 149.9 138.7 96.8 125.1 124.5 120.6 178.3 68.9 116.0 198.9 176.5 146.4 172.0 185.1 249.2 169.4 219.1 228.0 133.3 143.3 239.6 101.5 111.2 60.2 74.5 128.9 69.5 140.9 82.2 68.2 159.1 111.6 75.9 74.2 19.1 74.5 96.4 131.3 100.7 98.5 106.9 109.6 113.6 130.8 107.7 110.4 113.4 109.8 113.6 111.5 112.0 112.9 105.5 73.7 85.4 5.2 132.5 121.2 88.0 169.2 98.4 23.2 131.2 145.2 103.4 167.3 118.0 136.1 18.8 177.3 82.5 220.9 277.8 245.2 72.4 106.5 89.8 104.4 138.0 112.5 5.7 314.5 287.7 65.8 165.1 116.3 123.0 70.5 106.4 291.0 236.2 20.2 6.2 268.0 107.8 140.2 125.1 58.3 55.9 120.1 124.5 6.5 221.5 80.4 107.1 5.5 9.1 396.9 215.6 49.2 156.4 111.8 313.7 549.8 99.9 33.7 65.7 70.7 147.7 135.4 105.3 190.8 149.2 126.0 85.0 80.3 233.8 98.8 MRPL53 ENSG00000204822 "Mitochondrial ribosomal protein L53" Q96EL3 2 74471982-74472687 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034612, HPA056185" Uncertain Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA034612: , HPA056185: AB_2683060" "unprognostic (2.22e-2)" "unprognostic (1.94e-2)" "unprognostic (2.81e-2)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (7.36e-5)" "unprognostic (3.60e-2)" "unprognostic (1.24e-1)" "unprognostic (4.06e-2)" "prognostic favorable (1.37e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.16e-8)" "unprognostic (8.76e-2)" "unprognostic (2.79e-1)" "unprognostic (4.13e-1)" "unprognostic (2.45e-2)" 60.9 82.9 68.8 46.8 72.2 61.8 38.9 77.0 98.9 31.3 79.2 41.5 48.0 28.7 39.1 41.0 50.2 34.0 114.4 67.1 72.3 54.5 65.1 34.2 78.4 72.3 69.3 61.5 118.0 72.1 35.1 34.8 72.7 46.0 20.3 27.1 107.1 36.2 169.7 27.3 45.9 24.4 74.2 54.7 55.0 23.1 70.2 50.3 47.1 89.0 42.3 44.7 27.0 76.5 101.5 271.0 60.0 58.5 77.9 69.7 103.4 79.8 73.7 70.5 60.9 224.7 130.1 87.6 78.8 61.4 97.3 76.3 32.5 105.7 24.5 174.6 188.3 77.7 115.6 133.7 70.7 88.4 85.6 96.7 75.1 90.4 59.0 82.3 75.3 109.0 93.0 156.6 63.8 316.5 118.6 163.3 57.5 166.0 204.5 89.1 196.0 212.9 88.9 115.6 103.5 128.0 74.1 195.6 137.3 40.8 102.3 111.1 83.6 115.9 119.6 101.7 135.2 292.3 260.6 141.1 116.4 94.8 125.8 244.9 293.8 133.8 168.2 277.6 188.5 350.0 215.9 173.1 250.3 367.5 282.0 211.4 185.5 167.6 271.8 360.3 275.3 345.5 68.8 72.2 77.0 98.9 67.1 72.3 72.3 69.3 72.7 74.2 70.2 76.5 5.2 9.6 23.2 4.6 18.0 17.2 6.0 9.7 12.0 2.0 24.0 16.4 1.6 4.3 12.1 11.0 0.0 14.7 10.5 29.5 21.5 32.8 8.9 7.2 4.3 11.2 39.7 18.9 3.4 56.9 17.5 10.9 15.3 4.7 33.6 3.0 16.1 23.8 18.0 1.7 3.5 27.2 6.1 25.9 23.9 2.3 8.7 15.6 26.6 2.8 35.8 4.6 15.5 2.0 7.1 35.8 43.5 4.5 34.8 4.9 41.8 45.3 46.1 4.0 6.6 7.7 11.2 11.2 6.8 16.6 25.1 15.7 14.6 3.3 21.7 6.9 MRPL58 "DS-1, ICT1" ENSG00000167862 "Mitochondrial ribosomal protein L58" Q14197 17 75012670-75021261 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins" "Protein biosynthesis" "Hydrolase, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 60.1;Distal tubular cells: 56.7;Ductal cells: 50.9;Exocrine glandular cells: 60.3;Hofbauer cells: 48.1;Pancreatic endocrine cells: 53.7;Proximal tubular cells: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003634, HPA076987" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nucleoplasm, Plasma membrane" "HPA003634: AB_1851388, HPA076987: " "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" "unprognostic (1.94e-3)" "unprognostic (7.12e-2)" "unprognostic (3.16e-2)" "unprognostic (4.35e-2)" "unprognostic (1.38e-3)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (3.79e-3)" "unprognostic (4.98e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.66e-2)" "unprognostic (1.71e-1)" 22.7 36.3 22.1 18.0 22.8 22.8 24.6 24.4 23.0 17.1 31.9 25.9 19.1 19.4 18.2 32.1 17.5 13.1 49.1 21.9 23.6 34.7 47.2 16.3 24.4 23.4 22.6 14.2 27.4 25.0 14.0 19.3 23.4 18.6 22.8 11.2 21.8 18.6 79.0 28.4 21.7 18.8 23.3 21.6 26.0 10.5 22.9 18.3 18.7 50.3 23.8 24.5 19.9 24.5 81.1 111.4 36.5 42.1 38.3 37.9 50.5 46.7 50.7 95.7 80.7 86.3 49.5 56.0 37.3 46.8 58.9 56.3 75.6 80.7 100.2 28.1 87.7 43.8 50.5 72.2 72.5 92.5 28.8 40.9 37.8 63.3 101.0 32.3 73.8 57.0 71.7 39.9 54.8 100.9 80.7 63.4 27.5 125.3 147.1 41.2 64.8 81.2 71.1 58.5 33.5 64.1 40.3 72.5 92.9 46.7 97.5 75.6 31.6 50.8 56.0 54.3 89.7 41.0 34.8 63.2 58.5 102.5 43.5 26.6 41.2 21.4 30.8 40.9 27.1 33.8 38.0 31.4 55.3 29.3 27.8 31.1 4.0 42.2 36.1 37.2 67.2 42.5 22.1 22.8 24.4 23.0 21.9 23.6 23.4 22.6 23.4 23.3 22.9 24.5 18.8 32.1 8.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 22.5 32.8 0.0 0.0 8.1 25.8 0.0 60.1 11.4 0.0 56.7 50.9 0.0 29.3 18.3 8.4 0.0 0.0 0.0 60.3 40.5 8.9 0.0 19.0 1.3 22.3 0.0 0.0 48.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 15.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.8 0.0 0.0 121.1 21.1 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 29.1 7.4 43.5 0.0 0.0 MTREX "Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2" ENSG00000039123 "Mtr4 exosome RNA helicase" P42285 5 55307989-55425579 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, mRNA processing, mRNA splicing, rRNA processing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 42.3;Endometrial stromal cells: 44.0;Exocrine glandular cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037379 Supported Supported Nucleoplasm NA NA 13000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA037379: AB_10601713" "unprognostic (7.71e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-3)" "unprognostic (1.32e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (1.79e-2)" "unprognostic (5.08e-1)" "unprognostic (4.17e-2)" "unprognostic (1.46e-2)" "unprognostic (5.05e-2)" "unprognostic (7.67e-2)" "unprognostic (1.11e-2)" "unprognostic (2.09e-1)" "unprognostic (3.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.11e-1)" 20.4 22.7 10.2 21.9 11.5 18.5 22.0 17.4 12.7 22.5 14.4 17.7 24.6 22.1 14.1 19.1 17.8 19.8 24.3 9.7 11.2 20.8 19.6 16.7 25.9 11.1 10.8 20.1 21.2 26.6 17.2 18.9 11.5 21.6 19.9 17.8 18.9 14.7 29.9 20.8 24.1 13.8 11.4 19.2 20.9 23.4 10.3 21.9 25.8 22.5 21.8 21.0 19.8 14.9 40.9 49.2 38.4 39.9 32.8 35.0 49.5 33.4 28.3 39.7 50.1 57.1 51.2 79.3 37.4 33.1 52.9 28.5 76.8 50.3 59.9 14.2 53.2 51.6 45.4 45.9 31.3 33.4 44.8 27.5 31.3 42.9 51.6 33.6 35.1 29.7 60.9 45.0 37.9 35.8 32.3 36.5 38.4 16.8 46.6 39.5 44.1 33.9 41.3 56.9 42.0 28.8 40.4 24.5 35.4 42.4 52.5 44.8 33.2 10.0 27.5 28.4 62.0 31.5 33.6 59.0 27.0 69.5 40.8 3.6 5.0 5.4 7.2 4.7 6.9 6.1 5.7 6.8 6.4 6.4 6.1 6.2 1.3 4.5 7.9 6.7 5.6 4.1 10.2 11.5 17.4 12.7 9.7 11.2 11.1 10.8 11.5 11.4 10.3 14.9 27.6 32.1 42.3 0.0 10.1 0.0 0.0 0.0 0.0 0.0 22.3 13.8 0.0 0.0 21.7 20.2 0.0 25.0 24.6 0.0 11.7 32.0 0.0 28.2 44.0 10.0 0.0 0.0 0.0 40.7 21.5 16.2 0.0 26.2 25.2 30.8 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 13.9 0.0 0.0 0.0 0.0 35.7 0.0 0.0 8.3 0.0 0.0 22.3 26.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 34.9 11.6 31.7 0.0 0.0 MXD4 "bHLHc12, MAD4, MST149, MSTP149" ENSG00000123933 "MAX dimerization protein 4" Q14582 4 2247432-2262109 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 169.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053363 Supported Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 35: Non-specific - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA053363: AB_2682128" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-2)" "unprognostic (2.84e-2)" "unprognostic (3.54e-2)" "prognostic favorable (2.21e-5)" "unprognostic (1.64e-1)" "unprognostic (5.94e-2)" "unprognostic (8.37e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.39e-5)" "unprognostic (5.65e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (2.64e-2)" "unprognostic (4.12e-2)" 38.6 42.0 43.9 11.3 39.8 29.8 35.9 62.1 58.4 31.1 38.2 35.2 18.3 37.1 11.6 21.0 27.9 15.1 36.2 40.9 37.7 38.8 20.6 38.5 20.2 40.6 40.5 23.2 25.3 12.4 63.5 14.3 39.7 33.0 7.2 5.9 35.0 25.0 24.1 25.9 28.6 14.0 37.5 57.6 31.2 22.1 41.2 23.2 33.4 14.4 9.1 25.1 19.4 39.6 2.3 8.3 12.9 15.5 44.2 32.6 3.0 16.4 16.6 12.0 12.2 2.0 7.1 7.1 36.1 25.0 6.4 11.2 3.7 13.0 3.1 6.3 39.5 1.3 29.0 23.6 32.4 5.5 14.5 51.1 22.9 3.9 6.1 26.5 28.9 10.3 9.8 11.6 11.3 16.2 12.6 31.6 5.1 9.6 36.4 8.5 4.4 15.1 14.2 13.0 20.8 38.7 15.4 7.5 12.3 15.7 35.2 34.4 68.7 13.3 5.3 9.9 3.7 17.6 13.2 2.8 18.2 4.9 4.0 7.2 2.7 3.4 3.3 3.0 2.7 2.2 3.0 3.3 2.5 2.0 1.5 1.5 1.1 2.0 3.0 7.2 4.0 1.4 43.9 39.8 62.1 58.4 40.9 37.7 40.6 40.5 39.7 37.5 41.2 39.6 169.7 19.2 19.9 48.0 37.9 19.1 15.3 13.6 7.4 81.6 67.8 67.1 18.4 17.2 16.1 60.7 87.6 44.3 129.6 47.9 15.6 16.5 10.1 39.6 81.9 54.7 33.6 20.6 11.6 18.3 48.4 53.6 23.0 42.8 24.1 37.9 103.5 35.5 50.3 65.6 20.5 55.9 10.2 72.9 27.5 28.8 33.2 58.8 23.2 27.2 21.6 67.9 68.0 19.1 19.7 17.5 31.8 56.4 54.0 28.7 44.0 22.1 13.4 97.1 26.3 39.6 48.5 7.0 37.0 17.3 26.3 32.7 54.7 100.5 38.2 13.1 MYLIP "IDOL, MIR" ENSG00000007944 "Myosin regulatory light chain interacting protein" Q8WY64 6 16129086-16148248 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 352.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 57.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.54e-1)" "unprognostic (4.84e-3)" "unprognostic (2.79e-1)" "unprognostic (9.65e-3)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (1.11e-2)" "prognostic favorable (6.44e-6)" "unprognostic (2.75e-2)" "unprognostic (2.67e-2)" "unprognostic (5.44e-3)" "unprognostic (1.03e-2)" "prognostic favorable (3.67e-4)" "unprognostic (1.42e-2)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "prognostic favorable (4.11e-5)" 37.0 18.9 12.8 12.8 20.0 92.1 30.2 12.5 16.4 42.2 13.6 24.3 12.9 40.3 30.6 18.1 32.6 21.3 14.2 13.4 13.3 21.6 4.9 29.5 22.8 13.7 14.3 35.8 15.5 24.6 8.2 63.4 12.0 16.4 16.5 4.7 25.7 23.1 41.1 25.7 24.5 28.4 12.3 30.8 22.7 15.0 15.7 15.2 50.2 22.8 15.4 25.0 24.7 22.4 3.4 6.0 2.8 3.3 28.3 6.9 7.3 2.4 5.4 5.4 12.0 18.4 3.3 16.0 11.5 3.9 4.0 8.2 13.0 4.4 4.9 5.2 12.8 10.2 7.1 3.8 4.1 7.4 10.0 11.5 5.5 2.6 2.2 2.8 12.5 3.4 29.8 18.6 2.1 12.6 0.2 40.6 8.0 8.4 5.7 3.5 12.9 57.9 6.7 40.0 13.5 6.2 2.9 31.2 17.1 23.9 5.8 18.8 3.5 2.6 6.2 2.2 6.1 16.0 7.5 8.1 1.6 20.9 9.0 6.1 1.5 7.8 5.8 1.8 5.4 4.2 3.7 4.1 1.1 3.3 4.0 3.9 9.4 2.6 1.5 0.5 2.3 1.2 12.8 20.0 12.5 16.4 13.4 13.3 13.7 14.3 12.0 12.3 15.7 22.4 102.6 22.4 50.2 5.5 67.7 98.0 38.9 8.8 126.3 9.3 67.6 117.0 90.7 50.1 17.7 22.0 0.0 134.2 78.5 49.5 9.8 22.1 47.5 82.7 56.2 70.9 84.3 52.6 17.1 18.4 80.0 79.6 54.0 77.7 35.5 35.1 41.4 1.4 32.0 11.8 8.4 41.1 10.2 61.7 121.2 20.2 38.5 56.0 80.0 7.5 27.3 16.9 56.7 3.0 55.3 7.6 32.4 61.7 30.2 28.1 27.8 21.1 25.7 7.8 138.1 90.8 96.7 53.0 22.6 100.9 84.0 352.3 103.8 3.9 45.4 35.1 MZT2B "FAM128B, FLJ14346, MOZART2B" ENSG00000152082 "Mitotic spindle organizing protein 2B" Q6NZ67 2 130181737-130190729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1258.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 962.4" "Low region specificity" "Detected in all" "HPA051758, HPA052623" Approved Supported Centrosome,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Centrosome Cytosol "HPA051758: , HPA052623: AB_2681888" "unprognostic (8.09e-3)" "unprognostic (5.38e-2)" "unprognostic (2.40e-2)" "unprognostic (1.31e-2)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (1.06e-1)" "unprognostic (1.14e-1)" "unprognostic (2.28e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (9.37e-8)" "unprognostic (1.67e-1)" "unprognostic (2.04e-1)" "unprognostic (3.04e-1)" "unprognostic (2.09e-1)" 125.3 170.2 161.7 59.9 150.5 159.3 130.6 131.7 284.6 169.3 145.5 174.2 79.5 140.6 18.2 164.8 162.4 16.4 401.3 150.5 141.8 143.8 199.5 86.3 60.3 150.0 142.2 190.3 250.9 49.3 117.1 32.9 133.9 144.2 19.6 11.4 172.6 41.2 202.4 147.1 102.8 20.4 133.4 103.6 160.7 195.1 157.4 48.1 159.0 29.9 25.5 131.8 143.1 151.4 462.9 239.6 38.6 173.1 20.7 49.8 190.5 203.1 56.7 72.2 59.6 384.0 168.3 251.5 288.1 39.5 47.2 223.4 19.7 68.9 11.2 376.3 667.0 132.8 313.5 485.9 71.5 155.1 97.1 65.7 77.6 45.4 26.9 58.4 80.6 251.8 189.6 268.9 35.8 572.5 336.0 962.4 137.8 85.7 435.8 447.0 105.4 626.6 55.3 140.2 304.7 377.8 121.3 201.1 369.8 15.1 218.5 374.8 164.7 199.8 354.7 155.3 203.4 378.1 257.5 257.9 244.6 203.3 133.3 0.4 19.9 83.0 18.6 21.5 16.5 37.6 25.5 24.7 25.4 38.5 29.1 24.2 10.7 27.3 20.4 48.1 21.3 12.2 161.7 150.5 131.7 284.6 150.5 141.8 150.0 142.2 133.9 133.4 157.4 151.4 240.2 41.7 29.4 20.5 253.6 297.2 321.4 193.4 248.2 175.2 543.9 739.1 326.5 243.1 104.6 242.8 43.8 282.8 238.0 378.4 467.6 358.4 327.3 115.5 326.7 210.0 173.0 308.2 21.7 591.7 466.6 250.1 166.7 171.7 50.8 484.6 250.2 363.5 342.0 131.2 22.8 453.0 99.7 232.7 365.6 1258.6 249.8 202.4 268.6 14.0 179.7 358.3 150.4 16.6 24.5 584.9 281.6 143.7 278.7 375.9 181.7 801.3 61.7 110.6 164.3 169.1 277.3 165.4 183.3 418.2 377.2 165.1 282.3 338.4 360.7 358.0 NAA80 "FUS2, NAT6" ENSG00000243477 "N-alpha-acetyltransferase 80, NatH catalytic subunit" Q93015 3 50296402-50299416 "Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 65.5" "Cell type enhanced" "Detected in many" "Adipocytes: 6.5;Exocrine glandular cells: 8.8;monocytes: 9.3;Pancreatic endocrine cells: 6.5;Proximal tubular cells: 7.5;Theca cells: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "eosinophil: 56.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 56.3" "Cell line enhanced" "Detected in all" "HMC-1: 60.5" "Low region specificity" "Detected in all" HPA039576 Approved NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "HPA039576: AB_10794750" "prognostic favorable (3.62e-4)" "unprognostic (1.02e-2)" "unprognostic (6.04e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-1)" "unprognostic (7.78e-2)" "unprognostic (7.49e-2)" "unprognostic (4.62e-2)" "unprognostic (1.89e-1)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (4.38e-2)" "prognostic favorable (1.71e-4)" "unprognostic (1.88e-1)" "unprognostic (1.01e-1)" "unprognostic (9.16e-2)" "unprognostic (2.55e-1)" 13.4 12.2 8.2 7.6 9.2 32.4 13.9 10.9 15.2 16.8 3.1 12.3 6.4 13.3 7.0 15.4 15.4 6.3 17.2 8.8 6.5 19.3 14.6 15.5 10.3 11.6 8.0 17.5 15.1 9.0 14.3 5.8 11.9 19.1 7.7 3.8 13.8 10.6 18.0 22.5 13.4 6.8 5.3 16.5 17.7 65.5 7.3 8.2 14.4 7.2 9.7 13.1 15.9 8.9 8.0 6.2 9.0 9.5 10.7 12.3 6.0 7.4 14.6 11.5 9.9 5.4 15.0 24.6 5.5 12.9 9.4 9.9 5.3 24.2 4.7 15.6 9.0 49.2 37.7 12.3 9.4 8.3 60.5 14.8 16.8 19.3 13.3 17.0 14.1 13.2 4.4 22.7 10.5 8.3 9.9 37.7 5.0 3.6 19.9 6.4 3.2 29.9 19.4 3.9 6.3 8.9 8.4 17.5 3.5 5.5 7.6 23.4 11.7 9.2 9.2 11.4 7.3 15.4 8.9 6.1 15.9 15.5 8.8 13.7 3.1 56.3 7.1 4.2 10.3 10.4 9.7 8.6 5.2 7.5 7.6 6.4 0.9 9.8 2.7 2.6 9.4 5.5 8.2 9.2 10.9 15.2 8.8 6.5 11.6 8.0 11.9 5.3 7.3 8.9 6.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 3.8 4.1 0.0 0.0 0.0 3.7 0.0 5.4 4.5 0.0 3.9 4.8 0.0 3.1 3.4 2.1 0.0 0.0 0.0 8.8 5.1 2.1 0.0 3.2 0.0 3.6 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.4 0.0 0.0 7.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.1 2.1 6.4 0.0 0.0 NACC1 "BEND8, BTBD14B, BTBD30, NAC-1, NAC1" ENSG00000160877 "Nucleus accumbens associated 1" Q96RE7 19 13116862-13141147 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021238, HPA062245, CAB069927" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 47: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724" "unprognostic (2.19e-1)" "unprognostic (9.20e-3)" "unprognostic (2.67e-2)" "unprognostic (2.84e-2)" "unprognostic (2.62e-1)" "unprognostic (7.75e-2)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.93e-1)" "unprognostic (8.46e-2)" "unprognostic (2.40e-2)" "unprognostic (3.04e-2)" "unprognostic (7.35e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.74e-2)" 12.6 19.5 31.0 14.6 19.2 8.8 10.3 7.1 26.6 9.7 0.0 17.3 13.3 18.4 7.9 27.6 11.9 6.4 20.9 25.7 7.4 14.8 20.5 16.7 12.1 13.4 15.9 7.7 12.2 10.7 14.8 12.4 15.1 14.6 6.6 3.7 15.8 11.2 24.2 17.4 16.0 7.7 8.9 15.9 16.0 17.0 20.6 11.3 14.0 7.9 8.8 15.0 12.6 16.4 98.8 110.0 28.0 59.6 15.0 17.7 74.9 47.4 34.2 42.4 32.4 114.8 40.4 50.9 104.1 39.8 37.3 49.0 34.8 80.7 16.2 89.1 52.5 32.4 87.9 84.7 35.5 52.0 82.3 28.8 28.0 46.1 24.7 36.5 50.2 46.4 72.5 19.8 22.9 206.1 82.9 39.6 123.6 28.9 101.7 47.8 32.9 49.5 28.2 101.1 58.2 37.7 49.6 64.9 39.1 29.8 59.3 46.4 76.7 94.6 58.8 67.2 87.0 53.4 88.1 42.4 99.7 52.8 58.9 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.1 31.0 19.2 7.1 26.6 25.7 7.4 13.4 15.9 15.1 8.9 20.6 16.4 4.9 0.0 1.7 6.2 5.6 12.1 7.5 11.8 2.8 16.6 11.5 7.5 2.1 12.8 8.5 16.5 2.1 19.0 12.9 22.7 7.9 12.3 2.3 10.9 8.9 8.1 4.9 12.2 7.2 8.8 20.0 5.2 10.7 17.6 10.2 13.3 8.6 18.0 21.1 26.9 5.9 16.2 14.2 9.6 9.6 2.0 4.4 8.8 5.4 3.7 10.5 12.0 10.3 5.5 5.4 21.7 11.1 9.4 5.6 16.5 14.0 15.0 5.9 7.7 6.6 7.5 7.0 11.1 15.6 8.4 13.9 27.1 7.9 15.2 15.4 17.2 NAF1 ENSG00000145414 "Nuclear assembly factor 1 ribonucleoprotein" Q96HR8 4 163110073-163166890 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036241, HPA036242, HPA066090" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614" "unprognostic (6.24e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-2)" "unprognostic (2.58e-1)" "unprognostic (8.99e-2)" "unprognostic (2.00e-2)" "unprognostic (1.18e-2)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.64e-3)" "unprognostic (1.45e-1)" "unprognostic (8.73e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.17e-2)" "unprognostic (3.05e-1)" 9.5 8.1 4.7 7.6 5.9 7.6 8.3 3.9 7.1 8.7 9.2 7.2 4.7 10.4 6.1 7.0 12.3 7.0 6.5 6.2 3.5 6.8 7.1 7.0 8.7 2.4 3.7 10.9 7.7 10.7 4.8 6.6 1.8 8.5 8.1 13.5 7.6 8.6 19.4 8.3 4.9 8.7 3.1 7.3 6.0 13.3 2.5 7.1 10.2 10.3 7.9 9.5 4.8 4.0 15.2 12.7 16.0 16.4 9.2 14.5 18.8 17.6 11.7 15.1 15.0 14.4 17.8 39.4 5.0 10.9 12.2 12.5 32.7 18.9 19.7 17.5 20.2 41.7 11.4 12.3 16.1 27.2 14.3 13.7 16.5 18.5 14.9 15.6 13.6 12.5 47.7 20.3 20.4 15.0 31.8 15.5 20.9 11.5 12.5 26.1 11.8 20.7 15.0 6.9 17.3 13.1 11.6 20.9 13.0 13.9 11.3 11.8 14.4 18.0 15.6 14.1 20.2 12.7 19.1 30.2 17.1 15.6 18.2 0.0 0.5 0.0 0.7 0.5 0.2 0.6 0.7 1.0 0.8 0.7 1.0 0.7 0.0 0.4 0.5 0.8 0.2 0.5 4.7 5.9 3.9 7.1 6.2 3.5 2.4 3.7 1.8 3.1 2.5 4.0 15.2 6.4 16.7 24.8 25.9 32.4 23.6 10.5 19.4 10.9 10.7 12.8 4.0 11.5 8.0 9.2 18.8 14.3 19.0 4.2 3.9 9.8 48.0 35.7 13.3 9.2 19.2 11.1 44.8 6.8 15.6 25.1 9.2 22.1 10.8 10.2 12.1 5.0 11.7 8.4 30.9 8.2 4.1 17.9 13.3 19.1 6.8 32.8 8.8 19.7 6.0 10.3 4.1 31.7 29.8 7.8 4.0 5.3 16.4 14.4 2.8 8.9 30.3 14.7 32.9 29.8 24.7 23.6 16.2 14.8 41.1 21.3 24.9 13.0 8.0 13.1 NANOS1 "NOS1, ZC2HC12A" ENSG00000188613 "Nanos C2HC-type zinc finger 1" Q8WY41 10 119029714-119033730 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 10.2;Cardiomyocytes: 11.3;Cone photoreceptor cells: 10.4;Muller glia cells: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 80.4;SK-BR-3: 46.7;SK-MEL-30: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB012219 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "CAB012219: " "prognostic unfavorable (1.52e-4)" "unprognostic (1.17e-1)" "unprognostic (1.50e-3)" "unprognostic (1.59e-3)" "unprognostic (7.07e-3)" "unprognostic (2.01e-1)" "unprognostic (2.19e-2)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (2.70e-1)" "unprognostic (8.22e-3)" "unprognostic (8.79e-2)" "unprognostic (2.64e-4)" "unprognostic (7.89e-2)" "unprognostic (6.99e-2)" "unprognostic (2.78e-2)" "unprognostic (2.52e-3)" 9.5 11.3 7.4 0.3 7.3 0.2 8.3 7.4 7.7 1.9 5.0 2.9 0.3 2.1 1.7 1.0 1.0 0.2 10.3 5.9 11.8 4.6 0.3 1.1 0.4 8.8 8.9 0.3 2.2 0.3 2.8 6.3 8.5 1.0 0.4 4.1 1.3 0.9 38.6 1.6 0.9 1.8 7.1 0.3 3.4 1.9 9.2 0.3 7.1 1.7 0.3 3.3 1.0 10.9 16.4 1.3 2.2 0.4 7.4 1.1 9.7 0.4 0.5 0.4 0.2 2.0 5.6 8.7 2.2 0.1 0.0 5.8 2.7 2.9 0.7 2.6 6.6 0.2 3.8 1.8 3.5 1.0 0.0 1.5 11.7 0.1 1.6 2.4 0.4 3.0 1.7 1.0 0.5 2.3 2.2 2.8 7.1 3.4 1.3 0.0 2.7 5.9 3.1 1.3 6.3 80.4 4.7 46.7 37.4 12.2 7.4 4.7 0.5 0.0 3.4 0.1 0.8 2.4 8.6 3.2 0.7 2.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 7.4 7.3 7.4 7.7 5.9 11.8 8.8 8.9 8.5 7.1 9.2 10.9 5.7 6.4 1.1 2.0 1.3 0.8 5.0 1.3 0.6 4.1 10.2 6.1 11.3 1.5 1.2 1.8 10.4 6.5 6.3 4.4 0.0 0.6 0.2 3.9 2.8 1.7 3.0 0.0 0.5 0.2 0.4 4.0 1.1 3.7 0.0 2.6 0.7 0.1 0.7 1.7 2.3 3.8 0.0 0.0 2.1 0.1 1.8 0.9 0.0 0.0 0.0 14.7 1.0 2.0 0.2 0.3 0.1 0.7 1.6 2.9 0.2 0.5 1.2 2.1 0.0 7.7 3.9 0.4 1.0 0.8 1.3 1.0 2.9 0.7 2.1 1.3 NASP "DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999" ENSG00000132780 "Nuclear autoantigenic sperm protein" P49321 1 45583846-45618904 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 476.2;Spermatogonia: 514.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028136, HPA030518, HPA030520" Enhanced Enhanced Nucleoplasm NA Yes 170000 "Cluster 24: B-cells - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 5: NTERA-2 - Transcription" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510" "unprognostic (5.59e-2)" "unprognostic (1.34e-3)" "unprognostic (5.02e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (5.36e-3)" "prognostic unfavorable (4.96e-6)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (1.91e-8)" "unprognostic (1.62e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" "unprognostic (5.32e-2)" 66.2 39.6 57.4 55.9 62.6 165.0 58.8 60.6 95.7 67.4 57.1 52.7 34.6 54.6 29.9 55.2 65.6 26.7 51.0 57.2 68.0 48.6 52.0 50.4 91.5 65.0 61.6 72.4 34.9 41.1 40.9 61.9 63.0 54.1 51.5 38.2 43.5 43.4 41.7 46.7 58.3 45.1 56.0 83.3 47.3 108.9 62.4 100.7 48.1 22.2 97.7 51.1 56.0 65.3 191.3 110.8 520.2 184.6 85.8 44.9 243.8 150.9 112.4 230.5 286.5 205.7 134.4 357.9 103.5 65.8 251.9 180.2 351.9 161.0 291.5 164.0 222.9 462.7 201.6 326.9 30.2 489.3 186.4 52.5 38.3 254.0 87.6 60.1 159.5 294.8 396.3 204.1 157.6 131.4 559.6 445.0 755.5 189.5 93.1 697.4 454.0 343.8 115.3 189.4 198.3 239.8 248.7 140.4 159.7 389.2 100.8 377.0 86.7 105.5 322.8 204.4 250.0 124.5 251.2 616.2 107.6 306.7 107.3 6.4 9.4 10.9 14.1 12.1 16.4 16.1 16.1 16.3 14.3 22.3 13.9 13.7 4.0 9.7 7.3 14.7 22.0 9.1 57.4 62.6 60.6 95.7 57.2 68.0 65.0 61.6 63.0 56.0 62.4 65.3 196.5 57.7 106.7 70.8 136.1 78.1 135.2 72.4 133.7 45.3 77.4 87.4 58.4 37.1 99.1 36.8 37.5 319.3 150.8 64.8 31.3 55.0 16.6 119.6 138.1 138.4 51.3 142.8 32.7 37.4 223.2 100.6 81.1 137.9 115.2 134.2 90.3 38.6 108.1 43.7 34.8 68.1 44.7 43.7 62.6 26.6 94.8 82.7 40.9 31.9 52.3 60.9 62.8 63.8 160.3 29.8 44.9 78.2 107.4 88.6 28.9 36.6 109.1 77.3 85.5 148.1 106.6 476.2 514.5 92.1 57.0 268.2 142.2 90.7 101.7 85.3 NAXD "CARKD, FLJ10769, LP3298" ENSG00000213995 "NAD(P)HX dehydratase" Q8IW45 13 110615545-110639996 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 34.8;Distal tubular cells: 39.2;Extravillous trophoblasts: 26.7;Granulosa cells: 27.6;Syncytiotrophoblasts: 30.9;Theca cells: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010551 Approved NA NA 390000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "HPA010551: AB_1848669" "unprognostic (1.24e-1)" "unprognostic (5.14e-2)" "unprognostic (1.79e-2)" "prognostic favorable (3.15e-4)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (3.48e-2)" "unprognostic (2.89e-1)" "unprognostic (3.20e-1)" "unprognostic (9.01e-2)" "unprognostic (1.94e-2)" "unprognostic (4.36e-3)" "prognostic favorable (4.63e-5)" "unprognostic (2.19e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-1)" "unprognostic (1.62e-2)" 17.3 37.1 44.0 16.0 43.7 8.2 19.4 43.6 46.3 16.7 40.8 23.1 22.9 18.7 26.6 23.4 22.6 21.3 26.4 45.7 42.8 24.9 65.4 18.8 20.8 45.9 45.0 39.0 36.2 28.4 22.4 23.3 44.5 25.8 19.7 14.3 22.8 28.9 31.9 30.5 23.0 21.7 43.9 21.8 30.3 24.2 46.2 18.3 25.4 33.6 17.1 17.3 15.0 45.2 36.0 15.7 28.1 24.3 29.8 23.6 35.4 27.9 22.7 24.6 26.2 43.9 35.1 7.3 28.4 21.7 25.3 28.1 16.3 24.4 16.0 31.6 27.4 22.5 47.9 23.5 34.2 29.3 20.2 29.1 42.4 19.8 17.7 32.5 21.9 31.8 19.6 0.2 22.3 30.0 23.1 48.4 21.2 64.4 17.2 8.2 14.4 5.9 30.3 30.1 42.5 28.6 16.8 75.4 21.6 18.5 39.7 54.4 25.3 17.1 14.3 0.1 22.4 25.6 18.7 0.3 27.7 8.7 28.9 0.0 8.3 0.8 9.6 9.0 6.3 8.4 9.6 8.9 10.4 8.2 9.9 9.1 1.0 9.2 6.5 10.1 10.5 8.3 44.0 43.7 43.6 46.3 45.7 42.8 45.9 45.0 44.5 43.9 46.2 45.2 9.3 19.2 12.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 14.2 11.3 0.0 0.0 9.9 22.0 0.0 34.8 5.4 0.0 39.2 15.0 0.0 7.3 10.5 4.0 0.0 0.0 0.0 11.8 26.7 6.2 0.0 8.8 1.3 27.6 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 10.3 0.0 0.0 0.0 0.0 11.6 0.0 0.0 2.1 0.0 0.0 22.4 8.7 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 30.9 2.1 24.4 0.0 0.0 NAXE "AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1" ENSG00000163382 "NAD(P)HX epimerase" Q8NCW5 1 156591756-156609507 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Lipid transport, Transport" Isomerase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 136.7;Distal tubular cells: 201.5;Ductal cells: 112.8;Exocrine glandular cells: 100.1;Proximal tubular cells: 219.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043766, HPA048164" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3300000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Vesicles, Cytosol" "HPA043766: AB_2678660, HPA048164: AB_2680294" "unprognostic (1.27e-1)" "unprognostic (2.34e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.38e-2)" "unprognostic (5.32e-2)" "unprognostic (2.46e-3)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.08e-3)" "unprognostic (3.23e-2)" "unprognostic (3.14e-2)" "unprognostic (2.15e-2)" "unprognostic (8.05e-2)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-1)" 47.1 74.8 61.0 20.9 63.7 22.2 47.9 66.1 69.6 56.8 71.1 62.9 45.5 68.8 88.7 58.0 59.5 26.5 111.1 60.9 64.3 83.8 86.5 43.6 27.0 62.7 64.8 46.5 69.7 104.7 70.0 23.7 61.8 62.5 41.6 17.4 53.9 48.3 71.8 55.8 48.3 39.7 64.7 43.2 67.5 40.8 63.5 30.6 59.8 68.2 34.3 55.0 47.8 70.5 114.2 155.4 43.9 84.4 64.0 43.8 55.5 29.5 62.3 69.5 72.6 130.6 76.8 62.4 113.4 52.5 55.9 111.1 49.4 99.0 47.5 81.2 98.5 58.1 76.2 86.1 75.1 60.0 60.9 44.2 123.7 87.9 81.9 53.4 95.4 104.7 54.7 70.1 71.6 209.6 83.3 98.0 43.1 158.1 118.2 87.7 40.2 212.6 93.0 93.6 114.7 102.9 90.4 172.4 141.6 66.4 178.3 117.5 51.1 45.1 64.8 64.6 70.6 180.1 110.3 53.0 63.1 37.0 70.4 25.4 96.3 52.9 121.2 111.3 121.3 236.2 109.4 124.3 89.1 186.5 122.8 114.9 11.4 141.3 89.1 225.7 110.1 186.6 61.0 63.7 66.1 69.6 60.9 64.3 62.7 64.8 61.8 64.7 63.5 70.5 29.5 41.7 32.9 0.0 14.8 0.0 0.0 0.0 0.0 0.0 87.5 96.0 0.0 0.0 23.5 68.0 0.0 136.7 28.7 0.0 201.5 112.8 0.0 27.3 29.9 18.4 0.0 0.0 0.0 100.1 43.1 27.2 0.0 32.0 5.1 53.5 0.0 0.0 92.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 40.8 0.0 0.0 0.0 0.0 91.0 0.0 0.0 6.2 0.0 0.0 219.6 11.7 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 81.3 13.4 48.1 0.0 0.0 NBDY "LINC01420, NoBody" ENSG00000204272 "Negative regulator of P-body association" A0A0U1RRE5 X 56729241-56819179 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 336.5;Extravillous trophoblasts: 257.1;Proximal tubular cells: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (8.38e-3)" "unprognostic (2.46e-1)" "unprognostic (1.96e-3)" "prognostic unfavorable (3.14e-5)" "unprognostic (2.07e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (1.01e-2)" "unprognostic (2.23e-1)" "unprognostic (2.83e-1)" "unprognostic (2.59e-2)" "unprognostic (2.77e-1)" "unprognostic (2.09e-1)" "unprognostic (2.01e-2)" "unprognostic (2.18e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-2)" 27.5 39.3 36.3 20.9 36.2 18.8 25.8 34.5 48.0 29.0 32.7 25.2 17.8 27.6 47.5 25.8 31.9 27.5 27.5 34.9 42.2 43.9 13.8 29.6 26.9 34.6 39.9 29.6 15.6 34.6 41.4 24.7 39.4 28.7 22.4 23.4 20.3 27.9 11.1 30.5 21.2 30.3 35.1 27.9 22.5 13.0 39.1 35.9 41.5 18.2 24.9 35.1 27.9 34.5 34.2 52.1 63.6 53.7 74.2 66.4 15.5 46.6 75.4 25.7 42.1 25.0 67.4 14.7 111.1 54.2 52.8 23.0 59.0 58.0 32.9 0.2 73.5 43.6 49.6 6.4 76.7 49.5 44.4 80.2 68.9 45.3 81.0 77.8 68.8 48.7 17.7 36.7 50.4 59.0 62.3 14.3 84.2 55.5 92.2 30.2 42.8 53.0 68.8 49.3 27.7 43.1 100.8 47.1 46.7 113.7 60.7 22.7 59.3 42.9 35.3 75.5 29.0 40.7 26.3 39.8 36.2 26.9 34.6 66.4 54.7 6.0 70.5 62.5 73.1 86.1 89.1 78.6 98.7 86.7 85.6 82.1 5.0 103.4 66.9 175.9 93.2 68.2 36.3 36.2 34.5 48.0 34.9 42.2 34.6 39.9 39.4 35.1 39.1 34.5 128.6 28.9 34.5 0.0 24.6 0.0 0.0 0.0 0.0 0.0 83.2 88.9 0.0 0.0 18.0 117.7 0.0 143.1 40.5 0.0 336.5 110.8 0.0 71.9 60.4 55.2 0.0 0.0 0.0 95.5 257.1 31.0 0.0 68.5 39.1 67.2 0.0 0.0 142.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 0.0 0.0 91.5 0.0 0.0 0.0 0.0 126.2 0.0 0.0 5.4 0.0 0.0 262.5 29.9 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 148.9 25.6 119.5 0.0 0.0 NDUFAF8 C17orf89 ENSG00000224877 "NADH:ubiquinone oxidoreductase complex assembly factor 8" A1L188 17 81239305-81241310 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 264.3" "Cell type enhanced" "Detected in many" "Breast glandular cells: 130.5;Breast myoepithelial cells: 162.6;Distal tubular cells: 279.7;Proximal tubular cells: 337.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057732 Uncertain Approved Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA057732: AB_2683513" "unprognostic (4.33e-3)" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" "unprognostic (1.97e-1)" "unprognostic (9.32e-2)" "unprognostic (3.06e-1)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.71e-2)" "unprognostic (2.40e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.70e-6)" "unprognostic (5.74e-2)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" 47.8 65.1 164.7 28.2 167.7 37.0 40.3 159.5 264.3 32.9 156.0 49.5 21.8 30.4 33.6 45.9 32.0 9.8 110.7 161.5 158.1 68.6 79.1 27.5 26.5 160.1 160.0 33.6 56.3 40.1 54.2 14.5 159.1 44.1 29.4 24.0 36.7 20.2 144.5 33.0 31.6 21.8 161.1 40.4 45.5 30.7 166.1 30.8 38.7 93.0 32.1 45.2 31.6 159.9 142.1 199.9 73.2 72.1 80.4 84.9 79.0 122.1 49.3 82.0 47.1 102.5 60.0 131.6 60.2 86.2 68.2 69.2 69.2 117.4 97.8 33.3 437.1 99.8 222.2 233.3 84.7 139.2 60.8 113.5 140.2 59.3 124.8 87.8 133.0 103.6 132.5 77.3 106.8 130.4 194.6 145.1 41.1 114.6 288.2 121.6 104.8 96.7 89.5 96.1 84.1 107.7 100.5 82.2 126.1 107.2 115.1 127.7 81.5 101.4 154.8 73.2 123.2 110.2 41.1 124.0 91.7 72.8 79.9 41.2 80.1 69.1 73.4 67.1 73.4 103.6 80.4 88.9 82.0 87.6 96.4 94.4 10.3 78.0 76.2 138.0 87.3 77.5 164.7 167.7 159.5 264.3 161.5 158.1 160.1 160.0 159.1 161.1 166.1 159.9 47.9 19.2 17.3 0.0 24.9 0.0 0.0 0.0 0.0 0.0 130.5 162.6 0.0 0.0 9.3 101.2 0.0 120.5 41.0 0.0 279.7 98.1 0.0 59.8 75.1 21.6 0.0 0.0 0.0 124.6 99.0 32.0 0.0 48.1 1.3 73.5 0.0 0.0 129.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 0.0 0.0 51.1 0.0 0.0 0.0 0.0 117.4 0.0 0.0 10.6 0.0 0.0 337.8 3.6 0.0 0.0 0.0 40.5 0.0 0.0 0.0 0.0 45.6 23.1 96.8 0.0 0.0 NDUFB8 "ASHI, CI-ASHI" ENSG00000166136 "NADH:ubiquinone oxidoreductase subunit B8" O95169 10 100523740-100530000 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 876.5;Proximal tubular cells: 881.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003886, HPA065549" Supported Enhanced Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA003886: AB_1079463, HPA065549: " "unprognostic (4.07e-2)" "unprognostic (1.95e-3)" "unprognostic (2.28e-1)" "unprognostic (7.33e-2)" "unprognostic (4.88e-2)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (6.46e-2)" "unprognostic (8.33e-2)" "unprognostic (9.09e-2)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-2)" 152.6 199.3 431.2 103.4 439.3 171.5 135.8 427.1 606.3 127.3 416.7 237.8 161.0 145.8 163.0 170.2 132.4 88.0 482.4 444.8 441.9 249.9 262.0 108.6 132.0 438.5 439.4 130.4 115.5 331.0 186.7 83.0 441.9 132.2 145.0 127.1 163.6 135.8 408.9 128.2 147.8 125.5 411.8 133.3 201.0 66.2 442.5 140.6 130.1 512.8 119.9 162.9 132.9 448.3 250.2 419.6 222.3 383.1 159.6 158.8 238.5 168.1 370.9 259.3 278.8 575.4 278.1 260.7 146.4 185.6 189.1 289.5 162.9 269.7 194.5 172.9 417.8 183.9 350.3 465.7 217.6 379.3 302.6 191.6 240.7 249.2 329.3 180.4 283.7 361.1 194.5 159.3 218.4 304.1 369.7 472.9 144.7 324.3 377.9 252.4 237.6 346.1 298.8 281.3 147.9 209.7 122.0 227.4 250.9 147.3 338.2 332.8 185.5 139.5 158.7 151.5 296.8 288.4 286.4 334.8 277.6 398.2 159.3 299.4 530.8 478.1 406.0 558.8 483.1 616.1 498.0 468.1 589.7 546.7 538.1 514.0 122.7 478.0 489.6 655.0 817.6 1113.4 431.2 439.3 427.1 606.3 444.8 441.9 438.5 439.4 441.9 411.8 442.5 448.3 184.8 76.9 132.7 41.8 107.6 0.0 187.1 0.0 12.5 186.4 162.2 210.2 392.9 204.5 48.3 198.6 58.4 333.1 175.8 109.0 876.5 268.1 24.9 105.8 86.3 142.7 105.6 114.3 72.6 264.7 305.1 128.8 35.2 87.1 109.7 112.0 153.8 346.5 399.1 153.1 82.6 171.6 0.0 184.4 0.0 56.0 218.1 142.2 0.0 33.7 231.0 219.5 158.6 40.2 62.3 250.6 191.7 217.4 59.3 203.2 560.2 881.6 85.2 183.5 170.9 117.2 176.0 85.5 83.1 31.5 0.0 307.7 112.9 225.5 237.6 221.5 NECTIN2 "CD112, HVEB, PRR2, PVRL2, PVRR2" ENSG00000130202 "Nectin cell adhesion molecule 2" Q92692 19 44846175-44889223 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 136.6;Ductal cells: 215.6;Exocrine glandular cells: 154.2;Glandular and luminal cells: 126.1;Pancreatic endocrine cells: 241.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 10.4" "Lineage enhanced" "Detected in many" "granulocytes: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012759, CAB026138, HPA073459" Enhanced Approved "Nucleoli fibrillar center,Cell Junctions" NA Yes 5900000 "Cluster 52: Eosinophils - Transcription" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 39: CACO-2 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "Nucleoli fibrillar center, Cell Junctions" "CAB026138: , HPA012759: AB_1846227, HPA073459: " "unprognostic (3.30e-2)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (7.45e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-2)" "unprognostic (6.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.97e-1)" "unprognostic (6.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (2.15e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-2)" "unprognostic (2.05e-1)" 71.4 79.1 30.8 32.1 28.4 15.8 66.0 29.8 34.3 41.7 44.3 42.3 55.3 45.0 58.2 76.3 43.9 52.5 71.3 29.2 33.1 79.6 118.5 72.9 15.8 35.8 33.0 41.7 55.0 61.5 39.1 77.2 32.9 69.2 32.8 16.7 62.6 30.4 20.1 52.5 47.5 31.3 31.8 58.1 75.4 65.8 34.7 6.9 57.4 17.7 25.3 55.8 49.3 28.9 73.8 89.3 118.3 140.6 59.3 35.8 123.7 62.6 83.9 120.4 136.6 194.8 171.0 0.6 79.2 79.0 61.1 98.5 106.6 55.6 91.7 3.2 53.2 43.0 30.8 128.6 145.0 0.7 117.9 64.9 22.5 56.2 44.8 123.2 149.3 3.0 71.1 0.7 59.2 146.4 0.6 5.6 92.8 249.8 27.7 4.3 37.7 3.2 139.5 100.1 5.4 15.2 74.9 127.0 28.7 210.4 97.2 47.1 140.1 31.3 105.5 23.7 48.6 9.0 25.8 0.6 57.3 10.0 83.0 1.8 2.0 10.4 0.0 0.7 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.8 0.0 0.4 0.3 0.0 0.7 30.8 28.4 29.8 34.3 29.2 33.1 35.8 33.0 32.9 31.8 34.7 28.9 136.6 35.3 31.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 108.4 54.9 0.0 0.0 6.8 58.8 0.0 109.3 2.6 0.0 3.9 215.6 0.0 73.8 66.3 58.8 0.0 0.0 0.0 154.2 97.8 30.4 0.0 126.1 3.8 75.0 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 80.1 0.0 0.0 0.0 0.0 241.8 0.0 0.0 0.1 0.0 0.0 27.1 3.6 0.0 0.0 0.0 42.9 0.0 0.0 0.0 0.0 101.8 2.2 58.3 0.0 0.0 NECTIN3 "CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3" ENSG00000177707 "Nectin cell adhesion molecule 3" Q9NQS3 3 111070071-111275563 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 54.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Syncytiotrophoblasts: 117.3;Theca cells: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 117.4;TIME: 170.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009869, HPA011038" Approved Approved "Cell Junctions,Cytosol" NA NA 41000000 "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" Cytosol "Cell Junctions" "CAB009869: AB_2284699, HPA011038: AB_1079719" "unprognostic (3.76e-2)" "unprognostic (3.81e-3)" "unprognostic (1.74e-1)" "unprognostic (1.97e-2)" "unprognostic (1.02e-1)" "unprognostic (9.77e-2)" "unprognostic (3.26e-3)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (3.94e-2)" "unprognostic (5.33e-2)" "unprognostic (7.04e-2)" "prognostic favorable (9.82e-7)" "unprognostic (2.01e-1)" "unprognostic (1.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.05e-1)" 8.9 4.8 3.9 4.7 6.0 0.2 4.3 6.2 7.5 7.3 0.0 23.0 32.9 7.6 1.5 4.6 9.7 8.2 5.3 6.6 5.0 12.0 29.4 10.4 3.0 10.8 5.6 16.1 7.1 4.6 1.1 22.7 6.7 11.7 23.1 7.3 5.6 8.4 1.7 1.4 21.2 13.6 7.3 3.9 24.6 54.7 12.4 1.5 42.5 7.1 3.1 6.0 3.0 8.8 0.2 36.2 117.4 7.7 45.7 85.3 7.2 78.6 82.7 47.8 39.7 33.4 16.7 0.0 25.4 112.4 26.6 0.6 33.2 11.4 87.4 0.9 8.8 0.1 12.1 2.4 77.2 5.9 1.1 43.6 4.6 31.7 30.3 42.5 40.8 1.5 0.0 30.2 104.2 0.2 7.8 0.0 33.0 11.0 12.9 0.0 58.2 0.2 26.9 19.2 2.9 20.8 1.6 0.0 15.7 38.9 1.3 0.5 170.4 58.8 24.9 11.1 47.2 17.2 0.0 0.2 37.9 0.1 56.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 6.0 6.2 7.5 6.6 5.0 10.8 5.6 6.7 7.3 12.4 8.8 8.3 25.6 11.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.6 3.0 0.0 0.0 3.1 12.9 0.0 3.9 4.5 0.0 0.0 6.5 0.0 9.0 11.4 4.4 0.0 0.0 0.0 18.9 9.4 9.5 0.0 13.7 1.3 6.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 2.8 0.0 0.0 7.1 0.7 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 117.3 5.3 31.5 0.0 0.0 NELFB "COBRA1, KIAA1182, NELF-B" ENSG00000188986 "Negative elongation factor complex member B" 9 137255327-137273542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020259 Supported Supported Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA020259: AB_1847072" "unprognostic (2.56e-2)" "unprognostic (5.14e-2)" "unprognostic (1.26e-1)" "unprognostic (1.14e-2)" "unprognostic (3.27e-1)" "unprognostic (4.06e-1)" "unprognostic (5.58e-3)" "unprognostic (7.74e-3)" "unprognostic (2.04e-1)" "unprognostic (1.46e-1)" "unprognostic (5.03e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.31e-6)" "unprognostic (6.74e-3)" "unprognostic (1.01e-1)" "unprognostic (2.66e-2)" "unprognostic (4.04e-2)" 25.7 24.5 40.1 21.8 36.4 23.9 25.1 33.6 52.1 28.8 28.0 29.5 23.9 24.9 6.9 34.6 23.2 15.7 37.1 38.5 35.0 32.8 30.2 25.0 27.4 41.4 40.1 28.2 37.4 18.2 20.6 18.5 36.4 30.5 11.5 7.6 29.6 16.1 36.3 36.2 26.6 13.0 36.4 31.5 30.3 28.4 40.0 21.6 24.0 21.2 16.7 29.0 27.9 35.3 50.4 79.5 41.1 53.1 34.8 24.8 62.1 42.0 28.4 48.0 33.9 84.7 56.9 70.2 60.8 40.0 56.3 96.0 41.0 47.8 14.0 68.2 64.9 45.4 97.9 69.7 35.3 66.5 54.2 29.7 47.2 44.3 25.8 28.9 45.0 46.9 77.8 57.7 28.6 116.8 51.0 106.2 67.2 88.8 92.9 83.6 76.1 114.7 27.1 43.9 60.8 57.2 56.7 59.7 40.6 21.4 79.3 79.7 59.9 71.1 56.1 113.4 65.9 32.1 55.2 59.1 56.9 47.4 64.6 1.1 3.3 5.5 4.3 2.8 2.9 3.5 3.6 3.3 2.9 3.5 3.3 3.5 1.9 4.0 2.7 4.7 4.3 2.2 40.1 36.4 33.6 52.1 38.5 35.0 41.4 40.1 36.4 36.4 40.0 35.3 31.6 6.4 17.9 16.6 11.7 14.9 11.8 12.7 5.7 19.7 21.8 20.6 12.4 17.2 14.1 23.9 18.8 24.3 24.7 40.0 13.7 27.9 3.7 14.7 18.1 19.8 28.2 13.0 8.9 38.5 27.8 17.4 13.3 21.8 18.4 39.1 20.3 19.5 26.5 43.7 8.4 37.2 12.2 14.0 15.6 5.6 23.3 17.6 7.2 11.2 37.7 33.8 22.6 9.5 11.7 33.5 18.7 20.7 13.8 18.9 29.2 13.9 9.9 17.1 39.5 15.5 20.6 10.7 23.6 12.6 13.9 15.6 15.4 35.0 31.5 13.5 NEPRO "C3orf17, DKFZP434F2021, NET17" ENSG00000163608 "Nucleolus and neural progenitor protein" Q6NW34 3 113002444-113019861 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069654 Supported Nucleoplasm,Nucleoli Yes No "Cluster 15: NK-cells - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA069654: AB_2686164" "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (4.98e-2)" "unprognostic (1.72e-2)" "unprognostic (9.29e-3)" "unprognostic (5.40e-2)" "unprognostic (1.69e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (3.28e-2)" 6.7 6.7 4.7 7.0 5.4 10.6 8.8 6.9 6.5 6.5 6.3 7.0 7.1 8.4 10.3 6.0 6.5 7.4 8.4 5.2 4.9 6.3 5.9 6.4 12.3 5.8 5.3 8.1 8.2 6.9 6.6 6.7 5.6 6.6 5.4 11.7 6.9 6.1 18.7 10.8 7.0 5.8 5.1 8.8 8.3 11.3 5.3 9.4 11.5 7.7 7.8 6.7 5.3 7.9 13.6 10.9 17.3 13.0 5.5 10.1 9.2 12.6 8.1 6.9 4.7 10.1 8.5 17.6 6.6 4.3 9.6 13.7 12.7 5.8 9.4 3.5 8.0 27.3 10.0 7.5 10.0 17.4 9.4 15.7 10.0 5.5 14.2 18.8 6.1 17.2 9.5 13.5 5.2 8.6 15.1 10.3 18.1 12.0 14.0 12.1 13.7 9.3 7.8 11.2 11.9 17.3 7.3 9.1 21.4 12.7 10.4 14.7 12.4 9.4 9.3 3.6 9.1 13.3 11.2 20.6 15.2 13.6 7.0 1.9 1.3 1.6 2.2 1.6 2.3 1.8 2.6 1.9 1.8 1.4 3.2 3.2 0.8 4.3 0.7 1.3 1.2 1.4 4.7 5.4 6.9 6.5 5.2 4.9 5.8 5.3 5.6 5.1 5.3 7.9 16.3 9.6 12.8 0.0 7.6 0.0 0.0 0.0 0.0 0.0 17.4 16.9 0.0 0.0 10.5 18.4 0.0 18.4 23.4 0.0 17.6 14.1 0.0 11.9 20.7 6.3 0.0 0.0 0.0 12.6 15.5 9.3 0.0 16.1 17.7 24.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 14.4 0.0 0.0 4.5 0.0 0.0 14.8 8.7 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 20.4 9.1 33.9 0.0 0.0 NEU1 NEU ENSG00000204386 "Neuraminidase 1" Q99519 6 31857659-31862905 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 197.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 3.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "GAMG: 5.4;U-266/84: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015634, HPA021506" Approved Supported "Vesicles,Cell Junctions" NA NA 180000 "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Vesicles "Cell Junctions" "HPA015634: AB_1854386, HPA021506: AB_1854385" "unprognostic (3.84e-2)" "unprognostic (7.47e-2)" "unprognostic (9.64e-2)" "unprognostic (4.65e-2)" "unprognostic (3.00e-1)" "unprognostic (4.42e-3)" "unprognostic (1.38e-3)" "unprognostic (8.58e-3)" "unprognostic (7.49e-2)" "unprognostic (5.21e-2)" "unprognostic (4.44e-3)" "unprognostic (1.27e-1)" "unprognostic (2.70e-2)" "unprognostic (6.22e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (2.13e-3)" 23.9 57.2 0.7 0.4 0.8 0.0 22.4 2.5 1.2 21.2 1.2 25.1 0.7 19.5 0.0 14.9 16.8 1.0 22.5 0.7 0.6 43.7 29.9 28.9 0.3 0.8 0.5 20.3 35.9 0.3 33.0 0.2 0.8 26.5 0.0 1.6 38.6 0.0 21.3 20.1 24.3 0.1 0.3 25.3 29.8 8.2 1.0 0.0 31.8 0.0 0.0 23.2 16.2 1.7 0.3 0.2 0.8 1.4 1.8 0.4 0.7 0.2 0.2 0.3 0.3 1.5 0.6 0.7 0.4 0.1 5.4 0.3 2.2 0.0 0.4 2.5 0.3 0.6 0.9 1.2 1.4 0.9 1.8 1.0 0.2 1.4 0.7 0.2 0.6 0.9 1.1 1.2 0.5 0.3 0.6 0.0 0.6 0.5 0.4 0.9 0.4 0.9 1.0 0.4 0.7 0.4 0.2 0.3 0.7 0.9 0.9 0.5 0.7 1.1 0.8 0.7 0.6 3.7 9.6 0.9 1.7 0.4 0.4 1.3 0.3 0.4 0.2 0.3 0.1 0.2 0.2 0.1 0.2 0.6 0.2 0.3 3.0 0.3 0.2 0.3 0.2 0.1 0.7 0.8 2.5 1.2 0.7 0.6 0.8 0.5 0.8 0.3 1.0 1.7 65.7 25.6 46.3 5.2 57.0 34.3 48.5 45.0 39.9 26.4 87.7 55.8 29.0 51.5 54.8 47.8 25.0 62.8 100.5 83.7 9.8 114.2 0.8 29.3 53.5 42.8 113.5 4.6 6.3 59.6 57.8 73.8 32.6 60.8 67.9 17.4 30.7 34.5 170.9 10.1 7.6 39.9 79.3 63.0 65.9 1.4 27.7 93.0 71.2 9.4 25.8 48.8 9.2 5.0 4.0 34.4 88.1 23.3 81.7 89.0 115.0 59.9 29.2 32.7 26.3 60.8 43.7 5.4 10.0 29.3 41.6 197.0 81.7 40.3 41.1 34.6 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925472 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.6;Breast glandular cells: 1.4;Club cells: 2.5;Hofbauer cells: 1.3;Respiratory ciliated cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 3.7;Karpas-707: 5.9;SiHa: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Yes NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: AB_2665984" "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.1 0.9 3.0 0.1 3.1 0.0 0.3 1.0 2.5 0.4 0.0 0.8 0.1 0.5 0.2 0.3 0.3 0.1 0.0 2.6 6.7 0.7 0.0 0.1 0.1 0.3 0.7 0.4 1.5 1.8 1.7 0.1 0.5 0.9 0.3 1.0 0.4 0.6 0.0 0.3 0.4 0.7 0.2 0.1 0.6 0.2 4.8 0.0 0.4 0.1 0.1 0.2 0.2 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 5.9 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.1 1.0 2.5 2.6 6.7 0.3 0.7 0.5 0.2 4.8 0.7 0.3 0.0 3.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.9 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NIPSNAP2 GBAS ENSG00000146729 "Nipsnap homolog 2" O75323 7 55951793-56000181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "heart muscle: 266.5;skeletal muscle: 645.5;tongue: 784.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 226.9;Endometrial ciliated cells: 107.5;Proximal tubular cells: 106.8" "Cancer enhanced" "Detected in all" "glioma: 73.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 301.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063084 Enhanced Supported Mitochondria NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA063084: AB_2684938" "unprognostic (6.88e-2)" "unprognostic (6.53e-3)" "unprognostic (8.20e-3)" "unprognostic (4.95e-2)" "unprognostic (5.79e-2)" "unprognostic (1.53e-3)" "unprognostic (5.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (6.38e-3)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "prognostic favorable (3.02e-8)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (6.65e-3)" "unprognostic (3.59e-1)" 61.2 70.3 46.0 25.4 48.4 39.2 59.0 47.2 56.9 45.4 50.8 56.0 31.4 41.1 36.6 49.0 50.4 27.5 266.5 45.1 49.5 63.8 14.5 36.9 26.4 45.2 48.7 34.7 49.2 70.4 27.1 31.0 47.1 53.4 53.8 27.6 79.2 55.9 645.5 21.9 32.4 46.6 49.0 26.1 46.5 20.5 50.0 40.1 86.5 784.2 28.7 40.8 26.0 47.6 301.3 52.3 67.5 112.6 38.7 65.8 33.1 24.7 58.2 69.7 53.5 36.5 64.9 43.8 40.5 46.6 67.5 39.1 51.4 52.2 68.7 27.9 75.4 31.1 27.6 46.9 54.6 68.0 30.2 60.3 78.4 23.8 64.5 79.1 74.6 62.2 56.2 41.9 54.8 13.4 68.1 70.4 66.7 66.5 52.3 68.0 31.3 90.8 94.6 46.7 71.7 80.8 56.2 67.0 78.3 53.0 129.9 72.3 43.9 31.7 47.4 11.3 52.0 34.1 30.9 81.2 35.1 41.9 95.7 48.2 86.6 39.1 22.6 86.4 27.2 37.7 28.8 23.8 91.7 37.0 34.2 25.2 15.3 41.9 69.1 38.1 37.9 72.4 46.0 48.4 47.2 56.9 45.1 49.5 45.2 48.7 47.1 49.0 50.0 47.6 45.4 51.3 57.7 0.0 10.3 0.0 0.0 0.0 0.0 0.0 80.4 63.8 0.0 0.0 43.3 62.5 0.0 76.0 20.1 0.0 226.9 74.8 0.0 107.5 56.1 22.1 0.0 0.0 0.0 57.2 56.4 23.4 0.0 57.6 16.4 64.7 0.0 0.0 88.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 39.8 0.0 0.0 0.0 0.0 46.2 0.0 0.0 5.2 0.0 0.0 106.8 88.2 0.0 0.0 0.0 26.7 0.0 0.0 0.0 0.0 51.4 12.3 74.0 0.0 0.0 NKAPD1 "C11orf57, FLJ10726" ENSG00000150776 "NKAP domain containing 1" Q6ZUT1 11 112074086-112085150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1;Endometrial stromal cells: 35.4;Proximal tubular cells: 32.9;Theca cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039493, HPA039892" Approved Approved Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA039493: AB_10795036, HPA039892: AB_10795372" "unprognostic (5.93e-2)" "unprognostic (3.24e-1)" "unprognostic (6.45e-3)" "unprognostic (1.80e-1)" "unprognostic (1.45e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.17e-1)" "unprognostic (1.45e-2)" "unprognostic (8.61e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (7.05e-3)" "unprognostic (1.15e-2)" "unprognostic (2.86e-1)" "unprognostic (8.24e-2)" "unprognostic (1.41e-1)" 14.2 11.4 9.5 11.6 10.2 13.0 16.7 12.9 11.8 12.1 8.4 12.2 11.3 15.3 11.8 13.9 13.7 11.8 13.0 9.4 10.4 14.6 11.8 11.0 14.2 9.6 9.7 20.1 12.3 14.1 7.7 15.8 10.5 10.7 11.6 33.4 13.7 11.2 18.6 12.1 11.0 12.5 9.6 12.6 11.5 13.6 9.7 16.9 16.0 10.1 14.0 11.5 9.6 11.4 19.5 12.8 26.6 42.9 26.8 31.0 19.5 28.0 23.8 23.1 26.4 39.8 34.2 54.1 41.8 25.3 26.1 27.4 32.1 30.1 30.0 39.0 22.3 41.6 12.7 19.2 24.8 63.3 26.3 31.8 40.5 27.8 63.7 35.1 20.9 44.0 62.4 32.5 23.4 11.8 57.0 39.2 26.5 32.7 28.3 43.5 32.7 44.6 26.6 17.3 22.1 40.4 29.0 35.3 26.1 23.3 44.2 25.9 21.4 30.7 34.4 19.1 24.5 24.5 58.4 111.4 13.0 58.6 31.7 9.1 7.3 4.8 9.8 7.8 10.2 8.4 10.4 6.8 8.1 9.1 10.9 9.5 4.2 13.4 8.9 20.6 9.0 4.8 9.5 10.2 12.9 11.8 9.4 10.4 9.6 9.7 10.5 9.6 9.7 11.4 19.9 32.1 20.7 0.0 9.4 0.0 0.0 0.0 0.0 0.0 24.5 21.0 0.0 0.0 17.3 16.5 0.0 19.6 15.1 0.0 13.7 20.2 0.0 26.0 35.4 8.7 0.0 0.0 0.0 21.4 17.8 11.3 0.0 20.9 8.8 21.8 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 13.9 0.0 0.0 0.0 0.0 20.0 0.0 0.0 5.0 0.0 0.0 32.9 17.5 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 20.0 6.0 35.6 0.0 0.0 NME6 "IPIA-ALPHA, NM23-H6" ENSG00000172113 "NME/NM23 nucleoside diphosphate kinase 6" O75414 3 48290722-48301685 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017909 Approved Approved Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA017909: AB_1854530" "unprognostic (7.31e-3)" "unprognostic (1.87e-1)" "unprognostic (8.19e-3)" "unprognostic (2.09e-2)" "unprognostic (8.52e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.17e-7)" "unprognostic (1.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.00e-3)" "unprognostic (1.32e-1)" "unprognostic (2.98e-1)" "prognostic favorable (3.18e-5)" "unprognostic (1.98e-2)" "unprognostic (1.57e-2)" "unprognostic (1.23e-1)" "unprognostic (9.50e-2)" 8.7 7.7 6.3 10.4 6.4 8.1 12.1 9.2 6.3 10.2 8.7 11.6 13.2 9.3 8.5 12.1 14.8 8.9 13.5 7.1 6.5 11.1 10.3 10.2 12.2 5.9 6.3 12.4 11.6 12.4 6.0 14.2 5.7 9.5 11.5 7.6 10.9 8.7 17.7 10.0 10.4 12.4 4.9 9.6 11.5 6.2 6.4 9.4 12.2 17.2 13.7 9.6 9.0 6.3 30.0 19.1 24.3 18.3 18.2 23.4 22.1 27.2 18.3 37.5 27.3 30.5 26.5 30.1 14.0 20.5 36.5 10.1 21.9 27.2 24.1 36.1 21.3 17.9 24.1 26.6 25.7 24.3 20.7 19.7 33.8 34.4 42.9 19.3 19.8 21.1 33.9 23.6 14.0 13.9 21.4 11.3 22.3 19.5 23.3 12.7 22.9 25.3 21.2 23.6 7.7 12.7 19.8 21.0 26.1 17.8 23.9 22.5 22.1 8.3 33.0 21.2 39.4 27.0 40.9 26.1 16.3 31.9 18.4 47.3 33.4 76.4 40.9 36.0 36.6 43.5 37.4 35.2 39.9 38.0 28.1 27.2 37.3 40.4 42.1 34.5 33.5 25.1 6.3 6.4 9.2 6.3 7.1 6.5 5.9 6.3 5.7 4.9 6.4 6.3 13.1 28.9 20.7 2.3 16.4 5.0 8.5 18.2 9.6 11.9 14.1 13.6 10.4 15.7 19.4 9.2 14.6 49.5 18.4 8.2 39.2 24.8 2.6 16.1 17.5 12.8 4.2 8.0 2.5 30.1 41.6 12.4 11.7 11.8 10.1 22.8 7.9 7.9 34.4 10.1 3.2 10.8 12.2 9.3 9.7 1.7 11.8 13.7 16.0 1.9 23.4 17.6 18.6 2.5 2.7 31.3 8.3 7.2 10.8 12.8 16.6 16.4 30.6 11.5 13.1 7.7 12.2 9.3 15.0 12.4 4.1 19.7 14.7 15.1 12.8 7.1 NOP53 "GLTSCR2, PICT-1, PICT1" ENSG00000105373 "NOP53 ribosome biogenesis factor" Q9NZM5 19 47745546-47757058 "Predicted intracellular proteins" "Host-virus interaction, Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 605.5;Breast myoepithelial cells: 415.5;Cytotrophoblasts: 454.3;Exocrine glandular cells: 989.2;Extravillous trophoblasts: 570.3;Syncytiotrophoblasts: 506.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "B-cells: 311.8;NK-cells: 96.7;T-cells: 244.1" "Cell line enhanced" "Detected in all" "NB-4: 1305.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018999, HPA049600" Approved Supported Nucleoli NA NA "Cluster 37: B-cells - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoli "HPA018999: AB_1849733, HPA049600: AB_2680831" "unprognostic (2.08e-3)" "unprognostic (1.84e-1)" "unprognostic (4.02e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (1.56e-2)" "unprognostic (3.62e-3)" "unprognostic (1.89e-1)" "unprognostic (9.27e-2)" "unprognostic (2.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" 400.7 245.3 101.7 175.2 105.0 242.1 420.4 97.4 125.9 589.9 106.6 440.5 185.0 405.7 77.3 320.0 424.5 39.4 273.8 93.6 99.7 259.3 224.7 219.1 213.6 114.7 103.5 790.1 1016.5 123.0 201.7 78.4 105.4 386.3 64.1 70.2 397.0 104.5 308.6 635.8 333.6 60.1 108.4 358.9 445.3 116.5 107.3 225.3 302.8 110.0 128.3 411.8 422.5 105.6 99.7 103.0 90.7 214.6 110.6 184.2 176.8 60.6 110.5 57.8 85.3 95.5 194.8 440.3 87.0 71.2 44.2 139.8 52.9 88.8 30.2 133.0 177.8 142.6 85.1 113.5 163.0 207.4 271.6 162.5 198.9 50.8 136.1 188.0 92.3 183.1 176.8 206.5 52.3 86.9 577.2 1305.4 209.4 173.4 60.0 380.4 160.8 209.8 112.6 151.9 96.8 340.9 50.6 330.7 330.0 65.8 156.2 493.7 114.4 56.4 150.2 49.2 125.8 306.3 290.6 120.9 71.2 145.4 92.4 21.5 23.3 26.3 55.3 35.3 74.5 311.8 108.2 96.0 33.1 238.5 244.1 108.6 3.3 96.7 25.1 41.6 120.0 15.8 101.7 105.0 97.4 125.9 93.6 99.7 114.7 103.5 105.4 108.4 107.3 105.6 229.4 41.7 120.7 0.0 210.4 0.0 0.0 0.0 0.0 0.0 605.5 415.5 0.0 0.0 69.3 104.8 0.0 454.3 224.1 0.0 266.1 266.5 0.0 100.6 156.9 94.5 0.0 0.0 0.0 989.2 570.3 107.2 0.0 115.5 68.1 268.3 0.0 0.0 259.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.1 0.0 0.0 269.8 0.0 0.0 0.0 0.0 348.1 0.0 0.0 61.8 0.0 0.0 369.7 18.2 0.0 0.0 0.0 108.6 0.0 0.0 0.0 0.0 506.8 131.3 226.3 0.0 0.0 NPIPB2 ENSG00000234719 "Nuclear pore complex interacting protein family member B2" A6NJ64 16 11927259-11976643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.1" "Cell type enhanced" "Detected in some" "Distal tubular cells: 5.9;granulocytes: 2.5;Granulosa cells: 3.1;Proximal tubular cells: 4.4;Respiratory ciliated cells: 2.2;Theca cells: 2.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 15.5;U-266/70: 26.9" HPA053611 Supported Approved Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (8.80e-2)" "unprognostic (4.83e-1)" "unprognostic (5.20e-2)" "unprognostic (8.24e-2)" "unprognostic (2.45e-1)" "unprognostic (4.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.73e-1)" "unprognostic (5.92e-2)" "unprognostic (3.01e-3)" "unprognostic (2.80e-2)" "unprognostic (2.21e-1)" "unprognostic (4.89e-3)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (2.25e-1)" "unprognostic (2.58e-2)" 2.6 2.0 5.4 0.4 5.4 0.9 2.1 6.0 6.3 2.9 5.2 2.1 1.6 2.3 4.0 1.1 2.5 1.3 1.5 5.2 5.7 3.5 1.6 1.5 1.3 5.5 5.1 3.0 2.1 2.8 2.7 1.1 5.4 2.1 1.4 4.1 1.6 1.8 1.5 3.4 2.0 2.2 4.7 1.9 1.7 15.1 5.6 7.8 2.9 0.4 0.7 1.8 2.0 5.9 0.1 1.6 2.0 1.1 4.6 7.4 3.0 2.2 3.9 1.0 0.6 1.2 1.8 1.0 0.7 2.1 0.3 0.4 1.3 1.7 2.0 1.2 1.7 0.5 2.1 1.8 7.4 1.1 0.4 0.3 3.5 2.3 4.9 0.3 0.3 0.2 0.2 5.5 0.7 2.3 0.3 0.8 0.6 1.4 1.6 2.2 0.1 15.5 0.7 1.0 2.9 0.0 5.0 0.3 0.0 2.0 0.3 3.6 0.5 0.3 0.3 0.4 0.2 26.9 8.8 1.2 3.1 0.4 1.2 0.0 1.0 0.2 0.3 0.0 0.0 0.8 0.5 0.4 0.8 0.4 0.9 0.2 0.2 1.5 0.1 0.7 0.0 0.4 5.4 5.4 6.0 6.3 5.2 5.7 5.5 5.1 5.4 4.7 5.6 5.9 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.0 1.8 0.0 0.7 0.5 0.0 5.9 0.5 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.7 0.2 0.6 0.0 0.5 2.5 3.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 4.4 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.4 2.6 0.0 0.0 NR4A1 "GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3" ENSG00000123358 "Nuclear receptor subfamily 4 group A member 1" P22736 12 52022832-52059507 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 879.9;Basal squamous epithelial cells: 729.1;Glandular and luminal cells: 739.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "intermediate monocyte: 36.7;non-classical monocyte: 54.2" "Lineage enriched" "Detected in many" 15 "monocytes: 54.2" "Cell line enhanced" "Detected in many" "HeLa: 78.4;MCF7: 86.9;SK-BR-3: 80.5;SK-MEL-30: 150.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059742, HPA070142" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear membrane, Cytosol" "HPA059742: AB_2684119, HPA070142: AB_2732149" "unprognostic (2.40e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (1.74e-1)" "unprognostic (1.65e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-2)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (1.16e-1)" "prognostic favorable (6.99e-4)" "unprognostic (3.41e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-2)" "unprognostic (8.89e-3)" 709.0 562.0 21.7 96.9 19.6 34.5 227.6 141.0 79.9 151.6 44.4 227.1 29.7 124.6 7.2 133.6 495.8 377.4 671.5 21.5 28.5 203.5 95.5 290.9 45.9 21.8 17.4 876.0 88.4 86.9 442.4 41.9 21.0 303.2 71.4 28.3 146.5 85.9 294.1 225.7 111.9 144.2 13.0 36.0 264.6 32.4 21.5 59.1 301.7 71.9 3.8 296.5 186.0 22.6 5.7 28.2 5.6 10.2 4.0 1.3 21.3 5.4 10.8 4.3 6.0 28.2 5.4 5.9 2.3 9.7 4.2 3.2 16.9 2.6 2.5 0.3 6.0 8.1 78.4 8.3 4.1 3.1 26.5 0.8 3.3 4.2 0.3 2.9 1.3 6.6 7.9 1.4 0.3 86.9 2.2 8.5 15.3 9.2 3.1 2.7 0.9 14.6 0.2 2.2 4.6 14.0 17.4 80.5 150.9 3.8 5.1 9.1 0.0 4.2 13.3 2.8 4.7 46.8 25.2 13.0 2.8 2.3 23.7 0.3 1.3 0.0 0.2 36.7 0.3 0.9 0.1 0.1 3.7 0.8 0.5 0.1 0.4 0.2 54.2 0.3 0.2 2.0 21.7 19.6 141.0 79.9 21.5 28.5 21.8 17.4 21.0 13.0 21.5 22.6 328.9 240.4 879.9 4.2 259.5 445.7 289.5 211.3 729.1 34.8 353.8 384.9 9.8 65.8 178.4 86.5 125.1 64.5 102.1 195.7 5.9 19.9 19.7 346.9 183.5 209.6 345.3 16.0 17.4 12.3 34.7 378.8 380.7 739.1 674.8 45.3 227.0 10.1 54.1 16.8 5.9 492.5 105.8 64.4 527.4 7.3 30.4 283.0 371.8 8.4 6.3 85.4 0.0 6.6 1.3 5.1 277.2 23.7 244.1 160.6 74.6 0.9 92.6 94.6 124.9 268.0 379.3 2.5 13.4 200.2 472.8 110.5 135.1 85.1 259.0 86.8 NSD3 "FLJ20353, KMT3F, WHISTLE, WHSC1L1" ENSG00000147548 "Nuclear receptor binding SET domain protein 3" Q9BZ95 8 38269704-38382272 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 173.8;Syncytiotrophoblasts: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005659, CAB013721, HPA018893" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Mitochondria Nucleoplasm "CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833" "unprognostic (6.21e-2)" "unprognostic (3.73e-2)" "unprognostic (2.18e-2)" "unprognostic (4.12e-1)" "unprognostic (2.25e-1)" "unprognostic (1.53e-2)" "unprognostic (4.35e-2)" "unprognostic (1.97e-2)" "unprognostic (2.49e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (5.06e-2)" "unprognostic (5.60e-3)" "unprognostic (6.69e-2)" "unprognostic (4.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.60e-2)" 22.4 14.4 10.0 24.8 13.7 60.2 23.4 28.4 20.5 24.0 0.7 22.4 24.1 22.9 17.4 22.9 23.5 24.5 13.7 12.8 22.3 20.0 16.6 20.6 35.3 3.1 4.8 36.4 20.1 24.8 17.3 33.5 5.3 20.9 26.6 23.3 19.9 24.3 14.4 19.8 26.7 19.8 0.1 26.9 29.0 14.4 10.4 38.3 27.6 16.0 31.0 23.3 23.1 18.7 62.1 34.9 58.7 39.9 40.3 46.0 43.4 50.8 55.9 43.1 49.7 18.8 33.6 73.5 45.5 35.0 41.7 36.4 47.0 40.6 61.0 29.4 27.6 93.6 28.6 22.1 41.2 41.7 32.5 24.9 40.4 39.0 78.6 40.3 50.1 79.8 67.9 47.4 41.5 22.3 122.8 35.4 40.0 48.0 16.4 55.5 64.1 23.4 30.3 47.3 33.0 44.6 41.4 35.8 35.3 37.5 45.1 31.4 48.3 44.5 46.0 67.0 30.3 41.9 53.8 69.2 37.6 41.3 33.0 37.4 11.8 21.9 17.2 5.6 11.0 43.1 25.5 15.5 9.3 60.7 31.9 13.7 57.9 19.6 3.6 12.6 43.4 7.3 10.0 13.7 28.4 20.5 12.8 22.3 3.1 4.8 5.3 0.1 10.4 18.7 75.1 67.3 57.3 0.0 57.8 0.0 0.0 0.0 0.0 0.0 73.4 69.1 0.0 0.0 30.3 51.5 0.0 101.6 101.9 0.0 23.5 73.0 0.0 109.1 81.3 28.0 0.0 0.0 0.0 61.0 173.8 33.1 0.0 97.5 8.8 99.7 0.0 0.0 44.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 49.7 0.0 0.0 0.0 0.0 64.7 0.0 0.0 48.9 0.0 0.0 31.7 34.2 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 130.8 55.6 81.7 0.0 0.0 NSUN6 "ARL5B-AS1, FLJ23743, NOPD1" ENSG00000241058 "NOP2/Sun RNA methyltransferase 6" Q8TEA1 10 18545561-18659285 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 61.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045902 Approved Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA045902: AB_10962354" "unprognostic (7.34e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-3)" "unprognostic (9.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.33e-3)" "unprognostic (1.63e-2)" "prognostic favorable (8.42e-4)" "unprognostic (1.60e-1)" "unprognostic (2.45e-1)" "unprognostic (9.96e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.55e-5)" "unprognostic (2.23e-1)" "unprognostic (7.53e-3)" "unprognostic (3.18e-2)" "unprognostic (2.00e-3)" 6.4 12.2 13.6 7.5 14.3 12.4 9.3 16.0 15.9 9.0 13.5 6.1 8.6 9.6 12.2 5.7 8.7 6.0 8.6 14.0 14.1 10.6 61.1 6.5 11.3 13.8 14.8 12.7 12.0 7.8 17.2 6.5 14.7 10.5 8.4 12.9 8.4 5.6 4.5 9.1 8.7 6.1 13.9 9.8 8.5 17.5 13.8 11.8 12.0 4.8 10.9 9.1 7.6 17.6 7.5 6.3 16.6 12.3 8.1 11.1 7.2 10.3 2.5 8.4 11.3 12.0 11.2 17.0 4.3 4.0 5.9 11.0 17.1 10.8 10.8 16.6 13.9 17.8 8.8 14.5 8.3 8.1 11.6 8.6 10.3 8.0 5.5 8.3 3.9 20.0 25.1 16.1 8.2 4.2 18.6 9.3 8.5 14.8 4.8 13.1 8.6 17.4 6.3 9.1 8.9 11.0 8.7 9.0 7.3 11.3 5.8 6.4 6.7 7.0 8.1 12.8 7.6 9.9 11.0 18.8 5.0 14.5 4.3 1.5 3.5 2.8 4.4 4.7 7.0 8.0 6.3 5.6 2.9 6.1 7.8 6.7 1.6 5.3 8.2 4.0 10.5 2.5 13.6 14.3 16.0 15.9 14.0 14.1 13.8 14.8 14.7 13.9 13.8 17.6 75.4 9.6 15.1 57.8 34.9 28.7 17.1 11.0 30.1 33.2 32.4 34.7 8.1 18.6 13.6 9.2 22.9 10.1 39.6 19.5 5.9 10.0 19.7 23.6 38.9 37.5 14.5 20.8 43.5 12.7 8.0 19.2 40.2 49.0 17.7 32.0 26.7 86.6 7.4 25.2 45.0 24.5 18.3 24.2 52.4 12.7 25.7 28.5 12.4 23.4 15.3 15.3 17.5 43.7 57.6 11.1 20.0 17.0 31.0 10.1 40.2 10.9 14.5 28.9 13.1 20.1 19.1 49.5 21.8 21.3 26.7 6.7 31.0 26.7 18.7 14.2 NUDT4B NUDT4P1 ENSG00000177144 "Nudix hydrolase 4B" A0A024RBG1 1 148748894-148750099 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 6 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.8" "Cell line enhanced" "Detected in all" "CACO-2: 42.1;RT4: 34.5" "HPA017593, HPA047027, HPA057684" Approved Approved Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 39: CACO-2 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (1.24e-1)" "unprognostic (4.01e-2)" 4.9 6.8 0.2 3.6 0.4 23.6 1.8 0.0 0.9 4.4 0.3 5.7 5.3 3.7 2.6 8.1 7.0 17.7 20.8 0.5 0.6 9.8 3.9 2.6 6.8 1.3 0.5 16.1 11.9 4.6 0.3 7.7 0.4 7.5 6.1 0.6 23.6 3.1 5.3 1.3 5.2 3.6 0.3 3.0 4.1 7.7 0.3 3.2 7.9 8.1 3.7 11.1 0.6 0.6 3.5 3.8 1.5 4.7 6.3 5.1 9.3 4.1 6.2 4.4 4.2 42.1 14.8 3.5 1.7 3.7 4.2 5.7 6.8 3.0 2.2 11.0 3.3 8.5 2.3 5.4 8.4 5.8 2.6 10.6 9.7 5.5 5.1 5.3 16.5 4.3 17.6 13.8 4.2 3.0 7.9 1.1 8.3 3.4 6.2 9.7 2.2 10.0 3.2 34.5 3.0 4.4 3.5 8.6 23.7 1.0 11.7 11.0 9.1 5.8 4.5 9.6 6.3 3.2 5.2 4.5 2.7 8.7 17.4 0.0 0.1 2.8 0.0 0.3 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.2 0.2 0.2 0.4 0.0 0.9 0.5 0.6 1.3 0.5 0.4 0.3 0.3 0.6 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 NUFIP2 "182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1" ENSG00000108256 "Nuclear FMR1 interacting protein 2" Q7Z417 17 29255839-29294148 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 79.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067443 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Cytosol" "HPA067443: AB_2685841" "unprognostic (6.51e-2)" "unprognostic (6.96e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-2)" "unprognostic (3.38e-1)" "unprognostic (2.12e-1)" "unprognostic (4.94e-3)" "unprognostic (1.40e-1)" "unprognostic (3.79e-2)" "unprognostic (9.42e-3)" "unprognostic (1.60e-3)" "unprognostic (5.24e-2)" "unprognostic (1.28e-3)" "unprognostic (3.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.18e-2)" "unprognostic (6.04e-3)" 15.3 14.9 4.4 22.7 3.6 79.9 12.5 10.3 20.4 12.7 11.7 14.9 16.2 11.5 11.9 17.2 10.9 14.0 13.6 5.1 19.9 13.0 24.0 21.0 19.8 12.1 14.7 12.0 14.7 18.4 11.0 29.6 11.0 12.1 13.0 23.1 15.5 9.8 15.9 12.1 13.2 10.3 2.1 20.7 18.7 14.2 10.8 18.0 13.5 17.6 17.5 16.4 14.2 14.1 42.5 67.1 38.9 27.2 32.8 38.0 65.1 41.3 24.8 31.1 28.4 75.0 22.5 68.5 60.1 28.5 27.7 58.6 31.4 28.9 39.3 74.0 55.9 51.8 64.7 19.8 30.3 66.6 53.8 33.1 34.5 34.4 36.7 35.9 23.2 24.8 86.2 49.5 32.1 34.8 70.6 30.1 40.2 32.2 24.9 57.2 66.8 29.4 26.1 68.4 37.1 23.5 73.6 136.6 44.6 51.5 47.3 44.2 38.5 59.1 59.1 35.0 71.3 68.4 68.9 79.3 39.0 34.9 51.6 13.6 6.1 8.5 5.6 5.9 4.3 8.5 5.5 6.2 5.2 7.6 7.0 5.9 25.4 5.1 9.6 12.1 3.2 2.3 4.4 3.6 10.3 20.4 5.1 19.9 12.1 14.7 11.0 2.1 10.8 14.1 139.7 80.1 67.0 58.1 76.8 99.5 78.2 40.0 118.4 55.3 105.0 124.8 81.7 38.6 69.3 31.3 95.9 69.2 124.3 72.6 15.6 33.9 35.2 108.2 139.0 85.9 48.3 55.6 47.4 27.9 31.3 86.4 82.6 154.2 46.2 41.2 55.0 54.6 44.6 57.2 47.1 62.5 20.3 74.7 108.8 24.9 35.4 122.9 40.9 41.2 50.0 35.2 37.0 44.7 85.9 37.4 43.1 35.0 65.2 91.8 26.5 27.6 88.8 60.6 19.7 171.7 78.5 36.6 29.8 120.8 97.7 182.0 93.8 51.8 57.1 111.9 NXF1 "DKFZp667O0311, Mex67, TAP" ENSG00000162231 "Nuclear RNA export factor 1" Q9UBU9 11 62792123-62806302 "Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016327, HPA061593" Supported Supported Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB016327: AB_627608, HPA061593: AB_2684565" "unprognostic (2.45e-2)" "unprognostic (1.15e-3)" "unprognostic (2.34e-1)" "unprognostic (1.68e-3)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (5.40e-3)" "unprognostic (7.21e-3)" "unprognostic (2.54e-2)" "unprognostic (2.64e-1)" "prognostic favorable (4.08e-4)" "unprognostic (4.33e-3)" "unprognostic (8.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.38e-1)" "unprognostic (3.66e-3)" "unprognostic (1.25e-2)" 90.2 103.4 57.2 47.9 56.8 204.6 81.8 61.6 71.9 100.1 66.8 106.0 39.4 94.6 55.2 80.2 86.8 51.8 78.0 57.3 59.0 100.3 130.0 82.0 69.9 56.6 57.2 97.3 98.3 63.8 136.7 58.9 56.1 107.2 45.6 49.9 77.3 57.8 75.7 110.6 96.1 66.6 55.2 143.8 97.1 59.5 58.2 75.5 123.1 41.5 56.1 83.1 78.8 59.9 44.6 48.5 82.8 56.5 69.6 50.2 50.2 67.5 60.5 89.0 52.6 66.8 35.1 70.0 39.1 54.4 35.7 54.1 89.9 42.3 80.2 55.5 61.3 52.9 82.1 56.4 52.8 66.3 73.6 74.5 59.9 65.6 31.5 66.5 58.9 60.7 69.3 50.7 64.4 61.1 81.3 85.1 50.4 54.8 41.6 77.5 46.0 74.6 61.7 51.7 43.6 36.5 66.4 52.8 49.8 59.9 60.3 57.9 60.3 51.2 41.5 64.6 61.3 61.4 56.8 70.2 39.6 55.2 52.1 7.6 21.3 23.5 18.9 26.0 20.5 16.0 18.4 18.5 23.6 12.8 19.6 18.4 16.1 20.2 23.6 18.3 24.0 17.1 57.2 56.8 61.6 71.9 57.3 59.0 56.6 57.2 56.1 55.2 58.2 59.9 53.2 38.5 45.3 14.7 40.2 83.4 27.0 29.4 42.7 13.2 45.9 74.7 24.6 21.5 23.4 22.0 31.3 50.4 44.1 42.2 9.8 17.6 32.6 30.4 36.8 36.8 31.6 17.7 11.0 12.3 25.9 35.1 43.3 51.7 49.9 19.8 26.0 18.6 28.6 5.0 13.0 35.9 22.4 33.8 43.2 12.3 36.7 62.5 32.0 11.2 21.8 12.7 21.6 7.1 10.1 14.7 28.6 25.9 29.7 22.0 24.0 10.2 18.6 17.2 26.3 48.6 40.4 28.2 19.9 53.4 70.0 99.2 42.3 15.4 30.4 15.2 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 37.8;Glandular and luminal cells: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: AB_2673838" "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 11.9 14.4 7.5 7.2 9.2 15.0 14.0 10.4 10.1 13.3 8.4 10.8 13.4 9.4 17.2 7.8 8.8 10.6 10.0 7.6 8.2 16.7 21.8 9.5 6.7 8.9 8.6 10.3 29.1 32.4 12.4 14.2 9.2 16.6 12.7 15.2 21.7 12.2 9.0 10.3 13.6 8.8 8.7 8.5 13.1 8.3 8.2 6.4 19.9 9.5 7.1 11.5 8.2 11.9 12.6 13.9 15.1 12.1 17.5 16.3 28.8 19.9 12.2 12.7 12.8 28.2 29.7 8.7 23.5 9.9 11.6 32.3 11.4 10.9 12.5 7.1 10.9 8.2 17.7 15.9 16.4 13.8 9.6 12.5 21.3 15.4 24.1 13.2 13.8 9.0 32.1 17.3 15.3 13.5 9.7 14.3 21.6 46.0 5.0 11.2 10.5 25.0 26.1 12.9 11.0 17.2 15.1 33.0 24.5 26.9 29.1 12.4 13.2 18.1 11.5 12.2 18.9 20.2 13.3 13.3 9.8 7.4 16.7 1.4 9.0 2.5 3.0 8.9 4.5 3.6 3.8 4.2 7.6 2.3 4.7 3.6 3.9 10.0 11.4 4.8 5.7 3.9 7.5 9.2 10.4 10.1 7.6 8.2 8.9 8.6 9.2 8.7 8.2 11.9 28.1 28.9 37.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 18.8 16.5 0.0 0.0 29.7 25.8 0.0 22.0 12.6 0.0 9.8 22.8 0.0 26.8 27.0 9.8 0.0 0.0 0.0 25.4 25.7 12.3 0.0 38.6 12.6 26.4 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 6.7 0.0 0.0 0.0 0.0 24.7 0.0 0.0 4.0 0.0 0.0 10.7 15.3 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 28.0 6.9 29.0 0.0 0.0 OGA "MEA5, MGEA5, NCOAT" ENSG00000198408 O-GlcNAcase O60502 10 101784443-101818465 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 86.5;dendritic cells: 89.3;Glandular and luminal cells: 83.7;Granulosa cells: 69.4;Pancreatic endocrine cells: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036141, HPA076501" Approved Supported Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA036141: AB_10672079, HPA076501: AB_2686802" "unprognostic (4.34e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (8.69e-5)" "unprognostic (4.63e-1)" "unprognostic (2.06e-1)" "unprognostic (2.57e-2)" "unprognostic (2.65e-1)" "unprognostic (1.79e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-3)" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "unprognostic (1.68e-1)" "unprognostic (3.01e-1)" "unprognostic (3.21e-2)" "unprognostic (1.90e-1)" "unprognostic (9.23e-3)" 65.3 34.1 77.3 46.7 80.3 89.0 59.2 99.3 82.8 62.2 54.3 64.8 28.1 50.0 55.5 57.4 52.9 29.8 60.7 82.2 74.0 45.6 46.0 52.9 69.8 66.8 70.3 66.8 42.9 60.6 44.9 41.0 67.7 52.7 40.7 99.8 50.5 38.9 56.6 72.7 62.8 35.4 68.6 74.4 46.4 38.6 84.3 67.6 51.7 29.5 64.8 57.0 58.6 77.6 89.8 44.7 63.7 124.6 40.0 96.6 44.4 61.7 61.8 28.1 48.0 33.1 56.0 59.6 43.7 73.7 48.2 62.9 60.3 77.5 59.2 87.9 41.2 59.6 65.0 26.0 43.1 44.4 32.3 93.9 85.1 48.1 113.7 80.0 53.0 53.1 42.8 107.3 48.3 45.6 47.2 46.1 35.4 19.4 44.8 64.8 70.5 44.0 47.2 80.0 27.7 48.8 55.2 29.4 78.2 58.0 77.9 47.7 80.9 43.0 41.6 63.0 71.6 53.1 91.0 47.2 54.0 74.6 24.0 14.4 2.1 7.2 6.4 2.0 5.1 6.6 4.5 5.8 1.3 7.5 6.1 5.2 14.1 6.6 6.3 3.3 4.6 1.5 77.3 80.3 99.3 82.8 82.2 74.0 66.8 70.3 67.7 68.6 84.3 77.6 66.3 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 66.5 47.0 0.0 0.0 0.0 86.5 0.0 41.9 89.3 0.0 13.7 38.0 0.0 61.6 68.3 18.1 0.0 0.0 0.0 40.9 34.3 20.3 0.0 83.7 0.0 69.4 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 48.6 0.0 0.0 0.0 0.0 82.4 0.0 0.0 44.3 0.0 0.0 34.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 50.9 34.6 44.8 0.0 0.0 OR4D1 "OR4D3, TPCR16" ENSG00000141194 "Olfactory receptor family 4 subfamily D member 1" Q15615 17 58148449-58159555 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "dendritic cells: 2.4;T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 7: Non-specific - Mitochondria" 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.9 0.0 0.9 0.0 0.8 0.8 0.0 0.0 1.2 1.4 0.1 1.8 0.0 0.0 0.2 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.3 0.3 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 PAXX "C9orf142, XLS" ENSG00000148362 "PAXX non-homologous end joining factor" Q9BUH6 9 136992422-136993984 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 147.1;dendritic cells: 198.4;Distal tubular cells: 131.0;Extravillous trophoblasts: 216.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045268 Uncertain Supported Nucleoplasm NA NA 95000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA045268: AB_10963079" "unprognostic (1.85e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.14e-3)" "unprognostic (9.88e-3)" "unprognostic (1.95e-1)" "unprognostic (2.15e-1)" "unprognostic (2.13e-3)" "unprognostic (3.22e-1)" "unprognostic (3.10e-1)" "unprognostic (1.00e-2)" "prognostic favorable (6.71e-4)" "unprognostic (3.54e-2)" "unprognostic (1.75e-2)" "unprognostic (9.64e-3)" "unprognostic (3.66e-1)" "unprognostic (9.31e-2)" "unprognostic (8.97e-3)" 24.1 24.9 15.9 8.1 16.3 17.6 23.6 18.0 27.3 27.9 9.6 25.5 11.8 23.5 1.7 29.5 24.7 4.3 29.3 13.9 15.0 37.3 44.7 28.4 11.8 21.9 18.8 21.5 37.7 5.5 37.4 7.5 19.1 34.5 2.0 1.2 20.2 7.4 14.9 34.7 28.8 1.9 19.4 48.3 31.2 14.8 17.1 10.1 32.4 2.1 4.0 25.7 25.5 21.8 27.6 30.3 4.8 18.4 8.5 7.6 70.5 20.7 12.3 13.7 7.4 13.5 19.8 24.6 35.3 5.4 5.4 43.5 1.7 15.6 1.1 63.3 42.7 19.3 16.2 11.4 12.7 27.6 41.2 5.6 14.6 4.7 6.3 2.4 12.5 44.1 29.4 7.1 3.1 61.2 29.0 45.6 28.7 32.6 91.5 37.7 9.8 70.4 9.5 14.2 22.6 28.2 17.8 44.0 24.9 0.8 52.5 23.4 16.6 6.5 19.9 31.2 25.1 13.1 12.5 16.9 11.6 31.6 24.8 25.9 44.3 18.7 142.3 54.9 122.5 33.8 78.3 123.9 46.2 30.5 42.4 99.1 14.9 87.7 29.0 238.2 66.0 62.2 15.9 16.3 18.0 27.3 13.9 15.0 21.9 18.8 19.1 19.4 17.1 21.8 65.5 16.0 27.6 0.0 20.2 0.0 0.0 0.0 0.0 0.0 76.8 95.0 0.0 0.0 7.4 40.5 0.0 147.1 198.4 0.0 131.0 54.3 0.0 45.3 34.0 22.6 0.0 0.0 0.0 43.4 216.7 25.0 0.0 44.4 12.6 66.5 0.0 0.0 77.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.0 35.2 0.0 0.0 0.0 0.0 40.0 0.0 0.0 21.5 0.0 0.0 82.4 11.7 0.0 0.0 0.0 24.1 0.0 0.0 0.0 0.0 88.7 72.3 59.1 0.0 0.0 PCDHA6 "CNR2, CNRS2, CRNR2, PCDH-ALPHA6" ENSG00000081842 "Protocadherin alpha 6" Q9UN73 5 140827958-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 4.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.0;EFO-21: 8.4;hTERT-RPE1: 2.2;U-2 OS: 3.4;WM-115: 5.2" "Low region specificity" "Detected in many" "HPA059326, HPA078110" Enhanced Approved Vesicles "Secreted in brain" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 38: EFO-21 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA059326: AB_2683980, HPA078110: AB_2732371" "unprognostic (1.15e-1)" "unprognostic (7.00e-2)" "unprognostic (5.07e-1)" "unprognostic (2.79e-1)" "unprognostic (4.39e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-4)" "unprognostic (4.23e-3)" "unprognostic (8.38e-2)" "unprognostic (2.55e-1)" "unprognostic (1.23e-3)" "unprognostic (3.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.66e-3)" "unprognostic (2.56e-1)" "unprognostic (5.66e-3)" "unprognostic (3.55e-2)" 0.2 0.3 0.8 0.1 0.9 0.0 0.3 4.1 1.1 0.4 0.0 0.1 0.2 0.6 0.3 0.0 0.3 0.3 0.1 1.0 0.7 0.4 0.0 0.2 0.1 0.4 0.3 0.4 1.0 1.5 1.5 0.0 0.5 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.1 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.5 1.0 0.1 0.4 0.0 1.3 0.0 3.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 4.1 1.1 1.0 0.7 0.4 0.3 0.5 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCF11 KIAA0824 ENSG00000165494 "PCF11 cleavage and polyadenylation factor subunit" O94913 11 83156988-83187451 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 227.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 124.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040779 Supported Nucleoplasm,Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Mitochondria "HPA040779: AB_2677133" "unprognostic (1.53e-1)" "unprognostic (7.24e-2)" "unprognostic (3.99e-2)" "unprognostic (1.18e-1)" "unprognostic (3.24e-3)" "prognostic favorable (1.34e-4)" "unprognostic (3.74e-2)" "unprognostic (4.89e-3)" "unprognostic (1.12e-3)" "unprognostic (9.53e-2)" "unprognostic (6.07e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (3.91e-3)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "prognostic favorable (2.03e-5)" 20.1 13.9 9.8 23.5 15.0 42.5 23.7 29.1 13.6 19.2 6.0 19.6 16.3 22.4 15.2 19.5 17.7 17.2 13.5 9.3 10.9 14.9 16.9 22.8 32.4 13.1 12.7 28.3 17.0 16.6 10.4 16.7 14.0 18.7 19.9 26.6 15.4 16.2 26.3 27.8 20.8 23.8 10.9 28.7 16.4 24.7 12.1 33.4 24.3 19.5 29.6 17.0 13.5 17.9 26.3 18.4 29.4 25.3 34.4 33.4 23.5 24.7 18.2 23.2 17.7 31.5 25.7 58.9 18.1 18.0 21.9 25.8 43.2 17.0 22.3 42.1 14.8 34.5 26.3 22.4 19.4 40.9 36.8 23.9 32.1 17.7 25.6 31.2 23.8 38.8 40.9 27.9 21.9 27.9 38.7 45.2 30.7 44.6 20.5 36.4 37.1 35.2 20.2 38.4 24.4 27.0 30.1 23.7 24.3 26.9 23.7 28.0 24.6 33.0 16.9 24.5 16.6 25.0 45.2 124.6 14.5 26.8 26.0 14.8 7.2 14.9 10.1 6.8 8.5 10.9 6.9 7.3 6.9 9.9 7.8 8.2 17.1 13.5 5.5 7.1 5.5 5.8 9.8 15.0 29.1 13.6 9.3 10.9 13.1 12.7 14.0 10.9 12.1 17.9 96.4 41.7 63.5 58.1 90.6 53.7 79.8 30.7 101.9 48.4 84.4 81.0 42.7 35.8 43.4 46.0 33.3 30.2 90.1 49.8 25.4 22.9 203.3 55.5 70.8 66.8 31.8 62.5 32.0 18.1 26.9 58.8 40.2 83.6 37.2 48.0 56.7 21.7 37.6 55.5 37.9 51.0 26.4 57.8 41.0 40.3 60.3 87.4 28.4 45.0 52.5 34.5 58.7 40.7 72.0 19.2 46.2 45.1 69.0 71.6 83.4 14.2 29.0 55.3 39.5 227.3 66.8 46.7 17.9 100.4 62.7 39.4 81.7 42.7 50.3 71.1 PCNX2 "FLJ11383, KIAA0435, PCNXL2" ENSG00000135749 "Pecanex 2" A6NKB5 1 232983435-233295725 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Collecting duct cells: 12.9;Endometrial ciliated cells: 9.3;Endometrial stromal cells: 8.8;Glandular and luminal cells: 11.1;Granulosa cells: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013815, HPA014427" Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 5: NTERA-2 - Transcription" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "HPA013815: AB_2236561, HPA014427: AB_1855081" "unprognostic (3.15e-1)" "unprognostic (5.61e-3)" "unprognostic (1.92e-2)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.25e-2)" "unprognostic (3.79e-1)" "unprognostic (2.40e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.27e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" 4.2 2.1 8.4 2.5 8.9 2.2 3.8 6.2 18.3 4.0 0.0 2.3 1.5 3.1 6.6 3.6 4.2 3.9 1.7 15.7 1.8 4.8 0.6 2.5 5.0 1.9 4.7 7.1 4.5 3.6 14.8 1.0 2.5 4.7 2.1 11.5 4.7 3.6 3.1 4.7 5.2 2.4 0.3 3.9 3.4 2.8 8.2 3.3 5.6 0.6 3.7 4.7 5.1 6.8 5.1 12.0 6.4 0.1 10.3 11.1 1.9 3.0 8.6 3.1 5.3 3.9 6.0 10.5 6.8 8.1 11.1 8.2 2.9 8.5 7.1 8.9 8.7 0.1 6.6 0.0 4.6 3.5 2.0 8.5 7.4 6.0 23.6 10.3 5.8 7.7 0.0 5.5 3.0 3.0 9.8 0.2 20.7 4.2 7.2 0.1 1.7 1.5 5.5 7.7 11.0 9.2 4.4 1.8 1.8 3.6 4.3 0.9 2.2 8.4 5.4 9.6 9.9 6.5 7.3 0.1 7.7 3.8 9.9 0.3 0.2 0.1 0.7 0.1 0.5 0.3 0.6 0.7 0.5 0.3 0.2 0.5 0.1 0.2 0.1 0.1 0.7 0.3 8.4 8.9 6.2 18.3 15.7 1.8 1.9 4.7 2.5 0.3 8.2 6.8 7.0 9.6 5.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 6.9 7.4 0.0 0.0 6.8 12.9 0.0 0.4 5.8 0.0 7.9 6.4 0.0 9.3 8.8 1.1 0.0 0.0 0.0 3.3 1.6 3.6 0.0 11.1 1.3 8.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.7 0.0 0.0 1.7 4.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 6.5 4.3 0.0 0.0 PCNX3 "FLJ22427, PCNXL3" ENSG00000197136 "Pecanex 3" Q9H6A9 11 65615773-65637439 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;Endometrial ciliated cells: 13.5;Glandular and luminal cells: 20.4;Granulosa cells: 17.7;Pancreatic endocrine cells: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018084 Uncertain Approved Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 64: Macrophages - Immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA018084: AB_1855083" "unprognostic (9.93e-2)" "unprognostic (1.33e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-2)" "unprognostic (2.54e-1)" "unprognostic (1.70e-2)" "unprognostic (3.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (7.69e-3)" "unprognostic (7.06e-2)" "unprognostic (2.44e-2)" "unprognostic (8.52e-3)" "unprognostic (6.51e-3)" "unprognostic (1.93e-1)" "unprognostic (2.32e-2)" "unprognostic (4.82e-1)" 5.2 6.5 3.9 8.0 3.3 10.4 5.5 2.5 4.7 5.9 2.0 7.3 8.2 7.8 1.6 7.7 6.4 4.5 4.5 3.2 1.1 5.4 5.1 6.7 7.3 4.4 3.2 6.0 8.1 4.6 6.6 5.0 2.9 6.2 3.2 2.6 7.9 4.9 4.2 7.7 9.0 4.0 1.8 8.6 7.1 8.9 4.2 7.2 7.4 2.1 4.3 6.3 5.6 4.7 19.5 28.6 10.3 25.6 7.9 6.1 23.3 13.5 11.5 12.9 9.4 13.8 21.5 14.2 25.4 12.0 17.5 31.2 11.0 15.6 3.8 12.1 19.4 18.6 28.6 11.4 8.8 18.3 21.9 11.6 7.7 12.7 10.0 5.8 12.7 14.7 21.7 11.7 7.6 28.8 15.6 14.1 20.9 8.4 18.2 21.6 9.2 18.6 5.6 30.9 12.7 19.0 14.3 18.6 15.7 4.5 32.8 12.4 18.3 22.3 20.7 18.6 13.6 19.1 12.2 12.7 17.8 8.8 19.9 3.5 0.9 0.6 1.2 0.4 1.0 0.5 0.7 0.7 0.5 0.8 0.5 0.7 1.3 0.6 0.7 1.2 0.2 0.6 3.9 3.3 2.5 4.7 3.2 1.1 4.4 3.2 2.9 1.8 4.2 4.7 10.8 6.4 6.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 11.3 8.4 0.0 0.0 0.6 12.9 0.0 6.8 10.7 0.0 0.0 9.1 0.0 13.5 9.1 5.1 0.0 0.0 0.0 8.9 5.6 3.2 0.0 20.4 5.1 17.7 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 5.9 0.0 0.0 4.3 0.7 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 8.3 3.0 10.2 0.0 0.0 PCNX4 "C14orf135, PCNXL4" ENSG00000126773 "Pecanex 4" Q63HM2 14 60091911-60169133 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 42.8;Endometrial ciliated cells: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002076, HPA003390" Uncertain Approved Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA002076: AB_1078322, HPA003390: AB_2066703" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (1.89e-1)" "unprognostic (9.87e-2)" "unprognostic (2.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.83e-3)" "unprognostic (2.01e-1)" "unprognostic (1.54e-1)" "unprognostic (3.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.81e-1)" "prognostic favorable (6.84e-5)" "unprognostic (2.13e-1)" "unprognostic (2.08e-1)" "unprognostic (4.14e-2)" "unprognostic (8.59e-2)" 7.8 9.2 4.1 6.3 4.8 7.4 8.1 7.0 4.4 10.1 12.1 6.3 5.0 12.5 7.1 5.6 13.1 8.3 11.1 3.9 6.1 12.3 6.7 7.2 7.1 5.0 6.0 16.3 6.5 11.4 11.9 8.5 4.7 11.7 6.7 18.2 7.1 8.5 12.3 7.4 6.1 10.2 4.9 7.4 6.2 11.0 5.7 11.6 9.7 5.7 7.0 6.6 7.8 6.2 85.2 14.3 25.2 17.3 19.2 22.2 11.1 28.5 44.1 31.2 38.3 15.0 26.1 14.8 11.6 23.7 26.0 11.1 16.6 16.2 51.7 20.8 7.9 25.0 10.1 9.7 39.7 25.0 17.7 18.5 10.2 23.0 38.3 24.3 14.9 34.8 12.5 21.2 48.2 11.5 35.9 8.0 12.7 9.7 17.4 20.9 31.8 6.4 15.8 11.7 17.9 21.8 25.5 9.2 18.2 13.4 22.7 11.1 30.7 66.4 52.8 16.7 20.5 7.1 7.4 19.6 26.1 8.5 33.2 3.4 4.1 3.3 4.8 4.3 6.5 4.1 3.4 4.2 4.4 2.8 3.7 4.4 2.1 8.4 5.2 4.4 3.8 3.4 4.1 4.8 7.0 4.4 3.9 6.1 5.0 6.0 4.7 4.9 5.7 6.2 22.3 16.0 29.9 0.0 18.2 0.0 0.0 0.0 0.0 0.0 19.9 17.5 0.0 0.0 19.2 25.8 0.0 18.3 42.8 0.0 17.6 18.4 0.0 82.0 37.4 14.0 0.0 0.0 0.0 13.1 8.3 13.6 0.0 27.0 15.2 33.9 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 10.3 0.0 0.0 0.0 0.0 20.4 0.0 0.0 18.5 0.0 0.0 14.4 34.2 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 19.4 14.5 33.8 0.0 0.0 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245035-140303113 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavorable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 74.1 50.9 73.9 37.7 75.6 60.2 50.0 82.2 88.4 41.4 70.8 59.2 40.2 50.8 54.3 52.3 41.9 35.7 93.3 77.2 79.7 61.6 38.5 46.9 46.1 82.9 77.2 37.2 34.7 52.8 39.4 50.8 80.5 44.8 42.9 35.1 45.4 43.7 149.0 46.2 39.8 61.4 79.1 36.6 40.7 29.9 79.3 51.5 42.4 86.4 51.6 45.9 40.9 81.2 172.4 79.6 137.7 80.9 89.7 91.8 133.8 229.6 114.9 174.6 192.6 172.1 107.9 114.9 224.1 124.3 180.0 62.6 102.0 228.7 204.2 122.6 102.9 102.4 76.5 113.0 105.1 213.5 76.4 98.2 119.8 148.5 156.3 112.6 196.0 132.8 93.7 73.1 149.8 78.5 146.0 147.6 92.0 70.3 119.2 101.3 195.9 86.3 197.1 77.9 78.2 81.8 172.1 148.6 136.8 128.5 102.1 122.3 249.1 121.8 119.6 71.9 208.0 70.3 198.6 299.2 122.5 138.5 144.1 149.5 84.7 130.3 86.2 131.1 91.8 106.0 98.6 100.4 100.5 97.9 97.3 88.4 14.0 114.7 130.3 93.0 129.3 115.5 73.9 75.6 82.2 88.4 77.2 79.7 82.9 77.2 80.5 79.1 79.3 81.2 87.9 67.3 33.0 16.3 57.4 38.0 65.9 96.2 30.7 42.5 50.1 57.3 81.3 52.9 62.1 66.2 45.9 116.1 53.1 56.6 123.3 121.9 3.9 58.0 56.6 73.8 46.6 62.9 31.2 101.7 86.6 55.4 35.2 70.9 54.4 53.6 72.1 56.9 85.4 25.2 29.3 43.6 48.8 61.1 37.7 12.9 52.2 63.4 74.7 37.5 90.4 84.9 71.1 24.1 39.3 128.9 55.1 52.3 35.5 45.4 80.9 147.3 45.3 42.9 65.7 39.6 63.7 23.7 61.8 40.8 34.9 85.6 45.2 42.9 47.3 63.6 PHC2 "EDR2, HPH2" ENSG00000134686 "Polyhomeotic homolog 2" Q8IXK0 1 33323623-33431052 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 9 "neutrophil: 93.4" "Lineage enriched" "Detected in all" 11 "granulocytes: 93.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047403 Supported Supported Nucleoplasm NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 59: Non-specific - Translation" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA047403: AB_10964220" "unprognostic (8.58e-3)" "unprognostic (2.10e-1)" "unprognostic (9.51e-2)" "unprognostic (3.69e-1)" "unprognostic (2.00e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.28e-6)" "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (7.91e-2)" "unprognostic (3.08e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (2.35e-4)" "unprognostic (2.16e-1)" "unprognostic (1.57e-1)" "unprognostic (3.65e-2)" "unprognostic (1.72e-1)" 114.4 87.1 57.1 52.1 66.9 50.6 103.8 62.5 64.3 87.1 73.5 104.3 26.0 86.3 27.9 50.7 86.2 49.2 113.1 56.0 63.6 141.7 124.9 135.0 31.3 79.7 67.7 66.9 54.8 33.4 70.5 46.2 68.9 79.9 27.9 51.1 68.8 44.6 260.0 68.2 64.2 60.2 64.5 118.9 92.7 62.2 67.1 40.4 81.7 74.7 23.9 97.2 63.5 72.5 53.0 34.0 145.3 56.0 149.3 169.9 43.2 51.4 111.1 70.0 76.5 21.5 115.2 47.2 42.4 81.3 56.7 27.4 29.2 88.0 67.2 22.9 26.6 31.5 15.7 54.9 229.2 38.8 29.1 279.3 53.4 126.3 99.0 133.2 93.9 44.9 28.3 35.1 185.1 21.8 84.8 39.7 33.1 89.4 97.8 95.0 60.4 26.3 128.4 39.5 88.3 81.0 40.2 39.9 204.7 60.7 19.9 49.5 93.8 69.5 35.0 59.9 98.1 24.3 18.0 35.6 165.5 40.7 195.3 10.5 6.6 3.4 2.0 6.7 1.6 1.4 2.2 1.8 3.4 1.2 2.6 1.4 93.4 2.1 8.3 3.9 1.6 2.2 57.1 66.9 62.5 64.3 56.0 63.6 79.7 67.7 68.9 64.5 67.1 72.5 89.3 16.0 13.9 24.2 5.6 14.1 28.9 16.2 4.6 75.9 24.1 30.9 31.8 25.8 13.2 35.0 68.8 11.3 17.4 19.5 17.6 34.4 58.2 18.7 40.2 43.0 37.7 17.4 60.7 44.4 9.2 32.9 14.8 28.5 6.3 39.4 47.8 55.6 21.4 62.2 82.0 21.9 18.3 75.7 14.1 72.9 29.2 55.3 21.4 61.8 18.4 58.5 8.2 91.0 117.2 85.8 11.0 29.7 2.5 23.8 11.2 31.7 14.8 78.5 13.1 24.2 48.7 14.2 8.6 7.9 10.9 11.5 11.4 30.0 20.0 30.9 PJVK DFNB59 ENSG00000204311 Pejvakin Q0ZLH3 2 178451346-178462102 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 20.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 9.1;Distal tubular cells: 3.9;Granulosa cells: 6.1;Theca cells: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 2.8" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.8" "Cell line enhanced" "Detected in many" "SuSa: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042621 Approved Mitochondria No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA042621: AB_10797503" "unprognostic (4.01e-2)" "unprognostic (4.28e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-1)" "unprognostic (7.21e-3)" "unprognostic (9.36e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-1)" "unprognostic (8.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.90e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.22e-1)" "unprognostic (1.47e-1)" "unprognostic (2.41e-2)" "unprognostic (8.06e-3)" 3.0 1.8 6.9 1.3 7.2 1.4 4.8 6.9 10.7 2.7 6.9 1.9 1.2 3.9 7.3 1.2 2.8 2.9 1.4 7.0 7.0 3.2 2.8 1.5 1.9 7.6 7.3 7.1 1.3 1.1 4.1 1.2 7.5 2.8 1.2 6.4 2.7 3.0 3.5 4.2 1.4 2.0 7.3 1.4 1.2 20.7 7.1 1.2 2.5 0.9 1.7 1.9 1.4 7.7 0.2 1.8 2.3 1.9 3.0 3.1 1.2 1.5 1.4 1.2 2.0 0.7 3.1 2.1 1.5 0.9 1.0 0.9 1.7 1.0 0.9 0.7 0.6 0.7 2.9 0.4 3.0 0.6 0.2 3.2 2.2 1.4 3.2 3.8 1.5 4.1 0.4 1.3 1.5 0.5 2.1 1.3 2.8 0.2 0.8 2.7 1.7 1.3 2.0 1.0 1.6 1.3 0.5 0.3 0.6 6.8 0.7 0.7 1.0 1.5 0.6 0.4 0.1 4.3 2.8 0.7 0.7 1.1 0.6 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.0 0.5 0.5 0.3 0.4 0.2 0.0 2.8 0.0 0.0 6.9 7.2 6.9 10.7 7.0 7.0 7.6 7.3 7.5 7.3 7.1 7.7 1.6 6.4 9.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 2.4 0.0 0.0 1.8 1.8 0.0 1.1 0.5 0.0 3.9 1.4 0.0 1.8 2.6 0.4 0.0 0.0 0.0 0.9 0.5 1.4 0.0 1.6 0.0 6.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 4.7 0.0 0.0 PKN1 "DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1" ENSG00000123143 "Protein kinase N1" Q16512 19 14433053-14471867 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003982, CAB010278" Approved Approved "Plasma membrane,Cytokinetic bridge" Yes NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane" "Cytokinetic bridge" "CAB010278: AB_2163965, HPA003982: AB_1855440" "unprognostic (3.83e-2)" "unprognostic (2.14e-1)" "unprognostic (4.13e-2)" "unprognostic (1.13e-2)" "unprognostic (1.94e-1)" "unprognostic (4.58e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (8.55e-3)" "unprognostic (4.08e-3)" "unprognostic (2.11e-1)" "unprognostic (1.45e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (4.08e-1)" "unprognostic (2.24e-2)" 59.2 45.1 47.1 40.4 50.3 66.8 49.0 44.6 52.4 46.6 44.2 72.4 14.5 61.0 13.6 16.2 48.7 23.9 89.0 40.9 46.3 43.1 25.0 71.1 49.4 53.6 48.4 38.7 52.5 32.8 44.9 33.3 49.8 43.8 9.3 11.5 41.3 30.6 81.7 20.1 45.2 33.0 49.8 90.4 51.4 50.2 49.2 35.6 39.6 53.8 25.8 60.3 32.8 48.5 152.8 88.9 32.3 67.8 51.3 59.8 53.0 53.5 63.5 55.2 52.5 34.9 84.2 144.4 135.0 92.2 68.9 34.4 52.1 23.8 21.2 117.6 67.7 172.8 55.4 75.2 169.1 68.2 103.9 43.3 17.0 33.5 52.2 62.5 129.8 74.9 78.0 96.7 41.4 62.5 104.1 63.2 59.2 54.7 100.0 138.5 43.9 104.7 27.3 24.2 117.3 166.0 33.2 41.7 88.9 15.5 37.8 117.7 196.6 108.8 46.1 133.2 82.8 126.5 123.6 78.9 71.5 135.7 87.4 27.6 27.9 40.6 30.4 38.5 23.3 15.9 20.5 21.1 26.8 16.9 18.6 21.0 32.6 22.1 52.3 17.0 25.7 29.0 47.1 50.3 44.6 52.4 40.9 46.3 53.6 48.4 49.8 49.8 49.2 48.5 78.1 3.2 2.2 17.3 35.3 3.7 6.4 1.9 1.8 37.2 17.6 14.7 4.0 27.1 3.1 35.0 16.7 2.8 77.9 4.9 1.9 28.2 4.9 27.0 25.4 49.4 40.2 17.7 3.6 30.1 14.5 20.8 30.1 20.7 2.5 80.9 53.2 11.3 59.8 48.8 8.6 10.9 8.2 69.0 17.0 8.4 19.9 56.2 17.8 17.8 48.2 61.2 102.0 7.5 11.9 64.2 10.6 23.0 27.1 12.7 1.1 15.2 12.4 29.2 26.3 21.7 29.2 9.3 42.2 1.3 2.7 3.7 55.5 34.3 4.8 4.9 PLCG2 ENSG00000197943 "Phospholipase C gamma 2" P16885 16 81739097-81962685 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 706.3;choroid plexus: 347.5" "Cell type enhanced" "Detected in many" "Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2" "Cancer enhanced" "Detected in all" "renal cancer: 9.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004280, HPA020099, HPA020100" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 8200 "Cluster 5: Granulocytes - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Cytosol" Nucleoplasm "CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325" "unprognostic (2.86e-2)" "unprognostic (1.34e-1)" "unprognostic (1.09e-3)" "unprognostic (1.10e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.71e-4)" "unprognostic (6.23e-2)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" "unprognostic (4.58e-2)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" "prognostic favorable (4.88e-4)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-1)" "unprognostic (3.40e-3)" 9.0 4.2 69.4 33.0 141.3 30.3 8.5 706.3 105.2 5.0 347.5 8.6 17.3 8.6 22.5 4.6 5.5 13.4 4.3 40.1 122.6 23.4 14.3 9.4 66.8 301.3 122.7 1.6 3.9 2.8 1.2 8.2 207.3 2.8 7.0 0.5 7.1 3.4 1.9 4.0 19.4 8.8 241.5 34.8 8.7 2.0 283.3 10.0 6.9 3.6 72.0 10.1 3.9 437.2 1.4 3.2 0.6 2.9 0.2 0.2 4.0 0.3 0.4 2.3 0.8 0.9 8.1 183.3 30.1 0.2 7.4 4.2 4.0 0.5 1.4 1.4 2.1 22.1 0.4 0.3 1.2 22.3 84.2 0.3 1.8 1.3 1.0 0.3 4.2 8.1 2.5 15.0 0.4 5.7 2.6 55.5 3.1 2.3 1.3 75.1 0.1 23.7 0.5 3.9 1.4 0.4 5.0 1.6 1.5 3.9 3.3 67.7 1.1 0.4 3.2 0.4 0.6 35.2 61.4 403.4 0.3 30.0 1.6 9.4 12.1 76.2 1.9 16.1 0.9 51.1 0.6 2.9 10.7 49.6 0.8 1.9 65.7 41.3 36.8 7.0 0.5 6.9 69.4 141.3 706.3 105.2 40.1 122.6 301.3 122.7 207.3 241.5 283.3 437.2 187.0 12.8 54.0 0.0 138.3 2.9 1.6 2.3 1.8 224.8 139.5 113.0 7.2 28.6 13.1 16.5 104.3 13.6 94.0 0.4 13.7 2.6 20.5 65.5 88.0 61.7 21.5 23.2 0.7 0.0 2.2 30.6 16.8 86.6 40.4 29.0 37.1 43.2 27.7 101.0 0.8 2.7 65.1 47.4 9.4 30.7 11.1 46.7 8.8 95.5 21.8 221.7 47.4 2.0 1.3 0.1 9.8 4.9 138.6 3.5 5.5 5.9 6.9 196.2 6.6 28.0 51.9 4.8 2.9 3.0 2.3 11.1 48.2 8.7 1.9 6.5 PLCXD2 FLJ31579 ENSG00000240891 "Phosphatidylinositol specific phospholipase C X domain containing 2" Q0VAA5 3 111674676-111846447 "Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.3;retina: 14.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 60.7;Distal tubular cells: 160.4;Hepatocytes: 168.6;Proximal tubular cells: 196.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;NK-cells: 1.1;T-cells: 1.8" "Cell line enhanced" "Detected in many" "HBF TERT88: 7.1" "Low region specificity" "Detected in all" HPA055947 Uncertain Approved Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA055947: AB_2682981" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (7.26e-2)" "unprognostic (2.42e-1)" "unprognostic (3.09e-2)" "unprognostic (2.76e-2)" "unprognostic (1.36e-1)" "unprognostic (4.64e-1)" "unprognostic (3.47e-1)" "unprognostic (1.99e-2)" "unprognostic (3.38e-2)" "unprognostic (2.04e-1)" "prognostic favorable (1.23e-7)" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.99e-4)" 0.3 0.3 2.6 1.6 2.9 4.6 0.2 0.7 7.3 0.3 0.0 1.2 2.8 0.3 0.2 0.5 0.2 0.7 0.3 3.9 1.6 0.6 1.0 0.6 2.9 4.1 4.5 0.2 0.6 0.1 1.4 1.0 4.1 0.3 1.5 14.8 0.9 0.2 0.2 0.6 2.7 0.3 2.2 1.6 0.9 1.0 3.5 2.7 1.3 0.1 2.2 0.5 0.3 1.9 2.3 2.1 2.0 0.9 0.0 0.1 0.6 4.0 1.9 3.7 3.2 1.4 1.1 1.7 2.0 0.2 1.2 5.6 0.8 3.7 7.1 0.5 1.0 0.4 4.1 1.3 0.3 0.5 2.0 0.0 0.7 1.2 2.2 3.4 2.0 2.1 0.0 4.0 0.4 0.2 1.2 0.4 0.7 1.5 5.1 1.1 2.8 1.6 1.7 2.3 0.4 3.4 0.8 0.5 0.8 2.2 0.3 0.1 2.0 0.8 5.0 0.4 0.8 4.8 0.7 0.3 0.4 0.3 0.2 0.3 0.0 0.0 1.8 0.0 1.8 0.3 0.9 1.8 0.1 0.4 0.4 0.9 0.1 1.1 0.0 3.8 0.9 0.3 2.6 2.9 0.7 7.3 3.9 1.6 4.1 4.5 4.1 2.2 3.5 1.9 0.4 19.2 2.2 3.3 2.3 0.1 9.9 17.1 7.4 0.8 2.9 1.8 3.7 22.8 3.5 60.7 4.2 0.0 8.4 1.6 160.4 44.2 11.9 0.9 0.2 0.7 25.1 0.0 11.7 50.1 0.0 0.4 7.1 1.5 0.0 5.4 0.4 168.6 0.0 6.7 6.0 7.8 2.0 1.6 0.0 12.0 0.3 1.8 0.0 3.7 0.0 0.0 2.1 7.5 0.9 50.1 0.2 0.4 3.9 7.9 1.0 196.6 1.0 3.5 0.0 0.0 1.7 0.5 0.5 2.2 0.1 0.0 5.3 0.5 1.5 14.1 PLK2 SNK ENSG00000145632 "Polo like kinase 2" Q9NYY3 5 58453982-58460139 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 380.7;Extravillous trophoblasts: 257.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "NK-cell: 9.1" "Lineage enriched" "Detected in many" 4 "NK-cells: 9.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 1060.6;T-47d: 396.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009624, HPA069329" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Mitochondria, Cytosol" "CAB009624: AB_2167745, HPA069329: " "unprognostic (4.82e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (2.44e-2)" "unprognostic (1.06e-2)" "unprognostic (1.01e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" "unprognostic (3.46e-1)" "unprognostic (1.95e-3)" 24.3 8.4 25.6 7.4 35.7 9.3 40.6 6.4 31.2 37.9 16.4 11.8 9.3 29.0 9.3 35.5 21.0 32.1 54.7 44.4 10.4 15.7 31.1 32.3 7.2 8.1 12.3 19.3 23.4 5.9 6.3 47.6 8.4 17.7 14.6 2.1 42.9 10.5 7.4 47.3 12.9 26.6 7.3 83.6 10.4 38.1 11.8 7.2 18.0 13.6 7.6 29.8 32.1 16.8 131.1 115.6 38.3 3.1 19.9 31.9 15.1 27.1 44.8 86.3 49.8 8.6 112.1 0.0 176.3 95.2 208.3 159.8 1.7 61.5 75.6 0.3 3.5 0.0 50.8 9.7 106.1 0.6 3.6 18.7 82.0 33.3 90.9 1060.6 175.4 0.0 0.1 4.4 169.8 47.5 0.3 0.2 7.6 12.4 18.5 6.3 106.5 0.0 221.6 25.4 2.3 5.1 82.4 16.0 76.0 66.1 396.9 2.0 231.9 24.3 63.8 11.0 217.8 0.1 0.3 0.3 18.8 0.3 110.7 2.2 0.5 1.9 0.1 1.2 0.0 0.8 0.5 0.0 2.2 0.6 0.9 0.4 1.5 9.1 0.5 1.5 0.4 0.4 25.6 35.7 6.4 31.2 44.4 10.4 8.1 12.3 8.4 7.3 11.8 16.8 144.6 19.2 15.8 5.9 23.4 141.7 194.1 116.1 380.7 3.8 108.5 203.7 128.9 30.0 134.9 18.4 4.2 66.5 22.7 66.3 9.8 109.8 10.9 132.7 67.8 178.7 84.3 2.7 44.3 77.9 257.3 107.8 136.6 165.4 9.5 4.1 89.3 7.7 14.9 0.0 22.8 39.9 124.1 8.1 19.3 5.0 12.8 39.5 24.9 15.9 3.2 3.3 0.0 3.5 4.9 103.2 44.6 10.9 8.2 76.1 38.5 5.5 31.6 2.9 0.0 74.0 106.6 65.1 10.4 184.9 103.4 129.8 21.2 7.4 45.6 63.1 PLK3 "CNK, FNK, PRK" ENSG00000173846 "Polo like kinase 3" Q9H4B4 1 44800377-44805990 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Paneth cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060318 Enhanced NA NA "Cluster 35: T-regs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "HPA060318: AB_2684252" "unprognostic (1.06e-1)" "unprognostic (8.71e-2)" "unprognostic (3.69e-2)" "unprognostic (3.51e-3)" "unprognostic (3.09e-2)" "unprognostic (4.72e-2)" "unprognostic (1.02e-1)" "unprognostic (1.59e-1)" "unprognostic (5.12e-3)" "unprognostic (6.78e-2)" "unprognostic (7.67e-3)" "unprognostic (2.79e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.04e-1)" "unprognostic (1.43e-1)" "unprognostic (5.06e-2)" "unprognostic (1.35e-1)" 13.6 6.4 3.2 10.7 3.6 13.8 8.9 4.0 5.3 8.7 8.1 4.9 3.3 8.1 2.8 19.2 7.4 17.3 6.3 3.6 6.0 5.8 7.1 12.9 9.0 9.3 7.1 6.6 8.9 7.1 7.5 6.7 6.7 5.6 2.9 0.4 6.7 3.3 2.8 16.1 6.5 4.9 5.8 7.7 5.4 2.1 5.4 5.4 7.3 2.4 5.8 18.0 8.7 7.2 7.2 4.1 6.6 3.4 4.7 15.0 12.3 15.7 20.8 5.9 5.8 2.5 9.9 8.1 6.5 12.9 18.7 6.5 3.7 21.4 3.2 13.5 0.7 9.1 2.6 6.2 22.5 2.9 11.7 11.8 12.3 17.4 16.1 20.0 17.8 3.0 4.9 3.6 13.0 4.6 6.2 2.7 4.5 4.0 5.5 7.8 4.3 13.3 20.3 2.4 5.0 3.2 4.5 8.3 17.6 10.1 0.6 2.8 23.3 3.6 9.4 7.5 9.7 9.5 4.7 2.8 8.0 5.2 7.2 0.0 4.0 1.0 1.9 5.9 2.1 1.4 11.6 4.7 5.0 1.2 12.4 5.8 4.7 0.8 6.3 2.0 14.0 4.4 3.2 3.6 4.0 5.3 3.6 6.0 9.3 7.1 6.7 5.8 5.4 7.2 55.7 12.8 35.1 1.3 32.2 44.1 60.5 23.3 32.5 7.1 58.4 33.7 3.4 32.9 15.8 5.5 2.1 19.0 32.2 77.7 0.0 18.3 0.8 41.9 27.6 43.5 53.0 2.7 3.6 13.0 22.9 36.7 109.6 67.5 78.7 12.0 32.5 6.7 36.9 6.7 6.3 53.0 2.0 37.7 60.3 0.7 9.9 72.5 12.4 10.3 9.8 7.4 1.0 1.5 2.0 24.3 116.8 5.3 31.4 25.8 47.3 3.3 14.7 10.2 26.3 58.5 30.5 2.5 4.5 37.2 33.5 59.2 65.2 17.0 46.3 58.9 PLPBP PROSC ENSG00000147471 "Pyridoxal phosphate binding protein" O94903 8 37762595-37779768 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 101.8;Exocrine glandular cells: 49.8;Hofbauer cells: 47.3;Proximal tubular cells: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017033, HPA023646, HPA023733" Approved Enhanced Cytosol NA NA 34000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742" "unprognostic (1.55e-2)" "unprognostic (2.17e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-2)" "unprognostic (1.34e-1)" "unprognostic (2.35e-2)" "unprognostic (2.36e-1)" "unprognostic (7.78e-3)" "unprognostic (1.80e-1)" "unprognostic (4.28e-2)" "unprognostic (2.83e-2)" "unprognostic (2.59e-2)" "unprognostic (9.41e-3)" "unprognostic (3.16e-2)" "unprognostic (3.99e-2)" "unprognostic (2.90e-1)" "unprognostic (7.85e-2)" 34.2 23.1 22.2 21.2 24.3 14.6 23.3 25.3 27.1 22.1 26.8 47.2 34.5 19.2 23.3 20.2 27.5 19.1 39.2 24.0 25.0 58.5 78.2 25.7 25.0 22.8 24.9 24.7 40.3 37.4 16.2 20.1 23.7 20.2 37.9 10.9 28.3 27.8 46.4 17.0 37.3 25.9 23.7 25.0 33.5 8.4 24.5 27.4 31.8 42.1 29.0 22.9 16.1 28.6 50.3 45.4 35.1 32.0 25.9 31.1 31.6 55.2 45.8 34.7 38.9 51.6 24.3 58.4 61.9 39.9 55.5 41.4 65.4 52.5 56.6 49.9 34.3 79.4 16.4 51.7 51.6 36.8 52.5 22.9 49.8 33.0 52.0 37.6 52.3 78.3 42.8 42.1 28.7 34.8 116.4 32.4 43.0 92.8 41.9 73.6 46.6 34.8 56.5 60.0 21.5 25.1 45.4 20.0 56.8 25.4 44.2 48.6 52.1 19.1 60.7 69.8 38.1 43.3 90.9 43.0 27.4 51.8 35.0 164.3 109.6 136.1 85.6 130.0 90.0 77.8 87.8 83.6 115.2 61.9 77.0 74.3 46.9 75.9 147.4 66.5 116.7 110.2 22.2 24.3 25.3 27.1 24.0 25.0 22.8 24.9 23.7 23.7 24.5 28.6 35.9 9.6 26.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 27.8 23.0 0.0 0.0 8.1 31.3 0.0 21.2 20.0 0.0 101.8 38.2 0.0 12.8 20.7 13.5 0.0 0.0 0.0 49.8 31.6 13.9 0.0 19.6 12.6 14.8 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 11.9 0.0 0.0 0.0 0.0 33.2 0.0 0.0 1.8 0.0 0.0 82.2 13.8 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 12.9 9.8 17.1 0.0 0.0 PLXNA3 "6.3, Plxn3, PLXN4, SEX, XAP-6" ENSG00000130827 "Plexin A3" P51805 X 154458281-154477779 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058989 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA 94000 "Cluster 11: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Plasma membrane" Nucleoplasm "HPA058989: AB_2683872" "unprognostic (2.79e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-3)" "unprognostic (8.04e-3)" "unprognostic (1.63e-1)" "unprognostic (9.05e-3)" "unprognostic (1.06e-2)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (6.26e-2)" "unprognostic (1.05e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (2.30e-1)" "unprognostic (3.00e-1)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" 6.5 7.0 5.7 3.5 6.4 1.7 6.0 7.5 7.2 10.7 5.3 7.5 3.6 8.1 4.3 5.3 8.7 3.9 7.1 5.5 8.6 5.8 2.8 8.4 3.8 6.4 7.3 17.0 7.6 2.0 24.8 3.6 7.2 10.5 2.2 1.5 12.0 3.4 1.7 10.1 7.8 2.6 4.6 8.0 5.5 3.7 9.0 2.2 10.2 1.1 2.6 7.4 9.7 8.6 11.2 2.2 6.3 16.1 6.5 8.3 8.4 15.6 3.3 3.6 4.9 8.2 4.6 2.0 8.2 16.9 8.4 9.6 6.4 7.6 1.3 0.9 4.8 2.0 29.0 4.5 5.2 1.0 8.8 11.3 5.5 5.4 0.4 12.4 4.1 3.2 5.2 1.6 5.7 13.8 1.9 8.4 2.0 3.4 4.9 7.2 0.5 0.7 4.8 7.2 13.2 6.8 5.7 10.3 2.6 4.4 6.2 2.4 10.4 7.8 7.0 0.8 6.7 1.2 0.2 2.9 14.5 1.5 2.1 0.7 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.3 0.0 0.0 0.1 0.0 5.7 6.4 7.5 7.2 5.5 8.6 6.4 7.3 7.2 4.6 9.0 8.6 5.2 12.8 7.7 13.4 9.8 8.7 9.0 7.3 9.6 18.7 13.9 10.3 6.5 2.8 6.8 11.0 12.5 3.0 10.3 15.9 0.0 11.5 0.1 14.4 23.2 3.9 7.2 0.0 6.5 5.8 7.2 11.0 17.9 30.4 8.8 21.3 2.9 1.6 8.5 5.0 5.4 15.1 0.0 3.5 9.2 0.8 11.5 10.5 14.2 6.5 4.7 6.5 4.1 6.0 4.1 13.6 11.4 8.6 8.5 10.3 9.4 1.5 10.9 7.8 13.1 26.5 9.4 0.9 2.3 8.1 7.4 9.3 13.2 2.5 9.6 8.2 POLG2 "HP55, MTPOLB" ENSG00000256525 "DNA polymerase gamma 2, accessory subunit" Q9UHN1 17 64477785-64497054 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB017030, HPA023202, HPA078396" Approved Supported "Nuclear bodies,Mitochondria" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nuclear bodies" "CAB017030: , HPA023202: AB_1855523, HPA078396: " "unprognostic (1.76e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.02e-2)" "unprognostic (6.01e-2)" "unprognostic (2.91e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (4.38e-2)" "unprognostic (8.46e-2)" "unprognostic (3.14e-1)" "unprognostic (5.17e-3)" "prognostic unfavorable (6.59e-4)" "prognostic unfavorable (1.17e-5)" "unprognostic (5.17e-2)" "unprognostic (1.58e-1)" "unprognostic (2.88e-2)" "unprognostic (4.82e-2)" 4.5 5.8 2.7 4.4 3.0 3.6 4.5 3.9 4.5 6.8 3.0 4.7 3.5 4.7 2.0 4.0 5.6 2.4 5.0 2.8 3.6 5.7 5.3 3.9 5.4 3.2 3.0 7.9 4.7 2.4 4.0 2.9 3.1 5.1 1.9 2.6 3.9 2.9 6.8 4.2 5.6 2.0 2.9 7.5 4.0 12.8 3.1 6.3 5.8 4.2 4.0 4.8 5.3 3.9 8.1 10.4 6.7 7.6 7.2 4.7 8.4 4.6 4.6 7.0 5.9 10.1 6.2 15.7 5.4 2.8 6.5 5.3 9.3 3.9 8.8 4.6 11.0 9.9 12.2 10.5 7.0 14.2 10.6 4.5 4.7 5.3 7.2 8.4 4.7 7.6 18.3 4.7 6.5 10.0 15.3 15.4 7.3 8.6 11.2 13.3 23.8 14.2 6.4 2.4 9.3 10.0 4.4 7.1 8.0 8.7 7.4 12.0 6.1 7.0 9.9 5.8 12.3 8.4 7.2 11.3 5.9 13.4 4.8 7.2 5.2 6.0 6.5 3.2 6.6 10.7 7.5 6.2 9.7 11.9 9.7 9.7 0.9 5.8 8.4 4.4 8.1 4.0 2.7 3.0 3.9 4.5 2.8 3.6 3.2 3.0 3.1 2.9 3.1 3.9 24.6 12.8 21.2 7.8 19.6 8.2 13.7 7.8 16.5 5.0 30.1 37.5 18.4 12.8 13.3 3.7 0.0 13.0 22.7 31.7 0.0 5.4 14.7 16.5 26.7 16.0 10.9 20.4 9.1 3.8 14.4 19.2 14.8 29.2 13.3 9.9 14.6 4.7 9.2 6.7 7.4 13.9 6.1 6.9 7.1 7.3 6.5 17.7 7.2 11.2 8.0 4.5 18.6 13.0 14.1 2.9 21.8 3.0 6.3 9.8 8.9 5.2 7.1 9.2 6.6 92.0 18.4 49.7 9.2 10.8 8.7 4.0 16.2 15.2 19.8 5.2 POLR2A "POLR2, POLRA, RPB1" ENSG00000181222 "RNA polymerase II subunit A" 17 7484366-7514616 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.4;lymphoid tissue: 1.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012226, CAB016388, HPA021563, HPA053012" Enhanced Nucleoplasm,Cytosol NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "CAB012226: AB_304749, CAB016388: AB_677353, HPA021563: AB_1855526, HPA053012: AB_2682017" "unprognostic (2.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.58e-1)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (5.43e-2)" "unprognostic (8.77e-3)" "unprognostic (1.48e-1)" "unprognostic (5.19e-3)" "unprognostic (1.81e-1)" "unprognostic (1.52e-1)" "unprognostic (3.70e-2)" "unprognostic (1.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.30e-2)" "unprognostic (1.49e-1)" "unprognostic (4.70e-2)" 0.1 0.7 0.4 1.6 0.2 0.2 0.1 0.3 1.9 0.0 0.8 0.1 0.5 0.1 0.0 0.0 0.2 0.1 0.1 0.7 0.4 0.1 0.0 0.2 0.2 2.4 0.7 0.1 0.0 0.1 0.2 1.1 0.2 0.2 0.3 0.0 0.0 0.5 0.1 0.4 0.0 0.4 0.2 0.0 0.7 1.1 0.2 0.0 0.1 0.0 0.0 1.6 1.0 1.7 0.5 1.5 0.4 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.4 0.0 0.6 1.0 2.1 0.0 0.0 0.3 0.0 0.5 0.0 0.9 0.0 1.6 2.9 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 1.0 0.4 2.1 0.0 0.0 2.5 2.3 1.0 0.0 2.7 3.5 2.8 1.2 0.8 0.0 0.0 0.8 1.6 0.0 1.0 0.5 1.1 2.0 0.4 0.2 1.6 1.1 0.8 1.0 0.0 2.2 0.8 2.0 0.9 2.5 1.1 0.3 0.8 2.2 0.5 1.3 1.0 0.0 2.0 4.2 0.0 3.2 10.1 0.4 0.2 0.3 1.9 0.7 0.4 2.4 0.7 1.1 0.4 1.1 1.6 124.2 22.4 41.6 13.4 68.0 42.8 40.7 33.8 64.3 90.4 56.5 187.1 26.9 38.6 30.3 23.9 110.5 35.9 153.5 55.0 3.9 27.0 25.0 74.9 64.4 57.7 76.7 43.3 18.1 30.2 28.7 53.3 103.0 67.3 42.5 46.0 40.4 29.9 45.4 55.5 14.9 43.9 26.4 42.1 38.3 7.4 37.0 65.7 37.4 19.7 38.2 27.3 26.8 17.6 17.8 32.0 35.9 41.8 62.0 27.9 42.5 13.2 38.4 90.5 6.6 94.4 53.9 58.5 120.2 73.8 41.2 53.8 89.2 49.8 32.6 30.8 POU3F1 "OCT6, OTF6, SCIP" ENSG00000185668 "POU class 3 homeobox 1" Q03052 1 38043829-38046793 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 10.3;skin 1: 32.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 27.3;Breast myoepithelial cells: 39.1;Cone photoreceptor cells: 22.9;Suprabasal keratinocytes: 55.8" "Group enriched" "Detected in many" 4 "cervical cancer: 1.8;head and neck cancer: 4.4;melanoma: 4.8;testis cancer: 1.3;urothelial cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 24.1;HDLM-2: 23.9;NTERA-2: 7.5;SCLC-21H: 5.7;SK-MEL-30: 28.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055980, HPA073824" Enhanced Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA055980: AB_2682995, HPA073824: AB_2686635" "unprognostic (9.99e-2)" "unprognostic (1.63e-1)" "unprognostic (1.69e-1)" "unprognostic (1.43e-2)" "unprognostic (7.46e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.40e-1)" "unprognostic (4.61e-4)" "unprognostic (2.79e-2)" "unprognostic (1.97e-1)" "unprognostic (3.61e-2)" "unprognostic (2.67e-3)" 0.2 1.5 2.3 0.2 7.0 0.0 0.3 0.9 10.3 0.2 0.1 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.1 9.7 1.9 0.0 0.0 0.0 1.0 1.4 2.6 0.1 0.1 0.2 0.0 0.0 1.3 0.2 0.0 0.3 0.3 0.1 0.9 32.6 0.0 0.0 0.6 0.1 0.1 0.8 2.0 0.3 0.0 0.5 1.0 0.8 0.3 2.5 0.0 0.0 24.1 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 23.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 1.4 5.7 0.0 0.1 0.0 28.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.0 0.9 10.3 9.7 1.9 1.4 2.6 1.3 0.6 2.0 2.5 12.2 0.0 0.0 2.3 8.3 27.3 2.9 1.4 20.5 7.8 9.9 39.1 5.2 0.0 0.2 0.0 22.9 0.2 13.4 13.8 0.0 0.0 0.2 0.5 2.3 1.9 1.8 2.7 6.4 0.0 0.1 5.2 7.1 1.4 0.0 0.5 0.0 0.0 0.3 1.7 1.1 11.0 0.0 0.0 1.3 0.0 0.3 4.3 7.2 1.0 0.0 14.0 0.0 0.5 0.2 0.0 0.1 0.0 2.7 0.7 0.3 0.1 0.0 21.1 0.0 8.5 7.2 0.2 4.1 20.2 55.8 0.1 5.2 8.3 5.7 3.2 PPP1R10 "CAT53, FB19, p99, PNUTS" ENSG00000204569 "Protein phosphatase 1 regulatory subunit 10" Q96QC0 6 30600413-30618612 "Predicted intracellular proteins" "DNA-binding, Protein phosphatase inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "basophil: 7.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025501, HPA047248, HPA056756" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies" "CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227" "unprognostic (1.68e-1)" "prognostic favorable (4.84e-4)" "unprognostic (1.21e-1)" "unprognostic (9.31e-3)" "unprognostic (6.31e-2)" "unprognostic (9.57e-3)" "unprognostic (2.02e-1)" "unprognostic (1.36e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "prognostic favorable (9.74e-5)" "unprognostic (2.72e-1)" "unprognostic (8.02e-3)" "unprognostic (5.90e-2)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (3.74e-2)" 20.9 27.5 0.2 12.0 0.1 1.0 15.8 0.2 1.3 23.3 0.1 21.8 8.9 21.2 1.1 23.1 22.0 10.7 14.6 0.5 0.4 22.8 33.6 17.4 5.0 1.2 1.3 22.8 28.0 4.8 26.3 5.0 0.6 22.8 6.4 5.2 20.1 7.9 23.0 21.1 21.0 7.0 0.3 25.1 25.2 21.7 0.3 10.1 22.9 1.2 5.6 22.5 21.8 0.2 9.1 20.0 30.9 16.8 17.0 2.2 8.9 15.9 7.0 5.6 23.3 5.0 9.7 11.5 9.6 16.0 10.5 23.6 24.3 35.7 9.7 13.1 0.0 19.8 14.1 0.2 7.6 16.3 27.3 14.2 4.0 28.0 30.9 13.2 9.7 3.9 18.4 3.7 14.4 5.4 5.5 2.4 9.1 1.9 2.3 25.4 39.3 19.8 1.4 8.0 19.3 9.1 29.5 28.3 8.8 13.0 13.8 21.8 2.6 12.7 9.0 18.5 10.7 26.9 5.1 11.3 15.8 19.9 15.8 7.9 1.2 2.0 0.9 2.1 1.6 2.9 0.4 1.7 3.3 0.7 0.5 1.1 1.0 1.0 0.8 1.2 1.9 0.4 0.2 0.1 0.2 1.3 0.5 0.4 1.2 1.3 0.6 0.3 0.3 0.2 243.9 32.1 40.3 20.5 152.7 69.8 64.9 41.1 167.9 72.7 165.1 163.8 59.1 28.6 34.2 27.6 131.3 44.0 178.9 120.5 35.2 27.2 32.0 138.2 103.8 102.6 71.3 30.5 26.1 23.0 21.8 103.2 107.0 151.4 44.9 143.0 38.2 33.6 33.1 35.3 27.0 102.2 54.9 35.5 70.6 11.3 46.3 123.4 37.4 30.0 46.4 59.0 72.1 21.1 29.7 29.8 58.3 30.1 140.1 51.9 88.1 40.3 46.9 102.2 32.9 211.5 114.9 45.9 23.4 125.7 77.9 88.5 144.1 99.9 77.0 34.5 PPP1R15A GADD34 ENSG00000087074 "Protein phosphatase 1 regulatory subunit 15A" O75807 19 48872421-48876058 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 575.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 340.1" "Group enriched" "Detected in all" 5 "dendritic cells: 114.6;granulocytes: 340.1" "Cell line enhanced" "Detected in all" "HHSteC: 282.8;hTERT-HME1: 493.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018395, HPA020240" Approved Uncertain Vesicles NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Vesicles "CAB018395: AB_2237473, HPA020240: AB_1849404" "unprognostic (2.43e-3)" "unprognostic (3.21e-1)" "unprognostic (7.75e-2)" "unprognostic (1.17e-3)" "unprognostic (2.22e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.22e-1)" "unprognostic (6.43e-3)" "unprognostic (1.49e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" 199.1 84.7 33.3 49.5 37.4 575.6 97.7 45.9 54.1 99.5 66.9 78.9 36.0 70.1 11.3 98.3 147.4 82.0 185.6 34.8 36.2 95.0 85.1 226.7 33.1 44.8 32.7 101.2 33.4 23.1 65.0 74.8 42.9 60.5 45.5 10.9 41.6 38.6 88.5 191.5 58.8 101.8 29.4 69.0 90.7 23.3 38.7 52.0 69.4 60.6 20.2 110.6 108.4 46.9 55.8 23.7 24.9 20.5 71.2 40.4 39.3 95.1 148.0 106.5 95.9 36.5 27.6 19.1 25.0 69.0 145.5 39.4 9.3 49.7 79.8 10.7 14.4 86.4 14.4 18.1 282.8 20.2 119.2 55.1 135.5 147.0 493.7 48.0 56.3 21.5 118.2 155.6 69.5 6.1 11.1 27.9 6.2 100.3 42.3 12.6 23.1 6.5 22.3 63.8 14.2 24.3 49.2 33.2 230.2 26.0 11.9 36.1 60.6 126.3 31.8 89.3 58.5 82.8 72.1 17.9 46.2 13.7 154.8 161.8 49.4 91.3 22.5 31.1 19.6 36.7 22.2 18.7 35.9 29.7 12.3 11.0 340.1 13.8 37.6 114.6 31.5 36.9 33.3 37.4 45.9 54.1 34.8 36.2 44.8 32.7 42.9 29.4 38.7 46.9 499.1 288.4 225.1 2.3 387.2 482.2 989.5 232.0 730.1 25.0 294.3 220.7 173.3 127.2 204.3 12.9 35.5 104.8 290.3 435.6 3.9 224.0 4.6 619.6 427.4 370.4 170.9 213.5 4.1 94.5 219.0 466.3 430.7 1063.2 708.1 53.3 150.0 14.4 195.0 35.3 4.1 354.1 140.4 146.7 904.4 5.1 58.7 615.3 396.6 9.4 105.1 50.5 20.6 1.0 2.0 233.4 421.8 23.0 477.1 731.5 348.7 9.0 246.2 27.7 85.5 483.5 612.1 7.0 9.5 573.1 431.0 288.4 427.9 102.8 321.8 733.9 PPP1R2C "I-4, PPP1R2P9" ENSG00000102055 "PPP1R2C family member C" O14990 X 42777366-42778163 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 181 "testis: 71.0" "Cell type enhanced" "Detected in some" "B-cells: 4.5;dendritic cells: 8.2;T-cells: 22.0" "Cancer enriched" "Detected in single" 38 "testis cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 36: Testis - Spermatogenesis" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 PPP1R35 "C7orf47, MGC22793" ENSG00000160813 "Protein phosphatase 1 regulatory subunit 35" Q8TAP8 7 100435282-100436497 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.7" "Cell type enhanced" "Detected in all" "Spermatocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021604, HPA051607" Approved Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA021604: AB_2670774, HPA051607: AB_2681548" "unprognostic (2.17e-3)" "unprognostic (2.17e-1)" "unprognostic (7.40e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.15e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (6.99e-2)" "unprognostic (1.20e-1)" "unprognostic (6.77e-2)" "unprognostic (5.17e-2)" "unprognostic (1.85e-3)" "unprognostic (1.40e-1)" "unprognostic (9.51e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.97e-4)" 8.8 16.7 7.8 11.9 7.7 8.7 9.7 9.6 13.8 12.3 8.7 10.6 11.5 10.9 2.2 11.1 11.0 3.1 9.4 7.7 8.0 12.4 12.9 9.4 14.5 8.2 7.7 13.5 10.5 7.8 11.9 6.8 7.8 11.2 2.4 2.4 9.9 5.4 6.3 7.8 12.0 2.8 8.0 22.1 10.9 48.7 8.2 15.3 12.0 3.5 5.5 10.3 10.3 7.7 41.0 14.7 11.1 19.4 3.3 4.9 14.5 11.6 10.5 8.2 9.4 6.8 36.2 14.0 22.2 6.4 39.3 17.4 5.9 9.4 1.8 30.9 18.3 11.6 11.8 14.1 14.5 12.2 16.4 6.8 17.0 7.3 12.0 14.1 17.2 38.8 21.1 24.1 9.9 34.1 36.2 64.6 23.0 17.1 20.1 14.6 4.7 37.9 11.4 9.5 11.8 35.0 8.9 62.5 35.0 6.9 18.0 28.8 13.9 12.2 18.4 16.4 28.9 37.9 23.1 20.2 13.3 19.6 25.0 17.1 2.3 5.7 5.8 1.0 6.2 4.3 5.9 6.6 1.7 5.4 3.3 3.2 10.5 3.8 0.7 7.6 7.6 2.7 7.8 7.7 9.6 13.8 7.7 8.0 8.2 7.7 7.8 8.0 8.2 7.7 47.7 16.0 9.6 13.1 30.8 21.0 39.9 13.9 28.5 35.7 51.3 60.6 2.0 27.1 7.8 47.8 8.4 66.5 47.8 23.6 52.8 9.1 17.3 34.6 22.7 22.1 18.6 17.2 10.2 10.0 40.2 16.5 20.4 24.9 8.2 28.3 15.4 16.1 16.8 48.8 11.8 32.0 18.3 12.0 15.4 8.7 18.0 17.4 17.8 12.2 11.6 26.8 27.8 12.1 12.5 10.7 30.2 9.4 24.2 55.2 26.2 39.5 16.5 37.7 13.1 12.4 17.8 106.1 29.8 36.7 33.4 33.9 37.6 35.2 28.1 43.9 PRAG1 "DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223" ENSG00000275342 "PEAK1 related, kinase-activating pseudokinase 1" Q86YV5 8 8317736-8386439 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0;thyroid gland: 23.2" "Cell type enhanced" "Detected in many" "Adipocytes: 45.9;Breast glandular cells: 14.1;Breast myoepithelial cells: 11.0;Hofbauer cells: 18.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 35.0" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 50.2;NTERA-2: 32.1;SuSa: 32.1" "Low region specificity" "Detected in all" "HPA011776, HPA012066" Uncertain Uncertain "Nucleoli,Focal adhesion sites" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 5: NTERA-2 - Transcription" "Cluster 7: Non-specific - Mitochondria" Nucleoli "Focal adhesion sites" "HPA011776: , HPA012066: AB_1847706" "unprognostic (7.04e-3)" "unprognostic (7.90e-2)" "unprognostic (2.32e-1)" "unprognostic (2.95e-2)" "unprognostic (1.60e-1)" "unprognostic (2.92e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-3)" "unprognostic (2.64e-3)" "unprognostic (5.19e-2)" "unprognostic (4.95e-2)" "unprognostic (1.78e-1)" "prognostic favorable (4.81e-4)" "unprognostic (5.27e-2)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (5.22e-3)" 8.7 1.0 9.2 5.2 12.0 0.6 9.4 35.0 5.8 2.8 0.0 5.3 11.3 1.7 0.2 5.5 5.6 2.3 6.1 5.3 1.4 3.7 2.7 5.2 8.1 1.2 3.0 3.8 3.3 2.2 1.5 5.7 1.8 2.5 4.1 0.2 5.0 1.5 7.4 7.5 11.6 1.4 0.1 8.4 4.8 2.2 4.6 3.0 23.2 3.4 6.1 2.3 2.8 1.8 6.2 50.2 5.6 0.7 0.0 0.3 14.1 12.8 2.7 4.9 2.0 25.0 14.4 10.2 8.6 6.1 13.5 21.9 1.0 15.3 1.0 0.5 1.6 0.0 6.2 14.2 5.3 1.5 15.4 1.2 9.8 0.8 2.2 2.9 10.2 1.5 0.0 0.1 3.8 8.5 1.4 4.8 32.1 19.5 12.9 6.6 6.0 2.5 7.2 17.5 2.8 1.9 4.9 13.9 5.0 32.1 10.8 6.3 13.7 0.5 12.9 0.0 3.2 0.8 1.1 13.9 3.1 3.4 7.4 0.0 0.2 0.9 0.4 0.0 0.3 1.2 0.6 0.2 0.3 0.9 1.6 1.3 0.0 0.5 0.8 1.9 0.0 0.2 9.2 12.0 35.0 5.8 5.3 1.4 1.2 3.0 1.8 0.1 4.6 1.8 45.9 9.6 6.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 14.1 11.0 0.0 0.0 0.0 0.0 0.0 7.5 5.3 0.0 0.0 9.0 0.0 3.0 1.4 5.6 0.0 0.0 0.0 3.1 7.2 2.5 0.0 1.7 2.5 1.7 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.9 0.0 0.0 2.7 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.8 2.3 7.4 0.0 0.0 PRMT9 "FLJ46629, PRMT10" ENSG00000164169 "Protein arginine methyltransferase 9" Q6P2P2 4 147637785-147684163 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 112.6;Rod photoreceptor cells: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036844, HPA042537" Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Microtubules "Nucleoplasm, Cytosol" "HPA036844: AB_10672341, HPA042537: AB_2678043" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" "unprognostic (4.65e-3)" "unprognostic (2.35e-1)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (4.14e-2)" "unprognostic (7.29e-2)" "unprognostic (2.11e-2)" "unprognostic (2.33e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.72e-1)" "unprognostic (4.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.30e-2)" 3.2 9.9 1.4 2.8 1.8 8.5 4.1 3.1 2.4 2.8 1.8 2.3 1.4 4.6 3.1 2.9 3.3 3.0 2.8 2.0 1.8 4.3 3.4 3.2 3.5 1.4 1.6 11.3 3.3 6.1 3.6 3.0 1.5 3.4 2.6 5.2 2.7 3.3 3.3 2.8 1.8 2.7 1.6 2.8 3.1 7.1 1.7 4.5 5.7 2.5 3.0 2.5 2.3 1.6 2.8 1.8 4.3 3.3 3.3 5.6 3.8 3.1 4.9 4.6 4.8 1.4 3.1 9.8 1.3 2.7 2.3 1.9 5.1 2.6 6.3 3.5 3.0 5.4 3.6 2.3 2.5 8.0 2.8 3.9 2.7 2.8 2.5 3.7 3.9 4.8 5.4 5.5 3.9 1.6 6.8 3.1 2.2 2.7 3.2 4.5 3.7 3.6 3.7 2.2 2.7 4.1 4.9 3.8 2.5 2.8 1.6 1.7 3.3 2.9 2.4 3.3 3.4 6.2 5.3 6.1 3.3 4.8 2.2 6.1 4.2 8.6 4.7 4.7 4.6 7.4 5.7 5.8 3.0 7.2 7.1 6.2 2.8 4.3 3.5 4.4 5.5 2.1 1.4 1.8 3.1 2.4 2.0 1.8 1.4 1.6 1.5 1.6 1.7 1.6 8.7 0.0 5.3 9.8 40.4 0.0 4.2 0.0 26.7 56.5 11.7 21.8 5.9 7.2 0.6 35.0 112.6 14.5 51.6 6.2 5.9 7.0 73.1 9.2 9.5 8.4 17.4 10.3 29.8 6.5 14.8 12.9 11.2 13.0 33.7 15.6 12.8 6.9 17.2 50.5 29.8 7.2 0.0 36.5 0.0 13.4 18.0 63.7 0.0 17.8 10.9 48.1 16.5 20.6 16.3 7.4 6.2 17.0 18.4 4.1 7.4 5.5 1.5 81.1 13.1 6.2 18.5 36.5 19.6 4.3 0.0 15.2 61.2 18.5 6.3 2.0 PRR14 MGC3121 ENSG00000156858 "Proline rich 14" Q9BWN1 16 30650717-30656413 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052022, HPA060265, HPA075914" Uncertain Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: " "unprognostic (1.57e-1)" "prognostic favorable (8.19e-5)" "unprognostic (3.74e-3)" "unprognostic (1.42e-2)" "unprognostic (5.18e-2)" "unprognostic (5.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.42e-2)" "unprognostic (5.75e-2)" "unprognostic (1.82e-2)" "unprognostic (1.61e-2)" "unprognostic (5.69e-2)" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (4.54e-1)" "unprognostic (9.10e-2)" "unprognostic (2.31e-3)" 20.5 20.2 17.1 13.9 16.8 23.6 20.3 19.0 21.7 26.6 12.8 30.8 13.8 29.8 7.1 22.4 26.1 6.6 16.4 16.0 15.3 22.1 21.3 24.1 14.1 18.5 16.6 25.1 24.9 13.0 21.2 8.3 16.1 26.2 7.8 9.4 19.1 13.7 15.1 26.2 25.6 10.9 15.0 32.5 26.0 12.6 18.3 18.7 23.4 9.6 10.6 24.5 22.7 17.9 18.2 20.3 17.1 18.2 15.2 11.7 11.9 17.6 11.8 18.1 17.2 9.3 17.3 30.5 15.3 12.9 8.4 17.7 14.4 20.4 9.8 41.5 36.0 17.9 19.6 21.4 23.6 16.1 43.3 9.8 23.1 13.0 13.7 18.9 23.1 8.2 22.8 24.3 10.0 42.2 36.7 28.4 6.2 12.4 10.3 29.4 8.4 44.2 13.7 7.3 14.5 32.4 7.1 26.8 18.2 5.3 29.9 13.1 18.1 16.3 17.7 17.0 18.4 44.1 29.4 21.3 11.0 33.0 14.7 11.4 6.0 23.7 9.6 6.5 7.4 7.0 8.0 9.7 5.7 10.5 7.3 7.2 22.5 8.6 10.9 7.6 10.3 5.5 17.1 16.8 19.0 21.7 16.0 15.3 18.5 16.6 16.1 15.0 18.3 17.9 18.1 9.6 10.4 13.7 23.2 22.8 26.1 28.8 33.6 13.9 19.1 18.7 6.6 25.8 13.2 12.9 14.6 15.8 31.9 24.1 15.6 22.3 6.7 8.8 13.0 20.9 12.6 15.4 7.5 22.2 15.3 15.3 27.5 15.1 12.0 15.4 18.9 10.1 18.2 1.7 7.7 18.3 20.3 16.0 34.1 2.5 19.3 20.2 8.8 8.4 30.2 13.1 33.0 5.5 8.7 20.4 14.6 21.1 17.3 23.6 23.6 15.1 10.0 14.2 19.7 12.8 19.9 17.2 27.2 28.5 23.0 14.1 26.5 11.7 19.8 17.3 PRUNE1 "DRES-17, H-PRUNE, HTCD37, PRUNE" ENSG00000143363 "Prune exopolyphosphatase 1" Q86TP1 1 151008420-151035713 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 13.0;Breast glandular cells: 9.8;Breast myoepithelial cells: 8.9;Collecting duct cells: 11.0;Granulosa cells: 8.9;Proximal tubular cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 169.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028411 Uncertain Supported Cytosol NA NA 41000 "Cluster 5: Granulocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA028411: AB_10603229" "unprognostic (6.24e-2)" "unprognostic (2.24e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (6.91e-2)" "unprognostic (2.02e-1)" "unprognostic (2.12e-3)" "unprognostic (7.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.92e-2)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (3.48e-4)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" 10.1 9.5 12.2 7.7 12.1 4.4 14.9 16.1 15.1 15.0 12.4 14.8 12.5 14.8 15.6 12.4 16.0 9.2 33.4 12.4 12.6 18.8 14.3 10.8 10.8 12.0 12.5 17.2 10.7 20.9 12.6 7.1 11.9 12.2 14.5 10.8 13.2 14.4 29.4 11.5 12.0 14.1 11.9 11.2 11.2 18.3 12.8 16.2 32.5 21.4 12.6 13.7 11.9 13.5 11.0 11.6 20.2 19.3 24.3 6.6 10.9 5.1 11.2 18.7 16.4 14.1 13.0 22.2 21.7 6.9 5.5 15.5 19.9 13.4 14.6 24.5 22.6 26.6 11.8 20.4 13.5 17.5 13.0 8.4 24.7 10.2 9.5 15.4 9.2 29.4 21.1 18.3 8.9 26.2 27.2 14.1 18.7 39.7 15.0 24.2 12.8 21.5 13.4 14.9 28.7 23.5 17.5 23.5 16.1 28.3 32.6 25.7 6.3 6.6 7.8 7.5 8.1 44.1 40.0 169.1 6.5 13.0 16.9 19.1 8.1 17.8 16.4 7.8 19.8 14.4 18.1 18.6 11.9 15.4 21.7 17.5 18.6 18.8 12.2 6.4 18.5 22.3 12.2 12.1 16.1 15.1 12.4 12.6 12.0 12.5 11.9 11.9 12.8 13.5 4.5 6.4 13.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 9.8 8.9 0.0 0.0 3.1 11.0 0.0 4.1 3.2 0.0 0.0 6.0 0.0 4.3 7.8 2.1 0.0 0.0 0.0 5.7 4.8 2.5 0.0 6.4 0.0 8.9 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.0 0.0 0.0 8.9 2.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 5.1 2.8 4.8 0.0 0.0 PTBP1 "HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4" ENSG00000011304 "Polypyrimidine tract binding protein 1" P26599 19 797075-812327 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013507 Supported Supported Nucleoplasm NA NA 4500000 "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB013507: AB_2533082" "unprognostic (2.82e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-2)" "unprognostic (1.24e-1)" "unprognostic (6.01e-2)" "unprognostic (6.22e-2)" "prognostic unfavorable (2.71e-4)" "unprognostic (4.06e-3)" "unprognostic (2.08e-2)" "unprognostic (1.92e-2)" "unprognostic (5.47e-2)" "unprognostic (4.62e-3)" "unprognostic (2.41e-2)" "unprognostic (7.91e-3)" "unprognostic (4.28e-2)" "unprognostic (8.31e-2)" "unprognostic (3.72e-2)" 101.5 84.7 29.9 104.7 33.4 138.2 94.9 33.5 34.9 92.7 51.7 95.9 91.4 90.5 48.9 137.7 86.9 54.0 64.7 29.9 33.6 111.8 123.5 102.3 90.1 38.1 35.5 99.5 100.8 66.4 80.9 79.0 36.7 86.3 56.0 11.8 90.7 45.6 35.2 123.8 96.6 49.7 34.4 117.2 86.0 45.5 36.2 91.9 98.0 19.7 79.2 80.3 101.5 34.8 517.8 377.1 242.8 224.3 70.1 90.3 385.1 299.7 128.8 230.2 169.2 394.1 243.6 428.0 192.5 188.9 88.0 299.8 342.7 260.0 239.3 433.8 361.2 352.9 362.6 429.8 141.8 479.4 355.1 83.5 179.0 265.5 164.2 84.4 232.2 201.3 523.0 223.0 385.6 434.8 610.4 258.5 446.4 190.2 245.2 648.8 182.0 254.2 140.4 467.5 272.9 317.4 358.4 213.4 174.8 168.5 228.9 286.4 335.4 247.5 286.9 306.0 557.4 238.0 500.7 591.2 153.2 357.7 307.9 12.9 32.5 23.1 31.8 38.6 32.3 23.7 26.3 30.0 36.0 23.7 25.1 26.2 13.4 33.5 36.7 22.3 29.1 38.3 29.9 33.4 33.5 34.9 29.9 33.6 38.1 35.5 36.7 34.4 36.2 34.8 99.8 41.7 66.9 11.8 88.7 76.7 91.8 47.0 84.8 19.6 114.5 91.9 39.1 82.9 44.3 47.8 35.5 116.5 96.1 134.3 35.2 73.3 22.3 62.2 62.2 92.1 101.1 87.7 12.4 87.5 172.7 70.4 70.3 80.5 90.8 92.0 74.6 87.9 78.7 33.7 12.1 145.0 36.7 60.6 62.7 20.6 79.9 75.1 39.2 20.6 59.8 29.9 59.8 10.1 12.9 99.4 107.5 65.8 90.0 90.5 89.9 46.9 49.9 21.3 59.2 74.8 71.1 40.5 54.3 97.2 82.0 133.4 89.7 68.7 144.9 100.7 PTPA "PPP2R4, PR53" ENSG00000119383 "Protein phosphatase 2 phosphatase activator" Q15257 9 129110950-129148946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 51.9;Collecting duct cells: 53.3;Cytotrophoblasts: 49.5;Distal tubular cells: 54.8;Ductal cells: 70.3;Exocrine glandular cells: 62.3;Hofbauer cells: 53.9;Pancreatic endocrine cells: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005695, CAB022068, CAB035999" Approved Enhanced Nucleoplasm,Cytosol NA NA 4300000 "Cluster 39: Non-specific - mRNA processing" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "CAB022068: , CAB035999: , HPA005695: AB_1855658" "unprognostic (4.97e-2)" "unprognostic (1.70e-2)" "unprognostic (1.13e-2)" "prognostic favorable (6.50e-5)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.65e-2)" "unprognostic (6.44e-3)" "unprognostic (2.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" 47.2 118.0 157.8 56.2 154.0 52.9 60.9 136.2 185.0 73.5 124.6 105.2 49.6 87.4 55.8 116.8 77.3 49.3 176.7 158.5 141.6 125.5 154.2 72.6 49.9 151.3 148.8 63.8 70.4 146.7 73.1 49.8 147.6 119.0 51.3 43.4 97.1 86.8 340.8 73.7 57.1 92.1 143.2 82.8 83.5 124.5 162.7 59.1 75.3 206.2 54.9 71.1 62.2 148.5 108.9 183.9 111.0 219.9 74.4 94.5 118.3 115.5 120.2 144.8 100.1 103.4 135.4 113.9 83.3 187.3 173.1 184.1 110.9 138.2 100.6 198.6 68.1 64.6 193.6 101.7 229.1 113.1 147.2 114.6 133.1 109.8 101.8 230.9 146.5 120.3 102.0 124.7 117.1 293.8 103.0 76.6 186.8 301.0 193.0 108.3 93.7 216.2 159.0 119.8 120.6 86.9 220.4 237.3 147.3 99.4 253.4 55.0 101.7 127.6 113.8 129.9 165.2 114.9 284.1 96.8 153.2 79.1 180.7 7.6 19.2 9.8 20.8 18.4 19.9 10.8 15.8 18.5 23.0 13.4 13.8 13.9 6.1 20.4 18.3 16.4 16.9 20.4 157.8 154.0 136.2 185.0 158.5 141.6 151.3 148.8 147.6 143.2 162.7 148.5 19.8 3.2 8.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 51.9 38.6 0.0 0.0 3.1 53.3 0.0 49.5 9.2 0.0 54.8 70.3 0.0 33.7 21.8 19.0 0.0 0.0 0.0 62.3 44.2 12.2 0.0 32.9 8.8 24.8 0.0 0.0 53.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 61.8 0.0 0.0 0.9 0.0 0.0 41.9 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 37.9 4.0 31.8 0.0 0.0 PYCR3 "FLJ13852, PYCRL" ENSG00000104524 "Pyrroline-5-carboxylate reductase 3" Q53H96 8 143603210-143609773 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Collecting duct cells: 14.7;Ductal cells: 10.2;Exocrine glandular cells: 9.1;Extravillous trophoblasts: 11.8;Proximal tubular cells: 12.4;Theca cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 4.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053776, HPA063416, HPA069706" Uncertain Supported "Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 24: B-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "Cytokinetic bridge, Mitotic spindle" "HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178" "unprognostic (2.12e-2)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.06e-2)" "unprognostic (2.30e-1)" "unprognostic (7.68e-3)" "unprognostic (1.79e-1)" "unprognostic (1.96e-1)" "unprognostic (2.26e-2)" "unprognostic (5.85e-2)" "unprognostic (5.44e-2)" "unprognostic (1.82e-2)" "unprognostic (3.64e-2)" "unprognostic (2.96e-1)" "unprognostic (3.54e-2)" "unprognostic (2.54e-1)" 5.0 9.7 2.8 0.4 2.9 0.6 5.2 2.7 3.3 5.1 1.0 4.2 0.5 5.2 1.1 7.1 6.0 0.8 3.9 2.9 1.6 9.7 17.2 3.8 0.9 2.3 2.2 5.1 9.2 0.6 10.0 0.4 2.7 8.7 0.6 0.7 5.8 0.5 3.0 4.0 4.1 0.4 1.5 5.9 5.5 7.0 2.7 0.4 8.4 0.3 0.7 4.4 3.8 2.1 3.2 4.0 1.6 2.5 1.8 0.6 2.0 3.0 1.4 2.9 1.9 2.9 2.6 6.2 2.1 2.0 1.1 2.6 2.0 4.0 1.1 3.0 5.3 3.7 2.2 2.0 0.6 1.9 1.0 0.8 1.9 3.1 1.9 1.2 0.7 3.7 4.3 3.1 1.9 7.2 3.0 1.7 2.1 4.5 10.4 2.8 1.8 4.3 3.4 2.2 5.3 1.4 3.6 4.9 1.6 0.8 6.4 2.0 0.9 2.9 4.0 3.4 3.1 2.5 0.8 4.2 2.6 2.0 1.9 0.2 0.9 0.0 1.1 0.6 1.2 1.3 0.8 0.8 0.6 4.7 1.1 1.0 0.1 1.3 0.7 3.0 0.9 0.6 2.8 2.9 2.7 3.3 2.9 1.6 2.3 2.2 2.7 1.5 2.7 2.1 2.9 3.2 3.6 0.0 1.8 0.0 0.0 0.0 0.0 0.0 8.8 7.7 0.0 0.0 0.6 14.7 0.0 5.1 1.6 0.0 3.9 10.2 0.0 6.8 6.6 1.9 0.0 0.0 0.0 9.1 11.8 2.9 0.0 5.2 0.0 5.5 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.8 0.0 0.0 12.4 4.4 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.5 1.2 14.7 0.0 0.0 QTRT2 "FLJ12960, QTRTD1" ENSG00000151576 "Queuine tRNA-ribosyltransferase accessory subunit 2" Q9H974 3 114005833-114088422 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Alveolar cells type 2: 20.3;Endometrial stromal cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036827, HPA036828" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Intermediate filaments" "HPA036827: AB_2675336, HPA036828: AB_10696788" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (6.71e-3)" "unprognostic (1.01e-3)" "unprognostic (8.57e-2)" "unprognostic (4.41e-1)" "unprognostic (5.82e-3)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" "unprognostic (6.94e-2)" "unprognostic (6.48e-3)" "prognostic unfavorable (6.95e-4)" "unprognostic (1.44e-1)" "unprognostic (8.74e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-3)" 6.9 6.5 3.6 9.4 3.9 11.2 10.1 3.2 4.0 7.4 9.0 8.4 7.7 8.4 6.4 7.0 7.5 5.3 3.4 4.3 3.6 7.5 7.2 8.6 12.0 3.8 3.6 8.1 6.7 7.3 4.4 8.5 3.8 6.9 8.9 11.3 5.9 5.9 3.8 8.2 7.6 7.4 3.4 11.8 6.9 7.1 3.7 7.7 8.9 3.9 11.6 9.6 5.2 4.4 26.8 27.1 22.2 24.6 9.6 11.7 20.9 13.7 8.6 22.9 20.9 26.0 18.8 49.4 19.5 12.7 27.3 25.9 43.5 20.6 29.9 9.4 19.6 22.2 15.9 18.6 13.7 40.8 20.0 9.3 18.2 20.8 29.4 9.3 24.0 22.5 23.7 17.1 13.1 21.4 34.3 15.9 42.6 37.6 29.3 30.6 15.6 26.6 18.0 18.2 30.1 14.2 19.9 19.4 25.1 18.4 21.6 20.4 15.9 19.9 21.6 7.9 26.9 12.0 18.7 68.1 17.4 29.6 40.9 0.6 15.3 3.8 6.4 15.8 6.0 16.8 5.4 6.3 19.4 11.0 7.4 6.0 6.5 8.6 11.4 8.1 7.6 6.5 3.6 3.9 3.2 4.0 4.3 3.6 3.8 3.6 3.8 3.4 3.7 4.4 14.0 19.2 20.3 0.0 8.4 0.0 0.0 0.0 0.0 0.0 13.8 12.4 0.0 0.0 10.5 3.7 0.0 10.9 10.0 0.0 1.9 15.7 0.0 16.3 19.7 9.9 0.0 0.0 0.0 12.4 10.9 6.2 0.0 15.1 15.2 15.7 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 8.3 0.0 0.0 0.0 0.0 16.7 0.0 0.0 3.3 0.0 0.0 8.9 4.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 4.9 4.3 17.4 0.0 0.0 RAB5IF "C20orf24, PNAS-11, RCAF1, RIP5" ENSG00000101084 "RAB5 interacting factor" Q9BUV8 20 36605779-36612557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 216.9" "Cell type enhanced" "Detected in many" "Ductal cells: 215.9;Exocrine glandular cells: 348.7;Hofbauer cells: 242.6;Pancreatic endocrine cells: 442.2;Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057387 Uncertain Approved Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA057387: AB_2683425" "unprognostic (2.14e-1)" "unprognostic (4.75e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-3)" "unprognostic (3.88e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.56e-6)" "unprognostic (4.47e-3)" "unprognostic (3.89e-1)" "unprognostic (2.90e-1)" "unprognostic (2.37e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "unprognostic (9.98e-2)" 45.2 49.0 33.0 46.4 33.4 69.0 33.4 36.0 40.4 45.4 35.8 71.6 49.3 29.1 40.9 152.2 27.3 38.6 53.0 32.8 34.9 53.1 115.7 41.9 38.6 35.0 33.7 22.6 42.8 55.2 20.8 33.4 34.4 29.8 59.9 28.6 56.3 27.6 216.9 39.8 43.2 34.7 35.4 57.0 48.5 37.5 36.1 41.6 27.8 78.2 56.4 50.3 58.1 37.0 224.8 164.4 59.9 75.2 127.2 74.8 142.5 135.8 79.4 132.7 119.5 455.9 279.5 96.6 327.4 122.2 244.8 163.2 123.3 219.3 130.5 73.5 119.1 230.0 233.3 516.7 149.1 247.4 109.3 92.6 225.0 187.7 110.1 70.4 124.5 104.0 158.9 226.4 125.2 156.9 148.6 318.2 98.5 227.1 344.6 114.8 137.2 245.9 119.3 163.5 99.3 76.0 195.3 513.2 187.6 89.3 111.5 206.5 135.1 192.6 132.5 195.3 211.7 138.8 236.0 162.2 204.4 281.3 104.7 22.0 76.9 97.3 17.7 38.9 17.8 35.7 21.2 27.4 47.9 33.6 26.1 19.4 120.6 18.4 46.4 32.8 39.8 28.1 33.0 33.4 36.0 40.4 32.8 34.9 35.0 33.7 34.4 35.4 36.1 37.0 47.5 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 87.1 64.5 0.0 0.0 0.0 42.3 0.0 83.1 111.1 0.0 76.3 215.9 0.0 43.0 34.8 24.4 0.0 0.0 0.0 348.7 126.8 14.5 0.0 61.6 0.0 24.3 0.0 0.0 242.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 93.0 0.0 0.0 0.0 0.0 442.2 0.0 0.0 11.9 0.0 0.0 147.8 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 135.6 27.0 29.9 0.0 0.0 RACK1 "Gnb2-rs1, GNB2L1, H12.3" ENSG00000204628 "Receptor for activated C kinase 1" P63244 5 181236897-181248096 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 3642.0;Breast myoepithelial cells: 3742.9;Cytotrophoblasts: 3252.2;Exocrine glandular cells: 3361.4;Extravillous trophoblasts: 4389.3;Syncytiotrophoblasts: 3206.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004288, HPA021676" Uncertain Supported Nucleoplasm,Cytosol NA NA 630000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "CAB004288: AB_2247471, HPA021676: AB_1849868" "unprognostic (4.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.03e-2)" "unprognostic (1.07e-2)" "unprognostic (7.43e-2)" "prognostic unfavorable (2.98e-6)" "unprognostic (4.19e-1)" "unprognostic (3.04e-1)" "unprognostic (2.00e-1)" "unprognostic (2.07e-1)" "unprognostic (3.81e-1)" "unprognostic (1.05e-3)" "unprognostic (3.67e-1)" "unprognostic (1.78e-1)" "unprognostic (3.50e-1)" "unprognostic (2.62e-1)" 873.7 718.9 473.2 701.4 488.1 1590.2 1435.8 482.6 527.4 1091.1 505.6 1033.5 747.7 884.8 989.4 1154.9 1366.8 732.8 676.4 457.2 487.8 641.2 817.0 631.4 1358.7 519.6 485.3 2527.6 1504.7 721.7 582.6 763.8 514.8 716.2 922.6 286.5 1204.1 638.1 1167.2 1242.9 788.2 823.6 514.0 821.7 753.6 230.4 490.2 1703.2 820.4 1152.2 1590.1 1026.2 896.4 532.7 1606.0 1783.0 1498.7 2930.0 2671.8 4139.8 2576.4 1409.8 2832.1 2364.7 2463.4 3845.9 1671.3 3592.6 1735.5 2068.5 1668.5 1216.3 1867.9 6501.5 1729.1 3457.2 3068.4 1205.2 1939.5 2508.6 3610.1 3145.0 1193.1 4375.7 3664.7 1935.6 3427.8 2880.2 2705.8 2328.3 1610.6 2717.9 2117.6 3742.7 2435.7 2703.6 1535.1 1487.1 1504.9 2218.3 1536.5 3279.6 2733.5 2152.4 1969.8 2163.4 865.3 2682.2 4446.4 1015.6 1882.1 2802.9 2089.8 1297.4 1032.1 1029.1 2315.5 1767.8 2293.6 2063.5 1242.5 2470.7 1440.5 577.1 1163.9 290.3 829.2 908.1 1333.4 1732.3 1391.2 1062.0 1405.6 1689.0 1597.5 1348.6 138.6 1092.2 861.8 1037.0 1465.0 3377.9 473.2 488.1 482.6 527.4 457.2 487.8 519.6 485.3 514.8 514.0 490.2 532.7 896.6 576.9 935.7 0.0 698.1 0.0 0.0 0.0 0.0 0.0 3642.0 3742.9 0.0 0.0 452.5 498.4 0.0 3252.2 821.7 0.0 1749.1 1773.1 0.0 590.9 1560.3 523.7 0.0 0.0 0.0 3361.4 4389.3 783.3 0.0 818.8 671.1 1822.8 0.0 0.0 1964.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 669.4 0.0 0.0 1169.6 0.0 0.0 0.0 0.0 2097.2 0.0 0.0 200.2 0.0 0.0 2538.2 253.6 0.0 0.0 0.0 689.9 0.0 0.0 0.0 0.0 3206.0 503.5 2464.9 0.0 0.0 RBBP6 "P2P-R, PACT, SNAMA" ENSG00000122257 "RB binding protein 6, ubiquitin ligase" Q7Z6E9 16 24537693-24572863 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA replication, Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 143.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032866, HPA041725, HPA043544" Approved Enhanced "Nuclear speckles" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543" "unprognostic (1.04e-1)" "unprognostic (5.08e-2)" "unprognostic (3.35e-1)" "unprognostic (3.85e-2)" "unprognostic (1.97e-2)" "unprognostic (2.15e-2)" "unprognostic (1.08e-2)" "unprognostic (6.60e-2)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.77e-1)" "unprognostic (2.01e-2)" "unprognostic (1.21e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.22e-1)" "unprognostic (2.83e-2)" 27.1 25.0 22.9 21.1 23.8 143.6 25.9 33.1 29.9 27.8 21.7 31.5 15.0 33.6 26.3 23.2 32.4 25.5 23.9 22.8 23.5 24.3 26.8 27.9 29.7 24.2 22.8 38.8 22.2 21.8 28.1 31.7 24.4 26.0 20.4 51.1 21.4 19.9 29.7 34.6 26.0 24.1 23.9 29.4 25.6 45.5 24.4 26.6 27.2 25.7 23.5 25.3 24.7 27.7 35.4 18.4 42.5 44.4 31.9 32.9 45.9 28.1 26.1 25.1 27.3 20.5 28.3 49.6 20.3 24.4 28.7 33.3 46.2 24.8 41.9 26.9 35.7 41.9 57.1 58.6 24.7 57.5 23.7 28.8 33.7 33.2 38.9 28.6 36.9 42.2 54.5 43.8 29.7 36.5 45.5 51.2 48.7 24.0 17.3 62.8 42.5 43.3 24.7 31.7 33.4 28.5 39.7 35.1 52.3 47.0 27.4 49.7 32.3 31.0 22.8 27.0 30.8 37.7 40.9 60.9 25.1 36.5 26.1 7.1 1.2 2.0 2.0 2.0 2.2 2.0 2.1 1.5 0.9 1.7 1.8 2.0 2.5 3.5 1.1 3.7 1.7 0.6 22.9 23.8 33.1 29.9 22.8 23.5 24.2 22.8 24.4 23.9 24.4 27.7 139.1 86.6 115.3 47.3 125.7 100.7 103.5 40.8 223.1 67.1 145.6 160.8 147.0 44.3 56.5 27.6 100.1 46.3 88.9 71.5 25.4 48.8 307.5 109.8 123.7 93.7 82.0 83.1 52.5 47.6 57.6 127.1 121.8 203.1 51.3 127.8 64.2 59.5 38.4 62.2 53.4 76.0 28.5 53.5 70.2 41.9 72.4 101.5 62.2 54.4 54.0 53.1 52.5 61.3 58.7 56.4 32.8 58.6 173.7 99.9 54.5 23.9 52.0 61.4 52.6 247.0 112.9 100.3 45.8 161.0 101.7 101.5 110.2 105.3 69.3 111.9 RCC1L WBSCR16 ENSG00000274523 "RCC1 like" Q96I51 7 75027122-75074228 "Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 56.0;Distal tubular cells: 49.0;Extravillous trophoblasts: 42.3;Granulosa cells: 46.2;Proximal tubular cells: 37.0;Syncytiotrophoblasts: 54.5;Theca cells: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052184, HPA060643" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "HPA052184: AB_2681752, HPA060643: AB_2684335" "unprognostic (9.73e-2)" "unprognostic (9.42e-2)" "unprognostic (1.69e-1)" "unprognostic (5.87e-2)" "prognostic unfavorable (4.88e-4)" "unprognostic (8.91e-2)" "unprognostic (3.34e-3)" "unprognostic (7.36e-2)" "unprognostic (1.94e-1)" "unprognostic (7.40e-2)" "unprognostic (1.28e-3)" "unprognostic (6.35e-2)" "unprognostic (1.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.43e-1)" 27.4 46.3 19.6 17.3 21.4 14.0 25.2 19.5 22.5 24.0 22.9 35.0 19.0 28.2 6.8 30.7 21.9 12.7 53.1 18.5 19.6 40.1 59.8 20.2 18.7 21.4 20.2 28.8 28.8 18.2 27.2 15.4 19.3 30.6 10.3 5.3 22.8 17.5 103.1 22.0 23.2 12.7 20.8 25.3 28.8 21.6 22.0 12.4 25.9 45.9 12.7 32.0 23.1 20.5 44.8 59.2 34.8 54.0 24.5 19.8 45.3 42.9 30.5 36.1 29.5 64.6 53.5 47.2 18.9 34.8 46.9 51.9 29.8 28.8 15.0 52.0 47.7 35.1 41.5 61.3 34.6 56.6 53.7 24.7 23.1 31.4 24.9 24.2 32.4 7.7 113.8 29.5 28.3 92.8 1.5 84.6 80.0 53.2 52.1 24.5 27.4 98.6 31.5 38.9 34.5 55.3 57.1 119.0 54.4 24.3 83.8 58.3 35.8 46.9 38.5 40.7 56.5 32.4 26.7 73.6 35.8 58.3 63.6 3.5 2.3 1.4 4.2 3.1 3.4 3.6 4.6 3.7 3.3 4.2 4.3 5.3 0.8 4.6 2.3 3.3 3.7 1.7 19.6 21.4 19.5 22.5 18.5 19.6 21.4 20.2 19.3 20.8 22.0 20.5 15.9 0.0 7.3 0.0 5.9 0.0 0.0 0.0 0.0 0.0 15.2 15.5 0.0 0.0 2.5 22.0 0.0 56.0 13.0 0.0 49.0 24.3 0.0 11.7 17.7 8.0 0.0 0.0 0.0 20.6 42.3 10.5 0.0 13.8 5.1 46.2 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 18.1 0.0 0.0 1.8 0.0 0.0 37.0 2.9 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 54.5 6.6 53.8 0.0 0.0 RETREG2 "C2orf17, FAM134A, MAG-2, MGC3035" ENSG00000144567 "Reticulophagy regulator family member 2" Q8NC44 2 219176225-219185475 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 42.1;Collecting duct cells: 46.0;Ductal cells: 43.8;Exocrine glandular cells: 48.3;Pancreatic endocrine cells: 40.4;Proximal tubular cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011170, HPA011844, HPA075910" Approved Approved Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 43: Testis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA011170: AB_1845713, HPA011844: AB_2668544, HPA075910: " "unprognostic (2.63e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (7.95e-4)" "unprognostic (1.03e-1)" "unprognostic (2.88e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (1.49e-4)" "unprognostic (8.74e-2)" "unprognostic (9.61e-2)" "unprognostic (1.34e-2)" "unprognostic (4.37e-2)" "unprognostic (2.36e-1)" "unprognostic (4.29e-3)" "unprognostic (4.45e-2)" "unprognostic (4.47e-2)" "unprognostic (1.53e-2)" "unprognostic (3.70e-2)" 34.4 47.6 73.6 26.5 74.1 47.4 34.1 73.2 90.1 42.7 66.1 41.3 31.7 35.1 45.9 38.5 38.4 32.1 24.6 74.9 76.6 51.8 57.2 29.7 34.3 77.4 77.3 51.9 52.4 76.6 43.7 28.3 77.2 36.9 38.5 50.6 39.8 29.7 24.9 45.0 36.7 33.9 76.5 38.2 42.9 104.0 78.8 34.3 44.6 27.7 34.6 37.7 35.9 78.0 34.6 36.2 30.5 46.5 113.2 47.7 32.5 41.4 71.3 49.4 42.7 36.3 58.1 28.1 40.4 78.5 101.4 43.3 37.1 37.1 54.1 39.5 31.0 37.5 51.2 61.1 64.7 41.1 49.6 52.0 95.5 55.5 53.3 84.7 45.2 29.9 26.3 62.8 69.3 50.9 24.8 44.4 22.6 44.0 41.5 31.4 33.8 22.7 41.1 40.3 43.6 44.9 26.7 50.8 98.4 47.4 42.4 44.9 36.0 55.0 29.4 78.6 31.5 63.4 39.3 31.5 57.5 40.3 31.0 12.5 6.3 6.3 9.3 8.3 8.3 8.3 7.4 9.5 4.3 5.7 6.6 8.8 23.5 5.2 8.1 6.6 9.6 3.6 73.6 74.1 73.2 90.1 74.9 76.6 77.4 77.3 77.2 76.5 78.8 78.0 22.4 16.0 13.7 0.0 7.9 0.0 0.0 0.0 0.0 0.0 42.1 32.0 0.0 0.0 6.2 46.0 0.0 31.1 21.1 0.0 21.5 43.8 0.0 21.4 19.3 8.6 0.0 0.0 0.0 48.3 37.2 11.9 0.0 30.5 5.1 29.2 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 11.4 0.0 0.0 0.0 0.0 40.4 0.0 0.0 5.7 0.0 0.0 42.3 2.2 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 30.1 8.2 24.2 0.0 0.0 RETREG3 "DKFZp686B1036, FAM134C, FLJ33806" ENSG00000141699 "Reticulophagy regulator family member 3" Q86VR2 17 42579513-42610623 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 29.8;Collecting duct cells: 31.3;Pancreatic endocrine cells: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016492 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear membrane" Cytosol "HPA016492: AB_1853027" "unprognostic (6.79e-2)" "unprognostic (1.29e-2)" "unprognostic (2.78e-1)" "prognostic favorable (1.61e-4)" "unprognostic (5.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.53e-2)" "unprognostic (2.21e-1)" "unprognostic (2.61e-1)" "unprognostic (2.58e-2)" "unprognostic (1.00e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.24e-1)" "unprognostic (5.68e-1)" "unprognostic (9.64e-3)" "unprognostic (5.43e-2)" 16.2 21.7 17.3 13.2 16.6 6.9 16.9 16.4 18.9 23.0 18.7 19.0 14.2 18.5 21.3 29.2 16.8 10.9 16.2 17.0 17.4 19.5 33.4 17.4 19.5 16.9 18.0 19.6 39.9 18.9 20.4 20.9 17.7 25.5 16.8 31.4 23.2 14.0 22.4 33.9 20.7 15.1 16.8 30.1 22.8 38.7 19.1 20.6 16.3 16.4 21.6 19.4 23.1 15.0 12.0 36.6 15.8 25.8 39.6 21.9 22.5 16.9 22.7 19.6 22.9 17.5 25.3 26.3 23.1 27.5 20.1 45.9 20.5 25.3 18.9 28.2 19.3 10.7 22.2 31.0 27.2 18.6 26.5 33.6 34.2 21.5 21.8 21.7 21.3 19.0 22.3 25.4 15.7 20.7 27.5 26.9 10.0 22.5 9.0 14.7 24.2 27.2 22.5 38.2 28.2 19.3 18.1 14.6 26.1 28.9 41.5 14.2 27.2 21.0 12.8 21.1 16.2 43.4 55.3 22.7 19.3 11.6 16.2 54.9 16.2 36.4 44.5 19.2 39.1 23.7 36.5 42.9 15.1 24.8 35.1 40.4 13.8 28.2 24.1 15.0 57.0 36.4 17.3 16.6 16.4 18.9 17.0 17.4 16.9 18.0 17.7 16.8 19.1 15.0 16.7 25.6 29.8 0.0 8.8 0.0 0.0 0.0 0.0 0.0 21.7 18.3 0.0 0.0 6.2 31.3 0.0 22.4 24.7 0.0 7.9 16.4 0.0 14.5 16.7 7.4 0.0 0.0 0.0 25.4 16.0 7.4 0.0 20.0 7.6 26.8 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 7.2 0.0 0.0 0.0 0.0 33.8 0.0 0.0 8.8 0.0 0.0 13.4 5.1 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 20.4 8.1 17.3 0.0 0.0 REX1BD "C19orf60, FLJ20850, FLJ30108, FLJ34606, FLJ37391" ENSG00000006015 "Required for excision 1-B domain containing" Q96EN9 19 18588685-18592337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 154.6;Extravillous trophoblasts: 147.6;Hofbauer cells: 258.2;Proximal tubular cells: 222.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 64.5;PC-3: 98.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043414 Approved Approved Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA043414: AB_10797141" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (6.78e-3)" "unprognostic (1.22e-1)" "unprognostic (4.87e-3)" "unprognostic (2.52e-2)" "unprognostic (1.45e-1)" "unprognostic (4.60e-1)" "unprognostic (3.10e-1)" "unprognostic (5.50e-3)" "unprognostic (3.24e-2)" "unprognostic (3.19e-2)" "unprognostic (4.02e-2)" "unprognostic (9.27e-2)" "unprognostic (1.48e-1)" "prognostic favorable (8.47e-4)" 42.9 40.7 25.5 5.0 23.8 8.1 41.3 21.7 45.2 40.3 11.9 39.3 6.7 39.6 0.5 31.6 34.0 1.9 76.5 24.3 25.3 48.3 63.5 33.9 2.4 25.9 22.5 38.9 52.8 4.3 32.3 3.6 24.2 40.0 1.0 0.6 33.8 6.1 106.4 42.8 33.8 2.4 22.7 47.6 39.0 10.8 26.3 3.9 27.6 9.2 2.2 39.1 38.1 24.9 18.2 20.6 2.0 3.8 2.6 3.1 64.5 19.2 3.0 4.2 4.9 3.8 21.8 18.7 58.4 3.2 1.7 12.9 0.9 4.6 1.1 19.5 47.1 12.1 7.5 9.8 3.7 11.7 28.7 5.2 5.2 2.2 1.1 1.8 5.4 8.4 16.8 6.8 2.2 26.3 19.9 18.6 29.3 9.5 98.5 21.4 5.5 47.2 7.4 15.0 9.5 34.6 9.1 10.8 25.0 0.8 5.2 7.5 18.5 2.4 18.8 25.5 10.7 52.3 17.3 12.7 18.0 18.9 9.7 100.5 150.9 152.5 148.6 140.1 153.1 126.4 151.4 134.5 146.9 91.6 135.4 128.6 89.4 101.3 132.4 125.8 134.6 143.6 25.5 23.8 21.7 45.2 24.3 25.3 25.9 22.5 24.2 22.7 26.3 24.9 126.2 28.9 41.2 0.0 38.7 0.0 0.0 0.0 0.0 0.0 100.0 136.5 0.0 0.0 21.1 77.3 0.0 127.7 84.0 0.0 154.6 72.9 0.0 52.1 67.8 39.7 0.0 0.0 0.0 116.7 147.6 53.3 0.0 63.7 41.6 122.5 0.0 0.0 258.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 0.0 0.0 58.4 0.0 0.0 0.0 0.0 74.7 0.0 0.0 25.9 0.0 0.0 222.4 19.7 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 66.5 50.9 93.6 0.0 0.0 RGCC "bA157L14.2, C13orf15, RGC-32, RGC32" ENSG00000102760 "Regulator of cell cycle" Q9H4X1 13 41457550-41470871 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 415.4;lung: 694.9" "Cell type enhanced" "Detected in many" "Adipocytes: 1286.2;Basal prostatic cells: 676.2;Langerhans cells: 590.1;Prostatic glandular cells: 1415.5;T-cells: 532.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 159.9;T-reg: 90.9" "Lineage enriched" "Detected in many" 15 "T-cells: 159.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.5;BJ hTERT+: 316.0;Daudi: 105.1;U-698: 111.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035638, HPA063701" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" No No 910000 "Cluster 20: T-cells - T-cell receptor" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA035638: AB_10670152, HPA063701: AB_2685096" "unprognostic (1.39e-3)" "unprognostic (4.61e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.28e-1)" "unprognostic (4.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-2)" "unprognostic (3.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-3)" 197.6 21.5 186.3 27.7 226.9 415.4 132.6 218.8 236.7 36.1 148.2 34.7 16.9 43.6 7.6 18.6 31.1 42.2 145.9 195.8 196.6 56.9 25.0 694.9 38.1 209.1 204.8 9.1 41.3 48.1 35.3 150.7 205.3 61.5 9.2 5.7 111.5 19.0 47.3 58.0 29.1 33.5 186.7 37.0 37.8 24.8 198.2 70.5 144.0 61.8 21.0 47.5 39.6 241.0 1.1 0.5 34.9 0.0 6.7 57.5 1.4 0.8 316.0 0.2 1.2 44.8 0.7 105.1 0.9 4.0 0.1 1.0 1.2 2.1 0.4 11.1 5.1 0.0 7.9 3.5 3.3 3.7 1.2 4.5 6.7 1.2 43.1 0.6 36.1 24.0 8.3 0.1 1.0 0.3 24.0 2.3 0.5 4.7 0.8 0.1 0.0 0.1 0.3 0.0 1.3 0.4 0.3 0.0 0.7 3.0 0.9 20.1 24.6 0.2 3.8 2.2 0.4 0.2 0.1 111.9 0.3 2.4 0.8 0.0 0.8 0.1 5.6 0.5 5.6 5.3 46.5 14.7 6.1 10.7 159.9 35.0 0.6 0.4 0.1 1.8 90.9 10.2 186.3 226.9 218.8 236.7 195.8 196.6 209.1 204.8 205.3 186.7 198.2 241.0 1286.2 246.8 39.8 57.5 131.8 86.5 676.2 15.2 14.2 1.0 269.9 314.7 25.8 1.5 37.5 3.7 2.1 6.4 249.2 3.0 35.2 0.6 42.3 103.0 47.2 474.6 84.8 322.7 2.5 0.0 9.3 205.1 65.2 69.0 48.9 0.3 31.8 2.5 349.1 0.0 1.2 22.1 14.2 32.0 590.1 13.2 8.1 315.9 193.9 36.5 6.4 1.5 4.1 51.8 115.3 0.3 4.5 2.2 371.2 1415.5 0.1 0.8 33.7 3.1 124.9 45.4 116.0 155.3 5.0 11.2 65.1 11.1 532.4 43.8 7.8 159.7 RIOK2 FLJ11159 ENSG00000058729 "RIO kinase 2" Q9BVS4 5 97160867-97183247 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005681 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 54: Non-specific - Microtubule organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "Plasma membrane" "HPA005681: AB_1856286" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-2)" "unprognostic (8.04e-2)" "unprognostic (1.38e-1)" "unprognostic (4.51e-2)" "unprognostic (2.71e-3)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.11e-1)" "unprognostic (8.76e-2)" "unprognostic (6.63e-2)" "unprognostic (1.26e-3)" "unprognostic (3.60e-1)" "unprognostic (9.98e-2)" "unprognostic (1.43e-2)" "unprognostic (1.39e-2)" 15.0 14.6 12.5 13.5 13.7 21.5 14.7 16.6 21.3 12.9 14.1 13.3 13.0 11.6 12.2 13.5 12.3 7.8 16.3 12.5 14.7 14.2 18.1 10.3 14.3 13.5 13.5 14.8 16.7 11.3 15.1 12.1 13.5 12.0 12.7 19.4 11.8 9.3 21.4 11.3 11.2 9.3 13.9 14.6 13.3 12.6 13.7 13.7 11.9 14.2 13.6 13.2 12.1 15.9 19.0 22.0 20.3 38.5 25.9 28.6 32.1 48.1 29.0 33.0 43.2 30.4 32.5 41.7 53.1 21.3 51.6 21.7 34.2 27.4 44.9 29.3 18.5 20.3 44.0 42.9 23.6 38.5 27.2 18.5 20.8 40.1 39.8 25.0 27.0 30.8 31.7 25.4 38.0 31.9 46.4 47.8 22.5 10.6 23.9 51.9 38.3 61.9 25.7 16.9 23.7 17.9 27.5 28.3 35.6 29.6 29.6 36.4 28.5 41.2 28.9 33.0 51.8 25.3 36.4 95.2 24.0 39.7 38.4 17.9 26.2 15.8 24.6 30.7 34.4 24.0 31.5 27.8 29.4 18.6 33.9 36.5 5.0 30.7 23.8 29.2 31.7 22.7 12.5 13.7 16.6 21.3 12.5 14.7 13.5 13.5 13.5 13.9 13.7 15.9 14.9 9.6 12.8 7.8 16.9 26.4 17.9 25.2 12.5 16.2 11.1 11.4 20.5 10.0 17.4 7.3 12.5 19.6 26.9 6.4 17.6 17.3 1.3 10.7 18.0 14.0 9.6 8.4 10.9 14.9 24.8 21.1 14.8 10.5 27.9 12.7 8.2 8.1 18.3 13.5 11.0 12.7 18.3 9.4 9.2 3.0 13.4 11.0 5.4 3.7 16.5 13.4 14.4 9.0 15.0 11.4 10.1 16.1 19.1 10.4 11.8 17.3 13.3 17.7 6.6 17.4 22.9 23.5 20.7 10.1 18.9 17.4 19.6 19.4 12.6 12.0 RIOX1 "C14orf169, FLJ21802, JMJD9, MAPJD, NO66" ENSG00000170468 "Ribosomal oxygenase 1" Q9H6W3 14 73490933-73493394 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 9.1;dendritic cells: 8.0;Extravillous trophoblasts: 6.9;Hofbauer cells: 8.2;monocytes: 7.2;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003730 Supported "Nucleoli rim" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "Nucleoli rim" "HPA003730: AB_2667040" "unprognostic (4.70e-3)" "unprognostic (1.94e-2)" "unprognostic (2.45e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-3)" "unprognostic (1.73e-1)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (6.51e-2)" "unprognostic (5.36e-2)" "unprognostic (1.35e-3)" "unprognostic (4.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.05e-1)" "unprognostic (1.67e-1)" "unprognostic (7.97e-3)" "unprognostic (8.62e-2)" 3.8 4.2 5.1 5.1 4.5 7.8 3.7 6.5 5.0 3.7 4.6 4.5 3.9 5.3 4.8 5.5 4.4 2.4 4.9 4.5 4.9 4.2 6.8 3.9 6.7 4.3 4.1 3.8 6.4 5.4 3.5 2.8 4.1 3.3 3.7 1.9 4.6 3.8 3.6 4.0 5.1 4.0 3.7 5.6 4.9 13.6 4.9 9.4 3.4 3.0 6.9 4.5 3.3 5.7 17.5 15.5 9.9 15.3 12.5 7.0 19.0 11.7 8.5 11.8 10.6 13.5 8.8 29.7 8.4 10.1 9.9 20.4 19.1 11.6 9.8 19.0 21.0 18.7 9.0 9.0 6.9 0.0 24.1 7.6 10.6 11.4 5.2 7.5 10.8 17.0 13.8 10.7 10.7 27.6 33.1 21.4 10.8 15.1 26.0 26.1 15.4 9.0 11.8 12.9 20.5 14.8 19.4 34.4 12.7 9.8 34.4 18.6 15.6 0.0 19.5 10.2 0.1 14.6 16.9 10.2 5.2 15.3 11.8 0.1 1.3 3.4 3.7 2.3 4.3 2.3 3.6 2.9 1.8 1.6 3.3 2.5 0.5 3.2 1.4 3.1 1.7 0.8 5.1 4.5 6.5 5.0 4.5 4.9 4.3 4.1 4.1 3.7 4.9 5.7 2.9 3.2 1.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 5.4 3.2 0.0 0.0 3.1 5.5 0.0 9.1 8.0 0.0 5.9 3.8 0.0 4.2 4.0 2.1 0.0 0.0 0.0 5.7 6.9 1.5 0.0 4.7 2.5 5.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.4 3.4 3.5 0.0 0.0 RIOX2 "FLJ14393, JMJD10, mdig, MINA, MINA53, NO52" ENSG00000170854 "Ribosomal oxygenase 2" Q8IUF8 3 97941818-97972457 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 33.7;Distal tubular cells: 49.0;Endometrial ciliated cells: 25.7;Extravillous trophoblasts: 43.5;Syncytiotrophoblasts: 31.2;Theca cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007603, HPA008080, CAB013458" Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 8: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960" "prognostic unfavorable (4.41e-4)" "unprognostic (8.64e-2)" "unprognostic (1.59e-3)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.53e-3)" "unprognostic (1.64e-3)" "unprognostic (8.68e-2)" "unprognostic (9.68e-2)" "unprognostic (5.34e-2)" "unprognostic (1.56e-3)" "unprognostic (6.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (3.44e-3)" "unprognostic (1.76e-1)" 14.6 9.7 9.8 14.5 11.3 2.2 13.9 9.5 11.2 11.6 8.3 12.4 6.9 10.7 10.6 22.3 10.4 7.3 10.1 9.5 12.3 14.4 14.3 11.0 14.2 12.4 12.4 10.4 18.2 10.8 10.2 15.6 12.0 10.4 12.3 16.8 19.8 9.6 32.0 17.8 10.3 10.4 12.9 8.4 12.8 6.7 10.9 6.9 46.4 11.3 15.0 16.4 15.5 13.6 42.6 27.8 9.1 17.4 20.5 30.3 22.8 20.1 14.3 22.0 18.5 18.6 22.8 59.7 21.2 25.1 34.3 24.3 28.9 28.2 32.5 109.9 13.8 19.2 13.5 19.1 33.4 37.1 7.0 24.5 38.8 17.6 44.4 13.1 23.9 26.4 26.2 23.3 22.1 11.5 29.7 14.5 19.9 47.3 34.4 0.0 32.2 58.7 21.4 24.1 49.6 17.6 25.7 28.7 34.4 10.1 24.7 15.3 16.3 22.9 24.0 13.7 39.9 37.7 18.3 55.5 29.1 37.8 23.8 1.9 13.2 0.7 10.3 11.9 15.8 15.9 14.9 12.0 16.9 13.3 15.0 12.5 0.8 10.8 15.8 26.0 15.2 10.5 9.8 11.3 9.5 11.2 9.5 12.3 12.4 12.4 12.0 12.9 10.9 13.6 18.3 9.6 14.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 14.9 11.2 0.0 0.0 10.5 7.3 0.0 33.7 5.7 0.0 49.0 16.4 0.0 25.7 14.9 5.8 0.0 0.0 0.0 13.2 43.5 7.3 0.0 12.6 2.5 20.2 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.5 0.0 0.0 11.6 13.8 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 31.2 2.2 24.8 0.0 0.0 RIPK1 RIP ENSG00000137275 "Receptor interacting serine/threonine kinase 1" Q13546 6 3063824-3115187 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Inflammatory response, Necrosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010302, HPA015257" Supported Approved "Plasma membrane,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 18: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "CAB010302: AB_2178118, HPA015257: AB_1856294" "unprognostic (1.24e-1)" "unprognostic (6.83e-2)" "unprognostic (1.87e-1)" "unprognostic (7.75e-2)" "unprognostic (6.08e-2)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (1.96e-1)" "unprognostic (9.46e-2)" "unprognostic (1.46e-1)" "unprognostic (5.00e-2)" "unprognostic (3.29e-1)" "unprognostic (9.65e-3)" "unprognostic (3.44e-1)" "unprognostic (9.01e-2)" "unprognostic (1.38e-2)" "prognostic favorable (6.71e-4)" 18.5 12.0 1.9 9.3 1.9 0.5 16.2 1.8 3.8 12.8 2.4 17.5 12.3 14.5 5.3 17.6 12.8 10.6 11.8 1.8 1.9 13.7 23.6 13.5 10.1 2.2 1.9 8.5 17.4 12.2 12.3 10.9 2.0 13.7 13.0 2.4 16.4 8.9 11.7 20.7 19.9 11.9 2.0 19.4 16.5 5.3 2.0 11.9 14.4 5.0 13.0 15.5 13.7 1.9 14.4 9.8 12.9 12.4 27.6 19.2 5.5 21.4 30.8 22.8 26.7 12.4 8.0 13.8 20.9 30.1 23.2 14.3 17.9 17.2 24.3 27.8 9.4 16.7 4.5 6.9 17.2 15.6 20.1 24.8 15.1 20.4 15.3 17.6 20.6 6.2 19.4 4.6 22.0 17.8 10.7 7.7 8.8 17.4 12.7 11.8 10.9 14.5 17.3 27.2 11.3 12.2 14.7 7.8 22.4 26.0 15.2 8.7 25.1 20.6 12.1 8.2 16.4 9.8 15.3 13.5 8.9 7.0 27.7 0.1 0.4 0.9 0.6 0.9 1.0 0.3 0.9 1.7 1.0 1.2 0.7 0.7 0.0 1.5 0.5 0.5 1.7 0.8 1.9 1.9 1.8 3.8 1.8 1.9 2.2 1.9 2.0 2.0 2.0 1.9 28.6 6.4 12.0 17.3 14.7 11.0 10.3 6.6 16.5 4.4 14.7 17.8 8.6 17.2 16.7 9.2 12.5 8.9 21.9 27.1 5.9 9.4 2.0 10.5 14.0 16.7 6.6 7.2 23.1 12.9 7.7 18.3 27.0 13.4 10.8 8.7 10.0 14.6 11.6 5.0 26.7 17.7 4.1 6.7 11.1 0.8 6.8 15.3 3.6 11.2 13.8 6.6 12.3 14.6 16.2 13.8 11.7 6.0 22.3 11.3 12.7 8.7 17.4 21.4 19.7 32.5 17.9 1.2 2.8 20.5 9.9 11.9 20.8 10.6 11.3 14.5 RIPOR1 "FAM65A, FLJ13725" ENSG00000039523 "RHO family interacting cell polarization regulator 1" Q6ZS17 16 67518418-67546788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 49.2;Endothelial cells: 23.6;Hofbauer cells: 30.0;Pancreatic endocrine cells: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 11.2;eosinophil: 9.3;intermediate monocyte: 15.6;memory B-cell: 15.8;myeloid DC: 10.2;naive B-cell: 9.4;neutrophil: 6.6;non-classical monocyte: 15.1;plasmacytoid DC: 14.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005923 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Cytosol" "HPA005923: AB_1078809" "unprognostic (7.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.56e-3)" "unprognostic (3.71e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.38e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.82e-8)" "unprognostic (8.51e-2)" "unprognostic (3.52e-2)" "unprognostic (1.19e-1)" "unprognostic (7.46e-2)" 44.4 28.1 27.6 23.4 30.6 27.2 37.7 26.4 38.6 39.9 7.5 36.0 8.8 45.2 6.0 18.5 36.2 21.5 53.6 33.6 16.3 67.6 16.7 55.8 20.8 26.6 17.1 33.2 30.1 20.6 26.5 29.8 25.4 30.6 7.4 43.8 22.8 20.2 34.9 21.4 32.7 25.2 12.3 61.2 25.9 18.6 21.5 10.8 36.4 22.3 17.5 37.1 30.4 18.6 44.0 36.6 16.1 25.3 40.0 35.7 35.7 45.7 44.9 51.6 43.0 75.7 31.5 6.0 62.4 78.8 26.0 24.4 32.7 41.3 33.2 19.3 17.0 57.9 53.6 17.4 44.7 4.6 28.0 35.5 18.8 69.7 47.1 36.8 55.2 10.2 6.5 6.4 38.7 47.7 13.8 14.4 4.4 8.5 29.1 46.8 29.0 31.2 39.0 22.1 12.1 31.9 85.1 13.8 28.6 15.9 30.2 10.7 96.8 58.3 34.2 49.8 32.2 9.0 6.8 17.8 38.8 11.1 31.7 0.1 11.2 9.3 1.2 15.6 1.8 15.8 1.0 0.5 10.2 9.4 0.7 0.7 6.6 1.7 15.1 14.4 0.8 6.0 27.6 30.6 26.4 38.6 33.6 16.3 26.6 17.1 25.4 12.3 21.5 18.6 49.2 16.0 16.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 12.1 8.8 0.0 0.0 1.8 7.3 0.0 0.8 3.7 0.0 0.0 15.8 0.0 9.3 17.9 23.6 0.0 0.0 0.0 12.5 1.3 6.9 0.0 18.5 10.1 7.9 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 37.0 0.0 0.0 2.3 0.0 0.0 5.8 2.2 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 2.1 2.3 16.6 0.0 0.0 RIPOR2 "C6orf32, DIFF48, FAM65B, KIAA0386, MYONAP" ENSG00000111913 "RHO family interacting cell polarization regulator 2" Q9Y4F9 6 24804282-25042170 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell adhesion, Chemotaxis, Differentiation, Hearing, Myogenesis" "Developmental protein, Signal transduction inhibitor" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 82.6" "Cell type enhanced" "Detected in many" "B-cells: 57.4;dendritic cells: 98.4;Respiratory ciliated cells: 83.1;Syncytiotrophoblasts: 82.8;T-cells: 38.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "neutrophil: 951.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 951.9" "Cell line enhanced" "Detected in many" "AF22: 30.9;Daudi: 73.5;fHDF/TERT166: 73.2;U-266/70: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (4.05e-3)" "unprognostic (1.34e-3)" "unprognostic (3.55e-2)" "unprognostic (1.91e-2)" "unprognostic (1.47e-2)" "unprognostic (1.75e-2)" "unprognostic (5.89e-4)" "unprognostic (2.62e-2)" "unprognostic (1.54e-1)" "unprognostic (4.40e-3)" "unprognostic (1.64e-1)" "unprognostic (1.74e-2)" "unprognostic (8.55e-2)" "unprognostic (3.33e-2)" "unprognostic (2.30e-2)" "unprognostic (9.79e-2)" "unprognostic (1.14e-1)" 13.1 3.7 15.9 49.1 22.4 27.6 6.1 0.4 16.7 13.5 2.5 3.7 2.7 46.3 2.6 3.2 14.8 8.6 3.1 14.0 9.1 3.0 4.3 20.7 82.6 4.5 9.5 2.7 2.5 0.9 13.0 6.0 3.2 6.1 3.8 3.7 8.2 4.5 19.5 5.2 17.5 17.7 4.6 55.9 6.7 6.4 9.2 41.0 2.9 7.6 71.0 10.2 7.4 4.9 1.1 0.1 30.9 0.6 0.3 0.2 11.3 8.8 15.5 3.7 5.4 0.4 0.5 73.5 2.0 73.2 0.5 0.9 0.0 0.0 0.7 7.3 0.4 17.8 1.2 0.3 0.6 0.4 1.3 3.2 0.3 0.0 0.4 0.2 0.0 3.2 1.0 12.2 0.2 0.2 17.0 0.8 2.3 1.2 2.1 18.5 3.0 0.7 0.1 0.4 1.5 0.3 0.6 0.3 5.7 10.3 0.3 0.5 0.3 0.7 3.3 0.8 0.9 25.4 0.6 2.4 0.8 1.0 5.1 414.0 100.8 334.5 128.6 127.3 134.8 188.3 131.8 136.6 68.7 176.3 171.6 136.8 951.9 125.7 173.8 57.7 124.9 168.1 15.9 22.4 0.4 16.7 14.0 9.1 4.5 9.5 3.2 4.6 9.2 4.9 7.3 3.2 14.6 0.0 57.4 0.0 0.0 0.0 0.0 0.0 3.3 1.7 0.0 0.0 18.6 5.5 0.0 4.1 98.4 0.0 1.9 0.1 0.0 16.4 10.5 2.8 0.0 0.0 0.0 0.2 1.9 2.7 0.0 10.7 12.6 0.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 15.6 0.0 0.0 3.1 83.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 82.8 38.0 1.7 0.0 0.0 RMC1 "C18orf8, HsT2591, MIC1, WDR98" ENSG00000141452 "Regulator of MON1-CCZ1" Q96DM3 18 23503470-23531822 "Cancer-related genes, Predicted intracellular proteins" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 14.5;Proximal tubular cells: 19.9;Syncytiotrophoblasts: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043589 Uncertain Uncertain Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA043589: AB_2678568" "unprognostic (6.45e-2)" "unprognostic (6.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.51e-3)" "unprognostic (8.16e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (4.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.73e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" "unprognostic (1.25e-1)" "unprognostic (3.04e-2)" "unprognostic (4.13e-2)" 12.8 9.8 4.9 11.2 6.0 27.4 11.2 5.5 7.3 10.9 8.5 11.1 16.7 11.2 9.3 11.7 10.6 10.3 8.8 6.2 6.6 13.0 19.1 14.4 21.3 5.3 4.8 9.6 11.7 11.4 16.6 8.5 5.7 9.3 10.9 25.4 12.2 10.6 13.4 12.5 17.1 10.6 5.1 15.6 14.6 17.2 5.3 15.8 9.8 7.4 19.1 14.8 10.5 7.2 13.9 13.9 10.3 18.1 23.0 16.6 13.5 21.5 22.8 28.2 33.6 12.9 8.1 20.8 17.5 18.7 40.9 26.6 27.1 12.0 24.8 21.6 15.4 10.2 8.7 13.1 30.1 27.7 36.0 14.9 18.6 35.2 19.8 16.2 16.9 17.7 16.7 21.9 18.8 18.1 23.8 13.0 5.6 19.7 21.4 18.3 15.4 20.4 14.7 13.0 13.8 17.9 28.1 13.7 18.2 14.2 10.5 17.6 16.2 23.6 6.0 9.8 18.6 34.1 27.4 23.6 24.5 18.7 18.4 50.5 16.4 37.7 23.8 31.0 24.5 32.5 20.7 23.3 20.0 29.5 14.0 17.2 15.2 32.9 44.5 44.5 30.5 18.7 4.9 6.0 5.5 7.3 6.2 6.6 5.3 4.8 5.7 5.1 5.3 7.2 9.1 9.6 13.7 0.0 4.4 0.0 0.0 0.0 0.0 0.0 7.6 5.8 0.0 0.0 3.7 7.3 0.0 10.7 13.4 0.0 5.9 11.6 0.0 11.4 5.9 2.9 0.0 0.0 0.0 12.1 7.6 3.4 0.0 14.5 3.8 8.7 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 8.8 0.0 0.0 0.0 0.0 11.3 0.0 0.0 1.9 0.0 0.0 19.9 1.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 19.2 6.3 8.3 0.0 0.0 RNF227 LINC02581 ENSG00000179859 "Ring finger protein 227" A6NIN4 17 7913339-7916289 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "skin 1: 64.3" "Cell type enhanced" "Detected in some" "Adipocytes: 3.9;Breast glandular cells: 3.9;Breast myoepithelial cells: 4.1;Endometrial ciliated cells: 5.0;Endometrial stromal cells: 8.9;Glandular and luminal cells: 5.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 17.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 17.5" "Cell line enhanced" "Detected in many" "SiHa: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 61: Skin - Cornification" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "unprognostic (8.85e-3)" "prognostic favorable (8.89e-5)" "unprognostic (1.50e-2)" "unprognostic (4.88e-2)" "unprognostic (3.72e-3)" "unprognostic (1.44e-2)" "unprognostic (2.02e-5)" "unprognostic (9.48e-2)" "unprognostic (9.22e-3)" "unprognostic (2.94e-2)" "unprognostic (3.11e-2)" "unprognostic (3.31e-2)" "unprognostic (7.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.18e-1)" "unprognostic (3.30e-2)" "unprognostic (1.80e-2)" 5.8 3.2 5.3 1.9 5.5 1.7 4.8 7.0 6.4 3.4 4.1 2.9 3.5 6.2 4.6 4.5 5.0 1.9 1.8 5.5 5.5 2.6 1.1 3.5 2.5 4.9 5.0 5.1 3.5 4.7 3.9 2.2 4.7 2.9 2.0 11.9 3.1 2.1 1.4 64.3 2.9 2.6 4.7 3.0 2.5 3.3 5.4 2.3 1.7 1.6 2.7 2.2 4.1 5.2 7.0 1.4 2.6 2.6 2.0 1.8 2.2 6.5 2.6 1.8 2.0 4.1 2.0 1.3 3.8 2.6 1.6 5.0 1.5 3.3 3.2 0.8 1.7 1.8 5.1 0.3 3.8 3.8 3.3 2.3 9.4 2.9 3.1 0.9 0.4 6.9 2.1 1.3 4.1 0.8 5.1 4.8 1.8 2.1 1.0 2.4 6.4 1.5 2.6 0.9 1.1 3.6 14.1 0.6 2.8 0.8 1.7 2.8 0.4 0.1 3.6 3.1 1.3 1.8 0.6 1.9 3.8 4.2 4.9 17.5 1.3 0.4 1.7 0.9 2.2 1.9 1.9 2.2 2.0 1.3 3.5 2.4 0.8 2.7 0.8 1.3 1.5 1.5 5.3 5.5 7.0 6.4 5.5 5.5 4.9 5.0 4.7 4.7 5.4 5.2 3.9 3.2 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 3.9 4.1 0.0 0.0 0.0 0.0 0.0 1.3 2.7 0.0 1.9 1.0 0.0 5.0 8.9 1.1 0.0 0.0 0.0 0.2 0.5 1.9 0.0 5.5 0.0 2.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.8 2.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.7 0.7 2.2 0.0 0.0 RRP36 "C6orf153, dJ20C7.4" ENSG00000124541 "Ribosomal RNA processing 36" Q96EU6 6 43021623-43034156 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029904, HPA029905" Uncertain Enhanced Nucleoplasm,Nucleoli Yes No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA029904: AB_10611817, HPA029905: AB_2673244" "unprognostic (1.76e-1)" "unprognostic (4.47e-1)" "unprognostic (3.78e-2)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.61e-1)" "unprognostic (6.83e-2)" "unprognostic (1.32e-3)" "unprognostic (1.39e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.53e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" 30.0 34.6 19.4 27.4 19.7 28.7 28.7 21.5 23.2 26.0 19.8 29.0 20.8 25.5 22.9 37.8 23.2 19.0 30.1 20.3 22.3 35.1 37.3 25.5 32.3 21.3 20.9 18.4 35.8 34.7 31.9 24.2 22.0 28.5 24.3 16.6 27.1 25.0 51.3 34.3 25.9 29.7 20.8 33.3 30.6 17.7 21.0 31.1 23.4 34.8 35.2 30.0 26.4 20.8 141.5 77.9 75.8 111.3 79.7 74.0 63.6 108.9 97.7 136.1 132.6 141.9 59.8 64.7 86.3 113.8 100.1 73.5 127.7 131.8 149.3 82.5 129.9 104.1 82.7 153.2 92.3 87.5 77.7 75.6 79.0 163.0 69.1 48.7 112.2 57.6 128.2 68.4 127.8 148.1 106.0 95.6 84.3 249.7 79.6 98.7 74.7 74.9 83.2 130.5 96.4 84.5 80.1 72.8 129.1 70.6 100.1 106.0 91.2 125.1 95.1 83.4 173.8 63.8 103.9 172.0 54.5 108.6 119.1 2.4 2.2 2.0 3.3 3.0 2.7 4.5 2.4 4.2 2.3 1.4 2.2 4.5 2.5 2.0 2.4 6.0 1.4 0.8 19.4 19.7 21.5 23.2 20.3 22.3 21.3 20.9 22.0 20.8 21.0 20.8 26.8 0.0 15.6 4.6 14.7 13.4 11.2 13.5 5.7 16.1 19.7 22.1 15.1 20.0 14.1 20.2 16.7 29.3 33.1 12.7 13.7 33.7 10.1 18.3 26.5 18.5 13.9 4.6 8.1 44.8 41.8 18.0 12.8 18.0 6.3 27.3 21.0 36.0 29.1 18.5 8.1 12.6 12.2 16.6 11.7 23.0 11.8 20.0 14.2 2.8 26.1 36.9 20.6 6.6 9.6 44.0 7.4 18.8 18.8 17.7 12.4 20.5 10.0 20.3 6.6 19.3 24.7 9.5 10.6 16.5 18.6 33.7 16.5 61.5 14.2 14.3 RSRP1 "C1orf63, DJ465N24.2.1" ENSG00000117616 "Arginine and serine rich protein 1" Q9BUV0 1 25242249-25338213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058992, HPA067651" Uncertain Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA058992: AB_2683873, HPA067651: AB_2685879" "unprognostic (1.03e-1)" "unprognostic (4.52e-2)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (3.65e-2)" "unprognostic (3.81e-2)" "unprognostic (5.77e-3)" "unprognostic (3.67e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.02e-2)" "unprognostic (7.51e-3)" "unprognostic (1.73e-3)" "unprognostic (4.84e-2)" "unprognostic (1.87e-1)" "unprognostic (7.87e-2)" "prognostic favorable (2.91e-5)" 31.1 31.2 19.6 3.5 27.1 12.8 18.6 25.7 29.4 54.5 25.8 34.0 4.7 29.6 4.4 39.3 38.9 16.3 42.9 20.7 18.1 53.5 35.1 42.4 5.8 37.3 23.6 47.8 19.6 0.9 59.9 8.8 26.0 56.3 2.0 8.5 39.1 18.2 18.8 22.4 26.0 2.1 22.9 37.6 27.2 24.4 25.0 24.4 41.3 21.2 11.4 33.4 52.7 34.8 7.7 16.8 2.2 2.4 18.3 2.7 6.6 7.1 1.3 8.2 9.2 13.7 8.5 6.1 23.0 1.0 3.0 11.4 14.7 1.3 2.8 14.4 8.9 21.0 20.5 17.9 3.9 9.7 11.3 1.8 8.9 3.8 0.0 3.2 4.8 6.3 17.7 49.9 2.3 7.6 2.2 18.5 9.1 17.1 9.7 9.2 6.9 9.1 6.1 0.3 8.9 1.9 4.7 4.7 5.1 1.4 3.9 10.6 10.7 5.7 5.6 5.0 4.1 29.1 24.0 6.3 4.3 24.1 4.5 149.6 57.0 87.4 25.5 38.0 26.7 24.8 26.8 21.6 60.4 23.5 25.3 17.3 130.4 36.6 54.5 37.9 37.6 30.9 19.6 27.1 25.7 29.4 20.7 18.1 37.3 23.6 26.0 22.9 25.0 34.8 351.6 60.9 77.0 121.1 332.7 0.0 229.7 0.0 338.6 86.9 200.1 217.0 47.7 45.8 37.8 93.8 141.8 80.3 456.5 385.9 21.5 43.0 29.8 115.2 142.0 150.0 130.6 140.9 172.6 21.1 82.8 169.0 183.0 146.4 217.1 140.1 71.4 19.6 61.9 84.1 125.4 200.1 0.0 72.2 0.0 16.5 140.1 197.5 0.0 140.5 160.6 69.3 200.8 93.0 278.8 43.6 340.3 90.3 248.4 130.3 397.9 15.2 59.0 138.8 124.9 214.1 141.8 107.6 102.8 283.0 0.0 121.2 346.7 123.8 159.6 196.8 RTF2 "C20orf43, CDAO5, HSPC164, RTFDC1" ENSG00000022277 "Replication termination factor 2" Q9BY42 20 56468585-56519449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 162.8;Distal tubular cells: 156.5;Proximal tubular cells: 149.9;Syncytiotrophoblasts: 182.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053986 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA053986: AB_2682333" "unprognostic (1.65e-1)" "unprognostic (1.94e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.54e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (8.90e-2)" "unprognostic (4.02e-3)" "unprognostic (1.16e-1)" "unprognostic (8.98e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "unprognostic (4.58e-1)" "unprognostic (8.48e-3)" 73.8 72.7 101.4 65.9 113.3 128.5 65.7 117.4 106.7 66.2 88.3 79.2 60.5 70.6 48.9 64.2 64.8 49.2 85.9 97.2 106.7 68.7 63.8 58.1 70.7 113.7 109.6 71.1 59.3 63.0 67.8 55.4 115.0 58.2 54.2 61.3 51.2 62.2 181.4 69.6 60.8 65.4 111.1 67.8 59.3 57.0 108.4 79.2 60.6 111.1 76.2 73.8 57.5 123.5 132.8 93.3 91.1 91.3 111.1 97.9 85.9 198.5 148.1 280.0 158.5 192.6 125.2 110.4 232.0 161.5 139.7 144.9 92.4 153.8 190.7 52.6 72.9 138.9 97.4 150.8 127.9 201.3 186.6 88.1 156.5 126.0 106.9 119.7 121.3 118.1 109.6 114.3 139.1 253.9 171.6 173.0 68.8 185.2 175.9 116.3 247.2 149.5 119.1 86.1 95.1 103.1 208.2 355.0 199.0 66.7 165.0 191.7 131.5 242.2 156.0 133.0 165.1 94.6 116.1 156.9 190.7 134.7 135.1 309.4 205.4 562.3 125.6 192.8 106.2 115.7 106.4 122.5 223.6 134.0 119.7 110.6 580.4 197.4 200.5 189.6 152.2 254.1 101.4 113.3 117.4 106.7 97.2 106.7 113.7 109.6 115.0 111.1 108.4 123.5 87.2 51.3 61.2 0.0 20.9 0.0 0.0 0.0 0.0 0.0 54.1 56.9 0.0 0.0 34.0 66.2 0.0 162.8 50.9 0.0 156.5 104.5 0.0 47.8 51.2 38.8 0.0 0.0 0.0 96.3 109.5 37.3 0.0 47.7 90.8 57.9 0.0 0.0 110.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 92.0 0.0 0.0 0.0 0.0 101.9 0.0 0.0 5.3 0.0 0.0 149.9 34.2 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 182.9 26.4 89.8 0.0 0.0 RTL10 "BOP, C22orf29, FLJ21125" ENSG00000215012 "Retrotransposon Gag like 10" Q7L3V2 22 19846138-19854896 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Cytotrophoblasts: 20.6;Distal tubular cells: 13.7;Extravillous trophoblasts: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 95.9" "HPA000721, HPA001419" Uncertain NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" "HPA000721: AB_1079000, HPA001419: AB_1078999" "unprognostic (1.23e-1)" "unprognostic (1.79e-1)" "unprognostic (3.70e-2)" "unprognostic (2.29e-2)" "unprognostic (4.72e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (8.04e-5)" "unprognostic (2.26e-2)" "unprognostic (2.36e-2)" "unprognostic (1.63e-2)" "unprognostic (1.38e-1)" "unprognostic (3.79e-2)" "unprognostic (6.67e-2)" "unprognostic (7.20e-3)" "unprognostic (3.34e-1)" "unprognostic (1.27e-1)" "unprognostic (7.55e-2)" 3.0 3.5 2.4 3.9 3.3 4.8 4.5 2.4 4.2 4.5 0.6 3.0 7.1 4.6 6.7 7.5 8.8 2.5 3.1 3.9 1.5 3.5 3.7 5.1 5.1 1.3 0.4 5.1 7.3 6.1 4.0 5.1 0.9 6.2 3.0 3.5 7.1 5.0 4.3 13.3 4.7 3.8 0.0 4.1 4.2 2.3 1.8 10.8 5.7 3.9 7.2 4.1 4.6 1.6 18.9 7.6 8.5 9.5 9.1 8.0 10.7 10.4 12.0 15.0 9.1 15.5 10.4 16.4 4.3 17.8 4.6 26.4 8.6 17.0 6.6 5.6 12.9 8.7 17.6 10.9 5.8 25.7 7.4 6.0 19.9 12.6 10.6 7.2 14.1 9.9 95.9 6.0 14.5 12.5 21.0 7.8 4.6 21.4 10.3 11.8 25.1 4.0 5.5 17.3 13.9 5.0 10.8 12.2 10.3 8.8 13.4 5.7 18.2 14.7 16.8 4.8 10.0 5.3 5.0 9.8 5.6 6.9 9.9 2.6 1.4 3.1 1.8 1.6 1.7 1.1 2.0 1.8 1.3 1.4 3.9 3.0 2.3 0.8 4.0 2.6 3.0 1.8 2.4 3.3 2.4 4.2 3.9 1.5 1.3 0.4 0.9 0.0 1.8 1.6 3.6 22.4 9.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 8.3 5.8 0.0 0.0 5.0 9.2 0.0 20.6 2.2 0.0 13.7 7.6 0.0 8.8 5.0 4.4 0.0 0.0 0.0 5.0 16.6 2.4 0.0 9.7 1.3 10.8 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.2 0.0 0.0 1.4 0.0 0.0 5.4 5.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 4.7 2.1 6.4 0.0 0.0 RTL5 "KIAA2001, Mar5, Mart5, RGAG4, SIRH8" ENSG00000242732 "Retrotransposon Gag like 5" Q5HYW3 X 72127110-72131901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 7.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.6;Breast myoepithelial cells: 5.0;Endometrial ciliated cells: 3.8;Endometrial stromal cells: 8.9;Theca cells: 7.0" "Cancer enhanced" "Detected in all" "thyroid cancer: 13.4" "Region enhanced" "Detected in many" "cerebellum: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.7;AN3-CA: 4.2;SCLC-21H: 5.0;SH-SY5Y: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003652 Approved Approved Nucleoplasm NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA003652: AB_1079805" "unprognostic (7.97e-2)" "unprognostic (1.31e-2)" "unprognostic (5.29e-3)" "unprognostic (2.98e-2)" "unprognostic (3.93e-2)" "unprognostic (3.64e-1)" "unprognostic (4.20e-1)" "prognostic favorable (7.30e-4)" "unprognostic (1.62e-1)" "unprognostic (2.82e-1)" "prognostic favorable (3.41e-4)" "unprognostic (4.23e-1)" "unprognostic (4.18e-3)" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" 1.3 1.3 1.0 0.3 1.0 0.2 1.2 3.4 0.8 2.3 1.8 2.2 0.4 2.6 2.0 0.5 2.2 1.1 0.8 0.5 1.2 1.4 0.8 1.4 0.3 0.1 0.0 2.8 0.6 1.1 7.2 1.0 0.2 1.5 0.4 0.7 0.8 1.3 0.3 0.4 1.0 1.2 0.0 0.8 1.9 1.4 1.2 0.1 3.8 0.4 0.1 1.7 1.5 0.1 0.0 0.1 3.7 4.2 0.9 1.1 0.2 1.4 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.3 0.6 0.0 0.8 0.1 0.7 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 7.0 0.2 0.0 0.0 1.5 0.1 0.0 0.4 0.5 0.4 0.9 0.0 0.1 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 3.4 0.8 0.5 1.2 0.1 0.0 0.2 0.0 1.2 0.1 2.9 3.2 3.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 5.0 0.0 0.0 1.8 0.0 0.0 0.1 2.7 0.0 1.9 0.1 0.0 3.8 8.9 0.6 0.0 0.0 0.0 0.0 0.4 2.0 0.0 2.3 2.5 0.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 2.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 1.1 7.0 0.0 0.0 RTL6 "dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3" ENSG00000188636 "Retrotransposon Gag like 6" Q6ICC9 22 44492583-44498233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 11.1;Collecting duct cells: 12.9;Ductal cells: 8.4;Endometrial stromal cells: 12.9;Granulosa cells: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005697 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" Cytosol "HPA005697: AB_1079244" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (1.57e-1)" "unprognostic (9.64e-3)" "unprognostic (5.40e-2)" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.57e-2)" "unprognostic (1.65e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" 10.6 12.1 21.3 7.2 19.2 3.2 8.9 15.1 18.9 11.2 8.3 12.5 8.8 15.7 12.1 8.2 16.6 11.0 15.3 20.1 17.4 9.3 3.2 9.4 6.3 18.8 20.0 19.2 11.0 17.8 8.7 5.1 17.1 9.8 9.1 9.6 7.2 13.6 15.5 3.4 8.4 16.9 18.8 7.5 9.7 11.2 21.9 14.2 10.2 18.0 4.8 10.4 5.4 17.2 13.8 18.9 23.9 31.9 18.3 14.8 6.3 17.9 21.1 24.6 19.2 6.3 8.0 0.0 10.9 33.5 18.5 11.8 16.3 17.7 15.1 6.5 31.8 0.0 35.8 0.0 22.6 1.8 8.7 16.2 16.8 22.5 17.3 33.4 22.3 21.6 7.8 0.1 16.9 24.3 44.4 4.1 14.7 15.1 20.0 12.1 12.7 0.0 21.1 15.8 25.6 30.0 29.2 14.0 18.1 11.5 14.0 19.3 23.1 19.2 25.7 25.7 14.5 8.3 3.5 0.0 28.5 4.5 29.2 0.0 0.7 0.0 1.8 0.3 1.9 0.0 1.0 1.5 0.5 0.0 0.4 1.0 0.0 0.4 0.4 0.0 0.2 1.1 21.3 19.2 15.1 18.9 20.1 17.4 18.8 20.0 17.1 18.8 21.9 17.2 5.8 0.0 5.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.1 6.5 0.0 0.0 2.5 12.9 0.0 2.9 4.8 0.0 0.0 8.4 0.0 7.4 12.9 4.0 0.0 0.0 0.0 6.5 2.7 3.5 0.0 8.1 0.0 13.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.0 0.0 0.0 1.7 0.0 0.0 5.7 7.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.2 1.8 5.2 0.0 0.0 RTL8A "CXX1b, DKFZP564B147, FAM127B, MAR8A, SIRH6" ENSG00000203950 "Retrotransposon Gag like 8A" Q9BWD3 X 135050932-135052196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 109.5;Ductal cells: 71.3;Pancreatic endocrine cells: 78.2;Proximal tubular cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 174.7" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "unprognostic (2.10e-2)" "prognostic favorable (5.35e-4)" "unprognostic (2.07e-3)" "prognostic unfavorable (2.83e-4)" "unprognostic (9.91e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (1.10e-5)" "unprognostic (2.16e-2)" "unprognostic (4.48e-1)" "prognostic favorable (2.71e-4)" "unprognostic (2.05e-2)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-1)" "unprognostic (2.51e-1)" "unprognostic (3.35e-2)" "unprognostic (1.57e-2)" 38.5 30.3 22.4 6.9 25.6 4.7 36.3 25.1 38.0 46.1 12.3 44.3 10.2 45.0 4.9 57.4 41.0 9.2 43.0 21.6 27.1 37.7 19.2 32.2 6.6 25.0 24.4 47.5 20.2 10.1 51.0 10.7 23.7 41.9 5.8 7.7 31.6 17.3 19.9 39.0 28.8 10.3 21.8 26.5 30.5 12.1 24.7 6.0 38.1 8.6 4.1 44.7 43.4 27.8 47.9 57.1 28.4 62.8 29.5 25.3 40.9 18.8 17.8 45.3 49.4 59.1 20.1 0.0 50.4 29.4 50.3 29.9 14.8 32.8 14.5 16.4 52.1 9.4 59.7 0.0 71.6 3.0 13.6 48.0 55.7 46.6 20.9 17.6 33.9 9.4 15.0 0.0 21.4 174.7 3.3 30.4 14.7 12.5 57.0 10.4 29.4 0.1 9.0 26.5 52.3 67.2 21.7 15.9 50.6 10.7 17.5 8.5 35.0 34.4 29.3 66.4 46.8 7.1 12.6 0.2 20.0 13.4 27.9 31.7 19.5 21.0 6.9 27.8 6.0 4.4 7.3 8.7 14.0 5.5 8.1 9.2 4.6 4.6 34.1 10.8 5.0 8.6 22.4 25.6 25.1 38.0 21.6 27.1 25.0 24.4 23.7 21.8 24.7 27.8 43.9 60.9 19.8 0.0 5.6 0.0 0.0 0.0 0.0 0.0 52.6 63.5 0.0 0.0 26.0 62.5 0.0 60.1 7.4 0.0 109.5 71.3 0.0 39.3 49.6 21.7 0.0 0.0 0.0 63.5 60.7 22.6 0.0 38.1 11.4 34.8 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 14.5 0.0 0.0 0.0 0.0 78.2 0.0 0.0 1.8 0.0 0.0 110.5 14.6 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 28.2 5.0 54.1 0.0 0.0 RTRAF "C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1" ENSG00000087302 "RNA transcription, translation and transport factor" Q9Y224 14 51989514-52010694 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 316.0;Distal tubular cells: 309.1;Exocrine glandular cells: 289.7;Extravillous trophoblasts: 349.6;Proximal tubular cells: 303.7;Syncytiotrophoblasts: 261.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039824 Supported Supported Nucleoplasm NA NA 48000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA039824: AB_10793922" "unprognostic (2.99e-2)" "unprognostic (2.90e-1)" "unprognostic (7.89e-2)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (6.08e-2)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (2.23e-2)" "unprognostic (6.50e-2)" "unprognostic (2.80e-1)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" "unprognostic (3.34e-1)" "unprognostic (5.03e-2)" "unprognostic (5.74e-2)" "unprognostic (1.99e-1)" 92.9 92.7 47.2 73.7 48.9 138.9 87.2 50.8 60.3 69.3 52.5 93.5 61.3 71.1 87.0 79.1 64.5 67.8 151.6 46.6 50.9 77.3 78.9 64.0 105.5 50.4 48.6 96.5 114.0 74.1 65.6 68.2 49.4 66.6 88.7 56.3 76.8 58.7 155.8 79.6 67.3 76.9 51.4 61.2 98.9 142.2 49.0 107.0 81.2 102.2 105.3 87.9 62.8 54.6 214.6 142.1 239.8 233.7 157.7 208.3 228.8 166.9 183.6 180.9 203.1 153.2 184.0 290.8 174.0 139.5 142.2 167.1 226.2 152.6 234.7 158.0 126.5 113.3 287.8 206.7 252.1 243.8 125.0 158.5 155.6 136.6 223.5 210.1 207.2 269.6 118.8 135.1 177.3 237.6 310.8 306.3 187.1 247.8 238.1 278.6 228.0 138.0 176.1 245.2 169.0 171.6 211.0 376.7 274.7 301.3 252.8 190.4 146.0 196.6 216.4 167.2 212.7 50.5 76.2 295.7 96.9 189.3 228.7 54.8 93.3 58.7 73.5 104.7 91.1 108.8 102.0 88.6 117.6 90.9 93.2 95.2 19.2 96.1 112.5 107.9 144.0 126.6 47.2 48.9 50.8 60.3 46.6 50.9 50.4 48.6 49.4 51.4 49.0 54.6 168.6 44.8 67.2 0.0 39.2 0.0 0.0 0.0 0.0 0.0 181.7 232.8 0.0 0.0 39.0 73.5 0.0 316.0 83.1 0.0 309.1 226.6 0.0 164.3 108.1 77.5 0.0 0.0 0.0 289.7 349.6 77.4 0.0 103.6 61.8 242.8 0.0 0.0 240.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.5 0.0 0.0 154.5 0.0 0.0 0.0 0.0 232.4 0.0 0.0 13.0 0.0 0.0 303.7 49.6 0.0 0.0 0.0 95.2 0.0 0.0 0.0 0.0 261.6 53.6 233.9 0.0 0.0 RXRB "H-2RIIBP, NR2B2, RCoR-1" ENSG00000204231 "Retinoid X receptor beta" P28702 6 33193588-33200665 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 11.0;RH-30: 14.4;RT4: 12.1;T-47d: 16.1;U-266/70: 11.1;U-266/84: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002003, HPA063653" Supported Supported Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB002003: , HPA063653: AB_2685076" "unprognostic (3.51e-1)" "unprognostic (8.46e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-2)" "unprognostic (2.00e-2)" "unprognostic (4.71e-3)" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.67e-3)" "unprognostic (8.13e-3)" "unprognostic (9.53e-3)" "unprognostic (8.30e-2)" "unprognostic (1.55e-1)" "unprognostic (6.38e-2)" "unprognostic (8.53e-3)" 26.8 29.1 1.5 2.0 1.5 2.3 27.1 1.6 5.7 33.9 1.4 34.4 3.9 31.9 7.4 27.0 31.4 3.3 31.4 1.5 2.6 29.5 34.4 27.2 1.4 1.5 1.7 32.9 32.3 0.0 33.0 2.5 1.5 32.8 1.6 3.2 27.0 3.3 42.5 26.3 28.6 9.6 1.6 38.3 28.3 20.0 1.6 2.8 37.7 12.3 9.1 30.6 29.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 10.0 0.0 10.4 7.1 0.0 11.0 4.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 8.9 0.0 0.0 0.5 3.2 0.0 0.0 0.1 14.4 0.0 8.0 12.1 0.0 7.4 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 4.8 0.0 0.0 11.1 11.8 9.2 0.0 0.0 0.0 2.3 0.4 1.7 1.1 0.3 0.8 1.0 1.3 1.3 0.6 0.3 1.1 0.8 0.7 0.8 0.6 0.6 1.1 0.3 1.5 1.5 1.6 5.7 1.5 2.6 1.5 1.7 1.5 1.6 1.6 1.7 21.2 41.7 13.3 14.4 19.2 17.3 14.9 8.9 18.2 25.2 22.4 18.9 16.1 15.7 14.7 5.5 20.9 23.6 26.3 21.8 25.4 19.9 2.7 10.6 14.7 18.2 22.0 8.6 14.9 16.2 17.9 18.3 23.0 11.9 10.2 22.5 14.3 15.9 15.8 18.5 12.9 21.8 16.2 14.7 9.2 8.6 16.1 12.2 16.0 10.3 18.8 16.6 33.0 14.1 15.2 13.6 20.2 16.1 12.0 16.3 23.2 14.1 10.8 20.4 26.3 19.3 20.0 17.7 12.5 16.8 18.8 28.7 19.4 18.7 24.5 12.7 RXYLT1 "HP10481, TMEM5" ENSG00000118600 "Ribitol xylosyltransferase 1" Q9Y2B1 12 63779842-63809562 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transferase "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 37.2;Endometrial stromal cells: 34.5;Extravillous trophoblasts: 33.8;Syncytiotrophoblasts: 37.1;Theca cells: 45.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064014 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Golgi apparatus" "HPA064014: AB_2685176" "unprognostic (1.19e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (3.58e-1)" "unprognostic (1.33e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.47e-2)" "unprognostic (2.09e-3)" "unprognostic (3.17e-1)" "unprognostic (7.03e-2)" "unprognostic (1.39e-1)" "unprognostic (9.33e-2)" "unprognostic (5.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" 6.6 12.0 6.9 4.9 7.6 4.4 10.8 7.1 8.5 7.1 7.2 6.9 5.7 6.7 15.3 5.6 7.9 5.5 14.3 6.8 7.9 10.9 8.5 5.2 7.4 7.5 7.0 12.0 11.8 15.4 9.0 5.7 7.7 8.4 7.5 9.9 8.3 7.0 10.7 8.3 4.2 6.1 7.5 5.7 5.5 11.8 7.3 7.3 12.8 8.7 7.2 7.4 5.5 9.3 9.6 19.9 14.2 11.7 12.2 16.4 13.5 10.4 18.5 17.7 11.9 6.6 10.1 20.5 17.7 13.4 14.2 9.3 17.5 16.0 22.3 18.5 13.4 11.5 5.1 12.2 18.1 17.6 10.0 14.6 15.6 17.1 22.6 16.8 10.4 16.5 14.0 19.8 27.8 18.3 10.2 8.1 8.1 10.4 20.6 9.0 14.8 13.1 17.8 15.1 30.7 5.9 10.4 9.5 24.5 9.0 20.2 9.9 10.1 14.9 15.2 9.7 15.4 10.6 17.9 15.6 10.9 11.4 20.9 0.8 1.7 1.0 1.9 1.6 3.5 3.0 2.4 2.6 1.7 2.2 2.8 2.6 0.3 3.0 2.2 4.1 4.3 1.2 6.9 7.6 7.1 8.5 6.8 7.9 7.5 7.0 7.7 7.5 7.3 9.3 17.5 9.6 8.4 0.0 7.3 0.0 0.0 0.0 0.0 0.0 26.8 26.8 0.0 0.0 10.5 16.5 0.0 24.7 6.9 0.0 37.2 23.1 0.0 28.6 34.5 8.1 0.0 0.0 0.0 30.7 33.8 12.1 0.0 16.6 7.6 15.5 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 8.3 0.0 0.0 0.0 0.0 17.3 0.0 0.0 2.4 0.0 0.0 30.3 13.8 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 37.1 4.8 45.0 0.0 0.0 SAMD1 ENSG00000141858 "Sterile alpha motif domain containing 1" 19 14087851-14091036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041662, HPA049059" Uncertain Approved Mitochondria,Cytosol "Intracellular and membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol Mitochondria "HPA041662: AB_2677605, HPA049059: AB_2680616" "unprognostic (2.93e-2)" "prognostic favorable (7.41e-4)" "unprognostic (8.43e-2)" "unprognostic (3.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (2.66e-1)" "unprognostic (9.92e-2)" "unprognostic (3.86e-3)" "unprognostic (9.26e-3)" "unprognostic (4.00e-1)" "prognostic unfavorable (7.98e-5)" "prognostic favorable (8.31e-4)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" "unprognostic (2.45e-1)" 24.7 18.1 53.2 18.3 51.9 22.3 21.2 49.0 50.5 29.9 33.9 32.3 20.1 30.0 8.7 37.0 24.7 8.2 37.6 48.6 49.6 25.8 24.2 24.5 21.4 57.0 51.6 27.5 24.8 8.0 14.9 10.8 54.4 21.8 14.2 7.1 20.2 14.0 50.9 39.7 29.4 11.7 51.7 38.2 28.6 26.3 52.6 44.5 20.6 22.6 17.7 29.4 30.4 54.0 73.2 54.8 47.3 67.3 28.7 29.7 71.8 39.3 9.4 39.5 31.7 41.5 35.3 125.1 51.2 25.6 18.9 57.9 51.5 29.5 19.5 84.3 42.8 55.5 73.7 76.0 25.9 33.1 33.1 20.7 47.5 27.4 9.2 37.6 23.5 79.6 67.9 33.8 22.9 110.2 69.0 129.2 96.7 53.0 47.9 92.1 41.9 91.8 33.5 35.2 86.5 86.1 34.8 46.6 26.6 25.0 29.6 70.0 26.1 68.7 62.1 69.5 50.7 62.0 58.1 105.2 41.0 89.0 28.4 0.2 1.3 2.5 0.8 0.5 1.0 2.1 0.9 1.0 1.2 1.4 1.2 0.9 0.2 3.7 0.5 0.9 1.1 0.8 53.2 51.9 49.0 50.5 48.6 49.6 57.0 51.6 54.4 51.7 52.6 54.0 42.0 3.2 6.7 0.7 10.9 11.5 4.6 14.4 18.8 31.4 25.2 31.4 11.9 21.5 5.5 11.0 6.2 3.9 22.4 48.6 1.9 11.2 0.3 24.4 21.6 19.4 24.7 43.6 0.3 11.1 9.3 14.3 9.7 24.5 8.2 15.2 13.6 13.8 15.5 52.2 0.4 24.0 6.1 25.7 16.1 2.2 19.3 19.6 10.6 0.0 11.3 19.4 2.1 1.0 0.9 13.0 18.9 18.8 13.3 6.6 23.6 6.6 10.6 8.5 13.1 7.5 18.8 0.8 20.4 29.2 17.2 1.8 14.1 8.2 30.5 4.8 SAP18 "2HOR0202, MGC27131, SAP18p" ENSG00000150459 "Sin3A associated protein 18" O00422 13 21140514-21149084 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011352, CAB012273" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" Cytosol "CAB012273: , HPA011352: AB_1856563" "unprognostic (5.08e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-3)" "unprognostic (2.84e-1)" "unprognostic (5.21e-2)" "unprognostic (3.02e-1)" "unprognostic (3.18e-1)" "unprognostic (8.15e-2)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (4.14e-2)" "unprognostic (2.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.70e-2)" "unprognostic (3.70e-3)" "unprognostic (2.78e-2)" 125.7 164.3 140.9 122.9 152.2 242.3 121.6 149.6 198.9 120.4 137.8 141.8 137.4 123.8 97.5 159.2 112.9 82.4 195.8 147.4 160.7 190.4 171.1 106.5 118.0 154.7 153.8 109.5 134.6 114.2 129.6 111.7 157.7 109.7 58.5 89.5 126.3 73.0 297.9 119.5 127.5 51.7 164.1 107.6 119.5 194.3 155.7 115.5 110.7 156.3 64.8 131.7 118.5 170.7 182.1 99.3 159.5 173.1 169.0 140.5 246.9 227.1 167.2 205.5 151.3 181.1 342.4 187.3 272.0 189.1 223.4 186.5 198.1 142.4 231.5 288.0 100.4 267.6 121.2 305.9 191.8 367.1 207.5 143.0 159.7 157.5 187.1 158.4 157.3 223.1 128.8 103.6 188.2 231.0 417.0 599.0 200.7 501.5 109.7 261.1 251.4 187.1 295.7 160.7 185.0 161.1 145.7 213.8 296.5 176.5 206.8 528.0 192.6 126.0 141.9 230.1 268.9 159.6 243.6 536.7 122.5 214.9 236.4 433.0 431.5 540.0 344.1 485.0 349.3 493.7 418.2 410.9 427.8 443.6 405.9 402.9 430.5 395.3 547.4 568.8 517.5 909.3 140.9 152.2 149.6 198.9 147.4 160.7 154.7 153.8 157.7 164.1 155.7 170.7 638.0 134.6 143.5 15.0 291.7 458.6 336.3 640.9 310.7 101.5 298.9 594.9 592.9 194.5 383.8 233.6 41.7 566.2 397.4 353.6 759.2 396.5 1259.5 334.1 231.1 273.1 234.5 214.4 20.8 365.6 528.0 374.0 170.2 256.2 258.6 176.6 180.2 242.0 396.0 119.5 23.4 364.5 468.0 189.5 440.9 206.0 342.3 260.4 407.4 17.8 385.0 370.8 233.8 19.6 26.2 401.9 417.6 303.6 182.3 325.9 475.0 1100.6 446.8 132.3 203.8 362.5 438.3 547.7 319.9 271.7 422.2 908.3 338.8 254.2 344.7 419.9 SCYGR4 KRTAP28-4 ENSG00000284631 "Small cysteine and glycine repeat containing 4" A0A286YEV6 2 227616998-227618655 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.0;placenta: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "U-2197: 10.7" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" 0.1 0.0 1.1 0.6 0.4 1.0 0.0 0.4 1.0 0.0 0.0 0.0 0.2 0.2 2.0 0.1 0.0 0.1 0.1 0.5 0.3 0.1 0.8 0.1 0.2 0.6 0.4 0.1 0.4 0.0 5.0 0.7 0.1 0.0 1.4 0.1 0.1 0.2 0.6 0.0 0.1 0.2 0.2 0.0 0.4 0.6 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.3 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.5 0.1 0.1 10.7 0.2 0.1 0.0 0.3 0.1 0.0 0.2 0.9 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.2 0.0 0.0 1.1 0.4 0.4 1.0 0.5 0.3 0.6 0.4 0.7 0.2 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 SDHAF4 "C6orf57, Sdh8" ENSG00000154079 "Succinate dehydrogenase complex assembly factor 4" Q5VUM1 6 70566917-70589569 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031824 Supported Approved Nucleoplasm,Mitochondria "Intracellular and membrane" No No "Cluster 28: Myeloid DCs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Mitochondria Nucleoplasm "HPA031824: AB_10602113" "unprognostic (8.72e-2)" "unprognostic (1.64e-1)" "unprognostic (4.95e-2)" "unprognostic (9.96e-2)" "unprognostic (4.58e-1)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (3.18e-2)" "unprognostic (3.17e-1)" "prognostic favorable (1.95e-5)" "unprognostic (2.45e-2)" "unprognostic (9.37e-2)" "unprognostic (3.05e-1)" "unprognostic (9.94e-2)" 11.2 12.3 7.1 4.2 7.5 4.3 10.5 6.8 10.5 6.6 7.3 6.8 5.0 5.8 9.3 7.5 10.3 4.2 14.5 7.6 9.4 12.5 8.5 5.4 6.0 6.9 6.3 6.4 6.6 14.4 12.7 6.8 7.3 7.6 6.7 10.0 8.7 5.4 23.6 8.6 5.4 4.2 5.8 5.6 7.0 5.3 7.8 6.4 7.3 10.6 5.2 6.8 6.7 7.6 13.3 4.2 18.8 11.6 9.0 13.6 3.5 7.1 5.1 3.4 5.0 3.8 11.3 9.1 12.7 3.8 8.0 2.3 6.2 5.9 5.2 18.3 4.3 6.6 1.8 3.9 15.3 6.3 5.1 9.6 19.3 2.6 14.8 11.6 8.0 14.8 4.2 13.9 11.0 9.0 5.9 15.7 8.8 6.5 4.5 6.4 12.6 10.8 14.9 4.4 16.8 12.1 4.3 2.1 9.6 8.0 9.6 16.5 6.3 3.5 2.7 2.8 7.7 6.2 4.5 3.1 3.9 15.1 8.5 4.0 4.6 4.4 3.4 4.3 3.3 3.7 3.7 4.1 5.1 4.7 3.9 3.8 3.3 4.7 4.6 6.2 4.2 3.0 7.1 7.5 6.8 10.5 7.6 9.4 6.9 6.3 7.3 5.8 7.8 7.6 5.4 12.8 13.9 4.9 3.3 0.0 7.9 0.0 3.4 7.4 6.5 7.5 21.3 10.0 5.6 7.3 8.4 10.5 5.0 2.9 23.5 9.1 5.5 20.2 8.2 5.0 3.6 2.5 7.7 11.6 8.5 6.6 2.6 6.0 5.1 6.1 4.2 11.8 10.0 18.5 7.5 5.8 0.0 5.3 0.0 2.5 12.5 6.2 0.0 2.8 10.1 10.1 3.1 12.1 7.7 13.2 5.3 6.8 2.2 9.5 6.2 16.8 13.8 6.4 13.1 5.1 4.9 10.0 6.1 5.7 0.0 5.1 3.9 6.1 5.3 8.0 SELENOF SEP15 ENSG00000183291 "Selenoprotein F" O60613 1 86862445-86914424 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 248.6;Ductal cells: 235.9;Extravillous trophoblasts: 338.3;Hofbauer cells: 241.2;Syncytiotrophoblasts: 315.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054937 Approved Nucleoli,Cytosol "Intracellular and membrane" No No 420000 "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoli Cytosol "HPA054937: AB_2682642" "unprognostic (6.15e-2)" "unprognostic (6.98e-3)" "prognostic favorable (6.53e-4)" "unprognostic (6.20e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.65e-1)" "unprognostic (6.51e-3)" "unprognostic (3.38e-2)" "unprognostic (3.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (2.39e-2)" "unprognostic (1.09e-1)" "unprognostic (8.24e-3)" "unprognostic (1.34e-2)" 118.1 137.9 77.6 118.8 80.0 107.9 147.4 80.9 106.1 156.6 97.9 127.8 113.5 117.4 211.4 83.6 130.1 123.3 84.6 75.2 84.3 160.3 173.9 114.9 140.6 82.6 79.8 124.6 93.4 115.7 88.4 155.8 84.0 121.1 134.2 90.7 104.1 116.4 45.6 66.3 111.3 107.1 86.4 107.2 116.8 66.7 79.0 135.5 234.0 64.7 126.9 146.6 72.6 92.5 203.1 133.3 118.0 129.1 383.0 396.4 178.3 249.1 317.3 251.4 254.8 176.8 261.8 245.2 309.7 248.9 195.7 131.8 135.2 150.7 296.0 222.1 180.2 252.4 108.5 178.2 245.2 336.8 166.1 272.3 233.0 152.8 253.0 180.2 220.2 207.8 241.4 262.3 253.3 90.2 254.4 227.3 170.7 211.2 197.9 207.7 205.1 251.9 355.5 198.5 149.5 122.6 241.6 235.6 349.2 104.7 104.0 298.5 205.3 180.0 122.9 347.6 277.0 155.1 158.7 251.9 107.7 268.4 216.7 170.9 111.3 113.4 89.7 115.9 116.1 161.4 98.7 97.2 107.1 194.2 98.8 102.3 109.3 82.3 132.4 166.3 115.2 171.3 77.6 80.0 80.9 106.1 75.2 84.3 82.6 79.8 84.0 86.4 79.0 92.5 131.6 118.6 155.2 0.0 52.4 0.0 0.0 0.0 0.0 0.0 142.1 107.7 0.0 0.0 74.9 108.5 0.0 248.6 89.3 0.0 74.3 235.9 0.0 102.2 119.1 73.2 0.0 0.0 0.0 193.5 338.3 85.2 0.0 98.1 64.3 68.8 0.0 0.0 241.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 64.1 0.0 0.0 0.0 0.0 197.8 0.0 0.0 19.1 0.0 0.0 151.5 70.0 0.0 0.0 0.0 61.5 0.0 0.0 0.0 0.0 315.2 53.9 122.2 0.0 0.0 SELENOH "C11orf31, SELH" ENSG00000211450 "Selenoprotein H" Q8IZQ5 11 57741250-57743554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 444.1;Exocrine glandular cells: 315.1;Hofbauer cells: 416.3;Proximal tubular cells: 588.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048362 Uncertain Approved Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA048362: AB_2680370" "unprognostic (1.12e-2)" "unprognostic (3.05e-2)" "unprognostic (6.14e-2)" "unprognostic (1.18e-1)" "unprognostic (2.39e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.61e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.58e-1)" "unprognostic (7.56e-2)" "unprognostic (4.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.60e-1)" 96.0 167.2 38.4 31.6 41.1 39.4 95.6 36.4 70.0 91.4 39.5 82.0 31.7 73.7 11.9 135.0 72.7 20.6 117.5 39.9 43.2 125.6 171.2 85.9 42.5 38.2 38.7 96.4 110.8 9.2 104.6 26.2 39.6 110.6 13.1 5.4 99.4 16.2 117.0 79.6 88.0 15.0 37.5 130.1 91.3 66.8 41.1 14.5 103.2 6.2 27.9 87.0 86.3 39.7 116.5 84.5 79.8 47.6 7.6 29.1 18.8 43.1 30.3 36.4 19.8 26.7 56.2 51.0 120.7 15.4 31.0 50.9 26.6 47.1 8.3 75.7 85.3 67.8 59.0 66.4 63.7 105.1 140.0 38.4 43.3 39.0 19.4 39.9 50.4 68.9 70.2 44.0 23.7 112.6 103.5 181.1 155.6 32.8 89.6 122.5 75.6 106.7 23.6 62.2 46.0 105.1 39.1 35.2 133.6 18.3 102.2 79.7 64.1 41.1 101.2 90.3 64.2 269.8 226.2 41.3 95.3 89.0 106.1 295.2 385.8 204.5 160.2 417.6 151.4 346.4 209.6 171.4 396.4 349.2 282.1 208.8 29.7 187.7 394.2 488.1 175.3 469.5 38.4 41.1 36.4 70.0 39.9 43.2 38.2 38.7 39.6 37.5 41.1 39.7 182.7 166.7 151.8 0.0 61.0 0.0 0.0 0.0 0.0 0.0 273.3 267.0 0.0 0.0 74.3 150.8 0.0 288.7 77.7 0.0 444.1 256.7 0.0 175.5 95.2 90.2 0.0 0.0 0.0 315.1 280.8 68.4 0.0 104.1 133.7 148.5 0.0 0.0 416.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.1 0.0 0.0 102.4 0.0 0.0 0.0 0.0 288.7 0.0 0.0 14.8 0.0 0.0 588.6 142.8 0.0 0.0 0.0 74.7 0.0 0.0 0.0 0.0 147.2 49.0 190.5 0.0 0.0 SELENOI "EPT1, KIAA1724, SELI, SEPI" ENSG00000138018 "Selenoprotein I" Q9C0D9 2 26308547-26395891 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 22.0;Endometrial ciliated cells: 16.3;Glandular and luminal cells: 15.3;Pancreatic endocrine cells: 13.6;Syncytiotrophoblasts: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064125 Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA064125: " "unprognostic (6.29e-2)" "unprognostic (7.46e-2)" "unprognostic (1.38e-3)" "unprognostic (3.05e-3)" "unprognostic (1.50e-1)" "unprognostic (1.39e-2)" "unprognostic (7.44e-3)" "unprognostic (5.00e-3)" "unprognostic (7.79e-2)" "unprognostic (2.55e-2)" "unprognostic (6.65e-2)" "unprognostic (9.40e-2)" "unprognostic (1.52e-2)" "unprognostic (2.95e-1)" "unprognostic (1.76e-1)" "unprognostic (9.87e-3)" "unprognostic (1.42e-2)" 3.6 6.4 7.9 5.5 8.4 12.1 8.1 11.2 10.6 5.4 5.0 8.6 12.3 4.1 5.4 11.1 3.5 4.0 3.9 10.3 9.3 7.9 23.2 4.4 5.7 6.8 7.3 3.5 9.0 17.2 4.5 4.7 8.6 6.2 8.7 9.3 6.2 4.2 7.0 18.3 18.4 3.7 9.7 4.3 7.1 4.4 7.2 6.3 7.1 6.6 6.1 7.5 7.1 10.0 42.7 25.7 20.9 21.0 12.8 10.2 32.0 20.3 9.2 10.0 10.2 54.5 26.6 49.5 24.2 9.5 21.4 34.1 32.4 17.9 14.4 13.7 15.4 31.3 17.5 32.3 12.2 41.9 9.7 8.1 15.6 22.3 21.9 6.1 9.4 17.6 35.9 16.6 13.5 18.4 25.1 20.7 26.8 21.6 17.4 22.6 49.2 25.0 19.3 32.4 45.7 19.4 17.3 36.2 16.4 17.3 17.4 12.4 15.1 17.1 22.0 22.7 31.7 22.6 60.8 65.8 17.5 25.4 15.6 0.0 0.7 0.0 0.9 1.0 0.9 2.5 0.9 1.2 0.7 1.0 1.2 2.0 0.2 0.9 0.9 1.3 1.8 0.4 7.9 8.4 11.2 10.6 10.3 9.3 6.8 7.3 8.6 9.7 7.2 10.0 9.1 12.8 8.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 12.2 7.1 0.0 0.0 3.1 22.0 0.0 6.1 11.7 0.0 0.0 10.4 0.0 16.3 12.8 3.7 0.0 0.0 0.0 10.4 6.2 2.9 0.0 15.3 1.3 8.6 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 13.6 0.0 0.0 3.9 0.0 0.0 5.6 2.2 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 16.6 4.7 11.5 0.0 0.0 SELENOK SELK ENSG00000113811 "Selenoprotein K" Q9Y6D0 3 53884417-53891962 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 373.5;Proximal tubular cells: 415.0;Syncytiotrophoblasts: 350.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "basophil: 471.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 471.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA008196 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "HPA008196: AB_1856665" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (3.85e-1)" "prognostic favorable (7.18e-4)" "unprognostic (9.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.02e-2)" "prognostic favorable (3.76e-4)" "unprognostic (2.75e-1)" "unprognostic (5.21e-2)" "unprognostic (8.34e-2)" "unprognostic (1.14e-1)" "unprognostic (3.40e-2)" "unprognostic (8.43e-2)" "unprognostic (8.12e-2)" "unprognostic (9.35e-2)" "unprognostic (2.56e-3)" 39.6 51.9 52.3 27.0 53.0 70.1 35.8 55.2 67.9 29.8 52.3 35.9 23.3 29.1 64.4 27.8 33.9 23.4 90.1 52.0 55.8 42.1 74.2 38.3 23.7 55.0 53.7 48.6 51.7 55.7 62.8 26.5 55.5 34.6 29.3 86.5 29.7 28.5 86.7 24.1 30.4 18.7 55.7 32.3 39.6 32.0 53.3 26.7 43.0 61.2 29.4 35.5 26.1 58.4 22.4 14.9 34.3 23.3 52.1 32.8 36.8 32.0 40.5 43.4 48.9 33.4 33.1 33.8 13.8 23.4 48.7 13.8 40.7 24.5 37.8 59.6 50.3 21.1 61.4 77.6 49.1 28.3 48.6 19.8 40.3 30.1 39.4 25.2 35.3 25.1 20.1 86.3 38.5 24.7 18.5 33.5 33.4 27.5 55.1 11.5 20.9 61.9 51.3 37.1 17.5 49.5 21.9 29.4 32.7 37.5 19.6 44.0 20.6 24.4 28.7 62.2 45.7 62.8 76.3 31.4 36.8 37.3 38.2 471.4 41.7 110.7 69.5 47.2 67.5 60.3 63.0 70.0 36.6 49.0 55.0 63.0 94.1 52.2 56.6 66.3 72.1 82.6 52.3 53.0 55.2 67.9 52.0 55.8 55.0 53.7 55.5 55.7 53.3 58.4 223.1 134.6 103.9 0.0 173.5 0.0 0.0 0.0 0.0 0.0 233.7 237.5 0.0 0.0 53.9 149.0 0.0 162.3 373.5 0.0 189.8 258.5 0.0 150.1 113.5 62.7 0.0 0.0 0.0 199.6 239.6 86.9 0.0 237.9 237.1 59.1 0.0 0.0 162.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.6 0.0 0.0 74.9 0.0 0.0 0.0 0.0 282.5 0.0 0.0 110.6 0.0 0.0 415.0 53.9 0.0 0.0 0.0 86.0 0.0 0.0 0.0 0.0 350.1 155.9 94.7 0.0 0.0 SELENOM "SELM, SEPM" ENSG00000198832 "Selenoprotein M" Q8WWX9 22 31104772-31120069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 373.6;Breast myoepithelial cells: 436.2;Collecting duct cells: 309.0;Distal tubular cells: 309.1;Endometrial stromal cells: 349.5;Exocrine glandular cells: 586.6;Smooth muscle cells: 225.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "B-cells: 154.8;T-cells: 233.0" "Cell line enhanced" "Detected in many" "BJ: 152.2;BJ hTERT+: 143.8;HHSteC: 183.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008667, HPA019601" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 170000 "Cluster 20: T-cells - T-cell receptor" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "CAB008667: AB_1622762, HPA019601: AB_1856666" "unprognostic (5.29e-3)" "unprognostic (1.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.59e-3)" "unprognostic (1.45e-1)" "unprognostic (1.60e-2)" "unprognostic (1.60e-1)" "unprognostic (3.51e-3)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.55e-6)" "unprognostic (1.32e-2)" "unprognostic (3.80e-1)" "unprognostic (5.20e-2)" "unprognostic (3.19e-2)" 241.8 95.4 126.7 55.7 126.7 2.9 239.8 127.3 170.7 458.8 189.9 575.4 37.2 600.2 14.8 86.1 437.8 28.6 227.2 130.0 149.3 162.5 36.7 157.5 25.9 137.1 138.6 262.4 154.3 94.7 241.1 32.2 131.0 339.6 16.4 8.1 198.8 140.1 109.9 114.8 193.9 85.3 139.6 97.6 285.6 42.1 142.1 10.2 225.8 18.6 15.3 462.3 290.7 132.3 12.8 25.7 7.4 42.7 68.8 80.5 82.2 152.2 143.8 69.2 50.0 0.8 2.0 1.6 30.9 89.9 31.2 1.2 6.9 9.2 4.7 7.0 25.6 2.7 7.8 13.3 183.7 0.0 13.1 78.5 27.1 33.1 12.6 33.1 9.0 2.2 2.4 14.7 17.9 6.6 0.5 1.4 9.6 11.8 27.3 0.1 0.1 18.1 11.1 0.1 16.2 35.7 47.3 41.6 0.7 2.5 57.5 0.9 30.9 20.8 59.0 77.8 0.1 13.2 6.5 1.0 83.1 0.2 13.8 18.3 10.5 5.1 105.3 19.9 137.9 154.8 174.5 127.0 6.4 129.5 233.0 137.8 8.2 39.1 40.1 2.5 179.0 102.6 126.7 126.7 127.3 170.7 130.0 149.3 137.1 138.6 131.0 139.6 142.1 132.3 168.6 54.5 126.5 0.0 38.8 0.0 0.0 0.0 0.0 0.0 373.6 436.2 0.0 0.0 32.2 309.0 0.0 11.7 23.2 0.0 309.1 101.2 0.0 22.8 349.5 61.8 0.0 0.0 0.0 586.6 149.5 161.3 0.0 18.1 30.3 30.8 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 42.9 0.0 0.0 0.0 0.0 166.2 0.0 0.0 22.3 0.0 0.0 152.5 20.4 0.0 0.0 0.0 225.6 0.0 0.0 0.0 0.0 23.4 24.8 30.5 0.0 0.0 SELENON "MDRS1, RSMD1, RSS, SELN, SEPN1" ENSG00000162430 "Selenoprotein N" Q9NZV5 1 25800176-25818221 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Desmin-related myopathy, Disease variant, Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 99.2;Exocrine glandular cells: 42.3;Granulosa cells: 31.2;Hofbauer cells: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058076 Approved Uncertain Cytosol "Intracellular and membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA058076: AB_2683598" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (4.11e-1)" "prognostic favorable (2.23e-4)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (3.40e-5)" "unprognostic (1.94e-1)" "unprognostic (4.72e-1)" "unprognostic (3.32e-3)" "unprognostic (6.01e-2)" "unprognostic (3.07e-1)" "unprognostic (1.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.10e-1)" "unprognostic (5.56e-3)" "unprognostic (5.89e-2)" 65.7 48.0 51.6 34.0 51.2 17.0 60.8 45.5 53.3 43.8 74.2 42.5 17.4 48.8 19.5 36.5 40.2 30.1 60.7 49.6 48.5 52.5 20.3 51.8 20.5 72.8 55.2 51.7 60.1 37.0 40.2 38.9 52.1 58.2 20.8 11.7 45.7 39.6 56.3 30.2 31.0 56.2 54.1 43.4 43.4 12.0 62.6 13.6 53.8 39.7 16.3 46.9 35.6 50.2 52.6 49.5 160.9 138.4 102.5 178.8 54.4 62.2 93.4 67.7 53.9 12.9 54.2 0.1 40.4 94.6 74.8 49.9 42.4 66.2 51.1 55.8 32.6 51.4 18.2 16.0 73.8 11.0 116.6 191.7 43.8 71.0 35.5 79.9 214.4 17.4 18.5 7.2 64.7 26.8 2.3 15.7 61.0 40.9 33.7 45.4 70.3 6.4 27.7 14.8 33.5 56.9 39.4 35.3 52.7 43.0 35.6 36.1 180.5 68.4 46.2 126.6 37.1 5.8 0.2 1.4 94.8 15.9 84.4 2.7 1.2 1.6 0.7 1.0 0.4 0.7 0.6 0.5 0.8 0.4 0.9 0.6 0.2 0.3 1.1 0.1 0.7 0.4 51.6 51.2 45.5 53.3 49.6 48.5 72.8 55.2 52.1 54.1 62.6 50.2 99.2 9.6 10.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 23.0 19.3 0.0 0.0 3.7 20.2 0.0 16.4 3.8 0.0 0.0 18.6 0.0 6.5 22.4 21.5 0.0 0.0 0.0 42.3 11.4 12.5 0.0 13.5 2.5 31.2 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 3.1 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.9 0.0 0.0 14.9 3.6 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 13.0 2.2 8.6 0.0 0.0 SELENOO SELO ENSG00000073169 "Selenoprotein O" Q9BVL4 22 50200979-50217616 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 27.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 21.1;Granulosa cells: 34.7;Proximal tubular cells: 41.7;Theca cells: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071795, HPA079100" Approved Supported "Mitotic chromosome,Mitochondria" "Intracellular and membrane" Yes NA "Cluster 52: Eosinophils - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Mitotic chromosome" "HPA071795: , HPA079100: " "unprognostic (1.79e-1)" "unprognostic (2.07e-3)" "unprognostic (1.60e-1)" "unprognostic (2.50e-3)" "unprognostic (3.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.85e-2)" "unprognostic (5.91e-2)" "unprognostic (1.51e-1)" "unprognostic (5.62e-2)" "unprognostic (8.20e-3)" "unprognostic (8.91e-2)" "unprognostic (1.81e-2)" "unprognostic (7.31e-2)" "unprognostic (1.98e-1)" "unprognostic (2.52e-1)" "prognostic favorable (8.32e-4)" 6.7 6.7 2.3 4.5 3.4 13.9 4.8 11.7 6.8 5.6 2.5 5.3 8.0 5.9 2.8 8.2 5.7 4.1 5.3 3.0 1.1 6.6 27.9 4.7 6.4 4.6 2.7 5.0 13.1 3.0 4.1 3.0 3.7 5.6 2.0 2.9 7.7 4.1 12.3 8.2 6.5 2.4 2.3 6.5 7.0 3.7 3.1 4.4 5.1 4.1 3.9 5.1 6.1 6.0 12.0 7.7 4.2 4.7 5.6 4.1 8.6 11.8 5.6 7.0 5.5 10.6 7.5 7.9 9.2 4.7 3.9 26.2 6.5 10.7 1.4 2.3 29.9 5.7 17.4 6.4 2.8 10.6 6.9 5.4 7.2 4.5 3.5 4.5 5.8 5.3 7.8 5.6 2.9 18.6 5.7 16.4 3.7 2.8 15.6 17.6 5.9 11.8 4.3 15.3 8.4 9.3 12.8 11.3 7.5 2.1 8.7 7.5 9.5 6.0 8.3 6.5 7.1 13.8 3.6 4.7 6.8 6.9 3.5 0.0 1.1 1.3 0.2 0.4 0.5 0.0 0.2 0.5 1.1 0.2 0.1 0.4 0.5 0.0 0.4 0.4 0.2 0.3 2.3 3.4 11.7 6.8 3.0 1.1 4.6 2.7 3.7 2.3 3.1 6.0 11.8 0.0 21.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 13.3 13.2 0.0 0.0 5.6 9.2 0.0 3.1 12.2 0.0 15.6 3.6 0.0 11.8 10.9 3.0 0.0 0.0 0.0 4.6 2.4 6.0 0.0 15.2 3.8 34.7 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 4.5 0.0 0.0 41.7 3.6 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 1.9 5.5 29.6 0.0 0.0 SELENOS "AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP" ENSG00000131871 "Selenoprotein S" Q9BQE4 15 101270817-101277500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 229.2;Glandular and luminal cells: 211.7;Pancreatic endocrine cells: 226.1;Syncytiotrophoblasts: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 606.9" "Lineage enriched" "Detected in all" 5 "dendritic cells: 606.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010025 Approved Enhanced "Endoplasmic reticulum" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "HPA010025: AB_1079900" "unprognostic (1.90e-1)" "unprognostic (4.03e-2)" "unprognostic (1.06e-1)" "prognostic favorable (1.33e-4)" "unprognostic (2.42e-2)" "unprognostic (3.74e-3)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (9.83e-2)" "prognostic favorable (5.19e-4)" "unprognostic (2.42e-3)" "unprognostic (4.42e-1)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" "unprognostic (2.66e-2)" 65.6 75.4 30.6 48.4 32.8 50.6 55.0 33.8 39.8 50.1 39.7 82.4 80.0 41.9 75.5 55.6 44.6 45.5 66.3 29.8 32.7 48.7 84.7 59.6 49.2 35.2 33.2 41.6 103.7 51.1 44.5 57.6 35.3 53.6 87.2 28.7 73.8 49.1 71.0 48.4 82.2 42.9 33.7 58.7 67.2 92.7 32.4 24.1 55.8 48.7 53.1 60.7 45.3 36.3 45.3 68.8 61.2 54.5 129.8 91.1 52.4 136.4 100.2 89.8 90.2 82.3 105.0 33.6 49.6 117.5 150.8 125.1 66.6 59.7 58.6 63.5 91.8 57.2 62.5 86.8 206.5 43.5 63.9 80.2 166.3 60.3 177.7 70.7 68.1 44.3 58.3 369.0 97.4 71.7 31.7 67.6 46.8 169.9 45.7 41.6 50.1 74.7 90.7 104.2 34.5 88.5 93.0 85.7 193.8 79.9 64.0 96.2 73.6 84.0 57.1 116.4 103.3 272.5 246.3 49.9 92.2 50.8 104.2 134.4 66.4 81.2 94.1 84.0 91.1 62.2 71.4 101.1 58.6 51.4 53.7 79.6 23.1 95.6 100.1 606.9 71.4 63.7 30.6 32.8 33.8 39.8 29.8 32.7 35.2 33.2 35.3 33.7 32.4 36.3 164.0 118.6 108.6 0.0 47.8 0.0 0.0 0.0 0.0 0.0 172.5 129.4 0.0 0.0 64.4 154.5 0.0 125.9 87.7 0.0 31.3 183.9 0.0 127.0 165.2 53.3 0.0 0.0 0.0 189.3 229.2 91.6 0.0 211.7 30.3 53.5 0.0 0.0 120.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.4 0.0 0.0 92.0 0.0 0.0 0.0 0.0 226.1 0.0 0.0 101.0 0.0 0.0 73.0 56.9 0.0 0.0 0.0 78.5 0.0 0.0 0.0 0.0 303.7 40.4 100.9 0.0 0.0 SELENOT SELT ENSG00000198843 "Selenoprotein T" P62341 3 150602875-150630445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 215.1;Extravillous trophoblasts: 230.6;Hofbauer cells: 238.8;Pancreatic endocrine cells: 206.0;Proximal tubular cells: 176.8;Syncytiotrophoblasts: 489.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039780 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA039780: AB_10805594" "unprognostic (1.13e-1)" "unprognostic (4.03e-2)" "unprognostic (2.78e-1)" "unprognostic (1.92e-1)" "unprognostic (3.31e-1)" "unprognostic (1.34e-2)" "unprognostic (2.65e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-3)" "unprognostic (6.30e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-3)" "unprognostic (4.91e-2)" "unprognostic (4.08e-2)" "unprognostic (1.58e-1)" "unprognostic (3.41e-2)" 49.2 73.5 44.0 56.4 47.2 100.0 47.8 49.8 58.9 44.0 44.8 49.1 51.2 39.2 62.7 41.0 49.1 38.9 51.9 46.0 52.2 75.4 72.4 51.0 80.5 46.9 46.9 36.0 45.4 84.2 45.6 60.6 49.9 49.5 56.6 69.7 45.5 48.8 44.9 28.3 50.3 54.1 50.5 46.4 45.1 39.7 47.7 58.3 67.2 54.0 73.2 63.4 32.0 53.9 232.1 94.9 57.1 51.8 86.7 84.0 111.3 174.3 127.3 120.7 79.6 145.9 129.1 125.6 192.2 128.7 107.5 76.1 89.6 110.3 177.7 124.8 77.3 130.9 48.4 68.1 94.6 77.1 102.5 74.1 86.5 107.6 92.1 86.7 132.2 58.2 31.0 359.9 173.4 137.6 107.5 46.1 65.4 134.2 99.0 79.0 73.8 215.4 102.6 132.7 64.2 39.8 106.4 64.4 74.8 71.2 133.6 96.2 125.7 65.1 41.1 121.1 172.6 261.3 151.4 176.1 88.8 142.1 56.9 218.1 163.8 142.5 133.7 138.4 148.5 119.6 111.3 125.4 126.5 102.3 87.4 110.1 198.8 106.3 155.7 90.7 132.3 324.7 44.0 47.2 49.8 58.9 46.0 52.2 46.9 46.9 49.9 50.5 47.7 53.9 80.6 60.9 67.9 0.0 53.4 0.0 0.0 0.0 0.0 0.0 97.2 66.5 0.0 0.0 29.1 108.5 0.0 215.1 114.7 0.0 97.8 166.8 0.0 63.9 46.8 35.5 0.0 0.0 0.0 135.0 230.6 30.9 0.0 64.7 45.4 31.5 0.0 0.0 238.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 0.0 0.0 123.5 0.0 0.0 0.0 0.0 206.0 0.0 0.0 21.0 0.0 0.0 176.8 32.8 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 489.3 48.1 63.4 0.0 0.0 SELENOW "SELW, SEPW1" ENSG00000178980 "Selenoprotein W" P63302 19 47778585-47784686 "Predicted intracellular proteins" Antioxidant "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 1609.8;skeletal muscle: 1723.7;tongue: 1969.8" "Cell type enhanced" "Detected in many" "Adipocytes: 855.4;Breast myoepithelial cells: 490.5;Distal tubular cells: 633.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 541.5;HUVEC TERT2: 624.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.03e-1)" "unprognostic (8.98e-3)" "unprognostic (7.21e-2)" "unprognostic (2.98e-2)" "unprognostic (6.28e-2)" "unprognostic (4.17e-2)" "unprognostic (4.46e-3)" "prognostic favorable (5.44e-4)" "unprognostic (1.73e-1)" "unprognostic (2.42e-1)" "unprognostic (1.36e-1)" "unprognostic (6.78e-2)" "unprognostic (1.45e-3)" "unprognostic (4.58e-2)" "unprognostic (1.36e-1)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" 188.5 103.4 1283.6 107.6 1308.6 44.7 204.0 1297.0 1609.8 270.1 1374.7 535.1 127.4 218.5 258.8 266.6 306.9 240.5 988.8 1351.6 1261.2 146.6 109.6 199.7 112.1 1273.2 1296.9 170.9 132.6 168.7 138.6 153.5 1251.5 233.2 224.7 128.1 195.8 291.5 1723.7 312.3 177.5 467.0 1278.9 146.1 207.8 55.3 1333.8 113.7 156.7 1969.8 87.8 323.5 173.3 1321.9 74.4 119.6 174.0 141.4 124.7 268.1 43.7 76.7 59.6 71.4 53.8 49.6 57.1 0.0 64.3 163.1 70.1 57.8 293.6 389.6 124.1 216.4 72.9 34.9 61.7 63.2 138.0 9.1 131.8 285.1 541.5 119.4 113.0 158.7 624.7 109.1 46.4 28.6 317.7 179.0 156.6 115.4 68.0 186.0 91.4 26.9 18.3 23.5 208.0 130.8 72.4 51.5 77.6 203.0 77.9 299.2 114.2 43.7 213.9 71.0 151.2 50.7 141.3 46.3 153.1 16.1 75.3 93.2 165.0 309.3 187.8 448.3 303.8 226.2 265.1 182.4 333.6 311.7 147.8 159.2 331.0 288.3 19.9 216.1 293.5 166.8 436.6 414.1 1283.6 1308.6 1297.0 1609.8 1351.6 1261.2 1273.2 1296.9 1251.5 1278.9 1333.8 1321.9 855.4 333.3 282.3 0.0 20.4 0.0 0.0 0.0 0.0 0.0 347.1 490.5 0.0 0.0 219.7 154.5 0.0 157.0 127.3 0.0 633.9 278.3 0.0 350.2 221.5 220.8 0.0 0.0 0.0 244.5 327.9 145.5 0.0 188.4 119.8 153.8 0.0 0.0 251.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.3 0.0 0.0 156.6 0.0 0.0 0.0 0.0 243.7 0.0 0.0 21.3 0.0 0.0 380.8 303.9 0.0 0.0 0.0 210.7 0.0 0.0 0.0 0.0 182.4 66.9 341.7 0.0 0.0 SEM1 "C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1" ENSG00000127922 "SEM1 26S proteasome complex subunit" "P60896, Q6ZVN7" 7 96481626-96709891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 636.7;Endometrial ciliated cells: 571.3;Exocrine glandular cells: 537.4;Extravillous trophoblasts: 712.8;Pancreatic endocrine cells: 543.9;Proximal tubular cells: 533.4;Syncytiotrophoblasts: 872.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020429, HPA072648" Uncertain Approved Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA020429: AB_1859527, HPA072648: AB_2686543" "unprognostic (5.41e-3)" "unprognostic (6.25e-2)" "unprognostic (1.62e-2)" "unprognostic (2.14e-3)" "unprognostic (1.24e-3)" "unprognostic (6.16e-3)" "unprognostic (4.29e-1)" "unprognostic (1.17e-1)" "unprognostic (1.43e-1)" "prognostic favorable (2.52e-4)" "unprognostic (4.55e-1)" "unprognostic (6.92e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.32e-1)" "unprognostic (2.67e-2)" "unprognostic (2.64e-1)" "prognostic favorable (8.00e-5)" 137.1 178.9 100.5 118.2 101.2 77.8 124.2 101.7 161.4 135.9 100.3 146.0 121.8 132.5 118.5 193.9 114.9 34.8 193.2 98.4 108.9 130.0 262.8 102.7 87.9 102.6 107.5 167.3 103.7 105.5 122.2 106.7 103.0 118.2 77.8 85.0 131.4 69.0 360.5 144.8 116.1 64.2 98.6 96.9 126.7 183.7 101.2 136.8 106.6 150.2 84.7 113.4 144.8 104.0 570.7 327.0 448.1 468.1 187.4 162.3 241.7 453.4 220.0 186.9 232.5 298.3 459.4 373.6 1096.4 222.8 575.9 288.2 379.5 306.5 263.6 437.4 285.9 448.3 505.7 472.5 171.2 670.0 321.4 208.4 233.7 279.8 283.7 291.4 253.8 438.4 592.4 444.7 193.0 716.9 760.9 942.6 607.0 572.4 297.3 291.6 576.4 441.1 273.2 555.6 367.8 463.6 845.0 701.6 497.9 681.4 200.6 502.2 525.6 365.3 641.2 683.1 575.0 278.3 818.9 1080.9 399.4 574.3 515.8 292.6 385.3 109.0 279.9 443.1 268.4 336.4 363.1 332.7 570.6 312.5 282.4 284.0 27.0 300.4 392.8 622.8 546.6 375.7 100.5 101.2 101.7 161.4 98.4 108.9 102.6 107.5 103.0 98.6 101.2 104.0 288.2 173.1 224.5 0.0 47.2 0.0 0.0 0.0 0.0 0.0 212.6 325.2 0.0 0.0 103.4 244.6 0.0 636.7 93.1 0.0 412.8 382.5 0.0 571.3 314.1 127.6 0.0 0.0 0.0 537.4 712.8 129.5 0.0 450.0 102.2 258.9 0.0 0.0 393.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.0 0.0 0.0 241.3 0.0 0.0 0.0 0.0 543.9 0.0 0.0 19.6 0.0 0.0 533.4 149.4 0.0 0.0 0.0 140.3 0.0 0.0 0.0 0.0 872.3 65.9 187.2 0.0 0.0 SEMA4A "CORD10, FLJ12287, SEMAB, SemB" ENSG00000196189 "Semaphorin 4A" Q9H3S1 1 156147366-156177752 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Angiogenesis, Differentiation, Immunity, Neurogenesis" "Developmental protein" "Cone-rod dystrophy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 51.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 63.7;Plasma cells: 61.2;Skeletal myocytes: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 123.9;eosinophil: 120.2;intermediate monocyte: 132.7;myeloid DC: 183.0;neutrophil: 210.7;non-classical monocyte: 76.1" "Group enriched" "Detected in all" 13 "dendritic cells: 183.0;granulocytes: 210.7;monocytes: 132.7" "Cell line enhanced" "Detected in many" "Karpas-707: 151.8;U-698: 67.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069136 Supported NA NA 3300000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA069136: AB_2686093" "unprognostic (1.90e-1)" "unprognostic (2.39e-2)" "unprognostic (4.24e-1)" "unprognostic (5.20e-2)" "unprognostic (8.04e-2)" "prognostic favorable (1.09e-4)" "unprognostic (1.97e-1)" "unprognostic (2.50e-2)" "unprognostic (3.51e-1)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (8.20e-4)" "unprognostic (8.77e-2)" "unprognostic (4.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.28e-2)" 6.1 1.0 22.7 24.8 21.5 37.5 9.1 6.1 23.2 10.8 4.7 6.9 3.6 3.0 51.3 32.5 7.9 8.8 3.0 25.3 23.0 18.1 2.1 15.2 31.5 12.2 15.5 5.2 4.0 1.5 3.6 1.8 15.3 16.3 6.1 2.0 19.2 12.5 3.1 32.3 4.8 3.6 11.4 26.9 10.6 4.1 29.0 8.1 23.1 2.2 33.1 10.8 17.4 13.1 12.6 0.0 0.5 0.0 0.0 0.9 0.3 0.2 0.4 0.1 0.2 0.1 0.3 8.1 0.3 0.6 0.1 11.7 0.9 10.0 0.4 3.5 0.0 0.4 0.2 0.4 0.4 18.5 1.1 0.6 9.2 0.2 0.4 2.3 0.9 2.8 1.3 151.8 0.5 15.2 0.1 6.5 3.6 12.4 0.0 0.6 0.3 5.4 17.9 24.1 0.1 0.3 0.0 19.2 1.0 1.7 22.3 23.3 0.9 0.0 0.1 0.0 0.0 29.3 3.0 67.6 0.5 17.5 0.4 16.0 123.9 120.2 4.0 132.7 8.5 13.2 1.3 8.0 183.0 10.9 0.2 1.3 210.7 4.3 76.1 25.7 1.4 66.4 22.7 21.5 6.1 23.2 25.3 23.0 12.2 15.5 15.3 11.4 29.0 13.1 13.6 19.2 63.7 25.8 13.9 23.5 22.5 25.8 24.5 1.9 28.3 27.6 5.9 14.3 13.8 40.5 0.0 0.9 9.8 6.5 1.9 6.1 6.4 12.9 21.6 9.5 3.6 1.3 7.5 0.7 0.4 20.9 22.4 33.5 17.7 0.6 9.3 0.6 15.4 0.0 5.2 24.1 8.2 22.8 42.1 4.3 1.8 37.8 16.0 1.0 32.6 6.3 2.1 1.0 1.0 1.1 7.2 1.2 61.2 14.2 0.8 0.7 9.6 0.4 0.0 100.1 11.3 3.1 0.7 39.0 27.6 1.8 10.0 1.4 17.6 15.6 SEPHS2 "SPS2, SPS2b" ENSG00000179918 "Selenophosphate synthetase 2" Q99611 16 30443631-30445874 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 402.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 385.4;Proximal tubular cells: 384.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 477.5" "Low region specificity" "Detected in all" HPA047931 Approved Approved Nucleoplasm No No 29000 "Cluster 26: Non-specific - Mitochondria" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA047931: AB_2680216" "unprognostic (5.33e-2)" "unprognostic (2.02e-1)" "unprognostic (1.92e-2)" "unprognostic (9.85e-2)" "unprognostic (2.67e-2)" "unprognostic (6.29e-2)" "unprognostic (5.67e-2)" "unprognostic (7.69e-3)" "unprognostic (2.38e-1)" "unprognostic (9.86e-2)" "unprognostic (9.66e-3)" "unprognostic (1.49e-1)" "prognostic favorable (4.35e-8)" "unprognostic (2.24e-2)" "unprognostic (1.35e-1)" "unprognostic (3.25e-2)" "unprognostic (3.62e-2)" 27.5 30.6 16.8 33.7 17.5 26.0 33.8 18.5 19.9 24.8 21.2 75.5 136.0 19.9 23.9 20.4 20.5 34.0 27.8 18.5 20.5 158.5 402.6 28.8 44.8 18.5 18.9 14.9 35.2 48.9 20.4 25.1 19.5 28.7 65.9 19.7 33.6 23.2 41.7 21.1 105.8 25.9 18.6 29.8 62.5 11.5 20.2 43.5 37.7 32.3 41.9 27.7 14.2 19.8 77.6 68.9 23.8 83.1 71.7 45.7 62.5 52.3 64.5 50.5 62.2 42.9 57.7 110.8 79.0 56.0 45.7 42.1 44.5 47.9 51.0 71.2 137.5 110.8 35.9 204.0 90.5 62.0 477.5 58.4 100.5 47.6 87.7 31.6 47.0 80.1 91.1 69.7 45.4 114.5 93.9 127.8 59.3 58.0 51.4 90.2 41.8 85.3 62.6 68.9 50.5 43.1 44.8 129.3 179.7 47.8 113.7 204.2 39.6 52.2 37.1 50.9 32.0 59.6 103.4 57.6 45.3 114.3 59.7 8.7 19.4 30.2 14.8 16.1 22.2 17.8 20.9 21.4 21.6 20.2 25.0 17.2 17.6 31.9 20.5 15.4 22.8 14.8 16.8 17.5 18.5 19.9 18.5 20.5 18.5 18.9 19.5 18.6 20.2 19.8 76.2 44.8 40.3 3.9 34.3 37.5 1.4 47.6 58.6 0.5 66.2 52.7 49.4 1.5 39.4 64.4 0.0 1.3 41.5 108.9 385.4 112.2 0.1 34.2 25.1 32.4 35.5 20.8 6.7 82.7 1.1 30.4 68.8 59.2 31.0 20.5 0.7 9.1 1.4 0.0 8.6 31.0 63.1 2.9 34.9 0.1 0.0 42.5 44.4 5.6 37.1 0.2 1.0 5.5 4.6 57.4 42.4 0.0 30.6 1.6 11.1 384.9 27.2 1.1 0.0 2.0 49.4 0.8 0.8 45.4 42.6 1.2 35.7 52.6 46.0 0.9 SERTAD1 "SEI1, TRIP-Br1" ENSG00000197019 "SERTA domain containing 1" Q9UHV2 19 40421589-40425992 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 480.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063323 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" Nucleoplasm "HPA063323: AB_2684984" "unprognostic (2.23e-2)" "unprognostic (4.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.55e-1)" "unprognostic (3.44e-3)" "unprognostic (1.01e-2)" "unprognostic (3.82e-2)" "unprognostic (1.62e-1)" "unprognostic (5.21e-2)" "unprognostic (1.28e-1)" "unprognostic (9.46e-2)" "unprognostic (9.43e-2)" "unprognostic (1.74e-1)" "unprognostic (3.08e-3)" 27.1 9.3 8.1 7.3 7.8 28.7 10.7 9.4 12.1 9.1 8.5 12.0 6.7 11.3 2.1 18.8 15.2 12.7 21.2 9.0 7.5 21.9 14.1 22.3 5.8 8.7 7.9 6.9 15.1 4.4 8.9 6.6 8.7 11.1 3.0 0.9 8.4 4.2 15.1 15.5 10.8 7.1 8.4 10.0 18.8 3.8 9.7 5.5 11.6 13.2 3.5 11.0 11.9 8.7 18.5 21.4 3.0 7.4 8.3 5.9 8.0 29.0 8.7 15.4 15.1 9.5 14.6 3.6 13.4 9.8 4.4 7.4 2.4 26.2 4.7 10.1 5.1 3.2 5.0 8.3 9.4 1.1 11.0 9.6 15.8 16.8 3.1 7.4 8.7 3.1 6.8 5.6 14.1 27.7 1.7 5.6 2.3 13.2 14.2 2.2 4.8 9.3 8.2 12.8 0.9 1.4 15.3 14.0 14.5 3.4 14.0 3.1 16.2 15.2 17.2 12.3 19.8 8.1 3.6 4.8 21.3 4.8 7.2 22.5 21.9 15.0 9.7 19.8 5.8 13.3 9.5 9.3 26.1 12.7 10.9 7.8 17.5 15.9 19.4 23.8 14.2 13.6 8.1 7.8 9.4 12.1 9.0 7.5 8.7 7.9 8.7 8.4 9.7 8.7 480.2 73.7 52.3 2.3 138.2 126.2 196.5 83.4 243.6 5.0 221.4 299.7 83.2 32.9 51.5 31.3 0.0 46.0 203.8 246.0 23.5 62.6 1.4 100.0 72.1 156.1 106.1 6.1 1.1 61.7 72.8 159.7 169.7 126.7 132.9 27.9 86.7 12.8 53.9 3.3 0.6 152.3 46.8 28.9 98.3 4.2 16.4 102.6 94.3 4.7 30.0 17.9 6.2 1.5 0.8 91.6 300.8 10.9 69.7 130.9 158.9 18.5 31.7 2.4 39.5 292.5 201.5 1.7 5.4 174.7 130.4 130.2 150.4 24.2 102.0 111.9 SERTAD3 RBT1 ENSG00000167565 "SERTA domain containing 3" Q9UJW9 19 40440844-40444335 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 187.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068262 Approved Nucleoli NA Yes "Cluster 28: Myeloid DCs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoli "HPA068262: AB_2685965" "unprognostic (1.56e-2)" "unprognostic (3.57e-2)" "unprognostic (1.10e-1)" "unprognostic (6.55e-3)" "unprognostic (6.50e-2)" "unprognostic (6.74e-2)" "unprognostic (2.24e-2)" "unprognostic (3.51e-3)" "unprognostic (7.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.28e-3)" "unprognostic (2.80e-2)" "unprognostic (8.74e-3)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.18e-1)" "unprognostic (4.66e-3)" 31.9 21.5 10.9 18.7 12.5 22.7 23.3 12.1 11.8 19.9 12.3 29.8 21.5 22.5 26.6 25.9 24.8 25.5 27.9 10.7 12.3 21.2 17.3 24.0 21.8 14.1 12.6 25.8 14.9 22.4 17.7 31.4 13.0 29.1 22.9 2.5 18.0 27.0 27.5 19.4 19.8 27.4 12.4 24.8 24.4 16.1 12.3 16.0 24.8 37.1 16.2 26.1 24.5 14.2 36.6 65.3 22.4 30.4 25.7 38.4 32.6 28.3 38.8 39.7 34.3 24.9 27.2 16.6 12.6 37.9 23.9 12.6 23.0 28.3 21.7 19.2 10.7 11.4 21.5 21.3 31.4 3.2 34.7 35.7 37.3 24.6 17.9 31.7 33.3 8.0 34.6 11.9 32.0 55.4 7.1 14.2 12.7 30.8 17.5 10.1 15.1 14.6 31.4 27.6 3.6 15.1 25.6 42.1 22.9 33.7 37.3 30.6 28.7 34.2 27.7 27.4 23.2 19.0 10.5 14.7 27.5 12.7 15.6 44.8 59.0 66.1 18.5 59.2 19.0 39.9 20.4 20.5 64.7 36.6 14.8 17.7 80.3 22.5 51.7 69.8 17.6 40.0 10.9 12.5 12.1 11.8 10.7 12.3 14.1 12.6 13.0 12.4 12.3 14.2 78.4 9.6 12.0 2.9 42.0 46.1 55.8 139.9 91.6 4.6 81.5 50.9 10.5 11.5 45.4 23.9 4.2 89.8 44.2 40.7 31.3 32.1 11.4 26.0 24.8 42.1 49.1 3.0 0.3 30.5 105.4 38.9 27.5 30.7 21.0 13.2 33.9 6.6 35.0 3.3 0.5 50.8 42.7 27.0 55.3 6.9 28.6 32.1 33.8 8.4 29.1 19.3 4.1 1.5 3.7 37.1 48.5 30.5 16.3 50.5 47.8 22.7 28.0 0.8 59.2 20.2 50.4 15.7 20.0 64.2 43.0 187.4 33.6 17.6 30.6 49.8 SESN2 "DKFZp761M0212, HI95, SES2, SEST2" ENSG00000130766 "Sestrin 2" P58004 1 28259518-28282491 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 66.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 46.5;SK-MEL-30: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018191 Uncertain Approved Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA018191: AB_1856750" "unprognostic (7.05e-2)" "unprognostic (4.95e-3)" "unprognostic (1.43e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.78e-4)" "unprognostic (8.97e-2)" "unprognostic (2.50e-3)" "unprognostic (1.41e-1)" "unprognostic (1.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (2.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.84e-1)" "unprognostic (1.60e-1)" 10.9 9.0 6.4 2.9 6.3 19.4 8.5 5.8 7.5 7.4 5.2 10.1 7.6 8.2 1.6 20.0 7.9 3.3 6.3 5.9 7.1 15.9 24.7 9.6 2.0 7.5 7.5 27.9 10.6 4.4 6.6 4.8 6.9 6.2 4.0 1.4 8.5 1.9 7.6 5.3 8.8 2.9 6.8 6.9 11.1 10.7 9.5 2.4 5.3 2.4 2.0 7.6 8.8 7.1 5.6 3.0 7.1 11.8 11.3 8.9 38.6 10.5 9.6 6.3 7.4 4.3 4.0 6.3 4.3 4.8 7.0 5.5 8.3 7.4 4.3 5.7 7.7 2.6 4.3 7.3 37.0 9.5 13.7 28.1 46.5 16.9 40.0 2.9 7.0 14.6 15.2 29.3 5.9 3.2 3.5 2.6 5.7 2.6 6.0 5.3 1.9 14.6 4.2 9.3 2.4 2.8 3.0 2.4 58.5 7.8 6.5 13.4 4.1 3.2 9.9 7.3 6.4 37.9 10.4 10.0 7.5 9.5 7.2 0.0 1.5 1.3 5.7 1.2 2.7 1.1 2.0 2.8 1.5 0.7 1.2 2.5 3.9 2.5 1.9 1.7 2.4 1.8 6.4 6.3 5.8 7.5 5.9 7.1 7.5 7.5 6.9 6.8 9.5 7.1 26.4 0.0 5.0 3.6 9.9 17.0 21.1 14.2 26.7 11.6 21.4 15.1 7.3 12.8 9.0 7.3 8.4 31.2 30.6 35.9 3.9 24.3 6.5 11.8 8.9 7.8 13.1 2.7 3.9 16.9 27.0 11.8 13.7 12.1 4.5 10.9 9.3 19.8 13.8 0.0 6.1 11.2 16.2 5.7 22.2 3.7 2.5 20.0 7.2 4.7 5.9 6.6 9.2 3.5 1.4 31.9 15.2 3.4 13.0 13.6 27.7 23.4 8.3 7.8 0.0 7.9 14.3 5.6 12.5 19.8 12.5 66.9 20.7 7.3 12.8 29.9 SFPQ "PPP1R140, PSF" ENSG00000116560 "Splicing factor proline and glutamine rich" P23246 1 35176378-35193145 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009886, HPA047513, HPA054689" Enhanced Enhanced Nucleoplasm NA NA 640000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574" "prognostic favorable (9.56e-5)" "unprognostic (1.01e-1)" "unprognostic (1.02e-3)" "unprognostic (1.99e-1)" "unprognostic (5.53e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (7.91e-13)" "unprognostic (3.10e-1)" "unprognostic (4.00e-3)" "unprognostic (3.85e-2)" "unprognostic (2.20e-2)" "unprognostic (8.03e-3)" "unprognostic (1.25e-3)" "unprognostic (1.16e-2)" "unprognostic (3.97e-3)" "unprognostic (3.07e-1)" "unprognostic (3.77e-3)" 62.9 46.7 25.1 62.1 26.0 215.1 53.2 38.5 32.3 54.0 23.4 46.9 44.6 60.2 51.0 59.8 54.6 39.9 43.8 24.8 30.7 48.8 50.6 40.8 76.4 30.2 27.2 74.4 52.8 44.9 34.4 51.8 25.2 49.8 54.4 47.4 52.8 35.6 63.9 60.0 47.6 52.9 23.0 54.1 48.0 45.8 24.9 85.5 44.8 27.4 94.5 58.1 52.5 44.6 180.5 147.3 251.1 142.9 60.5 90.0 234.7 96.1 97.1 160.4 116.3 161.5 126.4 325.6 130.1 111.8 100.6 160.4 276.1 188.3 217.0 175.2 183.0 245.5 156.2 193.6 81.5 258.2 140.1 72.4 71.7 139.4 67.3 70.9 142.3 169.1 282.6 150.9 158.3 156.8 304.2 220.1 299.7 107.8 140.7 304.5 170.4 213.6 156.2 214.4 180.1 200.3 138.6 106.3 147.1 174.4 125.0 181.7 152.3 127.7 188.3 84.7 208.9 171.2 156.5 327.6 91.1 168.6 185.9 2.6 4.1 3.0 4.7 5.8 5.4 4.1 4.6 3.8 3.8 4.5 4.3 4.8 2.1 3.4 4.7 7.3 5.6 2.3 25.1 26.0 38.5 32.3 24.8 30.7 30.2 27.2 25.2 23.0 24.9 44.6 286.7 169.9 237.7 149.8 317.4 357.5 239.3 80.6 234.5 230.0 231.6 191.0 149.6 82.9 146.2 110.3 191.8 206.5 339.0 149.7 82.2 120.1 126.8 230.1 318.9 222.2 219.6 198.9 127.3 138.4 222.9 255.8 267.6 333.1 155.8 450.5 123.5 109.1 141.4 171.6 143.4 189.5 59.0 129.4 216.9 361.9 142.9 258.5 140.5 104.9 146.2 152.6 127.7 248.8 183.1 162.0 126.7 116.6 291.8 159.9 94.8 87.6 114.8 223.6 52.6 530.6 259.2 199.1 171.9 287.9 327.3 305.5 313.7 223.7 220.0 167.7 SHISAL2A "FAM159A, MGC52498" ENSG00000182183 "Shisa like 2A" Q6UWV7 1 52633168-52669683 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.7;intestine: 3.7;lymphoid tissue: 5.6" "Cell type enhanced" "Detected in some" "B-cells: 4.3;dendritic cells: 9.8;Endometrial stromal cells: 2.6;Hofbauer cells: 1.8;Macrophages: 2.2;T-cells: 6.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hypothalamus: 8.7" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 10.1;NK-cells: 5.9;T-cells: 7.0" "Cell line enhanced" "Detected in some" "Daudi: 4.1;Karpas-707: 9.4;NB-4: 2.9;RPMI-8226: 13.0" "Region enhanced" "Detected in some" "hypothalamus: 4.0" "Low region specificity" "Detected in some" HPA030744 Uncertain NA NA "Cluster 37: B-cells - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA030744: AB_10963060" "unprognostic (7.94e-6)" "unprognostic (8.50e-3)" "unprognostic (8.29e-3)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (9.67e-4)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (2.22e-2)" "unprognostic (4.45e-2)" "unprognostic (2.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-3)" "unprognostic (7.27e-2)" "unprognostic (2.79e-1)" "unprognostic (6.50e-2)" "unprognostic (2.64e-2)" 0.4 0.2 0.8 2.3 0.7 1.7 0.2 0.8 1.0 1.0 0.4 0.4 0.3 0.4 0.7 0.2 0.6 0.3 0.1 0.5 8.7 0.3 0.2 0.7 5.6 1.0 1.6 0.0 0.2 0.0 2.0 0.1 1.1 0.4 0.3 0.1 0.3 0.3 0.3 0.0 3.7 0.0 0.9 5.4 0.5 0.8 2.5 1.0 0.7 0.2 5.2 0.3 0.2 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 2.9 1.6 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 7.0 0.0 3.9 10.1 6.2 5.6 0.0 9.8 4.3 2.6 0.0 5.9 0.0 0.0 2.1 1.6 0.8 0.7 0.8 1.0 0.5 8.7 1.0 1.6 1.1 0.9 2.5 1.2 0.6 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.6 2.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 6.4 0.5 0.0 0.0 SHLD1 "C20orf196, FLJ25067, RINN3" ENSG00000171984 "Shieldin complex subunit 1" Q8IYI0 20 5750393-5864395 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;dendritic cells: 13.1;Distal tubular cells: 19.6;Exocrine glandular cells: 14.2;Hofbauer cells: 17.0;Pancreatic endocrine cells: 11.7;Proximal tubular cells: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 55.7;U-698: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040749 Approved Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum, Golgi apparatus, Vesicles" "HPA040749: AB_10673093" "unprognostic (2.03e-1)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "unprognostic (4.20e-3)" "unprognostic (6.15e-2)" "unprognostic (1.66e-1)" "unprognostic (1.72e-3)" "unprognostic (6.66e-2)" "unprognostic (9.04e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-2)" "unprognostic (7.59e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "prognostic favorable (4.05e-5)" 4.0 9.7 5.0 6.2 5.8 16.7 5.3 7.2 6.1 5.1 4.6 5.1 9.1 3.8 5.3 5.4 3.9 4.4 8.6 4.9 5.8 6.7 3.0 4.8 14.3 5.6 5.3 5.1 5.2 2.4 6.0 3.0 6.3 6.3 4.9 4.0 8.4 3.7 12.0 4.1 7.1 2.6 4.6 9.9 4.7 3.1 5.4 13.3 6.6 7.7 12.1 4.5 4.7 6.4 9.2 9.6 4.6 2.3 2.8 2.8 2.3 2.5 4.5 3.1 4.3 4.5 9.4 33.3 6.3 2.5 2.5 4.1 2.8 6.1 3.6 10.3 3.4 12.9 1.4 18.2 6.2 16.2 5.7 3.3 7.2 4.7 3.1 3.0 6.4 8.7 17.8 13.9 5.9 3.5 20.4 55.7 6.3 10.3 5.2 16.5 7.1 15.1 5.0 4.5 8.2 7.4 4.6 4.7 10.0 2.6 3.9 13.2 4.3 3.6 5.4 3.5 5.4 8.7 16.6 45.8 1.8 13.9 6.4 21.7 12.4 22.5 21.3 14.8 16.4 27.7 25.2 21.5 12.7 33.1 22.9 17.2 4.9 23.5 16.9 15.1 31.5 13.0 5.0 5.8 7.2 6.1 4.9 5.8 5.6 5.3 6.3 4.6 5.4 6.4 9.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 6.4 8.6 0.0 0.0 0.0 12.9 0.0 7.5 13.1 0.0 19.6 7.9 0.0 6.4 4.4 2.8 0.0 0.0 0.0 14.2 7.5 1.7 0.0 5.2 0.0 7.3 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 11.7 0.0 0.0 2.3 0.0 0.0 11.7 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 5.9 6.4 5.0 0.0 0.0 SHLD2 "bA163M19.1, FAM35A, FAM35A1, MGC5560, RINN2" ENSG00000122376 "Shieldin complex subunit 2" Q86V20 10 87094161-87191465 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 31.3;Endometrial stromal cells: 28.6;Glandular and luminal cells: 29.0;Proximal tubular cells: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036582 Uncertain Approved "Nucleoplasm,Actin filaments" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Actin filaments" "HPA036582: AB_10670233" "unprognostic (1.08e-1)" "unprognostic (2.72e-1)" "prognostic favorable (6.06e-4)" "unprognostic (1.77e-1)" "prognostic favorable (3.09e-4)" "unprognostic (5.34e-2)" "unprognostic (2.68e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (8.20e-2)" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" "unprognostic (6.44e-3)" "unprognostic (3.61e-2)" 15.6 20.1 10.8 12.6 8.4 9.6 17.3 7.3 10.0 11.9 10.2 15.7 22.3 11.4 7.0 12.8 11.2 10.7 10.3 8.6 10.5 32.1 37.2 11.6 13.1 27.5 10.9 12.7 12.4 6.1 10.9 9.7 8.8 14.9 16.5 15.6 14.3 9.5 10.6 12.0 24.8 12.2 9.3 11.9 12.0 8.0 10.1 10.4 23.3 11.7 14.4 13.3 11.2 8.7 33.6 26.7 14.9 34.4 16.4 15.8 21.7 22.1 31.0 29.0 31.8 30.8 25.2 24.4 12.1 30.2 17.0 21.9 37.2 16.9 29.8 35.1 24.6 33.9 24.3 29.1 25.4 53.4 28.5 14.5 30.4 26.6 45.4 25.6 19.6 26.3 43.7 42.7 27.2 19.2 43.7 37.8 17.2 24.2 18.4 26.8 29.6 27.0 26.6 27.7 7.4 30.6 17.1 19.9 29.8 13.7 44.0 29.6 19.4 16.5 15.0 24.8 44.7 23.9 55.8 58.5 27.8 65.4 9.1 7.1 7.3 2.8 6.7 11.8 13.7 9.2 10.0 10.0 11.3 8.8 10.0 10.1 0.1 12.5 9.5 3.9 10.4 8.7 10.8 8.4 7.3 10.0 8.6 10.5 27.5 10.9 8.8 9.3 10.1 8.7 21.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 20.9 13.2 0.0 0.0 0.0 5.5 0.0 7.2 17.4 0.0 31.3 12.6 0.0 16.7 28.6 4.2 0.0 0.0 0.0 13.7 15.1 7.9 0.0 29.0 0.0 20.2 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 8.8 0.0 0.0 0.0 0.0 14.7 0.0 0.0 7.6 0.0 0.0 48.2 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 2.2 7.8 19.1 0.0 0.0 SHLD3 "AC008560.1, CTC-534A2.2, FLJ26957, RINN1" ENSG00000253251 "Shieldin complex subunit 3" Q6ZNX1 5 65625027-65630928 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 17.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.0;dendritic cells: 5.9;Distal tubular cells: 3.9;Pancreatic endocrine cells: 4.6;Proximal tubular cells: 5.3;Syncytiotrophoblasts: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066071, HPA068764" Approved Supported Nucleoplasm,Nucleoli No No "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA066071: AB_2685609, HPA068764: AB_2686028" "unprognostic (7.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.38e-2)" "unprognostic (7.24e-3)" "unprognostic (5.09e-4)" "unprognostic (2.12e-2)" "unprognostic (1.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.17e-4)" 2.3 2.7 2.4 2.7 2.5 17.5 4.2 2.8 3.6 1.8 1.8 2.8 2.8 2.3 3.1 1.5 1.9 2.4 1.8 2.3 2.1 2.9 2.6 2.5 4.8 2.4 2.1 1.5 3.4 2.1 2.5 2.5 2.3 4.3 3.0 3.7 2.0 2.5 1.8 2.9 2.7 1.7 2.4 2.5 2.4 3.2 2.4 3.9 2.4 1.9 3.6 2.5 1.3 3.2 2.6 3.6 5.0 10.8 2.9 3.5 6.3 3.8 3.5 5.8 7.0 5.9 8.0 4.9 4.2 4.6 6.5 3.1 5.1 4.7 8.5 6.7 6.5 4.3 10.3 8.3 2.5 5.0 7.5 2.1 6.8 6.0 6.1 1.6 3.7 7.7 6.4 11.5 4.7 6.9 6.7 7.7 4.0 1.5 2.2 4.4 4.9 7.9 4.9 6.0 6.7 5.5 3.2 3.3 11.0 3.4 3.8 4.6 3.0 5.0 6.8 4.1 6.6 7.2 14.3 10.7 3.7 6.1 4.7 15.9 3.0 6.4 3.8 2.9 4.0 3.9 4.5 4.0 2.8 3.1 6.1 5.6 3.3 4.9 3.1 3.2 6.2 2.1 2.4 2.5 2.8 3.6 2.3 2.1 2.4 2.1 2.3 2.4 2.4 3.2 3.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.8 3.6 0.0 0.0 0.0 0.0 0.0 4.0 5.9 0.0 3.9 3.1 0.0 1.9 1.8 0.8 0.0 0.0 0.0 2.9 3.8 0.9 0.0 2.1 0.0 2.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.1 1.8 2.1 0.0 0.0 SIRT1 SIR2L1 ENSG00000096717 "Sirtuin 1" Q96EB6 10 67884656-67918390 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 292.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003855, HPA006295, HPA052351" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli fibrillar center, Mitochondria, Cytosol" "CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796" "unprognostic (1.55e-1)" "unprognostic (2.78e-1)" "unprognostic (9.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-2)" "unprognostic (2.48e-1)" "unprognostic (4.95e-2)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (2.18e-2)" "unprognostic (2.83e-2)" "unprognostic (9.67e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" 16.4 30.2 8.9 11.0 10.4 19.8 17.5 15.6 11.9 17.1 7.8 12.5 9.2 18.5 11.9 10.9 11.9 14.0 10.6 8.5 9.9 13.4 17.3 12.6 17.7 9.3 9.2 25.1 12.1 14.0 6.9 12.7 10.0 14.0 12.0 13.5 9.9 11.2 14.6 9.6 9.7 13.7 8.8 14.3 10.3 26.8 9.4 19.2 14.7 18.5 15.1 15.5 9.5 12.9 15.1 16.8 26.2 29.4 24.4 18.7 16.3 20.4 21.0 27.4 24.3 18.7 12.6 31.4 10.8 13.7 17.1 11.7 32.8 6.9 29.3 16.9 19.0 16.7 12.1 14.7 22.3 18.1 12.3 17.3 16.2 16.6 28.3 29.4 11.2 17.6 21.6 16.7 20.3 12.1 17.0 25.0 32.5 9.6 26.6 30.3 20.6 12.4 13.1 9.1 16.8 23.0 37.4 24.4 26.8 22.5 17.7 16.6 9.4 21.2 19.8 19.0 20.1 13.9 17.7 61.8 10.9 27.2 8.9 1.3 0.8 1.1 1.1 1.0 1.6 1.8 1.2 1.5 1.3 1.0 2.2 1.3 1.0 1.2 1.3 1.2 1.0 0.6 8.9 10.4 15.6 11.9 8.5 9.9 9.3 9.2 10.0 8.8 9.4 12.9 35.7 19.2 7.4 17.0 27.6 39.1 20.9 7.2 22.8 12.5 48.3 33.4 34.8 11.5 8.7 5.5 27.1 7.1 42.5 31.2 5.9 4.3 292.2 38.4 26.2 20.6 42.9 10.3 16.0 5.6 5.4 28.0 23.4 57.1 12.0 14.8 15.4 15.8 9.1 11.8 18.4 21.0 10.2 23.4 28.7 45.6 17.7 34.1 16.0 30.9 14.8 7.1 9.2 18.6 30.7 6.2 20.6 19.5 15.8 26.0 11.2 8.4 4.1 14.0 0.0 43.4 28.8 24.2 16.3 21.1 47.5 12.4 29.1 8.9 18.7 17.2 SKIL "SNO, SnoA, SnoN" ENSG00000136603 "SKI like proto-oncogene" P12757 3 170357678-170396835 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008472, HPA014233" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA008472: AB_1856933, HPA014233: " "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (3.95e-2)" "unprognostic (3.51e-3)" "unprognostic (7.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.21e-2)" "unprognostic (1.68e-2)" "unprognostic (2.52e-2)" "unprognostic (7.79e-2)" "unprognostic (2.26e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.19e-7)" "unprognostic (2.94e-2)" "unprognostic (7.34e-2)" "unprognostic (8.73e-2)" "unprognostic (3.34e-1)" 11.9 12.0 6.1 18.8 7.3 23.1 9.0 8.5 10.0 9.4 8.3 10.4 13.8 12.0 8.2 9.2 6.4 21.1 12.0 6.6 10.9 10.3 15.6 16.1 13.8 10.7 10.8 9.2 9.6 5.7 11.0 13.9 10.5 11.6 9.7 9.6 7.4 8.9 11.0 5.8 14.2 10.5 12.0 7.2 15.9 13.0 11.4 9.2 11.3 21.4 18.4 14.6 8.8 13.2 19.9 24.0 15.6 10.4 20.0 8.7 29.1 19.6 13.6 13.8 10.6 4.9 42.2 24.9 60.5 18.2 23.1 44.8 9.9 9.0 21.3 43.6 9.2 32.8 24.8 11.0 17.8 13.7 17.4 15.3 8.8 19.9 15.0 42.9 34.1 2.4 14.7 27.9 28.4 21.3 5.9 4.5 61.2 21.8 8.1 13.6 52.8 5.0 20.8 31.7 11.5 14.1 48.3 47.4 10.3 31.6 32.2 14.2 66.1 38.2 35.9 33.0 37.1 36.2 18.6 47.3 14.3 7.1 18.3 3.1 3.4 1.8 1.3 8.3 1.8 3.6 1.1 1.7 2.4 4.4 1.9 2.0 4.0 2.8 10.3 1.6 0.5 1.9 6.1 7.3 8.5 10.0 6.6 10.9 10.7 10.8 10.5 12.0 11.4 13.2 104.1 73.7 72.8 21.2 142.1 72.7 88.8 52.5 67.7 25.6 79.3 38.1 12.4 21.5 70.4 35.0 54.2 14.8 124.9 45.9 15.6 56.7 115.7 118.4 80.9 86.0 23.8 3.0 48.6 111.4 58.3 100.6 93.8 102.0 204.8 46.3 72.5 32.0 26.3 53.8 21.6 62.4 22.4 65.4 85.2 35.8 37.9 121.7 35.6 60.0 42.1 12.7 14.4 26.2 27.5 176.5 29.1 68.1 104.3 43.5 41.3 45.9 82.1 30.5 26.3 143.6 63.6 53.9 37.6 61.3 96.0 41.2 81.5 17.5 31.3 117.8 SLC38A2 "ATA2, KIAA1382, SAT2, SNAT2" ENSG00000134294 "Solute carrier family 38 member 2" Q96QD8 12 46358188-46372773 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 1118.3;Suprabasal keratinocytes: 1078.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 1198.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035180, HPA069672" Approved Supported "Plasma membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 85: Liver - Metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane" "HPA035180: AB_10669901, HPA069672: " "unprognostic (6.61e-3)" "unprognostic (2.87e-2)" "unprognostic (4.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.96e-1)" "unprognostic (1.00e-2)" "unprognostic (7.78e-2)" "unprognostic (5.50e-3)" "unprognostic (1.20e-1)" "unprognostic (3.79e-1)" "unprognostic (9.24e-3)" "unprognostic (1.75e-1)" "unprognostic (1.47e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.68e-2)" 112.8 113.0 36.1 71.6 48.5 95.4 88.5 53.9 50.2 91.7 25.8 58.3 33.6 92.9 38.6 108.1 83.6 131.3 60.7 32.4 46.1 64.8 307.3 117.0 67.1 52.2 42.7 130.1 74.7 91.5 27.9 162.1 53.5 52.8 49.7 27.0 77.2 43.1 108.5 204.4 54.4 115.8 44.2 75.3 63.0 25.4 44.2 100.4 63.1 174.7 78.1 98.9 88.0 73.0 83.7 179.9 157.6 444.1 356.7 347.7 118.1 382.8 921.2 313.0 254.0 108.2 151.2 0.1 504.2 627.9 215.3 271.1 107.9 335.1 299.1 67.0 61.0 105.8 208.7 339.9 548.8 88.0 108.7 357.2 718.4 199.5 1198.9 778.5 265.7 116.3 103.8 163.1 560.4 100.0 110.3 122.8 138.2 0.1 185.1 97.5 115.5 200.9 191.6 173.4 103.9 89.8 263.5 68.5 233.7 171.0 140.5 193.8 467.3 156.7 121.8 67.8 62.2 187.8 194.3 100.6 148.0 304.5 76.8 41.1 24.9 18.9 22.7 13.1 17.4 19.2 19.0 23.0 35.2 17.8 23.5 24.8 17.5 51.6 18.4 40.6 23.7 27.6 36.1 48.5 53.9 50.2 32.4 46.1 52.2 42.7 53.5 44.2 44.2 73.0 237.7 83.3 77.4 31.3 187.7 1118.3 134.1 262.8 653.9 40.5 315.7 252.2 153.6 108.7 123.9 57.0 70.9 53.8 292.3 114.6 5.9 41.2 5.5 228.5 245.0 234.7 76.7 109.0 54.6 51.1 49.3 219.1 328.2 464.0 81.6 138.3 227.7 265.9 54.0 53.8 58.9 175.0 130.2 143.3 303.6 12.4 263.2 193.8 250.8 59.0 52.6 74.3 70.0 42.3 136.2 79.4 83.5 85.0 322.2 181.7 67.4 24.4 50.3 68.7 282.7 184.8 339.5 6.7 15.5 532.6 1078.3 38.4 252.4 84.0 110.7 150.8 SMIM10L1 ENSG00000256537 "Small integral membrane protein 10 like 1" P0DMW3 12 11171194-11176016 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 39: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 7: Non-specific - Mitochondria" "unprognostic (2.27e-1)" "unprognostic (5.11e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-2)" "unprognostic (3.49e-2)" "unprognostic (1.36e-1)" "unprognostic (2.97e-3)" "unprognostic (3.14e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.71e-4)" "unprognostic (2.80e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.56e-4)" "unprognostic (8.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.45e-1)" "prognostic favorable (9.70e-4)" 5.9 16.1 12.0 4.8 12.1 5.8 4.9 11.3 15.5 4.4 11.8 9.8 5.2 6.7 7.9 4.2 4.6 3.5 14.4 12.4 12.5 7.5 10.6 4.7 4.7 12.3 12.5 3.8 4.8 5.6 8.8 4.8 12.3 6.6 4.5 7.3 11.5 6.2 21.7 2.7 5.9 5.5 13.0 6.1 6.4 3.2 12.4 6.2 6.0 10.2 4.0 6.9 3.9 12.6 10.5 6.3 16.6 7.3 13.2 9.6 14.5 15.4 9.2 9.9 7.7 13.3 9.2 8.7 6.7 8.7 12.6 6.8 9.9 7.7 12.6 30.3 11.7 15.9 9.2 12.9 9.1 22.4 5.1 8.5 6.7 10.1 10.1 11.8 8.1 14.5 11.6 7.7 11.4 10.1 15.7 18.6 26.9 5.7 8.1 13.0 19.8 9.3 12.5 11.9 8.8 9.7 12.5 7.6 23.0 27.0 4.1 15.1 9.9 17.7 25.1 7.7 15.5 6.6 14.5 21.3 12.9 13.0 16.3 22.1 9.7 11.4 8.9 8.3 9.6 6.1 9.3 9.4 7.9 7.4 10.3 8.5 1.2 12.8 7.9 9.6 10.4 9.0 12.0 12.1 11.3 15.5 12.4 12.5 12.3 12.5 12.3 13.0 12.4 12.6 33.8 16.0 27.4 0.0 25.6 0.0 15.3 0.0 23.3 26.7 33.6 38.2 88.4 35.8 18.0 7.3 25.0 56.7 47.3 9.3 52.8 48.7 5.2 33.1 26.0 36.1 12.2 40.0 0.0 50.7 23.9 28.0 17.3 21.0 16.4 24.9 29.3 34.9 43.8 26.9 0.0 18.5 0.0 25.8 0.0 9.9 26.4 26.8 0.0 0.0 38.5 29.5 56.7 0.0 0.0 52.7 13.3 32.4 41.8 23.4 38.0 68.1 16.8 34.4 32.9 22.9 33.6 11.5 22.0 19.8 0.0 17.9 30.7 46.8 17.3 11.1 SMIM26 "LINC00493, LOC388789" ENSG00000232388 "Small integral membrane protein 26" A0A096LP01 20 18567347-18569563 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 252.6;Breast myoepithelial cells: 317.5;Distal tubular cells: 389.4;Proximal tubular cells: 588.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068733 Approved Nucleoplasm,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA068733: AB_2686024" "unprognostic (1.20e-2)" "unprognostic (5.85e-2)" "unprognostic (2.83e-1)" "unprognostic (8.06e-2)" "unprognostic (2.68e-1)" "unprognostic (1.65e-1)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.67e-3)" "unprognostic (2.16e-1)" "unprognostic (2.68e-2)" "unprognostic (2.40e-2)" "unprognostic (2.02e-1)" "unprognostic (3.18e-1)" "prognostic favorable (7.84e-5)" 76.0 104.3 92.2 43.6 96.2 83.4 107.0 102.7 123.1 72.8 103.9 89.8 63.2 67.2 134.8 71.0 78.9 67.9 136.4 93.6 97.0 96.1 117.7 53.7 72.6 94.8 93.6 113.0 103.4 99.4 90.7 51.3 96.9 71.3 69.8 63.1 91.1 61.9 243.1 69.2 65.8 56.5 96.2 57.8 98.5 37.6 94.4 88.7 85.2 213.5 73.6 79.7 63.6 103.4 99.3 129.1 94.3 98.0 85.9 116.0 110.8 72.3 86.5 83.4 95.2 80.9 113.0 99.4 81.1 79.7 149.1 106.8 90.4 120.2 95.9 42.5 112.9 131.7 59.4 270.2 162.4 86.6 96.5 100.0 159.4 94.6 152.2 144.7 128.1 120.8 98.5 89.3 105.4 125.0 104.0 240.4 53.8 188.5 153.6 67.4 110.0 136.8 192.0 100.4 92.8 98.1 77.2 145.6 297.5 82.9 106.8 126.0 65.8 58.1 60.8 71.7 76.6 85.0 229.8 113.7 52.2 56.2 44.4 142.4 133.5 108.6 96.5 116.6 102.8 155.6 131.7 112.3 164.5 145.7 145.0 139.2 241.3 99.5 112.8 157.7 150.0 130.5 92.2 96.2 102.7 123.1 93.6 97.0 94.8 93.6 96.9 96.2 94.4 103.4 83.8 128.2 83.8 0.0 44.4 0.0 0.0 0.0 0.0 0.0 252.6 317.5 0.0 0.0 35.9 171.0 0.0 205.5 62.6 0.0 389.4 146.2 0.0 185.2 95.5 36.4 0.0 0.0 0.0 214.3 137.9 57.8 0.0 118.7 35.3 100.5 0.0 0.0 188.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.0 0.0 66.2 0.0 0.0 0.0 0.0 187.7 0.0 0.0 12.1 0.0 0.0 588.2 87.5 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 208.0 37.2 108.8 0.0 0.0 SMIM27 "C9orf133, TOPORS-AS1" ENSG00000235453 "Small integral membrane protein 27" A0A1B0GUW7 9 32551144-32568621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 48.6;Distal tubular cells: 119.3;Proximal tubular cells: 112.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 680.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 680.4" "Low cell line specificity" "Detected in all" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "prognostic favorable (4.18e-5)" "prognostic favorable (6.11e-4)" "unprognostic (1.47e-1)" "unprognostic (5.30e-2)" "unprognostic (4.88e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-1)" "unprognostic (4.74e-3)" "unprognostic (8.58e-2)" "prognostic favorable (8.39e-4)" "prognostic favorable (7.33e-5)" "unprognostic (1.30e-1)" "prognostic favorable (3.46e-4)" "unprognostic (7.64e-2)" "unprognostic (3.14e-1)" "unprognostic (2.38e-2)" "unprognostic (2.14e-3)" 10.0 19.0 22.4 9.3 23.3 17.4 10.4 25.9 28.0 9.1 21.5 11.5 9.6 8.4 13.8 8.6 8.4 3.0 17.5 22.4 24.8 18.6 9.0 9.8 12.2 23.4 22.6 8.5 19.8 13.0 24.0 4.8 23.2 10.2 4.0 18.9 11.9 6.0 28.5 11.0 10.7 4.0 23.1 16.6 12.8 41.7 22.6 17.1 11.7 13.7 8.7 9.4 8.1 26.2 13.8 7.2 13.7 12.4 5.9 17.8 7.5 6.4 10.2 5.3 10.8 1.9 3.5 10.3 10.0 10.2 9.7 5.3 9.4 6.2 7.7 20.0 21.1 50.5 22.5 17.5 13.5 13.0 8.2 13.1 9.6 5.2 12.2 15.1 12.3 33.6 7.4 25.6 9.7 10.3 22.6 52.5 17.0 13.9 14.5 11.1 6.1 18.8 12.8 7.1 10.2 12.4 16.5 6.3 8.8 16.5 5.0 11.0 6.3 3.6 9.5 4.9 6.9 28.5 23.8 38.0 22.7 7.6 3.0 116.8 47.3 332.4 79.5 51.3 107.8 122.1 114.0 93.7 41.8 129.3 135.6 117.4 680.4 93.3 54.9 56.9 129.0 62.9 22.4 23.3 25.9 28.0 22.4 24.8 23.4 22.6 23.2 23.1 22.6 26.2 22.2 28.9 30.1 0.0 13.4 0.0 0.0 0.0 0.0 0.0 38.6 48.6 0.0 0.0 9.3 29.5 0.0 26.4 27.3 0.0 119.3 20.4 0.0 43.9 18.1 8.1 0.0 0.0 0.0 32.2 12.6 6.4 0.0 29.2 25.2 15.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 6.2 0.0 0.0 0.0 0.0 22.9 0.0 0.0 5.3 0.0 0.0 112.9 29.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 20.0 16.7 11.2 0.0 0.0 SMIM29 "C6orf1, LBH, MGC57858" ENSG00000186577 "Small integral membrane protein 29" Q86T20 6 34246381-34249108 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 175.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 72.4;Ductal cells: 50.9;Hofbauer cells: 104.0;monocytes: 44.5;Proximal tubular cells: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 412.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037659, HPA037660" Uncertain NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 17: WM-115 - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "HPA037659: AB_2675591, HPA037660: AB_10671881" "unprognostic (2.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-2)" "unprognostic (2.10e-1)" "unprognostic (3.23e-1)" "unprognostic (1.93e-3)" "unprognostic (1.36e-2)" "unprognostic (2.62e-1)" "unprognostic (4.12e-2)" "prognostic favorable (7.98e-4)" "unprognostic (9.32e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (3.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.66e-1)" 19.4 29.7 133.7 14.4 129.9 14.7 19.5 131.5 175.9 26.5 98.3 24.2 8.4 19.8 34.5 26.9 17.0 17.1 29.8 131.3 135.5 22.5 18.7 27.8 21.3 138.0 136.0 16.4 15.4 18.6 33.4 13.2 142.4 22.8 6.1 16.1 16.2 16.3 24.5 48.8 17.9 12.2 133.5 30.8 16.9 11.7 139.1 14.6 25.7 23.5 15.5 24.0 26.0 128.0 25.1 31.1 6.2 33.3 79.2 62.2 6.7 24.6 58.4 27.4 34.4 7.6 12.3 14.1 19.8 28.6 56.6 15.6 12.7 31.3 8.9 36.0 17.3 10.5 6.1 19.9 45.4 12.0 62.0 33.7 28.4 38.5 37.6 38.4 40.9 11.6 13.5 81.8 64.0 17.9 13.5 24.2 1.9 42.8 21.5 5.5 3.8 25.1 33.1 32.4 26.0 12.1 2.6 23.8 70.9 5.3 14.1 19.1 26.4 62.1 14.4 65.1 21.6 42.9 66.1 4.7 35.4 25.7 82.9 99.1 83.8 412.8 78.7 62.7 52.6 133.3 62.4 69.1 59.7 126.4 41.8 61.8 231.6 57.1 48.3 50.1 90.3 64.0 133.7 129.9 131.5 175.9 131.3 135.5 138.0 136.0 142.4 133.5 139.1 128.0 18.1 9.6 13.6 0.0 5.6 0.0 0.0 0.0 0.0 0.0 28.5 20.8 0.0 0.0 6.8 31.3 0.0 37.8 13.6 0.0 72.4 50.9 0.0 9.9 8.6 15.5 0.0 0.0 0.0 24.0 11.8 8.0 0.0 15.0 12.6 10.8 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 44.5 0.0 0.0 0.0 0.0 25.3 0.0 0.0 1.9 0.0 0.0 43.8 10.2 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 35.4 9.4 17.8 0.0 0.0 SMIM30 LINC00998 ENSG00000214194 "Small integral membrane protein 30" A4D0T7 7 113116718-113118560 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 126.9;Distal tubular cells: 414.8;Hofbauer cells: 243.9;Proximal tubular cells: 396.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 38: Heart - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.25e-1)" "unprognostic (1.73e-3)" "unprognostic (6.77e-2)" "unprognostic (1.04e-2)" "unprognostic (2.44e-3)" "unprognostic (3.89e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.25e-2)" "unprognostic (5.00e-3)" "unprognostic (7.07e-3)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (2.46e-2)" "unprognostic (1.82e-1)" "unprognostic (2.63e-1)" "unprognostic (1.35e-1)" 44.6 53.2 40.8 26.8 41.5 12.2 47.2 41.4 57.8 37.2 40.8 33.3 32.3 30.6 70.9 39.5 30.5 37.4 205.3 40.7 42.7 83.7 57.6 40.0 38.5 42.8 40.0 26.9 41.6 83.9 26.3 29.4 42.5 37.6 35.6 43.5 47.8 30.0 142.5 20.8 27.6 39.0 42.5 41.4 39.4 19.7 41.0 30.2 60.0 149.6 31.8 50.6 21.5 44.8 48.0 24.1 56.3 49.6 100.8 159.8 0.2 57.3 95.0 60.5 94.0 25.1 82.7 57.4 69.5 72.0 104.5 29.9 55.8 126.5 146.8 37.9 113.3 130.3 32.7 42.9 66.8 179.2 0.4 120.8 120.1 91.6 46.8 111.0 95.7 60.6 176.1 52.4 199.6 24.7 76.3 196.4 58.6 72.6 66.0 47.7 136.2 156.9 118.8 63.9 85.1 61.8 43.1 85.6 140.2 97.5 57.5 117.4 55.1 96.8 49.6 110.9 86.2 77.6 102.6 205.3 126.9 161.0 138.0 2.0 15.8 12.5 16.1 17.6 17.9 19.6 18.3 16.9 25.2 17.0 17.2 17.5 0.6 19.7 14.1 36.5 23.2 16.7 40.8 41.5 41.4 57.8 40.7 42.7 42.8 40.0 42.5 42.5 41.0 44.8 32.6 51.3 68.9 0.0 10.4 0.0 0.0 0.0 0.0 0.0 77.4 42.7 0.0 0.0 32.8 126.9 0.0 76.2 8.2 0.0 414.8 102.3 0.0 51.5 37.8 27.7 0.0 0.0 0.0 69.8 61.8 20.7 0.0 43.5 32.8 27.0 0.0 0.0 243.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 44.5 0.0 0.0 0.0 0.0 83.7 0.0 0.0 1.3 0.0 0.0 396.3 32.8 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 41.6 11.0 70.8 0.0 0.0 SMIM33 ENSG00000283288 "Small integral membrane protein 33" A0A1B0GW64 5 139470778-139474772 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.1;salivary gland: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 7: Non-specific - Mitochondria" 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 0.3 0.2 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.1 0.4 0.3 0.2 0.1 0.2 0.1 0.3 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 SMYD5 "NN8-4AG, RAI15, RRG1, ZMYND23" ENSG00000135632 "SMYD family member 5" Q6GMV2 2 73214222-73227221 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015514, HPA049002" Uncertain Approved Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA015514: AB_2669205, HPA049002: AB_2680595" "unprognostic (1.75e-1)" "unprognostic (3.39e-1)" "unprognostic (5.22e-2)" "unprognostic (6.66e-3)" "unprognostic (3.86e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (6.58e-7)" "unprognostic (1.28e-1)" "unprognostic (1.60e-2)" "unprognostic (3.84e-2)" "unprognostic (3.84e-1)" "unprognostic (2.49e-1)" "unprognostic (3.03e-2)" "unprognostic (3.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (2.40e-1)" 13.3 19.1 27.2 12.1 27.8 11.6 14.8 24.3 30.5 15.5 22.0 12.5 7.3 14.4 19.4 14.1 19.5 7.3 17.9 28.2 28.0 18.8 15.2 9.8 13.1 28.9 26.5 28.3 18.4 17.9 15.4 13.1 28.8 15.4 11.3 13.0 12.2 13.4 17.7 14.5 12.4 14.5 25.9 16.2 11.4 17.4 26.9 8.2 14.3 13.0 16.0 17.5 13.1 26.9 24.3 45.2 27.0 25.9 19.3 28.4 45.7 22.8 23.0 43.4 26.6 59.4 24.4 43.1 20.9 38.6 52.1 24.4 42.2 49.4 39.1 26.3 29.7 41.8 19.5 65.9 26.0 41.5 16.5 24.0 31.4 39.7 47.3 19.2 26.7 33.9 44.9 20.2 27.9 34.1 38.8 27.1 42.2 50.8 36.3 25.6 50.6 35.5 28.6 34.6 17.4 25.9 20.7 30.7 26.4 24.4 25.0 14.7 18.5 29.7 46.3 36.5 38.1 22.0 17.7 38.2 33.5 35.2 24.3 0.0 1.4 0.0 5.1 3.9 11.1 6.0 7.0 6.8 3.2 6.2 7.0 7.7 0.0 4.5 4.3 3.0 3.1 4.5 27.2 27.8 24.3 30.5 28.2 28.0 28.9 26.5 28.8 25.9 26.9 26.9 4.1 3.2 5.6 5.2 5.6 5.1 3.9 2.3 1.8 10.2 5.4 6.7 7.2 2.8 4.4 5.5 4.2 9.0 3.4 2.4 1.9 8.5 0.5 2.8 4.2 4.9 0.0 9.5 5.0 8.8 10.4 4.5 2.6 3.7 7.0 9.5 2.9 4.8 5.9 5.0 5.2 4.4 4.1 2.4 2.5 2.9 2.8 2.7 5.4 2.8 3.7 4.0 4.1 1.5 3.5 5.6 1.5 3.0 3.1 5.0 1.3 8.1 1.3 5.3 6.6 4.0 4.6 6.7 11.1 5.7 3.4 4.8 4.5 4.6 5.6 3.6 SNAI1 "SLUGH2, SNA, SNAH, SNAIL, SNAIL1" ENSG00000124216 "Snail family transcriptional repressor 1" O95863 20 49982980-49988886 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 30.3" "Cell type enhanced" "Detected in many" "Adipocytes: 191.3;Endothelial cells: 54.4;Extravillous trophoblasts: 79.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.2" "Cell line enhanced" "Detected in many" "SiHa: 28.1;TIME: 39.3;WM-115: 25.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "spinal cord: 7.0" "CAB005883, HPA056831, HPA069985, CAB078687" Supported Supported Nucleoplasm NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB005883: AB_443967, CAB078687: AB_2665847, HPA056831: AB_2732606, HPA069985: AB_2732146" "unprognostic (4.60e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (4.76e-4)" "unprognostic (2.60e-2)" "unprognostic (1.15e-2)" "unprognostic (4.22e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (3.34e-3)" "unprognostic (9.85e-3)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.63e-7)" "unprognostic (3.75e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (8.82e-7)" "unprognostic (1.88e-2)" 30.3 12.0 2.5 4.4 2.3 4.5 16.8 2.7 2.8 6.1 2.7 5.1 1.0 7.0 0.7 2.7 9.6 16.5 16.0 2.2 3.8 8.3 5.2 16.7 2.1 4.5 2.7 2.4 5.1 1.3 6.5 7.2 2.6 4.1 0.8 0.3 3.9 2.4 2.3 4.6 3.3 3.1 2.4 9.7 5.9 3.9 4.2 0.8 15.4 1.3 0.7 9.4 4.6 3.0 1.2 0.9 5.4 0.7 1.6 1.0 10.9 4.7 5.8 0.9 0.6 8.9 1.4 0.7 12.6 8.4 5.6 0.1 1.6 0.0 0.5 0.1 1.1 0.6 2.0 5.4 13.6 1.5 4.3 3.1 0.3 2.0 0.0 14.3 14.0 0.7 7.0 0.2 0.0 2.0 0.1 1.6 7.2 0.8 3.8 2.5 1.4 0.8 6.4 0.0 2.3 5.6 28.1 7.1 1.2 4.6 1.4 6.5 39.3 0.0 6.8 0.0 0.1 0.2 0.1 7.5 2.3 2.1 25.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.5 2.3 2.7 2.8 2.2 3.8 4.5 2.7 2.6 2.4 4.2 3.0 191.3 0.0 5.3 0.3 11.8 5.2 2.4 0.5 5.2 0.6 18.6 37.0 4.5 2.8 3.8 0.0 0.0 8.3 29.7 2.8 0.0 1.5 3.0 5.8 18.6 54.4 1.8 0.0 0.6 0.2 79.9 31.7 5.6 8.7 1.3 1.0 17.5 0.3 8.0 3.3 0.4 4.5 2.0 6.4 40.3 0.8 5.6 35.6 5.4 0.0 1.0 0.8 0.0 0.0 0.7 4.7 1.6 14.3 2.2 1.6 1.4 0.2 1.0 0.4 6.6 7.6 17.5 1.4 3.8 7.2 4.8 14.0 12.2 7.2 3.0 0.6 SOCS1 "Cish1, JAB, SOCS-1, SSI-1, TIP3" ENSG00000185338 "Suppressor of cytokine signaling 1" O15524 16 11254408-11256204 "Cancer-related genes, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 102.5;dendritic cells: 191.9;T-cells: 161.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 13.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "HDLM-2: 107.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB010355, HPA074108" Approved Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Cytoplasmic bodies" "CAB010355: AB_2193144, HPA074108: AB_2686661" "unprognostic (4.50e-3)" "unprognostic (3.30e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-2)" "unprognostic (1.25e-2)" "prognostic favorable (1.10e-4)" "unprognostic (1.71e-2)" "unprognostic (4.09e-3)" "unprognostic (5.31e-3)" "unprognostic (4.82e-2)" "unprognostic (1.17e-1)" "unprognostic (5.39e-2)" "prognostic unfavorable (1.08e-6)" "unprognostic (1.56e-1)" "unprognostic (5.68e-2)" "unprognostic (6.08e-2)" "unprognostic (1.67e-1)" 10.7 4.2 0.9 14.3 1.0 9.9 6.9 5.8 1.1 15.6 0.7 5.0 2.0 5.9 1.1 5.4 4.6 2.3 5.1 0.9 1.3 23.2 26.9 9.7 13.5 2.5 1.2 9.4 3.1 0.7 14.8 3.8 2.7 6.3 0.9 0.1 4.9 1.7 2.1 7.4 12.4 1.0 1.9 18.6 8.0 7.6 2.6 9.8 4.4 0.5 10.2 6.6 7.0 1.0 2.8 0.5 1.1 0.2 3.3 0.5 4.0 2.2 15.7 1.0 1.3 0.7 0.5 6.3 4.7 1.0 2.9 1.1 0.4 0.2 0.2 107.8 0.8 1.7 0.0 8.6 1.4 0.0 18.5 1.4 0.3 2.2 0.2 0.4 0.3 0.6 14.4 1.8 0.1 2.5 7.2 4.0 11.4 0.2 1.7 0.7 0.7 0.7 1.2 0.5 1.5 0.2 0.5 3.7 1.2 3.1 0.0 0.9 0.1 1.3 6.4 0.9 1.5 0.4 0.6 10.0 2.6 0.8 1.3 13.6 0.1 10.2 2.1 0.0 1.9 1.5 2.4 2.6 0.0 5.3 2.6 2.3 0.3 6.1 0.1 1.3 2.8 0.4 0.9 1.0 5.8 1.1 0.9 1.3 2.5 1.2 2.7 1.9 2.6 1.0 102.5 0.0 4.4 1.6 67.7 12.2 17.4 1.9 8.6 1.9 33.8 55.5 10.3 2.8 0.7 51.5 6.2 24.1 191.9 30.6 23.5 18.4 64.8 18.1 19.9 14.3 26.0 8.4 0.0 8.5 4.8 61.5 26.0 36.9 52.8 4.9 8.2 3.4 4.5 0.0 0.2 17.7 8.2 5.8 25.7 24.7 7.2 33.8 30.2 1.0 14.2 6.7 24.7 0.5 0.0 5.0 20.2 41.8 89.0 7.4 19.0 9.2 2.5 4.8 0.0 30.2 34.2 0.8 8.3 10.1 6.8 57.7 161.5 23.0 11.8 11.6 SP140L ENSG00000185404 "SP140 nuclear body protein like" Q9H930 2 230327184-230403732 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA055864 Uncertain Approved Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA055864: AB_2682949" "unprognostic (1.44e-2)" "unprognostic (8.91e-2)" "unprognostic (4.44e-2)" "unprognostic (9.70e-3)" "unprognostic (2.07e-1)" "unprognostic (1.42e-2)" "unprognostic (1.22e-3)" "unprognostic (1.77e-1)" "unprognostic (3.87e-1)" "unprognostic (2.31e-2)" "unprognostic (4.87e-3)" "unprognostic (3.19e-1)" "prognostic unfavorable (5.09e-10)" "unprognostic (9.15e-2)" "unprognostic (7.81e-2)" "unprognostic (9.49e-2)" "unprognostic (2.00e-3)" 9.4 9.7 3.4 18.8 3.6 13.6 8.5 3.2 3.9 7.6 4.5 8.5 11.0 7.1 6.4 7.7 7.8 8.6 5.3 3.2 3.6 9.6 15.1 11.3 24.8 5.0 4.1 11.8 4.4 1.6 3.4 10.6 4.6 6.9 9.4 1.9 12.5 6.0 5.1 3.0 16.3 6.5 4.0 25.6 8.9 1.7 4.6 12.8 5.4 4.4 20.2 10.7 8.3 4.7 13.6 2.4 3.1 9.6 15.8 17.2 17.2 19.7 22.6 16.0 25.5 1.3 15.3 10.3 20.2 15.4 28.4 2.3 0.0 14.1 26.0 27.1 0.1 18.5 11.1 10.0 29.7 15.1 19.9 14.4 7.6 23.6 15.4 13.7 23.7 15.5 4.5 9.4 29.0 7.5 22.7 21.2 10.7 9.1 7.0 7.8 28.9 8.3 14.5 16.9 0.6 2.9 4.7 9.5 11.2 19.0 14.2 15.9 26.1 14.2 10.5 8.2 15.2 13.7 9.2 14.8 18.9 15.4 25.2 21.4 7.7 4.1 15.4 10.7 18.7 29.5 14.1 12.5 8.3 32.6 19.5 17.4 7.4 23.0 12.5 3.3 9.7 9.6 3.4 3.6 3.2 3.9 3.2 3.6 5.0 4.1 4.6 4.0 4.6 4.7 30.5 32.1 35.6 1.6 58.8 1.9 13.8 14.6 1.8 2.7 9.3 9.1 4.2 11.5 21.7 16.5 18.8 9.9 40.4 16.8 0.0 22.5 16.3 7.2 16.9 23.3 3.6 9.9 2.4 18.3 17.6 14.6 23.0 14.3 42.3 18.7 13.9 9.4 20.4 0.0 2.0 10.4 16.2 17.1 11.4 5.9 4.4 23.9 5.4 29.0 13.9 1.8 49.4 2.5 1.4 20.0 20.3 8.2 33.7 10.3 14.5 3.3 28.3 1.7 6.6 18.8 14.0 0.8 1.9 7.7 2.6 11.9 47.1 31.7 8.5 23.2 SPART "KIAA0610, SPG20, TAHCCP1" ENSG00000133104 Spartin Q8N0X7 13 36301638-36370180 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 75.0;Proximal tubular cells: 90.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 172.7" "Lineage enriched" "Detected in all" 7 "granulocytes: 172.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039053, HPA039054" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol "Plasma membrane" "HPA039053: AB_10672769, HPA039054: AB_2676323" "unprognostic (3.73e-2)" "unprognostic (9.39e-2)" "unprognostic (3.06e-2)" "unprognostic (4.60e-2)" "unprognostic (2.21e-2)" "unprognostic (1.10e-2)" "unprognostic (9.18e-3)" "unprognostic (9.58e-2)" "unprognostic (3.36e-2)" "unprognostic (2.22e-1)" "unprognostic (7.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.54e-1)" "unprognostic (9.26e-2)" "unprognostic (1.22e-1)" "unprognostic (1.54e-2)" "unprognostic (5.79e-2)" 42.3 48.4 36.9 18.0 42.8 23.6 32.5 43.4 50.6 49.2 42.3 37.8 12.7 42.4 67.1 24.5 44.5 37.4 25.7 35.3 39.4 48.4 19.9 27.0 15.7 42.4 40.5 63.6 14.6 29.5 29.6 39.8 42.1 34.7 13.3 43.3 17.3 36.4 33.5 18.4 15.4 52.8 41.2 30.7 21.1 27.6 38.3 16.7 35.6 33.7 11.2 35.5 29.9 51.0 0.1 22.4 59.5 0.0 127.9 106.6 42.4 54.1 81.3 53.7 52.8 0.1 0.0 0.0 32.9 65.9 98.2 31.2 81.4 38.0 57.5 4.4 46.9 69.4 28.3 14.6 128.0 72.8 134.3 106.2 59.5 44.4 61.9 131.7 79.6 18.7 30.6 11.9 97.5 5.2 21.7 120.8 30.0 0.0 7.8 0.0 99.4 2.5 62.5 28.2 6.2 14.5 46.3 18.3 58.9 85.3 10.5 84.7 66.8 40.0 20.1 55.9 32.2 14.2 0.2 0.1 44.6 61.8 71.0 172.7 22.1 30.1 13.5 21.7 13.1 10.1 18.6 5.4 15.7 9.7 24.5 13.1 35.0 14.2 23.8 19.3 4.8 18.1 36.9 42.8 43.4 50.6 35.3 39.4 42.4 40.5 42.1 41.2 38.3 51.0 43.5 35.3 51.5 0.0 6.1 0.0 0.0 0.0 0.0 0.0 30.8 30.1 0.0 0.0 40.2 27.6 0.0 52.7 18.6 0.0 66.5 26.2 0.0 59.4 62.6 15.9 0.0 0.0 0.0 15.0 59.7 39.8 0.0 38.1 58.0 75.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 16.8 0.0 0.0 3.5 0.0 0.0 90.4 65.6 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 64.3 10.8 59.2 0.0 0.0 SPINDOC "C11orf84, SPIN-DOC" ENSG00000168005 "Spindlin interactor and repressor of chromatin binding" Q9BUA3 11 63813456-63827716 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 7.2;Breast glandular cells: 6.7;Breast myoepithelial cells: 8.6;Cytotrophoblasts: 13.3;dendritic cells: 9.4;Endometrial stromal cells: 8.0;Granulosa cells: 9.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040128, HPA050313" Uncertain Approved "Nuclear speckles" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "HPA040128: AB_10673027, HPA050313: AB_2681083" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-2)" "unprognostic (2.82e-3)" "unprognostic (1.13e-1)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (2.20e-1)" "unprognostic (3.78e-3)" "unprognostic (1.44e-2)" "unprognostic (1.20e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (5.42e-5)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" 11.9 10.4 25.8 12.1 26.3 6.2 8.9 27.9 38.1 16.3 20.7 19.2 5.4 19.1 5.1 10.1 15.3 9.3 15.8 26.0 31.5 13.8 5.2 16.4 15.0 25.4 26.4 16.6 8.0 3.3 17.3 26.4 27.9 18.2 3.6 9.8 9.0 10.4 8.0 6.0 11.3 8.2 22.9 13.9 11.4 38.8 31.4 12.3 13.4 7.2 9.8 18.0 12.3 25.8 34.9 45.7 65.7 57.6 12.5 12.3 24.7 26.6 22.7 47.4 32.9 48.7 23.4 58.1 60.6 15.5 60.8 44.9 60.3 13.7 17.1 55.6 26.4 64.2 46.4 42.0 20.1 36.4 53.6 14.2 14.1 37.2 13.6 24.9 28.5 54.8 36.1 27.6 20.2 48.0 75.7 98.2 112.9 10.0 42.1 100.3 45.5 19.7 16.5 20.2 50.0 63.2 40.6 25.6 55.3 39.7 35.3 43.0 32.2 52.9 60.8 64.0 47.3 40.1 61.9 58.2 27.3 31.8 38.1 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 25.8 26.3 27.9 38.1 26.0 31.5 25.4 26.4 27.9 22.9 31.4 25.8 7.2 3.2 1.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 6.7 8.6 0.0 0.0 0.6 0.0 0.0 13.3 9.4 0.0 0.0 2.2 0.0 5.6 8.0 3.1 0.0 0.0 0.0 1.8 3.0 2.7 0.0 6.5 0.0 9.6 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.4 0.0 0.0 0.7 0.7 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 3.8 2.8 4.0 0.0 0.0 SPOUT1 "C9orf114, CENP-32, HSPC109" ENSG00000198917 "SPOUT domain containing methyltransferase 1" Q5T280 9 128819651-128829794 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 34.0;Extravillous trophoblasts: 25.2;Granulosa cells: 32.5;Hofbauer cells: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076946 Approved NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA076946: " "unprognostic (1.85e-1)" "unprognostic (3.51e-3)" "unprognostic (1.76e-2)" "unprognostic (3.32e-3)" "unprognostic (8.01e-2)" "unprognostic (1.66e-1)" "unprognostic (6.41e-3)" "unprognostic (5.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.27e-1)" "prognostic favorable (4.09e-4)" "unprognostic (1.44e-2)" "unprognostic (1.42e-2)" "unprognostic (1.98e-2)" "unprognostic (2.88e-1)" "unprognostic (1.09e-2)" "unprognostic (3.70e-2)" 17.0 19.0 20.8 14.3 21.4 13.5 18.3 20.2 25.6 20.0 19.1 18.3 11.2 17.6 5.7 25.7 19.9 9.1 21.2 20.0 20.8 26.0 45.1 16.8 18.9 20.6 20.9 20.0 22.9 9.1 20.6 9.5 19.9 32.7 5.5 6.5 18.7 8.6 20.6 23.7 20.6 8.1 19.4 30.8 22.9 13.2 21.4 13.4 22.8 6.0 10.3 22.8 19.8 21.6 13.7 31.2 25.2 37.2 14.1 14.2 44.5 14.5 8.7 26.3 14.2 44.1 24.1 27.5 15.6 14.9 26.8 56.3 23.3 22.6 8.7 26.3 24.2 21.8 51.6 36.6 15.4 32.6 39.2 14.8 18.9 18.2 18.9 11.2 19.6 40.3 44.7 24.0 14.9 88.1 40.8 66.5 33.2 63.5 39.5 44.0 24.1 48.7 17.5 25.4 29.6 28.7 27.7 40.7 19.0 14.0 40.3 36.5 20.0 37.3 16.6 25.6 38.2 26.1 47.0 28.9 23.7 28.3 30.8 5.5 11.7 6.1 24.7 12.6 25.5 19.1 19.9 22.8 13.9 19.3 19.5 19.7 2.9 25.2 10.3 15.7 19.8 17.4 20.8 21.4 20.2 25.6 20.0 20.8 20.6 20.9 19.9 19.4 21.4 21.6 9.3 3.2 10.2 0.0 4.8 0.0 0.0 0.0 0.0 0.0 19.2 12.2 0.0 0.0 8.1 9.2 0.0 34.0 10.8 0.0 11.7 15.7 0.0 6.4 10.2 6.1 0.0 0.0 0.0 17.6 25.2 4.3 0.0 7.7 13.9 32.5 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 15.5 0.0 0.0 0.0 0.0 15.7 0.0 0.0 1.8 0.0 0.0 19.3 4.4 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 10.4 5.4 12.1 0.0 0.0 SPSB3 "C16orf31, SSB-3" ENSG00000162032 "SplA/ryanodine receptor domain and SOCS box containing 3" Q6PJ21 16 1776712-1793700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046602 Uncertain Approved Mitochondria NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA046602: AB_2679717" "unprognostic (1.18e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-1)" "unprognostic (1.15e-3)" "unprognostic (1.82e-1)" "unprognostic (8.91e-4)" "unprognostic (1.07e-2)" "unprognostic (8.31e-2)" "unprognostic (5.65e-2)" "unprognostic (8.43e-2)" "unprognostic (3.41e-2)" "unprognostic (4.83e-2)" "unprognostic (5.25e-7)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (3.77e-1)" "unprognostic (4.72e-4)" 27.1 44.7 27.9 7.7 28.5 21.2 25.8 37.0 40.2 27.1 24.0 28.9 14.7 21.3 3.3 36.1 23.7 10.0 28.6 26.4 27.2 24.3 41.8 20.6 12.4 29.7 28.3 37.1 44.0 11.4 15.3 10.3 27.4 23.3 5.1 9.6 26.4 15.5 88.5 48.4 18.8 5.6 28.3 23.3 27.8 17.3 29.2 26.1 19.7 31.0 7.8 23.2 28.7 31.8 7.3 9.1 9.7 13.4 13.6 12.5 19.8 10.6 11.0 11.5 12.6 8.4 20.0 3.2 17.4 6.0 4.5 13.9 4.8 10.9 1.8 14.7 15.0 5.2 13.9 10.4 20.2 4.5 12.0 11.3 26.8 7.2 8.4 17.1 17.5 22.1 7.8 15.4 5.4 24.0 16.3 16.0 8.1 10.8 7.1 29.7 5.9 26.7 10.6 1.3 12.9 16.6 12.6 27.8 29.4 6.9 16.1 18.0 16.1 5.6 10.6 10.5 5.5 26.1 28.2 8.9 5.4 8.9 5.9 112.3 44.8 83.4 67.9 41.8 81.2 46.8 63.1 61.7 42.3 44.2 43.6 46.6 91.5 45.7 37.2 42.8 100.7 48.4 27.9 28.5 37.0 40.2 26.4 27.2 29.7 28.3 27.4 28.3 29.2 31.8 74.2 38.5 32.1 29.7 56.1 98.4 53.3 72.7 60.3 74.1 64.1 83.7 0.2 40.0 54.9 55.2 39.6 63.0 104.2 68.6 52.8 50.8 46.7 29.4 32.3 46.1 48.7 50.5 18.2 47.6 74.8 42.8 65.2 37.8 35.4 76.2 57.1 62.5 31.8 90.9 19.4 57.8 38.7 42.7 72.2 91.6 77.0 44.8 76.5 24.4 61.6 76.0 99.9 24.6 30.7 45.3 83.2 74.9 61.2 50.5 96.3 50.6 37.2 89.8 39.5 34.0 45.3 23.8 39.7 37.0 128.3 64.4 87.8 33.2 52.7 54.3 SPTLC1 "hLCB1, HSAN1, HSN1, LCB1, SPTI" ENSG00000090054 "Serine palmitoyltransferase long chain base subunit 1" O15269 9 92000087-92115413 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 94.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010860, CAB018747, HPA063907" Supported Supported "Endoplasmic reticulum" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.47e-1)" "unprognostic (3.51e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (4.22e-3)" "unprognostic (1.27e-1)" "unprognostic (4.06e-1)" "unprognostic (3.55e-3)" "unprognostic (8.37e-2)" "prognostic favorable (1.36e-6)" "unprognostic (1.13e-1)" "unprognostic (2.41e-2)" "unprognostic (4.28e-1)" "unprognostic (1.49e-1)" 35.6 32.6 24.0 27.3 27.0 23.3 44.1 26.0 34.2 43.1 28.6 42.3 34.7 40.4 41.3 54.3 36.7 34.1 21.5 24.3 26.6 42.8 23.4 33.6 25.7 27.8 27.5 43.8 26.5 48.0 17.3 42.4 28.0 32.9 44.1 19.8 31.3 28.1 14.2 41.3 37.9 31.4 27.9 26.3 37.1 26.5 25.6 25.9 53.0 18.6 34.4 37.2 34.7 31.6 73.0 48.8 46.8 41.6 120.0 92.0 78.4 74.7 94.2 65.3 66.3 31.5 150.7 38.6 45.1 93.9 78.3 198.4 49.7 68.1 73.0 39.8 36.1 36.7 32.7 51.7 80.5 65.5 49.9 82.6 92.6 68.0 74.8 72.3 62.5 43.5 83.8 46.6 91.1 69.6 34.7 47.6 67.5 97.4 57.9 39.4 58.7 33.3 84.1 37.9 35.0 37.2 104.4 81.1 61.3 62.4 39.2 54.2 72.3 58.8 48.0 73.9 56.8 33.2 44.4 23.9 74.2 39.3 79.4 32.4 33.1 20.2 16.7 36.1 17.0 15.4 18.0 17.4 30.6 15.5 21.4 16.6 33.3 18.5 34.2 18.4 25.7 25.5 24.0 27.0 26.0 34.2 24.3 26.6 27.8 27.5 28.0 27.9 25.6 31.6 40.7 38.5 38.3 27.7 22.1 10.6 13.6 14.5 26.2 6.9 33.2 20.6 4.1 4.3 25.9 36.8 14.6 12.7 24.4 8.0 9.8 53.4 94.8 34.7 42.5 23.1 2.4 7.2 35.3 56.4 15.6 32.3 13.7 47.4 24.6 26.9 6.1 4.3 11.0 6.7 32.5 7.2 12.2 5.7 10.3 26.1 6.2 24.6 12.4 20.6 22.0 13.7 7.2 36.7 52.1 60.8 7.1 6.0 26.2 9.8 11.7 28.5 28.0 8.7 13.1 12.1 23.5 35.3 25.9 27.6 9.1 21.8 21.9 33.2 6.9 14.5 SQOR "CGI-44, SQR, SQRDL" ENSG00000137767 "Sulfide quinone oxidoreductase" Q9Y6N5 15 45631148-45691281 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 210.0" "Cell type enhanced" "Detected in many" "Ductal cells: 118.1;Exocrine glandular cells: 176.2;Hofbauer cells: 134.3;monocytes: 154.5;Pancreatic endocrine cells: 156.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 304.0" "HPA017079, HPA041589" Enhanced Supported Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA017079: AB_1857467, HPA041589: AB_2677565" "unprognostic (6.15e-2)" "unprognostic (3.28e-2)" "unprognostic (2.15e-1)" "prognostic favorable (2.57e-4)" "unprognostic (2.75e-2)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "prognostic unfavorable (8.80e-4)" "unprognostic (1.81e-1)" "unprognostic (3.77e-1)" "unprognostic (6.65e-3)" "unprognostic (2.37e-1)" "unprognostic (3.14e-3)" "unprognostic (2.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.44e-2)" "unprognostic (4.38e-1)" 46.4 22.6 14.5 59.5 14.6 55.6 41.2 14.6 19.7 36.3 17.2 210.0 57.7 18.8 19.3 112.9 26.6 31.4 22.0 13.6 14.7 36.6 82.6 61.5 38.2 16.7 15.1 8.8 39.8 24.1 12.5 17.6 15.6 41.2 178.8 4.9 56.3 27.8 132.8 41.7 55.9 43.2 15.9 47.3 54.4 5.1 15.8 23.7 32.5 43.7 57.7 48.8 50.3 17.2 38.3 68.0 0.1 3.9 125.5 151.4 0.4 40.8 132.3 23.6 35.7 2.7 59.0 33.7 38.7 29.9 72.6 33.3 2.0 304.0 13.9 121.7 1.1 3.0 14.5 48.2 38.8 20.2 5.1 45.2 88.2 54.9 119.8 59.4 66.1 32.0 0.4 40.6 24.6 31.3 12.2 44.9 0.0 147.7 41.8 1.4 6.7 47.1 184.9 55.2 1.2 1.2 10.1 25.8 13.1 0.8 56.9 61.7 76.8 9.7 2.2 131.6 9.0 53.5 61.0 2.0 96.9 104.6 10.9 112.5 212.1 84.6 76.6 161.0 104.6 54.3 97.9 83.6 135.2 48.6 51.8 55.2 302.5 53.4 152.4 40.5 149.0 169.6 14.5 14.6 14.6 19.7 13.6 14.7 16.7 15.1 15.6 15.9 15.8 17.2 24.4 32.1 64.1 0.0 5.8 0.0 0.0 0.0 0.0 0.0 31.4 14.7 0.0 0.0 14.9 14.7 0.0 0.7 19.8 0.0 11.7 118.1 0.0 15.9 7.0 13.9 0.0 0.0 0.0 176.2 0.9 11.3 0.0 37.6 11.4 1.3 0.0 0.0 134.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.3 0.0 0.0 154.5 0.0 0.0 0.0 0.0 156.2 0.0 0.0 3.3 0.0 0.0 45.8 24.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.8 13.5 1.6 0.0 0.0 SRSF2 "PR264, SC-35, SC35, SFRS2, SFRS2A" ENSG00000161547 "Serine and arginine rich splicing factor 2" Q01130 17 76734115-76737333 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049905 Supported Approved Nucleoplasm,Cytosol NA NA 180000 "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA049905: AB_2680945" "unprognostic (2.50e-1)" "unprognostic (2.16e-3)" "unprognostic (2.73e-3)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.75e-2)" "unprognostic (4.19e-2)" "prognostic unfavorable (3.53e-8)" "unprognostic (1.19e-1)" "unprognostic (7.79e-3)" "unprognostic (7.03e-3)" "unprognostic (1.92e-1)" "unprognostic (1.07e-3)" "prognostic unfavorable (1.05e-7)" "unprognostic (3.85e-2)" "unprognostic (8.05e-2)" "unprognostic (1.95e-1)" "prognostic favorable (9.87e-4)" 106.0 106.8 27.8 95.5 29.6 184.7 92.1 29.9 34.0 83.6 37.7 100.3 86.2 88.9 64.0 129.5 89.5 42.1 78.5 29.2 32.9 83.0 115.2 95.4 111.6 30.8 28.5 85.6 88.3 48.4 81.9 66.0 30.3 78.0 71.6 53.4 90.6 52.3 91.7 96.5 113.2 49.0 31.3 121.6 94.4 49.5 30.0 94.2 102.1 36.0 100.2 80.0 94.3 36.0 318.7 239.8 289.5 207.5 70.9 58.5 300.5 197.3 146.8 225.4 207.0 257.2 216.8 478.0 143.3 188.7 164.3 279.9 293.3 229.0 230.2 202.3 489.3 357.9 246.6 311.9 79.3 404.4 210.6 65.2 51.1 186.2 54.0 91.1 179.9 212.0 373.4 209.6 183.7 251.0 460.0 440.9 339.5 186.4 340.2 455.0 310.6 360.5 156.5 225.2 247.7 350.8 227.1 196.3 120.4 154.0 238.8 301.6 187.9 206.9 271.3 139.4 330.0 278.2 219.2 552.9 187.3 318.9 177.1 2.5 40.9 10.0 26.0 53.3 26.0 23.5 17.7 26.7 67.0 19.6 20.1 19.4 4.4 35.6 33.6 49.2 24.0 33.0 27.8 29.6 29.9 34.0 29.2 32.9 30.8 28.5 30.3 31.3 30.0 36.0 271.3 118.6 105.6 57.5 396.7 460.8 439.7 205.9 540.1 151.9 291.7 277.9 86.2 148.7 141.5 88.3 91.8 339.4 548.0 233.1 156.5 199.1 203.6 176.8 181.9 204.3 266.3 366.6 51.1 157.3 579.7 233.9 196.7 257.4 218.4 241.7 116.7 125.1 251.3 99.3 55.4 246.9 132.2 143.7 480.4 162.0 159.1 273.5 282.8 63.7 226.9 153.3 196.7 55.8 87.9 189.0 288.7 127.5 492.0 384.8 250.5 128.7 97.4 188.9 118.3 286.8 242.1 272.3 296.8 489.5 443.4 316.0 469.1 185.4 329.4 459.4 SRSF3 "SFRS3, SRp20" ENSG00000112081 "Serine and arginine rich splicing factor 3" P84103 6 36594353-36605600 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012986, HPA056981" Supported Supported Nucleoplasm NA NA 1600000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB012986: AB_2533150, HPA056981: AB_2683299" "unprognostic (3.25e-1)" "unprognostic (1.08e-3)" "prognostic favorable (2.56e-4)" "unprognostic (8.19e-2)" "unprognostic (2.06e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (6.22e-5)" "unprognostic (2.92e-2)" "prognostic unfavorable (1.95e-4)" "prognostic favorable (1.37e-4)" "unprognostic (9.61e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (9.88e-2)" "unprognostic (3.33e-2)" "unprognostic (8.33e-2)" "unprognostic (1.06e-2)" 97.2 62.5 39.2 93.5 40.9 172.3 90.2 43.6 44.0 72.6 42.4 89.6 54.0 76.1 62.5 97.8 78.0 40.5 70.2 40.1 43.8 83.3 75.3 68.8 118.9 40.0 40.6 84.0 58.0 62.3 49.2 74.6 41.6 58.6 95.2 45.2 57.8 64.6 76.0 66.4 73.2 89.9 43.1 67.2 74.9 59.9 44.0 164.3 60.7 48.5 147.9 97.7 72.0 45.5 357.2 232.3 401.4 308.9 151.9 117.9 247.2 248.4 206.5 408.6 312.2 275.1 248.2 593.4 174.3 273.3 266.8 275.1 533.1 395.4 433.2 279.3 327.3 357.0 175.5 312.3 184.9 485.2 289.6 105.8 131.6 267.4 295.6 130.3 315.2 354.4 438.7 244.1 300.8 277.4 601.0 457.0 424.5 414.5 241.5 527.3 384.2 355.9 292.2 291.1 308.7 291.8 276.1 267.4 385.4 284.9 271.2 513.1 207.9 208.1 303.9 211.0 380.1 238.6 381.4 822.9 178.4 443.7 295.5 85.6 179.0 57.9 145.8 176.6 166.0 129.0 136.8 154.7 350.7 113.5 136.1 140.8 17.1 190.5 125.1 206.8 184.2 305.6 39.2 40.9 43.6 44.0 40.1 43.8 40.0 40.6 41.6 43.1 44.0 45.5 648.3 201.9 238.6 47.3 337.6 469.6 425.1 308.4 225.9 146.2 371.3 388.4 227.9 198.8 258.0 125.0 54.2 495.6 574.3 245.3 363.9 357.3 176.1 216.0 295.7 346.9 332.9 345.9 24.0 324.9 816.9 373.6 226.8 251.1 396.8 275.2 243.8 182.7 359.3 99.3 23.8 409.9 191.2 262.9 559.3 321.2 211.9 356.5 334.4 45.9 366.3 368.8 334.8 38.2 51.1 290.1 301.9 172.3 256.3 401.7 259.2 274.7 164.8 154.5 203.8 497.3 448.2 374.2 290.8 312.2 445.8 526.1 415.2 184.1 427.4 285.1 SRSF7 "9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2" ENSG00000115875 "Serine and arginine rich splicing factor 7" Q16629 2 38743599-38751494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043850, HPA056926" Supported Enhanced Nucleoplasm NA NA 1300000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA043850: AB_10964495, HPA056926: AB_2683277" "unprognostic (2.74e-1)" "unprognostic (1.53e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.86e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (3.24e-2)" "unprognostic (2.53e-2)" "unprognostic (2.61e-1)" "unprognostic (3.75e-1)" "unprognostic (4.44e-3)" "prognostic unfavorable (3.18e-8)" "unprognostic (1.02e-2)" "unprognostic (1.87e-1)" "unprognostic (1.72e-1)" "unprognostic (3.07e-3)" 68.3 44.5 30.5 59.3 31.8 132.8 53.3 32.3 36.0 37.3 33.9 55.0 30.4 43.8 40.7 65.3 45.2 24.0 37.7 32.3 33.6 47.0 49.4 50.5 72.0 30.8 30.2 34.6 33.6 36.1 30.0 50.7 30.8 38.9 52.2 25.0 37.4 34.5 41.9 37.8 46.2 52.9 33.3 45.8 50.6 54.0 30.7 87.0 34.3 27.7 90.1 68.4 40.9 34.4 271.3 229.3 304.4 197.1 91.8 71.8 213.7 225.2 96.6 222.9 177.9 272.9 202.4 436.1 150.9 148.2 206.9 149.2 385.7 277.1 266.7 274.7 240.9 264.3 154.8 281.2 78.1 329.3 185.4 43.4 92.8 153.3 295.0 94.3 187.9 180.3 388.5 171.1 191.6 298.9 421.2 289.9 331.5 313.3 208.4 367.8 253.4 248.0 168.2 257.3 207.2 201.6 215.3 190.1 156.5 189.7 172.8 295.0 163.1 134.3 210.2 116.3 317.6 186.6 297.8 658.9 159.1 339.1 189.3 23.4 71.2 27.8 59.8 103.3 65.0 63.3 46.1 60.3 142.4 40.7 51.4 59.7 6.8 65.7 61.7 85.8 53.4 77.5 30.5 31.8 32.3 36.0 32.3 33.6 30.8 30.2 30.8 33.3 30.7 34.4 445.1 80.1 208.8 31.3 453.7 259.5 460.8 255.9 220.3 122.7 226.9 367.2 67.8 87.2 177.0 64.4 118.9 313.7 730.0 214.7 156.5 195.4 173.6 104.6 193.5 245.7 178.0 153.5 96.6 132.2 478.1 264.0 258.9 130.4 320.4 273.2 150.0 85.3 241.9 121.1 82.2 222.5 140.4 123.4 242.6 45.2 138.5 289.2 152.9 65.6 222.6 253.9 239.9 74.9 100.8 149.0 179.3 109.9 337.7 309.9 192.1 94.1 116.4 225.8 118.3 317.9 408.1 286.7 287.3 163.0 243.5 250.2 652.4 186.4 242.8 344.7 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42596934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Cluster 13: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: AB_2680020" "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favorable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 21.0 17.1 27.6 18.5 28.6 33.9 21.9 28.8 37.1 19.8 26.7 17.5 19.0 12.6 17.8 21.2 15.7 10.4 18.7 28.2 28.4 24.5 32.4 19.6 35.4 28.2 27.8 19.1 21.6 13.5 25.1 9.9 28.3 35.9 13.6 13.7 19.1 8.6 16.2 24.9 25.6 7.4 28.4 31.6 22.7 10.1 27.8 23.6 20.4 11.0 30.2 19.4 18.5 31.5 32.3 14.0 29.0 26.4 34.9 27.8 17.3 20.6 22.4 28.7 32.2 27.1 29.1 43.3 18.2 13.6 31.6 17.9 33.9 28.0 30.9 21.7 40.5 46.9 28.9 45.3 25.4 62.5 36.2 22.1 17.7 23.7 21.9 20.6 31.4 39.1 43.2 65.4 23.1 29.3 44.8 76.4 45.9 42.7 34.2 23.6 20.6 61.2 32.3 38.2 16.2 23.0 17.6 27.2 29.8 30.2 35.8 57.4 19.5 18.0 29.0 42.8 38.0 46.5 76.3 73.5 26.3 66.1 17.0 60.4 56.4 84.9 88.4 66.0 121.0 120.3 116.3 106.2 62.1 104.3 99.5 101.1 75.8 83.0 50.9 74.5 139.2 90.4 27.6 28.6 28.8 37.1 28.2 28.4 28.2 27.8 28.3 28.4 27.8 31.5 39.3 12.8 16.7 5.5 96.3 107.1 70.1 101.5 91.0 16.2 78.6 77.8 19.3 42.9 46.1 27.6 8.4 57.1 102.9 39.2 56.7 43.4 4.3 47.0 37.9 37.0 55.1 67.3 13.6 49.2 75.8 39.0 39.8 71.9 45.7 39.6 32.5 61.0 66.8 23.5 11.2 51.1 79.3 38.6 51.2 3.7 34.5 43.0 51.6 6.5 69.3 38.1 88.6 3.0 25.8 50.6 58.9 15.8 72.4 75.6 121.4 85.2 28.2 26.8 13.1 26.4 32.5 19.4 24.7 84.5 138.1 37.4 103.2 34.5 53.7 99.2 SSC4D "S4D-SRCRB, SRCRB-S4D, SRCRB4D" ENSG00000146700 "Scavenger receptor cysteine rich family member with 4 domains" Q8WTU2 7 76389334-76409697 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.6;parathyroid gland: 7.0" "Cell type enhanced" "Detected in some" "Collecting duct cells: 11.0;Distal tubular cells: 3.9;Hepatocytes: 3.7;Spermatogonia: 3.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "EFO-21: 6.7;Hep G2: 9.6;SuSa: 10.7;U-2 OS: 25.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA062611 Uncertain "Secreted - unknown location" NA NA 980000 "Cluster 7: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 9: U-2 OS - Unknown function" "Cluster 7: Non-specific - Mitochondria" "HPA062611: AB_2684807" "unprognostic (3.39e-2)" "unprognostic (1.78e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (2.83e-6)" "prognostic unfavorable (7.08e-4)" "unprognostic (3.52e-2)" "unprognostic (3.78e-2)" "unprognostic (2.28e-1)" "unprognostic (1.49e-2)" "unprognostic (8.49e-3)" "unprognostic (3.18e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (2.59e-1)" "unprognostic (3.90e-1)" "unprognostic (2.56e-2)" "unprognostic (1.73e-2)" 0.7 0.3 0.2 0.0 0.4 0.0 0.3 0.0 0.2 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 2.6 0.4 0.1 0.0 0.2 0.2 0.7 2.2 7.0 2.6 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.3 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 1.1 0.1 0.0 0.5 0.0 0.0 1.0 0.0 0.3 0.0 0.8 0.2 0.0 0.0 0.1 1.0 0.5 0.0 0.0 10.7 0.2 0.0 0.0 0.0 25.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.5 1.6 0.1 0.0 0.5 0.0 0.6 0.4 1.4 1.4 2.1 0.0 0.0 11.0 0.0 0.3 0.0 0.2 3.9 1.9 0.1 0.5 0.1 0.3 0.0 0.0 1.6 1.7 1.4 0.4 0.0 0.4 0.0 0.7 1.1 3.7 2.8 1.7 1.4 0.1 0.0 0.6 0.0 0.4 0.9 0.9 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.4 0.1 0.4 0.0 0.4 0.4 1.3 0.0 0.2 0.0 0.8 0.6 0.6 3.5 1.0 0.0 0.3 0.1 0.6 0.2 0.4 STMP1 "C7orf73, Mm47, PL-5283" ENSG00000243317 "Short transmembrane mitochondrial protein 1" E0CX11 7 135662496-135693418 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 249.0;Distal tubular cells: 197.6;Extravillous trophoblasts: 261.3;Hofbauer cells: 185.2;Proximal tubular cells: 209.5;Syncytiotrophoblasts: 275.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 431.7;eosinophil: 127.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 431.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065565 Approved Mitochondria "Intracellular and membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA065565: AB_2685512" "unprognostic (3.94e-2)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (3.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.81e-1)" "unprognostic (2.99e-3)" "unprognostic (1.12e-1)" "unprognostic (4.43e-3)" "prognostic favorable (2.95e-4)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (7.21e-3)" "unprognostic (4.90e-2)" "unprognostic (9.99e-2)" "unprognostic (9.62e-3)" "unprognostic (6.81e-2)" 15.7 28.5 15.5 17.7 17.3 41.3 22.9 15.8 20.5 21.1 17.9 19.8 18.2 16.1 25.7 46.7 15.9 16.6 25.4 15.2 17.2 27.9 32.0 15.2 21.2 17.6 16.4 12.9 15.1 18.5 19.0 19.8 18.1 20.3 22.5 19.2 21.0 15.0 48.4 21.5 19.2 16.4 16.9 14.7 20.4 23.8 16.6 28.8 32.2 32.8 26.2 20.0 27.4 17.6 41.5 19.4 44.9 42.4 52.6 73.2 27.3 44.8 43.5 36.3 37.8 12.0 45.2 38.3 39.3 68.7 35.6 17.0 43.9 57.0 48.9 48.2 36.1 59.4 20.4 28.8 51.7 61.3 36.8 46.0 63.6 43.6 40.4 54.9 30.5 48.5 65.3 33.0 80.9 54.0 87.6 69.5 88.6 57.4 48.5 43.6 48.0 63.0 102.2 21.5 56.6 54.7 60.8 41.3 43.9 43.1 16.9 66.0 51.1 35.3 29.0 63.5 63.2 38.1 58.5 72.9 109.1 63.1 65.9 431.7 57.3 127.7 23.8 61.2 22.8 24.9 22.5 24.3 61.0 21.0 21.0 24.1 44.6 38.9 68.1 34.5 33.1 50.9 15.5 17.3 15.8 20.5 15.2 17.2 17.6 16.4 18.1 16.9 16.6 17.6 67.4 41.7 47.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 128.9 145.3 0.0 0.0 27.9 97.5 0.0 249.0 57.2 0.0 197.6 164.3 0.0 102.2 97.3 39.4 0.0 0.0 0.0 97.4 261.3 43.9 0.0 90.8 56.8 80.1 0.0 0.0 185.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.7 0.0 0.0 146.8 0.0 0.0 0.0 0.0 131.8 0.0 0.0 6.4 0.0 0.0 209.5 34.2 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 275.4 29.8 65.8 0.0 0.0 STN1 "bA541N10.2, FLJ22559, OBFC1" ENSG00000107960 "STN1 subunit of CST complex" Q9H668 10 103877569-103918184 "Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 37.4;Distal tubular cells: 41.1;Ductal cells: 34.6;Exocrine glandular cells: 79.2;Pancreatic endocrine cells: 62.9;Theca cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037924, HPA037925" Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA037924: AB_10671636, HPA037925: AB_10672469" "unprognostic (1.50e-1)" "unprognostic (4.22e-2)" "unprognostic (2.18e-2)" "unprognostic (5.58e-3)" "unprognostic (6.01e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (5.93e-2)" "unprognostic (1.72e-1)" "unprognostic (1.12e-3)" "unprognostic (3.76e-1)" "prognostic favorable (1.12e-6)" "unprognostic (1.21e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.83e-2)" 15.7 22.2 8.8 12.2 10.1 13.5 17.1 11.3 9.4 13.3 11.5 14.5 12.0 12.0 9.8 41.0 12.2 18.3 35.0 8.2 11.1 17.9 13.1 25.2 16.0 13.1 11.0 22.2 20.9 33.6 14.9 17.1 11.5 10.2 16.4 6.4 18.7 13.3 22.4 13.3 11.0 15.4 9.9 15.3 22.2 23.4 11.5 24.5 17.6 28.9 22.8 22.5 18.5 11.2 26.8 19.7 23.8 19.6 18.6 57.6 7.6 12.6 36.5 16.4 14.6 11.4 43.6 16.7 22.2 16.1 14.7 24.8 8.7 31.0 15.3 24.1 11.9 15.3 7.0 23.5 25.6 12.7 12.9 37.2 52.1 15.9 43.9 42.9 32.0 31.2 8.5 34.9 27.3 21.7 31.5 22.0 5.5 38.7 28.5 22.7 16.4 19.2 40.5 31.3 13.7 16.1 9.3 14.9 24.4 13.4 12.5 11.0 47.1 20.4 14.1 14.5 19.4 47.3 13.1 16.6 30.4 26.4 9.0 41.7 33.2 110.3 65.1 21.3 103.4 25.5 71.9 60.4 40.2 29.6 52.3 62.6 48.8 71.3 23.7 37.1 100.2 51.5 8.8 10.1 11.3 9.4 8.2 11.1 13.1 11.0 11.5 9.9 11.5 11.2 14.7 22.4 20.9 0.0 2.3 0.0 0.0 0.0 0.0 0.0 12.7 16.9 0.0 0.0 5.0 9.2 0.0 37.4 17.2 0.0 41.1 34.6 0.0 9.2 9.9 6.4 0.0 0.0 0.0 79.2 14.0 3.9 0.0 15.4 5.1 23.8 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 13.5 0.0 0.0 0.0 0.0 62.9 0.0 0.0 1.0 0.0 0.0 12.8 7.3 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 27.0 13.3 52.4 0.0 0.0 STPG3 "C9orf173, FLJ40246" ENSG00000197768 "Sperm-tail PG-rich repeat containing 3" Q8N7X2 9 137251261-137253483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 42.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.3;RPMI-8226: 1.4;SK-BR-3: 1.2;T-47d: 2.0;U-266/70: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA044352 Uncertain Vesicles NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA044352: AB_10965328" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (4.32e-3)" "unprognostic (4.72e-4)" "unprognostic (2.56e-1)" "unprognostic (1.22e-2)" "unprognostic (1.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.29e-1)" "unprognostic (3.93e-2)" "unprognostic (8.59e-4)" "unprognostic (2.09e-1)" "unprognostic (7.25e-2)" "unprognostic (2.65e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (7.95e-2)" 0.9 0.5 0.0 0.4 0.0 0.3 0.2 0.2 0.1 0.3 0.0 0.1 3.9 0.2 0.2 0.1 0.4 0.2 0.2 0.0 0.1 1.1 1.5 0.1 0.4 0.1 0.1 0.0 1.3 0.0 0.7 0.2 0.1 0.3 0.0 1.5 1.3 0.0 0.0 0.6 3.0 0.0 0.1 0.4 0.5 42.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.9 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.4 0.0 0.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 1.4 0.0 0.0 0.4 0.2 0.1 1.2 0.0 0.2 2.0 0.0 0.0 0.3 0.6 0.1 0.0 1.2 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 STRN4 "PPP2R6C, ZIN" ENSG00000090372 "Striatin 4" Q9NRL3 19 46719511-46746994 "Predicted intracellular proteins, Predicted membrane proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043051, HPA043527, HPA056706" Supported Approved Cytosol NA NA 32000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA043051: AB_2678290, HPA043527: AB_10959664, HPA056706: AB_2683214" "unprognostic (3.57e-2)" "unprognostic (7.96e-2)" "unprognostic (2.13e-2)" "unprognostic (7.39e-2)" "unprognostic (1.81e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (6.06e-8)" "unprognostic (8.31e-3)" "unprognostic (5.34e-2)" "prognostic unfavorable (2.98e-4)" "unprognostic (1.56e-1)" "unprognostic (9.41e-3)" "unprognostic (4.86e-3)" "unprognostic (6.74e-2)" "unprognostic (4.06e-2)" "unprognostic (6.04e-2)" "unprognostic (1.84e-1)" 34.2 25.3 25.5 19.5 25.3 37.6 32.8 15.5 31.1 33.5 19.7 38.0 22.6 37.0 7.9 48.1 32.8 19.6 37.1 32.5 21.4 29.2 23.0 33.8 21.2 19.1 18.8 30.9 36.5 21.3 22.8 20.4 17.6 33.2 12.8 9.7 31.0 19.8 36.1 42.5 30.5 17.7 17.8 42.8 33.8 85.3 24.9 19.4 27.7 15.5 11.6 35.2 34.2 23.5 60.8 79.2 67.5 50.2 19.1 21.1 47.7 51.2 27.4 52.0 45.3 59.7 52.5 30.1 30.2 42.0 42.5 42.2 31.9 49.8 20.3 43.7 66.9 66.3 52.4 51.4 60.8 54.1 69.5 33.8 49.1 33.5 45.5 26.2 46.8 34.9 59.2 38.2 22.1 41.4 60.6 143.4 51.8 63.5 37.1 55.1 41.2 23.3 34.9 107.0 83.5 89.8 71.7 66.1 34.5 29.0 49.7 60.5 64.3 38.8 58.4 26.9 76.4 48.5 74.1 45.0 33.9 33.8 81.9 4.2 6.0 2.8 1.0 9.1 0.3 1.4 0.8 0.7 3.1 2.5 0.4 0.9 9.3 1.4 5.7 2.7 0.3 5.8 25.5 25.3 15.5 31.1 32.5 21.4 19.1 18.8 17.6 17.8 24.9 23.5 28.4 3.2 7.5 6.2 7.7 17.2 10.7 11.6 6.2 14.7 17.7 15.0 12.1 14.3 8.9 7.3 12.5 14.6 10.4 28.3 1.9 12.6 11.4 15.7 17.9 23.9 17.5 11.6 13.7 15.4 18.1 11.4 15.3 18.2 0.0 22.5 20.3 12.3 14.8 30.3 11.1 23.0 10.2 24.1 14.6 19.6 17.7 22.9 10.6 13.1 16.9 7.9 2.1 5.5 12.1 19.8 17.7 19.9 8.0 18.3 15.4 7.4 9.0 7.9 6.6 13.4 14.3 19.8 44.9 16.8 17.3 20.0 8.5 18.6 18.9 17.8 STUM "C1orf95, DKFZp761P211" ENSG00000203685 "Stum, mechanosensory transduction mediator homolog" Q69YW2 1 226548764-226609230 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 234.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 9.8;Endometrial stromal cells: 3.8;Fibroblasts: 1.5;Glandular and luminal cells: 1.6;Smooth muscle cells: 2.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "medulla oblongata: 234.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 29.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 70.3;basal ganglia: 76.6;cerebral cortex: 75.5;hippocampal formation: 74.0;thalamus: 21.3" HPA074381 Approved Cytosol NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 36: HEL - Hemostasis" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA074381: AB_2732253" "unprognostic (3.23e-3)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" "unprognostic (2.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.41e-3)" "unprognostic (3.07e-1)" "unprognostic (5.15e-2)" "unprognostic (7.62e-2)" "unprognostic (3.28e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.14e-2)" "unprognostic (9.04e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-3)" 3.7 1.0 45.5 1.2 40.0 0.0 2.8 0.0 43.7 3.1 0.0 15.7 1.6 3.2 1.3 5.7 3.1 0.8 2.2 38.8 17.6 5.5 0.1 0.5 0.2 234.8 30.0 2.5 0.9 0.9 7.4 0.4 101.9 4.0 2.1 1.4 1.0 1.2 3.6 4.2 2.7 5.8 9.4 1.0 2.3 1.4 49.5 0.5 0.7 1.3 0.3 6.8 3.5 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 4.9 0.4 29.9 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.4 0.3 0.0 4.4 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 40.0 0.0 43.7 38.8 17.6 234.8 30.0 101.9 9.4 49.5 5.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.8 0.0 0.0 1.0 3.8 0.2 0.0 0.0 0.0 0.2 0.5 1.5 0.0 1.6 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 TATDN2 KIAA0218 ENSG00000157014 "TatD DNase domain containing 2" Q93075 3 10248023-10281218 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA036822 Approved Approved "Nuclear speckles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "HPA036822: AB_10671972" "unprognostic (4.51e-2)" "unprognostic (2.66e-3)" "unprognostic (2.75e-1)" "unprognostic (4.23e-2)" "unprognostic (9.88e-2)" "unprognostic (1.58e-2)" "unprognostic (2.57e-3)" "unprognostic (8.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.63e-1)" "prognostic favorable (4.66e-4)" "unprognostic (3.25e-1)" "unprognostic (1.87e-1)" "unprognostic (2.55e-2)" "unprognostic (1.70e-1)" "unprognostic (3.33e-1)" "unprognostic (2.48e-2)" 15.5 15.8 19.8 14.8 20.9 34.4 15.4 18.0 21.4 19.9 17.0 15.5 12.7 17.4 15.5 19.9 15.6 10.3 16.2 20.8 17.3 17.8 14.0 17.3 21.6 17.6 17.2 24.7 19.9 17.9 17.8 9.8 17.3 20.9 14.7 9.0 17.7 12.3 15.0 20.7 18.8 13.5 17.4 23.9 16.7 8.6 19.5 32.5 20.8 10.9 22.1 16.6 18.4 18.3 19.4 32.1 16.9 14.3 21.2 22.9 73.3 23.2 22.5 28.8 18.8 23.6 17.0 45.6 17.0 32.1 30.7 14.3 29.1 20.9 22.5 29.5 36.5 24.3 30.8 24.9 13.7 34.6 24.8 17.6 22.9 40.2 13.6 18.8 23.6 28.3 27.9 40.7 26.4 37.2 45.4 29.6 23.9 25.2 31.9 24.8 18.0 26.5 18.2 26.8 18.7 22.6 19.4 21.8 10.9 15.6 22.2 32.4 18.8 33.1 21.6 28.1 41.6 25.5 43.6 80.6 30.0 35.6 23.1 1.3 0.6 0.5 1.6 1.0 1.6 0.8 1.4 1.3 0.5 1.4 1.4 2.1 0.5 0.9 0.5 1.3 1.7 0.9 19.8 20.9 18.0 21.4 20.8 17.3 17.6 17.2 17.3 17.4 19.5 18.3 6.3 6.4 11.0 4.9 8.2 12.6 4.6 4.8 9.1 4.4 9.4 6.3 6.9 7.2 4.3 11.0 6.2 3.8 9.3 12.7 1.9 5.1 2.0 4.1 7.0 7.9 16.8 6.1 8.8 9.2 4.0 6.8 5.1 5.9 5.1 9.1 7.9 10.2 10.3 5.0 5.9 8.7 2.0 15.6 21.0 1.8 7.2 9.1 14.2 6.5 9.0 5.2 18.6 4.5 5.0 8.6 3.1 7.5 8.8 9.3 8.0 5.4 2.4 2.8 6.6 5.8 4.7 2.1 5.6 6.4 12.4 2.5 10.7 8.7 10.8 7.1 TBC1D10B "DKFZP434P1750, EPI64B, FLJ13130, Rab27A-GAPbeta" ENSG00000169221 "TBC1 domain family member 10B" Q4KMP7 16 30357102-30370494 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048894 Uncertain NA NA 250000 "Cluster 49: Eosinophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "HPA048894: AB_2680549" "unprognostic (2.55e-1)" "unprognostic (1.33e-3)" "prognostic unfavorable (1.35e-4)" "unprognostic (4.08e-3)" "unprognostic (2.85e-1)" "unprognostic (7.45e-2)" "prognostic unfavorable (8.94e-5)" "unprognostic (1.39e-2)" "unprognostic (3.58e-2)" "unprognostic (1.52e-1)" "unprognostic (4.17e-2)" "unprognostic (1.23e-3)" "unprognostic (2.03e-1)" "unprognostic (2.62e-2)" "unprognostic (7.42e-2)" "unprognostic (7.11e-2)" "unprognostic (2.59e-2)" 17.4 18.1 13.3 11.7 14.1 12.6 15.6 13.1 14.7 17.9 2.9 16.3 12.0 19.1 3.6 18.1 15.5 8.4 15.7 14.3 11.0 12.6 8.0 15.1 11.1 17.2 13.4 16.0 12.8 10.6 11.6 9.4 13.5 13.4 5.3 4.6 14.0 11.0 36.0 21.5 15.1 8.9 13.7 17.1 13.7 42.8 13.9 14.3 12.7 17.8 9.5 15.7 16.1 19.4 30.6 40.2 16.6 32.7 21.4 20.1 37.5 31.8 25.1 34.8 32.2 29.0 23.0 37.0 32.7 23.7 22.9 25.9 22.2 23.7 12.7 37.2 56.8 19.6 28.1 31.1 30.9 27.2 38.9 26.5 23.3 41.8 23.9 15.4 32.7 33.5 38.9 38.7 23.3 47.6 39.5 19.8 9.4 22.7 29.1 50.4 26.5 36.7 18.7 23.0 34.8 24.8 18.0 29.7 13.0 11.1 31.8 32.9 34.3 39.4 19.4 25.9 30.0 27.0 30.6 29.7 35.0 37.8 25.8 0.3 0.9 1.7 1.2 0.4 0.6 0.9 0.6 1.2 0.9 0.5 0.2 0.2 1.3 0.9 0.8 0.8 0.6 1.0 13.3 14.1 13.1 14.7 14.3 11.0 17.2 13.4 13.5 13.7 13.9 19.4 13.8 0.0 10.2 10.4 9.3 18.1 6.4 8.3 7.4 18.8 14.5 13.5 6.8 7.2 7.7 11.0 0.0 12.4 12.2 20.4 3.9 8.6 14.8 10.6 11.2 12.2 15.0 8.2 9.6 10.9 12.5 9.8 9.2 12.5 5.1 17.6 10.8 6.6 17.3 11.8 8.8 11.9 10.2 16.4 16.1 34.2 10.2 18.3 7.2 7.5 14.4 13.8 14.4 4.0 19.8 14.1 9.5 12.0 10.5 8.5 19.0 7.1 5.6 13.6 0.0 9.7 10.6 17.1 14.0 10.5 17.5 11.2 10.6 18.4 13.6 9.8 TBCC CFC ENSG00000124659 "Tubulin folding cofactor C" Q15814 6 42744498-42746103 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035073, HPA035074" Approved Supported Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA035073: AB_10602897, HPA035074: AB_2674448" "unprognostic (7.16e-2)" "unprognostic (9.88e-2)" "unprognostic (2.17e-1)" "unprognostic (4.23e-2)" "unprognostic (8.20e-2)" "unprognostic (6.79e-2)" "unprognostic (5.80e-3)" "unprognostic (1.41e-2)" "unprognostic (2.47e-1)" "unprognostic (3.96e-3)" "unprognostic (1.84e-2)" "unprognostic (1.92e-1)" "unprognostic (2.22e-1)" "unprognostic (2.28e-1)" "unprognostic (1.29e-1)" "unprognostic (6.31e-2)" "unprognostic (3.76e-3)" 10.4 15.0 15.9 17.8 15.8 39.6 9.9 15.4 18.3 9.9 12.3 17.0 14.5 14.4 12.9 16.1 15.6 10.1 16.0 16.4 16.3 11.9 13.1 11.6 29.1 18.0 14.1 12.2 14.9 11.3 11.1 7.6 18.8 11.3 9.9 15.4 14.5 11.8 26.7 16.8 23.5 10.7 15.2 30.1 15.5 18.0 14.7 21.9 14.0 14.4 19.5 13.1 10.0 16.6 34.5 11.2 16.9 31.7 23.9 16.0 22.3 23.2 26.1 25.3 27.4 17.4 13.3 31.0 18.3 22.7 21.0 29.5 22.9 23.2 14.0 17.0 25.0 16.3 16.7 29.7 27.2 17.9 25.5 26.2 27.8 19.7 16.1 22.7 20.1 17.1 37.8 27.4 22.9 42.4 14.8 34.3 15.8 93.5 30.4 14.8 20.3 20.3 24.5 18.6 64.7 28.1 15.1 25.8 41.1 15.4 28.3 59.7 21.9 24.1 21.6 19.6 32.3 36.1 43.7 53.0 11.8 24.2 23.7 139.1 91.4 174.5 105.5 79.2 108.9 101.7 111.9 116.7 83.5 90.9 129.6 119.9 162.1 170.8 74.1 142.3 154.8 170.4 15.9 15.8 15.4 18.3 16.4 16.3 18.0 14.1 18.8 15.2 14.7 16.6 19.3 3.2 24.0 2.6 50.8 25.1 25.9 49.3 51.2 55.0 25.4 29.1 6.8 24.3 25.7 11.0 41.7 21.4 83.8 25.1 33.2 38.6 30.3 23.0 21.2 20.9 45.3 13.0 7.0 30.9 23.5 17.1 18.3 22.9 31.0 21.0 19.6 10.0 18.8 18.5 7.8 21.2 71.2 16.2 27.8 10.2 17.7 15.9 28.4 8.4 33.6 46.3 77.2 5.0 12.8 28.5 27.0 20.7 37.1 15.9 29.8 23.9 22.0 51.7 19.7 13.0 46.1 50.1 22.7 30.7 24.9 21.1 80.2 26.6 22.3 22.1 TBCE "HRD, KCS, KCS1, pac2" ENSG00000285053 "Tubulin folding cofactor E" Q15813 1 235328570-235448952 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Dwarfism, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA026552, HPA026557" Approved NA NA "Cluster 46: Basophils - DNA binding" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "HPA026552: AB_1857797, HPA026557: AB_1857798" 0.9 0.7 1.1 1.3 0.8 1.3 0.8 2.4 1.7 0.8 0.1 1.0 0.8 1.5 0.5 0.6 0.7 0.6 1.1 1.0 1.3 1.2 0.7 0.8 1.5 1.9 1.1 1.9 1.6 0.8 1.3 2.2 1.2 0.9 1.9 0.7 0.8 3.5 0.8 1.4 0.7 0.5 1.0 1.2 1.6 1.4 2.4 1.0 2.4 1.2 0.9 1.7 8.4 2.5 8.9 5.7 1.5 2.4 5.9 3.7 1.9 6.3 3.3 2.2 6.6 4.4 9.0 1.5 3.8 3.9 3.4 3.2 4.5 6.3 6.7 2.2 3.5 2.8 0.6 5.6 5.2 0.8 1.0 3.4 3.9 1.3 2.3 5.2 6.2 2.3 3.9 4.2 8.1 2.0 10.0 4.8 1.9 5.2 3.8 2.0 2.2 2.7 9.3 8.5 3.6 6.4 4.0 1.3 9.5 10.8 3.5 4.6 7.8 4.5 5.2 5.6 6.5 5.8 6.2 2.5 6.0 3.0 2.5 2.4 2.3 2.9 2.4 1.8 2.0 2.4 2.6 1.3 2.4 2.1 0.5 1.8 2.5 1.8 2.7 2.1 1.1 0.8 2.4 1.7 1.0 1.3 1.9 1.1 2.2 0.5 1.4 1.7 10.1 0.0 5.9 17.9 8.9 3.1 5.2 8.2 5.2 9.2 6.9 9.4 0.0 4.3 7.0 7.3 4.2 0.0 8.6 4.3 0.0 3.5 10.9 3.4 12.3 5.9 3.5 6.9 22.4 1.6 0.0 5.5 9.7 4.3 3.8 7.7 2.2 5.9 0.0 6.7 26.1 5.3 4.1 4.7 2.7 6.2 10.8 6.6 8.8 10.3 8.9 8.9 11.3 11.6 22.0 3.1 4.1 7.5 6.6 2.9 5.2 1.4 5.7 13.1 0.0 5.9 7.6 14.0 8.8 7.5 2.8 0.0 8.8 8.5 8.3 3.9 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 11.6;Endometrial ciliated cells: 12.0;Exocrine glandular cells: 12.7;Extravillous trophoblasts: 26.6;Hofbauer cells: 14.6;monocytes: 11.9;Pancreatic endocrine cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 66.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 6: Brain - Smell perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: AB_2676320, HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 5.1 1.6 5.2 4.9 5.5 6.8 4.7 4.1 7.8 4.3 0.5 5.5 5.1 3.8 1.0 6.8 4.6 1.8 4.3 5.8 3.0 4.0 5.4 4.9 5.4 7.0 3.5 2.5 3.0 1.0 5.3 1.6 4.2 4.2 1.6 0.5 4.3 2.3 2.3 8.2 5.4 1.0 3.1 6.8 5.9 4.9 3.6 4.5 5.7 0.5 3.1 3.9 4.5 5.3 17.2 38.9 9.2 13.5 0.8 1.5 24.5 13.4 5.0 15.9 14.7 14.0 31.2 25.6 27.2 2.2 6.2 43.5 3.2 14.0 3.0 29.0 16.0 6.5 22.8 13.3 0.6 12.9 17.9 0.3 4.6 10.6 3.5 2.0 6.4 23.2 10.5 31.2 2.5 66.7 26.9 29.6 11.9 14.6 41.8 21.9 13.8 17.9 4.5 14.3 25.7 15.5 13.7 15.8 9.8 2.0 26.0 12.6 7.8 10.9 18.4 33.4 22.4 17.8 8.2 15.7 13.9 14.8 18.0 0.0 0.5 0.6 0.5 0.9 0.4 0.1 0.8 1.4 0.7 0.3 0.6 0.1 0.1 0.0 0.8 2.4 0.6 0.2 5.2 5.5 4.1 7.8 5.8 3.0 7.0 3.5 4.2 3.1 3.6 5.3 4.8 3.2 2.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 5.9 5.3 0.0 0.0 0.6 1.8 0.0 8.0 10.1 0.0 3.9 11.6 0.0 12.0 3.0 4.0 0.0 0.0 0.0 12.7 26.6 3.4 0.0 7.2 0.0 8.1 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 11.9 0.0 0.0 0.0 0.0 14.7 0.0 0.0 4.7 0.0 0.0 2.0 3.6 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.0 4.2 2.5 0.0 0.0 TENT2 "FLJ38499, GLD2, PAPD4, TUT2" ENSG00000164329 "Terminal nucleotidyltransferase 2" Q6PIY7 5 79612120-79686648 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 37.6;Glandular and luminal cells: 33.2;Granulosa cells: 31.9;Hofbauer cells: 33.9;Syncytiotrophoblasts: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054468 Approved Cytosol No No "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA054468: AB_2682497" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.25e-3)" "unprognostic (1.91e-1)" "unprognostic (8.03e-2)" "unprognostic (2.80e-3)" "unprognostic (2.10e-2)" "unprognostic (1.10e-1)" "unprognostic (6.80e-2)" "unprognostic (1.57e-3)" "unprognostic (9.37e-2)" "unprognostic (2.21e-1)" "unprognostic (7.71e-2)" "unprognostic (2.38e-1)" "unprognostic (8.43e-3)" "unprognostic (5.84e-3)" "unprognostic (2.67e-3)" 19.1 15.1 10.4 20.4 12.8 44.4 25.0 11.5 15.6 17.9 15.0 18.5 17.8 19.6 23.6 16.5 16.0 17.3 14.5 9.6 10.8 17.6 23.8 17.9 30.2 12.0 11.1 22.7 15.2 15.5 11.5 21.0 12.5 15.7 20.8 14.3 15.1 15.3 16.2 23.8 19.1 18.3 10.9 27.8 17.7 17.5 11.2 27.2 22.4 14.3 28.1 19.1 15.9 15.2 22.5 15.3 16.8 26.7 28.8 33.2 26.8 26.6 40.6 30.5 48.3 13.8 26.1 41.8 13.6 29.6 35.9 21.1 21.8 29.6 34.6 31.3 19.9 23.9 19.4 21.6 37.3 35.7 31.6 29.5 31.4 21.6 40.1 29.7 26.2 30.0 27.7 30.0 34.0 12.3 40.8 45.6 15.6 17.0 10.8 36.2 16.8 47.2 29.4 31.8 11.0 20.1 21.1 22.8 42.8 26.4 19.6 55.6 24.2 16.4 11.1 16.0 29.9 31.3 27.8 40.7 28.9 36.8 23.4 30.7 21.5 21.6 19.0 24.8 31.3 21.6 20.5 21.0 21.9 17.2 19.5 20.6 19.2 21.8 26.0 12.0 23.4 19.0 10.4 12.8 11.5 15.6 9.6 10.8 12.0 11.1 12.5 10.9 11.2 15.2 25.9 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 24.2 16.5 0.0 0.0 0.0 27.6 0.0 26.3 37.6 0.0 17.6 10.2 0.0 21.3 29.0 7.2 0.0 0.0 0.0 10.2 22.6 8.7 0.0 33.2 0.0 31.9 0.0 0.0 33.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 9.8 0.0 0.0 0.0 0.0 14.9 0.0 0.0 11.5 0.0 0.0 26.5 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 33.7 11.0 23.7 0.0 0.0 TENT5A "C6orf37, FAM46A, FLJ20037" ENSG00000112773 "Terminal nucleotidyltransferase 5A" Q96IP4 6 81491439-81752774 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 225.9;salivary gland: 104.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 73.1;Endometrial stromal cells: 70.6;Extravillous trophoblasts: 115.4;Glandular and luminal cells: 176.7;Syncytiotrophoblasts: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 81.9;HeLa: 86.1;HL-60: 95.6;THP-1: 162.0;U-937: 72.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051067, HPA067140" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA051067: , HPA067140: AB_2685788" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (5.39e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (2.62e-3)" "unprognostic (5.93e-2)" "unprognostic (2.48e-2)" "unprognostic (2.53e-1)" "unprognostic (1.03e-1)" "unprognostic (1.40e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (7.18e-2)" "unprognostic (6.38e-2)" "unprognostic (9.25e-2)" "unprognostic (9.66e-2)" 13.5 21.3 4.3 7.9 4.6 225.9 12.2 9.0 5.8 21.3 9.9 17.2 16.4 10.2 19.7 4.4 12.0 32.3 21.7 4.0 14.0 6.4 35.9 9.1 5.2 7.8 7.1 23.6 8.3 9.4 17.4 18.7 6.1 9.9 16.9 8.7 104.4 24.8 2.1 18.7 22.2 11.1 5.0 9.9 37.8 3.7 6.7 2.9 8.8 5.1 4.3 16.6 8.8 5.3 3.5 5.0 3.3 0.2 67.9 29.8 6.2 27.0 19.2 15.7 23.5 51.0 2.6 0.3 1.0 81.9 10.0 2.9 2.4 4.2 11.5 0.0 6.2 0.1 86.1 8.0 21.2 95.6 7.1 13.2 2.4 12.3 2.1 51.2 2.0 0.8 1.4 0.0 10.6 14.7 0.0 67.2 0.9 29.2 3.8 0.0 28.8 0.1 2.1 6.2 3.3 4.4 12.1 5.2 8.3 9.9 1.2 162.0 4.5 17.9 3.8 7.6 7.6 0.4 0.3 0.3 25.3 72.7 7.8 37.3 29.9 46.3 11.5 29.6 6.8 18.2 4.3 5.7 24.2 21.0 8.1 8.0 13.8 16.9 47.3 8.5 5.6 14.0 4.3 4.6 9.0 5.8 4.0 14.0 7.8 7.1 6.1 5.0 6.7 5.3 22.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 40.8 44.2 0.0 0.0 0.0 5.5 0.0 39.9 43.1 0.0 3.9 30.5 0.0 73.1 70.6 2.9 0.0 0.0 0.0 23.4 115.4 32.7 0.0 176.7 0.0 40.9 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 9.8 0.0 0.0 0.0 0.0 26.7 0.0 0.0 5.9 0.0 0.0 3.6 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 162.0 9.4 12.6 0.0 0.0 TENT5C "FAM46C, FLJ20202" ENSG00000183508 "Terminal nucleotidyltransferase 5C" Q5VWP2 1 117606048-117628389 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Host-virus interaction" "Nucleotidyltransferase, RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 89.1" "Cell type enhanced" "Detected in some" "B-cells: 41.8;Breast glandular cells: 34.0;Breast myoepithelial cells: 43.2;dendritic cells: 104.5;Plasma cells: 47.7;T-cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 29.3" "Group enriched" "Detected in many" 17 "B-cells: 13.3;granulocytes: 29.3;T-cells: 13.7" "Cell line enhanced" "Detected in many" "Karpas-707: 296.2;RPMI-8226: 185.5;U-266/70: 81.7;U-266/84: 72.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054049 Uncertain Supported Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA054049: AB_2682356" "unprognostic (3.76e-2)" "unprognostic (3.85e-3)" "unprognostic (3.24e-3)" "prognostic favorable (3.75e-5)" "unprognostic (1.17e-1)" "unprognostic (1.55e-3)" "unprognostic (3.29e-1)" "unprognostic (2.88e-2)" "unprognostic (5.75e-2)" "unprognostic (1.36e-3)" "unprognostic (9.41e-3)" "unprognostic (3.91e-2)" "prognostic favorable (2.77e-5)" "unprognostic (6.26e-2)" "unprognostic (3.16e-2)" "unprognostic (3.08e-2)" "unprognostic (1.10e-2)" 2.8 2.4 0.9 17.0 1.0 89.1 11.6 1.1 1.6 10.9 27.4 23.8 16.0 3.2 19.1 3.6 4.8 7.8 6.9 1.4 0.9 7.5 10.3 10.5 18.8 1.6 1.6 9.0 46.8 11.2 2.6 3.8 1.1 6.6 24.8 0.1 25.8 4.1 29.4 1.2 13.0 2.9 1.9 21.7 30.2 43.5 1.0 6.2 14.3 10.9 37.3 14.1 1.9 1.3 0.2 0.1 0.1 1.3 0.1 0.0 1.3 0.6 26.9 0.5 0.2 1.7 0.2 4.9 0.3 0.8 0.3 0.3 0.1 0.5 0.2 17.6 1.6 37.9 0.2 0.0 0.1 22.4 46.8 0.0 0.1 0.4 0.0 0.1 0.1 10.0 5.2 296.2 0.0 3.8 0.1 22.8 3.8 4.5 2.4 0.1 0.1 185.5 0.3 3.7 2.2 0.2 1.7 2.4 1.8 0.6 1.9 0.2 0.5 0.3 2.1 0.1 0.4 81.7 72.8 1.9 1.7 8.1 2.4 29.3 0.0 15.9 3.4 0.0 3.1 13.3 3.3 4.4 0.1 10.4 0.4 1.9 1.6 1.1 0.0 0.3 13.7 2.9 0.9 1.0 1.1 1.6 1.4 0.9 1.6 1.6 1.1 1.9 1.0 1.3 17.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 34.0 43.2 0.0 0.0 0.0 1.8 0.0 1.9 104.5 0.0 11.7 0.8 0.0 8.3 5.4 2.9 0.0 0.0 0.0 5.2 2.2 3.2 0.0 13.7 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 47.7 0.0 0.0 9.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 2.2 48.4 1.0 0.0 0.0 TEPSIN "C17orf56, ENTHD2, FLJ31528" ENSG00000167302 "TEPSIN adaptor related protein complex 4 accessory protein" Q96N21 17 81228277-81239091 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Cytotrophoblasts: 9.9;Syncytiotrophoblasts: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063410 Approved "Nuclear membrane,Nuclear speckles,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear membrane, Nuclear speckles, Golgi apparatus" "HPA063410: AB_2685008" "unprognostic (6.90e-3)" "unprognostic (1.03e-2)" "unprognostic (4.26e-2)" "unprognostic (3.64e-2)" "unprognostic (1.00e-1)" "prognostic favorable (9.96e-4)" "unprognostic (1.16e-2)" "unprognostic (4.85e-2)" "unprognostic (8.52e-2)" "unprognostic (2.29e-1)" "prognostic favorable (6.95e-4)" "unprognostic (4.99e-2)" "prognostic unfavorable (7.31e-8)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (3.58e-1)" "unprognostic (3.16e-3)" 11.4 12.1 8.3 7.4 8.5 13.0 11.3 8.4 12.8 12.9 9.1 14.2 10.8 11.2 4.0 13.3 11.5 4.3 10.2 8.3 8.1 16.6 17.7 12.0 11.0 9.4 8.5 9.3 15.8 3.3 11.4 5.3 8.9 15.3 4.0 1.6 12.0 3.0 10.0 14.6 19.7 4.4 8.3 28.6 15.6 13.3 9.1 10.3 16.0 3.2 5.8 13.5 11.8 8.8 9.5 14.2 5.1 8.6 3.5 5.7 10.0 8.2 4.7 8.5 7.6 9.1 6.8 6.9 4.5 5.5 8.0 11.8 5.3 7.3 3.8 4.1 18.7 5.7 8.1 13.0 5.4 6.0 12.8 3.4 9.1 3.8 4.2 5.9 13.4 9.7 6.7 6.7 5.3 8.4 11.2 15.7 5.7 7.5 11.6 6.9 7.1 7.4 3.3 6.1 6.7 8.5 9.7 11.1 11.5 9.9 9.1 11.3 8.0 11.2 6.6 8.5 8.3 9.4 6.5 5.5 8.3 5.3 5.7 2.4 1.2 4.0 0.8 1.6 0.5 1.2 0.5 0.6 1.3 1.8 0.3 0.4 2.1 0.4 1.0 1.4 0.8 0.8 8.3 8.5 8.4 12.8 8.3 8.1 9.4 8.5 8.9 8.3 9.1 8.8 8.6 9.6 5.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 6.9 7.1 0.0 0.0 1.3 1.8 0.0 9.9 8.8 0.0 0.0 4.7 0.0 3.2 5.8 3.0 0.0 0.0 0.0 5.3 7.2 2.5 0.0 6.2 6.3 8.6 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 6.0 0.0 0.0 3.3 0.0 0.0 2.3 2.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 10.5 3.9 5.1 0.0 0.0 TGFB1 "CED, DPD1, TGFB, TGFbeta" ENSG00000105329 "Transforming growth factor beta 1" 19 41301587-41353922 "Human disease related genes, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 438.3;Extravillous trophoblasts: 452.1;Macrophages: 188.8;NK-cells: 223.5;T-cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000361, HPA073356" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 1290000 "Cluster 52: Eosinophils - Transcription" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" Cytosol "CAB000361: AB_2201910, HPA073356: " "unprognostic (1.49e-2)" "unprognostic (5.43e-3)" "unprognostic (3.29e-2)" "unprognostic (4.90e-2)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (8.51e-3)" "unprognostic (5.63e-3)" "unprognostic (2.47e-2)" "unprognostic (5.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (1.19e-8)" "unprognostic (1.65e-3)" "unprognostic (2.79e-2)" "unprognostic (6.39e-2)" "unprognostic (4.86e-3)" 39.8 28.6 10.8 39.7 10.7 82.9 25.4 11.8 9.4 53.2 9.5 31.0 14.4 45.9 7.4 52.2 27.7 18.1 35.8 9.5 15.5 35.8 14.7 63.4 34.0 24.5 14.9 17.4 14.3 11.5 18.0 32.1 17.6 31.6 8.4 0.6 21.2 19.8 8.1 29.3 37.8 21.8 18.4 88.9 20.1 8.1 19.4 16.7 20.2 8.3 25.7 44.1 45.3 17.7 57.7 87.6 3.4 0.3 41.7 35.3 10.0 81.9 64.4 25.2 15.4 40.4 30.1 57.0 88.6 110.5 26.8 30.1 17.8 54.6 11.1 76.6 17.9 199.0 18.0 50.4 47.7 54.9 119.6 45.0 17.5 50.5 32.7 138.7 135.2 21.1 108.0 116.8 27.9 42.1 43.1 79.6 9.4 12.0 52.7 44.4 13.1 85.4 46.8 20.3 0.3 6.5 23.9 0.1 15.1 32.5 1.9 36.3 170.3 96.4 77.2 20.7 91.2 74.4 31.7 36.3 90.3 106.4 16.4 1.1 0.8 3.9 0.7 1.2 0.6 0.2 0.3 0.4 0.5 0.3 0.2 0.3 2.4 0.3 0.8 0.9 0.3 0.9 10.8 10.7 11.8 9.4 9.5 15.5 24.5 14.9 17.6 18.4 19.4 17.7 55.0 0.0 0.0 3.3 120.6 44.4 36.5 64.8 38.7 0.2 14.4 9.7 2.3 4.3 17.2 16.5 0.0 5.4 438.3 1.4 0.0 12.8 1.0 5.7 18.2 63.1 0.0 28.0 1.6 17.1 452.1 34.3 14.3 5.0 64.9 20.0 71.4 2.7 141.2 0.0 2.1 1.4 22.4 136.1 158.6 1.8 12.2 188.8 23.2 30.0 105.8 0.3 223.5 0.0 0.6 45.1 16.4 18.0 156.5 32.9 0.4 9.0 9.7 0.7 39.5 13.9 78.6 3.1 8.0 40.3 18.9 55.7 221.9 4.1 0.8 31.1 THAP12 "DAP4, P52rIPK, PRKRIR, THAP0" ENSG00000137492 "THAP domain containing 12" O43422 11 76349956-76381132 "Plasma proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 42.4;dendritic cells: 31.6;Endometrial stromal cells: 34.7;Theca cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 241.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008758, HPA077077" Approved Approved Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA008758: AB_1855714, HPA077077: " "unprognostic (2.79e-1)" "unprognostic (9.79e-2)" "unprognostic (1.16e-3)" "unprognostic (6.47e-2)" "unprognostic (8.85e-3)" "unprognostic (1.23e-1)" "unprognostic (4.03e-3)" "unprognostic (1.08e-1)" "unprognostic (6.68e-3)" "unprognostic (1.48e-1)" "unprognostic (1.57e-2)" "unprognostic (2.65e-2)" "unprognostic (7.98e-2)" "unprognostic (2.06e-1)" "unprognostic (3.95e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-2)" 25.7 21.9 13.8 20.1 14.2 33.4 29.7 13.6 16.3 21.4 13.2 24.1 19.9 24.2 21.1 11.2 19.0 16.7 17.2 14.4 13.8 19.6 19.5 21.8 33.0 13.1 14.2 20.3 41.6 14.2 9.5 26.2 13.1 17.1 25.7 37.2 15.6 19.0 31.7 14.5 20.0 22.0 13.9 26.0 21.5 18.1 14.2 30.6 22.1 32.9 28.7 20.4 15.0 13.6 37.7 29.3 54.6 31.1 36.4 51.5 33.4 38.0 38.9 46.4 40.8 58.9 38.9 100.8 57.1 36.2 40.7 36.5 67.4 44.6 73.9 78.3 21.5 72.2 20.2 27.4 40.2 92.3 34.9 37.1 57.8 41.3 76.9 28.1 40.7 70.5 85.3 55.3 42.0 40.4 81.4 51.9 22.7 98.5 31.8 60.3 124.7 105.0 27.1 38.8 53.1 35.6 36.7 40.1 20.5 36.5 40.6 35.8 36.7 55.4 91.7 114.2 33.9 49.9 56.6 241.7 13.3 50.8 30.6 0.7 1.5 1.7 4.5 1.6 5.2 3.3 4.7 5.0 2.1 3.6 3.4 4.4 0.5 5.6 1.5 0.9 4.7 1.7 13.8 14.2 13.6 16.3 14.4 13.8 13.1 14.2 13.1 13.9 14.2 13.6 42.4 25.6 25.3 0.0 13.6 0.0 0.0 0.0 0.0 0.0 29.6 24.0 0.0 0.0 6.2 11.0 0.0 14.2 31.6 0.0 13.7 10.9 0.0 13.6 34.7 9.8 0.0 0.0 0.0 26.4 21.5 11.3 0.0 19.3 7.6 24.5 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 8.3 0.0 0.0 0.0 0.0 14.1 0.0 0.0 7.6 0.0 0.0 16.3 5.8 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 16.3 13.4 34.4 0.0 0.0 THSD8 ENSG00000284491 "Thrombospondin type 1 domain containing 8" A0A1W2PP97 19 12802031-12813581 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Cell type enhanced" "Detected in single" "Breast myoepithelial cells: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: Non-specific - Mitochondria" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TIGD5 FLJ14926 ENSG00000179886 "Tigger transposable element derived 5" Q53EQ6 8 143597831-143603224 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 20.9;Theca cells: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 50: Non-specific - Ribosome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.90e-1)" "unprognostic (7.91e-2)" "unprognostic (1.21e-1)" "unprognostic (5.24e-2)" "unprognostic (1.22e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (2.79e-2)" "unprognostic (1.12e-1)" "unprognostic (6.72e-2)" "unprognostic (2.75e-3)" "unprognostic (3.16e-1)" "prognostic favorable (9.16e-5)" "unprognostic (1.44e-2)" "unprognostic (1.34e-1)" "unprognostic (2.32e-1)" "unprognostic (4.04e-1)" 2.1 2.9 1.8 0.2 1.6 0.1 2.1 4.0 2.0 3.0 0.5 3.1 0.4 3.2 0.1 3.5 3.0 0.2 3.6 1.5 1.6 3.0 2.3 1.7 0.3 2.1 2.0 4.0 5.9 0.7 3.8 0.1 1.7 3.0 0.1 0.1 2.7 0.3 4.4 3.7 2.7 0.1 1.5 3.6 3.0 1.5 1.7 0.2 3.0 0.4 0.2 3.2 2.5 2.0 0.9 1.5 0.4 1.2 0.6 0.6 0.6 0.5 0.4 0.5 0.4 0.5 0.6 1.7 2.7 0.4 0.5 1.2 0.4 0.4 0.0 5.9 1.8 1.0 1.7 0.2 1.1 0.4 1.4 0.6 1.1 0.3 0.5 0.7 0.4 0.4 1.2 0.2 0.2 1.6 2.9 1.7 0.6 1.0 2.9 1.1 0.3 0.8 0.5 0.6 1.4 1.8 1.1 0.9 1.2 0.1 2.6 1.2 0.7 1.0 0.8 1.0 3.5 0.9 0.4 0.2 0.6 0.7 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 1.6 4.0 2.0 1.5 1.6 2.1 2.0 1.7 1.5 1.7 2.0 5.0 3.2 1.3 0.7 3.8 1.7 5.4 0.9 1.2 16.0 6.3 4.6 5.9 4.3 1.3 5.5 20.9 1.4 4.9 5.1 0.0 2.3 1.0 4.0 8.1 4.4 0.0 4.0 0.8 1.8 1.3 4.2 2.0 5.5 1.3 15.4 4.6 2.6 3.4 16.8 1.1 3.6 0.0 3.2 0.8 0.7 7.8 3.0 0.0 1.0 3.2 10.0 6.2 0.5 0.4 3.6 1.7 4.5 1.0 4.9 3.3 2.2 1.1 15.1 0.0 10.6 4.2 0.8 1.2 2.4 1.0 1.8 3.5 29.3 5.1 3.8 TIMM29 "C19orf52, TIM29" ENSG00000142444 "Translocase of inner mitochondrial membrane 29" Q9BSF4 19 10928811-10933535 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 36.0;Ductal cells: 21.6;Extravillous trophoblasts: 31.4;Hofbauer cells: 22.4;Proximal tubular cells: 22.1;Syncytiotrophoblasts: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041858 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria Nucleoplasm "HPA041858: AB_10963429" "unprognostic (8.45e-2)" "prognostic favorable (9.93e-5)" "unprognostic (8.99e-2)" "unprognostic (5.21e-2)" "unprognostic (9.31e-2)" "unprognostic (8.10e-2)" "unprognostic (2.82e-3)" "unprognostic (1.42e-2)" "unprognostic (1.81e-1)" "unprognostic (5.92e-2)" "unprognostic (5.26e-3)" "unprognostic (1.80e-1)" "unprognostic (3.79e-3)" "prognostic favorable (7.03e-7)" "unprognostic (1.10e-1)" "unprognostic (2.35e-1)" "unprognostic (7.26e-3)" 8.4 11.7 4.6 5.4 4.5 10.1 8.4 3.7 6.1 10.4 3.5 11.0 8.0 11.0 1.1 14.9 9.0 3.1 13.5 4.9 3.8 11.5 12.2 8.1 6.0 5.8 4.3 7.9 9.9 3.3 10.7 4.6 4.2 10.1 2.0 1.1 10.1 3.8 23.5 13.9 9.7 2.1 3.8 10.7 11.0 13.0 4.2 5.3 7.5 5.9 2.8 10.5 11.4 4.7 21.3 8.0 6.2 10.4 5.3 5.1 16.7 14.3 7.6 10.7 9.9 14.7 7.0 18.0 24.7 7.0 5.8 20.1 3.3 8.9 1.8 21.3 25.0 20.7 8.4 10.0 8.4 15.8 15.5 4.5 8.6 7.5 3.2 4.3 6.5 15.7 23.1 15.4 4.1 19.0 17.4 29.1 21.8 6.6 34.0 23.4 8.7 22.3 4.7 8.6 15.6 15.8 16.9 9.1 18.3 2.3 13.1 16.7 10.7 17.1 10.0 21.6 23.1 49.7 52.8 19.8 10.6 19.3 14.8 3.7 8.7 9.8 5.3 9.3 8.9 17.9 10.6 11.7 5.8 15.0 10.1 8.3 1.7 11.3 7.4 11.0 12.8 3.8 4.6 4.5 3.7 6.1 4.9 3.8 5.8 4.3 4.2 3.8 4.2 4.7 6.9 3.2 5.8 0.0 3.5 0.0 0.0 0.0 0.0 0.0 9.6 8.4 0.0 0.0 1.3 16.5 0.0 36.0 13.8 0.0 19.6 21.6 0.0 9.6 10.9 4.9 0.0 0.0 0.0 10.5 31.4 5.2 0.0 9.2 1.3 10.5 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 2.4 0.0 0.0 22.1 0.7 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 35.7 5.5 14.7 0.0 0.0 TLNRD1 "MESDC1, MGC99595" ENSG00000140406 "Talin rod domain containing 1" Q9H1K6 15 81000923-81005788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 36.8;Exocrine glandular cells: 31.5;Extravillous trophoblasts: 31.5;Glandular and luminal cells: 27.7;Hofbauer cells: 35.2;Pancreatic endocrine cells: 44.1;Proximal tubular cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HDLM-2: 47.0;SK-MEL-30: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071716 Approved "Nucleoplasm,Cytoplasmic bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytoplasmic bodies" "HPA071716: AB_2732183" "unprognostic (1.32e-2)" "unprognostic (5.30e-2)" "unprognostic (9.29e-2)" "unprognostic (5.37e-3)" "unprognostic (9.10e-3)" "unprognostic (1.24e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (1.47e-5)" "unprognostic (1.68e-2)" "unprognostic (6.82e-2)" "unprognostic (1.81e-1)" "unprognostic (3.24e-1)" "prognostic unfavorable (1.87e-7)" "unprognostic (1.91e-1)" "unprognostic (1.44e-1)" "unprognostic (8.32e-2)" "unprognostic (3.82e-3)" 13.5 9.6 4.8 5.4 8.7 7.5 7.8 12.5 6.4 6.2 6.3 7.1 3.7 7.3 2.0 8.2 7.1 3.7 10.0 5.2 3.9 7.4 6.2 14.5 4.3 6.8 4.8 4.6 10.1 1.6 5.9 4.6 5.3 5.3 2.9 1.2 6.3 1.8 1.9 3.4 6.9 2.4 5.0 11.8 8.0 1.6 6.3 3.5 5.3 2.1 2.9 7.7 5.5 4.9 11.2 3.6 9.4 6.8 4.1 2.4 15.5 10.0 2.8 6.2 4.5 6.3 10.0 12.1 13.7 2.5 3.7 14.2 5.8 3.2 3.5 47.0 17.0 23.8 2.2 6.9 3.1 8.4 16.6 2.5 4.2 3.8 3.7 2.2 9.4 10.3 13.7 29.3 4.2 5.6 13.3 9.7 14.9 7.2 5.0 16.9 9.5 27.7 4.0 11.2 14.7 12.5 5.6 6.1 48.0 8.0 5.4 7.3 11.2 7.1 22.3 9.9 15.1 20.2 21.4 12.9 4.8 12.0 7.5 0.5 0.3 0.4 0.6 0.5 0.5 0.8 0.7 0.7 0.2 0.5 0.3 0.5 0.5 1.2 0.4 0.5 0.3 0.3 4.8 8.7 12.5 6.4 5.2 3.9 6.8 4.8 5.3 5.0 6.3 4.9 36.8 0.0 9.4 0.0 8.2 0.0 0.0 0.0 0.0 0.0 23.3 12.7 0.0 0.0 4.3 12.9 0.0 8.4 19.3 0.0 1.9 15.1 0.0 13.4 21.4 17.6 0.0 0.0 0.0 31.5 31.5 10.4 0.0 27.7 2.5 15.9 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 44.1 0.0 0.0 4.1 0.0 0.0 30.9 2.2 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 9.0 6.5 11.1 0.0 0.0 TMEM131L "DKFZp586H1322, KIAA0922" ENSG00000121210 "Transmembrane 131 like" A2VDJ0 4 153466346-153636711 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 49.4;lymphoid tissue: 48.3" "Cell type enhanced" "Detected in many" "Adipocytes: 13.6;Alveolar cells type 2: 9.6;B-cells: 9.9;dendritic cells: 13.2;Exocrine glandular cells: 9.3;monocytes: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 105.2;MOLT-4: 99.9;U-698: 122.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043472, HPA048443" Uncertain Approved "Nucleoli fibrillar center,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli fibrillar center" "HPA043472: AB_2678496, HPA048443: AB_2680395" "unprognostic (1.12e-1)" "prognostic favorable (6.69e-6)" "unprognostic (1.71e-1)" "unprognostic (3.75e-2)" "unprognostic (8.37e-2)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "unprognostic (3.30e-2)" "unprognostic (3.23e-2)" "unprognostic (4.11e-2)" "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (4.35e-3)" "unprognostic (2.92e-2)" "unprognostic (3.39e-2)" "unprognostic (3.94e-2)" "unprognostic (3.51e-2)" 9.8 1.7 1.6 20.9 4.0 49.4 7.2 1.0 2.7 5.6 1.0 6.4 2.3 6.3 9.4 6.7 5.0 4.9 8.7 1.5 1.6 3.5 20.7 6.6 47.8 1.9 1.4 4.6 31.2 1.1 3.9 3.9 1.9 5.9 4.6 0.4 8.1 4.8 24.5 6.9 10.9 6.9 1.0 24.6 6.1 4.4 2.0 48.3 4.1 6.2 45.4 6.1 6.0 2.8 5.8 3.7 15.7 16.5 9.1 7.9 0.3 8.3 4.0 5.6 7.1 25.8 3.7 105.2 2.0 11.1 6.2 5.7 12.1 14.3 8.5 9.7 8.7 20.6 7.0 6.7 5.9 22.9 1.2 7.3 8.7 7.4 6.9 6.3 14.4 19.1 19.7 0.4 5.7 10.7 99.9 16.6 14.0 0.2 5.4 34.3 15.2 6.8 3.8 2.4 11.7 9.1 6.5 14.2 8.6 8.0 5.5 16.6 11.6 7.5 13.2 9.1 6.9 11.2 12.1 122.4 2.2 13.5 6.2 11.8 19.4 21.1 12.3 36.8 16.7 28.2 15.5 11.7 20.9 27.3 25.8 17.5 21.0 24.3 31.6 2.1 20.9 17.6 1.6 4.0 1.0 2.7 1.5 1.6 1.9 1.4 1.9 1.0 2.0 2.8 13.6 6.4 9.6 0.0 9.9 0.0 0.0 0.0 0.0 0.0 5.5 4.3 0.0 0.0 1.8 0.0 0.0 0.5 13.2 0.0 1.9 2.0 0.0 1.3 8.2 3.2 0.0 0.0 0.0 9.3 0.2 3.7 0.0 1.1 5.1 5.8 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 16.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 4.8 0.0 0.0 1.5 5.8 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 7.2 5.1 0.0 0.0 TMEM14B MGC1223 ENSG00000137210 "Transmembrane protein 14B" Q9NUH8 6 10747759-10852753 "Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "unprognostic (5.45e-3)" "unprognostic (6.80e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (6.51e-4)" "unprognostic (5.45e-1)" "unprognostic (2.58e-3)" "prognostic unfavorable (9.35e-5)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "prognostic favorable (7.41e-4)" "unprognostic (2.14e-1)" "unprognostic (1.58e-1)" "unprognostic (8.24e-2)" "unprognostic (4.77e-2)" "unprognostic (4.83e-2)" "unprognostic (1.92e-1)" "unprognostic (1.07e-1)" 78.4 101.1 58.2 45.0 60.6 186.3 74.8 62.9 81.2 51.8 77.6 60.3 53.7 46.5 78.0 47.4 72.0 48.7 132.8 59.8 60.6 81.9 91.0 45.2 70.9 61.1 59.3 50.1 64.3 77.3 40.3 41.5 60.5 65.5 58.8 151.6 86.1 44.1 146.5 46.0 59.2 42.6 61.0 42.2 64.4 27.5 60.4 78.6 128.1 141.5 57.5 52.2 41.4 63.6 376.2 155.9 72.9 106.7 80.0 102.8 106.4 77.9 136.6 163.8 193.2 153.8 171.8 130.8 187.1 93.1 375.9 81.8 65.5 135.1 253.4 89.3 89.6 107.9 123.1 235.2 120.0 163.2 102.1 83.6 76.7 174.6 174.9 92.3 91.6 120.1 267.2 54.1 135.0 134.7 144.4 182.0 110.1 198.6 118.9 120.1 97.1 304.9 198.7 91.7 117.9 88.0 95.7 188.6 251.3 139.0 132.3 145.0 91.7 120.0 150.0 82.3 268.6 128.4 289.4 175.7 98.5 92.4 190.1 178.1 112.1 161.2 86.1 109.8 121.5 121.7 120.7 100.1 136.3 114.7 130.3 111.5 64.4 117.0 122.3 168.6 141.0 154.9 58.2 60.6 62.9 81.2 59.8 60.6 61.1 59.3 60.5 61.0 60.4 63.6 103.2 80.1 77.2 21.5 95.4 82.0 92.1 169.9 90.5 85.5 157.9 206.8 141.4 144.4 113.8 88.3 60.5 177.1 89.7 94.1 365.9 183.3 18.9 190.4 73.2 83.5 80.5 399.9 19.9 220.9 183.0 97.0 68.3 101.9 82.4 90.2 70.6 156.3 210.0 107.7 21.2 143.2 130.2 121.0 132.6 53.5 96.3 110.1 120.9 9.4 265.8 239.0 52.5 17.1 18.1 261.3 102.5 75.2 102.5 145.8 142.0 309.5 247.6 196.1 26.3 95.6 92.8 46.5 129.9 103.9 100.7 105.9 99.4 133.3 164.3 109.0 TMEM225B ENSG00000244219 "Transmembrane protein 225B" P0DP42 7 99598267-99611045 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 34 "testis: 137.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.0;Breast glandular cells: 3.0;Breast myoepithelial cells: 3.0;Exocrine glandular cells: 2.5;Granulosa cells: 2.9;Proximal tubular cells: 2.0;Theca cells: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 11.9;U-266/70: 6.6" "Low region specificity" "Detected in many" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.91e-3)" "unprognostic (5.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.95e-1)" "unprognostic (6.27e-3)" "unprognostic (2.75e-2)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.25e-1)" "unprognostic (7.08e-2)" "unprognostic (1.62e-1)" "unprognostic (4.00e-1)" "unprognostic (6.86e-2)" "unprognostic (1.17e-1)" "unprognostic (2.50e-1)" 3.5 2.0 2.3 0.2 2.6 0.3 3.1 2.2 4.0 2.3 1.9 1.2 0.3 1.9 3.5 1.4 2.4 1.0 0.7 2.3 2.6 3.5 0.7 1.4 0.6 2.7 2.4 1.5 1.3 2.5 2.9 1.3 2.5 2.2 0.5 0.7 1.7 1.4 0.8 3.9 1.2 0.8 2.5 1.2 1.1 137.0 2.5 1.8 2.5 0.0 1.1 1.5 2.0 2.9 1.1 1.5 0.8 0.2 3.8 1.0 0.0 0.5 2.6 1.4 1.6 0.1 0.9 1.2 0.0 0.0 0.5 0.1 0.4 0.0 2.9 3.8 0.6 0.2 0.0 0.3 1.2 0.9 0.8 0.3 0.5 0.1 2.3 5.1 0.0 1.9 0.6 11.9 0.6 0.0 2.0 4.6 0.1 0.0 0.0 0.7 1.1 1.7 0.4 0.1 0.5 1.1 0.3 0.0 0.4 0.6 0.0 0.6 0.0 0.5 1.7 3.7 0.2 6.6 1.6 2.3 0.6 1.4 1.1 0.0 0.0 1.3 0.6 0.1 1.1 1.0 0.8 0.4 0.5 2.2 0.8 1.4 0.3 1.3 0.2 1.4 0.6 0.6 2.3 2.6 2.2 4.0 2.3 2.6 2.7 2.4 2.5 2.5 2.5 2.9 0.5 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 3.0 0.0 0.0 0.6 0.0 0.0 1.2 0.8 0.0 0.0 1.1 0.0 0.5 0.8 0.1 0.0 0.0 0.0 2.5 0.4 1.0 0.0 0.5 1.3 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.2 5.4 0.0 0.0 TMEM234 "C1orf91, dJ622L5.7, FLJ90779, RP4-622L5" ENSG00000160055 "Transmembrane protein 234" Q8WY98 1 32214472-32222359 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA015049 Uncertain Approved Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA015049: AB_1856409" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.44e-3)" "unprognostic (3.09e-1)" "prognostic unfavorable (2.35e-5)" "unprognostic (2.67e-1)" "unprognostic (1.07e-2)" "unprognostic (6.49e-2)" "unprognostic (2.66e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.12e-5)" "unprognostic (1.95e-1)" "unprognostic (2.44e-1)" "unprognostic (7.92e-2)" "unprognostic (2.37e-2)" 6.5 7.4 5.7 2.6 5.8 2.8 6.8 5.0 6.4 7.9 7.4 6.4 2.2 7.6 9.4 9.0 7.3 3.4 9.2 5.7 6.1 9.7 6.3 6.4 3.5 5.9 6.7 9.9 5.8 6.9 12.3 5.9 6.0 8.5 4.1 6.1 7.2 7.0 3.0 4.8 5.2 4.4 5.2 7.5 5.6 9.0 5.8 3.1 12.3 1.7 3.5 6.6 7.6 5.4 10.0 7.5 4.2 4.4 12.0 9.4 4.4 14.6 10.5 7.3 5.5 5.4 9.8 3.1 16.1 13.5 5.7 8.0 5.4 10.5 6.2 6.4 5.9 6.1 11.9 6.2 8.7 7.4 4.0 11.9 10.5 7.6 5.5 12.8 10.7 3.3 5.9 1.9 12.4 3.0 2.9 6.2 7.6 2.5 5.7 4.0 3.3 3.6 16.3 5.1 5.3 5.4 10.6 5.7 5.0 13.6 2.8 2.3 12.9 2.6 4.1 10.3 10.6 3.1 1.8 1.3 8.0 2.6 9.8 25.9 11.9 19.1 5.8 13.3 9.3 6.9 4.6 6.6 11.4 6.9 3.3 4.2 35.8 10.8 9.3 8.6 3.1 6.7 5.7 5.8 5.0 6.4 5.7 6.1 5.9 6.7 6.0 5.2 5.8 5.4 7.5 9.6 1.5 10.4 8.3 2.7 6.6 14.5 5.2 5.3 9.0 9.1 3.6 4.3 11.4 23.9 2.1 26.0 5.0 17.4 1.9 20.9 27.8 17.9 9.1 7.5 6.0 7.4 10.8 15.5 23.0 9.1 16.3 10.0 3.8 10.8 6.4 5.6 19.3 1.7 7.8 11.8 10.2 8.3 3.2 55.6 9.3 8.2 14.2 8.4 11.4 8.6 9.2 3.5 2.8 18.4 12.2 7.9 5.1 5.6 12.5 11.0 23.7 13.5 6.6 5.7 9.2 31.8 15.0 5.9 3.1 21.3 6.9 15.2 9.9 8.0 TMEM250 "bA83N9.1, C9orf69" ENSG00000238227 "Transmembrane protein 250" H0YL14 9 136114581-136118875 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 17.1;Extravillous trophoblasts: 21.3;Pancreatic endocrine cells: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066070 Supported Supported Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 47: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA066070: AB_2685608" "unprognostic (2.79e-2)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "prognostic favorable (1.09e-4)" "unprognostic (4.99e-2)" "unprognostic (2.34e-2)" "unprognostic (4.34e-2)" "unprognostic (1.27e-3)" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (6.31e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-2)" "unprognostic (9.33e-3)" "unprognostic (1.09e-2)" "unprognostic (2.41e-2)" "unprognostic (1.64e-1)" 14.9 14.0 18.6 11.6 18.6 4.3 13.5 14.1 20.2 12.8 10.0 20.0 16.7 14.3 7.3 29.1 12.2 6.9 17.4 19.5 12.0 16.3 21.7 13.1 11.4 15.6 13.8 13.2 13.2 8.2 11.9 10.4 16.4 14.7 8.0 2.9 14.0 8.5 28.5 20.8 17.1 7.7 13.3 16.8 15.6 13.0 16.7 8.7 11.0 10.4 8.9 19.5 15.0 16.0 24.9 46.2 17.7 26.5 24.7 22.4 54.9 29.2 20.7 17.3 12.3 26.4 35.5 18.3 33.3 31.5 27.6 62.2 12.6 20.6 5.4 78.8 24.1 15.4 48.3 18.7 34.2 28.2 19.2 20.2 38.8 18.8 19.6 22.3 27.9 18.0 35.1 18.9 15.3 57.3 34.6 22.7 39.2 43.4 49.6 14.0 24.5 30.5 19.0 17.9 30.4 23.1 31.5 21.6 26.4 10.4 19.7 42.1 31.6 30.2 13.3 39.8 32.9 11.0 11.3 10.9 30.4 19.9 29.0 4.3 2.9 1.8 6.2 4.2 4.5 1.8 4.7 5.2 3.0 1.3 2.2 4.1 3.4 3.5 4.2 1.9 2.6 2.1 18.6 18.6 14.1 20.2 19.5 12.0 15.6 13.8 16.4 13.3 16.7 16.0 11.9 6.4 7.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 12.9 11.9 0.0 0.0 1.3 14.7 0.0 17.1 15.2 0.0 3.9 13.1 0.0 9.8 12.6 6.0 0.0 0.0 0.0 10.6 21.3 5.1 0.0 7.0 2.5 14.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 15.8 0.0 0.0 1.3 0.0 0.0 13.2 1.5 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 7.8 5.5 11.5 0.0 0.0 TMEM267 "C5orf28, FLJ21657" ENSG00000151881 "Transmembrane protein 267" Q0VDI3 5 43444252-43483893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 38.2" "Cell type enhanced" "Detected in many" "Breast glandular cells: 20.2;Collecting duct cells: 16.5;Cytotrophoblasts: 26.3;Distal tubular cells: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059946, HPA072991" Approved Nucleoplasm,Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 1: Thyroid gland - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "HPA059946: AB_2684175, HPA072991: " "unprognostic (8.20e-2)" "unprognostic (2.02e-2)" "unprognostic (7.60e-2)" "unprognostic (8.11e-3)" "unprognostic (1.57e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.82e-2)" "unprognostic (4.77e-3)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-2)" "unprognostic (4.40e-3)" 7.6 7.0 5.7 8.8 5.4 4.9 15.1 5.5 6.2 10.9 7.1 8.4 7.6 8.4 11.9 8.1 8.6 7.7 6.0 5.3 6.5 9.8 7.2 7.6 10.4 5.7 6.6 7.7 7.6 10.7 5.7 6.7 6.5 9.0 9.9 8.1 8.6 9.9 6.2 10.4 6.5 9.6 6.2 8.6 9.9 7.3 5.7 9.2 38.2 3.7 9.6 8.6 6.7 6.4 20.0 18.0 9.5 21.2 17.2 34.8 10.8 28.0 17.3 14.9 10.8 7.9 41.7 21.9 37.7 28.9 15.8 16.3 9.2 12.6 21.3 26.7 14.8 12.9 37.2 8.8 32.0 26.5 17.9 28.9 35.3 22.3 31.7 15.0 16.7 26.3 17.1 39.9 32.8 17.1 14.5 15.3 4.4 20.4 17.4 9.9 23.5 27.3 18.7 20.1 13.2 9.3 56.1 31.5 27.9 8.7 46.0 18.4 21.9 24.0 19.4 14.9 14.1 17.0 26.5 21.6 18.1 37.3 21.6 16.6 11.1 4.4 15.1 13.5 22.3 14.5 20.2 15.9 12.7 13.4 20.3 16.6 1.9 18.9 16.0 9.8 17.5 14.3 5.7 5.4 5.5 6.2 5.3 6.5 5.7 6.6 6.5 6.2 5.7 6.4 9.7 6.4 3.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 20.2 13.2 0.0 0.0 1.8 16.5 0.0 26.3 6.3 0.0 27.4 13.8 0.0 8.4 9.1 2.6 0.0 0.0 0.0 13.6 10.2 4.5 0.0 9.2 2.5 6.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.9 0.0 0.0 13.7 6.6 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 10.5 3.7 6.6 0.0 0.0 TMEM268 "C9orf91, DKFZp547P234, FLJ38045" ENSG00000157693 "Transmembrane protein 268" Q5VZI3 9 114611206-114646422 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 10.3;Breast glandular cells: 8.8;Endometrial stromal cells: 8.9;Glandular and luminal cells: 8.8;Granulosa cells: 9.6;Hofbauer cells: 8.9;monocytes: 19.1;Syncytiotrophoblasts: 8.8;Theca cells: 9.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017199 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA017199: AB_1845845" "unprognostic (8.57e-2)" "unprognostic (3.37e-1)" "unprognostic (8.33e-2)" "prognostic favorable (3.61e-4)" "unprognostic (2.09e-1)" "unprognostic (7.16e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.26e-2)" "unprognostic (2.22e-3)" "unprognostic (1.44e-1)" "unprognostic (6.67e-2)" "unprognostic (6.10e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 7.3 7.7 11.0 6.9 12.7 3.6 7.5 2.9 16.6 6.5 6.4 6.9 3.4 6.8 6.3 4.3 4.7 3.7 3.3 14.4 6.1 3.3 5.3 5.2 9.5 4.4 5.3 8.5 4.7 14.1 4.1 4.8 5.3 12.2 5.4 4.5 8.9 6.5 4.6 4.2 6.3 6.8 5.3 13.3 7.2 3.9 6.5 8.6 6.2 4.3 9.4 6.3 5.1 11.3 4.7 7.1 3.8 8.2 10.1 7.6 2.9 4.3 7.9 6.0 6.1 5.1 2.0 19.5 3.5 4.8 17.0 8.1 7.4 3.7 5.2 9.9 4.6 6.5 5.8 4.0 17.9 13.6 3.0 6.7 6.5 7.8 8.4 7.7 4.1 24.9 12.3 51.5 4.4 13.6 15.4 4.5 9.8 6.0 7.8 17.4 4.5 17.7 3.5 3.4 12.5 8.4 14.4 18.8 41.3 2.4 25.2 12.2 2.5 6.0 6.8 2.3 8.3 27.8 27.5 20.7 3.1 11.4 11.0 0.3 1.3 0.2 0.6 1.0 0.2 1.3 0.7 0.4 0.7 2.2 0.9 0.8 1.0 0.8 1.0 4.7 0.1 0.5 11.0 12.7 2.9 16.6 14.4 6.1 4.4 5.3 5.3 5.3 6.5 11.3 1.7 0.0 10.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 8.8 5.2 0.0 0.0 1.3 0.0 0.0 4.7 3.0 0.0 0.0 1.4 0.0 5.0 8.9 0.5 0.0 0.0 0.0 4.6 1.2 1.3 0.0 8.8 0.0 9.6 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 19.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.6 0.0 0.0 1.9 4.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 8.8 1.1 9.7 0.0 0.0 TNFSF12 "APO3L, DR3LG, TWEAK" ENSG00000239697 "TNF superfamily member 12" O43508 17 7549058-7557890 "Predicted secreted proteins" "Angiogenesis, Apoptosis, Differentiation" "Cytokine, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 115.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.7;BJ hTERT+: 18.4;HDLM-2: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035984, HPA052967" Uncertain Approved Vesicles "Secreted to blood" NA NA 853000 130000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA035984: , HPA052967: AB_2682000" "unprognostic (2.96e-3)" "unprognostic (2.96e-1)" "unprognostic (4.71e-2)" "prognostic favorable (5.70e-5)" "unprognostic (5.31e-2)" "unprognostic (7.91e-2)" "unprognostic (6.45e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (6.09e-2)" "unprognostic (6.20e-2)" "unprognostic (8.62e-2)" "unprognostic (3.29e-2)" "unprognostic (4.11e-2)" "unprognostic (3.15e-2)" "unprognostic (8.74e-2)" "unprognostic (2.38e-1)" 41.6 28.5 57.4 9.8 55.3 3.1 36.6 49.4 66.5 37.6 48.9 68.2 9.7 38.2 7.0 13.9 37.7 15.6 39.6 54.8 50.4 32.9 16.5 37.7 15.8 55.7 54.2 42.7 23.2 11.1 18.0 11.2 53.2 39.4 5.7 2.9 26.1 27.2 16.9 15.8 26.7 13.3 52.8 38.4 38.8 5.6 57.0 4.8 22.9 9.3 5.5 47.1 30.1 52.1 0.0 0.5 0.7 0.0 14.9 17.7 4.0 6.9 18.4 7.7 5.7 0.1 2.5 0.0 5.8 16.3 0.8 1.4 1.4 0.6 1.6 20.3 2.0 0.9 0.4 2.3 12.8 0.0 0.0 15.0 2.6 2.8 0.3 3.0 12.1 0.0 0.0 0.0 7.0 0.0 0.0 0.5 0.6 0.1 7.5 0.1 0.0 0.1 11.6 0.0 0.0 7.9 2.5 0.0 12.6 0.1 1.4 0.6 16.1 15.1 1.1 0.1 8.8 0.0 0.0 0.0 2.4 0.0 10.5 2.6 3.5 11.6 5.1 5.9 6.0 2.9 4.3 3.1 2.2 1.8 4.1 4.2 2.0 2.8 1.5 2.5 4.0 1.1 57.4 55.3 49.4 66.5 54.8 50.4 55.7 54.2 53.2 52.8 57.0 52.1 115.9 9.6 12.2 0.0 20.4 6.1 11.1 1.5 6.8 6.7 21.7 41.7 4.3 17.2 3.4 16.5 0.0 1.6 38.3 2.5 7.9 15.2 0.4 4.1 15.2 33.9 1.2 3.2 0.0 12.1 0.8 42.7 4.6 8.5 34.3 6.8 48.5 3.4 44.3 20.2 0.0 3.4 0.0 59.7 26.8 1.2 50.7 62.1 19.6 0.0 28.6 46.6 40.2 0.0 0.0 8.1 1.7 50.4 3.6 6.7 0.4 39.6 0.6 2.6 59.2 34.4 56.7 0.2 1.1 2.1 7.5 0.8 38.7 9.4 4.1 6.0 TOB1 "APRO5, TOB, TROB, TROB1" ENSG00000141232 "Transducer of ERBB2, 1" P50616 17 50862223-50867978 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 253.3" "Low region specificity" "Detected in all" HPA047839 Approved Approved Nucleoplasm,Vesicles NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "HPA047839: AB_2680175" "unprognostic (3.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.45e-1)" "unprognostic (6.78e-3)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "unprognostic (3.50e-3)" "unprognostic (1.53e-1)" "unprognostic (3.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.04e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.92e-3)" "unprognostic (9.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-2)" "unprognostic (6.97e-2)" 42.6 210.2 32.6 22.3 34.9 70.2 65.3 31.6 40.8 55.3 59.3 47.4 56.1 23.9 26.5 77.7 54.6 47.6 44.7 29.8 39.4 67.9 168.6 36.8 18.9 37.3 48.2 63.4 207.9 81.4 50.1 13.8 38.6 72.3 57.5 101.8 99.8 92.2 178.6 133.5 48.1 29.4 31.8 17.8 87.5 26.0 33.4 17.7 95.4 109.9 21.0 81.9 70.9 40.2 44.1 88.7 28.1 11.5 51.4 25.4 22.0 31.9 79.2 20.5 25.0 36.0 54.6 40.0 60.6 43.9 20.7 61.0 19.5 54.1 21.1 20.4 29.3 4.8 100.7 60.5 72.0 21.5 18.9 54.5 65.5 23.9 120.0 27.3 9.9 12.2 17.0 33.7 43.4 119.0 16.1 19.4 10.2 109.4 33.9 14.0 35.6 47.6 80.9 89.4 16.6 40.4 55.1 158.9 19.9 42.5 253.3 27.1 13.2 23.3 16.7 26.7 15.8 51.9 57.7 18.5 19.2 10.2 9.1 417.7 53.5 285.6 245.8 107.3 269.9 40.7 222.7 192.5 119.1 31.9 192.1 233.6 130.7 28.8 152.5 38.5 206.0 169.0 32.6 34.9 31.6 40.8 29.8 39.4 37.3 48.2 38.6 31.8 33.4 40.2 101.6 115.4 118.3 71.8 53.1 283.2 232.9 119.8 284.0 125.3 180.6 179.6 115.5 210.1 81.8 68.0 56.3 20.8 124.8 183.3 103.7 42.6 97.9 143.7 51.7 40.7 203.4 18.1 11.5 54.1 2.0 83.5 123.3 176.2 63.9 19.7 33.2 205.6 35.4 18.5 14.1 223.2 48.8 27.6 249.2 40.4 26.4 89.9 71.2 5.6 29.1 118.3 20.6 16.6 34.1 41.8 186.7 59.8 41.3 187.2 126.2 60.4 87.8 62.7 164.3 137.3 123.8 36.9 12.1 153.8 230.7 10.9 154.7 77.4 167.6 287.2 TOB2 "APRO5, bK223H9, TOB4, TOBL, TROB2" ENSG00000183864 "Transducer of ERBB2, 2" Q14106 22 41433494-41446801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016603, HPA054112" Approved Approved Cytosol NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 54: Non-specific - Microtubule organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA016603: AB_2669400, HPA054112: AB_2682385" "unprognostic (1.21e-3)" "unprognostic (3.10e-2)" "unprognostic (3.41e-1)" "prognostic favorable (3.08e-5)" "unprognostic (3.89e-2)" "unprognostic (1.38e-1)" "unprognostic (1.36e-1)" "unprognostic (5.36e-2)" "unprognostic (4.94e-2)" "unprognostic (5.74e-2)" "unprognostic (3.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.18e-6)" "unprognostic (1.50e-2)" "unprognostic (7.14e-2)" "unprognostic (1.85e-1)" "unprognostic (7.13e-2)" 46.1 31.3 39.3 15.6 56.3 9.7 25.5 78.1 40.1 26.5 18.5 30.1 22.4 25.0 11.8 26.6 38.4 28.8 41.2 39.3 43.8 24.6 27.1 20.7 18.5 61.7 42.9 38.0 29.0 35.6 22.8 22.0 44.0 26.6 15.5 55.0 17.2 19.4 86.5 27.1 23.9 20.1 39.5 20.6 30.5 13.6 52.0 19.6 36.1 68.1 19.7 23.3 21.0 71.9 36.8 16.6 28.5 19.4 65.4 45.5 27.5 23.9 36.7 29.8 26.2 21.9 17.0 22.4 23.5 34.8 11.6 31.4 26.7 13.4 27.1 23.0 34.2 12.3 23.9 33.4 44.8 33.5 15.9 42.1 22.5 35.6 15.4 30.1 30.2 7.6 18.9 24.5 24.6 40.8 13.9 19.2 24.4 48.1 17.6 29.7 19.2 19.4 21.3 25.3 13.1 8.8 60.0 32.2 44.6 17.7 17.9 16.5 37.9 29.3 27.1 23.0 22.7 22.9 10.7 12.2 17.8 14.2 19.7 3.9 5.9 4.1 7.5 8.0 7.1 10.0 6.2 6.3 5.3 7.5 3.2 4.7 3.8 3.8 8.4 8.0 5.5 6.1 39.3 56.3 78.1 40.1 39.3 43.8 61.7 42.9 44.0 39.5 52.0 71.9 48.5 48.1 59.6 48.6 61.4 126.8 66.6 24.3 105.3 56.0 83.1 56.9 59.8 58.6 31.7 47.8 64.6 34.7 56.9 76.9 23.5 29.7 41.1 88.6 59.3 45.3 54.3 16.8 12.2 19.1 37.3 54.1 42.3 116.9 34.1 13.7 52.5 29.7 19.6 25.2 15.1 67.7 10.2 22.0 117.9 61.6 66.8 51.4 53.4 14.0 34.6 58.3 18.6 10.1 43.6 32.3 60.0 82.0 26.2 73.6 103.6 29.2 45.9 105.2 52.6 97.4 60.9 23.8 28.9 88.7 136.7 63.3 57.4 19.6 61.9 92.2 TOGARAM1 "crescerin, Crescerin-1, FAM179B, KIAA0423" ENSG00000198718 "TOG array regulator of axonemal microtubules 1" Q9Y4F4 14 44962190-45074431 "Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 65.7;Endometrial stromal cells: 28.6;Granulosa cells: 30.1;Respiratory ciliated cells: 38.6;Theca cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 4.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050849, HPA053559" Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA050849: AB_2681257, HPA053559: AB_2682190" "unprognostic (2.91e-1)" "unprognostic (4.07e-2)" "unprognostic (2.04e-2)" "unprognostic (1.05e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (2.67e-2)" "unprognostic (2.69e-1)" "unprognostic (1.21e-1)" "unprognostic (5.63e-2)" "unprognostic (6.49e-2)" "prognostic favorable (8.38e-4)" "unprognostic (1.62e-1)" "unprognostic (2.15e-1)" "unprognostic (3.02e-2)" "unprognostic (1.60e-1)" 4.5 6.6 9.6 2.9 13.4 3.9 5.2 10.1 13.0 6.7 9.6 4.5 2.7 6.0 5.2 4.6 10.4 4.7 8.3 11.2 8.9 7.9 4.6 3.9 3.9 7.2 8.0 7.6 6.3 8.5 7.1 5.8 8.7 5.5 3.7 16.8 4.8 6.4 12.4 4.2 3.8 5.4 7.5 4.3 4.3 6.5 9.3 8.4 9.0 12.1 3.9 5.4 4.3 19.9 3.5 5.7 5.3 1.4 12.2 14.2 3.8 4.9 10.4 9.1 10.8 2.3 3.7 3.3 5.6 7.9 4.9 6.4 9.8 3.3 10.0 3.0 3.6 2.7 2.8 2.7 8.6 4.6 2.7 8.3 5.6 5.2 8.8 10.8 7.4 1.8 1.9 3.7 9.2 5.0 5.9 2.5 1.8 5.2 4.3 2.9 12.9 2.2 8.6 12.0 5.5 2.1 5.8 8.4 9.1 5.5 6.2 3.6 5.5 6.1 4.9 7.8 3.7 3.8 3.0 3.7 3.5 0.9 5.2 4.8 0.4 1.0 0.4 0.4 0.5 0.4 0.6 0.4 0.6 0.6 0.5 0.3 0.0 0.8 0.4 0.7 0.6 0.3 9.6 13.4 10.1 13.0 11.2 8.9 7.2 8.0 8.7 7.5 9.3 19.9 15.8 16.0 14.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 15.2 10.9 0.0 0.0 20.4 16.5 0.0 11.9 13.2 0.0 1.9 10.2 0.0 65.7 28.6 6.6 0.0 0.0 0.0 5.6 8.1 8.8 0.0 16.0 10.1 30.1 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 6.7 0.0 0.0 0.0 0.0 8.6 0.0 0.0 3.8 0.0 0.0 10.4 38.6 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 9.9 6.3 34.4 0.0 0.0 TOMM70 "KIAA0719, Tom70, TOMM70A" ENSG00000154174 "Translocase of outer mitochondrial membrane 70" O94826 3 100363431-100401089 "Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 34.9;Extravillous trophoblasts: 33.2;Proximal tubular cells: 48.6;Theca cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014589, CAB017156, HPA048020" Enhanced Enhanced Mitochondria NA NA "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234" "unprognostic (2.74e-2)" "unprognostic (2.25e-1)" "unprognostic (2.57e-2)" "unprognostic (2.69e-3)" "unprognostic (2.12e-2)" "unprognostic (5.96e-2)" "unprognostic (2.06e-3)" "unprognostic (5.01e-2)" "unprognostic (9.86e-2)" "unprognostic (1.21e-1)" "unprognostic (9.73e-3)" "unprognostic (5.38e-2)" "unprognostic (2.62e-3)" "unprognostic (1.73e-1)" "unprognostic (3.53e-1)" "unprognostic (3.34e-2)" "unprognostic (6.98e-3)" 29.7 23.1 21.8 19.5 38.7 16.6 31.5 20.6 24.4 19.8 19.1 27.7 29.3 24.5 21.3 28.9 20.4 16.1 38.8 23.6 23.0 36.8 61.7 15.9 22.2 21.3 18.6 30.8 26.8 27.2 14.8 23.4 21.9 26.4 29.8 45.4 21.9 26.9 66.4 19.8 24.4 26.7 17.9 19.2 21.5 19.6 22.9 29.6 30.1 76.1 25.9 27.3 17.8 19.5 70.2 48.3 39.8 57.9 55.4 60.0 52.0 57.9 49.6 52.2 53.8 68.7 39.0 83.2 49.9 49.7 46.6 67.4 73.1 53.4 76.7 31.6 33.7 95.2 30.3 67.3 34.6 117.2 41.8 53.7 48.6 46.5 75.6 46.5 38.8 40.1 69.2 65.6 63.3 51.9 79.6 47.5 55.2 107.4 101.2 72.0 80.9 89.0 42.6 52.2 72.2 60.1 42.3 67.0 77.9 38.2 87.1 65.8 35.2 45.5 60.3 25.8 44.0 71.1 108.8 139.1 44.1 70.0 35.2 1.1 1.0 1.2 1.9 1.1 2.3 2.0 2.3 2.0 1.4 1.4 2.3 2.5 0.2 2.7 1.3 1.4 1.0 0.8 21.8 38.7 20.6 24.4 23.6 23.0 21.3 18.6 21.9 17.9 22.9 19.5 24.2 6.4 25.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 30.0 20.2 0.0 0.0 11.2 14.7 0.0 26.8 11.5 0.0 11.7 19.0 0.0 13.8 34.9 10.0 0.0 0.0 0.0 20.1 33.2 12.9 0.0 25.4 7.6 27.1 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 5.7 0.0 0.0 0.0 0.0 22.5 0.0 0.0 2.3 0.0 0.0 48.6 10.2 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 16.3 6.3 32.9 0.0 0.0 TPTEP2-CSNK1E ENSG00000283900 "TPTEP2-CSNK1E readthrough" 22 38291918-38398522 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 2.4;B-cells: 1.8;Breast glandular cells: 1.9;Collecting duct cells: 9.2;Endometrial ciliated cells: 2.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 4.0;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 5 "dendritic cells: 3.5;granulocytes: 4.0" "Cell line enhanced" "Detected in many" "AF22: 5.2;Karpas-707: 9.1;U-266/70: 6.4" HPA026288 Uncertain NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA026288: AB_1847276" 2.9 0.5 0.9 0.7 2.0 2.4 2.8 1.0 1.8 2.5 0.7 1.2 0.3 2.5 0.8 1.0 2.8 0.9 2.1 1.1 2.0 1.1 0.7 1.9 0.5 1.3 1.2 1.0 0.6 2.3 1.5 1.1 1.1 1.2 0.3 2.2 1.6 0.6 1.5 1.7 0.9 0.9 1.2 0.9 0.9 1.3 1.4 0.3 1.8 0.9 1.3 1.3 1.4 2.5 0.7 0.0 5.2 0.5 0.8 1.2 0.7 1.5 4.7 0.7 0.7 0.0 0.4 0.0 0.8 1.2 0.7 0.7 0.5 0.7 0.8 3.5 1.4 0.6 2.6 0.2 0.8 1.4 1.1 0.9 2.2 0.2 0.2 3.5 1.5 0.3 0.5 9.1 0.3 0.2 0.0 0.4 0.6 0.0 0.0 1.2 0.8 2.3 0.7 0.0 0.9 0.3 0.2 0.1 1.9 1.5 0.1 0.5 4.3 0.0 0.7 0.1 0.0 6.4 4.8 1.8 1.7 0.5 0.6 0.4 0.2 4.0 0.0 0.0 0.0 0.7 0.3 0.0 0.3 0.3 0.0 0.0 1.1 0.7 0.0 3.5 0.7 0.1 0.9 2.0 1.0 1.8 1.1 2.0 1.3 1.2 1.1 1.2 1.4 2.5 2.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.9 1.4 0.0 0.0 0.0 9.2 0.0 0.0 0.8 0.0 0.0 0.9 0.0 2.0 1.0 0.3 0.0 0.0 0.0 1.3 0.0 0.4 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 TRA2B "Htra2-beta, PPP1R156, SFRS10" ENSG00000136527 "Transformer 2 beta homolog" P62995 3 185914558-185938103 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 444.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011692, HPA063597, HPA064972" Supported Enhanced Nucleoplasm,Cytosol NA NA 62000 "Cluster 6: Non-specific - Transcription" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396" "unprognostic (9.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.22e-2)" "unprognostic (7.58e-3)" "unprognostic (1.48e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.92e-1)" "unprognostic (2.65e-3)" "prognostic favorable (2.15e-4)" "unprognostic (1.07e-1)" "unprognostic (3.22e-3)" "unprognostic (1.71e-3)" "unprognostic (1.28e-2)" "unprognostic (2.64e-1)" "unprognostic (4.38e-1)" "unprognostic (4.36e-2)" 38.2 41.3 18.1 35.2 19.1 46.3 30.2 23.0 31.1 25.2 25.7 41.7 21.5 31.3 26.3 38.7 27.1 16.0 31.7 19.6 22.3 41.6 37.5 21.5 38.7 19.8 17.2 25.5 28.3 28.9 20.3 26.3 20.4 25.8 24.9 18.5 27.0 18.4 34.1 25.5 27.0 25.2 17.4 36.2 31.1 22.4 19.5 47.6 23.2 23.2 43.9 28.7 26.8 26.3 145.0 44.2 135.0 67.8 30.3 27.3 78.2 101.5 71.1 117.5 90.2 75.3 67.6 124.5 134.4 53.2 79.5 94.1 140.9 104.5 120.9 117.5 89.6 122.0 40.1 92.7 42.4 133.3 101.1 26.5 44.3 75.1 51.0 36.5 90.4 63.5 120.4 81.6 79.6 66.4 344.9 164.1 191.3 113.0 85.5 201.1 109.4 147.5 94.3 58.9 98.0 104.0 73.3 90.1 117.8 66.5 101.1 138.0 52.7 81.3 110.8 68.2 170.1 159.6 444.0 272.0 78.0 151.0 130.6 84.1 39.2 33.0 36.3 33.1 32.8 71.2 36.1 34.0 35.3 64.0 45.0 40.9 44.0 41.3 39.6 73.2 36.4 21.5 18.1 19.1 23.0 31.1 19.6 22.3 19.8 17.2 20.4 17.4 19.5 26.3 236.3 64.1 122.0 46.4 201.7 258.4 196.9 136.6 157.1 107.8 206.0 148.2 67.2 140.2 104.0 69.9 196.0 188.9 196.6 156.2 72.4 126.8 156.9 152.7 284.5 181.6 227.6 233.4 49.7 109.5 230.7 147.2 92.2 274.6 197.6 155.9 189.9 93.0 174.6 72.3 53.7 259.8 85.5 280.7 283.1 46.6 127.7 228.1 135.2 74.0 196.9 115.5 167.9 78.4 67.0 97.5 129.1 117.4 152.1 218.3 121.2 59.1 66.7 219.5 105.2 177.0 214.7 168.2 151.5 141.3 260.7 214.9 212.6 89.4 232.4 163.7 TRAF7 "DKFZp586I021, MGC7807, RFWD1, RNF119" ENSG00000131653 "TNF receptor associated factor 7" Q6Q0C0 16 2155698-2178129 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041229 Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Vesicles "Plasma membrane" "HPA041229: AB_10794194" "unprognostic (1.94e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (2.77e-3)" "unprognostic (7.08e-2)" "unprognostic (3.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (9.23e-2)" "unprognostic (6.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.43e-1)" "unprognostic (8.48e-2)" 29.1 29.4 16.5 24.4 15.1 35.0 28.2 18.2 23.0 32.1 17.0 38.0 40.0 31.2 11.6 54.6 30.4 22.2 21.3 17.9 14.6 28.1 51.5 33.2 22.9 17.8 15.3 23.5 37.4 14.6 32.1 20.6 14.8 27.0 17.4 8.5 34.7 16.5 30.4 47.7 35.2 18.8 14.2 34.5 35.6 14.8 17.7 19.1 25.6 9.9 18.6 34.5 34.8 14.3 57.7 72.2 40.3 72.5 40.8 76.5 47.4 43.4 53.9 49.9 44.6 88.2 72.1 36.6 50.2 55.4 31.8 65.9 38.1 76.8 18.8 58.3 48.8 52.4 98.5 68.3 53.8 56.3 72.7 76.2 62.8 48.1 62.6 41.0 97.4 70.6 57.1 47.9 48.2 131.1 58.3 65.2 79.7 78.7 34.8 107.4 66.7 74.2 40.2 30.4 80.9 67.2 36.3 68.5 48.6 20.9 78.1 68.2 74.3 60.2 83.9 56.7 48.2 69.2 55.0 48.4 34.4 35.9 47.8 4.0 9.1 7.3 4.5 12.4 4.3 5.5 4.4 4.7 11.2 3.9 3.1 3.8 6.2 2.9 8.9 5.3 6.5 5.3 16.5 15.1 18.2 23.0 17.9 14.6 17.8 15.3 14.8 14.2 17.7 14.3 18.9 0.0 9.2 12.4 18.2 28.8 21.1 34.2 22.8 15.9 31.6 27.9 4.9 21.5 20.8 14.7 6.2 23.5 17.4 56.4 17.6 39.0 5.0 23.6 34.6 26.5 34.0 33.6 8.9 59.0 36.3 19.0 38.7 27.9 9.5 22.1 26.0 32.3 42.2 37.0 8.2 38.7 34.6 41.8 21.3 13.1 24.8 26.8 10.6 8.4 33.9 12.6 6.2 6.6 4.9 53.0 43.6 22.2 24.0 33.8 80.0 29.2 19.7 10.9 6.6 11.9 18.3 8.5 25.3 50.7 32.5 26.7 16.0 29.0 42.5 38.5 TRAPPC2B "MIP-2A, SEDLP, SEDLP1, TRAPPC2P1" ENSG00000256060 "Trafficking protein particle complex 2B" P0DI82 19 57363551-57365405 "Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063308 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA063308: AB_2684982" "unprognostic (8.55e-2)" "unprognostic (1.07e-2)" "unprognostic (4.24e-1)" "unprognostic (5.27e-2)" "unprognostic (1.93e-1)" "unprognostic (6.69e-2)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.26e-1)" "unprognostic (4.49e-2)" "unprognostic (9.74e-2)" "unprognostic (1.39e-2)" 15.0 20.6 8.3 6.8 8.8 10.6 14.2 10.6 11.5 7.9 9.5 13.0 5.0 10.6 11.0 12.5 9.8 9.8 19.5 8.5 9.5 12.5 11.0 10.4 12.3 8.4 8.6 12.8 7.3 10.8 14.9 10.8 9.0 10.1 5.7 8.6 10.9 6.7 30.2 11.6 8.6 9.2 8.2 13.3 9.5 23.2 8.9 15.2 12.2 17.0 10.7 12.4 8.5 8.6 16.9 11.9 18.0 12.0 16.2 18.9 16.2 11.5 25.9 16.6 48.6 6.4 12.5 13.0 15.3 14.9 28.3 6.1 8.4 18.5 17.8 5.9 60.8 13.0 18.7 14.6 16.7 14.3 20.9 18.9 23.1 12.6 9.4 19.1 12.5 14.5 4.1 0.1 19.5 5.0 22.1 13.0 6.0 1.2 25.3 10.7 17.0 20.2 18.8 26.7 18.8 15.4 10.9 12.5 11.1 15.9 18.7 18.1 13.9 15.8 13.7 7.7 18.6 20.5 27.8 25.4 22.7 9.1 16.0 68.4 23.5 30.8 12.0 22.2 24.6 45.1 25.3 20.2 26.5 48.5 24.4 19.5 27.7 44.1 20.9 37.9 24.6 22.4 8.3 8.8 10.6 11.5 8.5 9.5 8.4 8.6 9.0 8.2 8.9 8.6 38.9 9.6 13.1 0.0 13.2 0.0 0.0 0.0 0.0 0.0 21.7 28.2 26.1 0.0 9.9 18.4 0.0 38.1 16.3 0.0 25.4 32.9 0.0 29.3 13.4 15.4 0.0 0.0 0.0 22.1 18.3 10.3 0.0 25.7 21.5 18.2 0.0 0.0 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 11.9 0.0 0.0 0.0 0.0 28.7 0.0 0.0 4.4 0.0 0.0 17.0 13.1 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 91.9 11.7 32.7 0.0 0.0 TRBC2 TCRBC2 ENSG00000211772 "T cell receptor beta constant 2" 7 142801041-142802748 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "intestine: 115.8;lymphoid tissue: 190.2" "Group enriched" "Detected in many" 4 "B-cells: 164.7;dendritic cells: 358.8;NK-cells: 264.7;T-cells: 498.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "T-reg: 76.0" "Lineage enriched" "Detected in many" 7 "T-cells: 76.0" "Cell line enriched" "Detected in some" 45 "MOLT-4: 277.9" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "prognostic favorable (8.04e-5)" "prognostic favorable (1.80e-4)" "unprognostic (4.19e-3)" "prognostic favorable (3.42e-8)" "unprognostic (5.53e-2)" "prognostic favorable (6.58e-5)" "unprognostic (3.21e-2)" "unprognostic (1.30e-2)" "prognostic favorable (2.81e-4)" "unprognostic (7.53e-3)" "unprognostic (5.96e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (2.90e-7)" "unprognostic (2.09e-1)" "unprognostic (1.47e-1)" "unprognostic (2.30e-2)" "unprognostic (4.09e-3)" 18.9 3.1 0.4 3.9 0.3 1.5 8.6 0.1 1.2 11.9 0.1 21.2 1.7 8.7 0.0 14.6 15.7 2.2 4.9 0.3 0.0 9.6 12.7 32.3 8.6 0.2 0.3 18.3 3.5 0.1 4.0 0.0 0.2 14.2 2.7 0.0 7.9 0.1 3.3 6.5 115.8 0.5 0.1 190.2 16.9 8.7 0.3 109.2 16.4 1.2 10.9 14.0 12.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 3.5 0.0 0.0 0.0 0.0 277.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.9 0.0 0.0 14.4 0.0 35.0 8.1 47.6 47.3 0.3 7.7 46.6 40.3 2.0 10.5 0.1 0.0 76.0 42.4 0.4 0.3 0.1 1.2 0.3 0.0 0.2 0.3 0.2 0.1 0.3 0.1 8.3 9.6 52.4 0.0 164.7 0.0 0.3 0.0 1.8 0.1 6.2 9.7 4.8 5.7 3.7 1.8 0.0 0.4 358.8 1.4 0.0 2.9 1.0 1.1 0.8 4.0 0.0 16.6 0.0 1.3 0.1 10.8 8.6 0.9 20.2 0.0 15.0 1.6 0.4 0.0 0.0 0.8 0.0 9.0 0.0 4.2 63.6 18.9 0.0 0.0 19.0 15.6 264.7 0.0 0.0 20.1 0.1 70.3 30.6 0.4 0.1 2.2 2.9 0.4 65.7 4.2 12.4 0.1 0.8 1.3 0.0 0.3 498.0 1.4 0.9 0.2 TRIM28 "KAP1, PPP1R157, RNF96, TF1B, TIF1B" ENSG00000130726 "Tripartite motif containing 28" Q13263 19 58544064-58550722 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 2817.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010066, HPA064033" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 140000 "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB010066: AB_2209905, HPA064033: AB_2685179" "unprognostic (2.76e-1)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (1.85e-6)" "unprognostic (1.20e-2)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (4.92e-3)" "unprognostic (9.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.67e-2)" "unprognostic (7.34e-2)" "unprognostic (4.22e-1)" "unprognostic (3.28e-2)" 103.1 111.0 83.5 103.8 85.9 217.5 104.4 91.1 100.1 152.9 77.5 159.9 90.8 163.3 42.8 132.6 142.8 73.6 114.7 83.1 80.1 122.1 104.6 103.5 142.5 85.5 83.4 228.1 183.7 89.4 98.7 108.9 89.1 128.8 57.8 39.4 108.4 108.8 172.4 143.3 117.7 94.6 86.0 137.4 136.7 215.5 82.8 186.6 117.9 77.0 109.2 147.7 115.1 97.2 481.6 1080.4 491.9 365.1 218.9 186.5 616.5 321.5 291.1 311.4 237.0 732.8 375.0 562.5 196.1 270.7 492.8 317.7 590.5 480.5 163.6 281.3 2817.1 1012.8 407.6 537.7 254.4 640.9 577.5 252.4 248.2 385.9 274.9 220.1 301.3 597.7 507.1 259.4 284.8 705.0 756.5 640.8 372.8 443.6 637.5 761.9 340.9 550.2 260.8 730.6 517.1 403.4 343.9 359.3 170.7 131.9 273.2 493.1 272.4 643.1 273.2 148.6 562.5 397.7 665.7 604.7 293.0 432.9 418.6 1.9 9.7 8.2 12.8 11.1 17.2 15.9 18.0 17.4 13.7 19.1 22.8 20.5 4.3 24.9 7.9 21.2 12.4 10.1 83.5 85.9 91.1 100.1 83.1 80.1 85.5 83.4 89.1 86.0 82.8 97.2 60.8 12.8 18.6 18.3 51.0 64.2 60.2 34.7 47.3 61.8 86.6 87.5 9.5 51.5 29.0 33.1 27.1 61.2 72.4 88.3 23.5 44.8 96.9 70.7 53.3 49.7 64.6 46.7 10.3 56.3 61.6 48.3 65.7 80.2 21.6 136.3 35.7 31.9 46.9 55.5 12.6 79.4 14.2 36.5 70.7 110.6 65.9 48.3 28.4 6.5 32.8 49.8 19.6 10.6 18.2 56.3 50.0 41.3 43.5 52.1 47.3 36.3 28.7 34.1 59.2 69.3 61.6 158.7 83.1 58.0 60.7 56.1 54.5 80.9 94.1 45.6 TRIM39 RNF23 ENSG00000204599 "Tripartite motif containing 39" Q9HCM9 6 30326479-30343729 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051120, HPA059496" Uncertain Supported Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA051120: AB_2681348, HPA059496: AB_2684040" "unprognostic (2.90e-1)" "unprognostic (1.61e-2)" "unprognostic (2.79e-2)" "unprognostic (2.86e-2)" "unprognostic (6.38e-2)" "unprognostic (4.55e-2)" "unprognostic (1.46e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-1)" "unprognostic (9.44e-2)" "prognostic favorable (2.50e-4)" "unprognostic (1.30e-2)" "unprognostic (4.69e-2)" "unprognostic (6.35e-3)" "unprognostic (1.46e-1)" "unprognostic (1.06e-1)" "unprognostic (2.39e-3)" 10.0 8.7 0.8 1.7 1.0 3.1 10.2 1.3 1.1 11.4 1.5 13.6 1.6 12.1 2.2 13.1 11.7 1.3 8.7 0.9 0.9 9.8 11.6 9.7 1.6 1.3 1.0 11.5 12.2 2.1 14.8 1.6 1.0 10.8 1.5 1.5 10.2 2.0 14.3 9.3 11.9 1.8 0.8 14.3 11.0 20.7 1.1 1.7 11.6 1.4 2.1 12.9 9.5 1.1 3.2 0.1 2.6 4.8 1.2 1.2 2.7 1.4 1.8 2.1 1.9 3.8 0.4 4.1 2.8 2.7 1.3 1.0 3.1 2.2 2.2 3.2 3.4 3.2 0.5 1.4 2.7 4.8 3.5 1.4 1.8 2.7 2.9 3.2 1.3 3.4 4.9 3.2 2.7 2.9 1.0 1.0 3.6 1.3 2.2 2.2 0.5 3.1 2.2 3.0 5.7 2.8 1.1 2.3 2.8 2.5 3.1 1.2 1.2 2.3 1.8 2.8 4.9 5.7 7.6 4.2 1.3 1.7 3.6 1.0 0.9 4.1 2.7 1.3 2.4 1.8 1.9 2.0 0.9 1.6 2.2 2.2 4.5 2.6 1.4 0.7 1.7 1.4 0.8 1.0 1.3 1.1 0.9 0.9 1.3 1.0 1.0 0.8 1.1 1.1 5.9 3.2 7.2 0.7 14.2 3.7 5.6 2.6 6.8 6.0 7.5 5.2 5.6 2.8 3.5 1.8 6.2 4.7 11.9 5.5 7.9 4.6 4.6 11.2 4.1 4.8 5.4 3.6 0.9 6.1 5.7 4.1 15.3 13.1 5.7 4.2 5.7 3.7 3.3 3.3 1.1 7.3 4.1 7.2 5.0 7.8 2.8 7.3 3.6 1.0 4.3 6.9 8.2 0.5 0.9 6.8 10.0 4.5 10.9 3.7 7.5 4.0 7.2 7.6 0.0 3.8 5.8 19.1 10.0 5.3 4.1 10.0 15.3 3.5 4.4 5.3 TRIM8 "GERP, RNF27" ENSG00000171206 "Tripartite motif containing 8" Q9BZR9 10 102644479-102658318 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023560, HPA023561" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Vesicles, Cytosol" "HPA023560: AB_10600414, HPA023561: AB_10601861" "unprognostic (4.32e-2)" "unprognostic (6.90e-2)" "unprognostic (3.02e-3)" "unprognostic (1.45e-1)" "unprognostic (1.78e-1)" "unprognostic (5.03e-1)" "unprognostic (3.82e-2)" "unprognostic (1.03e-1)" "unprognostic (2.15e-3)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (1.52e-1)" "unprognostic (9.55e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (8.34e-2)" "unprognostic (1.36e-2)" 80.1 47.6 67.2 21.5 68.1 26.0 58.4 62.9 55.0 63.0 35.8 50.9 17.8 53.5 9.3 42.0 55.6 22.0 67.8 55.0 56.5 77.9 62.2 70.3 18.3 72.4 72.7 45.2 80.4 36.6 43.5 21.3 64.7 55.5 9.5 18.1 69.1 21.9 80.8 48.3 43.8 17.1 60.4 42.8 61.9 20.1 84.4 18.7 67.4 38.8 11.8 62.9 49.9 54.2 96.4 18.7 16.3 28.7 17.2 40.6 21.1 34.4 59.3 32.1 24.6 30.7 93.0 30.7 102.9 57.5 11.4 32.7 12.2 40.4 21.3 34.4 23.4 78.3 12.9 67.4 55.8 15.5 28.3 47.0 21.9 64.8 32.9 83.4 40.6 13.6 17.3 33.4 24.3 45.5 27.8 57.7 12.7 25.6 38.0 18.6 49.2 16.6 37.4 48.0 12.3 26.2 18.8 17.2 42.6 16.9 58.4 28.2 94.8 40.9 22.4 23.3 68.8 49.0 28.5 16.3 65.5 39.2 9.7 14.0 5.2 2.7 6.8 4.6 6.5 8.9 7.3 5.4 4.5 7.4 6.4 5.7 17.9 6.0 5.7 12.4 7.5 4.5 67.2 68.1 62.9 55.0 55.0 56.5 72.4 72.7 64.7 60.4 84.4 54.2 46.0 57.7 71.2 33.6 29.5 31.5 12.6 21.2 21.6 33.4 53.9 45.3 38.0 38.6 33.6 88.3 8.4 13.0 52.8 15.4 41.1 63.2 1.1 91.5 61.7 30.1 21.6 2.5 8.9 44.9 2.6 38.9 20.4 81.6 8.8 32.2 31.8 33.3 25.4 28.6 13.6 32.8 18.3 40.5 24.1 1.7 31.1 43.5 17.8 13.1 58.1 26.1 24.7 18.1 17.6 65.0 16.4 34.3 18.6 30.5 32.0 53.0 38.5 15.1 13.1 35.7 38.4 2.4 5.1 19.8 22.9 10.9 26.6 38.9 21.4 30.1 TRIR "C19orf43, fSAP18, MGC2803, TERCIR" ENSG00000123144 "Telomerase RNA component interacting RNase" Q9BQ61 19 12730640-12734684 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 390.7;Exocrine glandular cells: 381.0;Extravillous trophoblasts: 514.9;Proximal tubular cells: 510.1;Syncytiotrophoblasts: 579.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059965 Approved Approved Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA059965: AB_2684182" "unprognostic (5.57e-2)" "unprognostic (2.73e-3)" "unprognostic (3.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (3.17e-3)" "unprognostic (1.93e-2)" "unprognostic (1.74e-1)" "unprognostic (9.33e-3)" "unprognostic (2.43e-3)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (4.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.63e-3)" "unprognostic (1.02e-2)" 171.6 146.4 162.7 76.7 168.5 133.5 161.3 163.0 211.3 168.9 153.2 191.4 78.2 164.6 108.6 170.1 141.8 45.6 169.1 156.0 169.9 164.8 261.8 132.8 98.7 167.8 158.5 166.4 152.3 76.3 131.9 71.9 160.5 144.9 68.6 53.5 137.9 61.4 167.0 162.4 155.4 66.2 165.4 178.7 163.3 99.6 170.5 104.7 124.6 73.5 107.6 163.1 152.4 163.7 276.7 148.0 185.0 135.2 146.5 156.5 174.3 230.8 144.4 175.7 171.6 195.9 94.1 221.0 294.2 142.8 143.0 188.6 185.5 150.3 143.1 250.9 353.8 147.8 177.6 327.5 140.0 214.8 265.8 158.9 182.6 134.4 108.6 151.1 171.0 156.5 208.3 88.4 168.0 612.7 350.0 504.5 200.8 161.7 416.8 302.3 141.1 222.1 209.2 192.7 203.9 268.2 158.0 159.4 277.4 122.8 138.6 311.5 175.5 212.9 164.4 323.0 296.0 292.2 341.3 248.1 173.7 257.0 147.3 22.5 22.9 85.3 25.0 22.0 28.2 66.5 31.4 31.1 21.5 48.6 29.5 26.1 45.3 23.7 20.2 29.1 37.7 13.8 162.7 168.5 163.0 211.3 156.0 169.9 167.8 158.5 160.5 165.4 170.5 163.7 264.0 70.5 76.0 0.0 93.5 0.0 0.0 0.0 0.0 0.0 262.4 287.0 0.0 0.0 34.0 183.9 0.0 390.7 254.9 0.0 272.0 313.9 0.0 162.2 165.6 95.0 0.0 0.0 0.0 381.0 514.9 92.1 0.0 153.6 25.2 177.4 0.0 0.0 359.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.5 0.0 0.0 247.6 0.0 0.0 0.0 0.0 351.9 0.0 0.0 29.7 0.0 0.0 510.1 30.6 0.0 0.0 0.0 113.7 0.0 0.0 0.0 0.0 579.3 113.6 162.0 0.0 0.0 TSPOAP1 "BZRAP1, KIAA0612, PRAX-1, RIM-BP1, RIMBP1" ENSG00000005379 "TSPO associated protein 1" O95153 17 58301228-58328795 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.0;Breast glandular cells: 7.1;Breast myoepithelial cells: 8.1;Collecting duct cells: 7.3;dendritic cells: 22.3;Endometrial ciliated cells: 9.3;Respiratory ciliated cells: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 127.5;HL-60: 52.6;NB-4: 52.6;REH: 99.9;THP-1: 33.0;U-266/70: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024662, HPA025244" Enhanced NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA024662: AB_2066340, HPA025244: AB_1845509" "unprognostic (2.03e-2)" "unprognostic (5.32e-2)" "unprognostic (4.60e-2)" "unprognostic (2.23e-1)" "unprognostic (2.24e-1)" "unprognostic (8.23e-4)" "unprognostic (1.24e-1)" "unprognostic (3.03e-3)" "unprognostic (1.03e-1)" "unprognostic (1.05e-1)" "prognostic favorable (9.15e-7)" "unprognostic (1.62e-1)" "unprognostic (7.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-1)" "unprognostic (3.82e-2)" "unprognostic (1.22e-2)" 9.7 28.6 71.0 5.6 66.2 40.6 18.4 45.1 92.0 47.3 45.7 35.7 4.0 38.4 6.5 11.0 62.5 5.8 18.1 68.9 47.9 36.6 16.6 18.0 10.8 45.0 49.0 65.9 33.2 14.4 69.9 1.7 44.8 49.1 3.5 17.9 27.7 16.2 8.9 11.8 19.1 6.3 40.2 25.3 26.4 3.7 56.9 13.2 44.9 3.2 5.0 25.0 22.6 52.8 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.0 0.8 0.0 2.8 2.6 0.5 0.0 0.4 0.0 0.0 0.1 127.5 1.1 0.7 1.7 0.0 0.2 52.6 5.1 0.0 0.6 0.0 0.0 12.5 0.0 17.8 2.0 9.3 0.0 0.0 18.1 52.6 0.8 0.0 0.1 99.9 0.0 13.7 0.3 0.1 7.2 4.9 0.2 0.2 0.0 0.1 0.2 33.0 0.0 0.0 1.1 0.2 0.1 36.4 7.2 9.5 0.1 1.6 0.0 0.2 0.0 0.0 1.7 0.0 0.7 0.0 0.1 0.4 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.0 0.0 0.3 71.0 66.2 45.1 92.0 68.9 47.9 45.0 49.0 44.8 40.2 56.9 52.8 0.6 9.6 9.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 7.1 8.1 0.0 0.0 4.3 7.3 0.0 0.0 22.3 0.0 1.9 0.9 0.0 9.3 3.1 0.2 0.0 0.0 0.0 0.2 0.7 1.0 0.0 3.7 1.3 4.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.8 8.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 4.0 0.1 0.0 0.0 TSPYL2 "CDA1, CINAP, CTCL, DENTT, HRIHFB2216, SE20-4, TSPX" ENSG00000184205 "TSPY like 2" Q9H2G4 X 53082367-53088540 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 367.4" "Cell type enhanced" "Detected in all" "dendritic cells: 190.0;T-cells: 224.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 114.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044133 Approved NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" "HPA044133: AB_10965838" "unprognostic (3.29e-2)" "unprognostic (2.68e-3)" "prognostic unfavorable (3.23e-4)" "unprognostic (3.87e-3)" "unprognostic (1.06e-1)" "unprognostic (9.58e-2)" "unprognostic (1.36e-1)" "unprognostic (5.99e-3)" "unprognostic (3.18e-2)" "unprognostic (1.59e-1)" "prognostic favorable (6.74e-8)" "unprognostic (1.29e-1)" "prognostic unfavorable (8.16e-7)" "unprognostic (6.50e-2)" "unprognostic (9.93e-2)" "unprognostic (2.31e-1)" "unprognostic (3.10e-2)" 73.3 148.7 92.9 23.8 100.7 67.3 65.8 92.1 110.7 137.9 39.1 112.4 9.2 121.1 59.2 31.2 125.4 31.2 94.9 93.1 121.0 48.0 39.7 75.4 33.7 69.0 83.5 367.4 70.0 22.6 311.8 10.7 82.7 131.8 11.4 35.3 42.7 55.6 99.3 48.4 77.8 30.0 58.5 85.5 86.7 163.1 118.9 20.2 87.2 26.8 22.3 120.4 81.8 85.5 4.3 13.8 14.0 57.7 10.5 12.7 19.9 29.9 31.6 19.3 18.7 20.4 9.5 32.2 5.5 15.9 14.7 12.5 11.6 11.8 17.5 8.1 25.1 8.1 60.9 26.7 30.9 13.3 9.9 24.8 21.3 26.2 44.2 11.6 14.0 11.1 6.4 29.1 10.7 19.4 18.9 15.8 21.1 6.4 25.5 14.8 17.5 23.8 3.4 23.7 17.0 10.3 23.6 8.6 16.3 63.9 13.0 4.0 20.4 8.8 14.7 114.4 5.7 31.2 20.9 29.6 14.8 21.6 18.5 4.8 0.1 2.2 7.4 0.7 9.3 6.0 10.6 6.0 0.2 7.7 14.1 10.4 1.2 7.4 1.3 15.2 8.4 5.8 92.9 100.7 92.1 110.7 93.1 121.0 69.0 83.5 82.7 58.5 118.9 85.5 45.4 9.6 43.5 17.3 98.0 40.8 80.8 20.3 63.7 100.1 48.8 60.7 33.3 10.0 30.3 18.4 45.9 5.0 190.0 9.2 1.9 8.8 11.1 28.1 47.0 38.9 72.7 5.2 43.4 6.0 15.8 64.3 40.2 61.2 64.6 36.7 27.8 5.8 6.2 30.3 65.0 18.7 14.2 11.4 79.0 11.9 39.1 51.7 44.4 9.4 5.1 53.0 11.3 13.6 9.4 5.1 12.0 51.9 141.4 44.9 4.2 1.4 19.1 34.3 59.2 76.4 75.4 59.7 94.2 17.7 36.4 16.4 224.7 29.6 12.0 31.0 TUBB4B "Beta2, TUBB2C" ENSG00000188229 "Tubulin beta 4B class IVb" P68371 9 137241287-137243707 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Deafness, Disease variant, FDA approved drug targets, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 2190.0;Late spermatids: 2907.1;Spermatocytes: 1717.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010880, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes "Cluster 38: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.24e-1)" "unprognostic (1.77e-3)" "unprognostic (1.50e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (9.98e-4)" "unprognostic (9.92e-3)" "unprognostic (2.90e-1)" "unprognostic (3.63e-1)" "unprognostic (2.34e-1)" "unprognostic (4.09e-2)" "unprognostic (2.47e-3)" "unprognostic (6.37e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.36e-6)" "unprognostic (1.69e-1)" 134.5 112.6 162.0 97.2 163.4 423.9 94.4 149.4 182.7 88.1 482.7 198.3 142.0 107.7 209.1 343.3 507.2 106.0 435.8 174.0 185.2 122.5 140.1 130.5 95.5 184.1 233.6 72.9 123.8 87.8 118.0 86.3 213.9 120.2 111.9 261.8 177.9 121.5 202.5 240.0 166.4 119.8 162.9 85.6 161.4 765.7 192.6 162.9 115.7 96.6 119.7 188.3 139.4 133.9 706.2 1032.5 431.7 314.2 213.2 223.6 600.5 643.7 536.0 872.4 598.6 1101.0 840.2 429.0 480.2 631.2 848.2 1305.1 539.5 1039.2 330.2 307.9 458.5 311.2 789.6 877.8 134.5 370.0 331.5 145.0 291.5 667.5 183.1 215.7 631.7 300.6 443.0 239.7 731.2 1936.4 337.4 504.2 457.8 1234.8 1778.1 423.5 822.2 394.2 666.8 647.8 301.5 323.6 853.9 485.8 173.2 244.2 699.0 397.6 495.6 618.1 685.0 710.0 863.6 92.4 274.9 475.1 503.6 286.9 549.8 95.7 30.0 43.2 40.5 30.1 38.2 32.6 31.3 34.4 34.9 30.8 19.7 26.7 56.4 24.4 30.5 36.3 44.7 32.6 162.0 163.4 149.4 182.7 174.0 185.2 184.1 233.6 213.9 162.9 192.6 133.9 478.5 221.2 146.3 21.5 315.8 326.2 945.7 458.7 327.2 508.1 286.9 389.5 91.9 143.0 284.1 143.5 300.3 346.6 640.9 744.1 221.1 348.6 2190.0 1191.6 224.8 203.9 391.5 419.9 30.1 446.8 545.5 247.8 274.7 415.0 189.2 200.9 142.5 139.2 265.9 244.0 24.3 503.6 323.5 59.9 214.9 2907.1 254.2 299.3 138.7 22.5 224.0 299.3 49.4 15.6 19.7 477.4 697.2 153.1 264.0 475.1 540.7 345.5 1558.7 763.3 111.7 261.8 416.0 1717.5 740.9 419.1 297.6 321.1 362.9 89.8 487.3 592.7 TUT4 "KIAA0191, PAPD3, TENT3A, ZCCHC11" ENSG00000134744 "Terminal uridylyl transferase 4" Q5TAX3 1 52408282-52553487 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "RNA-mediated gene silencing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 52.2;Cytotrophoblasts: 53.6;dendritic cells: 64.9;Endometrial ciliated cells: 59.5;Endometrial stromal cells: 96.1;Granulosa cells: 70.7;Theca cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027412, HPA027973" Supported Supported Nucleoli,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol Nucleoli "HPA027412: AB_1852281, HPA027973: AB_10603242" "unprognostic (2.74e-2)" "unprognostic (1.67e-2)" "unprognostic (1.19e-2)" "unprognostic (3.48e-2)" "unprognostic (1.36e-2)" "unprognostic (1.85e-3)" "prognostic unfavorable (9.00e-4)" "unprognostic (2.64e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-1)" "unprognostic (6.57e-3)" "unprognostic (3.11e-2)" "unprognostic (5.35e-3)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" 22.5 34.4 28.4 18.3 28.6 26.6 21.4 44.7 36.2 34.1 28.6 26.3 8.7 27.4 23.7 19.3 30.8 15.4 27.1 26.8 35.3 22.9 31.3 22.1 34.2 28.5 29.4 46.3 31.2 29.5 41.5 21.2 28.5 26.1 11.2 84.9 20.7 16.5 60.0 35.1 30.9 15.9 26.4 35.0 22.3 46.9 33.4 32.5 31.4 30.0 29.4 23.1 26.5 33.5 24.4 22.7 55.3 37.3 21.1 27.1 36.4 20.0 31.0 30.3 34.9 23.6 12.5 50.6 23.0 30.0 49.1 19.7 41.6 22.6 38.7 39.7 36.5 53.7 30.0 49.7 35.0 59.4 29.1 31.9 49.4 32.6 40.0 38.6 21.4 35.7 44.7 25.6 25.7 0.3 60.1 42.7 39.8 12.5 27.5 51.3 55.3 39.3 33.4 20.0 28.7 26.8 31.8 14.1 32.9 62.3 19.4 31.5 18.1 23.2 30.6 21.1 26.2 52.7 74.0 71.8 15.5 32.0 17.0 83.7 9.7 34.8 26.1 4.0 19.3 49.0 27.3 21.6 5.1 50.2 33.1 22.0 37.6 25.3 3.7 61.9 23.3 5.1 28.4 28.6 44.7 36.2 26.8 35.3 28.5 29.4 28.5 26.4 33.4 33.5 52.2 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 36.1 41.4 0.0 0.0 0.0 47.8 0.0 53.6 64.9 0.0 15.6 28.5 0.0 59.5 96.1 14.3 0.0 0.0 0.0 17.0 19.1 18.8 0.0 46.7 0.0 70.7 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 9.8 0.0 0.0 0.0 0.0 19.6 0.0 0.0 30.2 0.0 0.0 22.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 36.9 28.2 57.3 0.0 0.0 TWNK "C10orf2, FLJ21832, IOSCA, PEO, PEO1, TWINKLE, TWINL" ENSG00000107815 "Twinkle mtDNA helicase" Q96RR1 10 100987367-100994403 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA replication" "Helicase, Hydrolase" "Deafness, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 6.8;Breast myoepithelial cells: 6.6;Ductal cells: 5.4;Endometrial stromal cells: 7.2;Granulosa cells: 7.1;Theca cells: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002532 Uncertain NA NA "Cluster 44: Non-specific - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA002532: AB_1078311" "unprognostic (8.10e-2)" "unprognostic (9.65e-2)" "unprognostic (1.16e-1)" "unprognostic (2.19e-2)" "unprognostic (2.81e-2)" "unprognostic (1.19e-1)" "unprognostic (7.82e-3)" "unprognostic (7.99e-2)" "unprognostic (1.22e-1)" "unprognostic (7.95e-2)" "unprognostic (7.52e-2)" "unprognostic (1.96e-2)" "unprognostic (9.46e-2)" "unprognostic (9.82e-3)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" "unprognostic (1.45e-1)" 4.9 7.0 3.7 5.5 3.7 3.0 7.5 3.6 3.5 3.8 3.2 4.4 3.3 4.6 5.3 5.5 6.6 2.6 5.0 3.4 3.6 5.9 6.0 2.1 6.1 3.9 4.0 5.1 5.2 4.8 2.4 3.8 3.8 4.0 4.8 1.6 4.0 3.4 11.6 5.5 3.8 4.5 3.7 4.6 3.9 8.3 4.0 8.1 4.1 12.6 8.3 6.6 3.5 3.5 15.5 32.0 12.5 39.7 11.1 7.2 14.7 11.4 14.8 17.3 16.6 52.6 13.1 55.4 21.1 7.0 10.4 25.0 52.2 27.7 21.1 25.5 31.0 42.1 17.4 40.2 19.1 54.8 16.7 14.9 30.7 25.5 77.6 15.8 10.6 26.3 45.9 15.0 12.3 21.2 37.0 18.8 35.8 28.2 25.9 35.5 27.5 33.2 10.7 15.4 20.1 38.5 12.0 16.0 37.8 13.8 20.9 16.0 12.4 8.6 17.4 10.6 32.5 28.0 31.3 46.0 10.6 47.8 9.8 1.2 0.6 0.1 1.2 0.5 3.7 2.4 1.8 2.7 1.2 2.1 2.0 2.2 0.0 2.5 0.8 1.3 0.4 1.4 3.7 3.7 3.6 3.5 3.4 3.6 3.9 4.0 3.8 3.7 4.0 3.5 3.5 0.0 2.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 6.8 6.6 0.0 0.0 3.1 1.8 0.0 4.2 1.9 0.0 3.9 5.4 0.0 2.3 7.2 2.0 0.0 0.0 0.0 3.0 3.7 1.3 0.0 2.8 1.3 7.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.6 1.1 9.1 0.0 0.0 UBALD2 "FAM100B, MGC29814" ENSG00000185262 "UBA like domain containing 2" Q8IYN6 17 76265348-76271298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 229.1" "Cell type enhanced" "Detected in all" "Urothelial cells: 205.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 7.8;neutrophil: 29.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 29.2" "Cell line enhanced" "Detected in all" "HDLM-2: 324.7;Karpas-707: 401.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023046 Uncertain NA Yes "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA023046: AB_1848359" "unprognostic (1.33e-1)" "unprognostic (2.04e-3)" "unprognostic (3.14e-1)" "unprognostic (3.06e-1)" "unprognostic (9.21e-2)" "unprognostic (1.74e-1)" "unprognostic (3.22e-3)" "unprognostic (5.06e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (4.80e-2)" "unprognostic (3.78e-2)" "unprognostic (9.24e-2)" "unprognostic (3.45e-3)" "unprognostic (1.45e-3)" 43.9 19.4 36.1 54.4 38.0 229.1 43.6 36.5 48.8 33.1 32.4 53.6 80.0 24.5 8.0 97.9 29.4 14.8 44.5 32.5 53.6 39.1 35.2 72.0 45.0 68.4 42.9 17.7 43.6 26.6 22.1 21.9 47.0 33.3 17.9 6.9 59.5 10.9 172.4 63.0 81.5 8.9 35.8 75.1 51.5 23.0 45.2 38.8 34.2 25.9 25.5 33.1 49.6 44.1 118.6 26.2 23.7 18.9 29.2 27.5 56.0 42.7 32.8 17.9 20.3 30.8 127.9 31.2 44.0 12.5 19.7 43.3 12.1 24.1 14.1 324.7 30.5 34.5 31.4 29.0 20.1 40.9 162.8 24.9 31.8 19.1 50.3 21.0 57.4 99.6 55.5 401.9 23.3 61.3 193.2 99.4 21.8 71.4 48.1 93.9 49.6 87.3 33.8 66.6 60.3 57.4 30.1 41.2 217.0 25.8 29.8 106.3 42.3 35.8 52.1 60.3 68.9 177.7 149.2 67.8 41.6 34.0 99.8 7.8 1.8 3.3 2.3 1.5 1.9 2.7 3.9 2.4 0.7 2.1 4.6 3.7 29.2 1.4 1.1 3.9 2.8 0.6 36.1 38.0 36.5 48.8 32.5 53.6 68.4 42.9 47.0 35.8 45.2 44.1 81.6 22.4 17.6 5.2 99.8 71.9 84.5 15.5 18.8 12.8 95.5 78.2 18.0 67.2 16.6 23.9 14.6 9.0 115.3 117.2 15.6 31.4 25.5 126.6 43.1 53.1 36.3 59.8 5.1 30.8 18.6 23.5 42.8 181.6 22.2 21.6 29.6 34.3 29.2 11.8 5.8 84.5 10.2 60.5 55.6 8.2 19.9 87.9 49.8 8.4 27.5 31.3 50.4 6.0 8.7 44.7 80.6 20.3 106.6 93.2 119.3 22.4 30.2 18.7 19.7 25.5 28.8 5.1 4.5 38.7 106.3 27.9 100.9 30.6 72.4 205.6 UBC ENSG00000150991 "Ubiquitin C" P0CG48 12 124911604-124917368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000362, CAB005419, HPA041344, HPA049132" Supported NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "CAB000362: AB_2301097, CAB005419: AB_2180553, HPA041344: AB_2677422, HPA049132: AB_2680646" "unprognostic (7.46e-2)" "unprognostic (1.37e-1)" "unprognostic (1.24e-1)" "unprognostic (8.64e-3)" "unprognostic (2.41e-2)" "unprognostic (7.38e-2)" "unprognostic (6.35e-3)" "unprognostic (7.60e-3)" "unprognostic (1.48e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (7.90e-7)" "unprognostic (6.69e-2)" "unprognostic (2.74e-1)" "unprognostic (5.64e-2)" "unprognostic (8.81e-2)" 1262.3 939.6 1151.9 699.3 1221.6 2805.5 941.4 1314.4 1635.4 1055.3 1295.5 931.6 571.9 960.0 987.6 1641.4 1095.1 1356.3 1277.9 1143.2 1267.5 983.6 1652.7 1070.8 833.5 1278.5 1215.6 819.4 921.7 653.3 512.9 826.4 1231.8 709.8 1060.9 974.0 1114.7 1136.4 3463.2 933.2 836.0 1278.4 1259.5 799.3 813.0 1257.7 1239.5 767.6 912.2 3177.8 993.4 1144.9 1183.7 1600.9 1407.8 1259.6 1043.5 863.8 2845.1 1769.8 692.9 1750.1 2130.8 1259.1 1229.6 1129.7 1747.7 1272.9 1410.4 2133.4 2042.1 1026.2 2048.8 3325.1 1075.2 1480.4 760.1 971.1 831.8 2017.2 2199.3 1404.5 844.9 2035.2 2538.3 1500.0 2283.6 1644.8 1630.2 510.6 897.8 1259.9 1467.1 1270.4 1300.6 1641.0 966.5 835.3 1520.0 781.7 970.6 1182.5 1719.0 2164.3 1216.6 891.7 1691.7 1928.1 1622.1 619.9 1653.3 931.5 2019.6 2766.8 792.8 1496.9 1103.8 1460.9 1819.8 1608.8 1490.2 779.7 1805.4 335.0 532.6 606.0 431.8 517.4 412.7 315.8 375.2 450.0 310.2 295.5 292.5 350.7 989.3 401.3 653.5 432.6 499.4 1022.5 1151.9 1221.6 1314.4 1635.4 1143.2 1267.5 1278.5 1215.6 1231.8 1259.5 1239.5 1600.9 2304.5 1451.9 1227.6 128.0 1287.0 1219.8 3858.3 4028.1 1915.7 618.9 843.1 1183.4 915.2 683.4 2496.6 660.3 333.6 841.0 1282.5 1499.3 892.1 1475.7 4437.0 1595.5 1062.5 1370.6 747.6 340.1 42.3 1128.2 1268.9 1662.4 1305.8 2615.6 911.9 698.7 637.9 442.9 1295.9 518.2 49.3 1067.2 1564.5 654.8 1858.6 4032.6 786.9 1668.6 1220.2 124.6 1728.7 1784.0 520.1 31.7 106.2 1334.3 1613.6 830.1 2420.4 1775.3 1850.8 1023.9 1700.8 1215.7 611.4 1695.6 2149.7 1135.2 429.9 1523.5 1048.6 1754.1 1980.7 752.4 845.9 2349.3 UBE2D4 HBUCE1 ENSG00000078967 "Ubiquitin conjugating enzyme E2 D4 (putative)" Q9Y2X8 7 43926436-43956136 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 32.5" "Cell type enhanced" "Detected in many" "Distal tubular cells: 54.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 30.2" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (9.95e-3)" "unprognostic (6.76e-2)" "unprognostic (6.87e-2)" "unprognostic (8.94e-2)" "unprognostic (8.24e-2)" "unprognostic (5.24e-2)" "unprognostic (2.42e-1)" "unprognostic (3.58e-3)" "unprognostic (4.74e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.86e-4)" "prognostic favorable (5.77e-4)" "prognostic favorable (6.51e-4)" "unprognostic (1.11e-1)" "unprognostic (8.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.34e-1)" 5.8 8.3 11.7 2.4 12.2 2.2 5.0 14.2 17.6 4.6 9.8 6.5 2.4 4.5 5.7 5.2 4.5 3.4 10.9 12.3 11.2 6.9 10.7 4.4 2.7 12.0 11.7 5.1 10.0 4.6 5.1 2.8 11.9 5.7 2.9 6.9 5.6 4.4 32.5 4.9 3.9 4.4 11.8 4.7 4.6 3.0 11.5 2.7 4.9 27.8 2.7 5.3 5.2 12.7 4.9 4.0 2.4 11.0 11.0 4.5 1.8 2.3 5.8 2.9 3.7 2.1 5.6 4.6 6.3 6.3 8.1 5.3 3.1 2.5 4.4 10.5 5.4 5.0 5.8 5.4 4.1 10.9 9.8 3.4 5.2 3.3 5.0 4.2 3.6 5.5 5.6 9.2 4.0 3.0 6.5 6.1 5.4 5.9 5.1 4.0 3.3 7.1 6.2 5.9 8.8 30.2 5.0 9.7 3.8 4.4 4.9 3.3 3.2 1.9 6.0 4.1 6.9 13.5 10.8 2.2 5.7 14.2 10.9 10.2 14.5 17.5 11.1 23.8 11.4 12.8 13.5 12.5 15.1 12.7 16.2 13.4 1.4 9.9 28.7 13.0 12.6 8.8 11.7 12.2 14.2 17.6 12.3 11.2 12.0 11.7 11.9 11.8 11.5 12.7 14.9 0.0 6.5 8.8 10.4 6.2 9.1 9.4 4.0 9.6 24.3 24.3 24.6 14.3 10.0 16.5 2.1 11.9 11.9 8.4 54.8 18.7 6.2 8.9 7.2 12.9 18.7 9.9 14.2 28.4 20.3 14.9 8.2 8.7 4.5 11.1 12.5 25.4 27.4 11.8 13.5 8.0 8.2 11.6 14.1 10.7 12.2 12.5 16.0 8.4 18.4 18.8 5.2 20.1 12.1 14.1 7.6 21.8 11.2 12.1 15.5 52.0 5.5 11.6 6.6 23.0 10.5 15.6 9.6 10.8 11.2 7.7 8.8 16.5 8.4 12.3 UBE2M "hUbc12, UBC12" ENSG00000130725 "Ubiquitin conjugating enzyme E2 M" P61081 19 58555712-58558954 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 1197.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004993, HPA054551, HPA057800" Approved Enhanced "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" Yes No 49000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.35e-2)" "unprognostic (1.77e-1)" "unprognostic (1.17e-3)" "unprognostic (3.90e-3)" "unprognostic (4.86e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-3)" "unprognostic (1.96e-1)" "unprognostic (1.81e-1)" "unprognostic (8.63e-3)" "unprognostic (1.76e-1)" "unprognostic (5.85e-2)" "unprognostic (8.42e-3)" 46.3 66.1 133.2 39.2 138.8 82.2 42.8 116.7 199.7 48.9 104.0 72.5 41.7 48.1 36.3 61.8 51.3 30.9 111.0 141.2 129.3 63.2 45.6 46.3 43.4 123.5 124.4 46.0 47.5 84.5 69.7 45.0 127.7 48.3 32.5 49.7 48.5 46.1 174.0 56.6 41.6 39.5 111.9 49.3 55.8 81.0 124.4 51.7 44.3 104.5 43.7 58.3 45.8 139.1 161.8 272.1 119.3 124.8 61.7 71.9 112.2 166.0 117.4 97.8 82.8 162.7 109.7 161.9 135.5 93.4 198.1 105.9 130.1 138.6 69.2 207.3 1197.4 235.5 163.7 113.7 154.4 197.3 192.9 82.1 107.1 145.9 167.3 102.6 117.8 146.3 119.6 179.4 127.3 158.2 177.2 223.7 87.1 155.1 306.5 171.7 106.7 204.5 111.6 166.8 239.5 205.5 133.1 149.7 163.3 41.6 94.4 188.4 105.2 333.4 80.5 110.6 281.3 262.3 411.9 169.6 206.0 177.6 220.5 6.7 3.6 4.2 3.0 2.6 2.2 2.8 3.2 3.2 2.8 3.8 3.3 2.2 10.1 1.7 2.7 6.7 2.9 1.9 133.2 138.8 116.7 199.7 141.2 129.3 123.5 124.4 127.7 111.9 124.4 139.1 75.1 6.4 13.0 14.7 32.7 40.4 36.3 15.9 6.2 100.0 74.5 81.3 38.5 20.0 11.6 18.4 20.9 21.0 72.9 63.9 7.9 17.3 25.7 89.6 68.0 40.1 41.2 39.8 22.9 30.6 22.4 38.9 21.9 63.3 19.7 103.3 28.5 38.0 35.4 109.4 20.8 43.8 20.3 27.0 33.5 34.0 17.4 42.5 35.6 15.9 21.1 142.3 14.4 8.5 17.9 41.8 21.4 13.9 35.4 59.1 37.9 33.9 18.6 81.1 26.3 41.5 55.4 27.1 7.9 17.0 56.8 52.5 41.0 156.1 41.6 56.2 UBE2S E2-EPF ENSG00000108106 "Ubiquitin conjugating enzyme E2 S" Q16763 19 55399745-55407788 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 115.9;testis: 158.3" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 341.4;dendritic cells: 432.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015228, HPA057150" Approved Approved "Nucleoplasm,Plasma membrane" NA Yes "Cluster 37: B-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane" Nucleoplasm "CAB015228: , HPA057150: AB_2683351" "unprognostic (2.79e-1)" "unprognostic (2.42e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (9.54e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (8.00e-6)" "unprognostic (1.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.31e-1)" "unprognostic (8.08e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.05e-1)" "unprognostic (9.51e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" 16.3 17.6 17.1 21.8 17.3 115.9 11.0 15.7 23.7 16.8 10.9 18.5 11.4 17.2 5.5 37.1 15.1 13.1 24.8 25.2 23.8 13.0 11.5 16.2 35.7 17.0 16.5 14.8 7.7 6.8 28.8 13.6 22.2 15.1 9.3 9.4 12.0 6.2 15.5 12.0 16.2 15.0 16.7 25.7 17.6 158.3 18.9 47.8 10.3 5.7 30.9 16.2 17.8 21.3 532.9 279.4 241.3 193.8 15.3 21.6 42.9 419.3 126.1 253.2 229.1 191.1 183.6 508.6 169.5 106.4 304.5 152.9 243.6 109.5 111.4 402.0 810.5 305.8 162.8 62.5 45.1 370.0 286.0 23.8 30.2 186.7 179.1 55.0 100.6 272.7 310.0 347.0 161.3 139.5 503.2 191.3 605.3 147.2 470.6 437.4 185.5 185.8 69.2 111.5 609.3 330.0 534.5 131.2 248.6 72.6 93.8 198.1 155.9 151.9 432.8 130.7 1013.5 277.1 734.4 617.0 159.2 257.5 562.7 0.5 0.8 1.3 0.7 0.6 0.5 2.5 1.0 1.0 0.6 0.6 1.0 0.5 2.4 0.2 0.4 1.3 0.4 0.1 17.1 17.3 15.7 23.7 25.2 23.8 17.0 16.5 22.2 16.7 18.9 21.3 308.0 0.0 3.4 5.9 161.3 162.6 151.2 31.5 81.4 59.3 235.9 341.4 3.1 8.6 9.9 20.2 54.2 87.8 432.7 59.2 15.6 42.8 127.5 89.3 68.2 72.5 92.6 166.5 8.7 30.5 247.9 99.3 44.9 68.0 18.4 200.9 31.8 10.6 65.5 32.0 11.0 69.1 38.7 26.8 125.3 52.2 17.4 131.7 74.7 3.7 36.7 91.1 21.6 7.5 13.5 82.3 44.1 12.4 100.6 82.9 20.4 18.4 9.7 75.7 13.1 125.2 186.7 196.9 174.0 74.1 115.9 59.8 233.3 64.6 55.8 121.1 UBP1 LBP-1a ENSG00000153560 "Upstream binding protein 1" Q9NZI7 3 33388336-33441371 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003967 Supported Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 14: B-cells - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA003967: AB_10601829" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.81e-4)" "unprognostic (4.64e-2)" "unprognostic (9.35e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (9.45e-4)" "unprognostic (6.67e-3)" "unprognostic (3.92e-2)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (1.88e-2)" 23.6 21.4 18.6 31.2 20.8 24.5 24.4 24.3 22.9 23.9 14.2 34.7 29.7 28.7 26.8 29.6 23.2 24.4 31.3 21.2 19.9 23.4 32.4 30.5 44.1 15.0 16.6 29.2 31.0 24.6 22.9 22.2 15.5 25.7 34.6 28.5 23.5 39.5 23.0 26.5 28.7 37.0 17.0 32.6 27.0 16.9 20.0 43.6 26.5 27.6 43.8 35.6 23.0 18.4 48.9 58.6 44.3 74.0 66.1 48.0 21.6 57.7 64.0 67.8 68.4 57.1 42.5 91.2 33.1 85.2 48.6 33.1 133.3 67.6 82.9 50.2 40.7 97.9 57.0 68.7 46.2 71.8 40.5 40.0 54.4 65.7 66.3 55.5 82.5 49.6 90.7 49.0 66.1 46.5 57.5 42.5 105.4 38.6 59.7 59.8 32.4 84.7 47.9 72.8 30.5 36.3 45.9 78.8 50.3 58.5 59.6 86.2 68.8 59.4 45.7 67.8 81.1 38.8 74.9 92.4 51.4 82.7 45.0 3.5 1.6 1.7 2.1 1.7 2.0 1.1 2.1 2.1 2.5 0.8 2.4 2.0 0.4 2.2 2.4 2.0 1.4 1.6 18.6 20.8 24.3 22.9 21.2 19.9 15.0 16.6 15.5 17.0 20.0 18.4 18.0 6.4 20.9 29.7 15.4 25.5 9.7 13.6 19.9 24.6 35.3 17.8 29.3 18.6 10.0 11.0 14.6 7.9 22.2 30.0 3.9 11.8 1.6 12.8 23.5 23.5 12.1 21.7 58.3 14.5 9.4 15.8 17.9 18.4 2.5 27.2 21.4 41.6 14.8 23.5 50.9 27.8 10.2 27.3 27.6 3.5 9.9 25.5 26.6 29.0 27.3 7.7 20.6 34.2 35.5 14.3 17.1 17.7 15.7 17.1 17.3 10.9 8.1 17.8 13.1 15.6 19.7 14.3 13.8 26.8 31.1 5.5 20.5 24.9 28.4 13.2 UFD1 UFD1L ENSG00000070010 "Ubiquitin recognition factor in ER associated degradation 1" Q92890 22 19449911-19479202 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 121.1;Ductal cells: 115.7;Exocrine glandular cells: 142.2;Extravillous trophoblasts: 107.3;Pancreatic endocrine cells: 149.9;Syncytiotrophoblasts: 170.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 782.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030286, HPA030287" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" Nucleoli "HPA030286: , HPA030287: AB_10601830" "unprognostic (2.52e-1)" "unprognostic (5.41e-2)" "unprognostic (1.95e-3)" "unprognostic (7.61e-2)" "unprognostic (3.50e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-3)" "unprognostic (8.82e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.50e-8)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" 43.8 39.8 23.6 36.8 26.3 64.8 37.8 27.6 29.8 33.9 25.7 42.5 32.1 46.8 54.4 48.4 31.4 29.3 44.8 24.6 28.6 36.7 51.9 37.2 43.4 28.9 26.7 31.8 39.3 44.7 31.7 35.3 29.5 32.1 38.4 21.7 38.1 30.1 98.3 42.5 35.7 39.5 27.2 38.6 40.8 53.3 27.1 61.6 34.9 42.5 47.5 40.2 37.0 29.7 187.5 132.4 110.6 168.5 89.0 62.0 86.0 150.2 148.8 202.9 187.1 147.8 78.8 129.2 114.1 126.7 93.3 157.5 131.5 132.1 175.1 239.8 138.0 136.5 88.3 119.4 84.4 218.6 177.7 57.4 133.0 173.2 84.4 59.1 164.7 67.9 782.0 240.5 125.1 268.5 142.0 133.4 79.8 232.2 111.9 170.1 262.0 50.1 126.6 172.5 90.5 102.2 118.2 126.0 123.3 114.2 75.9 103.5 180.9 169.6 230.8 143.2 164.1 102.9 221.7 168.8 142.5 110.3 158.6 150.9 90.6 158.1 107.0 140.3 103.7 87.7 122.5 112.4 81.0 82.6 104.6 102.9 167.1 105.7 140.7 113.1 224.5 129.5 23.6 26.3 27.6 29.8 24.6 28.6 28.9 26.7 29.5 27.2 27.1 29.7 68.3 25.6 34.5 0.0 16.4 0.0 0.0 0.0 0.0 0.0 39.7 55.2 0.0 0.0 16.7 27.6 0.0 121.1 44.9 0.0 84.1 115.7 0.0 43.1 36.9 32.6 0.0 0.0 0.0 142.2 107.3 25.4 0.0 44.9 27.8 36.0 0.0 0.0 88.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 76.0 0.0 0.0 0.0 0.0 149.9 0.0 0.0 7.5 0.0 0.0 81.0 27.7 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.0 170.3 26.3 61.5 0.0 0.0 ULBP1 RAET1I ENSG00000111981 "UL16 binding protein 1" Q9BZM6 6 149963943-149973715 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 4.4;lung: 1.7;testis: 3.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.2;Breast myoepithelial cells: 3.0;Respiratory ciliated cells: 2.2;Squamous epithelial cells: 2.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 4.4;cerebral cortex: 1.9;hippocampal formation: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 16.5;HAP1: 29.3;HDLM-2: 17.1;HHSteC: 18.0;JURKAT: 26.1" "HPA007547, HPA071005" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA007547: AB_1079430, HPA071005: AB_2686332" "unprognostic (8.94e-3)" "unprognostic (2.44e-1)" "unprognostic (2.85e-2)" "unprognostic (2.33e-2)" "unprognostic (3.28e-4)" "unprognostic (6.69e-3)" "unprognostic (5.27e-2)" "unprognostic (2.47e-2)" "unprognostic (5.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.57e-12)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 0.2 0.1 0.1 0.2 0.1 0.3 0.0 4.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.6 0.2 0.4 0.1 1.7 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 3.3 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.2 2.1 1.0 1.6 0.0 3.3 6.8 3.2 3.0 0.9 0.6 2.0 0.2 3.1 3.5 0.7 16.5 6.9 0.7 29.3 1.4 2.7 17.1 3.8 0.3 0.6 0.0 18.0 0.1 1.2 9.1 6.8 13.6 2.5 0.0 1.1 26.1 3.3 0.0 3.5 2.7 4.3 0.0 0.5 1.4 2.3 0.0 1.3 0.5 0.0 0.4 1.0 0.4 4.4 2.0 0.0 1.3 2.9 6.4 0.3 1.6 0.0 1.4 0.0 0.5 0.7 2.3 8.7 5.0 3.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.1 4.4 1.9 1.6 0.2 0.1 0.2 0.5 0.1 0.1 0.2 1.6 6.4 2.2 0.0 0.5 0.1 0.5 0.0 0.6 0.0 1.0 3.0 0.9 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.1 0.2 0.6 1.1 0.0 0.0 0.1 0.6 0.0 1.6 0.0 0.7 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.5 0.0 0.3 0.3 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 2.2 0.0 0.0 1.6 1.3 0.2 0.2 2.5 0.6 0.0 0.7 0.2 0.3 0.1 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942014-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 6.1" "Cell type enhanced" "Detected in many" "Adipocytes: 28.9;Basal respiratory cells: 17.9;dendritic cells: 12.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 12.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enriched" "Detected in single" 6 "T-cells: 2.7" "Cell line enhanced" "Detected in many" "SiHa: 66.7;U-2197: 47.4" "CAB018974, HPA066741" Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 27: Brain & Skin - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Plasma membrane" "CAB018974: , HPA066741: " "unprognostic (2.09e-5)" "prognostic unfavorable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 1.5 0.7 1.3 0.6 1.6 1.8 0.7 1.6 2.6 0.9 0.7 0.2 0.2 0.1 0.1 6.1 0.2 0.5 2.0 3.0 1.0 2.1 0.5 3.4 0.3 1.8 1.2 0.0 0.4 0.6 0.5 1.6 1.8 0.2 0.1 0.2 0.7 0.1 0.3 0.5 0.2 0.7 0.8 0.2 0.3 1.5 1.1 0.7 1.2 0.7 0.8 1.4 1.6 1.7 19.9 1.8 0.5 6.1 1.1 5.6 3.3 20.1 11.8 20.6 16.8 7.4 11.0 0.0 29.9 23.0 29.6 13.9 7.6 18.4 11.8 9.1 3.9 1.1 2.8 0.0 7.1 0.0 1.5 2.7 13.9 18.3 8.0 16.7 11.9 16.6 2.5 0.0 15.4 13.9 1.8 0.0 0.0 3.6 10.2 3.0 4.5 0.0 29.0 5.7 0.6 0.0 66.7 1.4 1.9 3.2 1.8 8.5 18.8 13.5 17.1 47.4 23.5 0.0 0.1 0.9 19.2 10.7 9.9 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.8 1.5 0.0 0.0 0.3 1.8 0.0 0.4 0.0 0.0 1.7 0.5 1.3 1.6 1.6 2.6 3.0 1.0 1.8 1.2 1.8 0.8 1.1 1.7 28.9 0.0 1.3 0.0 1.2 3.7 6.5 17.9 7.4 0.0 1.3 4.4 0.3 0.0 9.4 1.8 0.0 0.0 12.1 0.5 0.0 7.5 7.0 0.3 0.5 9.1 0.0 0.0 3.0 8.8 0.5 3.0 1.1 0.2 0.0 0.1 7.1 0.2 2.2 0.0 0.7 0.3 2.0 0.8 2.1 8.0 0.0 3.1 1.8 0.0 0.0 0.4 4.1 0.5 0.3 4.5 0.0 0.0 1.4 1.4 0.0 0.1 1.4 0.0 0.0 1.0 4.2 3.1 7.0 11.8 2.8 0.0 11.0 0.6 0.4 5.2 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673686 "Disease related genes, Human disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 209.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 82.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 7.5 12.2 7.4 3.7 7.5 5.7 7.5 8.2 9.7 7.6 9.3 9.9 8.1 6.5 1.7 12.3 6.1 1.2 10.2 7.1 7.1 10.7 11.9 4.7 4.2 7.6 7.3 6.5 9.0 3.5 6.7 2.2 7.7 9.4 1.9 3.9 11.5 3.3 15.7 9.0 8.3 1.5 7.0 7.4 9.6 3.4 7.4 2.4 6.3 5.0 1.6 6.3 8.1 8.1 26.9 52.9 7.7 12.0 4.7 4.6 6.5 10.4 3.5 7.7 7.6 31.4 22.8 17.4 21.1 3.6 10.4 26.1 7.4 12.3 2.4 8.8 27.4 9.8 28.7 20.3 6.3 16.0 7.6 4.4 10.3 6.8 7.6 4.8 6.0 8.1 21.3 12.2 4.3 82.4 15.7 39.2 8.6 10.6 29.8 17.9 11.7 31.1 6.1 13.2 15.5 15.7 11.5 41.7 16.2 2.4 39.7 14.9 7.9 16.8 19.7 17.6 23.6 18.7 11.0 18.3 13.8 13.7 12.3 14.6 25.0 20.1 21.3 19.1 20.4 30.8 21.1 19.0 20.0 29.9 19.2 15.3 11.0 19.6 17.2 26.7 25.8 20.0 7.4 7.5 8.2 9.7 7.1 7.1 7.6 7.3 7.7 7.0 7.4 8.1 49.0 44.8 25.0 3.6 32.3 0.0 42.2 0.0 47.3 21.8 77.5 86.4 35.8 70.1 16.1 64.4 16.7 53.1 22.9 65.2 140.8 56.6 1.7 50.3 40.6 32.9 35.2 32.2 2.4 78.4 53.1 32.4 54.6 41.1 5.1 28.0 44.6 125.4 54.8 18.5 4.2 75.2 0.0 39.7 0.0 3.7 48.4 29.2 0.0 7.5 47.2 59.7 66.9 5.0 5.2 67.4 66.9 36.1 38.4 85.1 209.3 170.6 12.4 37.0 39.5 28.3 31.8 4.2 32.0 91.0 0.0 29.0 25.3 35.1 79.0 57.0 UTP11 "CGI-94, UTP11L" ENSG00000183520 "UTP11 small subunit processome component" Q9Y3A2 1 38009258-38024820 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 111.4;tongue: 85.5" "Cell type enhanced" "Detected in many" "Ductal cells: 60.2;Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 72.6;Syncytiotrophoblasts: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045830 Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA045830: AB_10969917" "unprognostic (1.95e-1)" "unprognostic (2.23e-1)" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (7.29e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.44e-8)" "unprognostic (3.51e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-3)" "unprognostic (1.40e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (1.42e-8)" "unprognostic (1.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" 15.4 18.7 11.0 15.4 11.9 16.7 13.6 11.9 15.9 11.4 10.6 18.4 11.3 15.9 13.4 18.4 12.3 12.9 19.9 11.7 11.6 12.3 17.0 11.4 14.9 12.9 12.3 11.0 15.6 12.0 7.3 14.8 12.4 13.7 13.3 7.0 14.1 12.8 111.4 14.6 9.9 19.7 12.0 10.7 14.0 15.1 11.9 13.5 11.0 85.5 17.5 19.7 11.0 14.7 37.6 22.9 38.5 36.8 27.8 37.8 34.6 41.5 39.4 55.4 50.4 32.8 44.9 62.6 37.9 34.2 27.2 31.6 44.2 37.2 68.8 47.3 39.9 72.6 27.9 28.8 37.9 72.7 45.3 35.3 23.7 61.4 53.3 34.1 44.6 47.6 84.1 32.5 63.5 26.6 56.9 75.4 92.1 41.9 29.1 49.7 80.8 57.3 36.5 36.2 49.8 41.5 36.1 30.7 67.8 40.1 28.1 44.5 33.2 36.8 45.0 40.8 80.0 31.0 65.8 52.6 49.3 79.3 46.5 18.1 27.6 15.2 23.1 30.6 24.3 15.0 18.3 19.3 27.6 17.5 16.3 20.3 8.3 32.2 36.5 26.3 23.4 20.5 11.0 11.9 11.9 15.9 11.7 11.6 12.9 12.3 12.4 12.0 11.9 14.7 37.9 35.3 43.6 0.0 5.7 0.0 0.0 0.0 0.0 0.0 29.8 27.6 0.0 0.0 21.1 25.8 0.0 54.2 23.6 0.0 39.2 60.2 0.0 23.6 43.5 31.4 0.0 0.0 0.0 67.4 51.7 23.4 0.0 24.8 25.2 19.0 0.0 0.0 52.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 19.1 0.0 0.0 0.0 0.0 72.6 0.0 0.0 3.5 0.0 0.0 49.4 25.5 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 77.8 10.5 39.1 0.0 0.0 UTP25 "C1orf107, DEF, DIEXF, MGC29875" ENSG00000117597 "UTP25 small subunit processor component" Q68CQ4 1 209827972-209857565 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 11.0;Endometrial stromal cells: 11.4;Glandular and luminal cells: 13.1;Granulosa cells: 10.7;Pancreatic endocrine cells: 11.2;Proximal tubular cells: 10.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026640 Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA026640: AB_2067139" "unprognostic (3.11e-3)" "unprognostic (1.14e-3)" "unprognostic (1.56e-2)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "unprognostic (4.75e-2)" "unprognostic (6.96e-3)" "unprognostic (2.03e-1)" "unprognostic (3.73e-2)" "unprognostic (1.42e-1)" "unprognostic (1.74e-3)" "unprognostic (1.52e-1)" "unprognostic (1.39e-2)" "unprognostic (9.86e-3)" "unprognostic (4.44e-2)" "unprognostic (8.49e-2)" "unprognostic (7.01e-2)" 3.6 2.9 2.9 4.0 3.1 2.9 6.5 1.2 3.2 3.6 1.5 3.4 2.8 4.2 3.4 3.2 4.5 2.6 2.4 2.9 2.5 3.5 4.4 2.5 4.9 1.5 2.3 7.1 3.5 3.6 1.5 3.2 2.2 3.0 3.8 2.3 3.0 3.2 2.6 4.6 3.0 3.9 1.8 3.9 3.3 2.0 2.4 3.5 4.2 2.8 4.7 4.1 3.2 3.0 9.5 9.6 3.5 6.3 7.4 6.9 10.2 11.9 14.4 8.4 7.7 6.1 10.3 11.5 6.9 12.7 10.2 10.2 10.6 7.3 11.5 8.3 10.3 6.1 6.6 4.2 5.2 9.0 6.1 6.8 10.2 13.8 12.8 7.3 7.0 6.1 15.6 7.3 8.8 4.8 8.1 5.1 15.3 8.7 7.0 6.4 11.2 14.7 6.1 8.7 8.2 10.0 6.1 15.5 12.3 9.3 6.4 7.1 8.3 17.7 8.2 11.5 13.1 8.0 9.4 11.0 7.7 6.7 7.2 4.1 2.3 0.7 3.7 3.0 5.1 5.3 4.0 3.6 3.1 4.5 5.0 4.5 0.2 4.9 4.1 2.1 3.2 2.5 2.9 3.1 1.2 3.2 2.9 2.5 1.5 2.3 2.2 1.8 2.4 3.0 8.6 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 9.9 10.0 0.0 0.0 0.0 11.0 0.0 6.8 6.7 0.0 7.9 10.2 0.0 10.6 11.4 4.0 0.0 0.0 0.0 9.1 7.8 3.1 0.0 13.1 0.0 10.7 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 11.2 0.0 0.0 1.4 0.0 0.0 10.8 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 4.0 3.2 6.6 0.0 0.0 VIRMA "DKFZP434I116, fSAP121, KIAA1429" ENSG00000164944 "Vir like m6A methyltransferase associated" Q69YN4 8 94487689-94553529 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 26.4;Endometrial stromal cells: 32.2;Granulosa cells: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031530 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear bodies" Nucleoplasm "HPA031530: AB_10600818" "unprognostic (2.51e-2)" "unprognostic (7.41e-3)" "unprognostic (3.43e-1)" "unprognostic (3.83e-3)" "unprognostic (1.83e-1)" "unprognostic (7.83e-2)" "unprognostic (7.54e-3)" "unprognostic (1.98e-3)" "unprognostic (1.27e-1)" "unprognostic (2.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (2.48e-1)" "unprognostic (1.68e-1)" "unprognostic (3.82e-2)" "unprognostic (9.87e-2)" 12.5 7.8 6.9 11.6 8.5 27.3 17.5 11.5 7.2 13.1 7.1 9.9 8.1 13.7 8.6 9.7 11.4 8.9 9.9 6.1 7.4 10.8 12.5 10.7 14.4 7.1 7.2 16.7 10.3 14.8 6.3 13.2 7.2 10.7 11.7 12.3 9.5 10.3 8.7 9.7 9.1 13.9 7.2 11.4 11.6 16.5 7.3 20.0 13.3 9.3 15.2 10.5 8.0 9.2 40.5 25.2 26.8 14.9 32.4 42.5 17.1 27.5 27.9 29.4 29.9 17.9 33.2 43.6 25.5 36.1 23.0 25.9 36.2 33.5 42.9 38.7 20.0 52.0 19.6 17.6 23.6 25.9 17.9 32.8 13.4 35.4 33.7 30.1 37.5 28.2 54.0 26.6 30.0 23.8 50.7 14.6 17.5 41.4 19.1 29.9 24.4 24.3 19.1 27.6 20.9 28.9 21.6 5.5 23.8 26.3 31.2 20.7 37.3 26.9 15.9 23.1 25.7 20.8 27.8 51.0 26.4 33.7 26.2 14.2 5.0 8.7 6.7 6.4 10.7 6.6 7.4 9.1 5.2 5.0 9.0 7.9 6.0 9.5 13.8 3.3 6.9 5.8 6.9 8.5 11.5 7.2 6.1 7.4 7.1 7.2 7.2 7.2 7.3 9.2 24.2 25.6 21.5 0.0 6.3 0.0 0.0 0.0 0.0 0.0 16.9 16.4 0.0 0.0 14.9 7.3 0.0 26.4 20.0 0.0 7.9 14.4 0.0 23.8 32.2 9.8 0.0 0.0 0.0 12.2 23.7 10.6 0.0 22.4 5.1 28.5 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 14.7 0.0 0.0 5.2 0.0 0.0 6.9 8.7 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 16.8 9.9 25.0 0.0 0.0 VPS26C "DCRA, DSCR3" ENSG00000157538 "VPS26 endosomal protein sorting factor C" O14972 21 37223420-37267919 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 26.4;Exocrine glandular cells: 28.0;Extravillous trophoblasts: 26.4;Hofbauer cells: 32.7;Pancreatic endocrine cells: 33.2;Proximal tubular cells: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023288 Uncertain Approved Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA023288: AB_1847872" "unprognostic (1.01e-3)" "unprognostic (6.42e-2)" "unprognostic (7.96e-3)" "unprognostic (2.15e-2)" "unprognostic (4.10e-3)" "unprognostic (2.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.40e-1)" "unprognostic (3.15e-1)" "unprognostic (7.76e-2)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "prognostic favorable (8.54e-4)" "unprognostic (1.72e-1)" "unprognostic (3.24e-1)" "unprognostic (5.24e-2)" "unprognostic (3.16e-1)" 19.8 24.5 14.8 18.5 16.1 21.4 15.8 16.8 15.8 16.3 15.9 26.6 28.0 14.8 11.4 21.2 13.8 19.6 24.9 14.4 15.6 32.9 29.5 22.1 22.6 16.1 15.9 17.4 22.6 17.7 8.6 21.4 16.6 14.3 26.0 13.6 16.9 15.8 31.5 15.7 26.9 19.9 16.2 20.2 21.2 7.5 16.5 28.1 18.1 37.8 23.6 21.9 14.2 17.6 31.8 13.8 30.2 26.5 55.4 49.4 34.3 29.9 66.2 26.6 40.2 19.2 32.7 22.0 11.7 70.0 63.9 15.0 32.6 32.1 26.1 52.8 23.5 37.6 13.6 18.7 49.1 27.8 24.3 43.5 31.2 31.0 50.4 48.1 51.4 40.5 24.0 46.8 52.5 14.1 47.2 23.7 34.4 48.7 13.8 44.8 14.5 32.5 32.8 23.7 24.4 32.6 20.6 40.9 65.5 39.0 38.4 22.0 41.0 30.6 10.8 33.2 18.5 71.3 78.0 30.3 48.3 47.9 35.2 58.6 48.6 84.9 50.7 60.5 46.8 37.5 43.1 45.4 47.7 29.4 39.8 41.0 50.1 52.9 55.7 19.4 54.9 54.1 14.8 16.1 16.8 15.8 14.4 15.6 16.1 15.9 16.6 16.2 16.5 17.6 18.1 9.6 21.9 0.0 4.3 0.0 0.0 0.0 0.0 0.0 14.5 13.3 0.0 0.0 6.8 9.2 0.0 16.0 23.8 0.0 21.5 26.4 0.0 12.5 12.7 8.4 0.0 0.0 0.0 28.0 26.4 5.4 0.0 16.1 8.8 19.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 16.5 0.0 0.0 0.0 0.0 33.2 0.0 0.0 3.1 0.0 0.0 29.7 4.4 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 14.6 8.5 10.1 0.0 0.0 VPS35L "C16orf62, MGC16824" ENSG00000103544 "VPS35 endosomal protein sorting factor like" Q7Z3J2 16 19555240-19706793 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 32.4;Cytotrophoblasts: 29.4;Distal tubular cells: 29.4;Hofbauer cells: 44.9;Syncytiotrophoblasts: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042969, HPA053547" Uncertain Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA042969: AB_10794920, HPA053547: AB_2682183" "unprognostic (7.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.17e-1)" "unprognostic (7.20e-2)" "unprognostic (1.51e-1)" "unprognostic (2.67e-1)" "unprognostic (1.15e-1)" "unprognostic (2.74e-1)" "unprognostic (2.52e-1)" "unprognostic (1.22e-3)" "unprognostic (3.57e-2)" "unprognostic (2.06e-1)" "prognostic favorable (1.31e-8)" "unprognostic (1.82e-3)" "unprognostic (8.92e-2)" "unprognostic (5.08e-2)" "unprognostic (1.13e-2)" 19.3 22.7 23.3 15.9 33.5 13.2 17.1 21.8 24.9 21.2 11.7 19.2 13.7 20.1 22.4 16.8 19.2 17.5 17.8 20.7 23.5 22.2 14.4 16.2 14.6 23.3 24.4 23.3 16.5 35.6 20.4 20.2 24.6 15.9 19.4 16.1 12.4 18.9 22.2 13.8 15.3 25.1 20.5 17.2 13.3 31.5 28.0 16.1 22.7 25.2 16.6 18.3 15.6 40.3 22.3 37.5 35.7 28.4 44.2 60.1 5.8 32.5 52.3 33.9 38.9 6.4 37.0 27.1 67.4 51.7 0.2 6.2 27.5 16.7 36.5 1.6 15.7 16.4 32.6 0.6 57.4 25.9 31.6 43.9 24.4 31.7 21.5 48.2 54.4 13.2 22.3 6.2 55.7 15.7 23.0 7.2 24.8 3.9 5.1 19.6 11.7 7.1 38.6 5.2 21.8 22.1 43.7 1.5 18.6 27.2 12.9 22.2 61.0 17.4 16.2 25.7 3.7 23.8 45.2 10.6 33.6 21.1 27.5 26.5 35.3 16.5 18.9 42.0 23.5 14.7 18.0 18.8 42.6 23.5 21.0 18.6 4.2 37.6 37.7 11.5 21.6 28.5 23.3 33.5 21.8 24.9 20.7 23.5 23.3 24.4 24.6 20.5 28.0 40.3 32.4 6.4 16.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 9.5 9.1 0.0 0.0 8.1 16.5 0.0 29.4 5.0 0.0 29.4 20.4 0.0 8.2 15.8 15.5 0.0 0.0 0.0 17.0 19.5 8.1 0.0 11.1 3.8 18.1 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 10.5 0.0 0.0 1.2 0.0 0.0 21.9 2.9 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 40.2 3.4 21.0 0.0 0.0 VXN "C8orf46, MGC33510" ENSG00000169085 Vexin Q8TAG6 8 66493520-66518524 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 123.8" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.1;Proximal tubular cells: 3.4;Syncytiotrophoblasts: 1.0" "Cancer enriched" "Detected in many" 6 "glioma: 16.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.5;GAMG: 5.4;HBF TERT88: 3.9;LHCN-M2: 4.4;T-47d: 5.8;WM-115: 4.5" "Group enriched" "Detected in all" 8 "amygdala: 159.7;basal ganglia: 78.9;cerebral cortex: 298.2;hippocampal formation: 219.3;white matter: 199.5" "Low region specificity" "Detected in all" HPA075134 Approved "Nuclear speckles" NA NA "Cluster 65: Brain - Ion transport" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "HPA075134: AB_2686736" "unprognostic (6.87e-2)" "unprognostic (7.85e-2)" "unprognostic (2.01e-1)" "unprognostic (8.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (7.53e-4)" "unprognostic (7.87e-3)" "unprognostic (1.45e-1)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "unprognostic (1.82e-1)" "unprognostic (6.36e-3)" "unprognostic (3.53e-4)" "unprognostic (1.86e-1)" "unprognostic (4.98e-2)" "unprognostic (2.91e-2)" 0.3 0.5 61.0 0.3 72.1 0.0 0.5 52.0 87.2 0.9 21.7 1.8 0.0 0.7 1.3 0.0 0.5 0.2 0.3 123.8 47.4 0.6 1.4 0.3 0.0 53.1 56.2 0.3 0.6 0.4 0.4 0.0 56.0 1.5 0.3 0.2 0.1 5.4 0.5 0.2 0.5 1.1 53.4 0.1 1.2 0.3 53.7 0.0 0.2 0.0 0.3 0.3 0.4 84.5 2.7 0.1 1.0 1.3 0.1 0.1 0.0 0.2 0.4 1.2 1.3 0.1 4.5 0.0 0.1 2.9 5.4 0.1 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.1 4.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 1.9 0.1 0.2 0.0 0.1 0.1 3.0 0.1 5.8 0.0 0.0 0.4 0.9 0.0 1.9 2.0 1.1 0.0 1.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.0 72.1 52.0 87.2 123.8 47.4 53.1 56.2 56.0 53.4 53.7 84.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.3 0.0 0.0 WASHC1 "FAM39E, FLJ00038, WASH1" ENSG00000181404 "WASH complex subunit 1" A8K0Z3 9 14475-73865 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 60.7;Distal tubular cells: 50.9;Proximal tubular cells: 47.5;Syncytiotrophoblasts: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA002689 Uncertain Supported Vesicles NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA002689: AB_1078803" "unprognostic (9.43e-2)" "unprognostic (1.62e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.33e-2)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (5.00e-1)" "unprognostic (5.40e-3)" "unprognostic (3.37e-3)" "unprognostic (6.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-1)" "unprognostic (3.38e-1)" "unprognostic (2.31e-2)" "unprognostic (1.02e-1)" 15.7 18.1 13.2 7.1 14.2 16.3 17.6 13.2 15.1 24.5 16.5 19.6 10.2 20.3 21.9 19.2 24.1 9.0 17.9 13.3 13.5 25.9 20.9 17.1 13.4 14.4 13.8 23.0 21.9 5.2 21.2 6.6 14.3 27.0 4.7 15.9 17.6 13.5 22.8 26.1 21.9 15.3 13.4 29.0 18.3 24.1 14.5 8.6 22.1 6.8 6.0 19.7 20.5 14.9 13.5 8.5 5.0 10.3 8.5 5.7 12.4 11.7 11.4 6.9 5.5 8.4 8.3 5.7 6.6 4.8 6.2 16.7 7.4 5.7 2.5 5.9 14.4 5.5 7.0 8.6 4.7 11.3 10.0 4.3 4.2 3.5 4.7 17.3 2.1 5.0 12.6 21.0 2.2 4.0 11.6 9.4 9.2 9.1 10.5 7.9 4.3 7.2 5.1 9.8 5.6 14.9 6.8 14.3 8.6 6.2 8.6 10.5 8.0 9.2 6.7 4.0 10.3 9.4 7.9 4.5 8.6 12.0 8.6 1.2 2.5 2.2 1.9 2.7 1.5 1.3 1.5 1.6 2.3 1.2 1.6 1.3 1.4 2.1 4.0 2.1 1.8 1.5 13.2 14.2 13.2 15.1 13.3 13.5 14.4 13.8 14.3 13.4 14.5 14.9 34.5 22.4 22.5 0.0 10.5 0.0 0.0 0.0 0.0 0.0 29.0 28.3 0.0 0.0 7.4 60.7 0.0 37.4 21.5 0.0 50.9 13.7 0.0 24.7 28.6 7.5 0.0 0.0 0.0 15.8 26.1 10.8 0.0 22.9 16.4 27.3 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 13.1 0.0 0.0 6.7 0.0 0.0 47.5 8.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 42.8 11.4 14.3 0.0 0.0 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133509 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Alveolar cells type 2: 28.5;Endometrial ciliated cells: 45.7;Respiratory ciliated cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavorable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 25.3 25.9 19.9 22.1 20.7 37.5 24.0 23.4 24.8 24.7 18.3 28.9 25.2 22.5 19.2 20.2 19.7 18.0 58.6 19.9 19.9 22.9 15.5 26.0 28.8 21.1 21.2 26.7 17.7 23.3 21.5 22.9 21.1 20.6 28.9 19.9 21.9 20.0 22.3 25.7 28.9 21.2 18.6 26.6 21.5 12.5 22.6 24.2 23.3 15.6 26.9 23.8 22.1 23.9 26.1 12.5 21.1 24.3 83.2 46.0 16.9 29.8 64.0 43.7 46.6 28.8 37.8 22.5 18.1 44.8 41.3 28.0 31.2 25.3 43.2 22.2 22.0 15.9 25.6 29.7 58.6 28.0 27.2 47.8 31.2 47.6 30.5 46.2 33.1 19.2 26.6 22.2 53.9 19.1 15.5 48.0 17.1 16.7 58.4 23.1 30.1 13.7 30.5 29.3 7.3 22.4 27.8 25.9 40.9 30.9 31.6 19.2 49.4 22.0 18.5 62.7 25.0 23.4 48.3 19.1 48.9 51.4 9.0 1.0 9.1 9.9 9.1 11.6 10.1 5.1 8.0 8.8 7.3 4.9 7.7 6.0 4.1 8.2 6.9 4.6 9.2 7.9 19.9 20.7 23.4 24.8 19.9 19.9 21.1 21.2 21.1 18.6 22.6 23.9 16.2 38.5 28.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 10.6 11.0 0.0 0.0 22.9 14.7 0.0 7.4 10.0 0.0 0.0 16.7 0.0 45.7 19.9 7.9 0.0 0.0 0.0 15.6 6.9 8.9 0.0 20.3 15.2 13.5 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 15.1 0.0 0.0 2.6 0.0 0.0 11.7 41.5 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 7.7 7.8 9.4 0.0 0.0 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792964 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 35.3;Alveolar cells type 2: 35.2;Collecting duct cells: 23.9;granulocytes: 30.3;Respiratory ciliated cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 19.4 15.7 10.9 17.3 11.8 42.5 17.5 14.8 14.9 19.1 13.5 20.3 15.2 16.8 12.4 13.5 14.9 16.5 22.0 11.3 11.4 18.0 15.9 17.7 20.2 12.5 12.2 21.6 11.6 21.4 13.9 13.7 12.7 15.6 22.0 14.2 15.3 14.6 17.1 17.6 19.7 19.0 9.6 19.3 15.0 12.9 14.1 21.2 17.1 9.8 18.7 17.7 14.6 14.0 24.5 25.9 20.7 23.5 52.1 45.8 12.4 28.4 45.8 32.4 30.8 16.0 23.3 20.1 18.8 41.7 30.8 21.6 23.2 13.0 32.6 18.9 19.2 20.9 32.3 12.3 55.0 21.4 24.6 43.4 30.4 35.4 26.1 31.6 33.7 16.5 33.9 15.7 40.1 12.8 14.0 35.9 14.8 14.7 3.9 17.4 30.5 10.5 23.8 38.2 10.0 22.3 32.8 16.1 39.4 21.0 22.1 20.6 58.1 16.8 18.0 44.7 19.1 21.5 36.3 19.6 23.5 49.4 9.2 14.1 17.1 11.7 12.2 17.9 11.8 9.9 10.1 12.7 11.7 9.2 10.0 8.9 16.8 12.5 22.8 8.1 10.4 13.3 10.9 11.8 14.8 14.9 11.3 11.4 12.5 12.2 12.7 9.6 14.1 14.0 16.2 35.3 35.2 0.0 3.0 0.0 0.0 0.0 0.0 0.0 11.3 8.8 0.0 0.0 11.8 23.9 0.0 6.8 11.8 0.0 3.9 13.5 0.0 11.3 17.9 6.1 0.0 0.0 0.0 14.0 6.4 7.9 0.0 13.9 30.3 13.7 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 10.3 0.0 0.0 0.0 0.0 11.9 0.0 0.0 3.8 0.0 0.0 12.8 24.8 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 7.8 7.0 12.1 0.0 0.0 WASHC3 "CCDC53, CGI-116" ENSG00000120860 "WASH complex subunit 3" Q9Y3C0 12 102012840-102062149 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 125.2;Hofbauer cells: 73.1;Proximal tubular cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038339 Uncertain Approved Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA038339: AB_2675966" "unprognostic (4.25e-2)" "unprognostic (1.61e-2)" "unprognostic (2.28e-1)" "unprognostic (3.45e-3)" "unprognostic (1.21e-2)" "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.63e-2)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "unprognostic (7.81e-2)" "unprognostic (7.41e-2)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" 27.3 32.2 41.3 14.2 41.9 13.2 24.7 42.8 57.2 26.4 38.3 33.7 13.6 27.5 35.7 28.4 18.0 17.7 35.0 42.8 44.9 41.6 41.1 20.6 22.8 44.6 43.9 20.3 17.4 37.8 33.4 20.0 45.2 26.1 20.7 25.3 19.8 34.9 34.5 20.1 20.5 29.3 43.4 22.7 27.3 98.1 43.5 31.2 25.7 42.2 26.2 28.8 23.4 44.2 17.1 23.3 20.1 12.6 75.2 90.9 18.9 23.3 48.0 33.6 37.3 18.8 16.0 18.0 16.4 52.9 34.2 32.1 21.4 57.0 44.5 41.8 12.9 25.3 15.9 29.5 67.0 22.4 13.9 55.9 72.4 42.1 42.2 92.1 46.3 43.5 15.3 19.6 88.4 23.1 23.6 39.9 6.1 32.7 41.0 13.6 30.4 27.2 59.4 27.7 19.6 10.8 32.6 22.9 50.2 36.5 29.1 12.8 25.5 41.5 9.9 24.7 16.3 49.5 32.7 22.7 59.0 15.6 17.8 125.7 41.3 95.3 37.5 66.6 45.4 61.9 56.3 50.7 56.1 49.4 41.2 49.4 18.2 59.9 70.9 54.9 118.5 52.8 41.3 41.9 42.8 57.2 42.8 44.9 44.6 43.9 45.2 43.4 43.5 44.2 55.4 28.9 41.5 0.0 18.5 0.0 0.0 0.0 0.0 0.0 36.4 55.4 0.0 0.0 14.2 33.1 0.0 60.3 28.4 0.0 125.2 47.9 0.0 40.5 49.2 15.0 0.0 0.0 0.0 38.8 48.5 24.8 0.0 27.4 40.4 36.1 0.0 0.0 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 46.5 0.0 0.0 0.0 0.0 35.5 0.0 0.0 5.4 0.0 0.0 98.9 22.6 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 39.4 18.8 60.9 0.0 0.0 WASHC4 "KIAA1033, SWIP" ENSG00000136051 "WASH complex subunit 4" Q2M389 12 105107324-105169130 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 44.1;Endometrial stromal cells: 48.3;Hofbauer cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045666, HPA046737" Uncertain Enhanced Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA045666: AB_2679411, HPA046737: AB_2679778" "unprognostic (2.68e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.85e-2)" "unprognostic (2.76e-1)" "unprognostic (1.10e-1)" "unprognostic (4.41e-1)" "unprognostic (9.79e-3)" "unprognostic (1.32e-2)" "unprognostic (3.14e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (1.49e-2)" "unprognostic (2.96e-1)" "unprognostic (4.61e-2)" "unprognostic (1.87e-1)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" 22.4 21.1 9.4 30.9 13.8 23.8 20.8 13.8 12.2 20.7 11.8 16.1 15.3 20.1 19.9 15.1 13.1 22.6 14.3 9.1 13.8 23.5 29.7 20.2 44.0 17.8 13.0 22.8 18.3 20.4 8.5 30.5 18.4 19.2 18.4 15.4 16.1 15.8 12.2 31.2 18.4 19.8 15.2 32.9 17.9 12.1 14.5 18.0 22.1 14.2 39.5 17.6 12.6 22.1 24.0 28.2 24.6 18.2 56.3 56.6 29.5 36.5 41.5 41.7 38.0 20.2 13.5 53.4 19.8 61.0 26.5 21.9 21.5 22.3 33.5 19.2 15.3 11.1 25.6 16.8 38.4 30.9 20.5 45.7 25.7 37.3 30.4 45.1 68.7 18.1 22.1 18.6 45.9 12.1 17.1 32.6 30.1 16.8 23.5 32.7 32.8 16.6 55.6 27.5 15.4 19.0 37.7 26.4 37.9 31.0 19.6 32.9 84.1 49.8 13.6 32.1 23.9 23.3 23.9 42.7 35.4 26.1 51.4 21.3 15.1 9.2 3.0 18.4 4.4 16.2 4.7 4.1 11.9 12.9 4.9 4.7 16.7 8.0 34.2 5.8 3.5 6.9 9.4 13.8 13.8 12.2 9.1 13.8 17.8 13.0 18.4 15.2 14.5 22.1 37.5 35.3 24.3 0.0 25.3 0.0 0.0 0.0 0.0 0.0 16.4 11.0 0.0 0.0 11.8 44.1 0.0 24.1 17.5 0.0 19.6 25.8 0.0 23.8 48.3 18.0 0.0 0.0 0.0 22.1 28.0 14.6 0.0 31.7 26.5 30.7 0.0 0.0 51.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.0 0.0 26.9 0.0 0.0 0.0 0.0 24.2 0.0 0.0 5.2 0.0 0.0 41.8 17.5 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 32.0 8.9 29.1 0.0 0.0 WASHC5 "KIAA0196, SPG8" ENSG00000164961 "WASH complex subunit 5" Q12768 8 125024260-125091819 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 19.8;Exocrine glandular cells: 17.2;Hofbauer cells: 21.8;Proximal tubular cells: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034216, CAB034219, HPA064649, HPA070916" Supported Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322" "unprognostic (1.98e-3)" "unprognostic (3.75e-2)" "unprognostic (8.40e-2)" "unprognostic (3.89e-3)" "unprognostic (2.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.74e-5)" "unprognostic (2.54e-2)" "unprognostic (3.54e-1)" "unprognostic (5.69e-2)" "unprognostic (9.10e-3)" "unprognostic (1.53e-1)" "unprognostic (9.39e-3)" "unprognostic (5.95e-2)" "unprognostic (2.17e-1)" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" 18.1 18.6 10.5 18.5 16.9 21.3 19.6 14.9 13.2 17.2 16.5 18.5 18.1 16.2 15.7 16.6 13.3 17.8 16.1 11.1 12.5 22.9 18.5 17.1 19.6 14.7 13.7 15.6 13.0 24.8 9.5 21.2 14.6 17.4 20.1 11.4 14.3 16.1 15.9 13.6 14.7 20.2 14.0 19.3 16.1 9.5 13.8 21.8 23.3 18.5 21.0 21.1 10.3 24.7 40.0 45.4 24.9 30.6 55.3 58.8 16.3 42.0 63.6 43.0 45.8 17.0 42.1 36.1 29.1 54.1 25.3 30.6 40.2 37.7 56.8 47.5 23.1 48.1 26.5 22.8 53.8 14.8 46.6 58.7 25.1 35.5 31.2 33.2 49.9 30.9 28.3 35.6 53.0 87.6 44.3 11.8 23.7 66.7 46.7 29.8 22.4 36.7 33.2 48.5 13.1 26.3 48.8 109.2 39.5 25.8 47.3 25.5 44.7 23.6 51.9 39.4 37.7 31.7 31.2 31.7 62.4 27.5 33.4 10.4 17.0 12.5 13.5 20.9 14.3 9.5 12.8 13.9 19.7 10.6 10.1 14.3 5.8 17.2 29.3 7.2 16.9 13.0 10.5 16.9 14.9 13.2 11.1 12.5 14.7 13.7 14.6 14.0 13.8 24.7 10.9 3.2 19.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 14.4 9.3 0.0 0.0 5.0 11.0 0.0 13.4 6.9 0.0 5.9 12.2 0.0 9.9 13.5 4.9 0.0 0.0 0.0 17.2 11.0 5.4 0.0 14.8 8.8 11.1 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 16.2 0.0 0.0 1.9 0.0 0.0 17.2 4.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 12.3 3.8 9.6 0.0 0.0 WDCP "C2orf44, FLJ21945, MMAP" ENSG00000163026 "WD repeat and coiled coil containing" Q9H6R7 2 24029347-24049575 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 9.2;Distal tubular cells: 7.9;Granulosa cells: 4.3;Theca cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041054 Approved Approved Nucleoli,Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoli Cytosol "HPA041054: AB_10796566" "unprognostic (1.07e-1)" "unprognostic (3.19e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.32e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (5.14e-8)" "unprognostic (7.69e-2)" "unprognostic (9.01e-3)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (5.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (7.76e-2)" "unprognostic (3.00e-1)" 2.6 3.7 3.9 3.8 4.1 1.4 4.4 4.7 4.0 3.5 4.6 4.2 2.5 4.2 3.7 3.2 3.2 2.7 3.4 3.8 4.0 3.5 4.1 2.6 6.6 3.9 4.1 5.4 2.6 5.0 2.3 4.2 4.0 3.6 2.9 6.3 2.9 4.5 6.1 2.9 3.3 3.5 3.9 4.2 3.0 4.9 4.3 7.7 3.1 8.7 7.0 3.6 2.7 4.6 12.3 18.8 20.1 14.0 13.6 10.7 7.2 14.6 7.8 15.1 14.1 17.2 5.6 32.0 6.2 7.5 12.6 8.8 28.7 10.0 15.6 19.4 16.4 19.7 8.5 17.8 9.3 18.0 13.0 6.5 7.6 15.6 7.7 7.8 14.3 18.4 27.5 8.7 15.9 5.6 23.8 10.8 24.3 12.2 14.3 25.7 33.8 12.9 7.1 6.1 15.4 21.3 7.2 7.0 9.1 14.0 5.4 7.9 13.9 12.0 13.1 7.2 13.6 14.4 19.2 45.2 7.7 19.0 9.5 0.0 1.8 1.1 5.2 2.7 5.3 3.3 3.3 3.8 3.1 2.9 4.6 5.0 0.4 3.9 2.0 1.1 5.4 3.3 3.9 4.1 4.7 4.0 3.8 4.0 3.9 4.1 4.0 3.9 4.3 4.6 3.1 3.2 3.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.7 2.7 0.0 0.0 0.6 9.2 0.0 2.9 1.8 0.0 7.9 2.3 0.0 1.5 3.2 1.6 0.0 0.0 0.0 2.0 2.5 1.4 0.0 1.0 0.0 4.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 1.4 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.1 1.0 4.5 0.0 0.0 YJU2 "CCDC94, FLJ10374" ENSG00000105248 "YJU2 splicing factor homolog" Q9BW85 19 4247080-4269088 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 29.7;Distal tubular cells: 23.5;Ductal cells: 23.5;Exocrine glandular cells: 32.9;Extravillous trophoblasts: 23.3;Pancreatic endocrine cells: 21.9;Syncytiotrophoblasts: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043606, HPA055675" Approved Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA043606: AB_10963431, HPA055675: AB_2682880" "unprognostic (1.75e-2)" "unprognostic (2.11e-3)" "unprognostic (1.81e-2)" "unprognostic (6.91e-3)" "unprognostic (1.96e-1)" "unprognostic (1.28e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.33e-1)" "unprognostic (7.53e-2)" "unprognostic (1.01e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.32e-4)" "prognostic favorable (8.04e-4)" "unprognostic (7.61e-2)" "unprognostic (3.12e-2)" "unprognostic (9.46e-3)" 15.6 17.0 16.9 11.0 19.1 44.3 16.7 18.9 22.3 14.9 14.3 16.2 13.3 18.5 7.6 20.1 15.4 7.3 16.3 16.8 16.6 19.1 20.4 12.5 15.2 20.0 17.6 18.4 23.8 11.8 11.3 10.0 18.2 17.6 7.6 8.0 16.3 8.7 23.4 23.5 17.8 7.1 17.1 20.4 19.4 15.4 18.0 12.6 17.4 13.9 10.7 16.4 14.7 21.4 30.7 29.1 16.0 12.9 9.3 12.3 16.3 12.2 15.3 22.2 24.4 26.2 18.3 35.5 13.5 18.3 19.1 22.8 26.1 28.8 15.4 20.6 25.8 22.9 19.4 31.0 13.7 30.1 30.6 13.1 17.0 19.6 28.8 13.5 18.2 16.9 33.0 40.1 9.3 42.2 31.9 18.7 38.3 13.9 22.0 18.4 13.5 31.6 21.1 29.7 22.9 23.9 10.8 23.3 21.8 9.2 16.8 27.9 20.5 15.7 16.4 31.8 30.5 43.2 33.0 35.2 21.9 31.6 17.1 21.3 19.6 31.0 25.7 25.5 23.2 31.0 24.6 23.8 24.0 33.1 29.0 24.2 12.1 23.4 19.3 25.0 33.4 18.9 16.9 19.1 18.9 22.3 16.8 16.6 20.0 17.6 18.2 17.1 18.0 21.4 11.2 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 9.4 9.0 0.0 0.0 0.0 9.2 0.0 29.7 10.1 0.0 23.5 23.5 0.0 7.6 7.7 7.0 0.0 0.0 0.0 32.9 23.3 4.4 0.0 11.6 0.0 10.4 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 18.6 0.0 0.0 0.0 0.0 21.9 0.0 0.0 1.7 0.0 0.0 19.6 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 45.7 4.7 11.9 0.0 0.0 YME1L1 YME1L ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110111-27155266 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nuclear bodies" "HPA066953: AB_2685753" "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 48.8 52.6 17.7 51.7 18.4 95.1 47.5 23.3 21.7 52.4 36.4 52.2 46.0 50.3 53.3 59.1 43.7 46.0 61.4 17.8 22.7 54.0 65.5 39.8 56.6 18.2 22.1 50.8 52.0 54.5 33.3 61.1 19.9 48.4 52.4 42.0 44.7 44.5 111.4 40.1 46.3 49.2 16.6 46.4 48.8 51.2 19.7 65.9 62.2 97.7 62.5 56.8 35.0 24.4 146.6 105.3 125.5 62.0 118.3 123.9 100.7 143.3 79.7 139.7 157.6 143.3 171.9 152.1 90.8 154.8 100.5 135.6 152.8 122.6 152.9 143.4 89.0 144.4 91.0 98.3 124.6 100.4 114.5 104.7 143.3 123.4 121.6 122.5 146.7 138.8 173.8 150.5 154.4 95.1 189.1 53.7 97.4 119.3 49.4 160.4 199.7 143.0 107.7 68.2 95.6 121.9 138.4 105.2 138.9 102.8 101.5 115.1 146.9 83.4 117.3 140.8 126.7 75.1 121.9 196.1 119.4 178.8 65.8 195.0 146.4 165.4 147.5 128.5 149.4 143.0 142.4 138.8 121.9 149.7 129.3 136.8 204.0 135.6 143.1 222.6 156.7 155.5 17.7 18.4 23.3 21.7 17.8 22.7 18.2 22.1 19.9 16.6 19.7 24.4 105.4 67.3 81.8 40.5 108.3 70.1 96.7 55.6 92.2 53.1 76.8 90.9 103.6 32.9 66.4 29.5 83.4 61.2 121.0 179.4 15.6 52.2 62.3 141.4 152.5 86.1 50.3 63.1 67.0 48.6 74.4 101.1 136.6 224.3 110.8 75.0 58.5 70.0 73.2 50.5 68.1 121.2 32.6 98.9 133.2 27.0 57.8 125.4 56.9 41.2 63.7 63.8 47.4 66.9 75.2 66.8 109.3 43.2 93.8 83.7 156.5 47.3 70.1 65.7 72.3 156.6 94.5 143.4 57.4 92.5 64.9 94.8 122.1 102.2 104.4 75.0 YTHDF1 "C20orf21, FLJ20391" ENSG00000149658 "YTH N6-methyladenosine RNA binding protein 1" Q9BYJ9 20 63195429-63216139 "Predicted intracellular proteins" Immunity RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 244.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "prognostic unfavorable (7.96e-4)" "unprognostic (2.52e-2)" "unprognostic (1.30e-1)" "unprognostic (3.47e-2)" "unprognostic (1.40e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.65e-5)" "unprognostic (6.34e-2)" "unprognostic (1.98e-1)" "unprognostic (2.14e-1)" "unprognostic (1.75e-2)" "unprognostic (1.68e-1)" "unprognostic (1.13e-1)" "unprognostic (4.09e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (9.60e-4)" "unprognostic (3.37e-2)" 22.1 21.7 28.7 17.2 28.2 41.1 19.7 28.4 31.1 19.0 25.3 20.2 18.6 20.9 24.9 19.9 20.4 18.9 20.8 27.7 29.0 22.3 31.0 23.6 24.5 31.5 29.6 19.6 25.7 26.6 28.5 23.9 28.2 20.0 17.7 18.9 24.1 17.5 46.5 25.1 21.3 18.9 28.7 24.3 23.2 18.4 29.2 24.9 26.3 35.5 22.4 21.0 17.4 29.4 46.0 54.6 43.8 48.3 42.1 30.5 106.5 32.6 36.4 99.3 43.0 244.5 51.8 45.7 66.7 36.0 48.7 55.4 54.6 68.3 70.7 20.8 33.7 56.7 48.5 87.4 52.6 53.2 65.2 38.6 80.3 41.0 45.1 32.4 41.2 36.5 70.8 45.8 33.6 60.2 78.1 66.6 53.4 78.2 54.9 59.1 70.3 51.5 38.8 55.8 59.7 36.1 67.7 131.1 66.3 71.3 63.8 69.5 38.4 91.4 99.4 43.9 50.7 53.8 40.6 55.6 45.9 53.8 42.2 0.0 1.9 3.2 3.1 1.8 3.6 2.9 3.1 2.0 2.3 2.3 3.4 2.5 2.0 2.6 1.8 3.1 3.2 1.1 28.7 28.2 28.4 31.1 27.7 29.0 31.5 29.6 28.2 28.7 29.2 29.4 24.4 19.2 24.8 14.7 15.5 34.3 16.1 11.0 13.6 19.6 28.9 21.7 15.3 14.3 13.2 20.2 8.4 15.9 26.4 15.3 7.9 15.5 3.2 15.8 19.9 22.7 29.2 12.0 15.5 17.3 26.1 17.1 15.8 18.4 12.0 19.9 20.7 31.9 33.6 28.6 17.7 17.8 4.1 26.1 19.4 3.6 17.4 17.3 12.4 12.2 13.8 25.1 14.4 20.1 22.5 37.6 10.3 17.7 23.5 27.8 12.8 16.5 12.7 21.0 6.6 24.1 17.8 37.8 33.4 15.8 41.8 16.0 16.8 18.5 19.3 25.1 ZBTB7A "DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A" ENSG00000178951 "Zinc finger and BTB domain containing 7A" O95365 19 4043303-4066899 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037214, CAB037285, HPA046387" Supported Approved Nucleoplasm NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 47: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB037214: AB_609875, CAB037285: AB_609874, HPA046387: AB_2679648" "unprognostic (8.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.02e-1)" "prognostic favorable (6.50e-6)" "unprognostic (7.54e-2)" "unprognostic (3.65e-3)" "unprognostic (3.71e-2)" "unprognostic (1.12e-1)" "unprognostic (1.56e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (3.75e-1)" "prognostic favorable (1.34e-6)" "prognostic favorable (1.79e-4)" "unprognostic (2.01e-1)" "unprognostic (4.25e-1)" "unprognostic (1.36e-2)" 15.2 13.2 23.0 8.7 23.1 12.8 12.9 12.0 58.3 16.6 1.7 22.5 16.3 20.0 3.3 39.1 15.4 5.8 14.0 29.4 13.7 9.8 15.0 13.7 6.6 19.8 13.7 12.0 9.5 8.9 13.4 4.9 19.0 13.5 6.4 8.1 16.2 7.3 33.7 25.9 17.5 4.8 6.8 13.3 18.9 4.4 25.0 5.7 12.7 10.4 5.6 18.9 21.2 28.1 26.5 13.5 2.1 7.5 16.5 17.2 9.3 19.2 11.0 5.0 5.2 4.9 10.7 12.4 12.4 13.7 6.9 23.1 2.7 8.9 4.3 23.4 13.2 7.1 10.2 6.3 11.7 10.1 25.2 9.5 14.5 6.9 7.1 10.6 5.7 5.5 14.4 10.2 5.7 18.3 13.1 7.6 5.5 11.8 16.9 9.8 6.3 12.4 8.0 11.7 9.8 7.4 11.6 24.8 11.5 1.8 13.9 17.9 18.0 19.2 9.3 26.6 24.4 23.6 10.6 6.9 24.7 10.3 12.3 0.7 0.9 0.3 0.7 1.1 0.5 1.1 0.3 0.5 0.2 0.6 0.3 0.6 1.5 1.2 1.0 0.7 0.3 0.2 23.0 23.1 12.0 58.3 29.4 13.7 19.8 13.7 19.0 6.8 25.0 28.1 76.3 41.7 32.8 27.4 73.1 88.5 69.7 26.5 175.2 104.7 73.5 57.4 26.6 104.4 27.7 42.3 54.2 22.6 93.7 185.8 27.4 20.9 5.5 66.4 63.8 64.5 47.9 118.0 39.0 20.2 10.7 54.1 77.5 67.6 26.6 21.6 72.8 67.9 23.6 159.9 35.5 115.6 8.2 72.9 80.7 7.7 44.1 74.3 37.4 25.3 52.1 32.7 76.2 17.6 34.2 33.1 98.0 49.2 71.6 83.6 68.0 19.9 31.0 72.8 32.9 80.0 60.2 3.8 1.8 181.1 113.9 53.8 74.9 36.5 136.3 113.0 ZC3H11B ZC3HDC11B ENSG00000215817 "Zinc finger CCCH-type containing 11B" A0A1B0GTU1 1 219608010-219613145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 5.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.3;Cardiomyocytes: 1.5;Collecting duct cells: 1.8;monocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026439, HPA028490, HPA028526" Uncertain Approved "Nuclear speckles" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533" "unprognostic (1.75e-1)" "unprognostic (5.54e-2)" "unprognostic (2.21e-1)" "unprognostic (2.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.92e-1)" "unprognostic (5.07e-1)" "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.30e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-2)" "unprognostic (7.87e-2)" "unprognostic (9.15e-2)" "unprognostic (2.56e-2)" "unprognostic (1.87e-2)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.3 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.3 0.4 0.2 0.1 0.0 0.2 0.2 5.1 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.4 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.1 0.3 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.3 1.5 0.0 0.0 1.8 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.6 0.8 0.3 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 ZC3H12A "FLJ23231, MCPIP1, Regnase-1" ENSG00000163874 "Zinc finger CCCH-type containing 12A" Q5D1E8 1 37474580-37484377 "Disease related genes, Predicted intracellular proteins" "Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 136.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 300.7;Basal squamous epithelial cells: 242.4;Langerhans cells: 232.8;Squamous epithelial cells: 217.6;Suprabasal keratinocytes: 225.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 48.8;RT4: 61.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA032052, HPA032053" Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" No No "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 15: RT4 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "Cytoplasmic bodies" Nucleoplasm "HPA032052: AB_10603241, HPA032053: AB_2674128" "unprognostic (2.35e-2)" "unprognostic (6.09e-3)" "unprognostic (1.51e-2)" "prognostic favorable (9.67e-4)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (9.03e-2)" "unprognostic (4.66e-3)" "unprognostic (1.05e-1)" "unprognostic (9.69e-3)" "unprognostic (9.01e-2)" "unprognostic (1.82e-2)" "prognostic unfavorable (5.95e-5)" "unprognostic (5.17e-2)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.77e-2)" 28.9 28.0 2.4 17.3 2.3 136.3 15.1 3.6 4.1 9.1 2.7 16.3 14.1 6.6 4.6 45.4 14.3 36.0 12.1 2.5 3.8 15.7 23.3 40.0 13.6 4.1 3.7 6.0 12.4 2.5 9.2 3.7 4.1 29.5 7.9 0.3 22.9 5.2 10.8 51.5 20.1 5.7 3.0 15.5 23.5 5.2 3.7 5.7 6.5 3.2 15.5 39.0 21.4 2.8 7.8 5.5 0.6 3.5 2.7 4.0 6.2 5.5 48.8 3.5 4.5 6.1 17.2 8.7 22.8 5.3 37.8 16.8 2.2 35.4 2.0 17.8 3.2 2.3 20.9 9.7 3.9 4.6 3.5 8.6 17.8 30.0 5.3 7.9 3.9 4.4 4.3 14.1 3.1 9.4 3.5 8.3 4.2 10.4 4.8 5.2 2.2 5.1 8.8 61.2 1.6 1.1 11.0 17.4 1.3 5.3 6.0 5.1 4.1 10.3 5.7 7.7 8.5 11.2 4.5 6.6 23.5 9.7 2.0 1.2 1.4 4.0 3.1 1.4 3.3 3.1 1.3 1.9 1.7 3.9 0.7 1.5 5.6 3.5 1.2 1.5 2.0 1.7 2.4 2.3 3.6 4.1 2.5 3.8 4.1 3.7 4.1 3.0 3.7 2.8 19.1 16.0 36.2 1.6 56.9 195.9 149.8 300.7 242.4 0.4 93.6 69.8 4.2 61.5 117.6 11.0 0.0 3.7 78.1 71.5 0.0 79.5 16.9 67.6 20.8 32.2 63.9 0.4 0.1 73.9 10.0 41.0 66.3 102.2 42.6 5.0 5.3 11.4 9.7 0.0 0.1 77.3 69.2 10.5 232.8 2.7 0.9 71.2 48.0 1.0 14.0 0.9 9.2 0.5 0.9 55.4 73.2 1.2 52.1 127.9 59.5 0.6 58.4 4.5 6.6 52.7 36.1 1.6 1.3 217.6 225.2 11.8 76.6 9.5 62.2 81.9 ZC3H4 "C19orf7, KIAA1064" ENSG00000130749 "Zinc finger CCCH-type containing 4" Q9UPT8 19 47064187-47113776 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040934, HPA041068" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA040934: AB_10795495, HPA041068: AB_10796567" "unprognostic (8.02e-3)" "unprognostic (3.68e-3)" "unprognostic (3.11e-2)" "unprognostic (1.91e-1)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (9.37e-2)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (2.93e-1)" "unprognostic (1.68e-2)" "unprognostic (1.53e-1)" "unprognostic (9.14e-2)" "unprognostic (3.00e-3)" "unprognostic (1.19e-1)" "unprognostic (5.90e-2)" "prognostic favorable (2.23e-4)" 8.0 7.7 11.6 8.3 11.6 5.6 8.1 11.9 9.8 9.7 3.3 10.3 6.7 11.5 3.2 11.5 9.1 3.7 8.7 9.6 8.3 8.4 10.4 6.9 9.0 11.5 11.1 10.6 10.8 4.8 9.8 3.8 9.7 9.1 4.0 5.2 8.3 4.7 10.5 10.4 10.3 4.7 9.3 12.5 9.0 11.2 11.2 9.6 9.4 5.3 6.3 9.6 8.8 11.0 14.4 22.2 13.5 19.3 7.4 4.6 13.7 11.3 6.4 10.4 7.0 15.9 15.8 30.3 8.2 7.7 6.4 24.5 5.9 16.1 6.6 18.8 9.6 21.6 13.9 12.2 6.4 20.7 22.1 7.8 4.4 9.6 7.6 5.6 8.6 18.4 21.2 11.2 6.9 25.2 23.6 34.9 20.1 9.7 7.4 36.5 11.6 13.7 8.0 23.2 16.4 23.1 17.3 14.3 8.6 6.5 15.0 16.6 15.2 14.1 13.7 9.1 16.1 14.5 12.7 26.4 11.0 16.6 20.5 2.6 0.9 1.5 2.2 1.6 2.3 2.1 1.9 2.3 1.2 1.9 1.7 1.9 2.7 2.3 1.6 3.0 1.3 0.6 11.6 11.6 11.9 9.8 9.6 8.3 11.5 11.1 9.7 9.3 11.2 11.0 19.4 3.2 13.1 10.7 16.6 22.3 6.2 8.4 6.8 23.8 18.0 10.0 12.8 28.6 11.7 20.2 14.6 6.6 14.7 20.0 9.8 10.8 18.0 13.0 16.0 14.7 19.2 20.0 8.8 11.6 7.4 12.7 9.7 18.2 12.6 17.5 19.2 16.5 12.9 16.8 9.9 18.4 8.2 28.3 20.0 6.8 16.8 18.9 7.2 13.1 23.3 14.3 17.5 12.5 17.6 10.9 14.6 9.8 8.2 9.7 15.1 11.5 12.6 23.8 6.6 16.0 13.8 15.6 9.8 14.7 22.4 8.6 16.1 9.8 17.1 7.5 ZCCHC3 "C20orf99, dJ1103G7.7" ENSG00000247315 "Zinc finger CCHC-type containing 3" Q9NUD5 20 297570-300321 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042972 Approved Vesicles NA NA "Cluster 10: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA042972: AB_10959663" "unprognostic (5.98e-3)" "unprognostic (1.38e-1)" "unprognostic (1.26e-2)" "unprognostic (1.01e-3)" "unprognostic (2.13e-1)" "unprognostic (3.04e-1)" "unprognostic (1.30e-2)" "unprognostic (1.90e-1)" "unprognostic (3.29e-1)" "unprognostic (6.55e-2)" "prognostic favorable (1.29e-4)" "unprognostic (4.30e-1)" "unprognostic (3.34e-3)" "unprognostic (6.33e-2)" "unprognostic (1.88e-1)" "unprognostic (3.67e-1)" "unprognostic (1.74e-2)" 9.9 11.3 14.5 11.7 14.1 17.8 8.4 15.8 16.8 10.8 15.9 8.9 9.8 11.2 12.5 6.8 13.0 8.3 9.8 13.5 19.5 10.9 10.0 8.6 17.7 14.8 15.7 18.2 10.8 11.7 10.9 20.1 15.1 9.2 7.5 8.5 8.8 10.7 9.8 6.1 11.4 8.1 13.2 15.4 10.3 9.6 17.7 23.1 8.9 12.6 15.7 9.8 6.3 14.2 24.0 18.4 56.7 28.4 18.3 18.6 33.6 14.7 16.2 16.2 16.7 28.4 14.0 21.8 9.6 9.5 16.7 32.6 29.2 16.5 15.3 11.8 26.8 44.1 9.3 90.0 21.2 50.9 11.7 18.2 19.2 9.9 11.7 16.8 26.2 24.4 55.7 21.5 12.7 10.6 38.8 62.1 50.7 23.3 19.6 56.5 27.1 27.7 14.4 15.2 23.5 34.7 17.5 34.9 46.8 24.2 16.0 93.8 11.4 16.6 16.3 6.8 17.8 39.1 53.9 42.3 6.0 32.4 16.3 2.5 1.2 2.2 1.6 0.7 1.5 1.7 1.4 1.3 0.9 2.1 1.6 1.6 0.4 1.1 0.5 2.1 1.4 0.8 14.5 14.1 15.8 16.8 13.5 19.5 14.8 15.7 15.1 13.2 17.7 14.2 17.3 0.0 9.1 8.8 12.6 15.8 22.7 3.5 11.4 26.9 16.1 12.8 7.6 17.2 4.9 9.2 8.4 22.4 22.3 13.0 3.9 5.9 0.7 22.6 28.0 16.4 21.0 17.9 6.8 5.4 13.4 14.5 8.2 14.9 0.0 16.1 19.2 10.2 11.0 37.0 8.0 16.2 4.1 9.8 9.7 2.1 17.4 11.5 12.4 8.4 11.0 19.6 8.2 7.1 12.3 5.2 10.3 10.5 8.9 16.3 12.2 6.8 8.9 22.1 6.6 14.2 12.3 5.8 7.6 7.2 5.7 20.7 11.1 21.2 13.3 16.0 ZFPM1 "FOG, FOG1, ZC2HC11A, ZNF89A" ENSG00000179588 "Zinc finger protein, FOG family member 1" Q8IX07 16 88453280-88537031 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 35.3;Muller glia cells: 58.0;Theca cells: 37.4" "Cancer enhanced" "Detected in all" "stomach cancer: 12.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 19.3;K-562: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046603 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Vesicles, Cytosol" "HPA046603: AB_2679718" "unprognostic (1.29e-1)" "unprognostic (2.42e-1)" "unprognostic (3.08e-2)" "unprognostic (3.32e-2)" "unprognostic (1.13e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-1)" "unprognostic (7.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (5.58e-2)" "unprognostic (3.05e-2)" "unprognostic (2.49e-4)" "unprognostic (1.99e-2)" "unprognostic (3.32e-1)" "unprognostic (4.89e-2)" "prognostic favorable (4.24e-4)" 2.1 2.5 4.8 1.9 2.4 9.2 1.9 5.7 5.8 2.3 4.2 1.7 12.4 2.2 1.0 1.8 4.0 1.5 4.8 5.8 2.1 3.7 8.6 2.1 2.7 3.5 3.2 2.2 10.4 1.4 5.6 0.8 2.6 3.2 0.8 0.7 2.8 1.3 1.6 3.7 6.8 0.2 1.6 4.9 13.7 5.7 3.3 1.5 4.0 0.3 1.2 2.3 2.0 1.6 1.4 3.8 2.8 5.9 0.5 0.1 11.9 4.0 0.5 1.3 0.4 12.1 1.5 5.9 3.0 0.6 1.4 9.5 0.1 3.3 0.3 4.6 2.5 19.3 8.1 10.7 2.1 1.1 6.2 1.3 2.1 1.4 0.5 1.4 1.3 1.6 29.2 0.4 1.0 7.3 6.9 7.0 1.9 9.3 3.2 2.0 1.3 2.9 1.3 4.8 7.7 12.8 4.9 0.3 3.9 1.4 3.1 3.1 4.8 4.9 3.1 2.2 0.8 1.4 1.0 0.5 1.4 2.3 4.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.8 2.4 5.7 5.8 5.8 2.1 3.5 3.2 2.6 1.6 3.3 1.6 16.7 3.2 2.2 12.4 4.8 0.9 6.1 0.7 0.0 20.7 13.5 25.8 17.2 5.7 0.4 1.8 29.2 0.4 27.5 10.8 1.9 1.3 0.7 24.1 23.7 6.3 6.0 4.8 6.8 5.1 0.2 10.9 14.3 20.1 0.0 16.0 5.0 8.8 0.9 35.3 8.0 6.7 0.0 5.3 1.2 1.1 0.9 7.5 1.8 8.4 1.6 58.0 2.1 5.5 13.4 2.9 6.2 1.5 9.5 1.4 1.3 1.3 0.4 23.9 0.0 16.1 12.4 0.7 1.0 1.9 1.4 0.3 9.6 37.4 5.2 2.1 ZMYM5 "MYM, ZNF198L1, ZNF237" ENSG00000132950 "Zinc finger MYM-type containing 5" Q9UJ78 13 19823482-19863649 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015544, HPA020879" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Golgi apparatus" "HPA015544: , HPA020879: AB_2670524" "unprognostic (4.14e-1)" "unprognostic (3.05e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (9.35e-2)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.31e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 7.0 7.8 2.6 7.1 3.6 12.2 7.9 3.5 3.4 6.7 3.9 5.9 6.2 7.6 8.6 7.6 5.4 9.2 5.4 2.2 2.9 6.6 6.9 6.7 10.3 3.9 3.2 6.7 5.4 5.5 4.8 7.1 3.5 8.2 6.2 9.0 5.7 5.5 6.2 7.8 6.6 6.9 2.9 7.5 7.3 23.4 3.3 10.1 8.6 7.7 8.9 7.2 5.8 5.0 8.5 4.4 9.6 7.7 6.5 10.3 3.6 7.8 12.2 12.5 10.3 10.6 16.5 11.8 8.4 11.2 15.5 7.9 7.1 9.3 14.0 9.5 5.7 22.1 7.9 7.4 21.0 15.9 11.4 12.5 11.0 6.8 12.7 12.8 12.7 7.6 9.0 10.0 12.0 21.4 11.9 16.4 5.2 11.0 6.4 13.2 12.3 4.6 10.5 9.4 9.0 8.2 10.1 8.2 27.4 10.2 12.7 13.7 10.6 6.8 5.1 9.2 5.8 15.9 7.7 17.6 6.8 6.9 11.2 16.1 5.4 8.6 8.7 5.2 9.3 9.9 9.9 8.5 5.7 8.6 7.7 8.2 10.7 8.0 7.4 7.8 8.9 4.2 2.6 3.6 3.5 3.4 2.2 2.9 3.9 3.2 3.5 2.9 3.3 5.0 34.1 28.9 17.3 33.0 35.7 24.3 20.8 20.3 43.9 29.7 27.4 26.8 16.2 22.8 18.9 11.0 18.8 17.9 32.4 10.7 7.9 15.5 16.0 24.0 24.0 21.3 27.6 22.3 36.2 10.5 9.6 24.4 19.9 25.4 33.6 19.6 15.0 7.9 11.4 28.6 35.8 11.9 24.4 12.9 24.0 20.8 22.7 23.9 21.4 26.2 17.0 15.2 16.5 30.7 52.9 14.2 16.9 18.4 20.7 16.8 10.7 11.2 10.4 30.3 32.9 27.2 24.7 92.7 51.1 56.5 21.7 8.3 38.3 15.5 11.4 32.9 ZNF184 ENSG00000096654 "Zinc finger protein 184" Q99676 6 27450743-27473118 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003226, HPA064793" Uncertain Supported Nucleoplasm NA NA "Cluster 13: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA003226: AB_2218705, HPA064793: AB_2732722" "unprognostic (8.86e-2)" "unprognostic (5.55e-2)" "unprognostic (2.27e-3)" "unprognostic (1.70e-1)" "unprognostic (4.99e-3)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (1.74e-2)" "unprognostic (1.17e-2)" "prognostic favorable (4.41e-5)" "unprognostic (2.59e-1)" "unprognostic (5.64e-2)" "unprognostic (2.77e-2)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.31e-2)" "unprognostic (5.79e-3)" 2.8 3.1 2.4 4.3 4.6 8.8 5.4 1.2 8.4 6.1 0.0 4.4 3.4 5.4 4.1 3.8 4.5 4.0 2.8 6.4 0.6 7.0 3.6 4.1 6.3 0.4 0.3 6.0 2.7 5.9 4.1 3.0 0.3 4.3 4.5 4.4 3.5 4.3 2.9 5.7 3.6 4.3 0.6 4.6 4.4 8.3 0.3 10.2 5.6 5.0 6.6 4.5 2.9 2.7 6.4 2.0 10.8 19.7 7.6 5.6 3.6 6.2 8.3 7.1 10.9 3.6 3.7 11.7 10.3 4.0 4.8 3.9 9.7 4.0 10.3 11.4 6.0 14.0 7.3 5.1 4.0 16.9 9.7 4.1 6.0 5.2 5.4 8.4 7.8 17.8 10.9 21.1 11.9 3.2 27.3 14.3 6.3 3.5 4.5 35.4 15.2 17.5 4.9 5.9 18.4 8.9 7.0 6.0 9.2 5.3 7.0 14.4 5.3 10.8 7.1 4.9 7.2 9.6 17.4 21.8 2.4 19.4 10.9 2.1 2.7 8.0 7.9 3.7 10.9 7.4 8.3 7.7 4.1 6.9 6.3 7.9 1.4 7.0 2.9 2.5 10.4 3.9 2.4 4.6 1.2 8.4 6.4 0.6 0.4 0.3 0.3 0.6 0.3 2.7 5.4 6.4 8.1 2.0 9.8 4.1 3.8 2.5 6.8 2.5 5.1 5.5 3.5 2.8 6.4 1.8 2.1 4.3 17.5 2.1 7.9 2.7 36.9 7.9 3.7 5.1 7.1 3.4 10.3 3.0 3.0 4.5 2.0 5.0 5.1 7.4 3.9 1.5 2.8 10.1 3.4 5.1 2.0 3.8 3.8 12.6 3.4 3.6 1.8 5.6 3.0 3.3 9.2 4.0 4.2 2.5 2.1 3.8 6.5 4.6 1.6 4.5 6.3 4.8 0.0 5.2 6.8 12.8 5.9 4.3 4.4 2.9 12.5 4.6 4.4 4.5 ZNF250 "MGC9718, ZFP647, ZNF647" ENSG00000196150 "Zinc finger protein 250" P15622 8 144876497-144902168 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020853 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" Cytosol "HPA020853: AB_1859152" "unprognostic (1.16e-3)" "unprognostic (9.56e-2)" "unprognostic (2.63e-1)" "unprognostic (2.60e-3)" "unprognostic (1.03e-1)" "unprognostic (5.95e-3)" "unprognostic (3.73e-3)" "unprognostic (2.72e-2)" "unprognostic (6.27e-2)" "unprognostic (7.37e-2)" "unprognostic (4.94e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.43e-7)" "unprognostic (2.23e-1)" "unprognostic (6.79e-2)" "unprognostic (5.82e-2)" "prognostic favorable (8.26e-4)" 4.7 3.9 3.2 3.3 3.2 2.9 5.6 10.5 4.7 9.7 2.3 6.9 4.8 7.4 2.8 6.4 7.6 3.3 4.9 2.4 4.5 7.6 4.0 5.1 3.0 3.0 3.2 9.7 4.9 6.0 7.3 5.5 3.3 7.5 3.6 7.9 6.0 5.2 4.8 10.9 5.2 4.2 1.5 5.5 4.9 4.5 3.3 4.5 10.0 5.8 3.3 6.3 8.6 3.4 5.1 2.9 13.4 11.1 6.8 5.9 4.3 5.6 6.4 9.4 7.7 2.4 3.9 12.0 9.8 6.5 3.8 6.6 5.3 4.8 6.0 3.8 7.8 10.8 14.9 3.5 2.0 1.8 3.6 3.9 6.5 5.6 4.5 7.2 3.9 7.1 8.6 11.5 7.9 6.8 12.6 4.1 4.0 6.0 12.5 14.4 5.9 5.0 7.8 3.7 13.2 10.1 11.8 4.4 5.3 5.3 6.3 6.1 5.1 9.2 8.8 7.3 5.3 5.6 5.1 8.0 4.7 6.2 4.1 3.2 5.1 5.8 10.5 2.7 8.1 10.3 7.7 5.8 6.6 9.7 8.9 7.3 2.9 6.0 3.7 2.6 11.7 4.5 3.2 3.2 10.5 4.7 2.4 4.5 3.0 3.2 3.3 1.5 3.3 3.4 5.8 12.8 3.0 10.7 10.7 5.5 3.2 7.5 10.2 8.4 4.3 6.6 4.3 1.5 3.9 5.5 0.0 2.3 18.6 2.4 3.9 7.5 7.4 5.1 6.0 5.5 4.2 1.7 11.9 1.9 1.3 5.2 2.6 4.9 2.5 6.3 5.0 2.1 1.7 8.4 17.5 1.9 12.2 2.2 8.0 3.0 4.1 3.0 5.4 4.7 2.0 3.3 5.2 11.1 7.8 2.6 1.0 5.3 8.2 3.3 3.7 3.4 5.0 9.9 13.1 4.1 6.1 14.3 8.7 4.4 5.5 1.9 10.9 4.9 3.4 2.3 ZNF331 "RITA, ZNF361, ZNF463" ENSG00000130844 "Zinc finger protein 331" Q9NQX6 19 53519527-53580269 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 284.5;dendritic cells: 298.4;granulocytes: 241.9;Langerhans cells: 245.5;Macrophages: 241.4;T-cells: 303.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 79.7;RT4: 63.4" "Low region specificity" "Detected in all" HPA063157 Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA063157: AB_2684951" "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (5.18e-2)" "unprognostic (1.55e-2)" "unprognostic (4.24e-1)" "unprognostic (8.16e-2)" "unprognostic (7.62e-3)" "unprognostic (3.25e-2)" "unprognostic (1.84e-2)" "unprognostic (4.40e-2)" "unprognostic (5.68e-3)" "unprognostic (2.69e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (6.74e-2)" 52.6 124.7 14.3 18.5 13.5 46.3 19.2 55.9 25.1 22.6 23.6 14.8 4.8 20.2 10.7 7.5 46.6 22.6 39.0 13.7 21.2 13.7 12.3 43.4 10.3 24.1 23.0 119.4 21.0 17.0 74.7 54.5 17.8 24.3 8.4 41.2 11.0 22.4 18.8 14.4 10.8 14.2 11.6 10.6 15.3 20.0 22.6 12.2 16.6 9.3 8.7 28.8 16.5 14.7 0.2 11.3 22.5 26.0 15.0 10.7 38.3 16.2 13.7 12.0 21.4 11.8 5.7 7.9 4.2 9.4 5.4 6.6 16.4 12.1 21.4 0.1 79.7 11.8 18.8 7.5 10.9 6.8 15.4 12.4 6.9 13.2 4.8 6.2 5.6 13.9 0.5 3.0 11.4 7.6 16.5 15.1 9.5 0.2 15.5 20.2 13.5 9.6 5.9 63.4 14.3 15.7 7.1 18.8 4.5 43.2 4.1 6.7 5.6 17.0 15.1 10.0 11.1 37.7 28.2 17.8 0.2 1.0 13.9 0.8 5.7 8.2 9.6 4.7 15.2 8.9 10.5 9.7 4.3 10.3 15.6 10.2 0.7 6.1 9.8 4.8 11.7 5.9 14.3 13.5 55.9 25.1 13.7 21.2 24.1 23.0 17.8 11.6 22.6 14.7 37.4 19.2 56.2 13.1 284.5 44.7 21.1 10.9 95.6 56.2 28.6 44.7 20.5 35.8 15.2 77.3 29.2 38.2 298.4 1.6 9.8 4.0 125.7 51.0 18.9 36.8 23.4 7.4 36.3 4.0 33.7 96.7 52.5 79.3 241.9 14.5 13.6 3.8 62.1 30.3 39.9 4.8 14.2 46.8 245.5 84.8 24.2 241.4 46.2 15.0 5.9 33.8 11.3 17.6 24.9 2.4 2.7 19.5 141.7 15.9 3.9 4.4 12.4 38.3 0.0 44.0 151.4 39.2 23.5 15.8 50.6 44.5 303.9 14.0 5.2 12.3 ZNF34 KOX32 ENSG00000196378 "Zinc finger protein 34" Q8IZ26 8 144772224-144787345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053925, HPA060755, HPA066805" Uncertain Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA053925: AB_2682311, HPA060755: AB_2684354, HPA066805: AB_2685725" "unprognostic (2.54e-1)" "unprognostic (3.50e-1)" "unprognostic (5.01e-2)" "unprognostic (7.60e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-2)" "unprognostic (3.26e-2)" "unprognostic (3.54e-2)" "unprognostic (2.85e-2)" "unprognostic (1.40e-2)" "unprognostic (9.84e-3)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (5.80e-2)" "unprognostic (2.09e-3)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" 9.3 4.2 8.5 2.8 9.3 3.3 8.6 12.8 10.5 10.4 8.1 10.2 2.2 9.1 4.7 3.8 10.0 3.6 5.8 8.6 9.4 6.0 5.0 5.5 3.9 9.0 9.0 10.8 5.1 6.2 9.7 4.7 9.6 7.5 3.6 12.4 4.5 7.3 6.3 8.1 5.6 6.6 8.4 4.9 5.6 6.4 9.0 5.4 8.2 6.4 3.0 9.1 7.4 10.9 2.1 3.0 5.7 4.7 4.7 4.8 1.4 1.8 4.1 4.6 3.8 0.8 3.3 3.1 3.4 4.9 2.6 2.0 3.4 3.9 3.6 2.9 2.8 6.3 5.4 2.7 4.3 1.8 3.4 4.8 4.4 3.5 7.7 5.0 3.2 2.0 4.2 2.6 4.1 5.0 3.8 2.7 3.9 4.7 3.3 3.3 2.1 4.1 2.6 2.2 5.6 4.0 4.1 3.0 3.1 3.6 3.2 2.3 2.0 4.3 3.9 3.4 3.9 3.4 1.2 3.9 3.1 2.7 5.1 8.2 6.7 12.9 6.6 6.5 5.7 7.2 6.2 7.8 10.2 7.4 4.3 6.5 1.0 6.1 16.3 4.8 5.1 4.8 8.5 9.3 12.8 10.5 8.6 9.4 9.0 9.0 9.6 8.4 9.0 10.9 17.2 6.4 5.1 3.3 5.5 3.7 2.8 3.9 5.2 7.8 4.6 9.1 3.0 1.5 3.9 0.0 0.0 2.7 2.4 1.4 5.9 3.0 10.6 3.2 7.7 7.9 0.0 1.7 4.8 1.3 3.1 6.7 1.1 4.9 5.1 3.8 2.9 2.1 1.8 13.5 6.2 1.7 6.1 1.2 4.5 7.9 7.2 4.1 3.6 2.8 8.2 6.2 2.1 3.0 8.2 1.1 3.2 4.9 2.7 2.0 2.8 2.3 1.1 9.1 6.6 8.5 7.5 16.4 9.9 8.4 4.8 2.3 4.9 4.2 2.3 0.9 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99473877-99504857 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 97.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Approved Enhanced Nucleoplasm,Cytosol Yes No "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favorable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.09e-4)" 13.3 9.6 8.6 10.3 9.5 97.0 12.5 16.4 8.3 11.9 8.8 12.5 10.3 10.4 6.9 12.6 12.5 7.3 12.2 7.7 9.0 10.4 10.1 13.3 13.6 9.8 9.1 13.9 9.7 7.7 9.4 8.1 9.0 13.5 8.6 5.4 10.2 7.7 12.2 15.4 14.3 7.8 8.5 19.2 11.5 10.6 9.4 12.8 10.2 9.6 11.3 11.9 12.2 10.6 10.3 10.2 6.6 14.0 10.4 7.1 13.1 8.5 11.6 9.9 9.7 11.0 11.0 12.4 12.2 9.2 13.5 9.6 9.2 11.2 9.8 9.1 12.0 12.2 12.0 12.1 8.3 17.4 20.0 9.4 9.6 9.6 10.2 7.3 11.6 10.5 17.6 24.0 9.3 19.6 18.3 28.8 15.0 12.9 12.0 10.2 7.3 22.1 11.0 14.7 7.8 16.5 10.2 24.6 16.9 16.5 6.4 21.8 11.9 11.7 12.0 17.4 10.9 19.7 22.1 20.0 8.5 17.4 12.9 56.8 20.6 36.6 31.7 25.5 33.2 24.5 31.8 34.3 22.6 23.6 38.5 30.8 37.8 36.8 26.8 32.8 37.7 24.6 8.6 9.5 16.4 8.3 7.7 9.0 9.8 9.1 9.0 8.5 9.4 10.6 29.3 16.0 19.7 5.2 37.1 35.6 36.1 16.4 16.5 9.7 20.6 14.6 11.4 8.6 16.6 11.0 12.5 15.8 56.7 26.3 17.6 15.7 10.4 17.3 12.9 22.2 20.8 31.5 4.6 14.1 18.2 17.5 25.0 24.4 58.9 17.1 17.5 12.3 18.9 15.2 5.0 16.9 8.2 25.5 29.6 2.9 15.5 29.3 28.4 1.9 19.3 13.6 45.3 7.1 5.6 16.4 20.8 13.5 31.8 29.2 29.7 11.7 19.4 11.7 13.1 22.6 19.7 41.9 30.6 21.5 35.5 29.7 54.3 24.6 18.6 65.6 ZNF444 "EZF2, FLJ11137, ZSCAN17" ENSG00000167685 "Zinc finger protein 444" Q8N0Y2 19 56132599-56160893 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 118.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056895, HPA065203" Approved Enhanced Nucleoplasm,Nucleoli Yes No "Cluster 26: Non-specific - Mitochondria" "Cluster 22: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA056895: AB_2683267, HPA065203: AB_2685431" "unprognostic (1.58e-1)" "unprognostic (3.34e-1)" "unprognostic (5.00e-2)" "unprognostic (1.23e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (1.32e-2)" "unprognostic (2.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.29e-2)" "unprognostic (1.35e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.70e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.87e-4)" 13.2 23.4 33.8 6.3 31.4 3.2 15.8 28.3 36.3 24.1 31.3 32.5 11.4 24.9 7.7 16.5 26.1 9.3 23.9 30.5 30.2 23.7 64.3 18.1 5.7 38.6 32.4 26.0 46.4 7.8 29.3 4.8 31.4 35.2 4.2 5.7 21.6 19.6 18.6 14.6 19.0 5.9 29.1 17.7 32.0 21.3 32.6 16.0 28.8 7.0 4.4 25.8 17.7 32.1 11.3 21.1 19.0 16.7 8.0 8.1 12.5 14.0 9.2 11.7 12.6 23.1 12.4 19.7 12.2 8.1 5.9 10.3 11.8 9.5 4.9 17.3 118.4 19.6 15.3 42.4 13.0 8.7 17.4 9.5 8.5 9.5 7.3 17.6 10.6 24.1 25.7 8.6 8.3 14.6 28.4 24.4 20.5 22.3 38.2 32.7 12.3 10.7 13.0 10.2 20.4 28.0 7.1 23.2 11.2 10.3 23.2 15.7 14.4 20.8 18.2 4.6 15.6 20.5 18.9 15.1 13.1 11.8 13.9 1.9 1.1 2.4 2.3 0.9 2.5 1.2 4.0 4.0 1.2 2.3 4.0 2.7 0.1 2.2 0.6 2.1 2.9 1.4 33.8 31.4 28.3 36.3 30.5 30.2 38.6 32.4 31.4 29.1 32.6 32.1 12.2 3.2 18.1 26.1 11.0 3.1 17.4 15.3 5.2 17.9 13.9 11.8 13.9 28.6 17.6 11.0 8.4 18.8 5.6 15.6 9.8 26.4 28.6 16.2 8.9 15.1 29.3 6.1 10.0 21.9 9.7 10.0 20.9 9.2 10.2 16.8 18.5 38.9 10.7 20.2 10.0 28.0 20.3 7.2 6.1 39.2 12.2 5.5 16.0 5.6 13.6 17.7 12.3 14.6 19.0 18.3 9.9 12.0 8.6 13.5 18.7 26.9 18.3 13.4 26.3 8.5 12.6 13.6 25.6 3.4 5.3 12.4 11.2 43.4 22.9 11.0 ZNF597 "FLJ33071, HIT-4" ENSG00000167981 "Zinc finger protein 597" Q96LX8 16 3432414-3443504 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 8.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001556 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 1: Thyroid gland - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA001556: AB_1080740" "unprognostic (1.98e-1)" "unprognostic (8.07e-2)" "unprognostic (1.03e-1)" "unprognostic (9.15e-3)" "unprognostic (2.88e-1)" "unprognostic (6.16e-2)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.34e-1)" "unprognostic (8.75e-3)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (4.58e-1)" "unprognostic (2.89e-1)" "unprognostic (5.99e-3)" 1.6 1.9 1.1 1.5 1.1 1.9 1.7 1.0 1.3 1.4 0.8 1.1 1.2 1.5 2.1 1.1 1.4 1.9 1.3 1.0 1.5 1.3 1.7 2.4 2.1 0.9 1.1 2.0 1.6 1.4 1.3 2.3 1.0 1.4 1.0 2.3 1.1 1.2 0.7 1.3 1.3 1.2 1.0 1.8 1.2 3.9 1.4 1.5 2.0 1.1 1.8 1.6 0.9 1.2 0.0 1.2 1.5 3.7 1.1 1.7 5.9 1.8 2.2 1.7 2.1 0.0 2.3 3.1 1.7 2.0 1.3 1.0 3.5 1.6 2.2 1.9 1.4 5.3 3.6 2.2 1.6 3.2 3.1 2.2 2.5 1.9 2.1 1.7 4.7 1.6 1.1 2.0 2.0 1.0 2.3 3.3 5.0 1.4 0.0 1.4 4.5 2.1 1.4 4.9 2.0 2.8 3.5 1.8 1.4 4.1 1.5 4.7 3.1 2.8 1.4 0.0 1.7 2.6 2.9 0.4 0.0 1.8 1.7 3.1 0.8 8.8 0.9 1.7 1.5 0.9 0.7 0.8 0.8 0.7 1.2 0.9 0.2 0.7 0.8 0.4 1.2 0.6 1.1 1.1 1.0 1.3 1.0 1.5 0.9 1.1 1.0 1.0 1.4 1.2 8.3 25.6 2.6 0.0 4.3 0.1 1.8 0.3 2.8 2.1 4.3 3.8 1.9 1.5 5.2 1.8 0.0 1.2 3.6 1.4 0.0 1.1 8.1 3.8 2.1 4.2 2.4 0.4 2.9 1.0 1.8 2.6 1.5 4.5 3.8 3.0 2.5 1.4 1.2 0.0 1.9 2.1 0.0 1.0 0.7 4.1 1.2 2.7 0.0 4.7 3.0 1.8 0.0 1.0 2.0 1.8 1.0 2.2 2.1 2.4 0.7 1.3 0.9 3.1 6.6 2.7 2.6 5.3 8.0 1.9 0.4 1.5 3.3 1.1 2.4 2.3 ZNF777 KIAA1285 ENSG00000196453 "Zinc finger protein 777" Q9ULD5 7 149431363-149461062 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003252 Approved Approved Nucleoplasm NA NA "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA003252: AB_1080755" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (3.37e-2)" "unprognostic (4.78e-2)" "unprognostic (6.64e-2)" "unprognostic (5.87e-3)" "unprognostic (4.52e-2)" "unprognostic (1.10e-1)" "unprognostic (6.15e-2)" "unprognostic (5.17e-3)" "unprognostic (2.64e-1)" "unprognostic (4.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.68e-1)" "unprognostic (8.23e-2)" "unprognostic (5.72e-2)" 7.5 6.6 5.9 4.4 5.4 7.9 7.7 5.8 7.0 8.7 2.3 9.0 4.5 10.4 3.3 6.2 8.4 3.6 7.1 6.0 6.3 6.2 7.3 5.3 5.1 5.9 5.3 10.0 7.5 6.4 8.5 4.9 5.1 8.9 3.3 3.4 7.5 5.2 13.9 11.7 6.3 5.2 4.7 6.7 7.3 6.7 5.9 5.7 7.3 7.0 3.9 9.0 7.9 5.5 14.9 18.0 11.9 17.3 8.7 7.0 15.3 9.4 9.9 12.5 10.8 11.3 9.3 9.4 18.5 10.7 7.7 9.7 11.7 14.3 6.8 15.3 17.8 9.2 5.0 11.4 14.7 13.2 12.9 8.3 16.1 10.1 14.6 6.6 6.8 12.4 30.2 0.0 7.2 19.2 27.9 18.0 14.5 6.6 10.5 22.7 6.1 19.8 7.7 11.4 12.9 18.1 16.2 16.5 15.7 4.3 7.8 21.7 10.7 10.4 4.1 20.8 15.5 8.6 8.2 4.4 7.8 9.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.9 5.4 5.8 7.0 6.0 6.3 5.9 5.3 5.1 4.7 5.9 5.5 4.0 0.0 1.7 5.9 3.8 1.1 1.4 0.3 2.8 6.5 3.9 5.5 2.9 2.8 0.1 1.8 6.2 2.0 4.2 3.1 0.0 1.2 2.6 2.9 4.8 2.9 1.8 6.6 6.9 1.0 3.8 2.8 2.0 4.5 0.0 8.2 2.9 5.7 1.6 1.7 6.7 3.1 0.0 2.2 1.3 3.8 2.8 2.0 0.0 4.7 0.2 5.5 2.1 3.0 3.5 1.1 3.1 3.4 1.6 2.4 1.4 1.6 0.8 5.5 0.0 5.2 3.7 1.5 4.6 2.5 1.8 3.8 3.5 6.6 2.8 1.0 ZNF837 ENSG00000152475 "Zinc finger protein 837" Q96EG3 19 58367618-58381030 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 9.3" HPA042833 Uncertain Approved Nucleoli NA NA "Cluster 32: T-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoli "HPA042833: AB_10806373" "unprognostic (2.61e-1)" "unprognostic (7.62e-2)" "unprognostic (1.33e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.07e-1)" "unprognostic (7.33e-3)" "unprognostic (1.02e-2)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" "unprognostic (1.92e-2)" "unprognostic (2.37e-3)" "unprognostic (6.02e-2)" "prognostic favorable (1.76e-5)" "unprognostic (2.35e-3)" "unprognostic (9.74e-2)" "unprognostic (1.90e-2)" "unprognostic (1.07e-2)" 1.2 2.5 0.8 0.4 0.8 0.1 1.7 0.6 0.8 2.3 1.8 1.7 0.9 2.4 0.0 2.4 3.1 0.1 0.6 0.7 0.8 3.2 4.9 1.0 0.4 2.1 2.3 2.8 3.0 0.5 2.9 0.1 1.1 2.8 0.1 0.9 2.4 0.3 0.3 3.1 1.9 0.1 1.5 2.2 2.0 2.1 0.9 0.5 4.1 0.0 0.2 1.5 1.8 1.3 1.5 0.7 0.9 1.0 0.1 0.3 1.6 1.4 0.3 0.0 0.1 0.3 1.5 1.8 1.2 0.0 0.6 0.4 0.1 0.0 0.0 0.9 9.3 0.8 0.2 0.1 0.3 0.6 0.5 0.5 0.3 0.1 0.1 0.3 0.1 2.3 1.1 0.5 0.1 2.0 4.2 1.7 2.4 0.6 2.4 3.6 0.4 1.8 0.2 1.1 2.8 3.6 1.1 0.9 1.7 0.1 1.1 0.8 0.4 2.1 0.1 0.6 0.5 2.2 1.8 1.6 1.3 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.8 0.6 0.8 0.7 0.8 2.1 2.3 1.1 1.5 0.9 1.3 1.1 3.2 1.8 0.0 3.2 0.9 1.2 2.2 6.2 2.6 2.9 3.2 1.4 1.5 1.7 3.7 0.0 1.7 0.4 2.3 7.9 4.3 4.3 2.3 1.8 1.4 1.2 0.8 1.1 5.2 1.2 1.6 2.6 2.0 0.0 4.8 1.8 4.0 1.0 1.7 1.0 3.2 4.1 0.8 0.3 0.6 1.8 0.8 3.6 0.0 3.0 2.2 4.1 2.5 1.1 2.9 2.4 1.2 0.3 2.5 3.0 6.8 0.6 0.6 0.0 2.1 1.8 2.5 5.8 2.6 1.7 2.2 2.0 4.7 2.8 1.1 ZRSR2 "U2AF1-RS2, U2AF1L2, URP, ZC3H22" ENSG00000169249 "Zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2" Q15696 X 15790472-15823260 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "prognostic favorable (7.96e-4)" "unprognostic (1.54e-2)" "unprognostic (7.31e-2)" "prognostic favorable (8.50e-5)" "unprognostic (8.08e-2)" "unprognostic (1.69e-1)" "unprognostic (6.14e-3)" "unprognostic (5.72e-3)" "unprognostic (8.46e-2)" "unprognostic (3.47e-3)" "unprognostic (6.90e-2)" "unprognostic (2.85e-2)" "prognostic unfavorable (4.87e-5)" "unprognostic (8.14e-2)" "unprognostic (3.04e-1)" "unprognostic (1.65e-2)" "prognostic favorable (2.97e-4)" 15.2 12.1 25.7 17.3 25.1 42.7 16.2 28.8 36.1 24.3 26.5 22.9 11.0 21.3 20.2 13.4 20.2 10.2 17.2 24.4 27.5 16.2 13.3 20.1 29.0 25.9 24.9 22.2 14.3 13.0 24.1 10.8 24.9 18.1 12.5 22.2 13.9 11.9 20.4 15.4 19.8 17.0 23.2 31.8 14.8 5.6 26.0 21.9 17.4 13.1 20.2 18.1 20.1 26.3 14.3 8.9 15.6 14.7 21.9 18.4 6.1 11.4 10.5 10.8 11.0 11.3 11.3 16.1 19.2 10.6 28.3 13.7 15.6 19.9 11.0 12.3 20.0 10.4 22.8 10.1 14.8 24.4 23.9 9.2 17.7 20.0 32.4 21.3 18.9 15.5 17.0 15.3 12.9 17.5 13.0 25.4 20.1 7.5 12.7 15.1 22.0 16.4 12.9 11.0 10.6 11.8 26.7 23.5 17.7 21.4 18.4 13.6 13.2 10.7 7.8 28.7 11.0 12.9 11.7 15.0 8.2 17.0 14.2 38.7 25.7 24.0 17.3 22.6 17.2 34.9 21.6 23.2 15.1 37.2 26.1 18.5 26.9 14.3 22.9 24.6 24.3 10.5 25.7 25.1 28.8 36.1 24.4 27.5 25.9 24.9 24.9 23.2 26.0 26.3 16.7 9.6 17.4 12.1 35.6 11.3 10.2 16.6 12.0 15.3 13.8 12.1 23.9 5.7 17.2 16.5 14.6 6.8 42.3 14.0 23.5 12.8 1.1 27.7 14.3 14.2 16.8 9.9 15.5 14.9 10.2 11.5 4.6 14.1 32.3 9.7 11.0 13.8 19.1 8.4 17.9 16.9 22.4 33.5 19.6 1.6 13.7 25.6 12.4 14.0 30.5 9.6 37.0 10.1 13.7 13.1 8.2 16.6 18.8 7.0 17.3 17.7 23.7 19.5 19.7 13.8 16.2 6.4 8.3 7.8 10.5 7.3 32.2 9.3 13.4 8.0 ZSWIM9 "C19orf68, LOC374920" ENSG00000185453 "Zinc finger SWIM-type containing 9" Q86XI8 19 48170680-48197620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2" "Cell type enhanced" "Detected in many" "Adipocytes: 6.1;Granulosa cells: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061028 Uncertain Approved Nucleoplasm NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA061028: AB_2684419" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (5.79e-3)" "unprognostic (1.65e-1)" "unprognostic (8.49e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.35e-5)" "unprognostic (1.26e-1)" "unprognostic (2.93e-1)" "unprognostic (6.96e-2)" "unprognostic (3.19e-3)" "unprognostic (2.20e-2)" "prognostic favorable (2.44e-4)" "unprognostic (3.59e-1)" "unprognostic (2.64e-1)" "unprognostic (7.07e-2)" "unprognostic (1.03e-1)" 3.8 2.4 17.0 2.2 15.6 2.4 3.2 10.1 14.4 5.3 7.4 6.9 2.2 6.1 0.8 4.1 4.9 1.2 5.3 13.6 13.3 2.9 2.6 3.0 2.5 18.2 14.8 5.6 4.6 2.6 3.6 1.7 13.3 4.2 1.3 1.6 3.5 2.5 9.1 5.4 4.0 2.2 12.5 3.6 3.9 4.0 13.8 1.9 4.3 2.8 1.4 6.1 4.7 14.2 9.5 10.4 6.1 4.5 3.9 2.2 5.5 7.2 3.8 3.3 3.8 1.7 3.0 7.6 3.4 3.3 4.1 7.8 2.0 4.4 3.6 11.5 7.6 4.8 7.0 4.4 4.2 4.4 3.9 2.3 3.5 4.8 5.7 5.9 3.4 6.0 1.2 4.0 2.1 5.1 4.8 18.5 3.8 8.9 6.6 8.9 5.5 2.1 2.3 7.7 4.2 5.2 10.0 3.1 5.0 3.7 4.3 6.6 8.6 3.9 7.1 3.3 7.9 6.5 7.0 4.5 2.3 6.2 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 15.6 10.1 14.4 13.6 13.3 18.2 14.8 13.3 12.5 13.8 14.2 6.1 3.2 3.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.3 5.5 0.0 0.0 0.6 3.7 0.0 5.6 2.2 0.0 3.9 4.1 0.0 3.2 5.6 2.4 0.0 0.0 0.0 5.8 2.8 2.4 0.0 5.5 2.5 11.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.7 0.0 0.0 2.4 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.7 1.7 5.8 0.0 0.0 ZUP1 "C6orf113, dJ412I7.3, ZUFSP" ENSG00000153975 "Zinc finger containing ubiquitin peptidase 1" Q96AP4 6 116635618-116668794 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 10.4;dendritic cells: 12.8;monocytes: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044426 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA044426: AB_10960887" "unprognostic (2.28e-3)" "unprognostic (2.45e-3)" "unprognostic (3.91e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (3.27e-1)" "unprognostic (5.88e-2)" "unprognostic (2.83e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (1.90e-3)" "unprognostic (2.54e-2)" "unprognostic (1.48e-1)" "unprognostic (7.33e-2)" "unprognostic (7.92e-3)" 4.4 4.5 4.2 6.2 4.7 13.5 5.6 7.2 6.3 4.0 3.0 5.1 10.5 3.6 4.1 5.6 3.1 5.5 2.7 4.3 4.6 4.6 4.3 5.0 8.7 4.4 4.4 2.5 5.7 4.2 3.9 5.3 4.6 5.0 5.7 6.0 3.8 4.0 3.1 5.5 7.1 4.1 4.5 6.0 4.7 6.1 4.7 7.5 4.6 3.3 8.7 6.1 4.1 5.9 6.6 6.3 13.9 26.2 7.9 10.3 10.4 14.0 13.3 13.5 16.3 11.5 7.3 23.3 11.6 8.9 15.2 10.3 15.8 10.1 17.9 14.0 18.1 18.0 9.5 20.0 12.3 21.1 21.3 9.2 15.7 11.0 18.7 10.0 12.5 17.4 32.1 11.6 17.9 10.7 10.2 16.0 10.3 9.9 6.8 13.9 12.1 9.6 15.0 6.6 12.1 14.0 10.0 8.3 8.6 11.8 4.9 15.9 10.7 8.6 5.8 5.3 11.9 10.7 14.9 24.0 7.7 12.8 12.8 19.5 7.5 7.6 7.0 8.9 8.2 9.5 7.9 8.1 10.1 10.4 8.6 6.4 2.9 8.3 11.0 6.9 11.7 6.5 4.2 4.7 7.2 6.3 4.3 4.6 4.4 4.4 4.6 4.5 4.7 5.9 6.7 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 5.3 5.2 0.0 0.0 0.0 1.8 0.0 10.4 12.8 0.0 9.8 9.7 0.0 7.4 8.7 2.2 0.0 0.0 0.0 8.0 8.3 2.2 0.0 8.4 0.0 10.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 12.4 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 9.3 4.4 6.0 0.0 0.0